{"doi":"10.3310\/hta12260","coreId":"177072","oai":"oai:aura.abdn.ac.uk:2164\/246","identifiers":["oai:aura.abdn.ac.uk:2164\/246","10.3310\/hta12260"],"title":"Systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip","authors":["De Verteuil, Robyn","Imamura, Mari","Zhu, S.","Glazener, Cathryn Margaret Anne","Fraser, Cynthia Mary","Munro, N.","Hutchison, James Douglas","Grant, Adrian Maxwell","Coyle, D.","Coyle, K.","Vale, Luke David"],"enrichments":{"references":[{"id":10521,"title":"1 Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer\u2019s disease: a rapid and systematic","authors":[],"date":"2001","doi":null,"raw":"By Griffiths CEM, Clark CM, Chalmers RJG, Li Wan Po A, Williams HC. Volume 5, 2001 No. 1 Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer\u2019s disease: a rapid and systematic review. By Clegg A, Bryant J, Nicholson T, McIntyre L, De Broe S, Gerard K, et al. No. 2 The clinical effectiveness and costeffectiveness of riluzole for motor neurone disease: a rapid and systematic review. By Stewart A, Sandercock J, Bryan S, Hyde C, Barton PM, Fry-Smith A, et al. No. 3 Equity and the economic evaluation of healthcare. By Sassi F, Archard L, Le Grand J. No. 4 Quality-of-life measures in chronic diseases of childhood. By Eiser C, Morse R. No. 5 Eliciting public preferences for healthcare: a systematic review of techniques. By Ryan M, Scott DA, Reeves C, Bate A, van Teijlingen ER, Russell EM, et al. No. 6 General health status measures for people with cognitive impairment: learning disability and acquired brain injury. By Riemsma RP, Forbes CA, Glanville JM, Eastwood AJ, Kleijnen J. No. 7 An assessment of screening strategies for fragile X syndrome in the UK. By Pembrey ME, Barnicoat AJ, Carmichael B, Bobrow M, Turner G. No. 8 Issues in methodological research: perspectives from researchers and commissioners. By Lilford RJ, Richardson A, Stevens A, Fitzpatrick R, Edwards S, Rock F, et al. No. 9 Systematic reviews of wound care management: (5) beds; (6) compression; (7) laser therapy, therapeutic ultrasound, electrotherapy and electromagnetic therapy. By Cullum N, Nelson EA, Flemming K, Sheldon T. No. 10 Effects of educational and psychosocial interventions for adolescents with diabetes mellitus: a systematic review. By Hampson SE, Skinner TC, Hart J, Storey L, Gage H, Foxcroft D, et al. No. 11 Effectiveness of autologous chondrocyte transplantation for hyaline cartilage defects in knees: a rapid and systematic review. By Jobanputra P, Parry D, Fry-Smith A, Burls A. No. 12 Statistical assessment of the learning curves of health technologies. By Ramsay CR, Grant AM, Wallace SA, Garthwaite PH, Monk AF, Russell IT. No. 13 The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review. By Dinnes J, Cave C, Huang S, Major K, Milne R. No. 14 A rapid and systematic review of the clinical effectiveness and costeffectiveness of debriding agents in treating surgical wounds healing by secondary intention. By Lewis R, Whiting P, ter Riet G, O\u2019Meara S, Glanville J. No. 15 Home treatment for mental health problems: a systematic review. By Burns T, Knapp M, Catty J, Healey A, Henderson J, Watt H, et al. No. 16 How to develop cost-conscious guidelines. By Eccles M, Mason J. No. 17 The role of specialist nurses in multiple sclerosis: a rapid and systematic review. By De Broe S, Christopher F, Waugh N. No. 18 A rapid and systematic review of the clinical effectiveness and costeffectiveness of orlistat in the management of obesity. By O\u2019Meara S, Riemsma R, Shirran L, Mather L, ter Riet G. No. 19 The clinical effectiveness and costeffectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review. By Chilcott J, Wight J, Lloyd Jones M, Tappenden P. No. 20 Extended scope of nursing practice: a multicentre randomised controlled trial of appropriately trained nurses and preregistration house officers in preoperative assessment in elective general surgery. By Kinley H, Czoski-Murray C, George S, McCabe C, Primrose J, Reilly C, et al. No. 21 Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) Acute day hospital versus admission; (2) Vocational rehabilitation; (3) Day hospital versus outpatient care. By Marshall M, Crowther R, AlmarazSerrano A, Creed F, Sledge W, Kluiter H, et al. No. 22 The measurement and monitoring of surgical adverse events. By Bruce J, Russell EM, Mollison J, Krukowski ZH. No. 23 Action research: a systematic review and guidance for assessment. By Waterman H, Tillen D, Dickson R, de Koning K. No. 24 A rapid and systematic review of the clinical effectiveness and costeffectiveness of gemcitabine for the treatment of pancreatic cancer. By Ward S, Morris E, Bansback N, Calvert N, Crellin A, Forman D, et al. Health Technology Assessment reports published to date 228No. 25 A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. By Lloyd Jones M, Hummel S, Bansback N, Orr B, Seymour M. No. 26 Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. By Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. No. 27 The cost-effectiveness of magnetic resonance imaging for investigation of the knee joint. By Bryan S, Weatherburn G, Bungay H, Hatrick C, Salas C, Parry D, et al. No. 28 A rapid and systematic review of the clinical effectiveness and costeffectiveness of topotecan for ovarian cancer. By Forbes C, Shirran L, Bagnall A-M, Duffy S, ter Riet G. No. 29 Superseded by a report published in a later volume. No. 30 The role of radiography in primary care patients with low back pain of at least 6 weeks duration: a randomised (unblinded) controlled trial. By Kendrick D, Fielding K, Bentley E, Miller P, Kerslake R, Pringle M. No. 31 Design and use of questionnaires: a review of best practice applicable to surveys of health service staff and patients. By McColl E, Jacoby A, Thomas L, Soutter J, Bamford C, Steen N, et al. No. 32 A rapid and systematic review of the clinical effectiveness and costeffectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in nonsmall-cell lung cancer. By Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N. No. 33 Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. By Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G. No. 34 Depot antipsychotic medication in the treatment of patients with schizophrenia: (1) Meta-review; (2) Patient and nurse attitudes. By David AS, Adams C. No. 35 A systematic review of controlled trials of the effectiveness and costeffectiveness of brief psychological treatments for depression. By Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A, et al. No. 36 Cost analysis of child health surveillance.","cites":null},{"id":10523,"title":"19 Clinical effectiveness and costeffectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10532,"title":"2 \u2018Cut down to quit\u2019 with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10487,"title":"2007;22:48\u201356. Secondary reference Duwelius PJ. Two-incision minimally invasive total hip arthroplasty: techniques and results to date. Instr Course Lect 2006;55:215\u201322. Duwelius,","authors":[],"date":"2003","doi":"10.1053\/j.sart.2004.08.002","raw":"J Arthroplasty 2007;22:48\u201356. Secondary reference Duwelius PJ. Two-incision minimally invasive total hip arthroplasty: techniques and results to date. Instr Course Lect 2006;55:215\u201322. Duwelius, 2003 Primary reference Duwelius PJ, Berger RA, Hartzband MA, Mears DC. Two-incision minimally invasive total hip arthroplasty: operative technique and early results from four centers.","cites":null},{"id":10480,"title":"23rd Annual Meeting,","authors":[],"date":"2005","doi":"10.1159\/000086600","raw":"23rd Annual Meeting, Amelia Island, FL, April 2005.","cites":null},{"id":10528,"title":"4 A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery. By Whiting","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10530,"title":"5 A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. By","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10476,"title":"A prospective randomized patient-blinded comparison of mini versus standard incision THA.","authors":[],"date":"2005","doi":null,"raw":"111. Wright JM, Rosse D, Rosse S. A prospective randomized patient-blinded comparison of mini versus standard incision THA. Annual Meeting of the American Academy of Orthopaedic Surgeons, Washington, DC, March 2005. Paper No. 139.","cites":null},{"id":10516,"title":"A review by","authors":[],"date":"2000","doi":null,"raw":"A review by Lord J, Victor C, Littlejohns P, Ross FM, Axford JS. Volume 4, 2000 No. 1 The estimation of marginal time preference in a UK-wide sample (TEMPUS) project. A review by Cairns JA, van der Pol MM. No. 2 Geriatric rehabilitation following fractures in older people: a systematic review. By Cameron I, Crotty M, Currie C, Finnegan T, Gillespie L, Gillespie W, et al. Health Technology Assessment reports published to date 226No. 3 Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research. By Davies SC, Cronin E, Gill M, Greengross P, Hickman M, Normand C. No. 4 Community provision of hearing aids and related audiology services. A review by Reeves DJ, Alborz A, Hickson FS, Bamford JM. No. 5 False-negative results in screening programmes: systematic review of impact and implications. By Petticrew MP, Sowden AJ, Lister-Sharp D, Wright K. No. 6 Costs and benefits of community postnatal support workers: a randomised controlled trial. By Morrell CJ, Spiby H, Stewart P, Walters S, Morgan A. No. 7 Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness. By French RS, Cowan FM, Mansour DJA, Morris S, Procter T, Hughes D, et al. No. 8 An introduction to statistical methods for health technology assessment. A review by White SJ, Ashby D, Brown PJ. No. 9 Disease-modifying drugs for multiple sclerosis: a rapid and systematic review. By Clegg A, Bryant J, Milne R. No. 10 Publication and related biases. A review by Song F, Eastwood AJ, Gilbody S, Duley L, Sutton AJ. No. 11 Cost and outcome implications of the organisation of vascular services. By Michaels J, Brazier J, Palfreyman S, Shackley P, Slack R. No. 12 Monitoring blood glucose control in diabetes mellitus: a systematic review. By Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R. No. 13 The effectiveness of domiciliary health visiting: a systematic review of international studies and a selective review of the British literature. By Elkan R, Kendrick D, Hewitt M, Robinson JJA, Tolley K, Blair M, et al. No. 14 The determinants of screening uptake and interventions for increasing uptake: a systematic review. By Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. No. 15 The effectiveness and cost-effectiveness of prophylactic removal of wisdom teeth. A rapid review by Song F, O\u2019Meara S, Wilson P, Golder S, Kleijnen J. No. 16 Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, cost-effectiveness and women\u2019s views. By Bricker L, Garcia J, Henderson J, Mugford M, Neilson J, Roberts T, et al. No. 17 A rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer. By Lister-Sharp D, McDonagh MS, Khan KS, Kleijnen J. No. 18 Liquid-based cytology in cervical screening: a rapid and systematic review. By Payne N, Chilcott J, McGoogan E. No. 19 Randomised controlled trial of nondirective counselling, cognitive\u2013behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care. By King M, Sibbald B, Ward E, Bower P, Lloyd M, Gabbay M, et al. No. 20 Routine referral for radiography of patients presenting with low back pain: is patients\u2019 outcome influenced by GPs\u2019 referral for plain radiography? By Kerry S, Hilton S, Patel S, Dundas D, Rink E, Lord J. No. 21 Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration. By O\u2019Meara S, Cullum N, Majid M, Sheldon T. No. 22 Using routine data to complement and enhance the results of randomised controlled trials. By Lewsey JD, Leyland AH, Murray GD, Boddy FA. No. 23 Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review. By Meads C, Cummins C, Jolly K, Stevens A, Burls A, Hyde C. No. 24 Outcome measures for adult critical care: a systematic review. By Hayes JA, Black NA, Jenkinson C, Young JD, Rowan KM, Daly K, et al. No. 25 A systematic review to evaluate the effectiveness of interventions to promote the initiation of breastfeeding. By Fairbank L, O\u2019Meara S, Renfrew MJ, Woolridge M, Sowden AJ, Lister-Sharp D. No. 26 Implantable cardioverter defibrillators: arrhythmias. A rapid and systematic review. By Parkes J, Bryant J, Milne R. No. 27 Treatments for fatigue in multiple sclerosis: a rapid and systematic review. By Bra\u00f1as P, Jordan R, Fry-Smith A, Burls A, Hyde C. No. 28 Early asthma prophylaxis, natural history, skeletal development and economy (EASE): a pilot randomised controlled trial. By Baxter-Jones ADG, Helms PJ, Russell G, Grant A, Ross S, Cairns JA, et al. No. 29 Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. By Marks D, Wonderling D, Thorogood M, Lambert H, Humphries SE, Neil HAW. No. 30 A rapid and systematic review of the clinical effectiveness and costeffectiveness of glycoprotein IIb\/IIIa antagonists in the medical management of unstable angina. By McDonagh MS, Bachmann LM, Golder S, Kleijnen J, ter Riet G. No. 31 A randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. By Turner J, Nicholl J, Webber L, Cox H, Dixon S, Yates D. No. 32 Intrathecal pumps for giving opioids in chronic pain: a systematic review. By Williams JE, Louw G, Towlerton G. No. 33 Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review. By Shepherd J, Waugh N, Hewitson P.","cites":null},{"id":10522,"title":"A study of the methods used to select review criteria for clinical audit. By Hearnshaw","authors":[],"date":"2002","doi":null,"raw":"By Sanderson D, Wright D, Acton C, Duree D. Volume 6, 2002 No. 1 A study of the methods used to select review criteria for clinical audit. By Hearnshaw H, Harker R, Cheater F, Baker R, Grimshaw G. No. 2 Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment. By Hyde C, Wake B, Bryan S, Barton P, Fry-Smith A, Davenport C, et al. No. 3 Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin\u2019s lymphoma: a systematic review and economic evaluation. By Wake B, Hyde C, Bryan S, Barton P, Song F, Fry-Smith A, et al. No. 4 A systematic review of discharge arrangements for older people. By Parker SG, Peet SM, McPherson A, Cannaby AM, Baker R, Wilson A, et al. No. 5 The clinical effectiveness and costeffectiveness of inhaler devices used in the routine management of chronic asthma in older children: a systematic review and economic evaluation. By Peters J, Stevenson M, Beverley C, Lim J, Smith S. No. 6 The clinical effectiveness and costeffectiveness of sibutramine in the management of obesity: a technology assessment. By O\u2019Meara S, Riemsma R, Shirran L, Mather L, ter Riet G. No. 7 The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review. By Berry E, Kelly S, Westwood ME, Davies LM, Gough MJ, Bamford JM, et al. No. 8 Promoting physical activity in South Asian Muslim women through \u2018exercise on prescription\u2019. By Carroll B, Ali N, Azam N. No. 9 Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation. By Burls A, Clark W, Stewart T, Preston C, Bryan S, Jefferson T, et al. No. 10 A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models. By Richards RG, Sampson FC, Beard SM, Tappenden P. No. 11 Screening for gestational diabetes: a systematic review and economic evaluation. By Scott DA, Loveman E, McIntyre L, Waugh N. No. 12 The clinical effectiveness and costeffectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation. By Clegg AJ, Colquitt J, Sidhu MK, Royle P, Loveman E, Walker A. No. 13 The clinical effectiveness of trastuzumab for breast cancer: a systematic review. By Lewis R, Bagnall A-M, Forbes C, Shirran E, Duffy S, Kleijnen J, et al. No. 14 The clinical effectiveness and costeffectiveness of vinorelbine for breast cancer: a systematic review and economic evaluation. By Lewis R, Bagnall A-M, King S, Woolacott N, Forbes C, Shirran L, et al. No. 15 A systematic review of the effectiveness and cost-effectiveness of metal-on-metal hip resurfacing arthroplasty for treatment of hip disease. By Vale L, Wyness L, McCormack K, McKenzie L, Brazzelli M, Stearns SC. No. 16 The clinical effectiveness and costeffectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. By Woolacott NF, Jones L, Forbes CA, Mather LC, Sowden AJ, Song FJ, et al. No. 17 A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept. By Cummins C, Connock M, Fry-Smith A, Burls A. No. 18 Clinical effectiveness and costeffectiveness of growth hormone in children: a systematic review and economic evaluation.","cites":null},{"id":10531,"title":"A systematic review and economic model of switching from nonglycopeptide to glycopeptide antibiotic prophylaxis for surgery.","authors":[],"date":"2008","doi":null,"raw":"By Hanney S, Buxton M, Green C, Coulson D, Raftery J. Volume 12, 2008 No. 1 A systematic review and economic model of switching from nonglycopeptide to glycopeptide antibiotic prophylaxis for surgery.","cites":null},{"id":6013895,"title":"All rights reserved. Appendix 10 Results of meta-analyses Comparison 01: Single mini-incision versus single standard incision (reported means and SDs)","authors":[],"date":"2008","doi":null,"raw":"nHealth Technology Assessment 2008; Vol. 12: No. 26 167 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. Appendix 10 Results of meta-analyses Comparison 01: Single mini-incision versus single standard incision (reported means and SDs) 1\/27 0\/29 0\/60 0\/60 0\/110 0\/109 197     198 2\/50 0\/52 1\/60 0\/60 0\/18 1\/18 0\/38 0\/43 0\/38 0\/21 0\/37 0\/39 7.96 (0.16 to 402.02) Not estimable Not estimable 7.96 (0.16 to 402.02) 7.85 (0.48 to 127.30) 7.39 (0.15 to 372.38) 0.14 (0.00 to 6.82) Not estimable Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  01 Revision rate (number having revision surgery) 01 RCT Chimento  2005  (RCT) Hart  2005  (Q-RCT) Ogonda  2005  (RCT) Subtotal (95% CI) Total events: 1 (Mini-incision), 0 (Standard incision) Test for heterogeneity: not application Test for overall effect: z = 1.04 (p = 0.30) 02 Comparative studies Asayama  2006 Ciminiello  2006 Li  2005 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Wright  2004 Total events: 3 (Mini-incision), 1 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 100.00 100.00 49.74 25.13 25.13 0.001 0.01 0.1 1 10 100 1000 Mini-incision Standard incisionAppendix 10 168 2\/28 0\/32 0\/60 0\/60 1\/60 1\/60 1\/70 1\/70 1\/109 1\/110 0\/20 0\/20 347     352 0\/52 1\/50 0\/99 0\/100 0\/51 0\/95 0\/60 0\/60 0\/33 0\/33 0\/34 0\/53 0\/38 0\/43 0\/38 0\/21 1\/73 4\/54 0\/50 1\/85 0\/42 1\/42 8.84 (0.54 to 145.71) Not estimable 1.00 (0.06 to 16.18) 1.00 (0.06 to 16.15) 1.01 (0.06 to 16.24) Not estimable 1.72 (0.43, 6.92) 0.13 (0.00 to 6.56) Not estimable Not estimable Not estimable Not estimable Not estimable Not estimable Not estimable 0.21 (0.03 to 1.24) 0.20 (0.00 to 11.83) 0.14 (0.00 to 6.82) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  02 Postoperative dislocation rates 01 RCT Chimento  2005  (RCT) Chung  2004  (Q-RCT) Hart  2005  (Q-RCT) Kim  2006  (Q-RCT) Ogonda  2005  (RCT) Shama  2006  (Q-RCT) Subtotal (95% CI) Total events: 5 (Mini-incision), 3 (Standard incision) Test for heterogeneity: 2 = 1.75, df = 3 (p = 0.63), I2 = 0% Test for overall effect: z = 0.76 (p = 0.45) 02 Comparative studies Asayama  2006 Berger  2004 Chen  2006 Ciminiello  2006 DiGioia  2003 O\u2019Brien  2005 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Teet  2006 Woolson  2004 Wright  2004 Total events: 1 (Mini-incision), 7 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 24.72 25.05 25.08 25.15 100.00 13.04 61.74 12.17 13.05 0.01 0.1 1 10 100 Mini-incision Standard incision 0\/60    0\/60 6\/70    5\/70 16\/105 19\/109 235       239 0\/52    0\/50 0\/60    0\/60 4\/38    2\/43 4\/38    3\/21 15\/50 13\/85 0\/42    0\/42 Not estimable 1.22 (0.36 to 4.15) 0.85 (0.41 to 1.76) 0.93 (0.50 to 1.74) Not estimable Not estimable 2.33 (0.44 to 12.21) 0.70 (0.14 to 3.60) 2.43 (1.03 to 5.73) Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  03 Implant position (cup, number poorly placed) 01 RCT Chung  2004  (Q-RCT) Kim  2006  (Q-RCT) Ogonda  2005  (RCT) Subtotal (95% CI) Total events: 22 (Mini-incision), 24 (Standard incision) Test for heterogeneity: 2 = 0.24, df = 1 (p = 0.62), I2 = 0% Test for overall effect: z = 0.21 (p = 0.83) 02 Comparative studies Asayama  2006 Ciminiello  2006 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Woolson  2004 Wright  2004 Total events: 23 (Mini-incision), 18 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 25.77 74.23 100.00 17.39 17.86 64.74 0.1 0.2 0.5 1 2 5 10 Mini-incision Standard incisionHealth Technology Assessment 2008; Vol. 12: No. 26 169 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 1\/28 1\/32 0\/60 0\/60 6\/60 7\/60 4\/70 4\/70 3\/105 8\/109 323     331 0\/52 0\/50 0\/60 0\/60 0\/30 0\/30 1\/34 3\/53 2\/38 2\/43 2\/38 1\/21 4\/73 4\/54 6\/50 3\/85 0\/42 0\/42 1.15 (0.07 to 18.88) Not estimable 0.84 (0.27 to 2.65) 1.00 (0.24 to 4.15) 0.40 (0.12 to 1.34) 0.70 (0.35 to 1.40) Not estimable Not estimable Not estimable 0.54 (0.07 to 4.19) 1.14 (0.15 to 8.42) 1.11 (0.10 to 12.27) 0.72 (0.17 to 3.06) 3.86 (0.96 to 15.59) Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  04 Implant postion (stem, number poorly placed) 01 RCT Chimento  2005  (RCT) Chung  2004  (Q-RCT) Hart  2005  (Q-RCT) Kim  2006  (Q-RCT) Ogonda  2005  (RCT) Subtotal (95% CI) Total events: 14 (Mini-incision), 20 (Standard incision) Test for heterogeneity: 2 = 1.28, df = 3 (p = 0.73), I2 = 0% Test for overall effect: z = 1.01 (p = 0.31) 02 Comparative studies Asayama  2006 Ciminiello  2006 De Beer 2004 O\u2019Brien  2005 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Teet  2006 Woolson  2004 Wright  2004 Total events: 15 (Mini-incision), 13 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 6.17 36.85 23.95 33.04 100.00 14.45 15.07 10.44 29.03 31.02 0.1 0.2 0.5 1 2 5 10 Mini-incision Standard incision 0\/60 0\/60 60     60 1\/60 0\/60 Not estimable Not estimable 7.39 (0.15 to 372.38) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  05 Implant migration 01 RCT Hart 2005 (Q-RCT) Subtotal (95% CI) Total events: 0 (Mini-incision), 0 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Ciminiello  2006 Total events: 1 (Mini-incision), 0 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 100.00 0.001 0.01 0.1 1 10 100 1000 Mini-incision Standard incisionAppendix 10 170 0     0 0\/33 3\/33 0\/10 1\/10 Not estimable 0.13 (0.01 to 1.27) 0.14 (0.00 to 6.82) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  06 Heterotopic ossification (number with ossification) 01 RCT Subtotal (95% CI) Total events: 0 (Mini-incision), 0 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies DiGioia  2003 Takahira Total events: 0 (Mini-incision), 4 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 74.41 25.59 0.1 0.2 0.5 1 2 5 10 Mini-incision Standard incision 3\/27    1\/28 0\/60    0\/60 28\/105 26\/100 192       197 0\/24    0\/25 0\/24    0\/11 0\/12    0\/21 0\/42    0\/42 3.00 (0.40 to 22.53) Not estimable 1.16 (0.63 to 2.15) 1.26 (0.70 to 2.27) Not estimable Not estimable Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  07 Cement quality (number with poor quality) 01 RCT Chimento  2005  (RCT) Hart  2005  (Q-RCT) Ogonda  2005  (RCT) Subtotal (95% CI) Total events: 31 (Mini-incision), 27 (Standard incision) Test for heterogeneity: 2 = 0.78, df = 1 (p = 0.38), I2 = 0% Test for overall effect: z = 0.76 (p = 0.45) 02 Comparative studies Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Woolson  2004 Wright  2004 Total events: 0 (Mini-incision), 0 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 8.52 91.48 100.00 0.1 0.2 0.5 1 2 5 10 Mini-incision Standard incisionHealth Technology Assessment 2008; Vol. 12: No. 26 171 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 0     0 0\/52 0\/50 Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  08 Limb length inequality (number with unequal lengths) 01 RCT Subtotal (95% CI) Total events: 0 (Mini-incision), 0 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Asayama  2006 Total events: 0 (Mini-incision), 0 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 0.1 0.5 1 2 10 Mini-incision Standard incision 20  460.00 (0.00)  20  462.50 (0.00) 28  127.00 (48.00)  32  170.00 (65.00) 60  136.00 (41.10)  60  200.50 (65.20) 60  318.80 (0.00)  60  544.40 (0.00) 70  445.80 (0.00)  70  567.50 (0.00) 109  314.20 (0.00)   110  365.80 (0.00) 347   352 52  217.50 (0.00)  50  247.00 (0.00) 99  154.00 (0.00)  100  278.00 (0.00) 51  175.49 (51.90)  95  293.68 (84.50) 60  201.67 (0.00)   60  191.73 (0.00) 30  180.00 (69.00)  30  246.70 (99.00) 50  387.00 (155.00)  57  469.00 (147.00) 10  699.00 (0.00)  10  540.00 (0.00) 38  244.00 (100.00)  43  265.00 (114.00) 38  244.00 (100.00)  43  304.00 (136.00) 50  603.00 (0.00)  85  507.00 (0.00) 42  151.80 (53.90)  42  173.20 (57.50) Not estimable \u201343.00 (\u201371.69 to \u201314.31) \u201364.50 (\u201384.00 to \u201345.00) Not estimable Not estimable Not estimable \u201357.71 (\u201373.84 to \u201341.58) Not estimable Not estimable \u2013118.19 (\u2013140.36 to \u201396.02) Not estimable \u201366.70 (\u2013109.88 to \u201323.52) \u201382.00 (\u2013139.46 to \u201324.54) Not estimable \u201321.00 (\u201367.60 to 25.60) \u201360.00 (\u2013111.61 to \u20138.39) Not estimable \u201321.40 (\u201345.24 to 2.44) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  09 Blood loss (intraoperative, ml) 01 RCT Charles 2006 (RCT) Chimento 2005 (RCT) Chung 2004 (Q-RCT) Hart 2005 (Q-RCT) Kim 2006 (Q-RCT) Ogonda 2005 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 1.48, df = 1 (p = 0.22), I2 = 32.2% Test for overall effect: z = 7.01 (p < 0.00001) 02 Comparative studies Asayama  2006 Berger  2004 Chen  2006 Ciminiello  2006 de Beer 2004 Howell  2004 Pilot  2006 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight %  31.60 68.40 100.00 37.19 9.81 5.54 8.42 6.87 32.18 \u2013100 \u201350 0 50 100 Mini-incision Standard incision N Mean (SD) N Mean (SD)Appendix 10 172 28  378.00 (151.00)  32  504.00 (205.00) 60  613.30 (0.00)  60  853.70 (0.00) 88   92 51  369.51 (65.05)  95  509.63 (117.39) 18  318.00 (223.00)  18  523.00 (210.70) 38  744.00 (260.00)  43  708.00 (221.00) 38  744.00 (260.00)  21  771.00 (235.00) 10  796.00 (0.00)  10  772.00 (0.00) \u2013126.00 (\u2013216.41 to \u201335.59) Not estimable \u2013126.00 (\u2013216.41 to \u201335.59) \u2013140.12 (\u2013169.72 to \u2013110.52) \u2013205.00 (\u2013346.73 to \u201363.27) 36.00 (\u201369.82 to 141.82) \u201327.00 (\u2013157.14 to 103.14) Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  10 Blood loss (total, ml) 01 RCT Chimento 2005 (RCT) Hart 2005 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: z = 2.73 (p = 0.008) 02 Comparative studies Chen  2006 Li  2005 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Takahira  2006 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 85.21 3.72 6.67 4.41 \u20131000 \u2013500 0 500 1000 Mini-incision Standard incision N Mean (SD) N Mean (SD) 0\/60 0\/60 0\/109 2\/110 169     170 2\/52 0\/50 1\/99 1\/100 2\/50 0\/57 2\/34 1\/53 0\/38 0\/43 0\/38 0\/21 1\/10 0\/10 2\/50 0\/85 Not estimable 0.14 (0.01 to 2.18) 0.14 (0.01 to 2.18) 7.25 (0.45 to 117.60) 1.01 (0.06 to 16.26) 8.67 (0.53 to 141.36) 3.27 (0.31 to 34.22) Not estimable Not estimable 7.39 (0.15 to 372.38) 15.18 (0.85 to 270.70) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  11 Fractures: intraoperative 01 RCT Hart  2005  (Q-RCT) Ogonda  2005  (RCT) Subtotal (95% CI) Total events: 0 (Mini-incision), 2 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: z = 1.41 (p = 0.16) 02 Comparative studies Asayama  2006 Beger  2004 Howell  2004 O\u2019Brien  2005 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Takahira  2006 Woolson  2004 Total events: 10 (Mini-incision), 12 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 100.00 100.00 17.09 17.18 17.03 24.09 8.63 15.98 0.01 0.1 1 10 100 Mini-incision Standard incisionHealth Technology Assessment 2008; Vol. 12: No. 26 173 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 0\/60 0\/60 0\/20 0\/20 80     80 3\/51 4\/95 0\/60 0\/60 1\/30 0\/30 Not estimable Not estimable Not estimable 1.44 (0.29 to 7.03) Not estimable 7.39 (0.15 to 372.38) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  12 Fractures: postoperative 01 RCT Hart  2005  (Q-RCT) Sharma  2006  (Q-RCT) Subtotal (95% CI) Total events: 0 (Mini-incision), 0 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Chen  2006 Chiminiello  2006 de Beer 2004 Total events: 4 (Mini-incision), 4 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 85.92 14.08 0.01 0.1 1 10 100 Mini-incision Standard incision 0\/28 0\/32 0\/60 0\/60 0\/60 0\/60 1\/70 0\/70 2\/109 0\/110 0\/20 0\/20 0\/60 0\/60 407     412 0\/52 1\/50 0\/99 0\/100 0\/60 0\/60 0\/50 1\/57 0\/34 0\/53 0\/38 0\/43 0\/38 0\/21 1\/50 0\/85 0\/42 0\/42 Not estimable Not estimable Not estimable 7.39 (0.15 to 372.38) 7.53 (0.47 to 121.10) Not estimable Not estimable 7.48 (0.78 to 72.16) 0.13 (0.00 to 6.56) Not estimable Not estimable 0.15 (0.00 to 7.78) Not estimable Not estimable Not estimable 14.88 (0.26 to 861.53) Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome: 13  Infection 01 RCT Chimento  2005  (RCT) Chung  2004  (Q-RCT) Hart  2005  (Q-RCT) Kim  2006  (Q-RCT) Ogonda  2005  (RCT) Sharma  2006  (Q-RCT) Zhang  2006  (RCT) Subtotal (95% CI) Total events: 3 (Mini-incision), 0 (Standard incision) Test for heterogeneity: 2 = 0.00, df = 1 (p = 0.99), I2 = 0% Test for overall effect: z = 1.74 (p = 0.08) 02 Comparative studies Asayama  2006 Berger  2004 Ciminiello  2006 Howell  2004 O\u2019Brien  2005 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Woolson  2004 Wright  2004 Total events: 1 (Mini-incision), 2 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 33.44 66.56 100.00 34.14 34.01 31.86 0.01 0.1 1 10 100 Mini-incision Standard incisionAppendix 10 174 1\/20 0\/20 0\/28 0\/32 0\/60 0\/60 0\/60 0\/60 1\/70 1\/70 0\/60 0\/60 298     302 0\/52 0\/50 0\/51 2\/95 0\/33 0\/33 0\/34 0\/53 2\/38 3\/43 2\/38 0\/21 1\/10 0\/10 1\/50 1\/85 0\/42 0\/42 348     432 7.39 (0.15 to 372.38) Not estimable Not estimable Not estimable 1.00 (0.06 to 16.15) Not estimable 1.95 (0.20 to 18.89) Not estimable 0.21 (0.01 to 3.93) Not estimable Not estimable 0.75 (0.12 to 4.53) 4.85 (0.26 to 89.99) 7.39 (0.15 to 372.38) 1.75 (0.10 to 31.21) Not estimable 1.16 (0.36 to 3.76) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  14 Nerve injury 01 RCT Charles  2006  (RCT) Chimento  2005  (RCT) Chung  2004  (Q-RCT) Hart  2005  (Q-RCT) Kim  2006  (Q-RCT) Zhang  2006  (RCT) Subtotal (95% CI) Total events: 2 (Mini-incision), 1 (Standard incision) Test for heterogeneity: 2 = 0.67, df = 1 (p = 0.41), I2 = 0% Test for overall effect: z = 0.58 (p = 0.56) 02 Comparative studies Asayama  2006 Chen  2006 DiGioia  2003 O\u2019Brien  2005 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Takahira  2006 Woolson  2004 Wright  2004 Subtotal (95% CI) Total events: 6 (Mini-incision), 6 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 33.49 66.51 100.00 16.14 42.28 16.10 8.94 16.54 100.00 0.01 0.1 1 10 100 Mini-incision Standard incision 0\/60 0\/60 60     60 0     0 Not estimable Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  15 Vascular injury 01 RCT Zhang 2006 (RCT) Subtotal (95% CI) Total events: 0 (Mini-incision), 0 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Subtotal (95% CI) Total events: 0 (Mini-incision), 0 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 0.1 0.5 0.2 1 5 21 0 Mini-incision Standard incisionHealth Technology Assessment 2008; Vol. 12: No. 26 175 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 0\/28                      0\/32 3\/60                      5\/60 0\/60                      0\/60 0\/109                    1\/110 0\/60                      2\/60 317                       322 0\/52                      1\/50 0\/30                      1\/30 0\/34                      3\/53 2\/38                      3\/43 2\/38                      2\/21 1\/50                      2\/85 Not estimable 0.59 (0.14 to 2.45) Not estimable 0.14 (0.00 to 6.88) 0.13 (0.01 to 2.15) 0.39 (0.12 to 1.30) 0.13 (0.00 to 6.56) 0.14 (0.00 to 6.82) 0.19 (0.02 to 1.95) 0.75 (0.12 to 4.53) 0.52 (0.06 to 4.22) 0.85 (0.08 to 9.02) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  16 DVT (deep venous thrombosis) 01 RCT Chimento  2005  (RCT) Chung  2004  (Q-RCT) Hart  2005  (Q-RCT) Ogonda  2005  (RCT) Zhang  2006  (RCT) Subtotal (95% CI) Total events: 3 (Mini-incision), 8 (Standard incision) Test for heterogeneity: 2 = 1.17, df = 2 (p = 0.56), I2 = 0% Test for overall effect: z = 1.54 (p = 0.12) 02 Comparative studies Asayama  2006 de Beer 2004 O\u2019Brien  2005 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Woolson  2004 Total events: 5 (Mini-incision), 12 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight %  71.62 9.51 18.86 100.00 6.34 6.35 17.71 30.03 22.07 17.49 0.1 0.5 0.2 1 10 5 2 Mini-incision Standard incision 0\/60                      0\/60 60                         60 0\/99                      0\/100 1\/34                      0\/53 Not estimable Not estimable Not estimable 12.92 (0.23 to 717.46) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  17 Pulmonary embolism 01 RCT Hart  2005  (Q-RCT) Subtotal (95% CI) Total events: 0 (Mini-incision), 0 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Berger  2004 O\u2019Brien  2005 Total events: 1 (Mini-incision), 0 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight %  100.00 0.001 0.1 0.01 1 1000 100 10 Mini-incision Standard incisionAppendix 10 176 20    95.20 (0.00)  20    87.70 (0.00) 28    70.30 (10.70)  32    70.00 (8.50) 60    49.00 (9.40)  60    55.10 (17.90) 60    71.00 (0.00)  60    70.00 (0.00) 70    52.00 (0.00)  70    61.00 (0.00) 109    60.30 (9.20)  110    65.90 (13.20) 20      0.00 (0.00)  20      0.00 (0.00) 60    75.00 (0.00)  60    69.00 (0.00) 427   432 50    58.60 (0.00)  50    57.90 (0.00) 99    72.00 (0.00)  100    66.00 (0.00) 51    88.41 (17.60)  95    90.85 (17.81) 60    55.45 (0.00)  60    56.95 (0.00) 30    46.60 (0.00)  30    44.50 (0.00) 33  120.00 (0.00)  33  100.00 (0.00) 50    97.00 (19.00)  57    84.00 (15.00) 18    91.00 (16.40)  18    97.00 (15.60) 32    74.00 (15.00)  51    80.00 (10.00) 10    99.50 (0.00)  10    81.00 (0.00) 38    84.00 (16.00)  43    93.00 (18.00) 38    84.00 (16.00)  21  102.00 (12.00) 10  126.50 (0.00)  10  119.90 (0.00) 50    97.00 (0.00)  85  105.00 (0.00) 42    71.40 (11.20)  42    77.70 (13.20) Not estimable 0.30 (\u20134.64 to 5.24) \u20136.10 (\u201311.22 to \u20130.98) Not estimable Not estimable \u20135.60 (\u20138.61 to \u20132.59) Not estimable Not estimable \u20134.42 (\u20136.72 to \u20132.13) Not estimable Not estimable \u20132.44 (\u20138.45 to 3.57) Not estimable Not estimable Not estimable 13.00 (6.45 to 19.55) \u20136.00 (\u201316.46 to 4.46) \u20136.00 (\u201311.88 to \u20130.12) Not estimable \u20139.00 (\u201316.40 to \u20131.60) \u201318.00 (\u201325.23 to \u201310.77) Not estimable Not estimable \u20136.30 (\u201311.54 to \u20131.06) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  18 Duration of operation (minutes) 01 RCT Charles 2006 (RCT) Chimento 2005 (RCT) Chung 2004 (Q-RCT) Hart 2005 (Q-RCT) Kim 2006 (Q-RCT) Ogonda 2005 (RCT) Sharma 2006 (Q-RCT) Zhang 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 4.51, df = 2 (p = 0.10), I2 = 55.7% Test for overall effect: z = 3.77 (p = 0.0002) 02 Comparative studies Asayama  2006 Berger  2004 Chen  2006 Ciminiello  2006 de Beer 2004 DiGioia  2003 Howell  2004 Li  2005 O\u2019Brien  2005 Pilot  2006 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Takahira  2006 Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight %  21.64 20.16  58.19 100.00  16.97  14.31 5.61 17.77  11.19 11.75  22.39 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26 177 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 20    5.35 (0.00)  20    5.70 (0.00) 28    5.80 (0.00)  32    5.50 (0.00) 60    4.41 (1.10)  60    5.34 (1.40) 109    3.65 (2.04)  110    3.68 (2.45) 20    0.00 (0.00)  20    0.00 (0.00) 60    7.00 (0.00)  60  13.50 (0.00) 297   302 52    2.96 (0.00)  50    2.94 (0.00) 100    1.90 (0.00)  100    3.50 (0.00) 51  11.16 (0.83)  95  12.83 (1.96) 60    3.70 (0.00)  60    3.63 (0.00) 30    5.13 (0.00)  30    5.10 (0.00) 33    3.80 (0.00)  33    3.90 (0.00) 50    4.40 (2.90)  57    5.70 (3.10) 35    5.40 (2.10)  53    6.20 (2.80) 40    5.60 (0.00)  40    6.70 (0.00) 10  22.00 (0.00)  10  23.40 (0.00) 50    4.30 (0.00)  85    4.00 (0.00) 42    6.12 (0.00)  42    6.07 (0.00) Not estimable Not estimable \u20130.93 (\u20131.38 to \u20130.48) \u20130.03 (\u20130.63 to 0.57) Not estimable Not estimable \u20130.60 (\u20130.96 to \u20130.24) Not estimable Not estimable \u20131.67 (\u20132.13 to \u20131.21) Not estimable Not estimable Not estimable \u20131.30 (\u20132.44 to \u20130.16) \u20130.80 (\u20131.83 to 0.23) Not estimable Not estimable Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  19 Length of hospital stay (days) 01 RCT Charles 2006 (RCT) Chimento 2005 (RCT) Chung 2004 (Q-RCT) Ogonda 2005 (RCT) Sharma 2006 (Q-RCT) Zhang 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 5.56, df = 1 (p = 0.02), I2 = 82.0% Test for overall effect: z = 3.29 (p = 0.001) 02 Comparative studies Asayama  2006 Berger  2004 Chen  2006 Ciminiello  2006 de Beer 2004 DiGioia  2003 Howell  2004 O\u2019Brien  2005 Panisello  2006 Takahira  2006 Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 63.71 36.29 100.00 73.69 11.80 14.51 \u20134 \u20132 0 2 4 Mini-incision Standard incision N Mean (SD) N Mean (SD) 0\/109                    2\/110 109                       110 0\/60                      0\/60 0\/42                      0\/42 0.14 (0.01 to 2.18) 0.14 (0.01 to 2.18) Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  20 Death (30 days) 01 RCT Ogonda 2005 (RCT) Subtotal (95% CI) Total events: 0 (Mini-incision), 2 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: z = 1.41 (p = 0.16) 02 Comparative studies Ciminiello  2006 Wright  2004 Total events: 0 (Mini-incision), 0 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 100.00 100.00 0.01 0.1 1 100 10 Mini-incision Standard incisionAppendix 10 178 0\/28                      2\/32 28                         32 0\/60                      0\/60 2\/42                      2\/42 0.15 (0.01 to 2.45) 0.15 (0.01 to 2.45) Not estimable 1.00 (0.14 to 7.36) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  21 Death (long term) 01 RCT Chimento 2005 (RCT) Subtotal (95% CI) Total events: 0 (Mini-incision), 2 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: z = 1.33 (p = 0.18) 02 Comparative studies Ciminiello  2006 Wright  2004 Total events: 2 (Mini-incision), 2 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 100.00 100.00 100.00 0.01 0.1 1 100 10 Mini-incision Standard incision 18    22.80 (0.00)  19    19.50 (0.00) 28  285.00 (185.00)  32  319.00 (177.00) 109    42.90 (97.40)  110    45.00 (96.80) 155   161 Not estimable \u201334.00 (\u2013125.96 to 57.96) \u20132.10 (\u201327.82 to 23.62) \u20134.41 (\u201329.18 to 20.36) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  22 Short-term patient-controlled anaesthesia (mg) 01 RCT Charles 2006 (RCT) Chimento 2005 (RCT) Ogonda 2005 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 0.43, df = 1 (p = 0.51), I2 = 0% Test for overall effect: z = 0.35 (p = 0.73) 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 7.26 92.74 100.00 \u2013100 \u201350 0 50 100 Mini-incision Standard incision N Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26 179 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 0    0 52      92.70 (0.00)  50      94.90 (0.00) 60    118.00 (0.00)  60    121.00 (0.00) 30    147.70 (0.00)  30    169.30 (0.00) Not estimable Not estimable Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  23 short-term total narcotic received (mg) 01 RCT Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Asayama  2006 Ciminiello  2006 de Beer 2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 60      2.20 (0.00)  60      2.64 (0.00) 60 60 Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  24 Short-term narcotic (days) 01 RCT Chung 2004 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % \u2013100 \u201350 0 50 100 Mini-incision Standard incision N Mean (SD) N Mean (SD)Appendix 10 180 0                           0 2\/52                      3\/49 0\/60                      0\/60 0\/30                      1\/30 Not estimable 0.62 (0.10 to 3.71) Not estimable 0.14 (0.00 to 6.82) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  25 Short-term pain (N of patients) 01 RCT Subtotal (95% CI) Total events: 0 (Mini-incision), 0 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative  studies Asayama  2006 Ciminiello  2006 de Beer 2004 Total events: 2 (Mini-incision), 4 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 82.75 17.25 0.1 0.5 0.2 1 10 25 Mini-incision Standard incision 18  3.94 (0.00)  19  3.68 (0.00) 70  0.00 (0.00)  70  0.00 (0.00) 109  3.30 (1.80)  110  3.36 (1.96) 20  4.05 (0.00)  20  6.25 (0.00) 217   219 38  1.50 (1.15)  43  2.15 (1.20) 38  1.50 (1.15)  21  2.10 (1.30) Not estimable Not estimable \u20130.06 (\u20130.56 to 0.44) Not estimable \u20130.06 (\u20130.56 to 0.44) \u20130.65 (\u20131.16 to \u20130.14) \u20130.60 (\u20131.27 to 0.07) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  26 Short-term pain (score) 01 RCT Charles 2006 (RCT) Kim 2006 (Q-RCT) Ogonda 2005 (RCT) Sharma 2006 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: z = 0.24 (p = 0.81) 02 Comparative studies Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 62.80 37.20 \u20134 \u20132 0 2 4 Mini-incision Standard incision N Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26 181 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 70  0.00 (0.00)  70  0.00 (0.00) 70    70 Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  27 Long-term pain (score) 01 RCT Kim 2006 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 0     0 51  60.00 (12.00)  95  116.00 (11.00) Not estimable \u201356.00 (\u201359.97 to \u201352.03) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  28 Time to return to normal activity (days) 01 RCT Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Chen  2006 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 \u2013100 \u201350 0 50 100 Mini-incision Standard incision N Mean (SD) N Mean (SD) 9\/28                    15\/32 28                         32 4\/52                      4\/49 0.55 (0.20 to 1.53) 0.55 (0.20 to 1.53) 0.94 (0.22 to 3.95) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  29 Use of walking aids: short-term (N of patients) 01 RCT Chimento 2005 (RCT) Subtotal (95% CI) Total events: 9 (Mini-incision), 15 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: z = 1.15 (p = 0.25) 02 Comparative  studies Asayama  2006 Total events: 4 (Mini-incision), 4 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 100.00 100.00 100.00 0.1 0.5 0.2 1 10 25 Mini-incision Standard incisionAppendix 10 182 60  21.40 (4.80)  60  24.80 (5.40) 60    60 \u20133.40 (\u20135.23 to \u20131.57) \u20133.40 (\u20135.23 to \u20131.57) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  30 Use of walking aids (days) 01 RCT Chung 2004 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: z = 3.65 (p = 0.0003) 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 6\/28                    15\/31 28                         31 19\/52                    16\/49 0.31 (0.11 to 0.91) 0.31 (0.11 to 0.91) 1.19 (0.52 to 2.68) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  31 Limp: short term (N of patients) 01 RCT Chimento 2005 (RCT) Subtotal (95% CI) Total events: 6 (Mini-incision), 15 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: z = 2.14 (p = 0.03) 02 Comparative  studies Asayama  2006 Total events: 19 (Mini-incision), 16 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 100.00 100.00 100.00 0.1 0.5 0.2 1 10 25 Mini-incision Standard incisionHealth Technology Assessment 2008; Vol. 12: No. 26 183 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 0\/27                      0\/29 27                         29 Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  32 Limp: long-term (N of patients) 01 RCT Chimento 2005 (RCT) Subtotal (95% CI) Total events: 0 (Mini-incision), 0 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative  studies Total events: 0 (Mini-incision), 0 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight % 0.1 0.5 0.2 1 10 25 Mini-incision Standard incision 107  \u201384.15 (10.56)  108  \u201383.36 ( 8.33) 60  \u201391.40 (0.00)  60  \u201378.50 (0.00) 167   168 60  \u201391.02 (0.00)  60  \u201394.93 (0.00) 30  \u201371.10 (9.80)  30  \u201366.60 (12.20) 33  \u201386.29 (0.00)  33  \u201380.44 (0.00) \u20130.79 (\u20133.33 to 1.75) Not estimable \u20130.79 (\u20133.33 to 1.75) Not estimable \u20134.50 (\u201310.10 to 1.10) Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  33 Harris hip score (3 months) 01 RCT Ogonda 2005 (RCT) Zhang 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: z = 0.61 (p = 0.54) 02 Comparative studies Ciminiello  2006 de Beer 2004 DiGioia  2003 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 100.00 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD)Appendix 10 184 27  \u201394.50 (0.00)  29  \u201394.50 (0.00) 60  \u201395.50 (0.00)  60  \u201393.50 (0.00) 70  \u201393.00 (0.00)  70  \u201391.00 (0.00) 60  \u201395.10 (0.00)  60  \u201395.60 (0.00) 217   219 52  \u201396.20 (0.00)  50  \u201396.20 (0.00) 51  \u201389.71 (3.62)  95  \u201383.78 (8.03) 33  \u201396.00 (0.00)  33  \u201394.00 (0.00) 18  \u201392.00 (0.00)  18  \u201390.00 (0.00) 20  \u201399.00 (0.00)  14  \u201397.00 (0.00) 37  \u201386.90 (4.10)  39  \u201384.20 (6.40) Not estimable Not estimable Not estimable Not estimable Not estimable Not estimable \u20135.93 (\u20137.83 to \u20134.03) Not estimable Not estimable Not estimable \u20132.70 (\u20135.10 to \u20130.30) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  34 Harris hip score (>3 months) 01 RCT Chimento 2005 (RCT) Chung 2004 (Q-RCT) Kim 2006 (Q-RCT) Zhang 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Asayama  2006 Chen  2006 DiGioia  2003 Li  2005 Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 61.66 38.34 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 16  91.99 (0.00)  19  89.60 (0.00) 107  74.40 (13.88)  108  73.95 (12.90) 123   127 Not estimable 0.45 (\u20133.13 to 4.03) 0.45 (\u20133.13 to 4.03) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  35 WOMAC osteoarthritis index (3 months) 01 RCT Charles 2006 (RCT) Ogonda 2005 (RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: z = 0.25 (p = 0.81) 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26 185 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 107  24.97 (7.33)  108  25.88 (6.29) 107   108 30  26.50 (8.40)  30  28.40 (7.50) \u20130.91 (\u20132.74 to 0.92) \u20130.91 (\u20132.74 to 0.92) \u20131.90 (\u20135.93 to 2.13) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  36 Oxford hip score (3 months) 01 RCT Ogonda 2005 (RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: z = 0.98 (p = 0.33) 02 Comparative studies de Beer 2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 100.00 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 60  \u201316.60 (0.00)  60  \u201314.10 (0.00) 60    60 Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  37 Merle d\u2019Aubigne-Charnley Score (3 months) 01 RCT Hart 2005 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 60  \u201317.40 (0.00)  60  \u201317.30 (0.00) 60    60 Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  38 Merle d\u2019Aubigne-Charnley Score (>3 months) 01 RCT Hart 2005 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD)Appendix 10 186 107  \u201338.48 (10.20)  108  \u201337.73 (9.48) 107   108 \u20130.75 (\u20133.38 to 1.88) \u20130.75 (\u20133.38 to 1.88) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  39 SF-12 physical component (3 months) 01 RCT Ogonda 2005 (RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: z = 0.56 (p = 0.58) 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 107  \u201350.61 (11.05)  108  \u201351.11 (10.54) 107   108 0.50 (\u20132.39 to 3.39) 0.50 (\u20132.39 to 3.39) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  40 SF-12 mental component (>3 months) 01 RCT Ogonda 2005 (RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: z = 0.34 (p = 0.73) 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 16  \u201340.80 (0.00)  19  \u201340.40 (0.00) 16    19 Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  41 SF-36 physical function (3 months) 01 RCT Charles 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26 187 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 0    0 109  \u201354.50 (4.29)  56  \u201356.24 (3.87) Not estimable 1.74 (0.45 to 3.03) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  42 SF-36 physical function (>3 months) 01 RCT Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Dorr  2007 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 0    0 109  \u201360.38 (3.84)  56  \u201360.74 (3.42) Not estimable 0.36 (\u20130.79 to 1.51) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  43 SF-36 mental component (>3 months) 01 RCT Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Dorr  2007 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD)Appendix 10 188 0                           0 0\/109                  21\/56 0\/20                      0\/14 0\/37                      5\/37 Not estimable 0.03 (0.01 to 0.09) Not estimable 0.12 (0.02 to 0.73) Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  44 Satisfaction (number of patients dissatisfied) 01 RCT Subtotal (95% CI) Total events: 0 (Mini-incision), 0 (Standard incision) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative  studies Corr  2007 Woolson  2004 Wright  2004 Total events: 0 (Mini-incision), 26 (Standard incision) Study or subcategory Mini-incision n\/N Standard incision n\/N Peto OR 95% CI Peto OR 95% CI Weight %  77.77  22.23 0.01 0.1 1 100 10 Mini-incision Standard incision 18  \u201315.22 (0.00)  19  \u201314.59 (0.00) 18    19 Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome: 45  Satisfaction  (score) 01 RCT Charles 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26 189 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 107  11.00 (0.00)  108  12.00 (0.00) 107   108 Not estimable Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  01 Mini-incision versus standard incision Outcome:  46 Scar contraction (% of total wound length from end of surgery) 01 RCT Ogonda 2005 (RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) Comparison 02: Single mini-incision versus single standard incision (reported means and SDs supplemented with calculated SDs from p-values) 20  460.00 (184.25)  20  462.50 (184.25) 28  127.00 (48.00)  32  170.00 (65.00) 60  136.00 (41.10)  60  200.50 (65.20) 60  318.80 (0.00)  60  544.40 (0.00) 70  445.80 (521.95)  70  567.50 (521.95) 109  314.20 (174.78)  110  365.80 (174.78) 347   352 52  217.50 (0.00)  50  247.00 (0.00) 99  154.00 (443.49)  100  278.00 (443.49) 51  175.49 (51.90)  95  293.68 (84.50) 60  201.67 (228.39)  60  191.73 (228.39) 30  180.00 (69.00)  30  246.70 (99.00) 50  387.00 (155.00)  57  469.00 (147.00) 10  699.00 (319.20)  10  540.00 (319.20) 38  244.00 (100.00)  43  265.00 (114.00) 38  244.00 (100.00)  43  304.00 (136.00) 50  603.00 (344.21)  85  507.00 (344.21) 42  151.80 (53.90)  42  173.20 (57.50) \u20132.50 (\u2013116.70 to 111.70) \u201343.00 (\u201371.69 to \u201314.31) \u201364.50 (\u201384.00 to \u201345.00) Not estimable \u2013121.70 (\u2013294.62 to 51.22) \u201351.60 (\u201397.90 to \u20135.30) \u201356.59 (\u201371.63 to \u201341.55) Not estimable \u2013124.00 (\u2013247.24 to \u20130.76) \u2013118.19 (\u2013140.36 to \u201396.02) 9.94 (\u201371.79 to 91.67) \u201366.70 (\u2013109.88 to \u201323.52) \u201382.00 (\u2013139.46 to \u201324.54) 159.00 (\u2013120.79 to 438.79) \u201321.00 (\u201367.60 to 25.60) \u201360.00 (\u2013111.61 to \u20138.39) 96.00 (\u201324.24 to 216.24) \u201321.40 (\u201345.24 to 2.44) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  09 Blood loss (intraoperative, ml) 01 RCT Charles 2006 (RCT) Chimento 2005 (RCT) Chung 2004 (Q-RCT) Hart 2005 (Q-RCT) Kim 2006 (Q-RCT) Ogonda 2005 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 2.94, df = 4 (p = 0.57), I2 = 0% Test for overall effect: z = 7.37 (p < 0.00001) 02 Comparative studies Asayama  2006 Berger  2004 Chen  2006 Ciminiello  2006 de Beer 2004 Howell  2004 Pilot  2006 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 1.73 27.48 59.48 0.76 10.55 100.00 1.14 35.27 2.60 9.30 5.25 0.22 7.98 6.51 1.20 30.52 \u2013100 \u201350 0 50 100 Mini-incision Standard incision N Mean (SD) N Mean (SD)Appendix 10 190 28  378.00 (151.00)  32  504.00 (205.00) 60  613.30 (0.00)  60  853.70 (0.00) 88    92 51  369.51 (65.05)  95  509.63 (117.39) 18  318.00 (223.00)  18  523.00 (210.70) 38  744.00 (260.00)  43  708.00 (221.00) 38  744.00 (260.00)  21  771.00 (235.00) 10  796.00 (0.00)  10  772.00 (0.00) \u2013126.00 (\u2013216.41 to \u201335.59) Not estimable \u2013126.00 (\u2013216.41 to \u201335.59) \u2013140.12 (\u2013169.72 to \u2013110.52) \u2013205.00 (\u2013346.73 to \u201363.27) 36.00 (\u201369.82 to 141.82) \u201327.00 (\u2013157.14 to 103.14) Not estimable \u2013125.80 (\u2013153.13 to \u201398.48) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  10 Blood loss (total, ml) 01 RCT Chimento 2005 (RCT) Hart 2005 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: z = 2.73 (p = 0.006) 02 Comparative studies Chen  2006 Li  2005 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Takahira  2006 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 85.21 3.72 6.67 4.41 100.00 \u20131000 \u2013500 0 500 1000 Mini-incision Standard incision N Mean (SD) N Mean (SD) 20    95.20 (23.29)  20    87.70 (23.29) 28    70.30 (10.70)  32    70.00 (8.50) 60    49.00 (9.40)  60    55.10 (17.90) 60    71.00 (0.00)  60    70.00 (0.00) 70    52.00 (15.84)  70    61.00 (15.84) 109    60.30 (9.20)  110    65.90 (13.20) 20      0.00 (0.00)  20      0.00 (0.00) 60    75.00 (16.60)  60    69.00 (16.60) 427   432 50    58.60 (0.00)  50    57.90 (0.00) 99    72.00(0.00)  100    66.00 (0.00) 51    88.41 (17.60)  95    90.85 (17.81) 60    55.45 (4.91)  60    56.95 (4.91) 30    46.60 (14.31)  30    44.50 (14.31) 33  120.00 (0.00)  33  100.00 (0.00) 50    97.00 (19.00)  57    84.00 (15.00) 18    91.00 (16.40)  18    97.00 (15.60) 32    74.00 (15.00)  51    80.00 (10.00) 10    99.50 (20.25)  10    81.00 (20.25) 38    84.00 (16.00)  43    93.00 (18.00) 38    84.00 (16.00)  21  102.00 (12.00) 10  126.50 (0.00)  10  119.90 (0.00) 50    97.00 (29.46)  85  105.00 (29.46) 42    71.40 (11.20)  42    77.70 (13.20) 7.50 (\u20136.94 to 21.94) 0.30 (\u20134.64 to 5.24) \u20136.10 (\u201311.22 to \u20130.98) Not estimable \u20139.00 (\u201314.25 to \u20133.75) \u20135.60 (\u20138.61 to \u20132.59) Not estimable 6.00 (\u20130.06 to 11.94) \u20133.70 (\u20135.67 to \u20131.74) Not estimable Not estimable \u20132.44 (\u20138.45 to 3.57) \u20131.50 (\u20133.26 to 0.26) 2.10 (\u20135.14 to 9.34) Not estimable 13.00 (6.45 to 19.55) \u20136.00 (\u201316.46 to 4.46) \u20136.00 (\u201311.88 to \u20130.12) 18.50 (0.75 to 36.25) \u20139.00 (\u201316.40 to \u20131.60) \u201318.00 (\u201325.23 to \u201310.77) Not estimable \u20138.00 (\u201318.29 to 2.29) \u20136.30 (\u201311.54 to \u20131.06) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  18 Duration of operation (minutes) 01 RCT Charles 2006 (RCT) Chimento 2005 (RCT) Chung 2004 (Q-RCT) Hart 2005 (Q-RCT) Kim 2006 (Q-RCT) Ogonda 2005 (RCT) Sharma 2006 (Q-RCT) Zhang 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 21.37, df = 5 (p = 0.0007), I2 = 76.6% Test for overall effect: z = 3.69 (p < 0.0002) 02 Comparative studies Asayama  2006 Berger  2004 Chen  2006 Ciminiello  2006 de Beer 2004 DiGioia  2003 Howell  2004 Li  2005 O\u2019Brien  2005 Pilot  2006 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Takahira  2006 Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 1.85 15.84 14.76 14.02 42.59 10.94 100.00 5.33 62.47 3.68 4.50 1.76 5.58 0.61 3.52 3.69 1.82 7.04 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26 191 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 18    22.80 (6.03)  19    19.50 (6.03) 28  285.00 (185.00)  32  319.00 (177.00) 109    42.90 (97.40)  110    45.00 (96.80) 155   161 3.30 (\u20130.59 to 7.19) \u201334.00 (\u2013125.96 to 57.96) \u20132.10 (\u201327.82 to 23.62) 3.11 (\u20130.73 to 6.95) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  22 Short-term patient-controlled anaesthesia (mg) 01 RCT Charles 2006 (RCT) Chimento 2005 (RCT) Ogonda 2005 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 0.79, df = 2 (p = 0.67), I2 = 0% Test for overall effect: z = 1.59 (p = 0.11) 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 97.60 0.17 2.23 100.00 \u2013100 \u201350 0 50 100 Mini-incision Standard incision N Mean (SD) N Mean (SD) 20    5.35 (1.63)  20    5.70 (1.63) 28    5.80 (2.20)  32    5.50 (2.20) 60    4.41 (1.10)  60    5.34 (1.40) 109    3.65 (2.04)  110    3.68 (2.45) 20    0.00 (0.00)  20    0.00 (0.00) 60    7.00 (0.00)  60  13.50 (0.00) 297   302 52    2.96 (0.56)  50    2.94 (0.56) 100    1.90 (5.74)  100    3.50 (5.74) 51  11.16 (0.83)  95  12.83 (1.96) 60    3.70 (5.08)  60    3.63 (5.08) 30    5.13 (0.87)  30    5.10 (0.87) 33    3.80 (0.77)  33    3.90 (0.77) 50    4.40 (2.90)  57    5.70 (3.10) 35    5.40 (2.10)  53    6.20 (2.80) 40    5.60 (0.00)  40    6.70 (0.00) 10  22.00 (0.00)  10  23.40 (0.00) 50    4.30 (2.17)  85    4.00 (2.17) 42    6.12 (2.27)  42    6.07 (2.27) \u20130.35 (\u20131.36 to 0.66) 0.30 (\u20130.82 to 1.42) \u20130.93 (\u20131.38 to \u20130.48) \u20130.03 (\u20130.63 to 0.57) Not estimable Not estimable \u20130.50 (\u20130.83 to \u20130.18) 0.02 (\u20130.20 to 0.24) \u20131.60 (\u20133.19 to \u20130.01) \u20131.67 (\u20132.13 to \u20131.21) 0.07 (\u20131.75 to 1.89) 0.03 (\u20130.41 to 0.47) \u20130.10 (\u20130.47 to 0.27) \u20131.30 (\u20132.44 to \u20130.16) \u20130.80 (\u20131.83 to 0.23) Not estimable Not estimable 0.30 (\u20130.46 to 1.06) 0.05 (\u20130.92 to 1.02) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  19 Length of hospital stay (days) 01 RCT Charles 2006 (RCT) Chimento 2005 (RCT) Chung 2004 (Q-RCT) Ogonda 2005 (RCT) Sharma 2006 (Q-RCT) Zhang 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 7.94, df = 3 (p = 0.05), I2 = 62.2% Test for overall effect: z = 3.03 (p < 0.002) 02 Comparative studies Asayama  2006 Berger  2004 Chen  2006 Ciminiello  2006 de Beer 2004 DiGioia  2003 Howell  2004 O\u2019Brien  2005 Panisello  2006 Takahira  2006 Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 10.30 8.44 51.77 29.49 100.00 48.52 0.91 11.07 0.69 11.83 16.61 1.77 2.18 3.99 2.43 \u20134 \u20132 0 2 4 Mini-incision Standard incision N Mean (SD) N Mean (SD)Appendix 10 192 0    0 52    92.70 (0.00)  50    94.90 (0.00) 60  118.00 (41.12)  60  121.00 (41.12) 30  147.70 (86.75)  30  169.30 (86.75) Not estimable Not estimable \u20133.00 (\u201317.71 to 11.71) \u201321.60 (\u201365.50 to 22.30) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  23 Short-term total narcotic received (mg) 01 RCT Subtotal (95% CI) Test for heterogeneity: 2 = 0.79, df = 2 (p = 0.67), I2 = 0% Test for overall effect: z = 1.59 (p < 0.11) 02 Comparative studies Asayama  2006 Ciminiello  2006 de Beer 2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight %  89.90 10.10 \u2013100 \u201350 0 50 100 Mini-incision Standard incision N Mean (SD) N Mean (SD) 18  3.94 (0.51)  19  3.68 (0.51) 70  0.00 (0.00)  70  0.00 (0.00) 109  3.30 (1.80)  110  3.36 (1.96) 20  4.05 (2.52)  20  6.25 (2.52) 217   219 38  1.50 (1.15)  43  2.15 (1.20) 38  1.50 (1.15)  21  2.10 (1.30) 0.26 (\u20130.07 to 0.59) Not estimable \u20130.06 (\u20130.56 to 0.44) \u20132.20 (\u20133.76 to \u20130.64) 0.09 (\u20130.18 to 0.36) \u20130.65 (\u20131.16 to \u20130.14) \u20130.60 (\u20131.27 to 0.07) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  26 Short-term pain (score) 01 RCT Charles 2006 (RCT) Kim 2006 (Q-RCT) Ogonda 2005 (RCT) Sharma 2006 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 9.63, df = 2 (p = 0.008), I2 = 79.2% Test for overall effect: z = 0.67 (p = 0.50) 02 Comparative studies Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 67.59 29.42 2.99 100.00 62.80 37.20 \u20134 \u20132 0 2 4 Mini-incision Standard incision N Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26 193 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 107  \u201384.15 (10.56)  108  \u201383.36 (8.33) 60  \u201391.40 (35.68)  60  \u201378.50 (35.68) 167   168 60  \u201391.02 (12.17)  60  \u201394.93 (12.17) 30  \u201371.10 (9.80)  30  \u201366.60 (12.20) 33  \u201386.29 (11.62)  33  \u201380.44 (11.62) \u20130.79 (\u20133.33 to 1.75) \u201312.90 (\u201325.67 to \u20130.13) \u20131.25 (\u20133.75 to 1.24) 3.91 (\u20130.44 to 8.26) \u20134.50 (\u201310.10 to 1.10) \u20135.85 (\u201311.46 to \u20130.24) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  33 Harris hip score (3 months) 01 RCT Ogonda 2005 (RCT) Zhang 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 3.32, df = 1 (p = 0.07), I2 = 69.9% Test for overall effect: z = 0.67 (p = 0.50) 02 Comparative studies Ciminiello  2006 de Beer 2004 DiGioia  2003 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 96.18 3.82 100.00 45.29 27.39 27.32 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 27  \u201394.50 (0.00)  29  \u201394.50 (0.00) 60  \u201395.50 (5.53)  60  \u201393.50 (5.53) 70  \u201393.00 (35.58)  70  \u201391.00 (35.58) 60  \u201395.10 (1.38)  60  \u201395.60 (1.38) 217   219 52  \u201396.20 (0.00)  50  \u201396.20 (0.00) 51  \u201389.71 (3.62)  95  \u201383.78 (8.03) 33  \u201396.00 (4.57)  33  \u201394.00 (4.57) 18  \u201392.00 (2.95)  18  \u201390.00 (2.95) 20  \u201399.00 (7.18)  14  \u201397.00 (7.18) 37  \u201386.90 (4.10)  39  \u201384.20 (6.40) Not estimable \u20132.00 (\u20133.98 to \u20130.02) \u20132.00 (\u201313.79 to 9.79) 0.50 (0.01 to 0.99) 0.35 (\u20130.13 to 0.83) Not estimable \u20135.93 (\u20137.83 to \u20134.03) \u20132.00 (\u20134.21 to 0.21) \u20132.00 (\u20133.93 to \u20130.07) \u20132.00 (\u20136.90 to 2.90) \u20132.70 (\u20135.10 to \u20130.30) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  34 Harris hip score (>3 months) 01 RCT Chimento 2005 (RCT) Chung 2004 (Q-RCT) Kim 2006 (Q-RCT) Zhang 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 5.92, df = 2 (p = 0.05), I2 = 66.2% Test for overall effect: z = 1.43 (p = 0.15) 02 Comparative studies Asayama  2006 Chen  2006 DiGioia  2003 Li  2005 Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 5.85 0.16 93.98 100.00 28.75 21.25 27.82 4.30 17.88 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD)Appendix 10 194 16  91.99 (17.51)  19  89.60 (17.51) 107  74.40 (13.88)  108  73.95 (12.90) 123   127 2.39 (\u20139.25 to 14.03) 0.45 (\u20133.13 to 4.03) 0.62 (\u20132.81 to 4.04) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  35 WOMAC osteoarthritis index (3 months) 01 RCT Charles 2006 (RCT) Ogonda 2005 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 0.10, df = 1 (p = 0.75), I2 = 0% Test for overall effect: z = 0.35 (p = 0.72) 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 8.65 91.35 100.00 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 16  \u201340.80 (2.13)  19  \u201340.40 (2.13) 16    19 \u20130.40 (\u20131.82 to 1.02) \u20130.40 (\u20131.82 to 1.02) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  41 SF-36 physical function (3 months) 01 RCT Charles 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: z = 0.55 (p = 0.58) 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 60  \u201316.60 (5.80)  60  \u201314.10 (5.80) 60    60 \u20132.50 (\u20134.58 to \u20130.42) \u20132.50 (\u20134.58 to \u20130.42) Review:  Minimal incision approaches to total hip replacement Comparison:  02 Mini-incision versus standard incision (p-value) Outcome:  37 Merle d\u2019Aubigne-Charnley Score (3 months) 01 RCT Hart 2005 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: z = 2.36 (p = 0.02) 02 Comparative studies Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26 195 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.","cites":null},{"id":10514,"title":"All rights reserved. Appendix 14 Balanced life table for general mortality (40% male, 60% female) Age (years) Mortality Age (years)","authors":[],"date":"2008","doi":null,"raw":"Health Technology Assessment 2008; Vol. 12: No. 26 221 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. Appendix 14 Balanced life table for general mortality (40% male, 60% female) Age (years) Mortality Age (years) Mortality 68 0.016562 89 0.153176 69 0.018324 90 0.164534 70 0.019946 91 0.179646 71 0.022501 92 0.196954 72 0.02522 93 0.217126 73 0.027967 94 0.232363 74 0.031561 95 0.255651 75 0.035162 96 0.27421 76 0.039297 97 0.29536 77 0.043814 98 0.314326 78 0.048593 99 0.329341 79 0.054145 100 0.356988 80 0.059932 101 0.356988 81 0.066966 102 0.356988 82 0.073952 103 0.356988 83 0.081779 104 0.356988 84 0.088514 105 0.356988 85 0.098279 106 0.356988 86 0.109397 107 0.356988 87 0.126424 108 0.356988 88 0.138485B oth standard and mini-incision THR patients would move through the model as shown. It is the cost and outcomes associated with the two forms of surgery that drive the cost\u2013utility results.","cites":null},{"id":10515,"title":"All rights reserved. Appendix 15 Cohort analysis showing 1000 patients as they progress through the 40-year model for both standard and mini-incision THR Stage Primary THR Successful THR Revision Successful THR Non-operative Dead (revision)","authors":[],"date":"2008","doi":null,"raw":"Health Technology Assessment 2008; Vol. 12: No. 26 223 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. Appendix 15 Cohort analysis showing 1000 patients as they progress through the 40-year model for both standard and mini-incision THR Stage Primary THR Successful THR Revision Successful THR  Non-operative  Dead (revision) management 0 1000 0 0 0 0 0 1 09 6 8 70 02 6 2 0 938 12 7 0 43 3 0 903 16 18 0 63 4 0 865 18 33 0 84 5 0 820 24 49 0 107 6 0 769 29 70 0 132 7 0 713 33 94 0 160 8 0 654 37 120 0 190 9 0 591 41 147 0 222 10 0 523 45 175 0 256 11 0 456 47 204 0 293 12 0 389 48 231 0 332 13 0 325 48 255 0 372 14 0 265 46 274 0 415 15 0 212 43 287 0 458 16 0 166 39 292 0 503 17 0 127 36 290 0 547 18 0 94 31 282 0 592 19 0 68 27 267 0 637 20 0 48 23 246 0 683 21 0 33 20 220 0 727 22 0 22 16 193 0 769 23 0 14 13 165 0 807 24 0 9 11 138 0 842 25 0 6 9 112 0 873 2 6 0 378 9 09 0 1 2 7 0 256 9 09 2 4 2 8 0 145 1 09 4 3 2 9 0 133 8 09 5 9 3 0 0 022 7 09 7 1 3 1 0 011 8 09 8 0 3 2 0 011 2 09 8 7 33 0 0 1 8 0 991 34 0 0 0 5 0 995 35 0 0 0 3 0 996 36 0 0 0 2 0 998 37 0 0 0 1 0 999 38 0 0 0 1 0 999 39 0 0 0 1 0 999 40 0 0 0 0 0 1000Volume 1, 1997 No. 1 Home parenteral nutrition: a systematic review. By Richards DM, Deeks JJ, Sheldon TA, Shaffer JL. No. 2 Diagnosis, management and screening of early localised prostate cancer. A review by Selley S, Donovan J, Faulkner A, Coast J, Gillatt D. No. 3 The diagnosis, management, treatment and costs of prostate cancer in England and Wales. A review by Chamberlain J, Melia J, Moss S, Brown J. No. 4 Screening for fragile X syndrome. A review by Murray J, Cuckle H, Taylor G, Hewison J. No. 5 A review of near patient testing in primary care. By Hobbs FDR, Delaney BC, Fitzmaurice DA, Wilson S, Hyde CJ, Thorpe GH, et al. No. 6 Systematic review of outpatient services for chronic pain control. By McQuay HJ, Moore RA, Eccleston C, Morley S, de C Williams AC. No. 7 Neonatal screening for inborn errors of metabolism: cost, yield and outcome. A review by Pollitt RJ, Green A, McCabe CJ, Booth A, Cooper NJ, Leonard JV, et al. No. 8 Preschool vision screening. A review by Snowdon SK, Stewart-Brown SL. No. 9 Implications of socio-cultural contexts for the ethics of clinical trials. A review by Ashcroft RE, Chadwick DW, Clark SRL, Edwards RHT, Frith L, Hutton JL. No. 10 A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment. By Davis A, Bamford J, Wilson I, Ramkalawan T, Forshaw M, Wright S. No. 11 Newborn screening for inborn errors of metabolism: a systematic review. By Seymour CA, Thomason MJ, Chalmers RA, Addison GM, Bain MD, Cockburn F, et al. No. 12 Routine preoperative testing: a systematic review of the evidence. By Munro J, Booth A, Nicholl J. No. 13 Systematic review of the effectiveness of laxatives in the elderly. By Petticrew M, Watt I, Sheldon T. No. 14 When and how to assess fast-changing technologies: a comparative study of medical applications of four generic technologies.","cites":null},{"id":10497,"title":"All rights reserved. Appendix 7 Detailed quality assessment score for the included trials and comparative studies (see","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10477,"title":"All rights reserved. Clinical effectiveness Search strategies used to identify reports of clinical effectiveness of minimally invasive hip arthroplasty MEDLINE","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10517,"title":"All rights reserved. Health Technology Assessment reports published to date No. 15 Ethical issues in the design and conduct of randomised controlled trials. A review by","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":6013904,"title":"All rights reserved. Health Technology Assessment reports published to dateNo. 15 Ethical issues in the design and conduct of randomised controlled trials. A review by","authors":[],"date":"2008","doi":null,"raw":"Health Technology Assessment 2008; Vol. 12: No. 26 225 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. Health Technology Assessment reports published to dateNo. 15 Ethical issues in the design and conduct of randomised controlled trials. A review by Edwards SJL, Lilford RJ, Braunholtz DA, Jackson JC, Hewison J, Thornton J. No. 16 Qualitative research methods in health technology assessment: a review of the literature. By Murphy E, Dingwall R, Greatbatch D, Parker S, Watson P. No. 17 The costs and benefits of paramedic skills in pre-hospital trauma care. By Nicholl J, Hughes S, Dixon S, Turner J, Yates D. No. 18 Systematic review of endoscopic ultrasound in gastro-oesophageal cancer. By Harris KM, Kelly S, Berry E, Hutton J, Roderick P, Cullingworth J, et al. No. 19 Systematic reviews of trials and other studies. By Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. No. 20 Primary total hip replacement surgery: a systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses.","cites":null},{"id":10520,"title":"All rights reserved. No. 34 A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. By MacLehose","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":6013887,"title":"All rights reserved. S t u d y C l i n i c a l p e r f o r m a n c e S a f e t y R e s o u r c e u t i l i t y H o w e l l ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":")Health Technology Assessment 2008; Vol. 12: No. 26 161 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  C l i n i c a l  p e r f o r m a n c e  S a f e t y  R e s o u r c e  u t i l i t y  H o w e l l ,  2 0 0 4 4 2 \u2713 \u2713 \u2713 \u2713 \u2713 L i ,  2 0 0 5 4 4 \u2713 \u2713 \u2713 O \u2019 B r i e n ,  2 0 0 5 4 5 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 P a n i s e l l o ,  2 0 0 6 7 4 \u2713 P i l o t ,  2 0 0 6 4 8 \u2713 \u2713 S z e n d r \u00f3 i ,  2 0 0 6 5 2 ( M I \/ M D ) \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 S z e n d r \u00f3 i ,  2 0 0 6 5 2 ( M I \/ S I ) \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 T a k a h i r a ,  2 0 0 6 7 8 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 T e e t ,  2 0 0 6 5 4 \u2713 \u2713 W o o l s o n ,  2 0 0 4 5 5 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 W r i g h t ,  2 0 0 4 5 6 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 C a s e  s e r i e s  a n d  r e g i s t r y F l \u00f6 r e n ,  2 0 0 6 3 9 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 H a r t z b a n d ,  2 0 0 6 4 1 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 P i p i n o ,  2 0 0 4 4 9 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 S i g u i e r ,  2 0 0 4 5 0 \u2713 \u2713 \u2713 \u2713 \u2713 S w a n s o n ,  2 0 0 5 5 1 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 N o r w e g i a n  A r t h r o p l a s t y  R e g i s t e r ,  2 0 0 5 \u2013 6 1 1 \u2713 c o n t i n u e d R e v i s i o n  r a t e  ( n u m b e r  h a v i n g r e v i s i o n  s u r g e r y ) P o s t o p e r a t i v e  d i s l o c a t i o n  r a t e s I m p l a n t  p o s i t i o n  ( c u p ,  n u m b e r p o o r l y  p l a c e d ) I m p l a n t  p o s i t i o n  ( s t e m ,  n u m b e r p o o r l y  p l a c e d ) I m p l a n t  m i g r a t i o n H e t e r o t o p i c  o s s i f i c a t i o n ( n u m b e r  w i t h  o s s i f i c a t i o n ) C e m e n t  q u a l i t y  ( n u m b e r  w i t h p o o r  q u a l i t y ) L i m b  l e n g t h  i n e q u a l i t y  ( n u m b e r w i t h  u n e q u a l  l e n g t h s ) B l o o d  l o s s  ( i n t r a o p e r a t i v e ,  m l ) B l o o d  l o s s  ( t o t a l ,  m l ) F r a c t u r e s :  i n t r a o p e r a t i v e F r a c t u r e s :  p o s t o p e r a t i v e I n f e c t i o n N e r v e  i n j u r y V a s c u l a r  i n j u r y D V T  P E D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s )Appendix 9 162 S t u d y  C l i n i c a l  p e r f o r m a n c e  S a f e t y  R e s o u r c e  u t i l i t y  T w o  i n c i s i o n s R C T  a n d  q u a s i -R C T P a g n a n o ,  2 0 0 7 a 7 2 P a g n a n o ,  2 0 0 7 b 7 3 Y a n ,  2 0 0 5 5 7 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 C o m p a r a t i v e  s t u d i e s D u w e l i u s ,  2 0 0 7 3 8 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 G r e i d a n u s ,  2 0 0 6 7 1 \u2713 \u2713 P a g n a n o ,  2 0 0 6 4 7 T a n a v a l e e ,  2 0 0 6 5 3 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 Y o o n ,  2 0 0 5 7 9 \u2713 \u2713 C a s e  s e r i e s A r c h i b e c k ,  2 0 0 4 2 7 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 D u w e l i u s ,  2 0 0 3 3 7 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 R e v i s i o n  r a t e  ( n u m b e r  h a v i n g r e v i s i o n  s u r g e r y ) P o s t o p e r a t i v e  d i s l o c a t i o n  r a t e s I m p l a n t  p o s i t i o n  ( c u p ,  n u m b e r p o o r l y  p l a c e d ) I m p l a n t  p o s i t i o n  ( s t e m ,  n u m b e r p o o r l y  p l a c e d ) I m p l a n t  m i g r a t i o n H e t e r o t o p i c  o s s i f i c a t i o n ( n u m b e r  w i t h  o s s i f i c a t i o n ) C e m e n t  q u a l i t y  ( n u m b e r  w i t h p o o r  q u a l i t y ) L i m b  l e n g t h  i n e q u a l i t y  ( n u m b e r w i t h  u n e q u a l  l e n g t h s ) B l o o d  l o s s  ( i n t r a o p e r a t i v e ,  m l ) B l o o d  l o s s  ( t o t a l ,  m l ) F r a c t u r e s :  i n t r a o p e r a t i v e F r a c t u r e s :  p o s t o p e r a t i v e I n f e c t i o n N e r v e  i n j u r y V a s c u l a r  i n j u r y D V T  P E D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s","cites":null},{"id":6013864,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) A s a y a m a ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"5Health Technology Assessment 2008; Vol. 12: No. 26 127 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) A s a y a m a ,  2 0 0 6 2 8 S t u d y  d e s i g n : p r o s p e c t i v e c o m p a r a t i v e  c o h o r t s L o c a t i o n :  U S A  a n d J a p a n R e c r u i t m e n t  d a t e s : S e p t e m b e r 2 0 0 1 \u2013 M a r c h  2 0 0 3 F u n d i n g : m a n u f a c t u r e r ( S t r y k e r O r t h o p a e d i c s , M a h w a h ,  N J ,  U S A ) D u r a t i o n  o f  F U : m i n i m u m  2  y e a r s ( d a t a  r e p o r t e d  u p  t o 4 2  m o n t h s ) I n c l u s i o n  c r i t e r i a :  n o n -c o m p l e x , c e m e n t l e s s ,  u n i l a t e r a l  c a s e s  w i t h n o  p r i o r  s u r g e r i e s  t o  t h e  a f f e c t e d h i p E x c l u s i o n  c r i t e r i a :  c o m p l e x  c a s e s ( N =  4 8 ) ,  i n c l u d i n g  m u l t i p l e  j o i n t p r o c e d u r e s  u n d e r  t h e  s a m e a n e s t h e t i c ,  p r e v i o u s  f r a c t u r e s  o r s u r g e r i e s ,  s e v e r e  p e l v i c d e f o r m i t i e s ,  o t h e r  s u r g i c a l a p p r o a c h ,  c e m e n t e d  f i x a t i o n , p o s t o p e r a t i v e  f r a c t u r e  ( N = 1 ) , h e m i a r t h r o p l a s t y ;  o b e s i t y  ( B M I  > 3 9 . 1 ) ;  c o -m o r b i d c o m p l i c a t i o n s  ( n =  3 ) ,  i n c l u d i n g c a r d i o v a s c u l a r ,  g a s t r o i n t e s t i n a l b l e e d i n g N e l i g i b l e :  1 3 8  ( 1 4 8  T H R s ) N s e l e c t e d :  9 6  p a t i e n t s  ( 1 0 2 c a s e s ) L o s t  t o  F U :  N R I n d i c a t i o n s :  o s t e o a r t h r i t i s :  M I  4 1 , S I  3 6 ;  r h e u m a t o i d  a r t h r i t i s :  M I  1 , S I  2 ;  a v a s c u l a r  n e c r o s i s :  M I  7 ,  S I  9 ; a n k y l o s i n g  s p o n d y l i t i s :  M I  0 ,  S I  2 ; d e v e l o p m e n t a l  d y s p l a s i a :  M I  0 ,  S I  1 ;  p o s t t r a u m a t i c  a r t h r i t i s :  M I  1 , S I  2 A g e  ( y e a r s ) :  M I  6 4 . 3  [ 1 9 \u2013 8 3 ] ,  S I :  6 5 . 1  [ 3 7 \u2013 8 9 ] ,  N S S e x  ( M \/ F ) :  M I  2 4 \/ 2 8 ,  S I  2 5 \/ 2 5 ,  N S M I :  N =  5 2  c a s e s S I :  N =  5 0  c a s e s O p e r a t i v e  a p p r o a c h M I :  8 \u2013 1 0  c m  s i n g l e -i n c i s i o n d i r e c t  l a t e r a l  a p p r o a c h U n c e m e n t e d S I :  1 5 \u2013 2 0 -c m  s i n g l e -i n c i s i o n t r a d i t i o n a l  d i r e c t  l a t e r a l a p p r o a c h U n c e m e n t e d A d d i t i o n a l  i n f o r m a t i o n : s u r g e r i e s  p e r f o r m e d  b y  a s i n g l e  s u r g e o n  w i t h o u t s p e c i a l  i n s t r u m e n t a t i o n M I S  =  l i m i t e d  i n c i s i o n  + l i m i t i n g  t h e  i n v o l v e m e n t  o f t h e  g l u t e u s  m a x i m u s  m u s c l e b e l l y I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) O p e r a t i o n  t i m e :  M I  5 0 ,  5 8 . 6  [ 3 2 \u2013 8 9 ] ,  S I  5 0 ,  5 7 . 9 [ 3 6 \u2013 9 0 ] ,  p =  0 . 7 1 5 A n a e s t h e t i c  t i m e :  M I  5 0 ,  1 0 0  [ 6 2 \u2013 1 3 3 ] ,  S I  5 2 ,  9 8 [ 7 1 \u2013 1 4 0 ] ,  N S I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) R e c o r d e d  b y  s u r g e o n :  M I  5 2 ,  2 1 7 . 5  [ 5 0 \u2013 6 0 0 ] ,  S I  5 0 ,  2 4 7  [ 1 0 0 \u2013 5 5 0 ] R e c o r d e d  b y  a n a e s t h e s i o l o g y :  M I  2 2 7 . 9  [ 7 5 \u2013 7 0 0 ] ,  S I  2 7 6  [ 5 0 \u2013 6 0 0 ] I n t r a o p e r a t i v e  f r a c t u r e  ( f e m o r a l ) : M I  2 \/ 5 2 ,  S I  0 \/ 5 0 P o s t o p e r a t i v e D i s l o c a t i o n :  M I  0 \/ 5 2 ,  S I  1 \/ 5 0  I n f e c t i o n I n f e c t i o n :  M I  0 \/ 5 2 ,  S I  1 \/ 5 0 A s e p t i c  w o u n d  p r o b l e m s :  M I  0 \/ 5 2 ,  S I  0 \/ 5 0 N e r v e  i n j u r y  ( n e r v e  p a l s y ) :  M I  0 \/ 5 2 ,  S I  0 \/ 5 0 D V T :  M I  0 \/ 5 2 ,  S I  1 \/ 5 0 P e r i -p r o s t h e t i c  f r a c t u r e :  s e e  e x c l u s i o n  c r i t e r i a L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) M I  5 2 ,  2 . 9 6  [ 1 \u2013 6 ] ,  S I  5 0 ,  2 . 9 4  [ 2 \u2013 4 ] ,  p =  0 . 8 5 8 P o s t o p e r a t i v e  p a i n T o t a l  i n t r a v e n o u s  n a r c o t i c  r e c e i v e d  d u r i n g h o s p i t a l i s a t i o n  ( e q u i a n a l g e s i c  e q u i v a l e n c y  t o m o r p h i n e )  ( m g ) :  M I  5 2 ,  9 2 . 7  [ 3 7 \u2013 1 8 0 ] ,  S I  5 0 ,  9 4 . 9 [ 3 8 \u2013 1 8 8 ] ,  N S F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e  a t  2  y e a r s :  9 6 . 2  f o r b o t h ,  N S R e v i s i o n  r a t e s :  M I  0 \/ 5 2 ,  S I  2 \/ 5 0 T i m e  t o  r e v i s i o n  ( m o n t h s ) : 1 \/ 2 r e v i s i o n  a t  l e s s  t h a n  1  m o n t h L o n g -t e r m  p a i n A t  2  w e e k s N o  p a i n :  M I  7 \/ 5 2 ,  S I  5 \/ 5 0 M i l d  p a i n :  M I  3 7 \/ 5 2 ,  S I  4 0 \/ 5 0 M o d e r a t e  p a i n :  M I  8 \/ 5 2 ,  S I  5 \/ 5 0 ,  N S A t  6  w e e k s N o  p a i n :  M I  3 8 \/ 5 2 ,  S I  3 8 \/ 4 9 ,  N S W a l k  w i t h o u t  l i m p :  M I  1 5 \/ 5 2 ,  S I  1 3 \/ 4 9 ,  N S W a l k  w i t h o u t  a i d :  M I  3 9 \/ 5 2 ,  S I  3 7 \/ 4 9 ,  N S A t  3  m o n t h s M i l d  p a i n :  M I  2 \/ 5 2 ,  S I  3 \/ 4 9 U s e  o f  w a l k i n g  a i d :  M I  4 \/ 5 2 ,  S I  4 \/ 4 9 V e r y  s l i g h t  l i m p :  M I  1 9 \/ 5 2 ,  S I  1 6 \/ 4 9 , N S L i m b  l e n g t h  i n e q u a l i t y :  M I  0 \/ 5 2 ,  S I  0 \/ 5 0 O t h e r \u2022 u r i n a r y  c o m p l i c a t i o n s  a t m i n i m u m  2 . 3  y e a r  f o l l o w -u p :  M I  3 \/ 5 2 ,  S I  0 \/ 5 0 \u2022 s h o r t n e s s  o f  b r e a t h  a t  m i n i m u m 2 . 3  y e a r  f o l l o w -u p :  M I  1 \/ 5 2 ,  S I  0 \/ 5 0 c o n t i n u e d C o m p a r a t i v e  s t u d i e sAppendix 8 128 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) B o d y  w e i g h t  ( k g ) :  M I  7 5 . 8 [ 4 6 \u2013 1 2 0 ] ,  S I  8 6 . 5  [ 5 2 \u2013 1 3 2 ] ,  p =  0 . 0 0 5 H e i g h t  ( c m ) :  M I  1 6 9 . 4  [ 1 5 2 \u2013 1 9 3 ] , S I  1 7 2 . 8  [ 1 5 2 \u2013 1 9 8 ] ,  N S B M I  ( k g \/ m 2 ) :  M I  2 6 . 1 2 [ 1 8 . 6 \u2013 3 9 . 1 ] ,  S I  2 8 . 6 7  [ 1 7 . 9 \u2013 3 8 . 3 ] , p =  0 . 0 0 7 T i m e  t o  r e t u r n  t o  u s u a l  a c t i v i t i e s  ( b e f o r e  d i s c h a r g e ) F i r s t  a m b u l a t i o n  ( d a y s ) :  M I  5 1 ,  1 . 0 6  [ 1 \u2013 2 ] ,  S I  4 9 , 1 . 1 0  [ 1 \u2013 2 ] ,  N S T o t a l  d i s t a n c e  a t  d a y  2  ( f t ) :  M I  5 1 ,  3 5 2  [ 1 0 \u2013 8 7 0 ] ,  S I  4 9 ,  3 7 9  [ 4 8 \u2013 2 0 0 0 ] ,  N S M a x .  d i s t a n c e  i n  a  s e s s i o n  ( f t ) :  M I  5 1 ,  1 9 3  [ 5 6 \u2013 3 0 0 ] , S I  4 9 ,  1 9 1  [ 3 0 \u2013 8 0 0 ] I m p l a n t  p o s i t i o n  ( p o s t o p e r a t i v e  r a d i o g r a p h i c a n a l y s i s )  C o m p o n e n t s  w e l l -p l a c e d ;  n o  d i f f e r e n c e  i n  q u a l i t y  o f c o m p o n e n t  p l a c e m e n t  A v e r a g e  a b d u c t i o n  o f  t h e  a c e t a b u l a r  c u p :  4 1 . 1 \u00b0 [ 2 2 \u2013 5 2 ] C u t  a n t e v e r s i o n :  4 . 8 \u00b0 [ 0 \u2013 1 0 . 8 ] F e m o r a l  o f f s e t  ( m m ) :  4 1 . 3  [ 2 7 \u2013 6 0 ] B o d y  w e i g h t  l e v e r  a r m  d i s t a n c e  ( m m ) :  1 0 6 . 1 [ 8 2 \u2013 1 2 4 ] \u2022 d i s c h a r g e  d i s p o s i t i o n ( h o m e \/ i n p a t i e n t  r e h a b i l i t a t i o n )  \u2013 T a b l e  4 \u2022 \u201c n o  u n s t a b l e  f i x a t i o n  a t 2 4 \u2013 4 2 m o n t h s \u201d  ( n o  a s e p t i c l o o s e n i n g ) c o n t i n u e","cites":null},{"id":6013866,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) B e r g e r ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 129 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) B e r g e r ,  2 0 0 4 2 9 S t u d y  d e s i g n : p r o s p e c t i v e c o m p a r a t i v e c o n s e c u t i v e  s e r i e s L o c a t i o n :  U S A R e c r u i t m e n t  d a t e s : N R F u n d i n g :  N R D u r a t i o n  o f  F U : i n i t i a l  p o s t o p e r a t i v e p e r i o d  o n l y I n c l u s i o n  c r i t e r i a :  p r i m a r y  T H R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  2 0 0 L o s t  t o  F U :  N R I n d i c a t i o n s :  N R A g e  ( y e a r s ) :  M I  5 7 ,  S I  5 9 M I :  N =  1 0 0 S I :  N =  1 0 0 O p e r a t i v e  a p p r o a c h M I :  3 . 2 5  [ 2 . 7 5 \u2013 3 . 7 5 ] -i n c h s i n g l e -i n c i s i o n ,  a n t e r o l a t e r a l a p p r o a c h C e m e n t e d \/ c e m e n t l e s s :  N R S I :  6 \u2013 8 -i n c h  s i n g l e  i n c i s i o n , s t a n d a r d  a n t e r o l a t e r a l a p p r o a c h C e m e n t e d \/ c e m e n t l e s s :  N R A d d i t i o n a l  i n f o r m a t i o n : s p e c i a l i s e d  r e t r a c t o r s  a n d r e a m e r s  i n  M I ;  s p e c i a l l y d e s i g n e d  p r o v i s i o n a l  n e c k a n d  h e a d  ( m i n i -i n c i s i o n i n s t r u m e n t  s e t ) ;  s p e c i a l r e t r a c t o r s  w i t h  b u i l t -i n  f i b r e -o p t i c  l i g h t s  m a y  a l s o  b e u s e d  i n  M I  M I  =  s m a l l  i n c i s i o n  + r e m o v i n g  2 0 \u2013 2 5 %  o f  t h e a b d u c t o r  o f f  t h e  t r o c h a n t e r S I  =  6 \u2013 8 -i n c h  i n c i s i o n  + r e m o v i n g  5 0 %  o f  t h e a b d u c t o r  o f f  t h e  t r o c h a n t e r  I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  9 9 ,  7 2 ,  S I  1 0 0 ,  6 6 I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  9 9 ,  1 5 4 ,  S I  1 0 0 ,  2 7 8 ,  p >  0 . 0 5 O p p o s i t e  m e t h o d  i n i t i a t e d M I  1 \/ 1 0 0 ,  S I  0 \/ 1 0 0 I n t r a o p e r a t i v e  f r a c t u r e M I  1 \/ 9 9 ,  S I  1 \/ 1 0 0 P o s t o p e r a t i v e D i s l o c a t i o n :  M I  0 \/ 9 9 ,  S I  0 \/ 1 0 0 I n f e c t i o n  o r  s k i n  b r e a k d o w n :  M I  0 \/ 9 9 ,  S I  0 \/ 1 0 0 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) :  M I  1 0 0 ,  1 . 9 .  S I  1 0 0 ,  3 . 5 ,  p >  0 . 0 5 O t h e r \u2022 P E :  M I  0 \/ 9 9 ,  S I  0 \/ 1 0 0 \u2022 m y o c a r d i a l  i n f a r c t i o n :  M I  0 \/ 9 9 ,  S I  0 \/ 1 0 0 \u2022 \u201c o t h e r  s e r i o u s  p r o b l e m s \u201d :  M I  0 \/ 9 9 ,  S I  0 \/ 1 0 0 \u2022 t r a n s f e r  r a t e  t o  a  r e h a b i l i t a t i o n f a c i l i t y :  M I  1 2 \/ 9 9 ,  S I  2 8 \/ 1 0 0 , p > 0 . 0 5 \u2022 r e a d m i s s i o n :  M I  0 \/ 9 9 ,  S I  0 \/ 1 0 0 c o n t i n u e dAppendix 8 130 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) C h e n ,  2 0 0 6 3 0 S t u d y  d e s i g n : p r o s p e c t i v e c o m p a r a t i v e  c o h o r t s L o c a t i o n :  C h i n a R e c r u i t m e n t  d a t e s : J u n e  2 0 0 2 \u2013 J a n u a r y 2 0 0 5 F u n d i n g :  N R D u r a t i o n  o f  F U : 0 . 5 \u2013 2 . 2  y e a r s I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  1 4 6 L o s t  t o  F U :  N R I n d i c a t i o n s :  o s t e o a r t h r i t i s  M I  1 2 ,  S I  1 9 ;  o s t e o n e c r o s i s  M I  8 ,  S I  1 5 ; d e f o r m i t y  M I  0 ,  S I  8 ;  f e m o r a l  n e c k f r a c t u r e  M I  3 1 ,  S I  5 3  A g e  ( y e a r s ) :  M I  6 8 . 0 6  ( 5 . 9 2 ) ,  S I  6 9 . 7 8  ( 8 . 5 7 ) S e x  ( M \/ F ) :  M I  2 8 \/ 2 3 ,  S I  5 4 \/ 4 1 B o d y  w e i g h t  ( k g ) :  M I  6 8 . 0 8  ( 4 . 6 ) , S I  7 0 . 5 9  ( 5 . 1 7 )  H a r r i s  h i p  s c o r e :  M I  2 6 . 1 6  ( 1 6 . 4 8 ) , S I  2 2 . 5 1  ( 1 6 . 7 5 ) P r e o p e r a t i v e  p a i n :  M I  8 3 . 7 8 ( 8 . 0 3 ) ,  S I  8 3 . 3 9  ( 8 . 3 3 )  P o s s i b l y  b a s e d  o n  H a r r i s  h i p  s c o r e C o -m o r b i d i t y C a r d i o p a t h y :  M I  2 \/ 5 1 ,  S I  5 \/ 9 5 H y p e r t e n s i o n :  M I  5 \/ 5 1 ,  S I  9 \/ 9 5 D i a b e t e s :  M I  1 1 \/ 5 1 ,  S I  2 1 \/ 9 5 O t h e r :  M I  2 \/ 5 1 ,  S I  3 \/ 9 5 M I :  N =  5 1  ( 3 6  s i n g l e -i n c i s i o n ,  1 5  t w o -i n c i s i o n )  S I :  N =  9 5 O p e r a t i v e  a p p r o a c h M I :  ( 1 )   1 0 -c m  s i n g l e -i n c i s i o n  p o s t e r i o r  ( G i b s o n ) a p p r o a c h ;  ( 2 )  t w o -i n c i s i o n M I S  2 9  c e m e n t e d ,  2 2  c e m e n t l e s s S I :  1 5 \u2013 2 0 -c m  s i n g l e -i n c i s i o n p o s t e r i o r  ( G i b s o n )  a p p r o a c h 5 6  c e m e n t e d ,  3 9  c e m e n t l e s s A d d i t i o n a l  i n f o r m a t i o n :  n o n e I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  5 1 ,  8 8 . 4 1  ( 1 7 . 6 0 ) ,  S I  9 5 ,  9 0 . 8 4  ( 1 7 . 8 1 ) I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  5 1 ,  1 7 5 . 4 9  ( 5 1 . 9 0 ) ,  S I  9 5 ,  2 9 3 . 6 8  ( 8 4 . 5 0 ) P o s t o p e r a t i v e D i s l o c a t i o n :  M I  0 \/ 5 1 ,  S I  0 \/ 9 5  N e r v e  i n j u r y L a t e r a l  t h i g h  n e r v e  p a r a l y s i s :  M I  0 \/ 5 1 ,  S I  2 \/ 9 5  P e r i -p r o s t h e t i c  f r a c t u r e :  M I  3 \/ 5 1 ,  S I  4 \/ 9 5 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) :  M I  5 1 ,  1 1 . 1 6  ( 0 . 8 3 ) , S I  9 5 ,  1 2 . 8 3  ( 1 . 9 6 ) T i m e  t o  r e t u r n  t o  u s u a l  a c t i v i t i e s  ( w e e k s ) :  M I  8 . 0 6 ( 1 . 8 ) ,  S I  1 6 . 4 3  ( 1 . 5 3 ) F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e  a t  6  m o n t h s :  M I  8 9 . 7 1  ( 3 . 6 2 ) ,  S I  8 3 . 7 8  ( 8 . 0 3 ) L o n g -t e r m  p a i n :  M I  3 0  ( 1 5 . 2 6 ) ,  S I  4 9 . 5 8  ( 1 6 . 3 8 ) ,  p <  0 . 0 5 P o s s i b l y  b a s e d  o n  H a r r i s  h i p  s c o r e S a t i s f a c t i o n P a t i e n t  s a t i s f a c t i o n  h i g h e r  i n  M I g r o u p  t h a n  i n  S I  g r o u p O t h e r \u2022 t o t a l  b l o o d  l o s s  ( o p e r a t i o n  + 1 \u2013 3 d a y s  p o s t o p e r a t i v e )  ( m l ) :  M I  3 6 9 . 5 1  ( 6 5 . 0 5 ) ,  S I  5 0 9 . 6 3 ( 1 1 7 . 3 9 )  c o n t i n u e","cites":null},{"id":6013857,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) C h i m e n t o ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 119 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) C h i m e n t o ,  2 0 0 5 3 1 , 6 8 S t u d y  d e s i g n :  R C T L o c a t i o n :  N e w  Y o r k , U S A R e c r u i t m e n t  d a t e s :  N o v e m b e r 1 9 9 9 \u2013 J u l y  2 0 0 0 F u n d i n g :  n o n e D u r a t i o n  o f  F U : 2 y e a r s I n c l u s i o n  c r i t e r i a :  B M I  < 3 0 E x c l u s i o n  c r i t e r i a :  p r i o r  h i p s u r g e r y ;  h i p  p a t h o l o g y  r e q u i r i n g e x t e n s i l e  e x p o s u r e  ( N =  0 ) N e l i g i b l e :  2 6 5  ( 2 5 1  s o l i c i t e d  f o r s t u d y ) N r a n d o m i s e d :  6 0 L o s t  t o  F U :  M I  1 ,  S I  3  ( i n c l u d i n g  2  d e a t h s ) I n d i c a t i o n s :  o s t e o a r t h r i t i s :  M I  2 8 \/ 2 8 ,  S I  3 2 \/ 3 2 A g e  ( y e a r s ) :  M I  6 7 . 2  ( 8 . 6 ) ,  S I  6 5 . 6 ( 1 0 . 5 ) ,  N S S e x  ( M \/ F ) :  M I  1 6 \/ 1 2 ,  S I  1 3 \/ 1 9 B o d y  w e i g h t  ( k g ) :  M I  7 1 . 7  ( 1 2 . 8 ) , S I  7 3 . 0  ( 1 3 . 0 ) ,  N S H e i g h t  ( c m ) :  M I  1 6 8  ( 9 . 3 ) ,  S I  1 7 1 ( 1 0 . 9 ) B M I  ( k g \/ m 2 ) :  M I  2 5 . 2  ( 3 . 1 ) ,  S I  2 4 . 8  ( 2 . 5 ) H a r r i s  h i p  s c o r e :  M I  5 4 . 2  ( 9 . 4 ) ,  S I  5 3 . 4  ( 7 . 9 ) M I :  N =  2 8 S I :  N =  3 2 O p e r a t i v e  a p p r o a c h M I :  8 -c m  s i n g l e -i n c i s i o n , m o d i f i e d  p o s t e r o l a t e r a l a p p r o a c h 2 7  h y b r i d  ( c e m e n t l e s s  c u p +  c e m e n t e d  s t e m ) ,  1  u n c e m e n t e d S I :  1 5 -c m  s i n g l e -i n c i s i o n , p o s t e r o l a t e r a l  a p p r o a c h 2 8  h y b r i d  ( c e m e n t l e s s  c u p +  c e m e n t e d  s t e m ) ,  4  u n c e m e n t e d A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  p e r f o r m e d  b y  o r s u p e r v i s e d  b y  t h e  s e n i o r a u t h o r  ( S c u l c o ) S m a l l  s p e c i a l i s e d  r e t r a c t o r s f o r  M I I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  2 8 ,  7 0 . 3  ( 1 0 . 7 ) ,  S I  3 2 ,  7 0 . 0  ( 8 . 5 ) ,  p =  0 . 4 I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  2 8 ,  1 2 7  ( 4 8 ) ,  S I  3 2 ,  1 7 0  ( 6 5 ) ,  p =  0 . 0 0 3 C o n v e r s i o n :  M I :  0 \/ 2 8  ( n o  i n c i s i o n s  n e e d e d e x t e n s i o n ) P o s t o p e r a t i v e D i s l o c a t i o n :  M I  2 \/ 2 8 ,  S I  0 \/ 3 2 ,  N S I n f e c t i o n :  M I  0 \/ 2 8 ,  S I  0 \/ 3 2 N e r v e  i n j u r y :  M I  0 \/ 2 8 ,  S I  0 \/ 3 2 D V T :  M I  0 \/ 2 8 ,  S I  0 \/ 3 2 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) M I  2 8 ,  5 . 8  [ 4 \u2013 1 3 ] ,  S I  3 2 ,  5 . 5  [ 3 \u2013 1 5 ] ,  N S P o s t o p e r a t i v e  p a i n  P a t i e n t -c o n t r o l l e d  e p i d u r a l  a n a e s t h e s i a  ( m l ) : M I  2 8 ,  2 8 5  ( 1 8 5 ) ,  S I  3 2 ,  3 1 9  ( 1 7 7 ) ,  N S O r a l  n a r c o t i c s  ( n ) :  M I  2 8 ,  3 . 2 7  ( 1 . 9 ) ,  S I  3 2 , 3 . 1 3  ( 2 . 6 ) ,  N S T i m e  t o  r e t u r n  t o  u s u a l  a c t i v i t i e s D a y s  t o  r e a c h  r e h a b i l i t a t i o n  g o a l s ( F i g u r e 2 ) ,  N S  T i m e  t o  t r a n s f e r  i n d e p e n d e n t l y T i m e  t o  a m b u l a t e  w i t h  a  w a l k e r T i m e  t o  a m b u l a t e  w i t h  a  c a n e T i m e  t o  n e g o t i a t e  s t a i r s  I m p l a n t  p o s i t i o n  ( p o s t o p e r a t i v e r a d i o g r a p h i c  a n a l y s i s )  S t e m  i n  v a r u s :  M I  1 \/ 2 8 ,  S I  1 \/ 3 2 ,  N S A c e t a b u l a r  c o m p o n e n t  a b d u c t i o n  a n g l e :  M I  2 8 ,  3 6 . 6 \u00b0 ( R 3 0 \u2013 4 5 ) ,  S I  3 2 ,  3 6 . 5 \u00b0 ( R 3 0 \u2013 4 7 ) ,  N S G a p  > 2  m m  i n  d o m e  o f  a c e t a b u l u m  ( =  u n c e m e n t e d ) :  M I  2 ,  S I  2 ,  N S F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e  ( a t  2  y e a r s ) :  M I  2 7 ,  9 4 . 5 ,  S I  2 9 ,  9 4 . 5 R e q u i r e d  a  c a n e  a t  6  w e e k s :  M I  9 \/ 2 8 ,  S I  1 5 \/ 3 2 ,  N S P e r s i s t e n t  l i m p  a t  6  w e e k s :  M I  6 \/ 2 8 ,  S I  1 5 \/ 3 1 ,  p =  0 . 0 4 P e r s i s t e n t  l i m p  a t  1  y e a r :  M I  0 \/ 2 7 ,  S I  0 \/ 2 9 R e v i s i o n  r a t e s :  M I  1 \/ 2 7 ,  S I  0 \/ 2 9 M o r t a l i t y  ( a t  2  y e a r s ) M I  0 \/ 2 8 ,  S I  2 \/ 3 2  ( u n r e l a t e d  t o  s u r g e r y ) S u r r o g a t e s  f o r  l o n g -t e r m  o u t c o m e s C e m e n t  q u a l i t y :  M I  A  =  4 \/ 2 7 ,  B  =  2 0 \/ 2 7 , C  =  3 \/ 2 7 ;  S I  A  =  8 \/ 2 8 ,  B  =  1 9 \/ 2 8 ,  C  =  1 \/ 2 8 ;  N S  f o r  o v e r a l l  g r a d i n g  o r  f o r  N o f  g r a d e  C O t h e r \u2022 t o t a l  b l o o d  l o s s  ( m l ) :  M I  2 8 ,  3 7 8  ( 1 5 1 ) ,  S I  3 2 ,  5 0 4  ( 2 0 5 ) ,  p =  0 . 0 0 9 \u2022 d i s c h a r g e  t o  h o m e \/ f a c i l i t y \u2022 s e r u m  I L -6  l e v e l s \/ c y t o k i n e \u2022 a t r i a l  f l u t t e r \u2022 v i s u a l  h a l l u c i n a t i o n  w h i l e  o n  t h e  P C E A p u m p \u2022 d e v e l o p e d  a  r a s h \u2022 e x p e r i e n c e d  a n a l g e s i c -r e l a t e d  c o n f u s i o n \u2022 s c i a t i c  p a i n  i n  t h e  c o n t r a l a t e r a l  l e g ( p e r i o p e r a t i v e  c o m p l i c a t i o n ) ? :  M I  1 \/ 2 8 ,  S I  0 \/ 3 2 c o n t i n u e dAppendix 8 120 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) C h u n g ,  2 0 0 4 3 2 S t u d y  d e s i g n :  q u a s i -R C T  ( a l t e r n a t e a l l o c a t i o n ) L o c a t i o n :  A u s t r a l i a R e c r u i t m e n t  d a t e s : N R F u n d i n g :  N R D u r a t i o n  o f  F U :  1 . 2  [ 0 . 8 \u2013 2 . 2 ]  y e a r s I n c l u s i o n  c r i t e r i a :  o s t e o a r t h r i t i s E x c l u s i o n  c r i t e r i a :  w e i g h t > 1 0 0 k g ;  s e m i -a n k y l o s e d  j o i n t s ; s e v e r e  p r o t r u s i o ;  d y s p l a s i a N e l i g i b l e :  1 2 0 N r a n d o m i s e d :  1 2 0 L o s t  t o  F U :  n o n e I n d i c a t i o n s :  o s t e o a r t h r i t i s :  M I 6 0 \/ 6 0 ,  S I  6 0 \/ 6 0 A g e  ( y e a r s ) :  M I  6 1  [ 4 1 \u2013 8 3 ] ,  S I  6 4  [ 4 8 \u2013 8 1 ] S e x  ( M \/ F ) :  M I  2 4 \/ 3 6 ,  S I  2 8 \/ 3 2 B o d y  w e i g h t  ( k g ) :  M I  8 4 ,  S I  8 6 . 5 M I :  N =  6 0 S I :  N =  6 0 O p e r a t i v e  a p p r o a c h M I :  9 . 2  [ 6 \u2013 1 1 ] -c m  s i n g l e -i n c i s i o n ,  p o s t e r o l a t e r a l a p p r o a c h P o r o u s -c o a t e d  c u p  + u n c e m e n t e d  s t e m S I :  2 0 . 0  [ 1 5 \u2013 2 8 ] -c m  s i n g l e -i n c i s i o n ,  p o s t e r i o r  a p p r o a c h P o r o u s -c o a t e d  c u p  + u n c e m e n t e d  s t e m A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  p e r f o r m e d  b y  o n e s u r g e o n  w i t h  n o  s p e c i a l i s e d e q u i p m e n t ;  e a r l y  r e s u l t s  o f M I  f r o m  f i r s t  6 0  c a s e s  I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  6 0 ,  4 9  ( 9 . 4 )  [ 3 5 \u2013 6 5 ] ,  S I  6 0 ,  5 5 . 1  ( 1 7 . 9 ) [ 3 0 \u2013 9 0 ] ,  N S I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  6 0 ,  1 3 6  ( 4 1 . 1 )  [ 7 5 \u2013 2 5 0 ] ,  S I  6 0 ,  2 0 0 . 5 ( 6 5 . 2 )  [ 9 5 \u2013 3 0 0 ] ,  p < 0 . 0 1 P o s t o p e r a t i v e D i s l o c a t i o n :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 I n f e c t i o n  ( w o u n d ) :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 N e r v e  i n j u r y :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 D V T :  M I  3 \/ 6 0 ,  S I  5 \/ 6 0 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) M I  6 0 ,  4 . 4 1  ( 1 . 1 )  [ 3 \u2013 7 ] .  S I  6 0 ,  5 . 3 4  ( 1 . 4 ) [ 4 \u2013 9 ] ,  p < 0 . 0 1 P o s t o p e r a t i v e  p a i n N a r c o t i c  u s e  ( d a y s ) :  M I  6 0 ,  2 . 2 ,  S I  6 0 ,  2 . 6 4 , N S T i m e  t o  r e t u r n  t o  u s u a l  a c t i v i t i e s U s e  o f  w a l k i n g  a i d s  ( d a y s ) :  M I  6 0 ,  2 1 . 4  ( 4 . 8 ) [ 1 4 \u2013 3 0 ] ,  S I  6 0 ,  2 4 . 8  ( 5 . 4 )  [ 1 4 \u2013 3 0 ] I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c  a n a l y s i s  \u2013 t i m i n g  u n c l e a r ) I m p l a n t  i n s e r t i o n  e r r o r s  o r  c o m p o n e n t m a l a l i g n m e n t :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 A l l  f e m o r a l  s t e m s  w i t h i n  3 \u00b0 o f  n e u t r a l a l i g n m e n t  w i t h  r e s p e c t  t o  t h e  f e m o r a l  s h a f t a x i s A l l  a c e t a b u l a r  c o m p o n e n t s  w i t h i n  t h e  4 0  t o 5 0 \u00b0 a b d u c t i o n  a n g l e  r a n g e F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e  a t  l a s t  f o l l o w -u p :  M I  9 5 . 5 , S I  9 3 . 5 ,  N S c o n t i n u e","cites":null},{"id":6013869,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) C i m i n i e l l o ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 131 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) C i m i n i e l l o ,  2 0 0 6 3 3 , 7 6 S t u d y  d e s i g n : p r o s p e c t i v e m a t c h e d -p a i r  s t u d y ; t h e  t w o  g r o u p s m a t c h e d  f o r  a g e , s e x ,  B M I ,  A m e r i c a n S o c i e t y  o f A n e s t h e s i o l o g i s t s ( A S A )  s c o r e , d i a g n o s i s ,  p r o s t h e s i s , t y p e  o f  f i x a t i o n , a n a e s t h e s i a ,  s u r g i c a l a p p r o a c h  a n d i n t r a o p e r a t i v e p a t i e n t  p o s i t i o n i n g L o c a t i o n :  U S A R e c r u i t m e n t  d a t e s : N R  ( 8 -m o n t h p e r i o d ) F u n d i n g :  n o n e D u r a t i o n  o f  F U : 6 w e e k s I n c l u s i o n  c r i t e r i a :  e n d -s t a g e o s t e o a r t h r i t i s E x c l u s i o n  c r i t e r i a :  N R  N e l i g i b l e :  1 2 0 L o s t  t o  F U :  N R I n d i c a t i o n s :  o s t e o a r t h r i t i s  M I  6 0 , S I 6 0 A g e  ( y e a r s ) :  M I  6 9 . 8  [ 3 9 \u2013 8 9 ] , S I 7 0 . 2  [ 4 2 \u2013 7 9 ] S e x  ( M \/ F ) :  M I  1 5 \/ 4 5 ,  S I  1 5 \/ 4 5 B M I  ( k g \/ m 2 ) :  M I  2 3 . 8 1 [ 2 0 . 1 \u2013 3 4 . 8 ] ,  S I  2 4 . 1 1  [ 2 1 . 2 \u2013 3 5 . 1 ] H a r r i s  h i p  s c o r e :  M I  4 9 . 2 6 [ 2 0 \u2013 7 5 ] ,  S I  5 6 . 1 3  [ 3 0 \u2013 8 0 ] O t h e r :  A S A  s c o r e M I :  N =  6 0 S I :  N =  6 0 O p e r a t i v e  a p p r o a c h M I :  s i n g l e -i n c i s i o n  ( < 5  i n c h ) , a n t e r o l a t e r a l  a p p r o a c h 6 0  u n c e m e n t e d  T H R  ( s t e m +  c o m p o n e n t ) S I :  s i n g l e -i n c i s i o n  (  5  i n c h ) , a n t e r o l a t e r a l  a p p r o a c h 6 0  u n c e m e n t e d  T H R  ( s t e m +  c o m p o n e n t ) A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  p e r f o r m e d  b y  o r s u p e r v i s e d  b y  a  s i n g l e s u r g e o n  a t  a  h i g h -v o l u m e j o i n t  a r t h r o p l a s t y  c e n t r e I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  6 0 ,  5 5 . 4 5  [ 4 0 \u2013 1 7 0 ] ,  S I  6 0 ,  5 6 . 9 5  [ 3 5 \u2013 9 0 ] ,  N S I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  6 0 ,  2 0 1 . 6 7  [ 4 0 \u2013 1 7 0 ] ,  S I  6 0 ,  1 9 1 . 7 3  [ 1 0 0 \u2013 4 0 0 ] , N S P o s t o p e r a t i v e D i s l o c a t i o n :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 I n f e c t i o n  ( d e e p  o r  s u p e r f i c i a l ) :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 P e r i -p r o s t h e t i c  f r a c t u r e :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 3 0 -d a y  m o r t a l i t y :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) M I  6 0 ,  3 . 7  [ 2 \u2013 7 ] ;  S I  6 0 ,  3 . 6 3  [ 2 \u2013 5 ] ,  N S P o s t o p e r a t i v e  p a i n E q u i a n a l g e s i c  r e q u i r e m e n t  u p  t o  6  w e e k s  ( m g ) :  M I  6 0 ,  1 1 8  [ 1 0 . 5 \u2013 4 5 0 . 6 ] ,  S I  6 0 ,  1 2 1  [ 8 . 6 \u2013 3 9 0 . 5 ] , N S I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c  a n a l y s i s  a t  6  w e e k s ) A c e t a b u l a r  c o m p o n e n t  o p t i m a l l y  p o s i t i o n e d  ( i . e . a n t e v e r s i o n  b e t w e e n  1 0 \u2013 2 0 \u00b0 a n d  a n  a b d u c t i o n a n g l e  b e t w e e n  3 0 \u2013 5 0 \u00b0 ) :  M I  6 0 \/ 6 0 ,  S I  6 0 \/ 6 0 F e m o r a l  c o m p o n e n t  o p t i m a l l y  p o s i t i o n e d  ( i . e .  t h e v a r u s  o r  v a l g u s  a n g l e  w a s  l e s s  t h a n  5 \u00b0 ) :  M I  6 0 \/ 6 0 , S I 6 0 \/ 6 0 F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e  a t  6  w e e k s :  M I  9 1 . 0 2  [ 6 0 \u2013 1 0 0 ] ,  S I  9 4 . 9 3 [ 7 0 \u2013 1 0 0 ] I m p r o v e m e n t  f r o m  p r e o p e r a t i v e H a r r i s  h i p  s c o r e :  M I  4 1 . 7 6  ( 1 1 . 0 6 ) S I  3 8 . 8 0  ( 1 1 . 2 5 ) ,  N S R e v i s i o n  r a t e s :  M I  1 \/ 6 0 ,  S I  0 \/ 6 0 T i m e  t o  r e v i s i o n  ( m o n t h s ) :  M I 8 m o n t h s L o n g -t e r m  p a i n  ( t h i g h  p a i n ) : M I 0 \/ 6 0 ,  S I  0 \/ 6 0 M o r t a l i t y  ( a t  6  w e e k s ) :  M I  0 \/ 6 0 , S I 0 \/ 6 0 S u r r o g a t e s  f o r  l o n g -t e r m o u t c o m e s I m p l a n t  m i g r a t i o n :  M I  1 \/ 6 0 ,  S I  0 \/ 6 0  O t h e r \u2022 d i s c h a r g e  t o  r e h a b i l i t a t i o n  f a c i l i t y : M I  4 9 \/ 6 0  ( 8 1 % ) ,  S I  4 6 \/ 6 0  ( 7 6 % ) c o n t i n u e dAppendix 8 132 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) d e  B e e r ,  2 0 0 4 3 4 S t u d y  d e s i g n : m a t c h e d  p a i r  s t u d y ; m a t c h e d  f o r  a g e , g e n d e r ,  B M I , d i a g n o s i s  a n d A m e r i c a n  S o c i e t y  o f A n e s t h e s i o l o g i s t s ( A S A )  s c o r e , s t r a t i f i e d  b y  s u r g e o n ; p i l o t  s t u d y D a t a  g a t h e r e d  f r o m a  p r o s p e c t i v e l y g a t h e r e d a r t h r o p l a s t y d a t a b a s e  o f  4 0 0 p r i m a r y  T H R s L o c a t i o n :  O n t a r i o , C a n a d a R e c r u i t m e n t  d a t e s : 1 6 -m o n t h  p e r i o d F u n d i n g :  N R  D u r a t i o n  o f  F U : 6 w e e k s I n c l u s i o n  c r i t e r i a :  o s t e o a r t h r i t i s ; p r i m a r y  T H R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  4 0 0 L o s t  t o  F U :  n o n e I n d i c a t i o n s :  o s t e o a r t h r i t i s  M I  3 0 , S I 3 0 A g e  ( y e a r s ) :  M I  7 1  ( 8 . 9 )  [ 4 5 \u2013 8 6 ] , S I  6 9  ( 1 2 . 3 )  [ 3 9 \u2013 8 5 ] ,  N S S e x  ( M \/ F ) :  M I  1 0 \/ 2 0 ,  S I  1 0 \/ 2 0 B M I  ( k g \/ m 2 ) :  M I  3 2 . 4  ( 5 . 0 ) [ 2 1 . 6 \u2013 4 1 . 7 ] ,  S I  3 1 . 7  ( 5 . 9 ) [ 1 9 . 6 \u2013 4 3 . 4 ] ,  p =  0 . 5 7 9 H a r r i s  h i p  s c o r e :  M I  3 6 . 8  ( 1 2 ) [ 2 1 \u2013 5 9 ] ,  S I  3 6 . 4  ( 6 . 8 )  [ 2 3 \u2013 4 8 ] ,  N S O x f o r d  h i p  s c o r e :  M I  4 3 . 6  ( 6 . 2 ) [ 3 1 \u2013 5 4 ] ,  S I  4 0 . 9  ( 6 . 6 )  [ 3 1 \u2013 5 3 ] ,  N S F l e x i o n :  s e e  T a b l e  1 A l l  p a t i e n t s  h a d  a n  a v e r a g e  A S A r a n g e  o f  2 ,  i n d i c a t i n g  m i l d s y s t e m a t i c  d i s e a s e M I :  N = 3 0  S I :  N = 3 0  O p e r a t i v e  a p p r o a c h M I :  7 . 7  [ 6 \u2013 1 0 ] -c m  s i n g l e -i n c i s i o n ,  d i r e c t  l a t e r a l a p p r o a c h 2 6 \/ 3 0  c e m e n t l e s s  s t e m 4 \/ 3 0  c e m e n t e d  s t e m 3 0 \/ 3 0  c e m e n t l e s s  a c e t a b u l a r c l u s t e r S I :  1 3 . 9  [ 1 1 \u2013 2 2 ] -c m  s i n g l e -i n c i s i o n ,  s t a n d a r d  d i r e c t l a t e r a l  a p p r o a c h 2 6 \/ 3 0  c e m e n t l e s s  s t e m 4 \/ 3 0  c e m e n t e d  s t e m 3 0 \/ 3 0  c e m e n t l e s s  a c e t a b u l a r c l u s t e r A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  o p e r a t e d  b y  o r s u p e r v i s e d  b y  2  s u r g e o n s  a t  a h i g h -v o l u m e  a r t h r o p l a s t y c e n t r e  w i t h  s t a n d a r d i n s t r u m e n t a t i o n  a n d r e t r a c t o r s  \u201c T h e  d i s s e c t i o n  d e e p  t o  t h e f a s c i a  l a t a  w a s  i d e n t i c a l  f o r b o t h  M I  a n d  S I  g r o u p s \u201d ( p . 9 4 6 ) I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  3 0 ,  4 6 . 6  [ 2 4 \u2013 9 0 ] ,  S I  3 0 ,  4 4 . 5  [ 1 7 \u2013 7 5 ] ,  p =  0 . 5 7 2 I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  3 0 ,  1 8 0  ( 6 9 )  [ 1 0 0 \u2013 3 0 0 ] ,  S I  3 0 ,  2 4 6 . 7  ( 9 9 ) [ 1 0 0 \u2013 6 0 0 ] ,  p =  0 . 0 4  P o s t o p e r a t i v e D V T :  M I  0 \/ 3 0 ,  S I  1 \/ 3 0 P e r i -p r o s t h e t i c  f r a c t u r e :  M I  1 \/ 3 0  ( f a l l  a t  h o m e ) ,  S I  0 \/ 3 0 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) M I  3 0 ,  5 . 1 3  [ 3 \u2013 8 ] ,  S I  3 0 ,  5 . 1 0  [ 4 \u2013 8 ] ,  p =  0 . 8 9 4 P o s t o p e r a t i v e  p a i n  E q u i a n a l g e s i c  o p i o i d  c o n s u m p t i o n  ( m g ) :  M I  3 0 , 1 4 7 . 7  [ 1 8 \u2013 3 3 7 . 9 ] ,  S I  3 0 ,  1 6 9 . 3  [ 2 3 . 3 \u2013 4 1 3 . 3 ] , p = 0 . 3 3 6 I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c  a n a l y s i s  a t  6  w e e k s )  F e m o r a l  s t e m  n e u t r a l  a l i g n m e n t :  M I  3 0 \/ 3 0 ,  S I  3 0 \/ 3 0 C u p  a c e t a b u l a r  l a t e r a l  o p e n i n g  ( c u p  a b d u c t i o n a n g l e ) :  M I  3 9 . 0 3 \u00b0 ( 6 . 5 )  [ 2 2 \u2013 5 2 ] ,  S I  3 7 . 7 \u00b0 ( 5 . 6 ) [ 2 4 \u2013 5 0 ] ,  p = 0 . 4 1 4 C u p  a n t e v e r s i o n  a n g l e :  M I  1 8 . 5 \u00b0 ( 6 . 8 )  [ 4 \u2013 3 0 ] , S I 1 6 . 5 \u00b0 ( 7 . 3 )  [ 0 \u2013 3 0 ] ,  p =  0 . 2 8 C o m b i n e d  a c e t a b u l a r  a n g l e :  M I  5 7 . 6 \u00b0 ( 9 . 6 )  [ 3 8 \u2013 8 0 ] , S I  5 4 . 2 \u00b0 ( 7 . 6 )  [ 4 0 \u2013 8 6 ] ,  p = 0 . 1 4 6 F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e  a t  6  w e e k s :  M I  7 1 . 1  ( 9 . 8 )  [ 4 1 \u2013 8 7 ] ,  S I  6 6 . 6  ( 1 2 . 2 ) [ 3 2 \u2013 8 4 ] ,  p =  0 . 1 9 3 O x f o r d  h i p  s c o r e  a t  6  w e e k s : M I 2 6 . 5  ( 8 . 4 )  [ 1 3 \u2013 4 0 ] ,  S I  2 8 . 4  ( 7 . 5 ) [ 1 9 \u2013 3 9 ] ,  p =  0 . 4 9 4  L o n g -t e r m  p a i n  S u b c u t a n e o u s  h e m a t o m a ,  m i l d s c i a t i c a  a n d  t h i g h  p a i n :  M I  0 \/ 3 0 , S I 1 \/ 3 0 O t h e r \u2022 i n f e r i o r  i s c h a e m i c  c h a n g e r e q u i r i n g  a d m i s s i o n  t o  c a r d i a c u n i t :  M I  0 \/ 3 0 ,  S I  1 \/ 3 0  c o n t i n u e","cites":null},{"id":6013871,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) D i G i o i a ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 133 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) D i G i o i a ,  2 0 0 3 3 5 , 6 3 , 7 0 S t u d y  d e s i g n : p r o s p e c t i v e m a t c h e d -p a i r  s t u d y ; m a t c h e d  b y d i a g n o s i s ,  g e n d e r , a g e  a n d  H a r r i s  h i p s c o r e L o c a t i o n : P e n n s y l v a n i a ,  U S A R e c r u i t m e n t  d a t e s : O c t o b e r  1 9 9 8 \u2013  ( e n d d a t e  N R ) F u n d i n g :  n o n e D u r a t i o n  o f  F U : 1 y e a r I n c l u s i o n  c r i t e r i a :  o s t e o a r t h r i t i s E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  s e l e c t e d  f r o m  c o h o r t s o f  1 2 1  ( M I )  +  1 2 0  ( S I )  p a t i e n t s N m a t c h e d :  6 6 L o s t  t o  F U :  N R I n d i c a t i o n s :  o s t e o a r t h r i t i s M I 3 3 \/ 3 3 ,  S I  3 3 \/ 3 3 A g e  ( y e a r s ) :  M I  6 5  [ 4 9 \u2013 8 0 ] ,  S I 6 5 [ 4 9 \u2013 7 6 ] ,  p =  0 . 8 6 S e x  ( M \/ F ) :  M I  1 9 \/ 1 4 ,  S I  1 9 \/ 1 4 B o d y  w e i g h t  ( k g ) :  M I  7 9 . 8 ,  S I  7 9 . 5 H e i g h t  ( c m ) :  M I  1 7 0 . 6 ,  S I  1 6 7 . 8 B M I  ( k g \/ m 2 ) :  M I  2 7 ,  S I  2 8 ,  p >  0 . 5 H a r r i s  h i p  s c o r e :  M I  5 2 . 2 9 [ 2 4 \u2013 7 4 ] ,  S I  5 3 . 4 4  [ 2 2 \u2013 7 6 ] , p = 0 . 8 8 M I :  N =  3 3  ( 3 5  h i p s ) S I :  N =  3 3  ( 3 5  h i p s ) O p e r a t i v e  a p p r o a c h M I  1 1 . 7  [ 7 . 3 \u2013 1 3 ] -c m  s i n g l e -i n c i s i o n  m o d i f i e d  p o s t e r i o r a p p r o a c h  w i t h  i m a g e -g u i d e d n a v i g a t i o n 3 3  p r e s s -f i t  a c e t a b u l a r c o m p o n e n t ;  2 7  c e m e n t e d a n d  6  n o n -c e m e n t e d  f e m o r a l i m p l a n t S I  2 0 . 2  [ 1 4 . 8 \u2013 2 6 ] -c m  s i n g l e -i n c i s i o n  s t a n d a r d  p o s t e r i o r a p p r o a c h  w i t h  i m a g e -g u i d e d n a v i g a t i o n 3 3  p r e s s -f i t  a c e t a b u l a r c o m p o n e n t ;  2 7  c e m e n t e d a n d  6  n o n -c e m e n t e d  f e m o r a l i m p l a n t A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  p e r f o r m e d  b y  o n e s u r g e o n  w i t h  s t a n d a r d r e t r a c t o r s M I S  =  m i n i -i n c i s i o n  + m i n i m i s i n g  s o f t  t i s s u e d i s s e c t i o n I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  3 3 ,  1 2 0 ,  S I  3 3 ,  1 0 0 P o s t o p e r a t i v e D i s l o c a t i o n  a t  1  y e a r :  M I  0 \/ 3 3 ,  S I  0 \/ 3 3 N e r v e  i n j u r y  a t  1  y e a r :  M I  0 \/ 3 3 ,  S I  0 \/ 3 3 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) M I  3 3 ,  3 . 8 ,  S I  3 3 ,  3 . 9 ,  p =  0 . 6 T i m e  t o  r e t u r n  t o  u s u a l  a c t i v i t i e s S e e  H a r r i s  h i p  s c o r e s I m p l a n t  p o s i t i o n  ( p o s t o p e r a t i v e  r a d i o g r a p h i c a n a l y s i s ) A c e t a b u l a r  c u p  a l i g n m e n t  f o r  b o t h  g r o u p s  w a s w i t h i n  5 \u00b0 o f  t h e  p r e o p e r a t i v e l y  p l a n n e d  p o s i t i o n ,  i . e .  4 5 \u00b0 o f  a b d u c t i o n  a n d  2 0 \u00b0 o f  f l e x i o n A v e r a g e  a b d u c t i o n  a f t e r  f i n a l  c u p  p l a c e m e n t :  4 6 \u00b0 [ 4 2 \u2013 4 8 \u00b0 ] A v e r a g e  f l e x i o n  ( c u p  a n t e v e r s i o n ) :  2 2 \u00b0 [ 1 8 \u2013 2 5 \u00b0 ]  F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e  a y  3  m o n t h s : M I 3 3 ,  i n c r e a s e  b y  3 4  p o i n t s [ 6 3 \u2013 9 6 ] ,  S I  3 3 ,  i n c r e a s e  b y  2 7  p o i n t s  [ 6 3 \u2013 9 5 ] ,  p =  0 . 0 4 5 ,  i . e .  M I 8 6 . 2 9 ,  S I  8 0 . 4 4 H a r r i s  h i p  s c o r e  b y  6  m o n t h s : M I 3 3 ,  i n c r e a s e  b y  4 1  p o i n t s [ 8 4 \u2013 1 0 0 ] ,  S I  3 3 ,  i n c r e a s e  b y  3 4  p o i n t s  [ 7 1 \u2013 1 0 0 ] ,  p =  0 . 0 1 7 H a r r i s  h i p  s c o r e  a t  1  y e a r :  M I  3 3 , 9 6  [ 8 6 \u2013 1 0 0 ] ,  S I  3 3 ,  9 4  [ 7 9 \u2013 1 0 0 ] , p = 0 . 0 8  ( N S ) L o n g -t e r m  p a i n S e e  d e t a i l e d  H a r r i s  h i p  s c o r e  r e s u l t s a b o v e S u r r o g a t e s  f o r  l o n g -t e r m o u t c o m e s H e t e r o t o p i c  o s s i f i c a t i o n :  M I  0 \/ 3 3 , S I 3 \/ 3 3  ( t y p e  I ) c o n t i n u e dAppendix 8 134 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) D o r r ,  2 0 0 7 3 6 , 6 5 S t u d y  d e s i g n : c o n t r o l l e d  b e f o r e -a n d -a f t e r  s u r v e y s L o c a t i o n :  U S A R e c r u i t m e n t  d a t e s : N R F u n d i n g :  r e s e a r c h f o u n d a t i o n  a n d m a n u f a c t u r e r ( Z i m m e r ) D u r a t i o n  o f  F U : 0 . 5 \u2013 1  y e a r I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a :  e n r o l l e d  i n  a r a n d o m i s e d  s t u d y  ( N =  2 3 ) ;  l i v e d o u t s i d e  s t a t e  a n d  d i d  n o t  r e t u r n f o r  6 -w e e k  F U  ( N =  1 1 ,  1 2  h i p s ) ; p r o b l e m  w i t h  l a n g u a g e  ( N =  4 ) ; y o u n g e r  t h a n  1 8  y e a r s  ( N =  1 ) N e l i g i b l e :  2 0 4 N f o l l o w e d -u p :  1 6 5 L o s t  t o  F U :  0 \/ 1 6 5  ( b u t  s e e e x c l u s i o n  c r i t e r i a ) I n d i c a t i o n s :  N R A g e  ( y e a r s ) :  M I  6 3 . 5  ( 1 2 . 3 ) , S I 6 5 . 6  ( 1 3 . 3 ) S e x  ( M \/ F ) :  M I  5 2 \/ 5 7 ,  S I  2 6 \/ 3 0 B M I  ( k g \/ m 2 ) :  M I  2 6 . 6 7  ( 4 . 3 ) , S I 2 6 . 4  ( 4 . 7 ) E m p l o y e d \/ r e t i r e d :  M I  7 0 \/ 3 9 , S I 3 6 \/ 2 0 P r e o p e r a t i v e  e x p e c t a t i o n s  f o r  a l l 1 4  q u e s t i o n s  f a v o u r e d  t h e  s m a l l -i n c i s i o n  a p p r o a c h M I :  N =  1 0 9  ( 1 3 1  h i p s ) S I :  N =  5 6  ( 5 6  h i p s ) O p e r a t i v e  a p p r o a c h M I :  9 . 6  ( 1 . 5 ) -c m  s i n g l e -i n c i s i o n  p o s t e r i o r  a p p r o a c h T y p e  o f  p r o s t h e s i s :  N R S I :  1 7 . 9  ( 3 . 5 -c m )  s i n g l e -i n c i s i o n  p o s t e r i o r  a p p r o a c h T y p e  o f  p r o s t h e s i s :  N R A d d i t i o n a l  i n f o r m a t i o n : s u r g e r i e s  p e r f o r m e d  b y  2 s u r g e o n s ;  r e s e a r c h  t o o l s i n c l u d e  ( 1 )  s p e c i a l l y  d e s i g n e d 1 4 -i t e m  q u e s t i o n n a i r e ,  ( 2 )  S F -3 6  v 2 ,  ( 3 )  8 -i t e m t e l e p h o n e  s u r v e y q u e s t i o n n a i r e P o s t o p e r a t i v e D V T :  1 \/ 1 6 5 P e r i -p r o s t h e t i c  f r a c t u r e :  1 \/ 1 6 5 H e a l t h -r e l a t e d  q u a l i t y  o f  l i f e S F -3 6  p h y s i c a l  c o m p o n e n t :  M I  1 0 9 , 5 4 . 5  ( 4 . 2 9 ) ,  S I  5 6 ,  5 6 . 2 4  ( 3 . 8 7 ) , s i g n i f i c a n t  d i f f e r e n c e  S F -3 6  m e n t a l  c o m p o n e n t :  M I  1 0 9 , 6 0 . 3 8  ( 3 . 8 4 ) ,  S I  5 6 ,  6 0 . 7 4  ( 3 . 4 2 ) , s i g n i f i c a n t  d i f f e r e n c e  S a t i s f a c t i o n  ( 8 -i t e m  t e l e p h o n e s u r v e y  a t  6  m o n t h s  t o  1  y e a r p o s t o p e r a t i v e ) Q 4 .  I s  c o s m e s i s  s t i l l  i m p o r t a n t ? ( y e s \/ n o \/ n o  d i f f e r e n c e )  ( % ) : M I 7 6 \/ 2 0 \/ 3 . 7 ,  S I  0 \/ 7 0 \/ 3 0 ,  p =  0 . 0 0 0 Q 5 .  H a p p y  w i t h  c o s m e s i s ? ( y e s \/ n o \/ n o  d i f f e r e n c e )  ( % ) : M I 1 0 0 \/ 0 \/ 0 ,  S I  3 9 \/ 3 8 \/ 2 3 ,  p =  0 . 0 0 0 O t h e r \u2022 P a t i e n t s \u2019  e x p e c t a t i o n s  a s m e a s u r e d  b y  1 4 -i t e m q u e s t i o n n a i r e  f o c u s i n g  o n  t h r e e d o m a i n s  o f  p a i n ,  f u n c t i o n  a n d p e r c e p t i o n :  \u201c D o  y o u  f e e l  t h a t  a p a t i e n t  w h o  h a s  h a d  a  s m a l l  h i p i n c i s i o n  ( 2 \u2013 4  i n c h e s  l o n g )  i s  m o r e l i k e l y  t o  h a v e  t h e  f o l l o w i n g  t h a n  a p a t i e n t  w h o  h a s  h a d  a  t r a d i t i o n a l i n c i s i o n  ( 1 0 \u2013 1 2  i n c h e s  l o n g ) ? \u201d c o n t i n u e","cites":null},{"id":6013884,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) D u w e l i u s ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"Health Technology Assessment 2008; Vol. 12: No. 26 151 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) D u w e l i u s ,  2 0 0 7 3 8 , 6 2 S t u d y  d e s i g n : m a t c h e d  p a i r s ; m a t c h e d  f o r  a g e , g e n d e r ,  B M I , d i a g n o s i s ,  f o l l o w -u p l e n g t h  a n d  W O M A C s c o r e L o c a t i o n :  U S A R e c r u i t m e n t  d a t e s : D e c e m b e r  2 0 0 2 \u2013 J u n e  2 0 0 4 F u n d i n g : m a n u f a c t u r e r ( Z i m m e r ) D u r a t i o n  o f  F U : t w o -i n c i s i o n :  1 . 2 [ 0 . 5 \u2013 2 . 0 ]  y e a r s ;  o n e m i n i -i n c i s i o n :  1 . 1 [ 0 . 5 \u2013 2 . 0 ]  y e a r s ; 1 3 \/ 4 3  i n  e a c h  g r o u p h a d  1 -y e a r  F U  d a t a I n c l u s i o n  c r i t e r i a :  b o t h  t w o -a n d o n e -i n c i s i o n  M I S :  p a t i e n t s  a g e d 1 8 y e a r s  o r  o l d e r  a t  t h e  t i m e  o f T H R  a n d  w h o  c o m p l e t e d  t h e w e e k l y  p a t i e n t  d i a r y F o r  t w o -i n c i s i o n :  a g e  < 7 0 y e a r s ; B M I < 4 0 ;  p a t i e n t s  w h o  d o  n o t h a v e  a  C r o w e  d y s p l a s i a c l a s s i f i c a t i o n  o f  c l a s s  I I I  o r  I V  a n d d o  n o t  h a v e  a n  e x c e s s i v e a n t e r i o r \u2013 p o s t e r i o r  b o w  o f  t h e f e m u r ;  t h e  d i a m e t e r  o f  t h e i n t r a m e d u a l l y  c a n a l  o f  t h e  f e m u r d o  n o t  e x c e e d  1 8  m m  a n d  t h e s i z e  o f  t h e  a c e t a b u l a r  c u p  d o  n o t e x c e e d  6 4  m m N o  s e l e c t i o n  c r i t e r i a  f o r  o n e  m i n i -i n c i s i o n ;  a n y  p a t i e n t s  w h o  d i d  n o t f i t  t h e  c r i t e r i a  f o r  t h e  t w o -i n c i s i o n p r o c e d u r e  w e r e  i n c l u d e d E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  2 8 4  N m a t c h e d :  8 6 L o s t  t o  F U  ( a t  1 2  m o n t h s ) :  2 M I  6 , M I  1 3 I n d i c a t i o n s :  o s t e o a r t h r i t i s  2 M I 4 3 \/ 4 3 ,  M I  4 3 \/ 4 3 A g e  ( y e a r s ) :  2 M I  5 7 . 4  ( 6 . 3 ) [ 4 0 \u2013 6 8 ] ,  M I  5 9 . 1  ( 8 . 2 )  [ 4 3 \u2013 7 4 ] S e x  ( M \/ F ) :  2 M I  2 4 \/ 1 9 ,  M I  2 4 \/ 1 9 2 M I :  N =  4 3 M I :  N =  4 3 O p e r a t i v e  a p p r o a c h 2 M I :  t w o -i n c i s i o n  m i n i m a l l y i n v a s i v e  s u r g e r y 4 3 \/ 4 3  t r i l o g y  a c e t a b u l a r c o m p o n e n t  ( +  1  o r  2 s c r e w s ) ,  4 3 \/ 4 3  f u l l y  c o a t e d f e m o r a l  s t e m  M I :  s i n g l e  p o s t e r i o r  m i n i -i n c i s i o n  m i n i m a l l y  i n v a s i v e s u r g e r y 4 3 \/ 4 3  t r i l o g y  a c e t a b u l a r c o m p o n e n t 1 1 \/ 4 3  V e r S y s  F u l l C o a t  s t e m , 3 2 \/ 4 3  V e r S y s  F i b e r  M e t a l M i d C o a t  s t e m A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  b y  e x p e r i e n c e d s u r g e o n ( s )  \u2013  n o t  p a r t  o f  t h e i n i t i a l  \u2018 l e a r n i n g  c u r v e \u2019  \u2013  w i t h i n t r a o p e r a t i v e  f l u o r o s c o p y ; s u r g i c a l  t e c h n i q u e  d e s c r i b e d e l s e w h e r e  ( s e e  p . 5 0  i n r e f . 3 8  f o r  r e f e r e n c e )  I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) 2 M I  4 3 ,  9 3 . 7  ( 9 0 )  [ 7 2 \u2013 1 3 5 ] ,  M I  4 3 ,  6 1 . 7 ( 6 0 )  [ 3 9 \u2013 1 1 1 ] ,  p =  0 . 0 0 2 I n t r a o p e r a t i v e  b l o o d  l o s s  ( a s  c o l l e c t e d  i n  a c e l l  s a v e r )  ( m l ) 2 M I  4 3 ,  3 6 6  ( 2 1 5 )  [ 1 5 0 \u2013 1 4 0 0 ] ,  M I  4 3 ,  2 4 7 ( 9 0 )  [ 1 0 0 \u2013 4 5 0 ] ,  p =  0 . 0 0 1  I n t r a o p e r a t i v e  f r a c t u r e  ( f e m o r a l  n e c k ) : 2 M I 3 \/ 4 3 ,  M I  1 \/ 4 3 P o s t o p e r a t i v e N e r v e  i n j u r y S c i a t i c ,  p e r o n e a l  o r  c o m m o n  f e m o r a l  n e r v e i n j u r y :  2 M I  0 \/ 4 3 ,  M I  0 \/ 4 3 S o m e  n u m b n e s s  i n  t h e  a n t e r o l a t e r a l  t h i g h : 2 M I  6 \/ 4 3  ,  M I  0 \/ 4 3  N e r v e  p a i n :  2 M I  0 \/ 4 3 ,  M I  0 \/ 4 3 L e n g t h  o f  h o s p i t a l  s t a y  ( h o u r s ) :  2 M I  4 3 ,  3 0 . 7 [ 1 2 . 9 \u2013 5 5 . 7 ] ,  M I  4 3 ,  4 4 . 6  [ 1 3 \u2013 1 0 2 ] , p < 0 . 0 0 1 ,  i . e .  M I  1 . 2 5  [ 0 . 5 \u2013 2 . 3 ]  d a y s ,  S I 1 . 9 [ 0 . 5 \u2013 4 . 3 ]  d a y s P o s t o p e r a t i v e  p a i n P r e s c r i p t i o n  a n t i -i n f l a m m a t o r y  u s e :  2 M I 4 7 %  ( 2 0 \/ 4 3 ) ,  M I  2 3 %  ( 1 0 \/ 4 3 ) ,  p =  0 . 0 4 T i m e  t o  r e t u r n  t o  u s u a l  a c t i v i t i e s  T i m e  t o  r e s u m e  d r i v i n g  ( d a y s ) :  2 M I  4 3 ,  1 3 [ 2 \u2013 3 1 ] ,  M I  4 3 ,  2 4  [ 6 \u2013 3 2 ] ,  p =  0 . 0 4 T i m e  t o  r e s u m e  s h o p p i n g  ( d a y s ) :  2 M I  4 3 , 1 4  [ 3 \u2013 2 4 ] ,  M I  4 3 ,  2 6  [ 6 \u2013 3 7 ] ,  p =  0 . 0 1 I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c  a n a l y s i s  a t 6 w e e k s  o r  3  m o n t h s ) F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e  ( f r o m  g r a p h ) :  6  w e e k s :  2 M I  8 4 ,  M I  8 4 3  m o n t h s :  2 M I  8 9 ,  M I  8 8 6  m o n t h s :  2 M I  9 4 ,  M I  8 8 1  y e a r :  2 M I  9 4 ,  M I  8 8 2 M I  b e t t e r  t h a n  M I :  n o  a s s i s t i v e  d e v i c e n e e d e d  a t  2  w e e k s  ( p =  0 . 0 0 1 )  a n d n e g o t i a t i n g  s t a i r s  w i t h o u t  a  r a i l i n g  a t 5 w e e k s  ( p =  0 . 0 0 4 ) A l s o  i n  F i g u r e  1 :  W O M A C  p h y s i c a l  f u n c t i o n , W O M A C  s t i f f n e s s .  T h e s e  d o  n o t  a p p e a r  t o b e  s i g n i f i c a n t l y  d i f f e r e n t  b e t w e e n  g r o u p s R e v i s i o n  r a t e s :  2 M I  0 \/ 4 3 ,  M I  0 \/ 4 3 H e a l t h -r e l a t e d  q u a l i t y  o f  l i f e S F -3 6  p h y s i c a l  f u n c t i o n  ( F i g u r e  1 ) :  2 M I  8 0 , M I  7 0 L o n g -t e r m  p a i n W O M A C  p a i n  s c o r e  ( f r o m  g r a p h ) 6  w e e k s :  2 M I  2 ,  M I  2 . 5 6  m o n t h s :  2 M I  1 . 8 ,  M I  1 . 6 1  y e a r :  2 M I  1 . 6 ,  M I  1 . 6 T o t a l  W O M A C  p a i n  s u b s c a l e  a t  6  w e e k s : 2 M I  3 . 3 1  [ 0 \u2013 1 1 ] ,  M I  1 . 2 2  [ 0 \u2013 1 0 ] ,  p =  0 . 0 0 3  M I  b e t t e r  t h a n  2 M I :  n o  p a i n  a t  n i g h t  a t 6 w e e k s  ( p =  0 . 0 0 2 8 )  a n d  p a i n  a t  n i g h t  i n b e d  a t  6  w e e k s  ( p =  0 . 0 0 4 ) S F -3 6  b o d i l y  p a i n  ( f r o m  g r a p h ) : 6  w e e k s :  2 M I  6 8 ,  M I  7 6 6  m o n t h s :  2 M I  7 5 ,  M I  7 5 1  y e a r :  2 M I  7 6 ,  M I  7 5 c o n t i n u e dAppendix 8 152 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) B M I  ( k g \/ m 2 ) N o r m a l  ( < 2 5 ) :  2 M I  2 1 \/ 4 3 , M I 2 1 \/ 4 3 O v e r w e i g h t  ( 2 5 \u2013 3 0 ) :  2 M I  1 5 \/ 4 3 , M I  1 5 \/ 4 3 O b e s e  ( > 3 0 ) :  2 M I  7 \/ 4 3 ,  M I  7 \/ 4 3 W O M A C  p a i n :  2 M I  9 . 1  ( 2 . 8 ) [ 4 \u2013 1 5 ] ,  M I  9 . 0  ( 2 . 9 )  [ 2 \u2013 1 4 ]  W O M A C  p h y s i c a l  f u n c t i o n :  2 M I 2 8 . 4  ( 9 . 6 )  [ 5 \u2013 4 5 ] ,  M I  2 9 . 8  ( 9 . 8 ) [ 8 \u2013 4 5 ] W O M A C  f i t n e s s :  2 M I  3 . 9  ( 1 . 6 ) [ 1 \u2013 8 ] ,  M I  4 . 4  ( 1 . 4 )  [ 2 \u2013 8 ]  S t e m  i n   3 \u00b0 v a r u s :  2 M I  1 \/ 4 3 ,  M I  1 \/ 4 3 ;  a l l  o t h e r  s t e m s  i n  n e u t r a l  a l i g n m e n t C u p  a b d u c t i o n  ( N o f  o u t l i e r s ;  t a r g e t  4 5 \u00b0 ) : 2 M I  4 \/ 4 3  ( > 5 0 \u00b0 ) ,  M I  2 \/ 4 3  C u p  a b d u c t i o n  a n g l e :  2 M I  4 3 ,  4 9 . 4 \u00b0 ( 4 . 2 ) [ 4 1 \u2013 6 0 ] ,  M I  4 3 ,  4 5 . 6 \u00b0 ( 5 . 3 )  [ 3 5 \u2013 5 7 ] , p = 0 . 0 0 0 3 C u p  a n t e v e r s i o n :  2 M I  4 3 ,  2 0 . 2 \u00b0 ( 5 . 3 )  [ 5 \u2013 2 5 ] , M I  4 3 ,  1 8 . 4  ( 7 . 9 )  [ 0 \u2013 3 5 ] ,  p =  0 . 2 6 2 4 N B :  r a d i o g r a p h s  w e r e  p e r f o r m e d i m m e d i a t e l y  p o s t o p e r a t i v e ,  a t  6  w e e k s , 3 m o n t h s ,  6  m o n t h s  a n d  a n n u a l  v i s i t s  M e d i c a l  O u t c o m e s  S t u d y  ( M O S )  s l e e p  s c a l e : M I  b e t t e r  t h a n  S I :  n o  t r o u b l e  f a l l i n g  a s l e e p ( p = 0 . 0 0 0 4 )  a n d  n o  t r o u b l e  f a l l i n g  b a c k  t o s l e e p  ( p = 0 . 0 0 3 ) L i m b  l e n g t h  i n e q u a l i t y  ( a t  6  w e e k s ) : 2 M I 6 \/ 3 9 ,  M I 6 \/ 3 8 S u r r o g a t e s  f o r  l o n g -t e r m  o u t c o m e s I m p l a n t  m i g r a t i o n  ( f r o m  t h e  r a d i o g r a p h  w i t h t h e  l o n g e s t  f o l l o w -u p ) :  2 M I  0 \/ 4 3 ,  M I  0 \/ 4 3 ( n o  c o m p o n e n t s  s u b s i d e d ) O t h e r P a t i e n t  c o m p l i a n c e  ( d i a r y  a n d  a t t e n d a n c e  a t s c h e d u l e d  e x a m i n a t i o n ) : 1  w e e k :  2 M I  9 1 %  [ 8 6 \u2013 9 5 ] ,  M I  8 8 % [ 7 7 \u2013 9 5 ] ,  N S 6  w e e k s :  2 M I  4 1 \/ 4 3 ,  M I  4 1 \/ 4 3 6  m o n t h s :  2 M I  3 3 \/ 4 3 ,  M I  2 8 \/ 4 3 ,  N S 1 2  m o n t h s :  2 M I  2 6 \/ 3 7 ,  M I  2 6 \/ 3 0 ,  p =  0 . 0 9 G r e i d a n u s ,  2 0 0 6 7 1 ( a b s t r a c t  o n l y ) S t u d y  d e s i g n : p r o s p e c t i v e c o m p a r a t i v e  c o h o r t s L o c a t i o n :  C a n a d a R e c r u i t m e n t  d a t e s : 2 0 0 2 \u2013 4 F u n d i n g :  N R D u r a t i o n  o f  F U :  N R  I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  N R L o s t  t o  F U :  N R I n d i c a t i o n s :  N R A g e  ( y e a r s ) :  n o  d i f f e r e n c e S e x  ( M \/ F ) :  n o  d i f f e r e n c e B M I  ( k g \/ m 2 ) :  n o  d i f f e r e n c e C o -m o r b i d  s t a t u s :  n o  d i f f e r e n c e W O M A C :  n o  d i f f e r e n c e O x f o r d  h i p  s c o r e :  n o  d i f f e r e n c e S F -1 2 :  n o  d i f f e r e n c e 2 M I :  N =  6 6 M I :  N =  9 9 O p e r a t i v e  a p p r o a c h 2 M I :  t w o -i n c i s i o n  a p p r o a c h M I :  s i n g l e -i n c i s i o n  a p p r o a c h P o s t o p e r a t i v e L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) S h o r t e r  f o r  2 M I ,  p <  0 . 0 5 P o s t o p e r a t i v e  p a i n A n a l g e s i c  u s e :  l e s s  f o r  2 M I ,  p <  0 . 0 5 c o n t i n u e","cites":null},{"id":6013876,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) F l \u00f6 r e n ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"Health Technology Assessment 2008; Vol. 12: No. 26 143 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) F l \u00f6 r e n ,  2 0 0 6 3 9 S t u d y  d e s i g n : c o n s e c u t i v e  c o h o r t s t u d y L o c a t i o n :  G e r m a n y R e c r u i t m e n t  d a t e s : 1 9 8 8 \u2013 1 9 9 1 F u n d i n g :  n o n e D u r a t i o n  o f  F U :  1 0 . 9 ( 1 . 1 )  y e a r s  [ r a n g e 1 0 \u2013 1 3  y e a r s ] I n c l u s i o n  c r i t e r i a :  i n i t i a l  c o h o r t  ( N =  1 2 2 )  r e p r e s e n t s  c o n s e c u t i v e s e r i e s  n o t  s e l e c t e d  f o r  a g e ,  s e x , b o n e  t y p e ,  b o d y  w e i g h t  o r d i a g n o s i s E x c l u s i o n  c r i t e r i a :  p a t i e n t s  w i t h l e s s  t h a n  1 0 -y e a r  F U N e l i g i b l e :  1 2 2  ( 1 3 7  h i p s ) L o s t  t o  F U :  4 3  ( o f  w h o m  3 2  d i e d ; a l l  3 2  w h o  h a d  d i e d  h a d  a n n u a l  F U a n d  n o n e  n e e d e d  r e v i s i o n ) 1 0 -Y e a r  f o l l o w -u p  g r o u p I n d i c a t i o n s :  o s t e o a r t h r i t i s  7 4 ; r h e u m a t o i d  a r t h r i t i s  5 A g e  ( y e a r s ) :  7 3  ( 1 2 . 9 )  [ 3 2 \u2013 9 7 ] S e x  ( M \/ F ) :  3 1 \/ 4 8 B o d y  w e i g h t  ( k g ) :  8 0 . 9  ( 1 8 . 3 ) H e i g h t  ( c m ) :  1 6 2  ( 9 . 5 ) I n i t i a l  g r o u p I n d i c a t i o n s :  o s t e o a r t h r i t i s  1 1 5 ; r h e u m a t o i d  a r t h r i t i s  7 A g e  ( y e a r s ) :  6 4  ( 1 3 . 4 )  [ 1 9 \u2013 9 1 ] S e x  ( M \/ F ) :  5 0 \/ 7 2 M I :  N =  7 9  ( 9 0  h i p s ) O p e r a t i v e  a p p r o a c h M I :  s i n g l e -m i n i -i n c i s i o n p o s t e r i o r  a p p r o a c h C e m e n t l e s s  c u p  a n d  s t e m A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  p e r f o r m e d  b y  a s i n g l e  s u r g e o n P o s t o p e r a t i v e D i s l o c a t i o n :  0 \/ 9 0 I n f e c t i o n :  0 \/ 9 0 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) : 7 9 ,  4 . 7  ( 2 . 0 )  [ 1 \u2013 1 3 ] I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c a n a l y s i s ,  m e a n  r a d i o g r a p h i c  F U 1 0 . 9  \u00b1 1 . 0  [ r a n g e  1 0 \u2013 1 3 ]  y e a r s ) S t e m s  i n  v a r u s :  1 2 \/ 7 0 S t e m s  i n  n e u t r a l  p o s i t i o n :  5 8 \/ 7 0 F u n c t i o n a l  r e s u l t s  ( a t  > 1 0  y e a r s ) M e a n  H a r r i s  h i p  s c o r e :  7 9 ,  9 2 . 3  ( 7 . 9 )  [ 6 6 \u2013 9 9 ] H a r r i s  h i p  s c o r e  ( E x c e l l e n t ,  9 0 \u2013 9 9 \/ G o o d ,  8 0 \u2013 8 9 \/ F a i r , 7 0 \u2013 7 9 \/ P o o r ,  < 7 0 ) :  6 5 \/ 1 8 \/ 6 \/ 1 H a r r i s  h i p  s c o r e  s u b s c a l e :  g a i t \u2022 l i m p  ( n o n e \/ s l i g h t \/ m o d e r a t e \/  s e v e r e ) :  6 7 \/ 2 0 \/ 3 \/ 0 \u2022 s u p p o r t  ( n o n e \/ c a n e  f o r  l o n g  w a l k s \/ c a n e  m o s t  o f  t h e t i m e \/ 1  c r u t c h \/ 2  c r u t c h e s \/ n o t  a b l e  t o  w a l k ) : 7 2 \/ 5 \/ 9 \/ 4 \/ 0 \/ 0 \u2022 d i s t a n c e  w a l k e d  ( u n l i m i t e d \/ 6  b l o c k s \/ 2  o r  3 b l o c k s \/ i n d o o r s  o n l y \/ b e d  a n d  c h a i r ) :  6 6 \/ 4 \/ 2 0 \/ 0 \/ 0 H a r r i s  h i p  s c o r e  s u b s c a l e :  a c t i v i t i e s \u2022 s t a i r s  ( n o r m a l l y  w i t h o u t  u s i n g  a  r a i l i n g \/ n o r m a l l y u s i n g  a  r a i l i n g \/ i n  a n y  m a n n e r \/ u n a b l e  t o  d o  s t a i r s ) : 2 9 \/ 5 7 \/ 2 \/ 2 \u2022 s h o e s  a n d  s o c k s  ( w i t h  e a s e \/ w i t h  d i f f i c u l t y \/ u n a b l e ) : 6 9 \/ 2 0 \/ 1 \u2022 s i t t i n g  ( c o m f o r t a b l y  i n  o r d i n a r y  c h a i r  f o r  1  h \/ o n  a h i g h  c h a i r  f o r  0 . 5  h \/ u n a b l e  t o  s i t  c o m f o r t a b l y  i n  a n y c h a i r ) :  8 6 \/ 2 \/ 2 R e v i s i o n  r a t e s :  8 \/ 9 0 T i m e  t o  r e v i s i o n  ( y e a r s ) :  9 0 ,  6 . 8  ( 1 . 8 )  [ 4 \u2013 1 0 ] L o n g -t e r m  p a i n M e a n s  s c o r e  f o r  H a r r i s  h i p  p a i n  s u b s c a l e :  9 0 ,  4 3 . 2 ( 2 . 7 )  [ 3 0 \u2013 4 4 ] H a r r i s  h i p  s c o r e  p a i n  s u b s c a l e  ( n o n e  o r  i g n o r e  i t \/ s l i g h t , o c c a s i o n a l ,  n o  c o m p r o m i s e  i n  a c t i v i t i e s \/ m i l d  p a i n ,  n o e f f e c t  o n  a v e r a g e  a c t i v i t i e s \/ m o d e r a t e  p a i n ,  t o l e r a b l e , s o m e  l i m i t a t i o n  o f  m o t i o n  a c t i v i t y  o r  w o r k \/ m a r k e d p a i n ,  s e r i o u s  l i m i t a t i o n  o f  a c t i v i t i e s \/ t o t a l l y  d i s a b l e d , c r i p p l e d ,  p a i n  i n  b e d ,  b e d r i d d e n ) :  8 0 \/ 7 \/ 3 \/ 0 \/ 0 \/ 0 M o r t a l i t y :  3 2 \/ 1 2 2  ( s e e  L o s t  t o  F U ) c o n t i n u e dAppendix 8 144 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) S u r r o g a t e s  f o r  l o n g -t e r m o u t c o m e s I m p l a n t  m i g r a t i o n :  0 \/ 7 0  ( n o s u b s i d e n c e  o f  s t e m ) C e m e n t  q u a l i t y :  2  c u p s  h a d p o l y e t h y l e n e -i n d u c e d  o s t e o l y s i s  i n z o n e  2 ,  a n d  3  a r t h r o p l a s t i e s  h a d r a d i o l u c e n t  l i n e s  (  2  m m )  i n  z o n e s 1  a n d  2 ;  5  c u p s  d e m o n s t r a t e d r a d i o l u c e n t  l i n e s  (  1  m m )  i n  a l l z o n e s O t h e r \u2022 d i s c h a r g e d  h o m e :  6 9 % \u2022 d i s c h a r g e d  t o  f a c i l i t y :  3 1 % \u2022 a s e p t i c  l o o s e n i n g :  0 \/ 7 0 \u2022 a t r o p h i c  b o n e  c h a n g e s :  4 0 \/ 7 0 \u2022 r a d i o l u s c e n t  l i n e s  (  2  m m ) : 1 0 \/ 7 0 \u2022 o s t e o l y s i s :  8 \/ 7 0 \u2022 c l i n i c a l  l o o s e n i n g :  \u2022 p o l y e t h y l e n e  w e a r :  \u2022 s c l e r o t i c  c h a n g e s  a r o u n d  t h e s t e m :  3 \/ 7 0 c o n t i n u e","cites":null},{"id":6013858,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) H a r t ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 121 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) H a r t ,  2 0 0 5 4 0 , 6 4 S t u d y  d e s i g n :  q u a s i -R C T  ( a l t e r n a t e a l l o c a t i o n  \u2013  a u t h o r c o n t a c t e d ) L o c a t i o n :  C z e c h R e p u b l i c R e c r u i t m e n t  d a t e s :  S e p t e m b e r 2 0 0 0 \u2013 F e b r u a r y  2 0 0 2 F u n d i n g :  N R D u r a t i o n  o f  F U :  3 . 2 5 [ 2 . 7 \u2013 3 . 8 ]  y e a r s  I n c l u s i o n  c r i t e r i a :  a g e  > 6 5  y e a r s ; B M I  < 3 5 E x c l u s i o n  c r i t e r i a :  c o a g u l a t i o n d i s o r d e r s ;  a n a e m i c  ( h a e m o g l o b i n l e v e l  < 1 2  g \/ d l ) N e l i g i b l e :  1 2 0 N r a n d o m i s e d :  1 2 0 L o s t  t o  F U :  n o n e I n d i c a t i o n s :  p r i m a r y  o s t e o a r t h r i t i s g r a d e  3  o r  4  M I  6 0 \/ 6 0 ,  S I  6 0 \/ 6 0 A g e  ( y e a r s ) :  7 2 . 4  [ 6 6 \u2013 7 8 ] S e x  ( M \/ F ) :  4 0 \/ 8 0 B o d y  w e i g h t  ( k g ) :  7 2 . 1  [ 6 1 \u2013 8 7 ] B M I  ( k g \/ m 2 ) :  2 7 . 6  [ 2 2 . 6 \u2013 3 4 . 9 ] M e r l e  d \u2019 A u b i g n \u00e9 -C h a r n l e y  s c o r e : M I  1 0 . 6 ,  S I  1 0 . 6 M I :  N =  6 0 S I :  N =  6 0 O p e r a t i v e  a p p r o a c h M I :  9 \u2013 1 0 -c m  s i n g l e -i n c i s i o n , p o s t e r o l a t e r a l  a p p r o a c h 6 0  C e m e n t e d  c u p  a n d  s t e m S I :  2 0 -c m  s t a n d a r d p o s t e r o l a t e r a l  a p p r o a c h 6 0  C e m e n t e d  c u p  a n d  s t e m A d d i t i o n a l  i n f o r m a t i o n :  T H R s p e r f o r m e d  b y  2  s e n i o r s u r g e o n s  w i t h  s t a n d a r d i n s t r u m e n t s  ( b u t  a  s l i g h t l y m o d i f i e d  b r o a d  M \u00fc l l e r r e t r a c t o r )  a n d  w i t h o u t f l u o r o s c o p y I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  6 0 ,  7 1  [ 5 5 \u2013 8 4 ] ,  S I  6 0 ,  7 0  [ 5 1 \u2013 8 6 ] I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  6 0 ,  3 1 8 . 8  [ 2 0 0 \u2013 4 6 0 ] ,  S I  6 0 ,  5 4 4 . 4 [ 3 9 0 \u2013 8 8 0 ] I n t r a o p e r a t i v e  f r a c t u r e M I  0 \/ 6 0 ,  S I  0 \/ 6 0 P o s t o p e r a t i v e D i s l o c a t i o n :  M I  1 \/ 6 0 ,  S I  1 \/ 6 0 I n f e c t i o n  ( d e e p ) :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 N e r v e  i n j u r y  ( l e g i o n  o f  t h e  s c i a t i c  n e r v e ) : M I  0 \/ 6 0 ,  S I  0 \/ 6 0 P e r i -p r o s t h e t i c  f r a c t u r e :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 D V T :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c  a n a l y s i s 3 d a y s  a f t e r  s u r g e r y  a n d  a t  t h e  l a s t  f o l l o w -u p  c o n t r o l  i n  J u l y  2 0 0 4 ) F e m o r a l  c o m p o n e n t  v a r u s  a l i g n m e n t  o f  < 3 \u00b0 [ r a n g e  4 \u2013 6 \u00b0 ] :  M I  6 \/ 6 0 ,  S I  7 \/ 6 0 F e m o r a l  c o m p o n e n t  c o r o n a l  a l i g n m e n t w i t h i n  3 \u00b0 o f  n e u t r a l  p o s i t i o n :  M I  5 4 \/ 6 0 ,  S I  5 3 \/ 6 0 C u p  i n c l i n a t i o n  a n g l e :  M I  6 0 ,  4 2 . 3 \u00b0 [ 3 6 \u2013 5 2 \u00b0 ] ,  S I  6 0 ,  4 2 . 4 \u00b0 [ 3 5 \u2013 5 0 \u00b0 ] C u p  a n t e v e r s i o n  a n g l e :  M I  6 0 ,  1 3 . 6 \u00b0 [ 6 \u2013 2 9 \u00b0 ] ,  S I  6 0 ,  1 3 . 6 \u00b0 [ 8 \u2013 2 4 \u00b0 ] F u n c t i o n a l  r e s u l t s M e r l e  d \u2019 A u b i g n \u00e9 \u2013 C h a r n l e y  s c o r e  a t 6 w e e k s  ( o v e r a l l ,  m a x .  1 8  p o i n t s ) :  M I  1 6 . 6 , S I  1 4 . 1 ,  p <  0 . 0 2 M e r l e  d \u2019 A u b i g n \u00e9 \u2013 C h a r n l e y  s c o r e  a t 1 2 m o n t h s  ( o v e r a l l ) :  M I 6 0 ,  1 7 . 4 ,  S I 6 0 , 1 7 . 3 ,  N S R e v i s i o n  r a t e s :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 S u r r o g a t e s  f o r  l o n g -t e r m  o u t c o m e s I m p l a n t  m i g r a t i o n  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 C e m e n t  q u a l i t y  ( n o  d e f e c t s ) :  M I  6 0 \/ 6 0 ,  S I  6 0 \/ 6 0 O t h e r \u2022 p o s t o p e r a t i v e  b l o o d  l o s s  i n t o  d r a i n a g e : M I  6 0 ,  6 1 3 . 3  [ 3 5 0 \u2013 1 1 8 0 ] ,  S I  6 0 ,  8 5 3 . 7 [ 5 1 0 \u2013 1 3 9 0 ] \u2022 p u l m o n a r y  e m b o l i :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 \u2022 a s e p t i c  l o o s e n i n g :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 \u2022 h a e m a t o m a :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 \u2022 s e r o m a :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 c o n t i n u e dAppendix 8 122 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) K i m ,  2 0 0 6 4 3 S t u d y  d e s i g n :  q u a s i -R C T ;  b i l a t e r a l s i m u l t a n e o u s  T H R s ( M I  o n  o n e  h i p  a n d S I  o n  t h e  o t h e r  h i p ) L o c a t i o n :  K o r e a R e c r u i t m e n t  d a t e s :  F e b r u a r y 2 0 0 2 \u2013 F e b r u a r y  2 0 0 3 F u n d i n g :  n o n e D u r a t i o n  o f  F U :  2 6 . 4 ( 2 4 \u2013 3 6 )  m o n t h s I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  7 5 N r a n d o m i s e d :  7 0  ( 1 4 0  h i p s ) L o s t  t o  F U :  n o n e I n d i c a t i o n s :  o s t e o a r t h r i t i s :  1 0 \/ 7 0 ( 1 4 % ) ;  o s t e o n e c r o s i s :  5 6 \/ 7 0 ( 8 0 % ) ;  a n k y l o s i n g  s p o n d y l i t i s :  4 \/ 7 0  ( 6 % )  A g e  ( y e a r s ) :  5 5 . 6  [ 4 3 \u2013 6 8 ] S e x  ( M \/ F ) :  5 3 \/ 1 7 B o d y  w e i g h t  ( k g ) :  6 5 . 8  [ 5 4 \u2013 9 8 ] H e i g h t  ( c m ) :  1 6 7 . 3  [ 1 4 8 \u2013 1 8 8 ] B M I  ( k g \/ m 2 ) :  2 5 . 6  [ 1 8 . 7 \u2013 3 5 . 6 ] H a r r i s  h i p  S c o r e :  M I  4 6 ,  S I  4 5 , p = 0 . 2 8 9 9 M I :  N =  7 0  h i p s S I :  N =  7 0  h i p s O p e r a t i v e  a p p r o a c h M I :  8 -c m  s i n g l e -i n c i s i o n m o d i f i e d  p o s t e r o l a t e r a l a p p r o a c h C e m e n t l e s s  c u p  a n d  s t e m S I :  1 5 \u2013 2 0 -c m  s i n g l e -i n c i s i o n s t a n d a r d  p o s t e r o l a t e r a l a p p r o a c h C e m e n t l e s s  c u p  a n d  s t e m A d d i t i o n a l  i n f o r m a t i o n : s u r g e r i e s  p e r f o r m e d  b y  o n e s u r g e o n  w i t h  s p e c i a l i s e d r e t r a c t o r s ,  r e a m e r s ,  c u p i n s e r t e r s  a n d  c e r a m i c  b e a r i n g h o l d e r  i n  M I M I  r a n d o m i s e d  t o  l e f t  o r r i g h t  h i p ;  t h e  o r d e r  o f  u s i n g M I  a n d  S I  a s s i g n e d a l t e r n a t e l y ,  i . e .  M I  f i r s t  o n  1 s t p a t i e n t  a n d  S I  f i r s t  o n  2 n d p a t i e n t  e t c . I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  7 0 ,  5 2  [ 4 8 \u2013 7 0 ] ,  S I  7 0 ,  6 1  [ 5 1 \u2013 8 0 ] ,  p < 0 . 0 0 1 I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  7 0 ,  4 4 5 . 8 ,  S I  7 0 ,  5 6 7 . 5 ,  p = 0 . 1 6 8 7  P o s t o p e r a t i v e D i s l o c a t i o n :  M I  1 \/ 7 0 ,  S I  1 \/ 7 0 I n f e c t i o n  ( d e e p  w o u n d ) :  M I  1 \/ 7 0 ,  S I  0 \/ 7 0 N e r v e  i n j u r y  ( p e r o n e a l  n e r v e  p a l s y ) :  M I  1 \/ 7 0 ,  S I  1 \/ 7 0 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) :  M I  a n d  S I  1 2 . 8  [ 9 \u2013 1 4 ] P o s t o p e r a t i v e  p a i n 1 0 -p o i n t  a n a l o g o u s  s c a l e  ( 0  =  n o  p a i n ) :  n o d i f f e r e n c e  b e t w e e n  g r o u p s  ( p > 0 . 0 5 )  a t  2 w e e k s ,  3  m o n t h s ,  6  m o n t h s ,  1  y e a r  a n d  2 y e a r s I m p l a n t  p o s i t i o n  ( p o s t o p e r a t i v e  r a d i o g r a p h i c  a n a l y s i s ) C u p  a b d u c t i o n  ( N o f  o u t l i e r s ,  g o a l  =  3 5 \u2013 4 5 \u00b0 ) :  M I  6 \/ 7 0 ,  S I  5 \/ 7 0 ,  p =  0 . 3 7 1 C u p  a n t e v e r s i o n  ( N o f  o u t l i e r s ,  g o a l  =  2 0 \u2013 3 0 \u00b0 ) :  M I  7 \/ 7 0 ,  S I  6 \/ 7 0 ,  p =  0 . 3 5 4 S t e m  v a r u s \/ v a l g u s :  M I  4 \/ 7 0 ,  S I  4 \/ 7 0 ,  p =  0 . 1 8 2 S t e m  a n t e v e r s i o n  ( N o f  o u t l i e r s ) :  M I  8 \/ 7 0 ,  S I  7 \/ 7 0 ,  p =  0 . 3 6 8 A n t e r o p o s t e r i o r  v i e w  s t e m  ( d e g r e e ) :  M I  1 . 8  ( 1 . 6 ) [ \u2013 2 ,  7 ] ,  S I  1 . 3  ( 1 . 3 )  [ \u2013 2 ,  5 ] A n t e r o p o s t e r i o r  v i e w  c u p  ( d e g r e e ) :  M I  4 4 . 3  ( 5 . 8 )  [ 3 0 ,  5 7 ] ,  S I  4 1 . 9  ( 7 )  [ 2 5 ,  5 5 ] L a t e r a l  v i e w  s t e m  ( a n t e v e r s i o n ,  d e g r e e )  M I  1 5 . 1 ( 4 . 9 )  [ 2 ,  2 6 ] ,  S I  1 2 . 5  ( 1 6 )  [ 0 ,  2 3 ] L a t e r a l  v i e w  c u p  ( d e g r e e ) :  M I  3 1 . 1  ( 7 . 1 )  [ 9 ,  4 6 ] ,  S I  2 6 . 9  ( 4 )  [ 1 7 ,  3 8 ] F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e :  M I  9 3  [ 8 6 \u2013 1 0 0 ] ,  S I  9 1  [ 8 5 \u2013 1 0 0 ] ,  p =  0 . 7 4 3 5 P a i n  r e l i e f :  s e e  p o s t o p e r a t i v e  p a i n L i m b  l e n g t h  i n e q u a l i t y  ( c m ) :  M I  0 . 6 ( 0 . 5 9 )  [ 0 \u2013 0 . 8 ]  l o n g e r  t h a n p r e o p e r a t i v e  l e n g t h ,  S I  0 . 7  ( 0 . 7 9 ) [ 0 \u2013 0 . 9 ]  l o n g e r  t h a n  p r e o p e r a t i v e l e n g t h ,  N S O t h e r \u2022 \u201c a t  t h e  f i n a l  f o l l o w -u p ,  a l l a c e t a b u l a r  a n d  f e m o r a l c o m p o n e n t s  w e r e r a d i o g r a p h i c a l l y  s t a b l e \u201d  ( n o  l o o s e n i n g ) c o n t i n u e","cites":null},{"id":6013878,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) H a r t z b a n d ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 145 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) H a r t z b a n d ,  2 0 0 6 4 1 S t u d y  d e s i g n : c o n s e c u t i v e  c a s e s e r i e s L o c a t i o n :  U S A R e c r u i t m e n t  d a t e s : J a n u a r y \u2013 M a y  2 0 0 0 F u n d i n g :  N R D u r a t i o n  o f  F U :  5 . 7 5 [ 5 . 6 \u2013 6 ]  y e a r s I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  9 8 L o s t  t o  F U :  N R I n d i c a t i o n s :  o s t e o a r t h r i t i s  7 6 \/ 1 0 0 ; d e v e l o p m e n t a l  d y s p l a s i a  o f  t h e  h i p 8 \/ 1 0 0 ;  a v a s c u l a r  n e c r o s i s  9 \/ 1 0 0 A g e  ( y e a r s ) :  M  6 1  [ 3 0 \u2013 9 3 ] ,  F  6 5 [ 4 0 \u2013 8 7 ] S e x  ( M \/ F ) :  4 1 \/ 5 7 B o d y  w e i g h t  ( k g ) :  M  9 2 . 6 [ 6 7 . 2 \u2013 1 3 1 . 5 ] ,  F  7 2 . 6  [ 3 8 . 6 \u2013 1 0 8 . 0 ] M I :  N =  9 8  ( 1 0 0  c a s e s ) O p e r a t i v e  a p p r o a c h M I :  7 . 2 6  [ 6 \u2013 8 ] -c m  s i n g l e -i n c i s i o n  p o s t e r o l a t e r a l a p p r o a c h A d d i t i o n a l  i n f o r m a t i o n :  t h e a u t h o r  p e r f o r m e d  a l l p r o c e d u r e s  I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) :  3 7 . 5 [ 2 7 \u2013 9 0 ] P o s t o p e r a t i v e D i s l o c a t i o n :  0 \/ 1 0 0 I n f e c t i o n  ( p o s t o p e r a t i v e  i n f e c t i o n s ) :  0 \/ 1 0 0 N e r v e  i n j u r y  ( n e r v e  p a l s y ) :  0 \/ 1 0 0 D V T :  4 \/ 1 0 0 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) :  1 0 0 ,  2 . 8 9 [ 3 \u2013 5 ] I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c  a n a l y s i s ) A v e r a g e  c u p  a b d u c t i o n :  1 0 0 ,  4 5 . 2 \u00b0 [ 3 0 \u00b0 \u2013 5 6 \u00b0 ] L o n g -t e r m  p a i n :  n o  s i g n i f i c a n t  p a i n L i m b  l e n g t h  i n e q u a l i t y  ( N o f  p a t i e n t s ) : 7 \/ 1 0 0 ,  w i t h  a  m a x i m u m  p o s t o p e r a t i v e l e n g t h  d i s c r e p a n c y  o f  0 . 5  c m S u r r o g a t e s  f o r  l o n g -t e r m  o u t c o m e s I m p l a n t  m i g r a t i o n :  n o  c o m p o n e n t s u b s i d e n c e  o r  l o o s e n i n g  o c c u r r e d P i p i n o ,  2 0 0 4 4 9 S t u d y  d e s i g n :  s i n g l e c o h o r t L o c a t i o n :  I t a l y ( G e n o a  a n d  M o n z a ) R e c r u i t m e n t  d a t e s : A p r i l  1 9 9 7 \u2013 J u l y  2 0 0 4 ( u n t i l  D e c e m b e r 2 0 0 2  i n  G e n o a , M o n z a  t h e r e a f t e r )  F u n d i n g :  N R D u r a t i o n  o f  F U : 1 \u2013 7 y e a r s I n c l u s i o n  c r i t e r i a :  g e n e r a l l y  g o o d q u a l i t y  o f  t h e  r e m a i n i n g  h e a l t h y f e m o r a l  b o n e ,  e s p e c i a l l y  a s t r u c t u r a l l y  i n t a c t  f e m o r a l  n e c k w i t h  n e a r -n o r m a l  i n c l i n a t i o n E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  3 6 8  ( 3 0 3  i n  G e n o a ,  6 5  i n  M o n z a ) L o s t  t o  F U :  3 7  ( 3 7  h i p s ) I n d i c a t i o n s :  c o x a r t h r i t i s  3 0 2 ; n e c r o s i s  o f  f e m o r a l  n e c k  2 9 ; c o x a r t h r i t i s  a n d  d y s p l a s i a  2 2 ; o t h e r  1 5 A g e  ( y e a r s ) :  6 0 S e x  ( M \/ F ) :  2 2 0 \/ 1 4 8 M I :  N =  3 6 8  ( 3 9 0  h i p s )  a t b a s e l i n e N =  3 3 1  ( 3 5 3  h i p s )  a t 1 \u2013 7 y e a r s O p e r a t i v e  a p p r o a c h M I :  t r a n s g l u t t e a l  d i r e c t  l a t e r a l a c c e s s ;  1 2 \u2013 1 5 -c m  i n c i s i o n  i n G e n o a ;  8 \u2013 1 0 -c m  i n c i s i o n  i n M o n z a 3 9 0  C F P  s t e m s ,  d e s i g n e d  f o r \u201c c o l l u m  f e m o r i s -p r e s e r v i n g \u201d t e c h n i q u e ,  a  m i n i -i n v a s i v e s u r g e r y  t h a t  p r e s e r v e s  a n d r e s p e c t s  a s  m u c h  a s  p o s s i b l e t h e  j o i n t  s t r u c t u r e  ( b o n e s t o c k  a n d  s o f t  t i s s u e s ) 3 8 8 \/ 3 9 0  c u p s  p o s i t i o n e d  b y p r e s s -f i t t i n g ;  2 \/ 3 9 0  c u p s  w i t h s c r e w s  ( d u e  t o  f r a c t u r e ) I n t r a o p e r a t i v e I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) :  3 6 8 ,  1 5 0 P o s t o p e r a t i v e I n f e c t i o n  ( d e e p  S .  a u r e u s i n f e c t i o n ) :  1 \/ 3 3 1 N e r v e  i n j u r y :  0 \/ 3 3 1 V a s c u l a r  i n j u r y :  0 \/ 3 3 1 P e r i -p r o s t h e t i c  f r a c t u r e :  3 \/ 3 3 1 I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c  a n a l y s i s i m m e d i a t e l y  p o s t o p e r a t i v e ) C u p  s l o p e  ( c u p  a b d u c t i o n  o u t s i d e  n o r m a l r a n g e ) :  < 5 0 \u00b0 1 8 \/ 3 5 3 ,  > 6 0 \u00b0 1 1 \/ 3 5 3 ;  5 0 \u2013 6 0 \u00b0 ( n o r m a l )  3 2 4 \/ 3 5 3 S t e m  a l i g n e d  i n  v a r u s  1 8 \/ 3 5 3 ,  i n  v a l g u s 3 \/ 3 5 3 ,  c o r r e c t l y  3 3 2 \/ 3 5 3 C u p  s a t  c o r r e c t l y  i n  t h e  c o t y l o i d  c a v i t y 3 4 2 \/ 3 5 3 ,  t o o  d e e p  4 \/ 3 5 3 ,  t o o  s h a l l o w 7 \/ 3 5 3 ,  s m a l l  g a p  b e n e a t h  t h e  p r o s t h e t i c  r i m 2 \/ 3 5 3  F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e  a t  1 \u2013 7  y e a r s : E x c e l l e n t ,  9 0 \u2013 1 0 0 :  3 2 1 \/ 3 5 3 G o o d ,  8 0 \u2013 8 9 :  2 0 \/ 3 5 3 F a i r ,  7 0 \u2013 7 9 :  8 \/ 3 5 3 P o o r ,  < 7 0 :  4 \/ 3 5 3 R e t u r n  t o  a  f u l l  n o r m a l  l i f e s t y l e  a t  1 \u2013 7  y e a r s : 9 6 %  ( 3 1 8 \/ 3 3 1 ) A b l e  t o  t a k e  u p  s p o r t s  a t  a  g o o d  a m a t e u r l e v e l  a t  1 \u2013 7  y e a r s :  1 2 %  ( 4 0 \/ 3 3 1 ) R e v i s i o n  r a t e s :  2 \/ 3 3 1 T i m e  t o  r e v i s i o n  ( m o n t h s ) :  a f t e r  2  m o n t h s L o n g -t e r m  p a i n T h i g h  p a i n  a t  2  m o n t h s :  7 \/ 3 3 1 P e r s i s t e n t  t h i g h  p a i n  a t  1 \u2013 7  y e a r s :  1 \/ 3 3 1 L i m b  l e n g t h  i n e q u a l i t y C h a n g e  l e s s  t h a n  1  c m :  2 8 \/ 3 3 1 C h a n g e  m o r e  t h a n  1  c m :  0 \/ 3 3 1 c o n t i n u e dAppendix 8 146 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  p e r f o r m e d  b y  s i n g l e s u r g e o n  ( i n  t w o  l o c a t i o n s ) M I S  =  s h o r t  i n c i s i o n  + p r e s e r v a t i o n  o f  t h e  f e m o r a l n e c k S t e m  s i z e  c o r r e c t  3 2 8 \/ 3 5 3 ,  o v e r s i z e d 1 4 \/ 3 5 3 ,  u n d e r s i z e d :  1 1 \/ 3 5 3 S u r r o g a t e s  f o r  l o n g -t e r m  o u t c o m e s I m p l a n t  m i g r a t i o n  ( a t  1 \u2013 7  y e a r s ) :  0 \/ 3 3 1  ( t h e i m p l a n t e d  c u p s  d i d  n o t  d e t a c h ,  m i g r a t e  o r m o b i l i s e ,  a n d  n o n e  p r e s e n t e d  o s t e o l y s i s  o r r a d i o l u c e n t  l i n e s ;  2  s t e m s  h a d  a s e p t i c l o o s e n i n g ,  w h i l e  t h e  i n t e g r a t i o n  o f  t h e i m p l a n t e d  s t e m  i n t o  t h e  b o n e  w a s  g e n e r a l l y g o o d  i n  t h e  r e m a i n i n g  3 5 1  c a s e s )  H e t e r o t o p i c  o s s i f i c a t i o n :  1 5 5 \/ 3 5 3 ( B r o o k e r \u2019 s  c l a s s i f i c a t i o n  g r a d e  I \/ I I \/ I I I \/ I V : 1 0 6 \/ 2 8 \/ 2 1 \/ 0 ,  w h e r e  I V  =  w o r s t ) O t h e r \u2022 m a s s i v e  d e t a c h m e n t  o f  t h e  s t e m ,  s e v e r a l m o n t h s  a f t e r  s u r g e r y :  1 \/ 3 5 3  ( p a t i e n t d i a g n o s e d  w i t h  g a s t r i c  c a r c i n o m a 2 m o n t h s  a f t e r  s u r g e r y ) \u2022 a l t e r e d  b o n e  r e m o d e l l i n g  a r o u n d  t h e s t e m  ( i n g r o w t h ) \u2022 s p o t -w e l d s c o n t i n u e","cites":null},{"id":6013873,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) H o w e l l ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 135 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) H o w e l l ,  2 0 0 4 4 2 S t u d y  d e s i g n : p r o s p e c t i v e c o n c u r r e n t c o m p a r i s o n L o c a t i o n :  C a n a d a R e c r u i t m e n t  d a t e s : J u n e  2 0 0 2 \u2013 J u n e 2 0 0 3 F u n d i n g :  l e a d  a u t h o r ( H o w e l l )  w a s s u p p o r t e d  b y  a  g r a n t f r o m  t h e  J o h n C h a r n l y  T r u s t D u r a t i o n  o f  F U : n o n e I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a  ( f o r  c o n t r o l  g r o u p ,  N =  1 6 ) :  t h e c o m p l e x i t y  o f  t h e  p r i m a r y  T H R  w a s  a f f e c t e d  b y p r e v i o u s  s u r g e r y  o r  b y  a  c o n g e n i t a l  c o n d i t i o n ;  d u r i n g t h e  o p e r a t i o n  r e q u i r e d  a n  a d d i t i o n a l  p r o c e d u r e ;  t h e a n t e r o l a t e r a l  a p p r o a c h  w a s  n o t  u s e d N e l i g i b l e :  1 1 8 L o s t  t o  F U :  N A I n d i c a t i o n s :  p r i m a r y  o s t e o a r t h r i t i s  ( O A )  M I  3 9 ,  S I  3 5 ; O A  s e c o n d a r y  t o  d y s p l a s i a  M I  5 ,  S I  9 ;  p o s t -t r a u m a t i c O A  M I  1 ,  S I  4 ;  a n k y l o s i n g  s p o n d y l i t i s  M I  0 ,  S I  3 ; o s t e o n e c r o s i s  M I  2 ,  S I  1 ;  d e v e l o p m e n t a l  p r o t r u s i o n M I  1 ,  S I  2 ;  r h e u m a t o i d  a r t h r i t i s :  M I  0 ,  S I 2 ;  m u l t i p l e e p i p h y s e a l  d y s p l a s i a  M I  2 ,  S I  0 ;  S C F E  w i t h  s e c o n d a r y d e g e n e r a t i o n  M I  0 ,  S I  1 A g e  ( y e a r s ) :  M I  5 9 . 8  ( 1 1 . 7 ) ,  S I 6 2 . 3  ( 1 3 . 5 ) S e x  ( M \/ F ) :  M I  3 4 \/ 1 6 ,  S I  2 7 \/ 3 0 B M I  ( k g \/ m 2 ) :  M I  2 6 . 2  ( 3 . 7 ) ,  S I 2 8 . 8  ( 5 . 8 ) ,  p =  0 . 0 0 7 C o -m o r b i d i t y  s c o r e :  M I  0 . 5  ( 1 . 0 1 ) ,  S I  0 . 5  ( 0 . 6 8 ) M I :  N =  4 6  ( 5 0  h i p s ) S I :  N =  5 6  ( 5 7  h i p s ) O p e r a t i v e  a p p r o a c h M I :  s i n g l e -m i n i -i n c i s i o n a n t e r o l a t e r a l  a p p r o a c h 3 6  c e m e n t l e s s ,  1 4  h y b r i d S I :  s t a n d a r d  s i n g l e -i n c i s i o n a n t e r o l a t e r a l  a p p r o a c h 3 5  c e m e n t l e s s ,  2 2  h y b r i d A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  b y  a  s i n g l e  s u r g e o n ( s e n i o r  a u t h o r ) ;  s t u d y r e p r e s e n t s  e a r l y  e x p e r i e n c e o f  t h e  s u r g e o n  w i t h  M I S ( i n i t i a l  l e a r n i n g  c u r v e ) I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  5 0 ,  9 7  ( 1 9 ) ,  S I  5 7 ,  8 4  ( 1 5 ) , p = 0 . 0 0 0 1 I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  5 0 ,  3 8 7  ( 1 5 5 ) ,  S I  5 7 ,  4 6 9 ( 1 4 7 ) ,  p =  0 . 0 0 7 I n t r a o p e r a t i v e  f r a c t u r e :  M I  2 \/ 5 0 ,  S I  0 \/ 5 7 P o s t o p e r a t i v e I n f e c t i o n C l o s t r i d i u m  d i f f i c i l e e n t e r o c o l i t i s : M I  0 \/ 5 0 ,  S I  1 \/ 5 7 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) M I  5 0 ,  4 . 4  ( 2 . 9 ) ,  S I  5 7 ,  5 . 7  ( 3 . 1 ) , p =  0 . 0 3 L i  2 0 0 5 4 4 S t u d y  d e s i g n : P r o s p e c t i v e c o m p a r i s o n  o f c o n s e c u t i v e  s e r i e s L o c a t i o n :  C h i n a R e c r u i t m e n t  d a t e s : M a r c h  2 0 0 3 \u2013  ( e n d d a t e  N R ) F u n d i n g :  N R D u r a t i o n  o f  F U :  0 . 9 [ 0 . 5 \u2013 1 . 7 ]  y e a r s  I n c l u s i o n  c r i t e r i a :  l a t e r  o s t e o n e c r o s i s  o f  f e m o r a l  h e a d E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  3 6 L o s t  t o  F U :  n o n e I n d i c a t i o n s :  o s t e o a r t h r i t i s  M I  0 ,  S I  6 ;  o s t e o n e c r o s i s M I  1 8 ,  S I  7 ;  f e m o r a l  n e c k  f r a c t u r e :  M I  0 ,  S I  5 A g e  ( y e a r s ) :  M I  [ 2 4 \u2013 5 7 ] ,  S I  [ 3 1 \u2013 7 1 ] S e x  ( M \/ F ) :  M I  1 3 \/ 5 ,  S I  1 4 \/ 4 B M I  ( k g \/ m 2 ) :  M I  2 4 . 6  [ 1 7 . 1 \u2013 3 0 . 1 ] ,  S I  2 6 . 1  [ 1 8 . 4 \u2013 3 2 . 5 ] M u s c u l a r  p a t i e n t  ( % ) :  M I  6 1 % ,  S I  N R H a r r i s  h i p  s c o r e :  M I  4 6 ,  S I  4 6 M I :  N = 1 8  ( 2 2  T H R s ) S I :  N =  1 8  ( 2 2  T H R s ) O p e r a t i v e  a p p r o a c h M I :  9 . 3  ( 0 . 4 )  [ 8 . 7 \u2013 1 0 . 5 ] -c m s i n g l e -i n c i s i o n  p o s t e r o l a t e r a l a p p r o a c h C e m e n t e d S I :  1 6 . 8  ( 2 . 3 )  [ 1 4 \u2013 2 0 ] -c m s i n g l e -i n c i s i o n  p o s t e r o l a t e r a l a p p r o a c h C e m e n t e d A d d i t i o n a l  i n f o r m a t i o n :  n o n e I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  1 8 ,  9 1 . 0  ( 1 6 . 4 )  [ 6 5 \u2013 1 2 0 ] , S I 1 8 ,  9 7 . 0  ( 1 5 . 6 )  [ 7 5 \u2013 1 5 0 ] , p > 0 . 0 5 F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e  a t  6  m o n t h s :  M I 9 2 , S I  9 0 ,  p >  0 . 0 5 R e v i s i o n  r a t e s :  M I  0 \/ 1 8 ,  S I  1 \/ 1 8 O t h e r \u2022 t o t a l  b l o o d  l o s s  ( m l ) :  M I  3 1 8 ( 2 2 3 . 1 )  [ 1 5 0 \u2013 1 1 0 0 ] ,  S I  5 2 3 ( 2 1 0 . 7 )  [ 2 0 0 \u2013 1 0 0 0 ] ,  p <  0 . 0 5 c o n t i n u e dAppendix 8 136 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) O \u2019 B r i e n ,  2 0 0 5 4 5 S t u d y  d e s i g n : r e t r o s p e c t i v e c o m p a r i s o n  o f c o n s e c u t i v e  s e r i e s  o f p a t i e n t s  L o c a t i o n :  C a n a d a R e c r u i t m e n t  d a t e s : M a y  2 0 0 3 \u2013 S e p t e m b e r  2 0 0 4 F u n d i n g :  n o n e D u r a t i o n  o f  F U : 6 w e e k s  I n c l u s i o n  c r i t e r i a :  d i r e c t  l a t e r a l a p p r o a c h ;  p r i m a r y  T H R s ,  p a t i e n t s w e r e  g i v e n  M I S  b a s e d  o n  t h e o v e r a l l  g i r t h  o f  t h e  p a t i e n t s  u p p e r t h i g h \/ h i p  g i r d l e E x c l u s i o n  c r i t e r i a :  p o s t e r i o r a p p r o a c h  ( N =  2 )  N e l i g i b l e :  8 5  ( 8 9  h i p s )  L o s t  t o  F U :  n o n e I n d i c a t i o n s :  p r i m a r y  o s t e o a r t h r i t i s M I  2 8 ,  S I  3 9 ;  r h e u m a t o i d  a r t h r i t i s M I  0 ,  S I  3 ;  p o s t t r a u m a o s t e o a r t h r i t i s  M I  0 ,  S I  3 ; o s t e o a r t h r i t i s  s e c o n d a r y  t o d y s p l a s i a  M I  2 ,  S I  5 ;  a v a s c u l a r n e c r o s i s  M I  4 ,  S I  1 ;  a n k y l o s i n g s p o n d y l i t i s  M I  0 ,  S I  1 ;  p s o r i a t i c M I 0 ,  S I  1  A g e  ( y e a r s ) :  M I  6 7 ,  S I  6 7 ,  N S S e x  ( M \/ F ) :  M I  1 9 \/ 1 3 ,  S I  2 5 \/ 2 6 ,  N S B o d y  w e i g h t  ( k g ) :  M I  7 9 . 2 ,  S I  9 0 . 9 , N S H e i g h t  ( c m ) :  M I  1 7 0 ,  S I  1 6 8 ,  N S B M I  ( k g \/ m 2 ) :  M I  2 7  ( 4 ) ,  S I  3 0  ( 9 ) A m e r i c a n  S o c i e t y  o f A n e s t h e s i o l o g i s t s  ( A S A )  s c o r e ( % ) :  M I  2 ,  S I  2 ,  N S M I :  N = 3 2  ( 3 4  h i p s ) S I :  N =  5 1  ( 5 3  h i p s ) O p e r a t i v e  a p p r o a c h M I :  1 0 -c m  s i n g l e -i n c i s i o n d i r e c t  l a t e r a l  a p p r o a c h C o m p o n e n t  f i x a t i o n :  9 7 % c e m e n t l e s s ,  3 %  h y b r i d ;  2 6 % a c e t a b l u l a r  s c r e w  f i x a t i o n S I :  > 1 0 -c m  s i n g l e -i n c i s i o n d i r e c t  l a t e r a l  a p p r o a c h C o m p o n e n t  f i x a t i o n :  8 7 % c e m e n t l e s s ,  1 3 %  h y b r i d ; 1 5 %  a c e t a b l u l a r  s c r e w f i x a t i o n A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  p e r f o r m e d  b y  o n e s u r g e o n .  F e a s i b i l i t y  s t u d y  f o r R C T I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  3 2 ,  7 4  ( 1 5 ) ,  S I  5 3 ,  8 0  ( 1 0 ) ,  p =  0 . 0 4 8 I n t r a o p e r a t i v e  f r a c t u r e M I  2 \/ 3 4 ,  S I  1 \/ 5 3 ,  N S C o n v e r s i o n :  M I  0 \/ 3 4 ,  S I  0 \/ 5 3 P o s t o p e r a t i v e E a r l y  d i s l o c a t i o n :  M I  0 \/ 3 4 ,  S I  0 \/ 5 3 I n f e c t i o n I n f e c t i o n :  M I  0 \/ 3 4 ,  S I  0 \/ 5 3 W o u n d  c o m p l i c a t i o n :  M I  0 \/ 3 4 ,  S I  0 \/ 5 3  N e r v e  i n j u r y N e u r o l o g i c a l  i n j u r y :  M I  0 \/ 3 4 ,  S I  0 \/ 5 3  D V T :  M I  0 \/ 3 4 ,  S I  3 \/ 5 3 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) :  M I  5 . 4  ( 2 . 1 ) ,  S I  6 . 2 ( 2 . 8 ) ,  p =  0 . 0 1 4 I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c  a n a l y s i s ) F e m o r a l  c o m p o n e n t  p o s i t i o n  v a r u s  > 5 \u00b0 :  M I  3 % ( 1 \/ 3 4 ) ,  S I  4 %  ( 2 \/ 5 3 ) F e m o r a l  c o m p o n e n t  p o s i t i o n  v a l g u s  > 5 \u00b0 :  M I  0 % ( 0 \/ 3 4 ) ,  S I  2 %  ( 1 \/ 5 3 ) F e m o r a l  c o m p o n e n t  p o s i t i o n  n e u t r a l  o r  w i t h i n  5 \u00b0 v a r u s \/ v a l g u s :  M I  9 7 % ,  S I  9 4 % N B :  o u t l i e r s  =  > 5 5 \u00b0 a n d  < 3 5 \u00b0 A b d u c t i o n  a n g l e :  M I  4 5 \u00b0 [ 3 4 \u2013 5 8 ] ,  S I  4 5 \u00b0 [ 2 5 \u2013 6 5 ] , p = 0 . 9 3 3  O t h e r \u2022 P E :  M I  1 ,  S I  0 \u2022 m y o c a r d i a l  i n f a r c t i o n :  M I  0 ,  S I  3 \u2022 g a s t r o i n t e s t i n a l  b l e e d i n g :  M I  0 , S I 1 \u2022 d i s c h a r g e d  h o m e :  M I  9 4 % , S I 7 7 % ,  p = 0 . 0 3 8 c o n t i n u e","cites":null},{"id":6013861,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) O g o n d a ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 123 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) O g o n d a ,  2 0 0 5 4 6 , 5 9 , 6 6 S t u d y  d e s i g n :  R C T L o c a t i o n :  B e l f a s t ,  U K R e c r u i t m e n t  d a t e s : D e c e m b e r 2 0 0 3 \u2013 J u n e  2 0 0 4 F u n d i n g :  n o n e  D u r a t i o n  o f  F U :  6  w e e k s  I n c l u s i o n  c r i t e r i a :  u n i l a t e r a l  h i p a r t h r o p l a s t y E x c l u s i o n  c r i t e r i a :  p r e v i o u s  h i p s u r g e r y ;  s e v e r e  i n f l a m m a t o r y p o l y a r t h r i t i s  N e l i g i b l e :  N R N r a n d o m i s e d :  2 1 9 L o s t  t o  F U :  S I  2  ( d e a t h s ) ;  a n o t h e r 2  c o u l d  n o t  b e  s e e n  a t  6  w e e k s ( g r o u p  n o t  s p e c i f i e d ) I n d i c a t i o n s :  o s t e o a r t h r i t i s  M I  1 0 7 \/ 1 0 9 ,  S I  1 0 7 \/ 1 1 0 ; r h e u m a t o i d  a r t h r i t i s  M I  2 \/ 1 0 9 ,  S I  1 \/ 1 1 0 ;  o s t e o n e c r o s i s  M I  0 \/ 1 0 9 , S I  2 \/ 1 1 0 A g e  ( y e a r s ) :  M I  6 7 . 4  ( 9 . 8 ) ,  S I  6 5 . 9 ( 1 0 . 3 ) ,  p =  0 . 2 5 S e x  ( M \/ F ) :  M I  4 9 \/ 6 0 ,  S I  5 8 \/ 5 2 B M I  ( k g \/ m 2 ) :  M I  2 8 . 2  ( 4 . 3 3 ) ,  S I  2 8 . 9 4  ( 4 . 3 3 ) ,  p =  0 . 2 1 M u s c u l a r  p a t i e n t M i d -t h i g h  c i r c u m f e r e n c e  ( c m ) :  M I  4 9 . 3  ( 5 . 3 ) ,  S I  5 0  ( 5 . 7 ) ,  p = 0 . 3 3 T h i g h  c i r c u m f e r e n c e  a t t r o c h a n t e r i c  r i d g e  ( c m ) :  M I  6 0 . 7 3 ( 5 . 7 ) ,  S I  6 1 . 5 3  ( 4 . 6 ) ,  p =  0 . 2 5 D e p t h  o f  s u b c u t a n e o u s  f a t  l a y e r ( c m ) :  M I  2 . 7 2  ( 1 . 5 9 ) ,  S I  2 . 8 3 ( 1 . 2 7 ) ,  p =  0 . 5 9 M a l e  w i t h  a  m i d -t h i g h c i r c u m f e r e n c e  > 5 5  c m :  M I  1 6 \/ 4 9 , S I  2 6 \/ 5 8 M I :  N =  1 0 9 S I :  N =  1 1 0 B e n n e t t ,  2 0 0 6 5 9 M I  N =  9 ,  S I  N =  8 O p e r a t i v e  a p p r o a c h M I  9 . 5  ( 0 . 9 5 ) -c m  s i n g l e -i n c i s i o n ,  p o s t e r i o r  a p p r o a c h  H y b r i d  ( c e m e n t l e s s  c u p  + c e m e n t e d  s t e m ) S I  1 5 . 8 1  ( 0 . 9 3 ) -c m  s i n g l e -i n c i s i o n ,  p o s t e r i o r  a p p r o a c h H y b r i d  ( c e m e n t l e s s  c u p  + c e m e n t e d  s t e m ) A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  p e r f o r m e d  b y  a n e x p e r i e n c e d  s u r g e o n  e x c e p t e x p o s u r e  p e r f o r m e d  b y a r t h r o p l a s t y  f e l l o w  i n  1 5 %  o f S I  g r o u p ;  n o  s p e c i a l i s e d e q u i p m e n t  u s e d .  P a t i e n t s r e c r u i t e d  c o n s e c u t i v e l y I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  1 0 9 ,  6 0 . 3  ( 9 . 2 ) ,  S I  1 1 0 ,  6 5 . 9  ( 1 3 . 2 )  O f  t h e  t h r e e  p h a s e s ,  i . e .  i n c i s i o n  t o  i n s e r t i o n  o f  t h e a c e t a b u l a r  l i n e r ,  i n s e r t i o n  o f  t h e  l i n e r  t o  r e d u c t i o n o f  t h e  h i p  a n d  r e d u c t i o n  t o  c l o s u r e  o f  t h e  s k i n , s i g n i f i c a n t  d i f f e r e n c e  i n  f i r s t  a n d  l a s t  p h a s e s  o f s u r g e r y  ( p =  0 . 0 0 1  a n d  p < 0 . 0 0 1 ,  r e s p e c t i v e l y ) I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  1 0 9 ,  3 1 4 . 2  [ 9 0 \u2013 1 3 1 0 ] ,  S I  1 1 0 ,  3 6 5 . 8 [ 1 0 0 \u2013 1 1 0 0 ] ,  p = 0 . 0 3 I n t r a o p e r a t i v e  f r a c t u r e M I  0 \/ 1 0 9 ,  S I  2 \/ 1 1 0 C o n v e r s i o n M I  0 \/ 1 0 9  ( 2  i n  S I  g r o u p  w o u l d  h a v e  b e e n  d i f f i c u l t w i t h  M I ) P o s t o p e r a t i v e D i s l o c a t i o n :  M I  1 \/ 1 0 9 ,  S I  1 \/ 1 1 0 I n f e c t i o n D e e p  i n f e c t i o n :  M I  1 \/ 1 0 9 ,  S I  0 \/ 1 1 0 S u p e r f i c i a l  i n f e c t i o n :  M I  1 \/ 1 0 9 ,  S I  0 \/ 1 1 0 D V T :  M I  0 \/ 1 0 9 ,  S I  1 \/ 1 1 0 3 0 -d a y  m o r t a l i t y  ( b e f o r e  d i s c h a r g e ) M I  0 \/ 1 0 9 ,  S I  2 \/ 1 1 0 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) M I  1 0 9 ,  3 . 6 5  ( 2 . 0 4 ) ,  [ 2 \u2013 1 3 ] S I  1 1 0 ,  3 . 6 8  ( 2 . 4 5 ) ,  [ 2 \u2013 2 2 ] ,  N S P o s t o p e r a t i v e  p a i n  N o  s i g n i f i c a n t  d i f f e r e n c e  i n  p a i n  s c o r e  ( r e c o r d e d w i t h  v i s u a l  a n a l o g u e  s c a l e )  i n  f i r s t  3 6  h o u r s ( O g o n a d a  T a b l e  I V ) F u n c t i o n a l  r e s u l t s ( a t  6  w e e k s ) H a r r i s  h i p  s c o r e  a t  6  w e e k s :  M I  1 0 7 ,  8 4 . 1 5  ( 1 0 . 5 6 ) ,  S I  1 0 8 ,  8 3 . 3 6 ( 8 . 3 3 ) ,  p =  0 . 5 4 W O M A C  a t  6  w e e k s :  M I  1 0 7 ,  7 4 . 4 ( 1 3 . 8 8 ) ,  S I  1 0 8 ,  7 3 . 9 5  ( 1 2 . 9 0 ) ,  p =  0 . 8 1 O x f o r d  h i p  s c o r e  a t  6  w e e k s :  M I  1 0 7 ,  2 4 . 9 7  ( 7 . 3 3 ) ,  S I  1 0 8 ,  2 5 . 8 8 ( 6 . 2 9 ) ,  p =  0 . 3 3 T i m e d  1 0 -m  w a l k  a t  6 w e e k s ( s e c o n d s ) :  M I  1 0 7 ,  1 3 . 5 2  ( 7 . 1 ) ,  S I  1 0 8 ,  1 2 . 3 6  ( 4 . 6 9 ) ,  p = 0 . 1 6 N o  s i g n i f i c a n t  d i f f e r e n c e  i n  u s e  o f w a l k i n g  a i d s  a t  6 w e e k s  ( L a w l o r T a b l e  5 ) R e v i s i o n  r a t e s :  n o  r e v i s i o n s H e a l t h -r e l a t e d  q u a l i t y  o f  l i f e S F -1 2  p h y s i c a l  c o m p o n e n t  a t  6 w e e k s :  M I  1 0 7 ,  3 8 . 4 8  ( 1 0 . 2 ) ,  S I  1 0 8 , 3 7 . 7 3  ( 9 . 4 8 ) ,  p =  0 . 5 8  S F -1 2  m e n t a l  c o m p o n e n t  a t 6 w e e k s :  M I  1 0 7 ,  5 0 . 6 1  ( 1 1 . 0 5 ) ,  S I  1 0 8 ,  5 1 . 1 1  ( 1 0 . 5 4 ) ,  p =  0 . 7 3 S a t i s f a c t i o n S c a r  m e a s u r e m e n t  a t  6  w e e k s  ( c m ) : M I 1 0 7 ,  8 . 4 4  ( 1 . 0 2 ) ,  S I 1 0 8 ,  1 3 . 9 5 ( 1 . 2 6 ) M e a n  c o n t r a c t i o n  a t  6  w e e k s  a s  % o f  t o t a l  w o u l d  l e n g t h e n  a t  t h e  e n d o f  s u r g e r y :  M I  1 0 7 ,  1 1 %  ( 1 . 0 6 \/ 9 . 5 c m ) , S I  1 0 8 ,  1 2 %  ( 1 . 8 6 \/ 1 5 . 8 1  c m ) ,  p =  0 . 7 0 c o n t i n u e dAppendix 8 124 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) P a i n  s c o r e  i n  f i r s t  7  d a y s  f o l l o w i n g  d i s c h a r g e :  M I  1 0 9 ,  3 3  ( 1 8 ) ,  S I  1 1 0 ,  3 3 . 6  ( 1 9 . 6 )  p  =  0 . 8 2 V o l u m e  o f  m o r p h i n e  u s e d  ( m g ) :  M I  1 0 9 ,  4 2 . 9 ( 9 7 . 4 ) ,  S I  1 1 0 ,  4 5 . 0  ( 9 6 . 8 ) ,  p =  0 . 8 9 T i m e  t o  r e t u r n  t o  u s u a l  a c t i v i t i e s N o  s i g n i f i c a n t  d i f f e r e n c e  i n  I o w a  l e v e l -o f -a s s i s t a n c e s c a l e  ( f r o m  s u p i n e  t o  s i t ,  s i t  t o  s t a n d  a n d m o b i l i s a t i o n  w i t h  a i d )  o n  d a y  2  ( N =  1 0 4  f o r  M I , 1 0 5  f o r  S I ) N o  s i g n i f i c a n t  d i f f e r e n c e  i n  1 0 -m  w a l k i n g  t i m e  o r s t a i r  c l i m b i n g  t i m e  ( N =  1 0 4  f o r  M I ,  1 0 5  f o r  S I ; O g o n d a  T a b l e  V ) N o  s i g n i f i c a n t  d i f f e r e n c e  i n  s t r i d e  a n a l y s i s  ( 1 0 0 p a t i e n t s  r a n d o m l y  s e l e c t e d  f r o m  t h e  s a m p l e ;  N i n e a c h  g r o u p  n o t  r e p o r t e d )  I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c  a n a l y s i s  i m m e d i a t e l y p o s t -o p e r a t i v e ) C u p  o u t l i e r s  ( < 3 0 \u00b0 o r  > 5 0 \u00b0 ) :  M I  1 6 \/ 1 0 5 ,  S I  1 9 \/ 1 0 9 , N S F e m o r a l  s t e m  a l i g n m e n t  o n  l a t e r a l  r a d i o g r a p h :  M I  p o s t e r i o r  =  2 5 \/ 1 0 5 ,  a n t e r i o r  4 \/ 1 0 5 ,  n e u t r a l  = 7 6 \/ 1 0 5 ,  S I  p o s t e r i o r  =  3 4 \/ 1 0 9 ,  a n t e r i o r  =  1 \/ 1 0 9 , n e u t r a l  =  7 4 \/ 1 0 9 F e m o r a l  s t e m  a l i g n m e n t  o n  a n t e r o l a t e r a l r a d i o g r a p h :  M I :  v a r u s  =  3 \/ 1 0 5 ,  v a l g u s  =  0 \/ 1 0 5 , n e u t r a l  =  1 0 2 \/ 1 0 5 ,  S I :  v a r u s  =  8 \/ 1 0 9 ,  v a l g u s  = 0 \/ 1 0 9 ,  n e u t r a l  =  1 0 1 \/ 1 0 9 C u p  a b d u c t i o n  a n g l e :  M I  1 0 5 ,  4 5 . 8 5 \u00b0 ( 5 . 0 ) ,  S I  1 0 9 , 4 6 . 6 5 \u00b0 ( 5 . 6 ) ,  N S S t e m  a n g l e :  M I 1 0 5 ,  0 . 8 1 \u00b0 ( 1 . 2 5 )  o f  v a r u s ,  S I  1 0 9 , 1 . 0 2 \u00b0 ( 1 . 4 9 )  o f  v a r u s ,  N S S u r r o g a t e s  f o r  l o n g -t e r m o u t c o m e s C e m e n t  q u a l i t y  ( a t  i m m e d i a t e  p o s t -o p e r a t i v e  p e r i o d ) :  M I  A  =  3 2 \/ 1 0 5 ,  B =  4 5 \/ 1 0 5 ,  C 1 =  2 3 \/ 1 0 5 ,  C 2  =  5 \/ 1 0 5 ,  D  =  0 \/ 1 0 5 ,  S I  A  =  2 9 \/ 1 0 9 ,  B  =  5 4 \/ 1 0 9 ,  C 1 =  2 2 \/ 1 0 9 ,  C 2  =  4 \/ 1 0 9 ,  D  =  0 \/ 1 0 9 ,  p =  0 . 9 3 B e n n e t t ,  2 0 0 6 5 9 F u n c t i o n a l  r e s u l t s  ( p r e o p e r a t i v e l y , 2 d a y s  p o s t o p e r a t i v e l y  a n d  6  w e e k s p o s t o p e r a t i v e l y ) T e m p o r a l \u2013 s p a t i a l  v a r i a b l e s :  N o s i g n i f i c a n t  d i f f e r e n c e  b e t w e e n g r o u p s  e x c e p t  f o r  c a d e n c e  o n  d a y  2 w i t h  M I  g r o u p  s h o w i n g  a  g r e a t e r r e d u c t i o n  t h a n  S I K i n e m a t i c  v a r i a b l e s :  N o  s i g n i f i c a n t d i f f e r e n c e  a t  D a y  2 ;  b e t w e e n  w e e k 6  a n d  d a y  2 ,  S I  h a d  a  g r e a t e r i m p r o v e m e n t  i n  h i p f l e x i o n \/ e x t e n s i o n  a n d  a  g r e a t e r r e d u c t i o n  i n  e x t e r n a l  r o t a t i o n ,  t h a n M I ;  b e t w e e n  w e e k  6  a n d p r e o p e r a t i v e l y ,  S I  h a d  a  g r e a t e r r e d u c t i o n  i n  p e l v i c  t i l t  a n d  i n e x t e r n a l  h i p  r o t a t i o n  t h a n  M I O t h e r \u2022 s e r u m  l e v e l s  o f  C -r e a c t i v e  p r o t e i n \u2022 p o s t o p e r a t i v e  s w e l l i n g  ( i n c r e a s e i n  m i d -t h i g h  c i r c u m f e r e n c e  a t 4 8 h o u r s ) \u2022 d i s c h a r g e  t o  h o m e \u2022 s u b g r o u p  a n a l y s i s  b y  m u s c u l a r  o r o b e s e  p a t i e n t s c o n t i n u e","cites":null},{"id":6013882,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) P a g n a n o ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"Health Technology Assessment 2008; Vol. 12: No. 26 149 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) P a g n a n o ,  2 0 0 7 a 7 2 ( a b s t r a c t  o n l y ) S t u d y  d e s i g n :  R C T , m a t c h e d  b y c o m p u t e r i s e d r a n d o m i s a t i o n  L o c a t i o n :  U S A R e c r u i t m e n t  d a t e s : N R F u n d i n g :  N R D u r a t i o n  o f  F U : 1 y e a r I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  N R N r a n d o m i s e d :  2 0 L o s t  t o  F U :  N R I n d i c a t i o n s :  N R A g e  ( y e a r s ) :  6 6 ,  m a t c h e d  b y c o m p u t e r i s e d  r a n d o m i s a t i o n S e x  ( M \/ F ) :  m a t c h e d  b y c o m p u t e r i s e d  r a n d o m i s a t i o n B o d y  w e i g h t  ( k g ) :  m a t c h e d  b y c o m p u t e r i s e d  r a n d o m i s a t i o n 2 M I :  N =  1 0 M I :  N =  1 0 O p e r a t i v e  a p p r o a c h 2 M I :  t w o -i n c i s i o n  a p p r o a c h ( M e a r s \/ B e r g e r  t e c h n i q u e ) , f l u o r o s c o p y  a s s i s t e d M I :  s i n g l e -i n c i s i o n  m i n i -p o s t e r i o r  a p p r o a c h F u n c t i o n a l  r e s u l t s G a i t  a n a l y s i s  a t  1  y e a r :  n o  d i f f e r e n c e P a g n a n o ,  2 0 0 7 b 7 3 ( a b s t r a c t  o n l y ) S t u d y  d e s i g n :  R C T , m a t c h e d  b y c o m p u t e r i s e d r a n d o m i s a t i o n  L o c a t i o n :  U S A R e c r u i t m e n t  d a t e s : N R F u n d i n g :  N R D u r a t i o n  o f  F U : 1 y e a r I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  N R N r a n d o m i s e d :  7 2 L o s t  t o  F U :  N R I n d i c a t i o n s :  N R A g e  ( y e a r s ) :  m a t c h e d S e x  ( M \/ F ) :  M I  2 0 \/ 1 6 ,  S I  2 0 \/ 1 6 ( m a t c h e d ) B o d y  w e i g h t  ( k g ) :  m a t c h e d 2 M I :  N =  3 6 M I :  N =  3 6 O p e r a t i v e  a p p r o a c h 2 M I :  t w o -i n c i s i o n  a p p r o a c h ( M e a r s \/ B e r g e r  t e c h n i q u e ) , f l u o r o s c o p y  a s s i s t e d M I :  s i n g l e -i n c i s i o n ,  m i n i -p o s t e r i o r  a p p r o a c h P o s t o p e r a t i v e P o s t o p e r a t i v e  p a i n  T i m e  t o  d i s c o n t i n u e  n a r c o t i c s :  s h o r t e r  f o r  2 M I  t h a n M I T i m e  t o  r e t u r n  t o  u s u a l  a c t i v i t i e s T i m e  t o  r e t u r n  t o  n o r m a l  a c t i v i t i e s :  s h o r t e r  f o r  M I t h a n  2 M I T i m e  t o  d i s c o n t i n u e  a m b u l a t o r y  a i d s :  s h o r t e r  f o r  M I T i m e  t o  c l i m b  s t a i r s :  s h o r t e r  f o r  M I c o n t i n u e dAppendix 8 150 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) Y a n ,  2 0 0 5 5 7 S t u d y  d e s i g n :  q u a s i -R C T ;  r a n d o m i s a t i o n m e t h o d  n o t d e s c r i b e d L o c a t i o n :  C h i n a R e c r u i t m e n t  d a t e s : D e c e m b e r  2 0 0 3 \u2013 J u n e  2 0 0 4 F u n d i n g :  N R D u r a t i o n  o f  F U : 6 m o n t h s  I n c l u s i o n  c r i t e r i a :  g o o d  h e a l t h ( b o d y  w e i g h t  < 1 0 0  k g ) ,  n o o s t e o p o r o s i s  a n d  n o  d e f o r m i t y , l o w  l i m b  l e n g t h  s h o r t i n g   2 c m E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  3 0 N r a n d o m i s e d :  3 0 L o s t  t o  F U :  N R I n d i c a t i o n s :  o s t e o a r t h r i t i s  M I  6 , S I 7 ;  o s t e o n e c r o s i s  o f  f e m o r a l h e a d  M I  8 ,  S I  6 ;  f e m o r a l  f r a c t u r e M I  1 ,  S I  3 A g e  ( y e a r s ) :  M I  6 3  [ 5 1 \u2013 6 9 ] ,  S I  6 1 [ 5 0 \u2013 7 0 ] S e x  ( M \/ F ) :  M I  6 \/ 9 ,  S I  7 \/ 8 H a r r i s  h i p  s c o r e :  M I  5 7 ,  S I  6 2 2 M I :  N = 1 5  S I :  N =  1 5 O p e r a t i v e  a p p r o a c h M I :  t w o -i n c i s i o n  T H R  w i t h 3 . 6  [ 3 . 0 \u2013 4 . 5 ]  a n d  5 . 7 [ 5 . 4 \u2013 6 . 5 ] -c m  i n c i s i o n s  S I :  1 2 . 0  [ 9 \u2013 1 4 ] -c m  s i n g l e -i n c i s i o n  p o s t e r o l a t e r a l a p p r o a c h I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  1 5 ,  1 0 0  [ 9 0 \u2013 2 2 0 ] ,  S I  1 5 ,  8 0  [ 6 0 \u2013 1 5 0 ] ,  p < 0 . 0 5 I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  1 5 ,  7 6 0  [ 6 0 0 \u2013 1 2 0 0 ] ,  S I  1 5 ,  6 5 0  [ 5 0 0 \u2013 8 0 0 ] , p < 0 . 0 5 P o s t o p e r a t i v e D i s l o c a t i o n :  M I  0 \/ 1 5 ,  S I  0 \/ 1 5 I n f e c t i o n :  M I  0 \/ 1 5 ,  S I  0 \/ 1 5 N e r v e  i n j u r y  ( t h i g h ) :  M I  1 \/ 1 5 ,  S I  0 \/ 1 5 P e r i -p r o s t h e t i c  f r a c t u r e :  M I  1 \/ 1 5 ,  S I  1 \/ 1 5 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) :  M I  6 ,  S I  1 3 , p < 0 . 0 0 1 I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c  a n a l y s i s ) F e m o r a l  s t e m :  a l l  n e u t r a l  p o s i t i o n A b d u c t i o n  o f  t h e  c u p :  M I  [ 4 1 \u2013 4 7 \u00b0 ] ,  S I  [ 4 0 \u2013 5 3 \u00b0 ] , p < 0 . 0 5 F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e :  A t  1  w e e k :  M I  8 1 ,  S I  7 2 ,  p < 0 . 0 5  A t  6  w e e k s :  M I  8 9 ,  S I  8 6 ,  p <  0 . 0 5  A t  3  m o n t h s :  M I  9 2 ,  S I  9 1 ,  p >  0 . 0 5 A t  6  m o n t h s :  M I  9 3 ,  S I  9 3 ,  p >  0 . 0 5 L i m b  l e n g t h  i n e q u a l i t y  ( c m ) :  M I  0 ,  0 . 3  [ 0 . 2 \u2013 0 . 5 ] ,  S I  1 5 ,  0 . 5 [ 0 . 3 \u2013 0 . 9 ] ,  p < 0 . 0 5C o m p a r a t i v e  s t u d i e s","cites":null},{"id":6013875,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) P a n i s e l l o ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 137 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) P a n i s e l l o ,  2 0 0 6 7 4 ( a b s t r a c t  o n l y ) S t u d y  d e s i g n : p r o s p e c t i v e c o m p a r a t i v e  c o h o r t s L o c a t i o n :  S p a i n R e c r u i t m e n t  d a t e s : N R F u n d i n g :  N R D u r a t i o n  o f  F U : s h o r t -t e r m I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  N R N r a n d o m i s e d :  8 0 L o s t  t o  F U :  N R I n d i c a t i o n s :  N R M I :  N =  4 0 S I :  N =  4 0 O p e r a t i v e  a p p r o a c h M I :  s i n g l e  m i n i -i n c i s i o n C e m e n t l e s s S I :  c l a s s i c  a p p r o a c h C e m e n t l e s s P o s t o p e r a t i v e L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) M I  5 . 6 ,  S I  6 . 7 P i l o t ,  2 0 0 6 4 8 S t u d y  d e s i g n : c o m p a r a t i v e  s t u d y ; p i l o t  s t u d y L o c a t i o n :  T h e N e t h e r l a n d s R e c r u i t m e n t  d a t e s : N o v e m b e r  2 0 0 4 \u2013 J a n u a r y  2 0 0 5 F u n d i n g :  N R D u r a t i o n  o f  F U : n o n e I n c l u s i o n  c r i t e r i a :  u n i l a t e r a l  T H R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  2 0 L o s t  t o  F U :  N A I n d i c a t i o n s :  N R A g e  ( y e a r s ) :  M I  6 7 . 9 ,  S I  6 7 . 5 ,  N S S e x  ( M \/ F ) :  M I  4 \/ 6 ,  S I  2 \/ 8 H e i g h t  ( c m ) :  M I  1 6 9 ,  S I  1 6 7 ,  N S B M I  ( k g \/ m 2 ) :  M I  2 9 . 1 ,  S I  2 6 . 4 , p = 0 . 0 4 8 A m e r i c a n  S o c i e t y  o f A n e s t h e s i o l o g i s t s  ( A S A )  g r a d i n g ( 1 \/ 2 \/ 3 \/ 4 ) :  M I  4 \/ 5 \/ 1 \/ 0 ,  S I  3 \/ 7 \/ 0 \/ 0 M I :  N =  1 0 S I :  N =  1 0 O p e r a t i v e  a p p r o a c h M I :  8 . 6 -c m  s i n g l e -i n c i s i o n a n t e r i o r  a p p r o a c h U n c l e a r  w h e t h e r  c e m e n t e d o r  c e m e n t l e s s S I :  1 7 . 4 -c m  s i n g l e -i n c i s i o n p o s t e r o l a t e r a l  a p p r o a c h U n c l e a r  w h e t h e r  c e m e n t e d o r  c e m e n t l e s s A d d i t i o n a l  i n f o r m a t i o n : 5 s u r g e o n s  e x p e r i e n c e d  i n c o n v e n t i o n a l  T H R ;  a l l a t t e n d e d  a  c a d a v e r  c o u r s e  o n m i n i -i n c i s i o n  T H R  ( l e a r n i n g c u r v e ) I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  1 0 ,  9 9 . 5 ,  S I  1 0 ,  8 1 . 0 ,  p =  0 . 0 5 6 I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  1 0 ,  6 9 9 ,  S I  1 0 ,  5 4 0 ,  p =  0 . 2 8  O t h e r \u2022 m u s c l e  d a m a g e  a n d  i n f l a m m a t i o n \u2022 h e a r t -t y p e  f a t t y  a c i d  b i n d i n g p r o t e i n  ( H -F A R B ) \u2022 i n t e r l e u k i n -6  ( I L -6 ) c o n t i n u e dAppendix 8 138 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) S z e n d r \u00f3 i ,  2 0 0 6 5 2 S t u d y  d e s i g n : p r o s p e c t i v e c o m p a r i s o n  o f c o n s e c u t i v e  c o h o r t s L o c a t i o n :  H u n g a r y R e c r u i t m e n t  d a t e s : J a n u a r y  2 0 0 3 \u2013 D e c e m b e r  2 0 0 4 F u n d i n g :  n o n e D u r a t i o n  o f  F U : 3 m o n t h s  I n c l u s i o n  c r i t e r i a :  p r i m a r y  T H R E x c l u s i o n  c r i t e r i a :  s e v e r e  f o r m s  o f c o n g e n i t a l  d i s l o c a t i o n s  o f  t h e  h i p r e v i s i o n  T H R N e l i g i b l e :  1 0 2 L o s t  t o  F U :  n o n e I n d i c a t i o n s  ( a l l  g r o u p s ) :  p r i m a r y o s t e o a r t h r i t i s  7 6 \/ 1 0 2 ;  s e c o n d a r y o s t e o a r t h r i t i s :  1 7 \/ 1 0 2 ;  a s e p t i c n e c r o s i s  o f  t h e  f e m o r a l  h e a d : 6 \/ 1 0 2 ;  p o s t -t r a u m a t i c  a r t h r i t i s 3 \/ 1 0 2 A g e  ( y e a r s ) :  M I  6 4  ( 1 2 )  [ 4 4 \u2013 8 8 ] , M D  6 2  ( 1 3 )  [ 3 8 \u2013 8 5 ] ,  S I  5 7  ( 1 3 ) [ 3 0 \u2013 8 0 ] B o d y  w e i g h t  ( k g ) :  M I  7 0  ( 1 3 . 5 ) [ 4 8 \u2013 1 0 2 ] ,  M D  7 8  ( 1 3 )  [ 6 1 \u2013 1 0 4 ] S I 7 8  ( 1 9 . 5 )  [ 5 0 \u2013 1 1 6 ] ,  p =  0 . 0 0 9 ( M I \u2013 M D ) ,  p =  N S  ( M D \u2013 S I ) , p = N S  ( M I \u2013 S I ) B M I  ( k g \/ m 2 ) :  M I  2 6  ( 3 . 3 ) [ 2 0 \u2013 3 5 . 4 ] ,  M D  2 8  ( 4 . 2 ) [ 1 7 . 8 \u2013 3 7 . 1 ] ,  S I  2 9 . 5  ( 7 ) [ 2 0 . 3 \u2013 4 4 . 2 ] ,  p =  0 . 0 2 6  ( M I \u2013 M D ) , p =  N S  ( M D \u2013 S I ) ,  p =  0 . 0 4 8 ( M I \u2013 S I ) M I :  N =  3 8 M D :  N =  4 3 S I :  N =  2 1 O p e r a t i v e  a p p r o a c h M I  8 . 8  ( 0 . 9 8 ) -c m  s i n g l e -i n c i s i o n ,  d i r e c t  l a t e r a l a p p r o a c h 2 4  c e m e n t e d , 1 4 u n c e m e n t e d M D :  1 2 . 6  ( 1 . 2 1 ) -c m  s i n g l e -i n c i s i o n ,  d i r e c t  l a t e r a l a p p r o a c h 2 5  c e m e n t e d , 1 8 u n c e m e n t e d S I :  1 6 . 1  ( 1 . 8 8 ) -c m  s i n g l e -i n c i s i o n ,  d i r e c t  l a t e r a l a p p r o a c h 1 1  c e m e n t e d , 1 0 u n c e m e n t e d A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e r i e s  p e r f o r m e d  b y  t h e s e n i o r  a u t h o r ;  f e m o r a l  s h a f t , b e n t  H o h m a n  r e t r a c t o r s  a n d s p i k e  r e t r a c t o r  a r e  u s e d .  N o f l u o r o s c o p e T H R  a l w a y s  s t a r t s  a s  a  s h o r t i n c i s i o n  ( < 1 0 c m )  a n d  t h e n e x t e n d e d  a s  n e c e s s a r y  d u r i n g s u r g e r y I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  3 8 ,  8 4  ( 1 6 )  [ 5 0 \u2013 1 2 0 ] ,  M D  4 3 ,  9 3  ( 1 8 ) [ 6 0 \u2013 1 3 0 ] , S I  2 1 ,  1 0 2  ( 1 2 )  [ 8 0 \u2013 1 2 0 ] ,  p =  0 . 0 2 0  ( M I \u2013 M D ) , p = 0 . 0 2 8  ( M D \u2013 S I ) ,  p <  0 . 0 0 1  ( M I \u2013 S I ) I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  3 8 ,  2 4 4  ( 1 0 0 )  [ 1 0 0 \u2013 5 5 0 ] ,  M D  4 3 ,  2 6 5  ( 1 1 4 ) [ 7 0 \u2013 6 0 0 ] ,  S I  2 1 ,  3 0 4  ( 1 3 6 )  [ 1 5 0 \u2013 6 0 0 ] ,  p =  0 . 3 9 9 ( M I \u2013 M D ) ,  p =  0 . 2 7 8  ( M D \u2013 S I ) ,  p =  0 . 0 9 8  ( M I \u2013 S I ) I n t r a o p e r a t i v e  f r a c t u r e  ( f e m o r a l  s h a f t ) :  M I  0 \/ 3 8 , M D  0 \/ 4 3 ,  S I  0 \/ 2 1 C o n v e r s i o n M I  0 \/ 3 8 ,  M D  4 3 \/ 4 3 ,  S I  2 1 \/ 2 1 P o s t o p e r a t i v e D i s l o c a t i o n :  M I  0 \/ 3 8 ,  M D  0 \/ 4 3 ,  S I  0 \/ 2 1 I n f e c t i o n :  M I  0 \/ 3 8 ,  M D  0 \/ 4 3 ,  S I  0 \/ 2 1 N e r v e  i n j u r y C o m p l e t e  s c i a t i c  n e r v e  p a l s y :  M I  0 \/ 3 8 ,  M D  0 \/ 4 3 ,  S I 0 \/ 2 1 T r a n s i e n t  f e m o r a l  n e r v e  p a l s y :  M I  2 \/ 3 8 ,  M D  3 \/ 4 3 , S I 0 \/ 2 1 D V T :  M I  2 \/ 3 8 ,  M D  3 \/ 4 3 ,  S I  2 \/ 2 1 P o s t o p e r a t i v e  p a i n  ( b y  t h e  i n d i v i d u a l  v i s u a l  a n a l o g u e s c a l e  a t  d a y  3 ) :  M I  3 8 ,  1 . 5  ( 1 . 1 5 )  [ 0 \u2013 5 ] ,  M D  4 3 , 2 . 1 5  ( 1 . 2 )  [ 0 \u2013 4 ] ,  S I  2 1 ,  2 . 1  ( 1 . 3 )  [ 0 \u2013 4 ] ,  p =  0 . 0 2 8  ( M I \u2013 M D ) ,  p =  0 . 8 7 6  ( M D \u2013 S I ) , p = 0 . 1 1 2  ( M I \u2013 S I ) I m p l a n t  p o s i t i o n  ( p o s t o p e r a t i v e  r a d i o g r a p h i c a n a l y s i s ) C u p :  %  h i p s  w i t h i n  n o r m a l  r a n g e  ( 3 5 \u00b0 \u2013 5 0 \u00b0 ) :  M I  8 9 %  ( 3 4 \/ 3 8 ) ,  M D  9 5 %  ( 4 1 \/ 4 3 ) ,  S I  8 5 %  ( 1 8 \/ 2 1 ) , p =  0 . 3 4 8  ( M I \u2013 S I ) ,  p =  0 . 2 0 9  ( M D \u2013 S I ) ,  p =  0 . 6 8 6 ( M I \u2013 S I )  F u n c t i o n a l  r e s u l t s :  \u201c d e p e n d e d  m o r e o n  t h e  g e n e r a l  c o n d i t i o n ,  a g e , c o e x i s t e n t  d i s e a s e s  o f  t h e  p a t i e n t r a t h e r  t h a n  t h e  l e n g t h  o f  i n c i s i o n \u201d  R e v i s i o n  r a t e s :  M I  0 \/ 3 8 ,  M D  0 \/ 4 3 , S I 0 \/ 2 1 P a t i e n t  s a t i s f a c t i o n :  M I  h i g h e s t , M D h i g h ,  S I  h i g h  ( o v e r  9 0 %  i n  a l l g r o u p s ) S u r r o g a t e s  f o r  l o n g -t e r m o u t c o m e s C e m e n t  q u a l i t y  \u201c p o o r \u201d :  M I  0 \/ 2 4 , M D  0 \/ 2 5 ,  S I  0 \/ 1 1  ( c e m e n t e d p r o s t h e s i s  o n l y ) O t h e r \u2022 t o t a l  b l o o d  l o s s :  M I  7 4 4  ( 2 6 0 ) , M D  7 0 8  ( 2 2 1 ) ,  S I  7 7 1  ( 2 3 5 ) ;  l e s s b l o o d  l o s s  f o r  c e m e n t e d  ( n = 6 0 , 6 4 2  m l )  v s  c e m e n t l e s s  ( n =  4 2 , 8 6 8  m l )  p r o s t h e s e s  ( p =  0 . 0 1 1 ) \u2022 p r e o p e r a t i v e  p a i n :  M I  7 . 8  ( 1 . 3 ) [ 5 \u2013 1 0 ] ,  M D  7 . 9  ( 1 . 3 )  [ 5 \u2013 1 0 ] , S I 8 . 5  ( 1 . 4 )  [ 5 \u2013 1 0 ] ;  d r o p  i n  p a i n f r o m  t h e  p r e o p e r a t i v e  t o p o s t o p e r a t i v e  l e v e l  h i g h e r  i n  M I g r o u p  ( p =  0 . 0 2 8 ) \u2022 l o o s e  a n d  u n s t a b l e  c o m p o n e n t : M I  0 \/ 3 8 ,  M D  0 \/ 4 3 ,  S I  0 \/ 2 1 \u2022 s w e l l i n g  a r o u n d  t h e  w o u n d : M I s o m e ,  M D  0 \/ 4 3 ,  S I  0 \/ 2 1 \u2022 w o u n d  n e c r o s i s :  M I  0 \/ 3 8 , M D 0 \/ 4 3 ,  S I  0 \/ 2 1  c o n t i n u e","cites":null},{"id":6013863,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) R a c h b a u e r ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 125 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) R a c h b a u e r ,  2 0 0 6 7 5 ( a b s t r a c t  o n l y ) S t u d y  d e s i g n :  R C T L o c a t i o n :  A u s t r i a R e c r u i t m e n t  d a t e s : N R F u n d i n g :  N R D u r a t i o n  o f  F U :  N R I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a :  B M I  > 3 5 , p r e v i o u s  h i p  s u r g e r y ,  p r e o p e r a t i v e n e u r o l o g i c a l  d e f i c i t s ,  a g e > 8 0 y e a r s N e l i g i b l e :  N R N r a n d o m i s e d :  1 2 0 L o s t  t o  F U :  N R I n d i c a t i o n s :  N R P a t i e n t  c h a r a c t e r i s t i c s : \u201c D e m o g r a p h i c a l l y  e q u a l l y d i s t r i b u t e d \u201d M I :  N =  6 0 S I :  N =  6 0 O p e r a t i v e  a p p r o a c h M I :  s i n g l e -i n c i s i o n  a n t e r i o r a p p r o a c h S I :  s i n g l e -i n c i s i o n  l a t e r a l t r a n s g l u t t a l  a p p r o a c h A d d i t i o n a l  i n f o r m a t i o n : s u r g e r i e s  p e r f o r m e d  b y  2 s u r g e o n s I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) :  n o  d i f f e r e n c e I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) M I  l e s s ,  S I  m o r e ,  p <  0 . 0 1 P o s t o p e r a t i v e P o s t o p e r a t i v e  p a i n  U s e  o f  a n a l g e s i c :  n o  d i f f e r e n c e P o s t o p e r a t i v e  p a i n  i n  t h e  f i r s t  w e e k :  M I  l o w e r ,  S I  h i g h e r ,  s i g n i f i c a n t  d i f f e r e n c e T i m e  t o  r e t u r n  t o  u s u a l  a c t i v i t i e s M I  s h o r t e r ,  S I  l o n g e r ,  s i g n i f i c a n t  d i f f e r e n c e S h a r m a ,  2 0 0 6 7 7 ( a b s t r a c t  o n l y ) S t u d y  d e s i g n :  q u a s i -R C T L o c a t i o n :  U K R e c r u i t m e n t  d a t e s : N R F u n d i n g :  N R D u r a t i o n  o f  F U : e a r l y  p o s t o p e r a t i v e p e r i o d  o n l y I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  N R N r a n d o m i s e d :  4 0 L o s t  t o  F U :  N R I n d i c a t i o n s :  N R A g e  ( y e a r s ) :  M I  6 6 . 9 5 ,  S I  6 8 . 5 5 ,  p =  0 . 5 1 B M I  ( k g \/ m 2 ) :  M I  2 6 . 5 ,  S I  2 4 . 4 ,  p =  0 . 0 2 9 O x f o r d  h i p  s c o r e :  M I  4 1 . 7 5 ,  S I  4 2 . 1 5 ,  p =  0 . 8 7 M I :  N =  2 0 S I :  N =  2 0 O p e r a t i v e  a p p r o a c h M I :  s i n g l e -i n c i s i o n  p o s t e r i o r a p p r o a c h S I :  1 2 -c m  s i n g l e -i n c i s i o n p o s t e r o l a t e r a l  a p p r o a c h A d d i t i o n a l  i n f o r m a t i o n :  n o n e I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  N R ,  S I  N R ,  p =  0 . 2 0 7 P o s t o p e r a t i v e D i s l o c a t i o n :  M I  0 \/ 2 0 ,  S I  0 \/ 2 0 I n f e c t i o n  ( s u p e r f i c i a l  o r  w o u n d ) :  M I  0 \/ 2 0 ,  S I  0 \/ 2 0 P e r i -p r o s t h e t i c  f r a c t u r e :  M I  0 \/ 2 0 ,  S I  0 \/ 2 0 L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) M I  1 . 6 5  d a y s  e a r l i e r  t h a n  S I ,  p =  0 . 0 4 2 P o s t o p e r a t i v e  p a i n 1 0 -p o i n t  v i s u a l  a n a l o g u e  s c a l e  a t  d a y  1 :  M I  4 . 0 5 ,  S I  6 . 2 5 ,  p  =  0 . 0 0 9 S i m i l a r  r e s u l t s  o n  d a y  2  a n d  d a y  o f  d i s c h a r g e c o n t i n u e dAppendix 8 126 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) Z h a n g ,  2 0 0 6 5 8 S t u d y  d e s i g n :  R C T L o c a t i o n :  C h i n a  R e c r u i t m e n t  d a t e s : A u g u s t 2 0 0 2 \u2013 F e b r u a r y  2 0 0 4 F u n d i n g :  N R  D u r a t i o n  o f  F U :  1 . 7 [ 1 \u2013 2 . 5 ]  y e a r s I n c l u s i o n  c r i t e r i a :  g o o d  h e a l t h ( B M I   2 7 )  E x c l u s i o n  c r i t e r i a :  B M I  > 2 7 , o s t e o p o r o s i s ,  f r a c t u r e ,  t u m o u r N e l i g i b l e :  1 2 0 N r a n d o m i s e d :  1 2 0 L o s t  t o  F U :  n o n e I n d i c a t i o n s :  o s t e o a r t h r i t i s :  M I  3 6 , S I  3 5 ;  r h e u m a t o i d  a r t h r i t i s :  M I  3 , S I  2 ;  o s t e o n e c r o s i s :  M I  2 1 ,  S I  2 3 A g e  ( y e a r s ) :  M I  6 1  [ 4 8 \u2013 7 2 ] ,  S I  6 2 . 5  [ 5 2 \u2013 7 7 ] S e x  ( M \/ F ) :  M I  2 5 \/ 3 5 ,  S I  2 8 \/ 3 2 H a r r i s  h i p  s c o r e :  M I  5 1 . 3 ,  S I  5 1 . 6 , N S M I :  N = 6 0  S I :  N =  6 0 O p e r a t i v e  a p p r o a c h M I :  7 . 9 -c m  s i n g l e -i n c i s i o n a n t e r i o r  a p p r o a c h S I :  1 6 . 3 -c m  s i n g l e -i n c i s i o n p o s t e r o l a t e r a l  a p p r o a c h A d d i t i o n a l  i n f o r m a t i o n :  n o n e I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) M I  7 5 ,  S I  6 9 ,  p  >  0 . 0 5 P o s t o p e r a t i v e I n f e c t i o n D e e p  i n f e c t i o n :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0  S u p e r f i c i a l  i n f e c t i o n :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0  N e r v e  i n j u r y :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0 V a s c u l a r  i n j u r y :  M I  0 \/ 6 0 ,  S I  0 \/ 6 0  D V T :  M I  0 \/ 6 0 ,  S I  2 \/ 6 0  L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) M I  7  [ 5 \u2013 8 ] ,  S I  1 3 . 5  [ 1 2 \u2013 1 6 ] F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e  a t  3  m o n t h s :  M I  9 1 . 4 ,  S I  7 8 . 5 ,  p <  0 . 0 5 H a r r i s  h i p  s c o r e  a t  f i n a l  v i s i t :  M I  9 5 . 1 ,  S I  9 5 . 6 ,  p > 0 . 0","cites":null},{"id":6013880,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) S i g u i e r ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 147 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) S i g u i e r ,  2 0 0 4 5 0 S t u d y  d e s i g n : r e t r o s p e c t i v e  s t u d y o f  c o n t i n u o u s  s e r i e s L o c a t i o n :  P a r i s , F r a n c e  R e c r u i t m e n t  d a t e s : J u n e  1 9 9 3 \u2013 J u n e 2 0 0 0 F u n d i n g :  n o n e D u r a t i o n  o f  F U : u n c l e a r .  S o m e  d a t a r e p o r t e d  u p  t o 3 y e a r s I n c l u s i o n  c r i t e r i a :  n o  p r e v i o u s  h i p s u r g e r y  E x c l u s i o n  c r i t e r i a :  o b e s e  p a t i e n t s r e q u i r i n g  l o n g e r  i n c i s i o n  ( N = 1 5 ) ; m u s c u l a r  m e n  ( N =  8 ) ;  c o n g e n i t a l p o s t e r i o r  d i s l o c a t e d  h i p s ; d y s p l a s t i c  h i p s ;  f r a c t u r e d  n e c k  o f t h e  f e m u r  o r  a c e t a b u l u m N e l i g i b l e :  N R L o s t  t o  F U :  4 5  p a t i e n t s  a f t e r  1 s t v i s i t I n d i c a t i o n s :  o s t e o a r t h r i t i s  9 5 0 ; c o n g e n i t a l  d y s p l a s t i c  h i p  4 6 ; a v a s c u l a r  n e c r o s i s  2 0 ; i n f l a m m a t o r y  a r t h r i t i s  1 1 ;  p o s t -t r a u m a t i c  o s t e o a r t h r i t i s  5 ; L e g g \u2013 C a l v \u00e9 \u2013 P e r t h e s  d i s e a s e  3 ; d i s a b i l i t y  a f t e r  e p i p h y s i o l y s i s  2 A g e  ( y e a r s ) :  6 7 . 8  [ 2 3 \u2013 9 3 ] S e x  ( M \/ F ) :  3 3 6 \/ 5 9 0  M I :  N =  9 2 6  ( 1 0 3 7  T H R s ) O p e r a t i v e  a p p r o a c h M I :  < 1 0 -c m  s i n g l e -i n c i s i o n a n t e r i o r  a p p r o a c h ,  w i t h o u t m u s c l e  o r  t e n d o n  s e c t i o n i n g  1 0 3 7  c e m e n t e d  p r o c e d u r e s A d d i t i o n a l  i n f o r m a t i o n : s u r g e r i e s  p e r f o r m e d  b y  2 s u r g e o n s  w i t h o u t  n a v i g a t i o n o r  i m a g e  i n t e n s i f i e r P o s t o p e r a t i v e D i s l o c a t i o n :  1 0 \/ 1 0 3 7  ( 0 . 9 6 % )  I n f e c t i o n  ( s e p t i c  c o m p l i c a t i o n ) :  5 \/ 9 2 6  =  5 \/ 1 0 3 7 h i p s P e r i -p r o s t h e t i c  f r a c t u r e :  M I  1 \/ 9 2 6 F u n c t i o n a l  r e s u l t s L i m p  ( p o s t o p e r a t i v e  p e r i o d , p o s s i b l y  < 3  m o n t h s ) :  0 \/ 9 2 6 R e v i s i o n  r a t e s  ( f o r  h a e m a t o m a ) : 0 \/ 9 2 6  S u r r o g a t e s  f o r  l o n g -t e r m o u t c o m e s H e t e r o t o p i c  o s s i f i c a t i o n :  M I  0 \/ 9 2 6 O t h e r \u2022 r e -o p e r a t i o n  a f t e r  f r a c t u r e :  2 \/ 9 2 6 \u2022 r e f u s e d  r e -o p e r a t i o n  a f t e r f r a c t u r e  a t  3  m o n t h s ,  8  m o n t h s a n d  3  y e a r s :  1 \/ 9 2 6 \u2022 f e m o r a l  p a r e s i s :  2 \/ 9 2 6 \u2022 a s c e p t i c  l o o s e n i n g :  3 \/ 9 2 6 \u2022 l o o s e n i n g  o f  s e p t i c  o r i g i n :  3 \/ 9 2 6 c o n t i n u e dAppendix 8 148 S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) S w a n s o n ,  2 0 0 5 5 1 S t u d y  d e s i g n : c o n s e c u t i v e  c a s e s e r i e s L o c a t i o n :  U S A R e c r u i t m e n t  d a t e s : M a y  1 9 9 7 \u2013 F u n d i n g : m a n u f a c t u r e r ;  p a r t i a l o r  i n  t o t a l  s u p p o r t  o f t h e  r e s e a r c h m a t e r i a l  ( P l u s O r t h o p e d i c s ,  S a n  D i e g o ,  C A , c o n s u l t i n g  f e e ) D u r a t i o n  o f  F U :  3 . 1 [ 2 \u2013 5 . 2 ]  y e a r s I n c l u s i o n  c r i t e r i a :  m i n i m u m  2 -y e a r F U E x c l u s i o n  c r i t e r i a :  d e a t h  o r  l o s s  t o F U  i n  f i r s t  2  y e a r s  ( N =  8 3 ) ; p a t i e n t s  r e q u i r i n g  e x t e n s i v e h a r d w a r e  r e m o v a l ,  h a v i n g s i g n i f i c a n t  d e f o r m i t y ,  r e q u i r i n g s t r u c t u r a l  b o n e  g r a f t s  o r u n d e r g o i n g  f e m o r a l  o s t e o t o m y ; n o  p a t i e n t s  w e r e  e x c l u d e d b e c a u s e  o f  w e i g h t  o r  B M I N e l i g i b l e :  8 4 2  ( 1 1 1 5  T H R s ) L o s t  t o  F U :  8 3  ( n o t  i n c l u d e d  i n t h e  s t u d y ;  s e e  a b o v e ) I n d i c a t i o n s :  o s t e o a r t h r i t i s 8 1 2 \/ 1 0 0 0 ;  r h e u m a t o i d  a r t h r i t i s 1 9 \/ 1 0 0 0 ;  o s t e o n e c r o s i s  6 8 \/ 1 0 0 0 ; d e v e l o p m e n t a l  d y s p l a s i a  o f  t h e  h i p 2 2 \/ 1 0 0 0 ;  o t h e r  7 9 \/ 1 0 0 0 A g e  ( y e a r s ) :  6 2 . 3  ( 1 3 . 5 )  [ 2 3 \u2013 9 3 ] S e x  ( M \/ F ) :  4 1 5 \/ 5 8 5  ( b a s e d  o n  N o f h i p s ) B o d y  w e i g h t  ( k g ) :  7 6 . 7  ( 1 9 . 2 ) [ 4 3 \u2013 1 6 3 ] H e i g h t  ( c m ) :  1 6 9  ( 1 0 )  [ 1 2 6 \u2013 1 9 8 ] B M I  ( k g \/ m 2 ) :  2 6 . 5  ( 5 . 7 ) [ 1 4 . 3 \u2013 5 6 . 5 ] H a r r i s  h i p  s c o r e :  3 4  ( 1 2 )  [ 2 5 \u2013 4 5 ] O t h e r D o r r  b o n e  t y p e s C h a r n l e y  f u n c t i o n a l  c l a s s e s M I :  N =  7 5 9  ( 1 0 0 0  T H R s ) O p e r a t i v e  a p p r o a c h M I :  8 . 8  ( 2 . 0 )  [ 6 \u2013 1 6 ] -c m s i n g l e -i n c i s i o n ,  p o s t e r i o r a p p r o a c h T a p e r e d  t i t a n i u m  f e m o r a l c o m p o n e n t  +  h e m i s p h e r i c a l p r e s s -f i t  i n g r o w t h  a c e t a b u l a r c o m p o n e n t ;  s u p p l e m e n t a l a c e t a b u l a r  s c r e w s  w e r e  u s e d i n  m o s t  p a t i e n t s  A d d i t i o n a l  i n f o r m a t i o n :  a l l p r o c e d u r e s  p e r f o r m e d  b y o n e  s u r g e o n  ( a u t h o r )  w i t h  a C h a r n l e y  r e t r a c t o r  ( m o d i f i e d t o  m i n i m i s e  s k i n  t e n s i o n )  a n d s t a n d a r d  h e m i s p h e r i c a l p o w e r  r e a m e r s ,  l e n g t h  o f i n c i s i o n  l a r g e l y  d e p e n d e n t  o n p a t i e n t s \u2019  B M I  \u201c M i n i m a l l y  i n v a s i v e \u201d  s u r g e r y d e f i n e d  a s  m i n i -i n c i s i o n  + m i n i m i s e  s o f t  t i s s u e d i s s e c t i o n I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) :  1 0 0 0 ,  6 1 . 2  ( 2 4 . 2 ) [ 2 3 \u2013 2 7 4 ] I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) 1 0 0 0 ,  3 1 7 . 3  ( 2 3 0 . 6 )  [ 1 0 0 \u2013 2 0 0 0 ] I n t r a o p e r a t i v e  f r a c t u r e  ( f e m o r a l  s h a f t ) :  7 \/ 1 0 0 0 T r o c h a n t e r i c  f r a c t u r e :  3 \/ 1 0 0 0 P o s t o p e r a t i v e D i s l o c a t i o n :  3 0 \/ 1 0 0 0 I n f e c t i o n D e e p  i n f e c t i o n :  3 \/ 1 0 0 0  S u p e r f i c i a l  i n f e c t i o n :  5 \/ 1 0 0 0 N e r v e  i n j u r y  ( t r a n s i e n t  n e r v e  p a l s y ) :  6 \/ 1 0 0 0  D V T  a n d \/ o r  P E :  1 2 \/ 1 0 0 0 P e r i -p r o s t h e t i c  f r a c t u r e  ( f e m o r a l  s h a f t ) :  3 \/ 1 0 0 0 ( a f t e r  f a l l s  i n  t h e  e a r l y  p o s t o p e r a t i v e  p e r i o d ) L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) :  1 0 0 0 ,  3 . 7  ( 1 . 8 ) [ 2 \u2013 1 8 ] T i m e  t o  r e t u r n  t o  u s u a l  a c t i v i t i e s T i m e  t o  b e g i n  u n r e s t r i c t e d  n o r m a l  d a i l y  a c t i v i t i e s ( s e l f -r e p o r t ) :  4 . 2  [ 1 \u2013 1 1 ]  w e e k s I m p l a n t  p o s i t i o n  ( r a d i o g r a p h i c  a n a l y s i s  a t  e a c h  F U v i s i t  a t  6  w e e k s ,  3  a n d  6  m o n t h s ,  1  y e a r  a n d  y e a r l y t h e r e a f t e r ) F e m o r a l  c o m p o n e n t s  i n  < 5 \u00b0 o f  v a r u s :  7 \/ 1 0 0 0 C u p  i n c l i n a t i o n  < 3 0 \u00b0 o r  > 5 0 \u00b0 :  3 0 \/ 1 0 0 0 C u p  a n t e v e r s i o n  < 0 \u00b0 o r  > 3 0 \u00b0 :  1 0 \/ 1 0 0 0 C u p  a b d u c t i o n  a n g l e :  4 1 . 2 \u00b0 C u p  a n t e v e r s i o n :  1 4 . 6 \u00b0 F u n c t i o n a l  r e s u l t s H a r r i s  h i p  s c o r e :  1 0 0 0 ,  9 2  ( 9 ) [ 6 7 \u2013 1 0 0 ]  R e v i s i o n  r a t e s :  2 1 \/ 1 0 0 0 L i m b  l e n g t h  i n e q u a l i t y  ( w i t h i n  7  m m o f  e a c h  o t h e r ) :  9 1 2 \/ 1 0 0 0 ,  i . e . 8 8 \/ 1 0 0 0  n o t  e q u a l M o r t a l i t y :  s e e  e x c l u s i o n  c r i t e r i a O t h e r \u2022 d e l a y e d  w o u n d  h e a l i n g :  1 0 \/ 1 0 0 0 \u2022 \u201c a c u t e  m e d i c a l  c o m p l i c a t i o n s \u201d : 4 1 \/ 1 0 0 0 c o n t i n u e dT w o  i n c i s i o n s R C T s  a n d  q u a s i -R C T s","cites":null},{"id":6013886,"title":"All rights reserved. S t u d y d e t a i l s P a r t i c i p a n t c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t t e r m L o n g t e r m ( i n c l u d i n g s u r r o g a t e s ) Y o o n ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"dHealth Technology Assessment 2008; Vol. 12: No. 26 155 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) Y o o n ,  2 0 0 5 7 9 ( a b s t r a c t  o n l y ) S t u d y  d e s i g n : c o m p a r i s o n  o f c o n s e c u t i v e  p a t i e n t s L o c a t i o n :  K o r e a R e c r u i t m e n t  d a t e s : N R F u n d i n g :  N R D u r a t i o n  o f  F U : e a r l y  r e s u l t s  o n l y I n c l u s i o n  c r i t e r i a :  N R E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  N R L o s t  t o  F U :  N R I n d i c a t i o n s :  o s t e o a r t h r i t i s  2 7 ; o s t e o n e c r o s i s  1 6 3 ;  r h e u m a t o i d a r t h r i t i s  8 ;  a n k y l o s i n g  s p o n d y l i t i s 6 ;  i n f e c t i o n  s e q u e l a e  9  2 M I :  N =  1 1 8 M I :  N =  1 0 0 O p e r a t i v e  a p p r o a c h 2 M I :  t w o -i n c i s i o n  a p p r o a c h M I :  7 . 5 -c m  s i n g l e -i n c i s i o n a p p r o a c h I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) 2 M I  7 2 [ 5 0 \u2013 1 1 5 ] ,  M I  5 2 [ 3 5 \u2013 7 5 ] P o s t o p e r a t i v e L e n g t h  o f  h o s p i t a l  s t a y  ( d a y s ) S h o r t e r  f o r  2 M I P o s t o p e r a t i v e  p a i n  P e r i o d  u s i n g  c r u t c h e s :  s h o r t e r  f o r  2 M IAppendix 8 156 C a s e  s e r i e s S t u d y  d e t a i l s P a r t i c i p a n t  c h a r a c t e r i s t i c s I n t e r v e n t i o n \/ c o m p a r a t o r O u t c o m e s S h o r t  t e r m L o n g  t e r m  ( i n c l u d i n g  s u r r o g a t e s ) A r c h i b e c k ,  2 0 0 4 2 7 S t u d y  d e s i g n : p r o s p e c t i v e  s u r v e y o f  t r a i n e e  s u r g e o n s ( N =  1 5 9 )  d o i n g  8 5 1 c a s e s ,  L o c a t i o n :  U S A  R e c r u i t m e n t  d a t e s : O c t o b e r  2 0 0 2 \u2013 A p r i l 2 0 0 4 F u n d i n g : m a n u f a c t u r e r ( Z i m m e r ) D u r a t i o n  o f  F U :  N R I n c l u s i o n  c r i t e r i a :  1 5 9  s u r g e o n s l e a r n i n g  t w o -i n c i s i o n  M I  r e p o r t e d 8 5 1  p r o c e d u r e s E x c l u s i o n  c r i t e r i a :  N R N e l i g i b l e :  8 3 1  ( 8 5 1  c a s e s ) L o s t  t o  F U :  N R I n d i c a t i o n s :  o s t e o a r t h r i t i s  6 6 0 \/ 8 5 1 ; p o s t -t r a u m a t i c  a r t h r i t i s  1 0 \/ 8 5 1 ; o s t e o n e c r o s i s  1 3 8 \/ 8 5 1 ;  o t h e r 1 1 \/ 8 5 1 A g e  ( y e a r s ) :  6 1  [ 2 1 \u2013 1 0 0 ] S e x  ( M \/ F ) :  4 3 5 \/ 3 9 6 B o d y  w e i g h t  ( k g ) :  7 7 . 6  [ 3 4 . 5 \u2013 1 6 0 ] B M I  ( k g \/ m 2 ) :  2 6  [ 1 0 \u2013 5 6 ] \u201c P a t i e n t  d e m o g r a p h i c s  f o r  8 5 1 c a s e s  s h o w e d  t h e  p o p u l a t i o n  w a s t y p i c a l  f o r  T H R  p a t i e n t s ,  w i t h  a s l i g h t  p r o p e n s i t y  f o r  y o u n g e r  a n d t h i n n e r  p a t i e n t s \u201d  ( p .  2 3 3  o f r e f . 2 7 )  2 M I :  N =  8 3 1  ( 8 5 1  c a s e s ) O p e r a t i v e  a p p r o a c h T w o -i n c i s i o n  M I S  w i t h  5 . 8 [ 1 . 5 \u2013 1 9 ] -c m  a n t e r i o r  i n c i s i o n a n d  3 . 7  [ 1 \u2013 2 1 ] -c m  p o s t e r i o r i n c i s i o n C e m e n t l e s s  a c e t a b u l a r  a n d f e m o r a l  c o m p o n e n t s  A d d i t i o n a l  i n f o r m a t i o n :  a l l s u r g e o n s  a t t e n d e d  Z i m m e r t r a i n i n g  o n  t w o -i n c i s i o n p r o c e d u r e s  a n d  w e r e  a s k e d t o  r e p o r t  t o  t h e  c o m p a n y  o n t h e i r  f i r s t  1 0  c a s e s ;  4 9 \/ 1 5 9 s u r g e o n s  c o m p l e t e d  t h e i r f i r s t  1 0  c a s e s  ( 4 9 0  i n d e x c a s e s ,  o f  w h i c h  1 1  c a s e s  n o t r e p o r t e d ) ;  f l u o r o s c o p y  w a s u s e d ;  d a t a  w e r e  s e l f -r e p o r t e d  b y  t h e  s u r g e o n s i n v o l v e d  ( p o s s i b l e  u n d e r -r e p o r t i n g  o f  c o m p l i c a t i o n s ) I n t r a o p e r a t i v e D u r a t i o n  o f  o p e r a t i o n  ( m i n u t e s ) :  8 5 1 ,  1 4 8 [ 5 0 \u2013 4 5 5 ] D e c r e a s e d  a s  N o f  c a s e s  i n c r e a s e d ( p < 0 . 0 5 ) I n t r a o p e r a t i v e  b l o o d  l o s s  ( m l ) :  8 5 1 ,  4 9 6 [ 3 0 \u2013 2 8 0 0 ]  I n t r a o p e r a t i v e  f r a c t u r e :  6 2 \/ 8 5 1 P o s t o p e r a t i v e D i s l o c a t i o n :  8 \/ 8 5 1 I n f e c t i o n D e e p  i n f e c t i o n :  4 \/ 8 5 1 S u p e r f i c i a l  i n f e c t i o n :  3 \/ 8 5 1 N e r v e  i n j u r y :  2 7 \/ 8 5 1  P e r i -p r o s t h e t i c  f r a c t u r e :  2 \/ 8 5 1 R e v i s i o n  r a t e s :  5 \/ 8 5 1 E a r l y  r e v i s i o n  o r  r e o p e r a t i o n :  8 \/ 8 5 1 \u2022 2  r e o p e r a t i o n s :  r e m o v a l  f o r  t h e  T H R d o n e  f o r  i n f e c t i o n \u2022 1  o p e n  r e d u c t i o n  a n d  i n t e r n a l  f i x a t i o n  f o r a  f e m o r a l  s h a f t  f r a c t u r e \u2022 1  r e v i s i o n  f o r  f r a c t u r e  a n d  s t e m s u b s i d e n c e \u2022 3  r e v i s i o n s  f o r  d i s l o c a t i o n  \u2022 1  r e v i s i o n  f o r  e a r l y  a c e t a b u l a r  l o o s e n i n g O t h e r S u b g r o u p  a n a l y s i s  o f  4 7 9  i n d e x  c a s e s  b y  4 9 s u r g e o n s \u2022 p r e v a l e n c e  o f  k e y  c o m p l i c a t i o n s  a s  a f u n c t i o n  o f  c a s e  n u m b e r  ( N S ) ,  s u r g e o n v o l u m e  o f  T H R s  b e f o r e  t r a i n i n g ( p = 0 . 0 0 0 3 )  a n d  p a t i e n t  B M I  ( p = 0 . 0 5 ) \u2022 t o  e x p l a i n  d i f f e r e n c e  b e t w e e n  s u r g e o n s w h o  d i d  n o t  r e p o r t  a  k e y  c o m p l i c a t i o n a n d  t h o s e  w h o  d i d  \u2013  r e g r e s s i o n  a n a l y s i s c o n t i n u e","cites":null},{"id":6013892,"title":"All rights reserved. S t u d y P a t i e n t -c e n t r e d m e a s u r e s C a s e s e r i e s a n d r e g i s t r y F l \u00f6 r e n ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":"nHealth Technology Assessment 2008; Vol. 12: No. 26 165 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  P a t i e n t -c e n t r e d  m e a s u r e s C a s e  s e r i e s  a n d  r e g i s t r y F l \u00f6 r e n ,  2 0 0 6 3 9 \u2713 \u2713 H a r t z b a n d ,  2 0 0 6 4 1 \u2713 P i p i n o ,  2 0 0 4 4 9 \u2713 \u2713 \u2713 \u2713 S i g u i e r ,  2 0 0 4 5 0 \u2713 S w a n s o n ,  2 0 0 5 5 1 \u2713 \u2713 T w o  i n c i s i o n s R C T  a n d  q u a s i -R C T P a g n a n o ,  2 0 0 7 a 7 2 \u2713 P a g n a n o ,  2 0 0 7 b 7 3 \u2713 \u2713 \u2713 Y a n ,  2 0 0 5 5 7 \u2713 \u2713 D u w e l i u s ,  2 0 0 7 3 8 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 C o m p a r a t i v e  s t u d i e s G r e i d a n u s ,  2 0 0 6 7 1 \u2713 P a g n a n o ,  2 0 0 6 4 7 \u2713 \u2713 \u2713 c o n t i n u e d D e a t h  ( 3 0 -d a y s ) D e a t h  ( l o n g -t e r m ) S h o r t -t e r m  p a t i e n t -c o n t r o l l e d  a n a e s t h e s i a  ( m g ) S h o r t -t e r m  t o t a l  n a r c o t i c  r e c e i v e d  ( m g ) S h o r t -t e r m  n a r c o t i c  ( d a y s ) S h o r t -t e r m  p a i n  ( n o .  o f  p a t i e n t s ) L o n g -t e r m  p a i n  ( n o .  o f  p a t i e n t s ) S h o r t -t e r m  p a i n  ( s c o r e ) L o n g -t e r m  p a i n  ( s c o r e ) T i m e  t o  r e t u r n  t o  n o r m a l  a c t i v i t y  ( d a y s ) T i m e  t o  r e t u r n  t o  s h o p p i n g  ( d a y s ) T i m e  t o  r e t u r n  t o  d r i v i n g  ( d a y s ) U s e  o f  w a l k i n g  a i d s :  s h o r t -t e r m  ( n o .  o f  p a t i e n t s ) U s e  o f  w a l k i n g  a i d s  ( d a y s ) L i m p :  s h o r t -t e r m  ( n o .  o f  p a t i e n t s ) L i m p :  l o n g -t e r m  ( n o .  o f  p a t i e n t s ) H a r r i s  h i p  s c o r e  (   3  m o n t h s ) H a r r i s  h i p  s c o r e  ( > 3  m o n t h s ) W O M A C  o s t e o a r t h r i t i s  i n d e x  (   3 m o n t h s ) O x f o r d  h i p  s c o r e  (   3  m o n t h s ) M e r l e  d \u2019 A u b i g n \u00e9 \u2013 C h a r n l e y  s c o r e  (   3 m o n t h s ) M e r l e  d \u2019 A u b i g n \u00e9 \u2013 C h a r n l e y  s c o r e  ( > 3 m o n t h s ) S F -1 2  p h y s i c a l  c o m p o n e n t  (   3 m o n t h s ) S F -1 2  m e n t a l  c o m p o n e n t  (   3 m o n t h s ) S F -3 6  p h y s i c a l  f u n c t i o n  (   3 m o n t h s ) S F -3 6  p h y s i c a l  f u n c t i o n  ( > 3 m o n t h s ) S F -3 6  m e n t a l  c o m p o n e n t  ( > 3 m o n t h s ) S a t i s f a c t i o n  ( n o .  o f  p a t i e n t s  d i s s a t i s f i e d ) S a t i s f a c t i o n  ( s c o r e ) S c a r  c o n t r a c t i o nAppendix 9 166 S t u d y  P a t i e n t -c e n t r e d  m e a s u r e s T a n a v a l e e ,  2 0 0 6 5 3 \u2713 Y o o n ,  2 0 0 5 7 9 C a s e  s e r i e s A r c h i b e c k ,  2 0 0 4 2 7 D u w e l i u s ,  2 0 0 3 3 7 \u2713 D e a t h  ( 3 0 -d a y s ) D e a t h  ( l o n g -t e r m ) S h o r t -t e r m  p a t i e n t -c o n t r o l l e d  a n a e s t h e s i a  ( m g ) S h o r t -t e r m  t o t a l  n a r c o t i c  r e c e i v e d  ( m g ) S h o r t -t e r m  n a r c o t i c  ( d a y s ) S h o r t -t e r m  p a i n  ( n o .  o f  p a t i e n t s ) L o n g -t e r m  p a i n  ( n o .  o f  p a t i e n t s ) S h o r t -t e r m  p a i n  ( s c o r e ) L o n g -t e r m  p a i n  ( s c o r e ) T i m e  t o  r e t u r n  t o  n o r m a l  a c t i v i t y  ( d a y s ) T i m e  t o  r e t u r n  t o  s h o p p i n g  ( d a y s ) T i m e  t o  r e t u r n  t o  d r i v i n g  ( d a y s ) U s e  o f  w a l k i n g  a i d s :  s h o r t -t e r m  ( n o .  o f  p a t i e n t s ) U s e  o f  w a l k i n g  a i d s  ( d a y s ) L i m p :  s h o r t -t e r m  ( n o .  o f  p a t i e n t s ) L i m p :  l o n g -t e r m  ( n o .  o f  p a t i e n t s ) H a r r i s  h i p  s c o r e  (   3  m o n t h s ) H a r r i s  h i p  s c o r e  ( > 3  m o n t h s ) W O M A C  o s t e o a r t h r i t i s  i n d e x  (   3 m o n t h s ) O x f o r d  h i p  s c o r e  (   3  m o n t h s ) M e r l e  d \u2019 A u b i g n \u00e9 \u2013 C h a r n l e y  s c o r e  (   3 m o n t h s ) M e r l e  d \u2019 A u b i g n \u00e9 \u2013 C h a r n l e y  s c o r e  ( > 3 m o n t h s ) S F -1 2  p h y s i c a l  c o m p o n e n t  (   3 m o n t h s ) S F -1 2  m e n t a l  c o m p o n e n t  (   3 m o n t h s ) S F -3 6  p h y s i c a l  f u n c t i o n  (   3 m o n t h s ) S F -3 6  p h y s i c a l  f u n c t i o n  ( > 3 m o n t h s ) S F -3 6  m e n t a l  c o m p o n e n t  ( > 3 m o n t h s ) S a t i s f a c t i o n  ( n o .  o f  p a t i e n t s  d i s s a t i s f i e d ) S a t i s f a c t i o n  ( s c o r e ) S c a r  c o n t r a c t i o","cites":null},{"id":6013890,"title":"All rights reserved. S t u d y P a t i e n t -c e n t r e d m e a s u r e s O n e i n c i s i o n R C T a n d q u a s i -R C T C h a r l e s ,","authors":[],"date":"2008","doi":"10.2307\/3977547","raw":")Health Technology Assessment 2008; Vol. 12: No. 26 163 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. S t u d y  P a t i e n t -c e n t r e d  m e a s u r e s O n e  i n c i s i o n R C T  a n d  q u a s i -R C T C h a r l e s ,  2 0 0 6 6 9 \u2713 \u2713 \u2713 \u2713 \u2713 C h i m e n t o ,  2 0 0 5 3 1 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 C h u n g ,  2 0 0 4 3 2 \u2713 \u2713 \u2713 H a r t ,  2 0 0 5 4 0 \u2713 \u2713 K i m ,  2 0 0 6 4 3 \u2713 \u2713 \u2713 O g o n d a ,  2 0 0 5 4 6 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 \u2713 R a c h b a u e r ,  2 0 0 6 7 5 \u2713 \u2713 \u2713 S h a r m a ,  2 0 0 6 7 7 \u2713 Z h a n g ,  2 0 0 6 5 8 \u2713 \u2713 C o m p a r a t i v e  s t u d i e s A s a y a m a ,  2 0 0 6 2 8 \u2713 \u2713 \u2713 \u2713 \u2713 B e r g e r ,  2 0 0 4 2 9 C h e n ,  2 0 0 6 3 0 \u2713 \u2713 C i m i n i e l l o ,  2 0 0 6 3 3 \u2713 \u2713 \u2713 \u2713 \u2713 c o n t i n u e d D e a t h  ( 3 0 -d a y s ) D e a t h  ( l o n g -t e r m ) S h o r t -t e r m  p a t i e n t -c o n t r o l l e d  a n a e s t h e s i a  ( m g ) S h o r t -t e r m  t o t a l  n a r c o t i c  r e c e i v e d  ( m g ) S h o r t -t e r m  n a r c o t i c  ( d a y s ) S h o r t -t e r m  p a i n  ( n o .  o f  p a t i e n t s ) L o n g -t e r m  p a i n  ( n o .  o f  p a t i e n t s ) S h o r t -t e r m  p a i n  ( s c o r e ) L o n g -t e r m  p a i n  ( s c o r e ) T i m e  t o  r e t u r n  t o  n o r m a l  a c t i v i t y  ( d a y s ) T i m e  t o  r e t u r n  t o  s h o p p i n g  ( d a y s ) T i m e  t o  r e t u r n  t o  d r i v i n g  ( d a y s ) U s e  o f  w a l k i n g  a i d s :  s h o r t -t e r m  ( n o .  o f  p a t i e n t s ) U s e  o f  w a l k i n g  a i d s  ( d a y s ) L i m p :  s h o r t -t e r m  ( n o .  o f  p a t i e n t s ) L i m p :  l o n g -t e r m  ( n o .  o f  p a t i e n t s ) H a r r i s  h i p  s c o r e  (   3  m o n t h s ) H a r r i s  h i p  s c o r e  ( > 3  m o n t h s ) W O M A C  o s t e o a r t h r i t i s  i n d e x  (   3 m o n t h s ) O x f o r d  h i p  s c o r e  (   3  m o n t h s ) M e r l e  d \u2019 A u b i g n \u00e9 \u2013 C h a r n l e y  s c o r e  (   3 m o n t h s ) M e r l e  d \u2019 A u b i g n \u00e9 \u2013 C h a r n l e y  s c o r e  ( > 3 m o n t h s ) S F -1 2  p h y s i c a l  c o m p o n e n t  (   3 m o n t h s ) S F -1 2  m e n t a l  c o m p o n e n t  (   3 m o n t h s ) S F -3 6  p h y s i c a l  f u n c t i o n  (   3 m o n t h s ) S F -3 6  p h y s i c a l  f u n c t i o n  ( > 3 m o n t h s ) S F -3 6  m e n t a l  c o m p o n e n t  ( > 3 m o n t h s ) S a t i s f a c t i o n  ( n o .  o f  p a t i e n t s  d i s s a t i s f i e d ) S a t i s f a c t i o n  ( s c o r e ) S c a r  c o n t r a c t i o nAppendix 9 164 S t u d y  P a t i e n t -c e n t r e d  m e a s u r e s d e  B e e r ,  2 0 0 4 3 4 \u2713 \u2713 \u2713 \u2713 D i G i o i a ,  2 0 0 3 3 5 \u2713 \u2713 D o r r ,  2 0 0 7 3 6 \u2713 \u2713 \u2713 H o w e l l ,  2 0 0 4 4 2 L i ,  2 0 0 5 4 4 \u2713 O \u2019 B r i e n ,  2 0 0 5 4 5 P a n i s e l l o ,  2 0 0 6 7 4 P i l o t ,  2 0 0 6 4 8 S z e n d r \u00f3 i ,  2 0 0 6 5 2 ( M I \/ M D ) \u2713 \u2713 S z e n d r \u00f3 i ,  2 0 0 6 5 2 ( M I \/ S I ) \u2713 \u2713 T a k a h i r a ,  2 0 0 6 7 8 T e e t ,  2 0 0 6 5 4 W o o l s o n ,  2 0 0 4 5 5 \u2713 \u2713 W r i g h t ,  2 0 0 4 5 6 \u2713 \u2713 \u2713 \u2713 c o n t i n u e d D e a t h  ( 3 0 -d a y s ) D e a t h  ( l o n g -t e r m ) S h o r t -t e r m  p a t i e n t -c o n t r o l l e d  a n a e s t h e s i a  ( m g ) S h o r t -t e r m  t o t a l  n a r c o t i c  r e c e i v e d  ( m g ) S h o r t -t e r m  n a r c o t i c  ( d a y s ) S h o r t -t e r m  p a i n  ( n o .  o f  p a t i e n t s ) L o n g -t e r m  p a i n  ( n o .  o f  p a t i e n t s ) S h o r t -t e r m  p a i n  ( s c o r e ) L o n g -t e r m  p a i n  ( s c o r e ) T i m e  t o  r e t u r n  t o  n o r m a l  a c t i v i t y  ( d a y s ) T i m e  t o  r e t u r n  t o  s h o p p i n g  ( d a y s ) T i m e  t o  r e t u r n  t o  d r i v i n g  ( d a y s ) U s e  o f  w a l k i n g  a i d s :  s h o r t -t e r m  ( n o .  o f  p a t i e n t s ) U s e  o f  w a l k i n g  a i d s  ( d a y s ) L i m p :  s h o r t -t e r m  ( n o .  o f  p a t i e n t s ) L i m p :  l o n g -t e r m  ( n o .  o f  p a t i e n t s ) H a r r i s  h i p  s c o r e  (   3  m o n t h s ) H a r r i s  h i p  s c o r e  ( > 3  m o n t h s ) W O M A C  o s t e o a r t h r i t i s  i n d e x  (   3 m o n t h s ) O x f o r d  h i p  s c o r e  (   3  m o n t h s ) M e r l e  d \u2019 A u b i g n \u00e9 \u2013 C h a r n l e y  s c o r e  (   3 m o n t h s ) M e r l e  d \u2019 A u b i g n \u00e9 \u2013 C h a r n l e y  s c o r e  ( > 3 m o n t h s ) S F -1 2  p h y s i c a l  c o m p o n e n t  (   3 m o n t h s ) S F -1 2  m e n t a l  c o m p o n e n t  (   3 m o n t h s ) S F -3 6  p h y s i c a l  f u n c t i o n  (   3 m o n t h s ) S F -3 6  p h y s i c a l  f u n c t i o n  ( > 3 m o n t h s ) S F -3 6  m e n t a l  c o m p o n e n t  ( > 3 m o n t h s ) S a t i s f a c t i o n  ( n o .  o f  p a t i e n t s  d i s s a t i s f i e d ) S a t i s f a c t i o n  ( s c o r e ) S c a r  c o n t r a c t i o","cites":null},{"id":10509,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es )","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10501,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es ) A sa ya m a,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10498,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es ) C hi m en to ,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10502,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es ) C im in ie llo ,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10505,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es ) C up : % of c om po ne nt s th at w er e ou tli er s:","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10503,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es ) D iG io ia ,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10510,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es ) D uw el iu s,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10499,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es ) H ar t,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10506,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es ) H ar tz ba nd ,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10500,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es ) O go nd a,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10508,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es ) Pa gn an o,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10504,"title":"All rights reserved. S tu dy d et ai ls P ar ti ci pa nt c ha ra ct er is ti cs In te rv en ti on \/co m pa ra to r Out co m es S ho rt t er m Lon g te rm (in cl ud in g su rr og at es ) Pa ni se llo ,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10526,"title":"All rights reserved. Volume 9,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":6013819,"title":"All rights reserved.Clinical effectiveness Search strategies used to identify reports of clinical effectiveness of minimally invasive hip arthroplasty MEDLINE","authors":[],"date":"2008","doi":null,"raw":"Health Technology Assessment 2008; Vol. 12: No. 26 91 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Clinical effectiveness Search strategies used to identify reports of clinical effectiveness of minimally invasive hip arthroplasty MEDLINE (1966\u2013February Week 3 2007), EMBASE (1980\u20132007 Week 8) (MEDLINE In-Process 1 March 2007) Ovid multi-file search. URL: http:\/\/gateway.ovid.com\/athens 1 Arthroplasty, Replacement, Hip\/ 2 Total Hip Prosthesis\/ use emez 3 Hip Prosthesis\/ 4 (hip adj3 (arthroplast$ or replace$ or prosthes$ or implant$)).tw. 5 or\/1-4 6 Osteoarthritis,Hip\/su 7 exp Arthritis\/su 8 (osteoarthritis or arthritis).tw. 9 hip.tw,hw. 10 (7 or 8) and 9 11 or\/6,10 12 Hip Joint\/su use mesz 13 Hip\/su use mesz 14 Hip Surgery\/ use emez 15 (arthroplast$ or replace$ or prosthes$ or implant$).tw. 16 (12 or 13 or 14) and 15 17 5 or 11 or 16 18 Surgical procedures,minimally invasive\/ 19 Robotics\/ 20 Video-assisted Surgery\/ 21 (minimal$ adj3 (invasiv$ or access$ or surg$)).tw. 22 ((small or single or double or mini or one or two) adj3 incision$).tw. 23 computer aid$.tw. 24 robotic$.tw. 25 (key hole or keyhole).tw. 26 (less adj5 invasiv$).tw. 27 or\/18-26 28 17 and 27 29 humans\/ 30 animals\/ or nonhuman\/ 31 30 not (29 and 30) 32 28 not 31 33 remove duplicates from 32 Science Citation Index (1985\u20132 March 2007), Biosis (1985\u20131 March 2007) Web of Knowledge. URL: http:\/\/wok.mimas.ac.uk\/ #1 TS=(hip SAME arthroplast*) #2 TS=(hip SAME replace*) #3 TS=(hip SAME prosthes*) #4 TS=(hip SAME implant*) #5 TS=(hip SAME (surgery or surgical)) #6 #1 or #2 or #3 or #4 or #5 #7 TS=(minimal* SAME (invasiv* or access* or surg*)) #8 TS=((small or single or double or mini or one or two) SAME incision*) #9 TS=(robotic* or computer-aid*) #10 #7 or #8 or #9 #11 #6 and #10 Cochrane Library (Issue 1, 2007) URL: http:\/\/www3.interscience.wiley.com\/ cgi-bin\/mrwhome\/106568753\/HOME #1 MeSH descriptor Arthroplasty, Replacement, Hip, this term only #2 MeSH descriptor Hip Prosthesis, this term only #3 MeSH descriptor Osteoarthritis, Hip, this term only with qualifier: SU #4 MeSH descriptor Arthritis explode all trees with qualifier: SU #5 MeSH descriptor Hip Joint, this term only with qualifier: SU #6 MeSH descriptor Hip, this term only with qualifier: SU #7 (arthroplast* or replace* or prosthes* or implant*) #8 (((#5 OR #6 ) AND #7) #9 (hip near\/3 (arthroplast* or replace* or prosthes* or implant*)) #10 (osteoarthritis or arthritis) and (hip) #11 (hip) #12 (#4 AND #11) #13 (#1 OR #2 OR #3 OR #8 OR #9 OR #10 OR #12) #14 MeSH descriptor Surgical Procedures, Minimally Invasive, this term only #15 MeSH descriptor Robotics, this term Health Technology Assessment 2008; Vol. 12: No. 26 93 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. Appendix 1 Search strategies#16 MeSH descriptor Video-Assisted Surgery, this term only #17 (minimal* near\/3 (invasiv* or access* or surg*)) or ((small or single or double or mini or one or two) near\/3 incision*) or (computer aid*) or (robotic* or key hole or keyhole) or (less near\/3 invasiv*) #18 (#14 OR #15 OR #16 OR #17) #19 (#13 AND #18) National Research Register (Issue 4, 2006) URL: http:\/\/www.update-software.com\/National\/ 1 MeSH Arthroplasty, Replacement, Hip 2 MeSH Hip Prosthesis 3 MeSH Osteoarthritis, Hip QUALIFIERS SU 4 MeSH Arthritis QUALIFIERS SU EXPLODE 1 5 MeSH Hip Joint QUALIFIERS SU 6 MeSH Hip QUALIFIERS SU 7 (arthroplast* or replace* or prosthes* or implant*) 8 ((#5 or #6) and #7) 9 (hip near\/3 (arthroplast* or replace* or prosthes* or implant*)) 10 ((osteoarthritis OR arthritis) AND hip) 11 hip 12 (#4 and #11) 13 (#1 OR #2 OR #3 OR #8 OR #9 OR #10 OR #12) 14 MeSH Surgical Procedures, Minimally Invasive 15 MeSH Robotics 16 MeSH Video-Assisted Surgery 17 (minimal* near (invasiv* or access* or surg*) 18 (small or single or double or mini or one or two) near incision*) 19 (computer aid*) 20 (robotic* or key hole or keyhole) 21 (less near invasiv*) 22 #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 23 #13 and #22 Clinical Trials (December 2006) URL: http:\/\/clinicaltrials.gov\/ct\/gui\/c\/r Hip and minimally and (arthroplasty or replacement) Current Controlled Trials (December 2006) URL: http:\/\/www.controlled-trials.com\/ Hip and Minimal% and (arthroplast% or replac% or implant% or prosthes% or surg%) Cost-effectiveness and economic evaluations Search strategies used to identify reports of cost-effectiveness and economic evaluations of minimally invasive hip arthroplasty MEDLINE (1966\u2013February Week 3 2007), EMBASE (1980\u2013Week 8 2007) (MEDLINE In-Process 1 March 2007) Ovid multi-file search. URL: http:\/\/gateway.ovid.com\/ 1 Arthroplasty, Replacement, Hip\/ 2 Total Hip Prosthesis\/ use emez 3 Hip Prosthesis\/ 4 (hip adj3 (arthroplast$ or replace$ or prosthes$ or implant$)).tw. 5 or\/1-4 6 Osteoarthritis,Hip\/su 7 exp Arthritis\/su 8 (osteoarthritis or arthritis).tw. 9 hip.tw,hw. 10 (7 or 8) and 9 11 or\/6,10 12 Hip Joint\/su use mesz 13 Hip\/su use mesz 14 Hip Surgery\/ use emez 15 (arthroplast$ or replace$ or prosthes$ or implant$).tw. 16 (12 or 13 or 14) and 15 17 5 or 11 or 16 18 Surgical procedures,minimally invasive\/ 19 Robotics\/ 20 Video-assisted Surgery\/ 21 (minimal$ adj3 (invasiv$ or access$ or surg$)).tw. 22 ((small or single or double or mini or one or two) adj3 incision$).tw. 23 computer aid$.tw. 24 robotic$.tw. 25 (key hole or keyhole).tw. 26 (less adj5 invasiv$).tw. 27 or\/18-26 28 17 and 27 29 exp &quot;costs and cost analysis&quot;\/ 30 economics\/ 31 exp economics,hospital\/ 32 exp economics,medical\/ 33 economic,pharmaceutical\/ 34 exp budgets\/ 35 exp models, economic\/ 36 exp decision theory\/ 37 ec.fs. use mesz 38 monte carlo method\/ 39 markov chains\/ 40 exp quality of life\/ 41 &quot;Value of Life&quot;\/ Appendix 1 9442 cost of illness\/ 43 exp health status indicators\/ 44 cost$.ti. 45 (cost$ adj2 (effective$ or utilit$ or benefit$ or minimis$)).ab 46 economics model$.tw. 47 (economics$ or pharmacoeconomic$ or pharmo-economic$).ti. 48 (price$ or pricing$).tw. 49 (financial or finance or finances or financed).tw. 50 (value adj2 (money or monetary)).tw. 51 quality adjusted life.tw. 52 disability adjusted life.tw. 53 (qaly? or qald? or qale? or qtime? or daly?).tw. 54 (euroqol or euro qol or eq5d or eq 5d).tw. 55 (hql or hqol or h qol or hrqol or hr qol).tw. 56 (hye or hyes).tw. 57 (health adj3 (indicator? or status or utilit?)).tw. 58 markov$.tw. 59 monte carlo.tw. 60 (decision$ adj2 (tree? or analy$ or model$)).tw. 61 or\/29-60 62 28 and 61 63 Remove duplicates from 62 Science Citation Index (1985\u20132 March 2007) Web of Knowledge URL: http:\/\/wok.mimas.ac.uk\/ #1 TS=(hip SAME arthroplast*) #2 TS=(hip SAME replace*) #3 TS=(hip SAME prosthes*) #4 TS=(hip SAME implant*) #5 TS=(hip SAME (surgery or surgical)) #6 #1 or #2 or #3 or #4 or #5 #7 TS=(minimal* SAME (invasiv* or access* or surg*)) #8 TS=((small or single or double or mini or one or two) SAME incision*) #9 TS=(robotic* or computer-aid*) #10 #7 or #8 or #9 #11 #6 and #10 #12 TS=economic* #13 TS=cost* #14 TS=(price* OR pricing*) #15 TS=(financial or finance*) #16 TS=(decision* SAME (tree* OR analy* or model*)) #17 TS=markov* #18 TS=monte carlo #19 TS=(health SAME (indicator* or status or utilit*)) #20 TS=quality of life #21 TS=quality adjusted life #22 TS=disability adjusted life #22 TS=(qaly* or qald* or qale* or qtime* or daly*) #23 TS=(euroqol* or euro qol* or eq5d or eq 5d) #24 TS=(hql or hqol or h qol or hrqol or hr qol) #25 TS=(hye or hyes) #26 #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24 or #25 #17 #11 and #26 NHS EED (December 2006) URL: http:\/\/www.york.ac.uk\/inst\/crd\/nhsdhp.htm #1 MeSH Arthroplasty, Replacement, Hip EXPLODE 1 2 #2 MeSH Hip Prosthesis EXPLODE 1 #3 hip #4 arthroplasty OR replac* OR prosthes* OR implant* #5 #3 And #4 #6 #1 OR #2 OR #5 Search strategy for additional search for utilities, cost data and revision rates for total hip arthroplasty MEDLINE (1995\u2013January Week 5 2007), EMBASE (1995\u20132007 Week 5) (MEDLINE In-Process 8 February 2007) Ovid multi-file search URL: http:\/\/gateway.ovid.com\/athens 1 Arthroplasty, Replacement, Hip\/ 2 Total Hip Prosthesis\/ use emez 3 Hip Prosthesis\/ 4 (hip adj3 (arthroplast$ or replace$ or prosthes$ or implant$)).tw. 5 or\/1-4 6 Hip Joint\/su use mesz 7 Hip\/su use mesz 8 Hip Surgery\/ use emez 9 (arthroplast$ or replace$ or prosthes$ or implant$).tw. 10 (6 or 7 or 8) and 9 11 5 or 10 12 exp quality of life\/ 13 &quot;Value of Life&quot;\/ 14 cost of illness\/ 15 exp health status indicators\/ 16 quality adjusted life.tw. 17 disability adjusted life.tw. 18 (qaly? or qald? or qale? or qtime? or daly?).tw. 19 (euroqol or euro qol or eq5d or eq 5d).tw. 20 (hql or hqol or h qol or hrqol or hr qol).tw. 21 (hye or hyes).tw. (70) 22 (health adj3 (indicator? or status or utilit?)).tw. 23 markov$.tw. 24 monte carlo.tw. 25 (decision$ adj2 (tree? or analy$ or model$)).tw. 26 or\/12-24 27 11 and 26 Health Technology Assessment 2008; Vol. 12: No. 26 95 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.28 27 and eng.la. (1076) 29 limit 28 to yr=&quot;1995 - 2007&quot; 30 remove duplicates from 29 31 (case reports or letter).pt. 32 30 not 31 33 exp &quot;costs and cost analysis&quot;\/ 34 economics\/ 35 exp economics,hospital\/ 36 exp economics,medical\/ 37 economics,pharmaceutical\/ 38 exp budgets\/ 39 exp models, economic\/ 40 exp decision theory\/ 41 ec.fs. use mesz 42 monte carlo method\/ 43 markov chains\/ 44 cost$.ti. 45 (cost$ adj2 (effective$ or utilit$ or benefit$ or minimis$)).ab. 46 economics model$.tw. (16) 47 (economics$ or pharmacoeconomic$ or pharmo-economic$).ti. 48 (price$ or pricing$).tw. 49 (financial or finance or finances or financed).tw. 50 (value adj2 (money or monetary)).tw. 51 or\/33-50 52 11 and 51 53 united kingdom\/ use emez 54 exp great britain\/ use mesz 55 53 or 54 56 52 and 55 57 remove duplicates from 56 58 exp prosthesis failure\/ 59 prosthesis-related infection\/ use mesz 60 prosthesis infection\/ use emez 61 hip prosthesis\/ae 62 follow-up studies\/ use mesz 63 follow-up\/ use emez 64 10 year$.ti. 65 ten year$.ti. 66 (11 year$ or eleven year$).ti 67 (12 year$ or twelve year$).ti. 68 (13 year$ or thirteen year$).ti. 69 (14 year$ or fourteen year$).ti. 70 (15 year$ or fifteen year$).ti. 71 (20 year$ or twenty year$).ti. 72 cohort studies\/ 73 or\/58-63,72 74 11 and 73 75 ((failed or failure) adj3 (prosthes$ or arthroplast$ or operat$)).tw. 76 ((re operat$ or reoperat$ or revision) adj rate$).tw. 77 (follow up or long term or longterm).ti. 78 or\/64-71,75-77 79 74 and 78 80 79 not 31 81 limit 80 to english language 82 limit 181to yr=&quot;1995 - 2007&quot; 83 remove duplicates from 82 84 32 or 57 or 83 General searches Search strategies used to identify reports of clinical or cost effectiveness of minimally invasive hip arthroplasty HMIC (1979\u2013January 2007) URL: http:\/\/gateway.ovid.com\/ 1 joint replacement surgery\/ 2 arthroplasty\/ 3 hip.tw,hw. 4 (1 or 2) and 3 5 (hip adj3 (arthroplast$ or replac$ or prosthes$)).tw. 6 4 or 5 7 hip joint replacement\/ 8 6 or 7 9 minimally invasive therapy\/ 10 (minimal$ adj3 (invasiv$ or access$ or surg$)).tw. 11 ((small or single or double or mini or one or two) adj3 incision$).tw. 12 or\/9-11 13 8 and 12 DARE and HTA Databases (December 2006) NHS Centre for Reviews and Dissemination URL: http:\/\/nhscrd.york.ac.uk\/welcome.htm #1 MeSH Arthroplasty, Replacement, Hip EXPLODE 1 2 #2 MeSH Hip Prosthesis EXPLODE 1 #3 hip #4 arthroplasty OR replac* OR prosthes* OR implant* #5 #3 And #4 #6 #1 OR #2 OR #5 National Registries consulted AOA National Joint Replacement Registry (Australian). URL: http:\/\/www.dmac.adelaide.edu.au\/aoanjrr\/index.j sp Canadian Joint Replacement Registry. URL: http:\/\/secure.cihi.ca\/cihiweb\/dispPage.jsp?cw_pag e=services_cjrr_about_e Danish Hip Arthroplasty Registry. URL: http:\/\/www.dhr.dk\/ENGLISH.htm European Arthroplasty Register. URL: http:\/\/www.ear.efort.org\/ Finnish Arthroplasty Registry. URL: http:\/\/www.nam.fi\/english\/publications\/ Appendix 1 96Norwegian Arthroplasty Register. URL: http:\/\/www.haukeland.no\/nrl\/ Romanian Arthroplasty Register. URL: http:\/\/www.rne.ro\/site\/ Scottish Arthroplasty Project. URL: http:\/\/www.arthro.scot.nhs.uk\/ Swedish National Hip Arthroplasty Regstry. URL: http:\/\/www.jru.orthop.gu.se\/ New Zealand National Joint Registry. URL: http:\/\/www.cdhb.govt.nz\/NJR\/ UK National Joint Registry. URL: http:\/\/www.njrcentre.org.uk\/ Conference Proceedings Abstracts: Amercian Academy of Orthopaedic Surgeons (AAOS) 2003 Annual Meeting, San Fransisco, CA, March 2003. 2004 Annual Meeting, New Orleans, LA, March 2004. 2005 Annual Meeting, Washington, DC, February 2006. 2006 Annual Meeting, Chicago, IL, March 2006.","cites":null},{"id":6013911,"title":"All rights reserved.No. 19 Clinical effectiveness and costeffectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic","authors":[],"date":"2008","doi":null,"raw":"Health Technology Assessment 2008; Vol. 12: No. 26 229 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.No. 19 Clinical effectiveness and costeffectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation. By Bryant J, Loveman E, Chase D, Mihaylova B, Cave C, Gerard K, et al. No. 20 Clinical medication review by a pharmacist of patients on repeat prescriptions in general practice: a randomised controlled trial. By Zermansky AG, Petty DR, Raynor DK, Lowe CJ, Freementle N, Vail A. No. 21 The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation. By Jobanputra P, Barton P, Bryan S, Burls A. No. 22 A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. By Kaltenthaler E, Shackley P, Stevens K, Beverley C, Parry G, Chilcott J. No. 23 A systematic review and economic evaluation of pegylated liposomal doxorubicin hydrochloride for ovarian cancer. By Forbes C, Wilby J, Richardson G, Sculpher M, Mather L, Reimsma R. No. 24 A systematic review of the effectiveness of interventions based on a stages-ofchange approach to promote individual behaviour change. By Riemsma RP, Pattenden J, Bridle C, Sowden AJ, Mather L, Watt IS, et al. No. 25 A systematic review update of the clinical effectiveness and costeffectiveness of glycoprotein IIb\/IIIa antagonists. By Robinson M, Ginnelly L, Sculpher M, Jones L, Riemsma R, Palmer S, et al. No. 26 A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS. By Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, et al. No. 27 A randomised controlled crossover trial of nurse practitioner versus doctor-led outpatient care in a bronchiectasis clinic. By Caine N, Sharples LD, Hollingworth W, French J, Keogan M, Exley A, et al. No. 28 Clinical effectiveness and cost \u2013 consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders. By Adi Y, Ashcroft D, Browne K, Beech A, Fry-Smith A, Hyde C. No. 29 Treatment of established osteoporosis: a systematic review and cost\u2013utility analysis. By Kanis JA, Brazier JE, Stevenson M, Calvert NW, Lloyd Jones M. No. 30 Which anaesthetic agents are costeffective in day surgery? Literature review, national survey of practice and randomised controlled trial. By Elliott RA Payne K, Moore JK, Davies LM, Harper NJN, St Leger AS, et al. No. 31 Screening for hepatitis C among injecting drug users and in genitourinary medicine clinics: systematic reviews of effectiveness, modelling study and national survey of current practice. By Stein K, Dalziel K, Walker A, McIntyre L, Jenkins B, Horne J, et al. No. 32 The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature. By Crow R, Gage H, Hampson S, Hart J, Kimber A, Storey L, et al. No. 33 The effectiveness and cost-effectiveness of imatinib in chronic myeloid leukaemia: a systematic review. By Garside R, Round A, Dalziel K, Stein K, Royle R. No. 34 A comparative study of hypertonic saline, daily and alternate-day rhDNase in children with cystic fibrosis. By Suri R, Wallis C, Bush A, Thompson S, Normand C, Flather M, et al. No. 35 A systematic review of the costs and effectiveness of different models of paediatric home care.","cites":null},{"id":6013923,"title":"All rights reserved.No. 2 \u2018Cut down to quit\u2019 with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic","authors":[],"date":"2008","doi":"10.1136\/bmj.b1024","raw":"Health Technology Assessment 2008; Vol. 12: No. 26 239 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.No. 2 \u2018Cut down to quit\u2019 with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. By Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D. No. 3 A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on longterm risk of fracture and cost of disease management. By Thornton J, Ashcroft D, O\u2019Neill T, Elliott R, Adams J, Roberts C, et al. No. 4 Does befriending by trained lay workers improve psychological well-being and quality of life for carers of people with dementia, and at what cost? A randomised controlled trial. By Charlesworth G, Shepstone L, Wilson E, Thalanany M, Mugford M, Poland F. No. 5 A multi-centre retrospective cohort study comparing the efficacy, safety and costeffectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. By Hirst A, Dutton S, Wu O, Briggs A, Edwards C, Waldenmaier L, et al. No. 6 Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. By Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, et al. No. 7 The use of economic evaluations in NHS decision-making: a review and empirical investigation. By Williams I, McIver S, Moore D, Bryan S. No. 8 Stapled haemorrhoidectomy (haemorrhoidopexy) for the treatment of haemorrhoids: a systematic review and economic evaluation. By Burch J, Epstein D, Baba-Akbari A, Weatherly H, Fox D, Golder S, et al. No. 9 The clinical effectiveness of diabetes education models for Type 2 diabetes: a systematic review. By Loveman E, Frampton GK, Clegg AJ. No. 10 Payment to healthcare professionals for patient recruitment to trials: systematic review and qualitative study. By Raftery J, Bryant J, Powell J, Kerr C, Hawker S. No. 11 Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. By Chen Y-F, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, et al. No. 12 The clinical effectiveness and costeffectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. By Hockenhull JC, Dwan K, Boland A, Smith G, Bagust A, D\u00fcndar Y, et al. No. 13 Stepped treatment of older adults on laxatives. The STOOL trial. By Mihaylov S, Stark C, McColl E, Steen N, Vanoli A, Rubin G, et al. No. 14 A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial. By Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, et al. No. 15 The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation. By Hind D, Tappenden P, Tumur I, Eggington E, Sutcliffe P, Ryan A. No. 16 Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation. By Colquitt JL, Jones J, Tan SC, Takeda A, Clegg AJ, Price A. No. 17 Systematic review of the clinical effectiveness and cost-effectiveness of 64-slice or higher computed tomography angiography as an alternative to invasive coronary angiography in the investigation of coronary artery disease. By Mowatt G, Cummins E, Waugh N, Walker S, Cook J, Jia X, et al. No. 18 Structural neuroimaging in psychosis: a systematic review and economic evaluation. By Albon E, Tsourapas A, Frew E, Davenport C, Oyebode F, Bayliss S, et al. No. 19 Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. By Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, et al. No. 20 Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. By Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, et al. No. 21 Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation. By Ara R, Tumur I, Pandor A, Duenas A, Williams R, Wilkinson A, et al. No. 22 Topical or oral ibuprofen for chronic knee pain in older people. The TOIB study. By Underwood M, Ashby D, Carnes D, Castelnuovo E, Cross P, Harding G, et al. No. 23 A prospective randomised comparison of minor surgery in primary and secondary care. The MiSTIC trial. By George S, Pockney P, Primrose J, Smith H, Little P, Kinley H, et al. No. 24 A review and critical appraisal of measures of therapist\u2013patient interactions in mental health settings. By Cahill J, Barkham M, Hardy G, Gilbody S, Richards D, Bower P, et al. No. 25 The clinical effectiveness and costeffectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4\u20135 years: a systematic review and economic evaluation. By Carlton J, Karnon J, Czoski-Murray C, Smith KJ, Marr J. No. 26 A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip.","cites":null},{"id":6013907,"title":"All rights reserved.No. 34 A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. By MacLehose","authors":[],"date":"2008","doi":null,"raw":"Health Technology Assessment 2008; Vol. 12: No. 26 227 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.No. 34 A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. By MacLehose RR, Reeves BC, Harvey IM, Sheldon TA, Russell IT, Black AMS. No. 35 Intravascular ultrasound-guided interventions in coronary artery disease: a systematic literature review, with decision-analytic modelling, of outcomes and cost-effectiveness. By Berry E, Kelly S, Hutton J, Lindsay HSJ, Blaxill JM, Evans JA, et al. No. 36 A randomised controlled trial to evaluate the effectiveness and costeffectiveness of counselling patients with chronic depression. By Simpson S, Corney R, Fitzgerald P, Beecham J. No. 37 Systematic review of treatments for atopic eczema. By Hoare C, Li Wan Po A, Williams H. No. 38 Bayesian methods in health technology assessment: a review. By Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. No. 39 The management of dyspepsia: a systematic review. By Delaney B, Moayyedi P, Deeks J, Innes M, Soo S, Barton P, et al. No. 40 A systematic review of treatments for severe psoriasis.","cites":null},{"id":6013919,"title":"All rights reserved.No. 4 A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery. By Whiting","authors":[],"date":"2008","doi":null,"raw":"Health Technology Assessment 2008; Vol. 12: No. 26 235 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.No. 4 A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery. By Whiting P, Gupta R, Burch J, Mujica Mota RE, Wright K, Marson A, et al. No. 5 Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies. By Dundar Y, Dodd S, Dickson R, Walley T, Haycox A, Williamson PR. No. 6 Systematic review and evaluation of methods of assessing urinary incontinence. By Martin JL, Williams KS, Abrams KR, Turner DA, Sutton AJ, Chapple C, et al. No. 7 The clinical effectiveness and costeffectiveness of newer drugs for children with epilepsy. A systematic review. By Connock M, Frew E, Evans B-W, Bryan S, Cummins C, Fry-Smith A, et al. No. 8 Surveillance of Barrett\u2019s oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. By Garside R, Pitt M, Somerville M, Stein K, Price A, Gilbert N. No. 9 Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation. By Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, et al. No. 10 Evaluation of molecular techniques in prediction and diagnosis of cytomegalovirus disease in immunocompromised patients. By Szczepura A, Westmoreland D, Vinogradova Y, Fox J, Clark M. No. 11 Screening for thrombophilia in high-risk situations: systematic review and costeffectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. By Wu O, Robertson L, Twaddle S, Lowe GDO, Clark P, Greaves M, et al. No. 12 A series of systematic reviews to inform a decision analysis for sampling and treating infected diabetic foot ulcers. By Nelson EA, O\u2019Meara S, Craig D, Iglesias C, Golder S, Dalton J, et al. No. 13 Randomised clinical trial, observational study and assessment of costeffectiveness of the treatment of varicose veins (REACTIV trial). By Michaels JA, Campbell WB, Brazier JE, MacIntyre JB, Palfreyman SJ, Ratcliffe J, et al. No. 14 The cost-effectiveness of screening for oral cancer in primary care. By Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M et al. No. 15 Measurement of the clinical and costeffectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis. By Goodacre S, Sampson F, Stevenson M, Wailoo A, Sutton A, Thomas S, et al. No. 16 Systematic review of the effectiveness and cost-effectiveness of HealOzone\u00ae for the treatment of occlusal pit\/fissure caries and root caries. By Brazzelli M, McKenzie L, Fielding S, Fraser C, Clarkson J, Kilonzo M, et al. No. 17 Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. By Lewis SW, Davies L, Jones PB, Barnes TRE, Murray RM, Kerwin R, et al. No. 18 Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation. By Rodgers M, Nixon J, Hempel S, Aho T, Kelly J, Neal D, et al. No. 19 Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial. By Kennedy TM, Chalder T, McCrone P, Darnley S, Knapp M, Jones RH, et al. No. 20 A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry\u2019s disease and mucopolysaccharidosis type 1. By Connock M, Juarez-Garcia A, Frew E, Mans A, Dretzke J, Fry-Smith A, et al. No. 21 Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. By Wright M, Grieve R, Roberts J, Main J, Thomas HC on behalf of the UK Mild Hepatitis C Trial Investigators. No. 22 Pressure relieving support surfaces: a randomised evaluation. By Nixon J, Nelson EA, Cranny G, Iglesias CP, Hawkins K, Cullum NA, et al. No. 23 A systematic review and economic model of the effectiveness and costeffectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. By King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, et al. No. 24 The clinical effectiveness and costeffectiveness of enzyme replacement therapy for Gaucher\u2019s disease: a systematic review. By Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, et al. No. 25 Effectiveness and cost-effectiveness of salicylic acid and cryotherapy for cutaneous warts. An economic decision model. By Thomas KS, Keogh-Brown MR, Chalmers JR, Fordham RJ, Holland RC, Armstrong SJ, et al. No. 26 A systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use. By Robinson L, Hutchings D, Corner L, Beyer F, Dickinson H, Vanoli A, et al. No. 27 A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of costeffectiveness and cost\u2013utility for these groups in a UK context. By Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, et al. Health Technology Assessment reports published to date 236No. 28 Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation. By Shepherd J, Jones J, Takeda A, Davidson P, Price A. No. 29 An evaluation of the clinical and costeffectiveness of pulmonary artery catheters in patient management in intensive care: a systematic review and a randomised controlled trial. By Harvey S, Stevens K, Harrison D, Young D, Brampton W, McCabe C, et al. No. 30 Accurate, practical and cost-effective assessment of carotid stenosis in the UK. By Wardlaw JM, Chappell FM, Stevenson M, De Nigris E, Thomas S, Gillard J, et al. No. 31 Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. By Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, et al. No. 32 The cost-effectiveness of testing for hepatitis C in former injecting drug users. By Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, et al. No. 33 Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation. By Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, et al. No. 34 Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy. By Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, et al. No. 35 Psychological therapies including dialectical behaviour therapy for borderline personality disorder: a systematic review and preliminary economic evaluation. By Brazier J, Tumur I, Holmes M, Ferriter M, Parry G, Dent-Brown K, et al. No. 36 Clinical effectiveness and costeffectiveness of tests for the diagnosis and investigation of urinary tract infection in children: a systematic review and economic model. By Whiting P, Westwood M, Bojke L, Palmer S, Richardson G, Cooper J, et al. No. 37 Cognitive behavioural therapy in chronic fatigue syndrome: a randomised controlled trial of an outpatient group programme. By O\u2019Dowd H, Gladwell P, Rogers CA, Hollinghurst S, Gregory A. No. 38 A comparison of the cost-effectiveness of five strategies for the prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling. By Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, et al. No. 39 The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review. By Waugh N, Black C, Walker S, McIntyre L, Cummins E, Hillis G. No. 40 What are the clinical outcome and costeffectiveness of endoscopy undertaken by nurses when compared with doctors? A Multi-Institution Nurse Endoscopy Trial (MINuET). By Williams J, Russell I, Durai D, Cheung W-Y, Farrin A, Bloor K, et al. No. 41 The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. By Pandor A, Eggington S, Paisley S, Tappenden P, Sutcliffe P. No. 42 A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their costeffectiveness. By Chen Y-F, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, et al. No. 43 Telemedicine in dermatology: a randomised controlled trial. By Bowns IR, Collins K, Walters SJ, McDonagh AJG. No. 44 Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model. By Davies L, Brown TJ, Haynes S, Payne K, Elliott RA, McCollum C. No. 45 Clinical effectiveness and costeffectiveness of laparoscopic surgery for colorectal cancer: systematic reviews and economic evaluation. By Murray A, Lourenco T, de Verteuil R, Hernandez R, Fraser C, McKinley A, et al. No. 46 Etanercept and efalizumab for the treatment of psoriasis: a systematic review. By Woolacott N, Hawkins N, Mason A, Kainth A, Khadjesari Z, Bravo Vergel Y, et al. No. 47 Systematic reviews of clinical decision tools for acute abdominal pain. By Liu JLY, Wyatt JC, Deeks JJ, Clamp S, Keen J, Verde P, et al. No. 48 Evaluation of the ventricular assist device programme in the UK. By Sharples L, Buxton M, Caine N, Cafferty F, Demiris N, Dyer M, et al. No. 49 A systematic review and economic model of the clinical and costeffectiveness of immunosuppressive therapy for renal transplantation in children. By Yao G, Albon E, Adi Y, Milford D, Bayliss S, Ready A, et al. No. 50 Amniocentesis results: investigation of anxiety. The ARIA trial.","cites":null},{"id":6013921,"title":"All rights reserved.No. 5 A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. By","authors":[],"date":"2008","doi":"10.1111\/j.1369-7625.2007.00454.x","raw":"Health Technology Assessment 2008; Vol. 12: No. 26 237 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.No. 5 A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. By Raynor DK, Blenkinsopp A, Knapp P, Grime J, Nicolson DJ, Pollock K, et al. No. 6 Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation. By Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, et al. No. 7 Glucocorticoid-induced osteoporosis: a systematic review and cost\u2013utility analysis. By Kanis JA, Stevenson M, McCloskey EV, Davis S, Lloyd-Jones M. No. 8 Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection. By Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, et al. No. 9 Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. By Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, et al. No. 10 Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only. By Isaacs AJ, Critchley JA, See Tai S, Buckingham K, Westley D, Harridge SDR, et al. No. 11 Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation. By Shepherd J, Jones J, Hartwell D, Davidson P, Price A, Waugh N. No. 12 Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. By Tappenden P, Jones R, Paisley S, Carroll C. No. 13 A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment. By Wilson J, Yao GL, Raftery J, Bohlius J, Brunskill S, Sandercock J, et al. No. 14 A systematic review and economic evaluation of statins for the prevention of coronary events. By Ward S, Lloyd Jones M, Pandor A, Holmes M, Ara R, Ryan A, et al. No. 15 A systematic review of the effectiveness and cost-effectiveness of different models of community-based respite care for frail older people and their carers. By Mason A, Weatherly H, Spilsbury K, Arksey H, Golder S, Adamson J, et al. No. 16 Additional therapy for young children with spastic cerebral palsy: a randomised controlled trial. By Weindling AM, Cunningham CC, Glenn SM, Edwards RT, Reeves DJ. No. 17 Screening for type 2 diabetes: literature review and economic modelling. By Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, et al. No. 18 The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation. By Garside R, Pitt M, Anderson R, Mealing S, Roome C, Snaith A, et al. No. 19 The clinical effectiveness and cost-effectiveness of gemcitabine for metastatic breast cancer: a systematic review and economic evaluation. By Takeda AL, Jones J, Loveman E, Tan SC, Clegg AJ. No. 20 A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. By Collins R, Cranny G, Burch J, Aguiar-Ib\u00e1\u00f1ez R, Craig D, Wright K, et al. No. 21 The clinical effectiveness and costeffectiveness of treatments for children with idiopathic steroid-resistant nephrotic syndrome: a systematic review. By Colquitt JL, Kirby J, Green C, Cooper K, Trompeter RS. No. 22 A systematic review of the routine monitoring of growth in children of primary school age to identify growth-related conditions. By Fayter D, Nixon J, Hartley S, Rithalia A, Butler G, Rudolf M, et al. No. 23 Systematic review of the effectiveness of preventing and treating Staphylococcus aureus carriage in reducing peritoneal catheter-related infections. By McCormack K, Rabindranath K, Kilonzo M, Vale L, Fraser C, McIntyre L, et al. No. 24 The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis. By McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, et al. No. 25 A randomised controlled trial and economic evaluation of direct versus indirect and individual versus group modes of speech and language therapy for children with primary language impairment. By Boyle J, McCartney E, Forbes J, O\u2019Hare A. No. 26 Hormonal therapies for early breast cancer: systematic review and economic evaluation. By Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L. No. 27 Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. By Bryant J, Picot J, Levitt G, Sullivan I, Baxter L, Clegg A. No. 28 Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. By McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, et al. Health Technology Assessment reports published to date 238No. 29 Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: costeffectiveness and expected value of information analyses. By Colbourn T, Asseburg C, Bojke L, Philips Z, Claxton K, Ades AE, et al. No. 30 Clinical effectiveness and costeffectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. By Garrison KR, Donell S, Ryder J, Shemilt I, Mugford M, Harvey I, et al. No. 31 A randomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. By Prescott RJ, Kunkler IH, Williams LJ, King CC, Jack W, van der Pol M, et al. No. 32 Current practice, accuracy, effectiveness and cost-effectiveness of the school entry hearing screen. By Bamford J, Fortnum H, Bristow K, Smith J, Vamvakas G, Davies L, et al. No. 33 The clinical effectiveness and cost-effectiveness of inhaled insulin in diabetes mellitus: a systematic review and economic evaluation. By Black C, Cummins E, Royle P, Philip S, Waugh N. No. 34 Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. By Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, et al. No. 35 The Birmingham Rehabilitation Uptake Maximisation Study (BRUM). Homebased compared with hospital-based cardiac rehabilitation in a multi-ethnic population: cost-effectiveness and patient adherence. By Jolly K, Taylor R, Lip GYH, Greenfield S, Raftery J, Mant J, et al. No. 36 A systematic review of the clinical, public health and cost-effectiveness of rapid diagnostic tests for the detection and identification of bacterial intestinal pathogens in faeces and food. By Abubakar I, Irvine L, Aldus CF, Wyatt GM, Fordham R, Schelenz S, et al. No. 37 A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. By Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, et al. No. 38 Clinical effectiveness and costeffectiveness of different models of managing long-term oral anticoagulation therapy: a systematic review and economic modelling. By Connock M, Stevens C, Fry-Smith A, Jowett S, Fitzmaurice D, Moore D, et al. No. 39 A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. By Soares-Weiser K, Bravo Vergel Y, Beynon S, Dunn G, Barbieri M, Duffy S, et al. No. 40 Taxanes for the adjuvant treatment of early breast cancer: systematic review and economic evaluation. By Ward S, Simpson E, Davis S, Hind D, Rees A, Wilkinson A. No. 41 The clinical effectiveness and costeffectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. By Burr JM, Mowatt G, Hern\u00e1ndez R, Siddiqui MAR, Cook J, Lourenco T, et al. No. 42 Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models. By Davis A, Smith P, Ferguson M, Stephens D, Gianopoulos I. No. 43 Contamination in trials of educational interventions. By Keogh-Brown MR, Bachmann MO, Shepstone L, Hewitt C, Howe A, Ramsay CR, et al. No. 44 Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. By Facey K, Bradbury I, Laking G, Payne E. No. 45 The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. By Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, et al. No. 46 Drug-eluting stents: a systematic review and economic evaluation. By Hill RA, Boland A, Dickson R, D\u00fcndar Y, Haycox A, McLeod C, et al. No. 47 The clinical effectiveness and costeffectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model. By Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, et al. No. 48 Recruitment to randomised trials: strategies for trial enrolment and participation study. The STEPS study. By Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, et al. No. 49 Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial. By Sharples L, Hughes V, Crean A, Dyer M, Buxton M, Goldsmith K, et al. No. 50 Evaluation of diagnostic tests when there is no gold standard. A review of methods. By Rutjes AWS, Reitsma JB, Coomarasamy A, Khan KS, Bossuyt PMM. No. 51 Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding. By Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, et al. No. 52 A review and critique of modelling in prioritising and designing screening programmes. By Karnon J, Goyder E, Tappenden P, McPhie S, Towers I, Brazier J, et al. No. 53 An assessment of the impact of the NHS Health Technology Assessment Programme.","cites":null},{"id":6013917,"title":"All rights reserved.Volume 9,","authors":[],"date":"2008","doi":null,"raw":"Health Technology Assessment 2008; Vol. 12: No. 26 233 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Volume 9, 2005 No. 1 Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. By Ozolins M, Eady EA, Avery A, Cunliffe WJ, O\u2019Neill C, Simpson NB, et al. No. 2 Do the findings of case series studies vary significantly according to methodological characteristics? By Dalziel K, Round A, Stein K, Garside R, Castelnuovo E, Payne L. No. 3 Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions. By Wilson BJ, Torrance N, Mollison J, Wordsworth S, Gray JR, Haites NE, et al. No. 4 Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia. By Fowler C, McAllister W, Plail R, Karim O, Yang Q. No. 5 A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. By Shenfine J, McNamee P, Steen N, Bond J, Griffin SM. No. 6 Impact of computer-aided detection prompts on the sensitivity and specificity of screening mammography. By Taylor P, Champness J, GivenWilson R, Johnston K, Potts H. No. 7 Issues in data monitoring and interim analysis of trials. By Grant AM, Altman DG, Babiker AB, Campbell MK, Clemens FJ, Darbyshire JH, et al. No. 8 Lay public\u2019s understanding of equipoise and randomisation in randomised controlled trials. By Robinson EJ, Kerr CEP, Stevens AJ, Lilford RJ, Braunholtz DA, Edwards SJ, et al. No. 9 Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies. By Greenhalgh J, Knight C, Hind D, Beverley C, Walters S. No. 10 Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. By Smith SC, Lamping DL, Banerjee S, Harwood R, Foley B, Smith P, et al. No. 11 Clinical effectiveness and costeffectiveness of drotrecogin alfa (activated) (Xigris\u00ae) for the treatment of severe sepsis in adults: a systematic review and economic evaluation. By Green C, Dinnes J, Takeda A, Shepherd J, Hartwell D, Cave C, et al. No. 12 A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. By Dinnes J, Deeks J, Kirby J, Roderick P. No. 13 Cervical screening programmes: can automation help? Evidence from systematic reviews, an economic analysis and a simulation modelling exercise applied to the UK. By Willis BH, Barton P, Pearmain P, Bryan S, Hyde C. No. 14 Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation. By McCormack K, Wake B, Perez J, Fraser C, Cook J, McIntosh E, et al. No. 15 Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. By Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, et al. No. 16 A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. By Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, et al. No. 17 Clinical effectiveness and costeffectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation. By Hartwell D, Colquitt J, Loveman E, Clegg AJ, Brodin H, Waugh N, et al. No. 18 A randomised controlled comparison of alternative strategies in stroke care. By Kalra L, Evans A, Perez I, Knapp M, Swift C, Donaldson N. No. 19 The investigation and analysis of critical incidents and adverse events in healthcare. By Woloshynowych M, Rogers S, Taylor-Adams S, Vincent C. No. 20 Potential use of routine databases in health technology assessment. By Raftery J, Roderick P, Stevens A. No. 21 Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. By Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, et al. No. 22 A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. By Stevenson M, Lloyd Jones M, De Nigris E, Brewer N, Davis S, Oakley J. No. 23 A systematic review to examine the impact of psycho-educational interventions on health outcomes and costs in adults and children with difficult asthma. By Smith JR, Mugford M, Holland R, Candy B, Noble MJ, Harrison BDW, et al. No. 24 An evaluation of the costs, effectiveness and quality of renal replacement therapy provision in renal satellite units in England and Wales. By Roderick P, Nicholson T, Armitage A, Mehta R, Mullee M, Gerard K, et al. No. 25 Imatinib for the treatment of patients with unresectable and\/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation. By Wilson J, Connock M, Song F, Yao G, Fry-Smith A, Raftery J, et al. No. 26 Indirect comparisons of competing interventions. By Glenny AM, Altman DG, Song F, Sakarovitch C, Deeks JJ, D\u2019Amico R, et al. No. 27 Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling. By Robinson M, Palmer S, Sculpher M, Philips Z, Ginnelly L, Bowens A, et al. Health Technology Assessment reports published to date 234No. 28 Outcomes of electrically stimulated gracilis neosphincter surgery. By Tillin T, Chambers M, Feldman R. No. 29 The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. By Garside R, Stein K, Castelnuovo E, Pitt M, Ashcroft D, Dimmock P, et al. No. 30 Systematic review on urine albumin testing for early detection of diabetic complications. By Newman DJ, Mattock MB, Dawnay ABS, Kerry S, McGuire A, Yaqoob M, et al. No. 31 Randomised controlled trial of the costeffectiveness of water-based therapy for lower limb osteoarthritis. By Cochrane T, Davey RC, Matthes Edwards SM. No. 32 Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain. By Thomas KJ, MacPherson H, Ratcliffe J, Thorpe L, Brazier J, Campbell M, et al. No. 33 Cost-effectiveness and safety of epidural steroids in the management of sciatica. By Price C, Arden N, Coglan L, Rogers P. No. 34 The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis. By Symmons D, Tricker K, Roberts C, Davies L, Dawes P, Scott DL. No. 35 Conceptual framework and systematic review of the effects of participants\u2019 and professionals\u2019 preferences in randomised controlled trials. By King M, Nazareth I, Lampe F, Bower P, Chandler M, Morou M, et al. No. 36 The clinical and cost-effectiveness of implantable cardioverter defibrillators: a systematic review. By Bryant J, Brodin H, Loveman E, Payne E, Clegg A. No. 37 A trial of problem-solving by community mental health nurses for anxiety, depression and life difficulties among general practice patients. The CPN-GP study. By Kendrick T, Simons L, Mynors-Wallis L, Gray A, Lathlean J, Pickering R, et al. No. 38 The causes and effects of sociodemographic exclusions from clinical trials. By Bartlett C, Doyal L, Ebrahim S, Davey P, Bachmann M, Egger M, et al. No. 39 Is hydrotherapy cost-effective? A randomised controlled trial of combined hydrotherapy programmes compared with physiotherapy land techniques in children with juvenile idiopathic arthritis. By Epps H, Ginnelly L, Utley M, Southwood T, Gallivan S, Sculpher M, et al. No. 40 A randomised controlled trial and costeffectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. By Hobbs FDR, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, et al. No. 41 Displaced intracapsular hip fractures in fit, older people: a randomised comparison of reduction and fixation, bipolar hemiarthroplasty and total hip arthroplasty. By Keating JF, Grant A, Masson M, Scott NW, Forbes JF. No. 42 Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland. By Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, et al. No. 43 The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. By Castelnuovo E, Stein K, Pitt M, Garside R, Payne E. No. 44 Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis. By Knowles R, Griebsch I, Dezateux C, Brown J, Bull C, Wren C. No. 45 The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation. By Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, et al. No. 46 The effectiveness of the Heidelberg Retina Tomograph and laser diagnostic glaucoma scanning system (GDx) in detecting and monitoring glaucoma. By Kwartz AJ, Henson DB, Harper RA, Spencer AF, McLeod D. No. 47 Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. By Clar C, Cummins E, McIntyre L, Thomas S, Lamb J, Bain L, et al. No. 48 Systematic review of effectiveness of different treatments for childhood retinoblastoma. By McDaid C, Hartley S, Bagnall A-M, Ritchie G, Light K, Riemsma R. No. 49 Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis. By Roderick P, Ferris G, Wilson K, Halls H, Jackson D, Collins R, et al. No. 50 The effectiveness and cost-effectiveness of parent training\/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in children.","cites":null},{"id":10485,"title":"Annual Meeting of the American Academy of Orthopaedic Surgeons,","authors":[],"date":"2005","doi":"10.1177\/1938640009334348","raw":"Annual Meeting of the American Academy of Orthopaedic Surgeons, Washington, DC, March 2005. Paper No. 147.","cites":null},{"id":10536,"title":"Assessm ent 2008;Vol. 12: N o. 26 Total hip replacem ent approaches in the m anagem ent of arthritic disease of the hip","authors":[],"date":null,"doi":null,"raw":null,"cites":null},{"id":10534,"title":"Assessment Programme 242 Diagnostic Technologies & Screening Panel Members Chair, Dr Ron Zimmern, Director of the Public Health Genetics Unit, Strangeways Research Laboratories, Cambridge Ms Norma Armston, Freelance Consumer Advocate,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10533,"title":"Assessment reports published to date 240 Health Technology Assessment","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":6013924,"title":"Assessment reports published to date 240Health Technology Assessment","authors":[],"date":"2008","doi":null,"raw":"Health Technology Assessment reports published to date 240Health Technology Assessment 2008; Vol. 12: No. 26 241 Health Technology Assessment Programme Prioritisation Strategy Group Members Chair, Professor Tom Walley, Director, NHS HTA Programme, Department of Pharmacology & Therapeutics, University of Liverpool Professor Bruce Campbell, Consultant Vascular & General Surgeon, Royal Devon & Exeter Hospital Professor Robin E Ferner, Consultant Physician and Director, West Midlands Centre for Adverse Drug Reactions, City Hospital NHS Trust, Birmingham Dr Edmund Jessop, Medical Adviser, National Specialist, Commissioning Advisory Group (NSCAG), Department of Health, London Professor Jon Nicholl, Director, Medical Care Research Unit, University of Sheffield, School of Health and Related Research Dr Ron Zimmern, Director, Public Health Genetics Unit, Strangeways Research Laboratories, Cambridge Director, Professor Tom Walley, Director, NHS HTA Programme, Department of Pharmacology & Therapeutics, University of Liverpool Deputy Director, Professor Jon Nicholl, Director, Medical Care Research Unit, University of Sheffield, School of Health and Related Research HTA Commissioning Board Members Programme Director, Professor Tom Walley, Director, NHS HTA Programme, Department of Pharmacology & Therapeutics, University of Liverpool Chair, Professor Jon Nicholl, Director, Medical Care Research Unit, University of Sheffield, School of Health and Related Research Deputy Chair, Dr Andrew Farmer, University Lecturer in General Practice, Department of Primary Health Care, University of Oxford Dr Jeffrey Aronson, Reader in Clinical Pharmacology, Department of Clinical Pharmacology, Radcliffe Infirmary, Oxford Professor Deborah Ashby, Professor of Medical Statistics, Department of Environmental and Preventative Medicine, Queen Mary University of London Professor Ann Bowling, Professor of Health Services Research, Primary Care and Population Studies, University College London Professor John Cairns, Professor of Health Economics, Public Health Policy, London School of Hygiene and Tropical Medicine, London Professor Nicky Cullum, Director of Centre for Evidence Based Nursing, Department of Health Sciences, University of York Professor Jon Deeks, Professor of Health Statistics, University of Birmingham Professor Jenny Donovan, Professor of Social Medicine, Department of Social Medicine, University of Bristol Professor Freddie Hamdy, Professor of Urology, University of Sheffield Professor Allan House, Professor of Liaison Psychiatry, University of Leeds Professor Sallie Lamb, Director, Warwick Clinical Trials Unit, University of Warwick Professor Stuart Logan, Director of Health & Social Care Research, The Peninsula Medical School, Universities of Exeter & Plymouth Professor Miranda Mugford, Professor of Health Economics, University of East Anglia Dr Linda Patterson, Consultant Physician, Department of Medicine, Burnley General Hospital Professor Ian Roberts, Professor of Epidemiology & Public Health, Intervention Research Unit, London School of Hygiene and Tropical Medicine Professor Mark Sculpher, Professor of Health Economics, Centre for Health Economics, Institute for Research in the Social Services, University of York Professor Kate Thomas, Professor of Complementary and Alternative Medicine, University of Leeds Professor David John Torgerson, Director of York Trial Unit, Department of Health Sciences, University of York Professor Hywel Williams, Professor of Dermato-Epidemiology, University of Nottingham Current and past membership details of all HTA \u2018committees\u2019 are available from the HTA website (www.hta.ac.uk) \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Health Technology Assessment Programme 242 Diagnostic Technologies & Screening Panel Members Chair, Dr Ron Zimmern, Director of the Public Health Genetics Unit, Strangeways Research Laboratories, Cambridge Ms Norma Armston, Freelance Consumer Advocate, Bolton Professor Max Bachmann, Professor of Health Care Interfaces, Department of Health Policy and Practice, University of East Anglia Professor Rudy Bilous Professor of Clinical Medicine & Consultant Physician, The Academic Centre, South Tees Hospitals NHS Trust Ms Dea Birkett, Service User Representative, London Dr Paul Cockcroft, Consultant Medical Microbiologist and Clinical Director of Pathology, Department of Clinical Microbiology, St Mary's Hospital, Portsmouth Professor Adrian K Dixon, Professor of Radiology, University Department of Radiology, University of Cambridge Clinical School Dr David Elliman, Consultant in Community Child Health, Islington PCT & Great Ormond Street Hospital, London Professor Glyn Elwyn, Research Chair, Centre for Health Sciences Research, Cardiff University, Department of General Practice, Cardiff Professor Paul Glasziou, Director, Centre for Evidence-Based Practice, University of Oxford Dr Jennifer J Kurinczuk, Consultant Clinical Epidemiologist, National Perinatal Epidemiology Unit, Oxford Dr Susanne M Ludgate, Clinical Director, Medicines & Healthcare Products Regulatory Agency, London Mr Stephen Pilling, Director, Centre for Outcomes, Research & Effectiveness, Joint Director, National Collaborating Centre for Mental Health, University College London Mrs Una Rennard, Service User Representative, Oxford Dr Phil Shackley, Senior Lecturer in Health Economics, Academic Vascular Unit, University of Sheffield Dr Margaret Somerville, Director of Public Health Learning, Peninsula Medical School, University of Plymouth Dr Graham Taylor, Scientific Director & Senior Lecturer, Regional DNA Laboratory, The Leeds Teaching Hospitals Professor Lindsay Wilson Turnbull, Scientific Director, Centre for MR Investigations & YCR Professor of Radiology, University of Hull Professor Martin J Whittle, Clinical Co-director, National Co-ordinating Centre for Women\u2019s and Childhealth Dr Dennis Wright, Consultant Biochemist & Clinical Director, The North West London Hospitals NHS Trust, Middlesex Pharmaceuticals Panel Members Chair, Professor Robin Ferner, Consultant Physician and Director, West Midlands Centre for Adverse Drug Reactions, City Hospital NHS Trust, Birmingham Ms Anne Baileff, Consultant Nurse in First Contact Care, Southampton City Primary Care Trust, University of Southampton Professor Imti Choonara, Professor in Child Health, Academic Division of Child Health, University of Nottingham Professor John Geddes, Professor of Epidemiological Psychiatry, University of Oxford Mrs Barbara Greggains, Non-Executive Director, Greggains Management Ltd Dr Bill Gutteridge, Medical Adviser, National Specialist Commissioning Advisory Group (NSCAG), London Mrs Sharon Hart, Consultant Pharmaceutical Adviser, Reading Dr Jonathan Karnon, Senior Research Fellow, Health Economics and Decision Science, University of Sheffield Dr Yoon Loke, Senior Lecturer in Clinical Pharmacology, University of East Anglia Ms Barbara Meredith, Lay Member, Epsom Dr Andrew Prentice, Senior Lecturer and Consultant Obstetrician & Gynaecologist, Department of Obstetrics & Gynaecology, University of Cambridge Dr Frances Rotblat, CPMP Delegate, Medicines & Healthcare Products Regulatory Agency, London Dr Martin Shelly, General Practitioner, Leeds Mrs Katrina Simister, Assistant Director New Medicines, National Prescribing Centre, Liverpool Dr Richard Tiner, Medical Director, Medical Department, Association of the British Pharmaceutical Industry, London Current and past membership details of all HTA \u2018committees\u2019 are available from the HTA website (www.hta.ac.uk)Health Technology Assessment 2008; Vol. 12: No. 26 243 Therapeutic Procedures Panel Members Chair, Professor Bruce Campbell, Consultant Vascular and General Surgeon, Department of Surgery, Royal Devon & Exeter Hospital Dr Mahmood Adil, Deputy Regional Director of Public Health, Department of Health, Manchester Dr Aileen Clarke, Consultant in Public Health, Public Health Resource Unit, Oxford Professor Matthew Cooke, Professor of Emergency Medicine, Warwick Emergency Care and Rehabilitation, University of Warwick Mr Mark Emberton, Senior Lecturer in Oncological Urology, Institute of Urology, University College Hospital Professor Paul Gregg, Professor of Orthopaedic Surgical Science, Department of General Practice and Primary Care, South Tees Hospital NHS Trust, Middlesbrough Ms Maryann L Hardy, Lecturer, Division of Radiography, University of Bradford Dr Simon de Lusignan, Senior Lecturer, Primary Care Informatics, Department of Community Health Sciences, St George\u2019s Hospital Medical School, London Dr Peter Martin, Consultant Neurologist, Addenbrooke\u2019s Hospital, Cambridge Professor Neil McIntosh, Edward Clark Professor of Child Life & Health, Department of Child Life & Health, University of Edinburgh Professor Jim Neilson, Professor of Obstetrics and Gynaecology, Department of Obstetrics and Gynaecology, University of Liverpool Dr John C Pounsford, Consultant Physician, Directorate of Medical Services, North Bristol NHS Trust Dr Karen Roberts, Nurse Consultant, Queen Elizabeth Hospital, Gateshead Dr Vimal Sharma, Consultant Psychiatrist\/Hon. Senior Lecturer, Mental Health Resource Centre, Cheshire and Wirral Partnership NHS Trust, Wallasey Professor Scott Weich, Professor of Psychiatry, Division of Health in the Community, University of Warwick Disease Prevention Panel Members Chair, Dr Edmund Jessop, Medical Adviser, National Specialist Commissioning Advisory Group (NSCAG), London Mrs Sheila Clark, Chief Executive, St James\u2019s Hospital, Portsmouth Mr Richard Copeland, Lead Pharmacist: Clinical Economy\/Interface, Wansbeck General Hospital, Northumberland Dr Elizabeth Fellow-Smith, Medical Director, West London Mental Health Trust, Middlesex Mr Ian Flack, Director PPI Forum Support, Council of Ethnic Minority Voluntary Sector Organisations, Stratford Dr John Jackson, General Practitioner, Newcastle upon Tyne Mrs Veronica James, Chief Officer, Horsham District Age Concern, Horsham Professor Mike Kelly, Director, Centre for Public Health Excellence, National Institute for Health and Clinical Excellence, London Professor Yi Mien Koh, Director of Public Health and Medical Director, London NHS (North West London Strategic Health Authority), London Ms Jeanett Martin, Director of Clinical Leadership & Quality, Lewisham PCT, London Dr Chris McCall, General Practitioner, Dorset Dr David Pencheon, Director, Eastern Region Public Health Observatory, Cambridge Dr Ken Stein, Senior Clinical Lecturer in Public Health, Director, Peninsula Technology Assessment Group, University of Exeter, Exeter Dr Carol Tannahill, Director, Glasgow Centre for Population Health, Glasgow Professor Margaret Thorogood, Professor of Epidemiology, University of Warwick, Coventry Dr Ewan Wilkinson, Consultant in Public Health, Royal Liverpool University Hospital, Liverpool Current and past membership details of all HTA \u2018committees\u2019 are available from the HTA website (www.hta.ac.uk)Health Technology Assessment Programme 244 Current and past membership details of all HTA \u2018committees\u2019 are available from the HTA website (www.hta.ac.uk) Expert Advisory Network Members Professor Douglas Altman, Professor of Statistics in Medicine, Centre for Statistics in Medicine, University of Oxford Professor John Bond, Director, Centre for Health Services Research, University of Newcastle upon Tyne, School of Population & Health Sciences, Newcastle upon Tyne Professor Andrew Bradbury, Professor of Vascular Surgery, Solihull Hospital, Birmingham Mr Shaun Brogan, Chief Executive, Ridgeway Primary Care Group, Aylesbury Mrs Stella Burnside OBE, Chief Executive, Regulation and Improvement Authority, Belfast Ms Tracy Bury, Project Manager, World Confederation for Physical Therapy, London Professor Iain T Cameron, Professor of Obstetrics and Gynaecology and Head of the School of Medicine, University of Southampton Dr Christine Clark, Medical Writer & Consultant Pharmacist, Rossendale Professor Collette Clifford, Professor of Nursing & Head of Research, School of Health Sciences, University of Birmingham, Edgbaston, Birmingham Professor Barry Cookson, Director, Laboratory of Healthcare Associated Infection, Health Protection Agency, London Dr Carl Counsell, Clinical Senior Lecturer in Neurology, Department of Medicine & Therapeutics, University of Aberdeen Professor Howard Cuckle, Professor of Reproductive Epidemiology, Department of Paediatrics, Obstetrics & Gynaecology, University of Leeds Dr Katherine Darton, Information Unit, MIND \u2013 The Mental Health Charity, London Professor Carol Dezateux, Professor of Paediatric Epidemiology, London Dr Keith Dodd, Consultant Paediatrician, Derby Mr John Dunning, Consultant Cardiothoracic Surgeon, Cardiothoracic Surgical Unit, Papworth Hospital NHS Trust, Cambridge Mr Jonothan Earnshaw, Consultant Vascular Surgeon, Gloucestershire Royal Hospital, Gloucester Professor Martin Eccles, Professor of Clinical Effectiveness, Centre for Health Services Research, University of Newcastle upon Tyne Professor Pam Enderby, Professor of Community Rehabilitation, Institute of General Practice and Primary Care, University of Sheffield Professor Gene Feder, Professor of Primary Care Research & Development, Centre for Health Sciences, Barts & The London Queen Mary\u2019s School of Medicine & Dentistry, London Mr Leonard R Fenwick, Chief Executive, Newcastle upon Tyne Hospitals NHS Trust Mrs Gillian Fletcher, Antenatal Teacher & Tutor and President, National Childbirth Trust, Henfield Professor Jayne Franklyn, Professor of Medicine, Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham Dr Neville Goodman, Consultant Anaesthetist, Southmead Hospital, Bristol Professor Robert E Hawkins, CRC Professor and Director of Medical Oncology, Christie CRC Research Centre, Christie Hospital NHS Trust, Manchester Professor Allen Hutchinson, Director of Public Health & Deputy Dean of ScHARR, Department of Public Health, University of Sheffield Professor Peter Jones, Professor of Psychiatry, University of Cambridge, Cambridge Professor Stan Kaye, Cancer Research UK Professor of Medical Oncology, Section of Medicine, Royal Marsden Hospital & Institute of Cancer Research, Surrey Dr Duncan Keeley, General Practitioner (Dr Burch & Ptnrs), The Health Centre, Thame Dr Donna Lamping, Research Degrees Programme Director & Reader in Psychology, Health Services Research Unit, London School of Hygiene and Tropical Medicine, London Mr George Levvy, Chief Executive, Motor Neurone Disease Association, Northampton Professor James Lindesay, Professor of Psychiatry for the Elderly, University of Leicester, Leicester General Hospital Professor Julian Little, Professor of Human Genome Epidemiology, Department of Epidemiology & Community Medicine, University of Ottawa Professor Rajan Madhok, Consultant in Public Health, South Manchester Primary Care Trust, Manchester Professor Alexander Markham, Director, Molecular Medicine Unit, St James\u2019s University Hospital, Leeds Professor Alistaire McGuire, Professor of Health Economics, London School of Economics Dr Peter Moore, Freelance Science Writer, Ashtead Dr Andrew Mortimore, Public Health Director, Southampton City Primary Care Trust, Southampton Dr Sue Moss, Associate Director, Cancer Screening Evaluation Unit, Institute of Cancer Research, Sutton Mrs Julietta Patnick, Director, NHS Cancer Screening Programmes, Sheffield Professor Robert Peveler, Professor of Liaison Psychiatry, Royal South Hants Hospital, Southampton Professor Chris Price, Visiting Professor in Clinical Biochemistry, University of Oxford Professor William Rosenberg, Professor of Hepatology and Consultant Physician, University of Southampton, Southampton Professor Peter Sandercock, Professor of Medical Neurology, Department of Clinical Neurosciences, University of Edinburgh Dr Susan Schonfield, Consultant in Public Health, Hillingdon PCT, Middlesex Dr Eamonn Sheridan, Consultant in Clinical Genetics, Genetics Department, St James\u2019s University Hospital, Leeds Professor Sarah Stewart-Brown, Professor of Public Health, University of Warwick, Division of Health in the Community Warwick Medical School, LWMS, Coventry Professor Ala Szczepura, Professor of Health Service Research, Centre for Health Services Studies, University of Warwick Dr Ross Taylor, Senior Lecturer, Department of General Practice and Primary Care, University of Aberdeen Mrs Joan Webster, Consumer member, HTA \u2013 Expert Advisory NetworkHow to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (http:\/\/www.hta.ac.uk). A fully searchable CD-ROM is also available (see below). Printed copies of HTA monographs cost \u00a320 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents. Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is \u00a32 per monograph and for the rest of the world \u00a33 per monograph. You can order HTA monographs from our Despatch Agents: \u2013 fax (with credit card or of\ufb01cial purchase order) \u2013 post (with credit card or of\ufb01cial purchase order or cheque) \u2013 phone during of\ufb01ce hours (credit card only).","cites":null},{"id":10535,"title":"authors would like to know your views about this report.","authors":[],"date":null,"doi":null,"raw":"Fax: +44 (0) 23 8059 5639 Email: hta@hta.ac.uk http:\/\/www.hta.ac.uk ISSN 1366-5278 Feedback The HTA Programme and the authors would like to know your views about this report.","cites":null},{"id":10511,"title":"Comparison 03: Single mini-incision versus single standard incision (reported means and SDs supplemented with calculated SDs from p-values and imputed SDs)","authors":[],"date":"2006","doi":null,"raw":"Comparison 03: Single mini-incision versus single standard incision (reported means and SDs supplemented with calculated SDs from p-values and imputed SDs) 20  460.00 (184.25)    20  462.50 (184.25) 28  127.00 (48.00)  32  170.00 (65.00) 60  136.00 (41.10)  60  200.50 (65.20) 60  318.80 (72.74)  60  544.40 (72.74) 70  445.80 (521.95)  70  567.50 (521.95) 109  314.20 (174.78)  110  365.80 (174.78) 347   352 52  217.50 (88.91)  50  247.00 (88.91) 99  154.00 (443.49)  100  278.00 (443.49) 51    75.49 (51.90)  95  293.68 (84.50) 60  201.67 (228.39)  60  191.73 (228.39) 30  180.00 (69.00)  30  246.70 (99.00) 50  387.00 (155.00)  57  469.00 (147.00) 10  699.00 (319.20)  10  540.00 (319.20) 38  244.00 (100.00)  43  265.00 (114.00) 38  244.00 (100.00)  43  304.00 (136.00) 50  603.00 (344.21)  85  507.00 (344.21) 42  151.80 (53.90)  42  173.20 (57.50) \u20132.50 (\u2013116.70 to 111.70) \u201343.00 (\u201371.69 to \u201314.31) \u201364.50 (\u201384.00 to \u201345.00) \u2013225.60 (\u2013251.63 to \u2013199.57) \u2013121.70 (\u2013294.62 to 51.22) \u201351.60 (\u201397.90 to \u20135.30) \u201398.89 (\u2013111.92 to \u201385.87) \u201329.50 (\u201364.02 to 5.02) \u2013124.00 (\u2013247.24 to \u20130.76) \u2013118.19 (\u2013140.36 to \u201396.02) 9.94 (\u201371.79 to 91.67) \u201366.70 (\u2013109.88 to \u201323.52) \u201382.00 (\u2013139.46 to \u201324.54) 159.00 (\u2013120.79 to 438.79) \u201321.00 (\u201367.60 to 25.60) \u201360.00 (\u2013111.61 to \u20138.39) 96.00 (\u201324.24 to 216.24) \u201321.40 (\u201345.24 to 2.44) Review:  Minimal incision approaches to total hip replacement Comparison:  03 Mini-incision versus standard incision (dummy) Outcome:  09 Blood loss (intraoperative, ml) 01 RCT Charles 2006 (CT) Chimento 2005 (RCT) Chung 2004 (Q-RCT) Hart 2005 (Q-RCT) Kim 2006 (Q-RCT) Ogonda 2005 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 124.36, df = 5 (p < 0.00001), I2 = 96.0% Test for overall effect: z = 14.88 (p < 0.00001) 02 Comparative studies Asayama  2006 Berger  2004 Chen  2006 Ciminiello  2006 de Beer 2004 Howell  2004 Pilot  2006 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 1.30 20.60 44.59 25.03 0.57 7.91 100.00 12.71 1.00 30.79 2.27 8.12 4.58 0.19 6.97 5.68 1.05 26.64 \u2013100 \u201350 0 50 100 Mini-incision Standard incision N Mean (SD) N Mean (SD)Appendix 10 196 20    95.20 (23.29)  20    87.70 (23.29) 28    70.30 (10.70)  32    70.00 (8.50) 60    49.00 (9.40)  60    55.10 (17.90) 60    71.00 (12.77)   60    70.00 (12.77) 70    52.00 (15.84)  70    61.00 (15.84) 109    60.30 (9.20)  110    65.90 (13.20) 20    67.54 (12.77)  20    68.38 (12.77) 60    75.00 (16.60)  60    69.00 (16.60) 427   432 50    58.60 (8.91)  50    57.90 (8.91) 99    72.00 (8.91)  100    66.00 (8.91) 51    88.41 (17.60)  95    90.85 (17.81) 60    55.45 (4.91)  60    56.95(4.91) 30    46.60 (14.31)  30    44.50 (14.31) 33  120.00 (8.91)  33  100.00 (8.91) 50    97.00 (19.00)  57    84.00 (15.00) 18    91.00 (16.40)  18    97.00 (15.60) 32    74.00 (15.00)  51    80.00 (10.00) 10    99.50 (20.25)  10    81.00 (20.25) 38    84.00 16.00)  43    93.00 (18.00) 38    84.00 (16.00)  21  102.00 (12.00) 10  126.50 (8.91)  10  119.90 (8.91) 50    97.00 (29.46)   85  105.00 (29.46) 42    71.40 (11.20)  42    77.70 (13.20) 7.50 (\u20136.94 to 21.94) 0.30 (\u20134.64 to 5.24) \u20136.10 (\u201311.22 to \u20130.98) 1.00 (\u20133.57 to 5.57) \u20139.00 (\u201314.25 to \u20133.75) \u20135.60 (\u20138.61 to \u20132.59) \u20130.84 (\u20138.75 to 7.07) 6.00 (0.06 to 11.94) \u20132.86 (\u20134.62 to \u20131.10) 0.70 (\u20132.79 to 4.19) 6.00 (3.52 to 8.48) \u20132.44 (\u20138.45 to 3.57) \u20131.50 (\u20133.26 to 0.26) 2.10 (\u20135.14 to 9.34) 20.00 (15.70 to 24.30) 13.00 (6.45 to 19.55) \u20136.00 (\u201316.46 to 4.46) \u20136.00 (\u201311.88 to \u20130.12) 18.50 (0.75 to 36.25) \u20139.00 (\u201316.40 to \u20131.60) \u201318.00 (\u201325.23 to \u201310.77) 6.60 (\u20131.21 to 14.41) \u20138.00 (\u201318.29 to 2.29) \u20136.30 (\u201311.54 to \u20131.06) Review:  Minimal incision approaches to total hip replacement Comparison:  03 Mini-incision versus standard incision (dummy) Outcome:  18 Duration of operation (minutes) 01 RCT Charles 2006 (CT) Chimento 2005 (RCT) Chung 2004 (Q-RCT) Hart 2005 (Q-RCT) Kim 2006 (Q-RCT) Ogonda 2005 (RCT) Sharma 2006 (Q-RCT) Zhang 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 25.07, df = 5 (p = 0.0007), I2 = 72.1% Test for overall effect: z = 3.19 (p = 0.001) 02 Comparative studies Asayama  2006 Berger  2004 Chen  2006 Ciminiello  2006 de Beer 2004 DiGioia  2003 Howell  2004 Li  2005 O\u2019Brien  2005 Pilot  2006 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Takahira  2006 Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 1.49 12.71 11.84 14.84 11.25 34.16 4.95 8.78 100.00 9.83 19.56 3.32 38.83 2.29 6.49 2.79 1.10 3.47 0.38 2.19 2.30 1.97 1.13 4.37 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD) 28  378.00 (151.00)  32  504.00 (205.00) 60  613.30 (178.00)  60  853.70  (178.00) 88   92 51  369.51 (65.05)  95  509.63 (117.39) 18  318.00 (223.00)  18  523.00 (210.70) 38  744.00 (260.00)  43  708.00 (221.00) 38  744.00 (260.00)  21  771.00 (235.00) 10  796.00 (112.72)  10  772.00 (112.72) \u2013126.00 (\u2013216.41 to \u201335.59) \u2013240.40 (\u2013304.10 to \u2013176.70) \u2013202.45 (\u2013254.52 to \u2013150.38) \u2013140.12 (\u2013169.72 to \u2013110.52) \u2013205.00 (\u2013346.73 to \u201363.27) 36.00 (\u201369.82 to 141.82) \u201327.00 (\u2013157.14 to 103.14) 24.00 (\u201374.80 to 122.80] Review:  Minimal incision approaches to total hip replacement Comparison:  03 Mini-incision versus standard incision (dummy) Outcome:  10 Blood loss (total, ml) 01 RCT Chimento 2005 (RCT) Hart 2005 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 4.11, df = 1 (p = 0.04), I2 = 75.7% Test for overall effect: z = 7.62 (p < 0.00001) 02 Comparative studies Chen  2006 Li  2005 Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Takahira  2006 Test for heterogeneity: 2 = 21.50, df = 4 (p = 0.0003), I2 = 81.4% Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 33.17 66.83 100.00 79.16 3.45 6.19 4.07 7.10 \u20131000 \u2013500 0 500 1000 Mini-incision Standard incision N Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26 197 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 20    5.35 (1.63)  20    5.70 (1.63) 28    5.80 (2.20)  32    5.50 (2.20) 60    4.41 (1.10)  60    5.34 (1.40) 109    3.65 (2.04)  110    3.68 (2.45) 20    5.24 (1.66)  20    6.74 (1.66) 60    7.00 (1.66)  60  13.50 (1.66) 297   302 52    2.96 (0.56)  50    2.94 (0.56) 100    1.90 (5.74)  100    3.50 (5.74) 51  11.16 (0.83)  95  12.83 (1.96) 60    3.70 (5.08)  60    3.63 (5.08) 30    5.13 (0.87)  30    5.10 (0.87) 33    3.80 (0.77)  33    3.90 (0.77) 50    4.40 (2.90)  57    5.70 (3.10) 35    5.40 (2.10)  53    6.20 (2.80) 40    5.60 (0.99)  40    6.70 (0.99) 10  22.00 (0.99)  10  23.40 (0.99) 50    4.30 (2.17)  85    4.00 (2.17) 42    6.12 (2.27)  42    6.07 (2.27) \u20130.35 (\u20131.36 to 0.66) 0.30 (\u20130.82 to 1.42) \u20130.93 (\u20131.38 to \u20130.48) \u20130.03 (\u20130.63 to 0.57) \u20131.50 (\u20132.53 to \u20130.47) \u20136.50 (\u20137.09 to \u20135.91) \u20131.85 (\u20132.13 to \u20131.58) 0.02 (\u20130.20 to 0.24) \u20131.60 (\u20133.19 to \u20130.01) \u20131.67 (\u20132.13 to \u20131.21) 0.07 (\u20131.75 to 1.89) 0.03 (\u20130.41 to 0.47) \u20130.10 (\u20130.47 to 0.27) \u20131.30 (\u20132.44 to \u20130.16) \u20130.80 (\u20131.83 to 0.23) \u20131.10 (\u20131.53 to \u20130.67) \u20131.40 (\u20132.27 to \u20130.53) 0.30 (\u20130.46 to 1.06) 0.05 (\u20130.92 to 1.02) Review:  Minimal incision approaches to total hip replacement Comparison:  03 Mini-incision versus standard incision (dummy) Outcome:  19 Length of hospital stay (days) 01 RCT Charles 2006 (RCT) Chimento 2005 (RCT) Chung 2004 (Q-RCT) Ogonda 2005 (RCT) Sharma 2006 (Q-RCT) Zhang 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 310.31, df = 5 (p < 0.00001), I2 = 98.4% Test for overall effect: z = 13.23 (p < 0.00001) 02 Comparative studies Asayama  2006 Berger  2004 Chen  2006 Ciminiello  2006 de Beer 2004 DiGioia  2003 Howell  2004 O\u2019Brien  2005 Panisello  2006 Takahira  2006 Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 7.37 6.04 37.06 21.11 7.11 21.32 100.00 42.11 0.79 9.60 0.60 10.27 14.42 1.54 1.89 10.57 2.64 3.46 2.11 \u20134 \u20132 0 2 4 Mini-incision Standard incision N Mean (SD) N Mean (SD) 0      0 52    92.70 (45.73)  50    94.90 (45.73) 60  118.00 (41.12)  60  121.00 (41.12) 30  147.70 (86.75)  30  169.30 (86.75) Not estimable \u20132.20 (\u201319.95 to 15.55) \u20133.00 (\u201317.71 to 11.71) \u201321.60 (\u201365.50 to 22.30) Review:  Minimal incision approaches to total hip replacement Comparison:  03 Mini-incision versus standard incision (dummy) Outcome:  23 Short-term total narcotic received (mg) 01 RCT Subtotal (95% CI) Test for heterogeneity: not applicable Test for overall effect: not applicable 02 Comparative studies Asayama  2006 Ciminiello  2006 de Beer 2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 38.18 55.58 6.24 \u2013100 \u201350 0 50 100 Mini-incision Standard incision N Mean (SD) N Mean (SD)Appendix 10 198 18  3.94 (0.51)  19  3.68 (0.51) 70  3.76 (0.97)  70  4.43 (0.97) 109  3.30 (1.80)  110  3.36 (1.96) 20  4.05 (2.52)  20  6.25 (2.52) 217   219 38  1.50 (1.15)  43  2.15 (1.20) 38  1.50 (1.15)  21  2.10 (1.30) 0.26 (\u20130.07 to 0.59) \u20130.67 (\u20130.99 to \u20130.35) \u20130.06 (\u20130.56 to 0.44) \u20132.20 (\u20133.76 to \u20130.64) \u20130.22 (\u20130.43 to \u20130.02) \u20130.65 (\u20131.16 to \u20130.14) \u20130.60 (\u20131.27 to 0.07) Review:  Minimal incision approaches to total hip replacement Comparison:  03 Mini-incision versus standard incision (dummy) Outcome:  26 Short-term pain (score) 01 RCT Charles 2006 (RCT) Kim 2006 (Q-RCT) Ogonda 2005 (RCT) Sharma 2006 (Q-RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 22.29, df = 3 (p < 0.0001), I2 = 86.5% Test for overall effect: z = 2.12 (p = 0.03) 02 Comparative studies Szendr\u00f3i  2006  MI\/MD Szendr\u00f3i  2006  MI\/SI Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 39.58 41.43 17.23 1.75 100.00 62.80 37.20 \u20134 \u20132 0 2 4 Mini-incision Standard incision N Mean (SD) N Mean (SD) 27  \u201394.50 (1.68)  29  \u201394.50 (1.68) 60  \u201395.50 (5.53)  60  \u201393.50 (5.53) 70  \u201393.00 (35.58)  70  \u201391.00 (35.58) 60  \u201395.10 (1.38)  60  \u201395.60 (1.38) 217   219 52  \u201396.20 (4.72)  50  \u201396.20 (4.72) 51  \u201389.71 (3.62)  95  \u201383.78 (8.03) 33  \u201396.00 (4.57)  33  \u201394.00 (4.57) 18  \u201392.00 (2.95)  18  \u201390.00 (2.95) 20  \u201399.00 (7.18)  14  \u201397.00 (7.18) 37  \u201386.90 (4.10)  39  \u201384.20 (6.40) 0.00 (\u20130.88 to 0.88) \u20132.00 (\u20133.98 to \u20130.02) \u20132.00 (\u201313.79 to 9.79) 0.50 (0.01 to 0.99) 0.27 (\u20130.15 to 0.69) 0.00 (\u20131.83 to 1.83) \u20135.93 (\u20137.83 to \u20134.03) \u20132.00 (\u20134.21 to 0.21) \u20132.00 (\u20133.93 to \u20130.07) \u20132.00 (\u20136.90 to 2.90) \u20132.70 (\u20135.10 to \u20130.30) Review:  Minimal incision approaches to total hip replacement Comparison:  03 Mini-incision versus standard incision (dummy) Outcome:  34 Harris hip score (>3 months) 01 RCT Chimento 2005 (RCT) Chung 2004 (Q-RCT) Kim 2006 (Q-RCT) Zhang 2006 (RCT) Subtotal (95% CI) Test for heterogeneity: 2 = 6.39, df = 3 (p < 0.09), I2 = 53.1% Test for overall effect: z = 1.26 (p = 0.21) 02 Comparative studies Asayama  2006 Chen  2006 DiGioia  2003 Li  2005 Woolson  2004 Wright  2004 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 22.81 4.52 0.13 72.54 100.00 23.54 21.98 16.25 21.27 3.29 13.67 \u201310 \u20135 0 5 10 Mini-incision Standard incision N Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26 199 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.","cites":null},{"id":10512,"title":"Comparison 05: Two incisions versus single standard or mini-incision (reported means and SDs supplemented with calculated SDs from p-values)","authors":[],"date":"2005","doi":null,"raw":"Comparison 05: Two incisions versus single standard or mini-incision (reported means and SDs supplemented with calculated SDs from p-values) 15  760.00 (147.06)  15  650.00 (147.06) 43  366.00 (215.00)  43  247.00 (90.00) 110.00 (4.75 to 215.25) 119.00 (49.34 to 188.66) Review:  Minimal incision approaches to total hip replacement Comparison:  05 Two incisions versus single standard or mini-incision (p-value) Outcome:  07 Blood loss (intra-operative, ml) 01 RCT Yan 2005 (Q-RCT) 02 Comparative studies Duwelius  2007 Study or subcategory Two incisions Single incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 \u20131000 \u2013500 0 500 1000 N Mean (SD) N Mean (SD) Two incisions Single incision 35  699.00 (168.56)  35  603.00 (168.56)    96.00 (17.03 to 174.97) Review:  Minimal incision approaches to total hip replacement Comparison:  05 Two incisions versus single standard or mini-incision (p-value) Outcome:  08 Blood loss (total, ml) 01 RCT 02 Comparative studies Tanavalee  2006 Study or subcategory Two incisions Single incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 \u20131000 \u2013500 0 500 1000 N Mean (SD) N Mean (SD) Two incisions Single incision 15  100.00 (26.74)  15    80.00 (26.74) 43    93.70 (90.00)  43    61.70 (60.00) 35  168.00 (86.82)  35  113.00 (86.82) 100    72.00 (0.00)  118    52.00 (0.00) 20.00 (0.86 to 39.14) 32.00 (\u20130.33 to 64.33) 55.00 (14.32 to 95.68) Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  05 Two incisions versus single standard or mini-incision (p-value) Outcome:  13 Duration of operation (minutes) 01 RCT Yan 2005 (Q-RCT) 02 Comparative studies Duwelius  2007 Tanavalee  2006 Yoon  2005 Study or subcategory Two incisions Single incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 61.29 38.71 \u2013100 \u201350 0 50 100 N Mean (SD) N Mean (SD) Two incisions Single incisionAppendix 10 208 15  6.00 (5.22)  15  13.00 (5.22) 43  1.25 (0.88)  43    1.90 (0.88) \u20137.00 (\u201310.74 to \u20133.26) \u20130.65 (\u20131.02 to \u20130.28) Review:  Minimal incision approaches to total hip replacement Comparison:  05 Two incisions versus single standard or mini-incision (p-value) Outcome:  14 Length of hospital stay (days) 01 RCT Yan 2005 (Q-RCT) 02 Comparative studies Duwelius  2007 Study or subcategory Two incisions Single incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 100.00 \u201310 \u20135 0 5 10 N Mean (SD) N Mean (SD) Two incisions Single incision 43  14.00 (21.11)  43  26.00 (21.11)   \u201312.00 (\u201320.92 to \u20133.08) Review:  Minimal incision approaches to total hip replacement Comparison:  05 Two incisions versus single standard or mini-incision (p-value) Outcome:  18 Time to return to shopping (days) 01 RCT 02 Comparative studies Duwelius  2007 Study or subcategory Two incisions Single incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 \u2013100 \u201350 0 50 100 N Mean (SD) N Mean (SD) Two incisions Single incision 43  13.00 (24.45)  43  24.00 (24.45) 26  32.00 (8.14)  26  34.00 (8.14) \u201311.00 (\u201321.33 to \u20130.67) \u20132.00 (\u20136.42 to 2.42) Review:  Minimal incision approaches to total hip replacement Comparison:  05 Two incisions versus single standard or mini-incision (p-value) Outcome:  19 Time to return to driving (days) 01 RCT 02 Comparative studies Duwelius  2007 Pagnano  2006 Study or subcategory Two incisions Single incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 15.49 84.51 \u201310 \u20135 0 5 10 N Mean (SD) N Mean (SD) Two incisions Single incisionHealth Technology Assessment 2008; Vol. 12: No. 26 209 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. 26  28.00 (11.25)  26  27.00 (11.25)        1.00 (\u20135.12 to 7.12) Review:  Minimal incision approaches to total hip replacement Comparison:  05 Two incisions versus single standard or mini-incision (p-value) Outcome:  20 Use of walking aids (days) 01 RCT 02 Comparative studies Pagnano  2006 Study or subcategory Mini-incision Standard incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 \u201310 \u20135 0 5 10 N Mean (SD) N Mean (SD) Two incisions Single incision 15  \u201389.00 (4.01)  15  \u201386.00 (4.01) 43  \u201389.00 (0.00)  43  \u201388.00 (0.00) \u20133.00 (\u20135.87 to \u20130.13) Not estimable Review:  Minimal incision approaches to total hip replacement Comparison:  05 Two incisions versus single standard or mini-incision (p-value) Outcome:  21 Harris hip score (3 months) 01 RCT Yan 2005 (Q-RCT) 02 Comparative studies Duwelius  2007 Study or subcategory Two incisions Single incision WMD (fixed) 95% CI WMD (fixed) 95% CI Weight % 100.00 \u201310 \u20135 0 5 10 N Mean (SD) N Mean (SD) Two incisions Single incision(Coyle D and Coyle K, University of Ottawa: personal communication, 18 May 2007) Based on the completed SF-36 questionnaire data, SF-6D scores were calculated using the algorithm of Brazier and colleagues.80 Overall data were collected for the 40 participants within the study. There were, however, a number of individuals with missing data. To look at the impact of this, three analyses were conducted, each using a different approach to missing values. In the first analysis, a last value carried forward approach was used. There were, however, four participants who did not have any data for the baseline assessment and these individuals were therefore removed from the analysis, leaving 36 participants in the analysis. In the second analysis, data from all participants were included without regard to whether or not they had complete data. Consequently, the number of participants with data to analyse changes from one analysis period to the next. In the final analysis, all cases that did not have a complete data set were deleted, which left only 24 individuals within the analysis. In each of these three analyses, mean scores of each time point were compared in an analysis of covariance adjusting for baseline SF-6D scores. Overall, the differences between the minimally invasive arm and the control arm were small and the different approaches to handling missing values did not significantly affect the results (Tables 55\u201357).","cites":null},{"id":10493,"title":"Comparison of gait kinematics in patients receiving minimally invasive and traditional hip replacement surgery: a prospective blinded study. Gait Posture 2006;23:374\u201382. Pagnano,","authors":[],"date":"2006","doi":"10.1016\/j.gaitpost.2005.04.008","raw":"Bennett D, Ogonda L, Elliott D, Humphreys L, Beverland DE. Comparison of gait kinematics in patients receiving minimally invasive and traditional hip replacement surgery: a prospective blinded study. Gait Posture 2006;23:374\u201382. Pagnano, 2006 Pagnano MW, Trousdale RT, Meneghini RM, Hanssen AD. Patients preferred a mini-posterior THA to a contralateral two-incision THA. Clin Orthop 2006; 453:156\u20139. Pilot, 2006 Pilot P, Kerens B, Draijer WF, Kort NP, ten Kate J, Buurman WA, et al. Is minimally invasive surgery less invasive in total hip replacement? A pilot study. Injury 2006;37:S17\u201323. Pipino, 2004 Pipino F. CFP prosthetic stem in mini-invasive total hip arthroplasty. J Orthop Traumatol 2004;5:165\u201371. Siguier, 2004 Siguier T, Siguier M, Brumpt B. Mini-incision anterior approach does not increase dislocation rate: a study of 1037 total hip replacements. Clin Orthop 2004; 426:164\u201373. Swanson, 2005 Swanson TV. Early results of 1000 consecutive, posterior, single-incision minimally invasive surgery total hip arthroplasties. J Arthroplasty 2005:20:26\u201332. Szendr\u00f3i, 2006 Szendr\u00f3i M, Sztrinkai G, Vass R, Kiss J. The impact of minimally invasive total hip arthroplasty on the standard procedure. Int Orthop 2006;30:167\u201371. Tanavalee, 2006 Tanavalee A, Jaruwannapong S, Yuktanandana P, Itiravivong P. Early outcomes following minimally invasive total hip arthroplasty using a two-incision approach versus a mini-posterior approach. Hip Int 2006;16:S17\u201322. Teet, 2006 Teet JS, Skinner HB, Khoury L. The effect of the \u201cmini\u201d incision in total hip arthroplasty on component position. J Arthroplasty 2006;21:503\u20137. Woolson, 2004 Primary reference Woolson ST, Mow CS, Syquia JF, Lannin JV, Schurman DJ. Comparison of primary total hip replacements performed with a standard incision or a mini-incision. J Bone Joint Surg Am 2004;86A: 1353\u20138. Secondary reference Mow CS, Woolson ST, Ngarmukos SG, Park EH, Lorenz HP. Comparison of scars from total hip replacements done with a standard or a mini-incision.","cites":null},{"id":10470,"title":"Costs, effects and C\/E ratios alongside a clinical trial. Health Econ","authors":[],"date":"1994","doi":"10.1002\/hec.4730030505","raw":"105. Van Hout B, Al M, Gordon G. Costs, effects and C\/E ratios alongside a clinical trial. Health Econ 1994;3:309\u201319.","cites":null},{"id":10473,"title":"Description of a new technique.","authors":[],"date":null,"doi":"10.1097\/01.brs.0000320236.93689.2e","raw":"Description of a new technique. J Arthroplasty 2006;21:1038\u201346.","cites":null},{"id":10507,"title":"Ex cl us io n cr ite ri a: d ea th o r lo ss t o FU in fi rs t 2 ye ar s","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":10482,"title":"Final decision (subject to clarification of \u2018unclear\u2019 points) Include Unclear Exclude Health Technology Assessment","authors":[],"date":"2008","doi":null,"raw":"Final decision (subject to clarification of \u2018unclear\u2019 points) Include Unclear Exclude Health Technology Assessment 2008; Vol. 12: No. 26 99 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. Appendix 2 Study eligibility formMinimally invasive hip arthroplasty versus conventional hip arthroplasty for the treatment of arthritic disease of the hip Reviewer ID: Date: __________________ Study Study ID: Country: RCT  Quasi-RCT  Funding: government\/private\/manufacturer\/other (specify) Cohort study (Comparative)  Additional information on study design (e.g. prospective\/ Cohort study (one-group)  retrospective, method of randomisation): Unclear  Participants Recruitment dates: ___________________________ Number of eligible patients: __________________Number of patients randomised: _____________ Criteria for Inclusion: Criteria for Exclusion: Intervention Surgical technique No of Patients Intervention 1 Intervention 2 Intervention 3 Comments: (i.e. operator information, specialised equipment used, length of incision) Health Technology Assessment 2008; Vol. 12: No. 26 101 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. Appendix 3 Data extraction formPatient Characteristics Specify Intervention 1 Intervention 2 Intervention 3 Overall Age (years) Sex (M\/F) Body weight (kg) Height BMI Muscular patient* (%) Significant bone deformity* (%) Severe osteoporosis* (%) Emergency case (%) Follow-up period: __________________________ Number of patients lost to follow-up: _______________ Comments: * Note details on how assessed Indications for total hip replacement Specify Intervention 1 Intervention 2 Intervention 3 Overall Total (No.) Arthritis \u2022 Degenerative arthritis (osteoarthritis) \u2022 Rheumatoid arthritis Deformity Appendix 3 102Operative approach Specify Intervention 1 Intervention 2 Intervention 3 Overall Total (No.) Operative method performed? \u2022 Anterolateral \u2022 Lateral \u2022 Posterolateral \u2022 Transtrochanteric Type and name of prosthesis used? Cemented or uncemented procedure? Short-term Outcomes Intra-operative Intervention 1 Intervention 2 Intervention 3 Duration of operation (min) Operating theatre throughput Blood loss Opposite method initiated (pre-operative) Intra-operative fracture Conversion (intra-operative) Post-operative Dislocation Infection (specify, e.g. wound) Nerve injury Vascular injury Deep vein thrombosis Peri-prosthetic fracture 30 day mortality Length of hospital stay Health Technology Assessment 2008; Vol. 12: No. 26 103 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Post-operative pain (specify) Time to return to usual activities (days) Implant position (radiographic analysis) Other Long-term Outcomes Intervention 1 Intervention 2 Intervention 3 Functional result (Harris hip, Mayo and Charnley scores) Pain relief Revision rates Time to revision (months) Health related quality of life Long term pain Limb length inequality Mortality Surrogates for long-term outcomes \u2022 Implant migration (radiostereometry anal) \u2022 Heterotopic ossification \u2022 Component orientation \u2022 Cement quality Other (e.g. patient perception\/satisfaction) Additional information\/Other comments Contact with Author Date: \u2026\u2026\u2026\/\u2026\u2026\u2026\/\u2026\u2026\u2026 Signature: \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Appendix 3 104Minimally invasive hip arthroplasty versus conventional hip arthroplasty (Verhagen et al., 1998)26 Reviewer ID: Date: Question Yes No Unclear 1. Was a method of randomisation performed? Adequate approaches to sequence generation \u2022 Computer-generated random tables \u2022 Random number tables Inadequate approaches to sequence generation \u2022 Use of alternation, case record numbers, birth dates or week days 2. Was the treatment allocation concealed? Adequate approaches to concealment of randomisation \u2022 Centralised or pharmacy-controlled randomisation \u2022 Serially numbered identical containers \u2022 On-site computer based system with a randomisation sequence that is not readable until allocation \u2022 Other approaches with robust methods to prevent foreknowledge of the allocation sequence to clinicians and patients Inadequate approaches to concealment of randomisation \u2022 Use of alternation, case record numbers, birth dates or week days \u2022 Open random number lists \u2022 Serially numbered envelopes 3. Were the groups similar at baseline regarding the most important prognostic indicators? 4. Were the eligibility criteria specified? 5. Was the outcome assessor blinded? 6. Was the care provider blinded? 7. Was the patient blinded? 8. Were point estimates and measures of variability presented for the primary outcome measures? 9. Did the analysis include an intention-to-treat analysis? Health Technology Assessment 2008; Vol. 12: No. 26 105 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. Appendix 4 Quality assessment form \u2013 RCTsIncluded studies (full-text papers) Archibeck, 2004 Archibeck MJ, White RE Jr. Learning curve for the two-incision total hip replacement. Clin Orthop 2004; 429:232\u20138. Asayama, 2006 Asayama I, Kinsey TL, Mahoney OM. Two-year experience using a limited-incision direct lateral approach in total hip arthroplasty. J Arthroplasty 2006; 21:1083\u201391. Berger, 2004 Berger RA. Mini-incision total hip replacement using an anterolateral approach: technique and results. Orthop Clin North Am 2004;35:143\u201351. Chen, 2006 Chen J, Chen W, Zhou J, Huang H. Clinical research and following results on the minimal incision and traditional total hip arthroplasty. Fudan Xuebao (Yixueban) 2006;33:257\u201382. Chimento, 2005 Primary reference Chimento GF, Pavone V, Sharrock N, Kahn B, Cahill J, Sculco TP. Minimally invasive total hip arthroplasty: a prospective randomized study. J Arthroplasty 2005; 20:139\u201344. Secondary reference Sculco TP, Jordan LC, Walter WL. Minimally invasive total hip arthroplasty: the Hospital for Special Surgery experience. Orthop Clin North Am 2004;35:137\u201342. Chung, 2004 Chung WK, Liu D, Foo LS. Mini-incision total hip replacement \u2013 surgical technique and early results.","cites":null},{"id":10469,"title":"Guidance on the methods of technology appraisal (reference N0515). London: National Institute for Clinical Excellence;","authors":[],"date":"2004","doi":null,"raw":"104. NICE. Guidance on the methods of technology appraisal (reference N0515). London: National Institute for Clinical Excellence; 2004. URL: http:\/\/www.nice.org.uk\/page.aspx?o=201973.","cites":null},{"id":10471,"title":"Guidance on the selection of prostheses for primary total hip replacement.","authors":[],"date":"2000","doi":null,"raw":"106. NICE. Guidance on the selection of prostheses for primary total hip replacement. Technology Appraisal Guidance No 2. London: National Institute for Clinical Excellence; 2000. URL: http:\/\/guidance.nice.org.uk\/TA2\/guidance\/pdf\/ English. Accessed April 2007.","cites":null},{"id":10524,"title":"How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical","authors":[],"date":"2003","doi":null,"raw":"By Parker G, Bhakta P, Lovett CA, Paisley S, Olsen R, Turner D, et al. Volume 7, 2003 No. 1 How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. By Egger M, J\u00fcni P, Bartlett C, Holenstein F, Sterne J. No. 2 Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. By Mowatt G, Vale L, Perez J, Wyness L, Fraser C, MacLeod A, et al. No. 3 Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn\u2019s disease. By Clark W, Raftery J, Barton P, Song F, Fry-Smith A, Burls A. No. 4 A review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are rhesus negative. By Chilcott J, Lloyd Jones M, Wight J, Forman K, Wray J, Beverley C, et al. No. 5 Systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing\u2019s sarcoma and neuroblastoma. By Riley RD, Burchill SA, Abrams KR, Heney D, Lambert PC, Jones DR, et al. No. 6 The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model. By Roderick P, Davies R, Raftery J, Crabbe D, Pearce R, Bhandari P, et al. No. 7 The clinical effectiveness and costeffectiveness of routine dental checks: a systematic review and economic evaluation. By Davenport C, Elley K, Salas C, Taylor-Weetman CL, Fry-Smith A, Bryan S, et al. No. 8 A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women\u2019s preferences in the management of menorrhagia. By Kennedy ADM, Sculpher MJ, Coulter A, Dwyer N, Rees M, Horsley S, et al. No. 9 Clinical effectiveness and cost\u2013utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation. By Meads C, Salas C, Roberts T, Moore D, Fry-Smith A, Hyde C. No. 10 Evaluation of molecular tests for prenatal diagnosis of chromosome abnormalities. By Grimshaw GM, Szczepura A, Hult\u00e9n M, MacDonald F, Nevin NC, Sutton F, et al. Health Technology Assessment reports published to date 230No. 11 First and second trimester antenatal screening for Down\u2019s syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). By Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. No. 12 The effectiveness and cost-effectiveness of ultrasound locating devices for central venous access: a systematic review and economic evaluation. By Calvert N, Hind D, McWilliams RG, Thomas SM, Beverley C, Davidson A. No. 13 A systematic review of atypical antipsychotics in schizophrenia. By Bagnall A-M, Jones L, Lewis R, Ginnelly L, Glanville J, Torgerson D, et al. No. 14 Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. By Donovan J, Hamdy F, Neal D, Peters T, Oliver S, Brindle L, et al. No. 15 Early thrombolysis for the treatment of acute myocardial infarction: a systematic review and economic evaluation. By Boland A, Dundar Y, Bagust A, Haycox A, Hill R, Mujica Mota R, et al. No. 16 Screening for fragile X syndrome: a literature review and modelling. By Song FJ, Barton P, Sleightholme V, Yao GL, Fry-Smith A. No. 17 Systematic review of endoscopic sinus surgery for nasal polyps. By Dalziel K, Stein K, Round A, Garside R, Royle P. No. 18 Towards efficient guidelines: how to monitor guideline use in primary care. By Hutchinson A, McIntosh A, Cox S, Gilbert C. No. 19 Effectiveness and cost-effectiveness of acute hospital-based spinal cord injuries services: systematic review. By Bagnall A-M, Jones L, Richardson G, Duffy S, Riemsma R. No. 20 Prioritisation of health technology assessment. The PATHS model: methods and case studies. By Townsend J, Buxton M, Harper G. No. 21 Systematic review of the clinical effectiveness and cost-effectiveness of tension-free vaginal tape for treatment of urinary stress incontinence. By Cody J, Wyness L, Wallace S, Glazener C, Kilonzo M, Stearns S, et al. No. 22 The clinical and cost-effectiveness of patient education models for diabetes: a systematic review and economic evaluation. By Loveman E, Cave C, Green C, Royle P, Dunn N, Waugh N. No. 23 The role of modelling in prioritising and planning clinical trials. By Chilcott J, Brennan A, Booth A, Karnon J, Tappenden P. No. 24 Cost\u2013benefit evaluation of routine influenza immunisation in people 65\u201374 years of age. By Allsup S, Gosney M, Haycox A, Regan M. No. 25 The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and nonheart-beating donors. By Wight J, Chilcott J, Holmes M, Brewer N. No. 26 Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment. By Williams JG, Cheung WY, Cohen DR, Hutchings HA, Longo MF, Russell IT. No. 27 Evaluating non-randomised intervention studies. By Deeks JJ, Dinnes J, D\u2019Amico R, Sowden AJ, Sakarovitch C, Song F, et al. No. 28 A randomised controlled trial to assess the impact of a package comprising a patient-orientated, evidence-based selfhelp guidebook and patient-centred consultations on disease management and satisfaction in inflammatory bowel disease. By Kennedy A, Nelson E, Reeves D, Richardson G, Roberts C, Robinson A, et al. No. 29 The effectiveness of diagnostic tests for the assessment of shoulder pain due to soft tissue disorders: a systematic review. By Dinnes J, Loveman E, McIntyre L, Waugh N. No. 30 The value of digital imaging in diabetic retinopathy. By Sharp PF, Olson J, Strachan F, Hipwell J, Ludbrook A, O\u2019Donnell M, et al. No. 31 Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. By Law M, Wald N, Morris J. No. 32 Clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer: systematic review and economic evaluation. By Ward S, Kaltenthaler E, Cowan J, Brewer N. No. 33 Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review. By Hummel S, Paisley S, Morgan A, Currie E, Brewer N. No. 34 Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system. By Royle P, Waugh N. No. 35 Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. By Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K. No. 36 A randomised controlled trial to evaluate the clinical and costeffectiveness of Hickman line insertions in adult cancer patients by nurses. By Boland A, Haycox A, Bagust A, Fitzsimmons L. No. 37 Redesigning postnatal care: a randomised controlled trial of protocol-based midwifery-led care focused on individual women\u2019s physical and psychological health needs. By MacArthur C, Winter HR, Bick DE, Lilford RJ, Lancashire RJ, Knowles H, et al. No. 38 Estimating implied rates of discount in healthcare decision-making. By West RR, McNabb R, Thompson AGH, Sheldon TA, Grimley Evans J.","cites":null},{"id":10465,"title":"Is revision as good as primary hip replacement? A comparison of quality of life.","authors":[],"date":null,"doi":null,"raw":"90100. Robinson AH, Palmer CR, Villar RN. Is revision as good as primary hip replacement? A comparison of quality of life. J Bone Joint Surg Br 1999;81: 42\u20135.","cites":null},{"id":10488,"title":"Joint Surg Am 2003;85A:2240\u20132. Secondary references Berger RA, Duwelius PJ. The two-incision minimally invasive total hip arthroplasty: technique and results.","authors":[],"date":null,"doi":null,"raw":"J Bone Joint Surg Am 2003;85A:2240\u20132. Secondary references Berger RA, Duwelius PJ. The two-incision minimally invasive total hip arthroplasty: technique and results.","cites":null},{"id":10481,"title":"Journals (full-text search)","authors":[],"date":"2006","doi":null,"raw":"24th Annual Meeting, San Antonio, TX, April 2006. Journals (full-text search) Journal of Arthroplasty (2000\u2013February 2007) Science Direct. URL: www.sciencedirect.com\/ Journal of Bone and Joint Surgery, American Volume (2000\u2013March 2007) URL: http:\/\/www.ejbjs.org\/ Journal of Bone and Joint Surgery, British Volume (2000\u2013February 2007) URL: www.jbjs.org.uk\/ Clinical Orthopaedics and Related Research (2000\u2013February 2007) Ovid Journals. URL: http:\/\/gateway.ovid.com\/athens Hip* and (minimal* or MIS or incision*) Websites searched for other evidence-based reports and background information American Academy of Orthopaedic Surgeons. URL: http:\/\/www.aaos.org\/ American Association of Hip and Knee Surgeons. URL: http:\/\/www.aahks.org\/ British Hip Society. URL: http:\/\/www.britishhipsociety.com\/ British Orthopaedic Association. URL: http:\/\/www.boa.ac.uk\/ Depuy International (Johnson & Johnson). URL: http:\/\/jnjgateway.com\/ Smith and Nephew. URL: http:\/\/www.smithnephew.com\/ Styker. URL: http:\/\/www.stryker.com\/ Zimmer. URL: http:\/\/www.zimmer.co.uk\/ Health Technology Assessment 2008; Vol. 12: No. 26 97 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Minimally invasive hip arthroplasty versus conventional hip arthroplasty for the treatment of arthritic disease of the hip Assessor initials: __________ Date assessed: __________ Study identifier (surname of first author + year of publication) Type of study Q1. Is the study (circle one number) Yes Unclear No 1. a randomised controlled trial, or 2. a comparative study (at least 2 groups) or 3. a case series\/cohort study? 4. other Go to Design: FU: next question Exclude Participants in the study Yes Unclear No Q2. Are some or all of the participants in the study adults with arthritis (excluding osteoporosis, fracture or tumour)? Go to next question Exclude Interventions in the study Yes Unclear No Q3. Did some or all of the participants receive minimally invasive primary total hip replacement (and not revision surgery or hip resurfacing or computer modelling surgery)? Go to next question Exclude Outcomes in the study Yes Unclear No Q4. Does the study report short-term and\/or long-term outcome data on the patients that underwent the intervention(s)? For case series\/cohort studies only rare complications and long-term  Include Exclude outcomes are to be collected.","cites":null},{"id":10495,"title":"Ko Tsa Chih 2006;44:512\u201315 (in Chinese). Included studies (abstracts only) Charles,","authors":[],"date":"2006","doi":null,"raw":"Chung Hua Wai Ko Tsa Chih 2006;44:512\u201315 (in Chinese). Included studies (abstracts only) Charles, 2006 Charles MN, Fejbel RJ, Kim P. Minimally invasive surgery of the hip \u2013 a randomized pilot study. Annual Meeting of the Canadian Orthopaedic Association, Toronto, June 2006. Poster 88. Greidanus, 2006 Greidanus NV, Garbuz DS, Masri BA, Duncan CP, Callaghan JJ, Hozack WJ. Comparative cohort study of 2-incision versus 1-incision MIS THA. Annual Meeting of the American Academy of Orthopaedic Surgeons, Chicago, March 2006. Paper No. 200. Pagnano, 2007a Pagnano MW, Meneghini RM, Kaufman K, ColemamWood K, Berg E, Hanssen AD. No benefit of the 2-incision technique over miniposterior total hip arthroplasty: a comprehensive gait analysis and strength testing study. J Arthroplasty 2007;22:301. Pagnano, 2007b Pagnano MW, Leone J, Hanssen AD, Trousdale RTM, Berg E. A prospective randomized clinical trial shows that 2-incision total hips do not recover quicker than miniposterior total hips. J Arthroplasty 2007;22:303. Panisello, 2006 Panisello JJ, Canales V, Herrera A, Mateo J, Peguero A. Effectiveness of mini-incision technique in primary hip replacement. J Bone Joint Surg Br 2006;88B:63. Rachbauer, 2006 Rachbauer F, Rosiek R, Nogler M, Kessler O. The benefits of the direct anterior approach in minimally invasive THA. Annual Meeting of the American Academy of Orthopaedic Surgeons, Chicago, March 2006. Paper No. 202. Sharma, 2006 Sharma S, Bharma MS. A prospective randomised pilot study to compare early post-operative recovery after conventional versus minimal incision posterior approach for total hip joint replacement. J Bone Joint Surg Br 2006;88B:243. Takahira, 2006 Takahira N, Uchiyama K, Takasi S, Katano M, Itoman M. Prospective comparison study of clinical data between the minimal incision and conventional incision in total hip arthroplasty. 19th Annual Symposium of the International Society for Technology in Arthroplasty, New York, October 2006. Abstract A9-3. Yoon, 2005 Yoon TR, Moon E, Rowe SM, Jung ST, Seo HY, Lee JY. Minimally invasive total hip arthroplasty: comparison between one-incision and two-incision technique.","cites":null},{"id":10494,"title":"Mini-incision for total hip Appendix 5 108 arthroplasty: a prospective, controlled investigation with 5-year follow-up evaluation.","authors":[],"date":"2004","doi":null,"raw":null,"cites":null},{"id":6013853,"title":"Mini-incision for total hip Appendix 5 108arthroplasty: a prospective, controlled investigation with 5-year follow-up evaluation.","authors":[],"date":"2004","doi":null,"raw":"Clin Orthop 2005;441:80\u20135. Wright, 2004 Wright JM, Crockett HC, Delgado S, Lyman S, Madsen M, Sculco TP. Mini-incision for total hip Appendix 5 108arthroplasty: a prospective, controlled investigation with 5-year follow-up evaluation. J Arthroplasty 2004; 19:538\u201345. Yan, 2005 Yan Z-Q, Chen Y-S, Yang Y, Li W-J, Chen Z-R, Zhang G-J. Two-incision minimal invasive approach for total hip replacement. Acta Acad Med Shanghai 2005; 32:557\u201360 (in Chinese). Zhang, 2006 Zhang XL, Wang Q, Jiang Y, Zeng BF. Minimally invasive total hip arthroplasty with anterior incision.","cites":null},{"id":10472,"title":"Minimal access surgery for total hip arthroplasty \u2013 current beliefs and activity profile in the UK.","authors":[],"date":null,"doi":"10.1308\/003588407X160800","raw":"107. White SP, Smith EJ. Minimal access surgery for total hip arthroplasty \u2013 current beliefs and activity profile in the UK. Ann R Coll Surg Engl 2007;89:36\u201340. 108. Khan RJK, Fick D, Khoo P, Yao F, Nivbrant B, Wood D. Less invasive total hip arthroplasty.","cites":null},{"id":10475,"title":"Minimally invasive hip arthroplasty: what role does patient preconditioning play.","authors":[],"date":"2006","doi":"10.2106\/JBJS.F.01153","raw":"110. Parvizi J, Pour AE, Sharkey PF, Rothman RH, Callaghan JJ, Hozack WJ. Minimally invasive hip arthroplasty: what role does patient preconditioning play. Annual Meeting of the American Academy of Orthopaedic Surgeons, Chicago, March 2006. Paper No. 201.","cites":null},{"id":10484,"title":"minimally invasive total hip arthroplasty: length doesn't matter.","authors":[],"date":"2004","doi":"10.1016\/j.arth.2004.05.003","raw":"De Beer, 2004 de Beer J, Petruccelli D, Zalzal P, Winemaker MJ. Single-incision, minimally invasive total hip arthroplasty: length doesn't matter. J Arthroplasty 2004; 19:945\u201350. DiGioia, 2003 Primary reference DiGioia AM III, Plakseychuk AY, Levison TJ, Jaramaz B. Mini-incision technique for total hip arthroplasty with navigation. J Arthroplasty 2003; 18:123\u20138. Secondary references DiGioia AM III. Mini incision supported by navigation.","cites":null},{"id":10474,"title":"Muscle damage after total hip arthroplasty done with the two-incision and mini-posterior techniques.","authors":[],"date":null,"doi":"10.1016\/j.arth.2006.02.003","raw":"109. Mardones R, Pagnano MW, Nemanich JP, Trousdale RT. Muscle damage after total hip arthroplasty done with the two-incision and mini-posterior techniques. Clin Orthop 2005;441: 63\u20137.","cites":null},{"id":10486,"title":"Navigation in minimally invasive total knee arthroplasty and total hip arthroscopy. Oper Tech Orthop 2006; 16:207\u201310. Dorr,","authors":[],"date":"2007","doi":"10.1053\/j.oto.2006.06.004","raw":"Hafez MA, Seel MJ, Jaramaz B, DiGioia AM III. Navigation in minimally invasive total knee arthroplasty and total hip arthroscopy. Oper Tech Orthop 2006; 16:207\u201310. Dorr, 2007 Primary reference Dorr L, Thomas D, Long W, Polatin P, Sirianni L. Psychologic reasons for patients preferring minimally invasive total hip arthroplasty. Clin Orthop 2007; 458:94\u2013100. Secondary reference Inaba Y, Dorr LD, Wan Z, Sirianni L, Boutary M. Operative and patient care techniques for posterior mini-incision total hip arthroplasty. Clin Orthop 2005; 441:104\u201314. Duwelius, 2007 Primary reference Duwelius PJ, Burkhart RL, Hayhurst JO, Moller H, Butler JB. Comparison of the 2-incision and miniincision posterior total hip arthroplasty technique.","cites":null},{"id":10529,"title":"No. 1 Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation. By Dundar","authors":[],"date":"2007","doi":null,"raw":"By Hewison J, Nixon J, Fountain J, Cocks K, Jones C, Mason G, et al. Volume 11, 2007 No. 1 Pemetrexed disodium for the treatment of malignant pleural mesothelioma: a systematic review and economic evaluation. By Dundar Y, Bagust A, Dickson R, Dodd S, Green J, Haycox A, et al. No. 2 A systematic review and economic model of the clinical effectiveness and cost-effectiveness of docetaxel in combination with prednisone or prednisolone for the treatment of hormone-refractory metastatic prostate cancer. By Collins R, Fenwick E, Trowman R, Perard R, Norman G, Light K, et al. No. 3 A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. By Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N, et al. No. 4 The clinical effectiveness and costeffectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women. By Stevenson M, Davis S, Lloyd-Jones M, Beverley C.","cites":null},{"id":10527,"title":"No. 1 The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer\u2019s disease. By Loveman E,","authors":[],"date":"2006","doi":null,"raw":"By Dretzke J, Frew E, Davenport C, Barlow J, Stewart-Brown S, Sandercock J, et al. Volume 10, 2006 No. 1 The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer\u2019s disease. By Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, et al. No. 2 FOOD: a multicentre randomised trial evaluating feeding policies in patients admitted to hospital with a recent stroke. By Dennis M, Lewis S, Cranswick G, Forbes J. No. 3 The clinical effectiveness and costeffectiveness of computed tomography screening for lung cancer: systematic reviews. By Black C, Bagust A, Boland A, Walker S, McLeod C, De Verteuil R, et al.","cites":null},{"id":10479,"title":"Orthopaedic Association (BOA) Annual Congress,","authors":[],"date":"2004","doi":null,"raw":"British Orthopaedic Association (BOA) Annual Congress, Manchester, September 2004.","cites":null},{"id":10467,"title":"Patient-reported outcome in total hip replacement. A comparison of five instruments of health status.","authors":[],"date":null,"doi":"10.1302\/0301-620X.86B6.14950","raw":"102. Ostendorf M, van Stel HF, Buskens E, Schrijvers AJ, Marting LN, Verbout AJ, et al. Patient-reported outcome in total hip replacement. A comparison of five instruments of health status. J Bone Joint Surg Br 2004;86:801\u20138.","cites":null},{"id":10466,"title":"Presidential guest address: the Swedish Hip Registry: increasing the sensitivity by patient outcome data. Clin Orthop","authors":[],"date":"2005","doi":"10.1097\/01.blo.0000193517.19556.e4","raw":"101. Malchau H, Garellick G, Eisler T, Karrholm J, Herberts P. Presidential guest address: the Swedish Hip Registry: increasing the sensitivity by patient outcome data. Clin Orthop 2005;441:19\u201329.","cites":null},{"id":10483,"title":"Primary reference Ciminiello","authors":[],"date":"2006","doi":null,"raw":"J Orthop Surg 2004;12:19\u201324. Ciminiello, 2006 Primary reference Ciminiello M, Parvizi J, Sharkey PF, Eslampour A, Rothman RH. Total hip arthroplasty: is small incision better? J Arthroplasty 2006;21:484\u20138. Secondary reference Rothman RH, Ciminiello M, Parvizi J. Total hip arthroplasty: does incision length matter. Annual Meeting of the American Academy of Orthopaedic Surgeons, Washington, DC, March 2005. Paper No. 137.","cites":null},{"id":10492,"title":"Primary reference Ogonda","authors":[],"date":"2005","doi":null,"raw":"Clin Orthop 2005;441:99\u2013103. Ogonda, 2005 Primary reference Ogonda L, Wilson R, Archbold P, Lawlor M, Humphreys P, O\u2019Brien S, et al. A minimal-incision technique in total hip arthroplasty does not improve early postoperative outcomes. A prospective, randomized, controlled trial. J Bone Joint Surg Am 2005;87:701\u201310. Secondary references Lawlor M, Humphreys P, Morrow E, Ogonda L, Bennett D, Elliott D, et al. Comparison of early postoperative functional levels following total hip replacement using minimally invasive versus standard incisions. A prospective randomized blinded trial.","cites":null},{"id":10513,"title":"Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. Appendix 12 Summary of included economic evaluations Study identification Author and year Duwelius,","authors":[],"date":"2008","doi":null,"raw":null,"cites":null},{"id":6013899,"title":"TABLE 57 Analysis of cases with complete datasets Period Group N Mean SD SE of mean Adjusted p-Value difference (SE)","authors":[],"date":"2008","doi":null,"raw":"TABLE 57 Analysis of cases with complete datasets Period Group N Mean SD SE of mean Adjusted  p-Value difference (SE) Preoperation Control 14 0.6722 0.13263 0.03545 MIS 10 0.5762 0.17112 0.05411 3 months postoperation Control 14 0.7844 0.08720 0.02330 MIS 10 0.7915 0.09543 0.03018 Difference 0.030 (0.037) 0.437 6 months postoperation Control 14 0.7902 0.07735 0.02067 MIS 10 0.8170 0.05719 0.01808 Difference 0.028 (0.031) 0.371 1 year postoperation Control 14 0.8415 0.10403 0.02780 MIS 10 0.7899 0.04939 0.01562 Difference \u20130.031 (0.035) 0.398 2 years postoperation Control 14 0.8350 0.07544 0.02016 MIS 10 0.8066 0.07307 0.02311 Difference \u20130.015 (0.032) 0.644 SD, standard deviation; SE, standard error.Health Technology Assessment 2008; Vol. 12: No. 26 213 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. Appendix 12 Summary of included economic evaluations Study identification Author and year Duwelius, 2006 (unpublished) Interventions studied\/ Mini-incision and MIS 2-incision total hip replacement (THR)\/ comparators standard THR Hypothesis\/question To evaluate the cost-effectiveness at 6 weeks of minimally invasive THR (mini-incision and two mini-incision) relative to the standard technique in patients with advanced degenerative joint disease Key elements of the study Type of study Cost-effectiveness analysis based on data from 10 hospitals in various geographic locations in the USA. Non-randomised, unmatched cohorts Target population\/ Patients with advanced degenerative joint disease in 10 USA study sample hospitals Setting Secondary care with inclusion of some community costs.","cites":null},{"id":10490,"title":"The two-incision minimally invasive total hip arthroplasty: technique and results.","authors":[],"date":"2008","doi":"10.1053\/j.sart.2004.08.002","raw":"Health Technology Assessment 2008; Vol. 12: No. 26 107 \u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved. Appendix 5 List of included studiesDuwelius PJ, Berger RA. The two-incision minimally invasive total hip arthroplasty: technique and results.","cites":null},{"id":10489,"title":"Total hip arthroplasty using the minimally invasive two-incision approach. Clin Orthop","authors":[],"date":"2003","doi":"10.1053\/j.sart.2007.09.003","raw":"Berger RA. Total hip arthroplasty using the minimally invasive two-incision approach. Clin Orthop 2003; 417:232\u201341.","cites":null},{"id":10491,"title":"Two-incision minimally invasive total hip arthroplasty: techniques and results to date. Instr Course Lect 2006;55:215\u201322. Fl\u00f6ren,","authors":[],"date":"2006","doi":null,"raw":"Duwelius PJ. Two-incision minimally invasive total hip arthroplasty: techniques and results to date. Instr Course Lect 2006;55:215\u201322. Fl\u00f6ren, 2006 Fl\u00f6ren M, Lester DK. Durability of implant fixation after less-invasive total hip arthroplasty. J Arthroplasty 2006;21:783\u201390. Hart, 2005 Primary reference Hart R, Stipcak V, Janecek M, Visna P. Component position following total hip arthroplasty through a miniinvasive posterolateral approach. Acta Orthop Belg 2005;71:60\u20134. Secondary reference Hart R, Stipcak V, Janecek M, Visna P. Radiological study of THA after mini-incision technique. Hip Int 2005;15:98\u2013101. Hartzband, 2006 Hartzband MA. Posterolateral mini-incision total hip arthroplasty. Oper Tech Orthop 2006;16:93\u2013101. Howell, 2004 Howell JR, Masri BA, Duncan CP. Minimally invasive versus standard incision anterolateral hip replacement: a comparative study. Orthop Clin North Am 2004; 35:153\u201362. Kim, 2006 Kim Y-H. Comparison of primary total hip arthroplasties performed with a minimally invasive technique or a standard technique. J Arthroplasty 2006;21:1092\u20138. Li, 2005 Li Z, Shi Z, Guo W, Zhang N, Sun W. Preliminary experiences in minimally invasive and mini-incision surgery total hip arthroplasty for late osteonecrosis of the femoral head. Chung Kuo Hsiu Fu Chung Chien Wai Ko Tsa Chih 2005;19:710\u201313 (in Chinese). O\u2019Brien, 2005 O\u2019Brien DA, Rorabeck CH. The mini-incision direct lateral approach in primary total hip arthroplasty.","cites":null},{"id":10468,"title":"Waiting for total hip arthroplasty: avoidable loss in quality time and preventable deterioration.","authors":[],"date":null,"doi":"10.1016\/j.arth.2003.09.015","raw":"103. Ostendorf M, Buskens E, van Stel H, Schrijvers A, Marting L, Dhert W, et al. Waiting for total hip arthroplasty: avoidable loss in quality time and preventable deterioration. J Arthroplasty 2004;19: 302\u20139.","cites":null},{"id":10525,"title":"What is the best imaging strategy for acute stroke? By","authors":[],"date":"2004","doi":null,"raw":"By Bankhead CR, Brett J, Bukach C, Webster P, Stewart-Brown S, Munafo M, et al. Volume 8, 2004 No. 1 What is the best imaging strategy for acute stroke? By Wardlaw JM, Keir SL, Seymour J, Lewis S, Sandercock PAG, Dennis MS, et al. No. 2 Systematic review and modelling of the investigation of acute and chronic chest pain presenting in primary care. By Mant J, McManus RJ, Oakes RAL, Delaney BC, Barton PM, Deeks JJ, et al. No. 3 The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling. By Garside R, Stein K, Wyatt K, Round A, Price A. No. 4 A systematic review of the role of bisphosphonates in metastatic disease. By Ross JR, Saunders Y, Edmonds PM, Patel S, Wonderling D, Normand C, et al. No. 5 Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda\u00ae) for locally advanced and\/or metastatic breast cancer. By Jones L, Hawkins N, Westwood M, Wright K, Richardson G, Riemsma R. No. 6 Effectiveness and efficiency of guideline dissemination and implementation strategies. By Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. No. 7 Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei. By Bryant J, Clegg AJ, Sidhu MK, Brodin H, Royle P, Davidson P. No. 8 Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. By Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. No. 9 Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. By Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. No. 10 A systematic review and economic evaluation of magnetic resonance cholangiopancreatography compared with diagnostic endoscopic retrograde cholangiopancreatography. By Kaltenthaler E, Bravo Vergel Y, Chilcott J, Thomas S, Blakeborough T, Walters SJ, et al. No. 11 The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis. By Barton P, Jobanputra P, Wilson J, Bryan S, Burls A. No. 12 Clinical effectiveness and costeffectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review. By Pandor A, Eastham J, Beverley C, Chilcott J, Paisley S. No. 13 Clinical effectiveness and costeffectiveness of pioglitazone and rosiglitazone in the treatment of type 2 diabetes: a systematic review and economic evaluation. By Czoski-Murray C, Warren E, Chilcott J, Beverley C, Psyllaki MA, Cowan J. No. 14 Routine examination of the newborn: the EMREN study. Evaluation of an extension of the midwife role including a randomised controlled trial of appropriately trained midwives and paediatric senior house officers. By Townsend J, Wolke D, Hayes J, Dav\u00e9 S, Rogers C, Bloomfield L, et al. No. 15 Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. By Oliver S, Clarke-Jones L, Rees R, Milne R, Buchanan P, Gabbay J, et al. No. 16 A multi-centre randomised controlled trial of minimally invasive direct coronary bypass grafting versus percutaneous transluminal coronary angioplasty with stenting for proximal stenosis of the left anterior descending coronary artery. By Reeves BC, Angelini GD, Bryan AJ, Taylor FC, Cripps T, Spyt TJ, et al. No. 17 Does early magnetic resonance imaging influence management or improve outcome in patients referred to secondary care with low back pain? A pragmatic randomised controlled trial. By Gilbert FJ, Grant AM, Gillan MGC, Vale L, Scott NW, Campbell MK, et al. No. 18 The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis. By Clark W, Jobanputra P, Barton P, Burls A. No. 19 A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder. By Bridle C, Palmer S, Bagnall A-M, Darba J, Duffy S, Sculpher M, et al. No. 20 Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. By Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N. No. 21 Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. By Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, et al. No. 22 Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus. By Dretzke J, Cummins C, Sandercock J, Fry-Smith A, Barrett T, Burls A. Health Technology Assessment reports published to date 232No. 23 Clinical effectiveness and costeffectiveness of prehospital intravenous fluids in trauma patients. By Dretzke J, Sandercock J, Bayliss S, Burls A. No. 24 Newer hypnotic drugs for the shortterm management of insomnia: a systematic review and economic evaluation. By D\u00fcndar Y, Boland A, Strobl J, Dodd S, Haycox A, Bagust A, et al. No. 25 Development and validation of methods for assessing the quality of diagnostic accuracy studies. By Whiting P, Rutjes AWS, Dinnes J, Reitsma JB, Bossuyt PMM, Kleijnen J. No. 26 EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. By Garry R, Fountain J, Brown J, Manca A, Mason S, Sculpher M, et al. No. 27 Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon- and glatiramer acetate for multiple sclerosis. By Tappenden P, Chilcott JB, Eggington S, Oakley J, McCabe C. No. 28 Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis. By Dalziel K, Round A, Stein K, Garside R, Price A. No. 29 VenUS I: a randomised controlled trial of two types of bandage for treating venous leg ulcers. By Iglesias C, Nelson EA, Cullum NA, Torgerson DJ on behalf of the VenUS Team. No. 30 Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. By Mowatt G, Vale L, Brazzelli M, Hernandez R, Murray A, Scott N, et al. No. 31 A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. By Claxton K on K, Ginnelly L, Sculpher M, Philips Z, Palmer S. No. 32 The Social Support and Family Health Study: a randomised controlled trial and economic evaluation of two alternative forms of postnatal support for mothers living in disadvantaged inner-city areas. By Wiggins M, Oakley A, Roberts I, Turner H, Rajan L, Austerberry H, et al. No. 33 Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review. By Green JM, Hewison J, Bekker HL, Bryant, Cuckle HS. No. 34 Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status. By Critchley HOD, Warner P, Lee AJ, Brechin S, Guise J, Graham B. No. 35 Coronary artery stents: a rapid systematic review and economic evaluation. By Hill R, Bagust A, Bakhai A, Dickson R, D\u00fcndar Y, Haycox A, et al. No. 36 Review of guidelines for good practice in decision-analytic modelling in health technology assessment. By Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, et al. No. 37 Rituximab (MabThera\u00ae) for aggressive non-Hodgkin\u2019s lymphoma: systematic review and economic evaluation. By Knight C, Hind D, Brewer N, Abbott V. No. 38 Clinical effectiveness and costeffectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation. By Jones L, Griffin S, Palmer S, Main C, Orton V, Sculpher M, et al. No. 39 Pegylated interferon -2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation. By Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J. No. 40 Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segmentelevation acute coronary syndromes: a systematic review and economic evaluation. By Main C, Palmer S, Griffin S, Jones L, Orton V, Sculpher M, et al. No. 41 Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups. By Beswick AD, Rees K, Griebsch I, Taylor FC, Burke M, West RR, et al. No. 42 Involving South Asian patients in clinical trials. By Hussain-Gambles M, Leese B, Atkin K, Brown J, Mason S, Tovey P. No. 43 Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. By Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N. No. 44 Identification and assessment of ongoing trials in health technology assessment reviews. By Song FJ, Fry-Smith A, Davenport C, Bayliss S, Adi Y, Wilson JS, et al. No. 45 Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine By Warren E, Weatherley-Jones E, Chilcott J, Beverley C. No. 46 Supplementation of a home-based exercise programme with a class-based programme for people with osteoarthritis of the knees: a randomised controlled trial and health economic analysis. By McCarthy CJ, Mills PM, Pullen R, Richardson G, Hawkins N, Roberts CR, et al. No. 47 Clinical and cost-effectiveness of oncedaily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation. By Green C, Colquitt JL, Kirby J, Davidson P, Payne E. No. 48 Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis. By Vickers AJ, Rees RW, Zollman CE, McCarney R, Smith CM, Ellis N, et al. No. 49 Generalisability in economic evaluation studies in healthcare: a review and case studies. By Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, et al. No. 50 Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations.","cites":null},{"id":10478,"title":"Wrightington Hospital,","authors":[],"date":"2005","doi":null,"raw":"Annual Meeting, Wrightington Hospital, March 2005.","cites":null}],"documentType":{"type":null}},"contributors":["University of Aberdeen, School of Medicine & Dentistry, Division of Applied Health Sciences","University of Aberdeen, School of Medicine & Dentistry, Division of Applied Medicine"],"datePublished":"2008-06","abstract":"Objectives: To assess the clinical effectiveness and cost-effectiveness of minimal incision approaches to total hip replacement (THR) for arthritis of the hip. Data sources: Major electronic databases were searched from 1966 to 2007. Relevant websites were also examined and experts in the field were consulted. Review methods: Studies of minimal (one or two) incision THR compared with standard THR were assessed for inclusion in the review of clinical effectiveness. A systematic review of economic evaluations comparing a minimal incision approach to standard THR was also performed and the estimates from the systematic review of clinical effectiveness were incorporated into an economic model. Utilities data were sourced to estimate quality-adjusted life-years (QALYs). Due to lack of data, no economic analysis was conducted for the two mini-incision surgical method. Results: Nine randomised controlled trials (RCTs), 17 non-randomised comparative studies, six case series and one registry were found to be useful for the comparison of single mini-incision THR with standard THR. One RCT compared two mini-incision THR with standard THR, and two RCTs, five non-randomised comparative studies and two case series compared two mini-incision with single mini-incision THR. The RCTs were of moderate quality. Most had fewer than 200 patients and had a follow-up period of less than 1 year. The single mini-incision THR may have some perioperative advantages, e.g. blood loss [weighted mean difference (WMD) \u201357.71 ml, p < 0.01] and shorter operative time, of uncertain practical significance. It may also offer a shorter recovery period and greater patient satisfaction. Evidence on long-term outcomes (especially revision) is too limited to be useful. Lack of data prevented subgroup analysis. With respect to the two-incision approach, data were suggestive of shorter recovery compared with single-incision THR, but conclusions must be treated with caution. The costs to the health service, per patient, of single mini-incision THR depend upon assumptions made, but are similar at 1 year (\u00a37060 vs \u00a37350 for standard THR). For a 40-year time horizon the costs were \u00a311,618 for mini-incision and \u00a311,899 for standard THR. Two existing economic evaluations were identified, but they added little, if any, value to the current evidence base owing to their limited quality. In the economic model, mini-incision THR was less costly and provided slightly more QALYs in both the 1- and 40-year analyses. The mean QALYs at 1 year were 0.677 for standard THR and 0.695 for mini-incision THR. At 40 years, the mean QALYs were 8.463 for standard THR and 8.480 for mini-incision. At 1 year the probabilistic sensitivity analyses indicate that mini-incision THR has a 95% probability of being cost-effective if society\u2019s willingness to pay for a QALY were up to \u00a350,000. This is reduced to approximately 55% for the 40-year analysis. The results were driven by the assumption of a 1-month earlier return to usual activities and a decreased hospital length of stay and operation duration following mini-incision THR. If mini-incision THR actually required more intensive use of resources it would become approximately \u00a3200 more expensive and would only be cost-effective (cost per QALY > \u00a330,000) if recovery was 1.5 weeks faster. A threshold analysis around risk of revision showed, using the same cost per QALY threshold, mini-incision THR would have to have no more than a 7.5% increase in revisions compared with standard THR for it to be no longer considered cost-effective (one more revision for every 200 procedures performed). Further sensitivity analysis involved relaxing assumptions of equal long-term outcomes where possible. and broadly similar results to the base-case analysis were found in this and further sensitivity analyses. Conclusions: Compared with standard THR, minimal incision THR has small perioperative advantages in terms of blood loss and operation time. It may offer a shorter hospital stay and quicker recovery. It appears to have a similar procedure cost to standard THR, but evidence on its longer term performance is very limited. Further long-term follow-up data on costs and outcomes including analysis of subgroups of interest to the NHS would strengthen the current economic evaluation.The Health Services Research Unit and the Health Economics Research Unit are both core funded by the Chief Scientist Office of the Scottish Government Health Directorates.Peer reviewedPublisher PD","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"Gray Publishing","rawRecordXml":"<record><header><identifier>\n        \n            \n                oai:aura.abdn.ac.uk:2164\/246<\/identifier><datestamp>\n                2010-08-09T10:43:19Z<\/datestamp><setSpec>\n                com_2164_632<\/setSpec><setSpec>\n                com_2164_364<\/setSpec><setSpec>\n                com_2164_330<\/setSpec><setSpec>\n                com_2164_634<\/setSpec><setSpec>\n                com_2164_705<\/setSpec><setSpec>\n                col_2164_633<\/setSpec><setSpec>\n                col_2164_635<\/setSpec><setSpec>\n                col_2164_706<\/setSpec>\n            <\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:doc=\"http:\/\/www.lyncode.com\/xoai\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n            \nSystematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip<\/dc:title><dc:creator>\nDe Verteuil, Robyn<\/dc:creator><dc:creator>\nImamura, Mari<\/dc:creator><dc:creator>\nZhu, S.<\/dc:creator><dc:creator>\nGlazener, Cathryn Margaret Anne<\/dc:creator><dc:creator>\nFraser, Cynthia Mary<\/dc:creator><dc:creator>\nMunro, N.<\/dc:creator><dc:creator>\nHutchison, James Douglas<\/dc:creator><dc:creator>\nGrant, Adrian Maxwell<\/dc:creator><dc:creator>\nCoyle, D.<\/dc:creator><dc:creator>\nCoyle, K.<\/dc:creator><dc:creator>\nVale, Luke David<\/dc:creator><dc:contributor>\nUniversity of Aberdeen, School of Medicine & Dentistry, Division of Applied Health Sciences<\/dc:contributor><dc:contributor>\nUniversity of Aberdeen, School of Medicine & Dentistry, Division of Applied Medicine<\/dc:contributor><dc:subject>\nArthroplasty, Replacement, Hip<\/dc:subject><dc:subject>\nCost-benefit Analysis<\/dc:subject><dc:subject>\nSurgical Procedures, Minimally Invasive<\/dc:subject><dc:subject>\nTechnology Assessment, Biomedical<\/dc:subject><dc:subject>\nTreatment Outcomes<\/dc:subject><dc:subject>\nRD Surgery<\/dc:subject><dc:description>\nObjectives: To assess the clinical effectiveness and cost-effectiveness of minimal incision approaches to total hip replacement (THR) for arthritis of the hip. Data sources: Major electronic databases were searched from 1966 to 2007. Relevant websites were also examined and experts in the field were consulted. Review methods: Studies of minimal (one or two) incision THR compared with standard THR were assessed for inclusion in the review of clinical effectiveness. A systematic review of economic evaluations comparing a minimal incision approach to standard THR was also performed and the estimates from the systematic review of clinical effectiveness were incorporated into an economic model. Utilities data were sourced to estimate quality-adjusted life-years (QALYs). Due to lack of data, no economic analysis was conducted for the two mini-incision surgical method. Results: Nine randomised controlled trials (RCTs), 17 non-randomised comparative studies, six case series and one registry were found to be useful for the comparison of single mini-incision THR with standard THR. One RCT compared two mini-incision THR with standard THR, and two RCTs, five non-randomised comparative studies and two case series compared two mini-incision with single mini-incision THR. The RCTs were of moderate quality. Most had fewer than 200 patients and had a follow-up period of less than 1 year. The single mini-incision THR may have some perioperative advantages, e.g. blood loss [weighted mean difference (WMD) \u201357.71 ml, p < 0.01] and shorter operative time, of uncertain practical significance. It may also offer a shorter recovery period and greater patient satisfaction. Evidence on long-term outcomes (especially revision) is too limited to be useful. Lack of data prevented subgroup analysis. With respect to the two-incision approach, data were suggestive of shorter recovery compared with single-incision THR, but conclusions must be treated with caution. The costs to the health service, per patient, of single mini-incision THR depend upon assumptions made, but are similar at 1 year (\u00a37060 vs \u00a37350 for standard THR). For a 40-year time horizon the costs were \u00a311,618 for mini-incision and \u00a311,899 for standard THR. Two existing economic evaluations were identified, but they added little, if any, value to the current evidence base owing to their limited quality. In the economic model, mini-incision THR was less costly and provided slightly more QALYs in both the 1- and 40-year analyses. The mean QALYs at 1 year were 0.677 for standard THR and 0.695 for mini-incision THR. At 40 years, the mean QALYs were 8.463 for standard THR and 8.480 for mini-incision. At 1 year the probabilistic sensitivity analyses indicate that mini-incision THR has a 95% probability of being cost-effective if society\u2019s willingness to pay for a QALY were up to \u00a350,000. This is reduced to approximately 55% for the 40-year analysis. The results were driven by the assumption of a 1-month earlier return to usual activities and a decreased hospital length of stay and operation duration following mini-incision THR. If mini-incision THR actually required more intensive use of resources it would become approximately \u00a3200 more expensive and would only be cost-effective (cost per QALY > \u00a330,000) if recovery was 1.5 weeks faster. A threshold analysis around risk of revision showed, using the same cost per QALY threshold, mini-incision THR would have to have no more than a 7.5% increase in revisions compared with standard THR for it to be no longer considered cost-effective (one more revision for every 200 procedures performed). Further sensitivity analysis involved relaxing assumptions of equal long-term outcomes where possible. and broadly similar results to the base-case analysis were found in this and further sensitivity analyses. Conclusions: Compared with standard THR, minimal incision THR has small perioperative advantages in terms of blood loss and operation time. It may offer a shorter hospital stay and quicker recovery. It appears to have a similar procedure cost to standard THR, but evidence on its longer term performance is very limited. Further long-term follow-up data on costs and outcomes including analysis of subgroups of interest to the NHS would strengthen the current economic evaluation.<\/dc:description><dc:description>\nThe Health Services Research Unit and the Health Economics Research Unit are both core funded by the Chief Scientist Office of the Scottish Government Health Directorates.<\/dc:description><dc:description>\nPeer reviewed<\/dc:description><dc:description>\nPublisher PDF<\/dc:description><dc:date>\n2008-07-25T08:27:22Z<\/dc:date><dc:date>\n2008-07-25T08:27:22Z<\/dc:date><dc:date>\n2008-06<\/dc:date><dc:type>\nJournal Article<\/dc:type><dc:type>\nText<\/dc:type><dc:identifier>\nde Verteuil, R., Imamura, M., Zhu, S., Glazener, C., Fraser, C., Munro, N., Hutchison, J., Grant, A., Coyle, D., Coyle, K., and Vale, L., (2008). Systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip. Health Technology Assessment, 12 (26).<\/dc:identifier><dc:identifier>\n1366-5278<\/dc:identifier><dc:identifier>\nPure: 275277<\/dc:identifier><dc:identifier>\nhttp:\/\/hdl.handle.net\/2164\/246<\/dc:identifier><dc:identifier>\nhttp:\/\/dx.doi.org\/10.3310\/hta12260<\/dc:identifier><dc:language>\nen<\/dc:language><dc:format>\n1422785 bytes<\/dc:format><dc:format>\n243 p.<\/dc:format><dc:format>\napplication\/pdf<\/dc:format><dc:publisher>\nGray Publishing<\/dc:publisher>\n<\/oai_dc:dc>\n<\/metadata>\n        <\/record>","journals":[{"title":null,"identifiers":["issn:1366-5278","1366-5278"]}],"language":{"code":"en","id":9,"name":"English"},"relations":[],"year":2008,"topics":["Arthroplasty, Replacement, Hip","Cost-benefit Analysis","Surgical Procedures, Minimally Invasive","Technology Assessment, Biomedical","Treatment Outcomes","RD Surgery"],"subject":["Journal Article","Text"],"fullText":"A systematic review of the clinical\neffectiveness and cost-effectiveness and\neconomic modelling of minimal incision\ntotal hip replacement approaches \nin the management of arthritic \ndisease of the hip\nR de Verteuil, M Imamura, S Zhu, \nC Glazener, C Fraser, N Munro, J Hutchison, \nA Grant, D Coyle, K Coyle and L Vale\nHealth Technology Assessment 2008; Vol. 12: No. 26\nHTA\nHealth Technology Assessment\nNHS R&D HTA Programme\nwww.hta.ac.uk\nThe National Coordinating Centre for Health Technology Assessment,\nAlpha House, Enterprise Road\nSouthampton Science Park\nChilworth\nSouthampton SO16 7NS, UK.\nFax: +44 (0) 23 8059 5639 Email: hta@hta.ac.uk\nhttp:\/\/www.hta.ac.uk ISSN 1366-5278\nFeedback\nThe HTA Programme and the authors would like to know \nyour views about this report.\nThe Correspondence Page on the HTA website\n(http:\/\/www.hta.ac.uk) is a convenient way to publish \nyour comments. If you prefer, you can send your comments \nto the address below, telling us whether you would like \nus to transfer them to the website.\nWe look forward to hearing from you.\nJune 2008\nH\ne\na\nl\nt\nh\n \nT\ne\nc\nh\nn\no\nl\no\ng\ny\n \nA\ns\ns\ne\ns\ns\nm\ne\nn\nt\n \n2\n0\n0\n8\n;\nV\no\nl\n.\n \n1\n2\n:\n \nN\no\n.\n \n2\n6\nT\no\nt\na\nl\n \nh\ni\np\n \nr\ne\np\nl\na\nc\ne\nm\ne\nn\nt\n \na\np\np\nr\no\na\nc\nh\ne\ns\n \ni\nn\n \nt\nh\ne\n \nm\na\nn\na\ng\ne\nm\ne\nn\nt\n \no\nf\n \na\nr\nt\nh\nr\ni\nt\ni\nc\n \nd\ni\ns\ne\na\ns\ne\n \no\nf\n \nt\nh\ne\n \nh\ni\npHow to obtain copies of this and other HTA Programme reports.\nAn electronic version of this publication, in Adobe Acrobat format, is available for downloading free of\ncharge for personal use from the HTA website (http:\/\/www.hta.ac.uk). A fully searchable CD-ROM is\nalso available (see below). \nPrinted copies of HTA monographs cost \u00a320 each (post and packing free in the UK) to both public and\nprivate sector purchasers from our Despatch Agents.\nNon-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is\n\u00a32 per monograph and for the rest of the world \u00a33 per monograph.\nYou can order HTA monographs from our Despatch Agents:\n\u2013 fax (with credit card or of\ufb01cial purchase order) \n\u2013 post (with credit card or of\ufb01cial purchase order or cheque)\n\u2013 phone during of\ufb01ce hours (credit card only).\nAdditionally the HTA website allows you either to pay securely by credit card or to print out your\norder and then post or fax it.\nContact details are as follows:\nHTA Despatch Email: orders@hta.ac.uk\nc\/o Direct Mail Works Ltd Tel: 02392 492 000\n4 Oakwood Business Centre Fax: 02392 478 555\nDownley, HAVANT PO9 2NP , UK Fax from outside the UK: +44 2392 478 555\nNHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of \n\u00a3100 for each volume (normally comprising 30\u201340 titles). The commercial subscription rate is \u00a3300 \nper volume. Please see our website for details. Subscriptions can only be purchased for the current or\nforthcoming volume.\nPayment methods\nPaying by cheque\nIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd\nand drawn on a bank with a UK address.\nPaying by credit card\nThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard,\nMastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email.\nPaying by of\ufb01cial purchase order\nYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK.\nWe cannot at present accept purchase orders from commercial companies or from outside the UK.\nHow do I get a copy of HTA on CD?\nPlease use the form on the HTA website (www.hta.ac.uk\/htacd.htm). Or contact Direct Mail Works (see\ncontact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.\nThe website also provides information about the HTA Programme and lists the membership of the various\ncommittees.\nHTAA systematic review of the clinical\neffectiveness and cost-effectiveness and\neconomic modelling of minimal incision\ntotal hip replacement approaches \nin the management of arthritic \ndisease of the hip\nR de Verteuil,1,2 M Imamura,1 S Zhu,1\nC Glazener,1 C Fraser,1 N Munro,3 J Hutchison,4\nA Grant,5 D Coyle,6,7 K Coyle7 and L Vale1,2*\n1 Health Services Research Unit, Institute of Applied Health Sciences,\nUniversity of Aberdeen, UK\n2 Health Economics Research Unit, Institute of Applied Health Sciences,\nUniversity of Aberdeen, UK\n3 NHS Grampian, Aberdeen, UK\n4 Department of Surgery, University of Aberdeen, UK\n5 Institute of Applied Health Sciences, University of Aberdeen, UK\n6 Department of Epidemiology and Community Medicine, University of\nOttawa, Canada\n7 Coyle Consultancy, Ottawa, Canada\n* Corresponding author\nDeclared competing interests of authors: none\nPublished June 2008\nThis report should be referenced as follows:\nde Verteuil R, Imamura M, Zhu S, Glazener C, Fraser C, Munro N, et al. A systematic\nreview of the clinical effectiveness and cost-effectiveness and economic modelling of\nminimal incision total hip replacement approaches in the management of arthritic disease\nof the hip. Health Technol Assess 2008;12(26).\nHealth Technology Assessment is indexed and abstracted in Index Medicus\/MEDLINE,\nExcerpta Medica\/EMBASE and Science Citation Index Expanded (SciSearch\u00ae) and \nCurrent Contents\u00ae\/Clinical Medicine.NIHR Health Technology Assessment Programme\nT\nhe Health Technology Assessment (HTA) Programme, part of the National Institute for Health\nResearch (NIHR), was set up in 1993. It produces high-quality research information on the\neffectiveness, costs and broader impact of health technologies for those who use, manage and provide\ncare in the NHS. \u2018Health technologies\u2019 are broadly defined as all interventions used to promote health,\nprevent and treat disease, and improve rehabilitation and long-term care.\nThe research findings from the HTA Programme directly influence decision-making bodies such as the\nNational Institute for Health and Clinical Excellence (NICE) and the National Screening Committee\n(NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that\nthey form a key component of the \u2018National Knowledge Service\u2019.\nThe HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are\nthree routes to the start of projects. \nFirst is the commissioned route. Suggestions for research are actively sought from people working in the\nNHS, the public and consumer groups and professional bodies such as royal colleges and NHS trusts.\nThese suggestions are carefully prioritised by panels of independent experts (including NHS service\nusers). The HTA Programme then commissions the research by competitive tender. \nSecondly, the HTA Programme provides grants for clinical trials for researchers who identify research\nquestions. These are assessed for importance to patients and the NHS, and scientific rigour.\nThirdly, through its Technology Assessment Report (TAR) call-off contract, the HTA Programme\ncommissions bespoke reports, principally for NICE, but also for other policy-makers. TARs bring \ntogether evidence on the value of specific technologies.\nSome HTA research projects, including TARs, may take only months, others need several years. They can\ncost from as little as \u00a340,000 to over \u00a31 million, and may involve synthesising existing evidence,\nundertaking a trial, or other research collecting new data to answer a research problem.\nThe final reports from HTA projects are peer-reviewed by a number of independent expert referees\nbefore publication in the widely read journal series Health Technology Assessment. \nCriteria for inclusion in the HTA journal series\nReports are published in the HTA journal series if (1) they have resulted from work for the HTA\nProgramme, and (2) they are of a sufficiently high scientific quality as assessed by the referees and editors.\nReviews in Health Technology Assessment are termed \u2018systematic\u2019 when the account of the search,\nappraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the\nreplication of the review by others.\nThe research reported in this issue of the journal was commissioned by the HTA Programme as project\nnumber 06\/46\/01. The contractual start date was in November 2006. The draft report began editorial\nreview in May 2007 and was accepted for publication in February 2008. As the funder, by devising a\ncommissioning brief, the HTA Programme specified the research question and study design. The authors\nhave been wholly responsible for all data collection, analysis and interpretation, and for writing up their\nwork. The HTA editors and publisher have tried to ensure the accuracy of the authors\u2019 report and would\nlike to thank the referees for their constructive comments on the draft document. However, they do not\naccept liability for damages or losses arising from material published in this report.\nThe views expressed in this publication are those of the authors and not necessarily those of the \nHTA Programme or the Department of Health.\nEditor-in-Chief: Professor Tom Walley\nSeries Editors: Dr Aileen Clarke, Dr Peter Davidson, Dr Chris Hyde, \nDr John Powell, Dr Rob Riemsma and Professor Ken Stein\nProgramme Managers:  Sarah Llewellyn Lloyd, Stephen Lemon, Kate Rodger, \nStephanie Russell and Pauline Swinburne\nISSN 1366-5278\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008\nThis monograph may be freely reproduced for the purposes of private research and study and may be included in professional journals provided\nthat suitable acknowledgement is made and the reproduction is not associated with any form of advertising.\nApplications for commercial reproduction should be addressed to: NCCHTA, Alpha House, Enterprise Road, Southampton Science Park,\nChilworth, Southampton SO16 7NS, UK.\nPublished by Gray Publishing, Tunbridge Wells, Kent, on behalf of NCCHTA.\nPrinted on acid-free paper in the UK by St Edmundsbury Press Ltd, Bury St Edmunds, Suffolk. GObjectives: To assess the clinical effectiveness and \ncost-effectiveness of minimal incision approaches to\ntotal hip replacement (THR) for arthritis of the hip. \nData sources: Major electronic databases were\nsearched from 1966 to 2007. Relevant websites were\nalso examined and experts in the field were consulted. \nReview methods: Studies of minimal (one or two)\nincision THR compared with standard THR were\nassessed for inclusion in the review of clinical\neffectiveness. A systematic review of economic\nevaluations comparing a minimal incision approach to\nstandard THR was also performed and the estimates\nfrom the systematic review of clinical effectiveness\nwere incorporated into an economic model. Utilities\ndata were sourced to estimate quality-adjusted life-\nyears (QALYs). Due to lack of data, no economic\nanalysis was conducted for the two mini-incision\nsurgical method. \nResults: Nine randomised controlled trials (RCTs), 17\nnon-randomised comparative studies, six case series\nand one registry were found to be useful for the\ncomparison of single mini-incision THR with standard\nTHR. One RCT compared two mini-incision THR with\nstandard THR, and two RCTs, five non-randomised\ncomparative studies and two case series compared two\nmini-incision with single mini-incision THR. The RCTs\nwere of moderate quality. Most had fewer than 200\npatients and had a follow-up period of less than 1 year.\nThe single mini-incision THR may have some\nperioperative advantages, e.g. blood loss [weighted\nmean difference (WMD) \u201357.71 ml, p < 0.01] and\nshorter operative time, of uncertain practical\nsignificance. It may also offer a shorter recovery period\nand greater patient satisfaction. Evidence on long-term\noutcomes (especially revision) is too limited to be\nuseful. Lack of data prevented subgroup analysis. With\nrespect to the two-incision approach, data were\nsuggestive of shorter recovery compared with single-\nincision THR, but conclusions must be treated with\ncaution. The costs to the health service, per patient, of\nsingle mini-incision THR depend upon assumptions\nmade, but are similar at one year (\u00a37060 vs \u00a37350 for\nstandard THR). For a 40-year time horizon the costs\nwere \u00a311,618 for mini-incision and \u00a311,899 for\nstandard THR. Two existing economic evaluations were\nidentified, but they added little, if any, value to the\ncurrent evidence base owing to their limited quality. In\nthe economic model, mini-incision THR was less costly\nand provided slightly more QALYs in both the 1- and\n40-year analyses. The mean QALYs at 1 year were\n0.677 for standard THR and 0.695 for mini-incision\nTHR. At 40 years, the mean QALYs were 8.463 for\nstandard THR and 8.480 for mini-incision. At 1 year the\nprobabilistic sensitivity analyses indicate that mini-\nincision THR has a 95% probability of being cost-\neffective if society\u2019s willingness to pay for a QALY were\nup to \u00a350,000. This is reduced to approximately 55%\nfor the 40-year analysis. The results were driven by the\nHealth Technology Assessment 2008; Vol. 12: No. 26\niii\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAbstract\nA systematic review of the clinical effectiveness and \ncost-effectiveness and economic modelling of minimal incision\ntotal hip replacement approaches in the management of arthritic\ndisease of the hip\nR de Verteuil,1,2 M Imamura,1 S Zhu,1 C Glazener,1 C Fraser,1 N Munro,3\nJ Hutchison,4 A Grant,5 D Coyle,6,7 K Coyle7 and L Vale1,2*\n1 Health Services Research Unit, Institute of Applied Health Sciences, University of Aberdeen, UK\n2 Health Economics Research Unit, Institute of Applied Health Sciences, University of Aberdeen, UK\n3 NHS Grampian, Aberdeen, UK\n4 Department of Surgery, University of Aberdeen, UK\n5 Institute of Applied Health Sciences, University of Aberdeen, UK\n6 Department of Epidemiology and Community Medicine, University of Ottawa, Canada\n7 Coyle Consultancy, Ottawa, Canada\n* Corresponding authorassumption of a 1-month earlier return to usual\nactivities and a decreased hospital length of stay and\noperation duration following mini-incision THR. If mini-\nincision THR actually required more intensive use of\nresources it would become approximately \u00a3200 more\nexpensive and would only be cost-effective (cost per\nQALY > \u00a330,000) if recovery was 1.5 weeks faster. \nA threshold analysis around risk of revision showed,\nusing the same cost per QALY threshold, \nmini-incision THR would have to have no more \nthan a 7.5% increase in revisions compared with\nstandard THR for it to be no longer considered cost\neffective (one more revision for every 200 procedures\nperformed). Further sensitivity analysis involved\nrelaxing assumptions of equal long-term outcomes\nwhere possible. and broadly similar results to the base-\ncase analysis were found in this and further sensitivity\nanalyses. \nConclusions: Compared with standard THR, minimal\nincision THR has small perioperative advantages in\nterms of blood loss and operation time. It may offer a\nshorter hospital stay and quicker recovery. It appears\nto have a similar procedure cost to standard THR, but\nevidence on its longer term performance is very\nlimited. Further long-term follow-up data on costs and\noutcomes including analysis of subgroups of interest to\nthe NHS would strengthen the current economic\nevaluation.\nAbstract\nivHealth Technology Assessment 2008; Vol. 12: No. 26\nv\nList of abbreviations .................................. vii\nExecutive summary .................................... ix\n1 Background ................................................ 1\nDescription of underlying health problem  1\nCurrent service provision ........................... 1\nDescription of new intervention  ................ 2\n2 The decision problem ................................ 5\n3 Effectiveness ............................................... 7\nMethods for reviewing effectiveness .......... 7\nResults ........................................................ 9\nSummary and conclusions of the evidence \nfor and against the intervention ................ 45\n4 Systematic review of economic \nevaluations ................................................. 49\nMethods ...................................................... 49\nResults ........................................................ 49\nSummary of results and discussion ............ 52\nConclusions ................................................ 53\n5 Economic evaluation .................................. 55\nEconomic model  ........................................ 55\nSummary of evidence on \ncost-effectiveness ........................................ 70\n6 Implications for other parties .................... 73\nQuality of life for the family and carers  .... 73\nFinancial impact for the patient and \nothers .......................................................... 73\n7 Implications for the NHS .......................... 75\nTraining ...................................................... 75\nFair access and equity issues  ...................... 75\nBudgetary impact on the NHS .................. 76\nThe use of two-incision approaches ........... 76\n8 Discussion ................................................... 77\nMain results ................................................ 77\nAssumptions, limitations and \nuncertainties ............................................... 77\n9 Conclusions ................................................ 83\nImplications for the NHS  .......................... 83\nImplications for patients and carers .......... 83\nImplications for research  ........................... 83\nAcknowledgements .................................... 85\nReferences .................................................. 87\nAppendix 1 Search strategies .................... 93\nAppendix 2 Study eligibility form ............. 99\nAppendix 3 Data extraction form ............. 101\nAppendix 4 Quality assessment form \u2013 \nRCTs ........................................................... 105\nAppendix 5 List of included studies  ......... 107\nAppendix 6 List of ongoing trials ............. 111\nAppendix 7 Detailed quality assessment \nscore for the included trials and comparative\nstudies ......................................................... 115\nAppendix 8 Characteristics of included \nstudies ......................................................... 117\nAppendix 9 Summary of outcomes \nreported in the included studies ................ 159\nAppendix 10 Results of meta-analyses ...... 167\nAppendix 11 Detailed analyses of SF-6D \nscores based on the trial by Charles and\ncolleagues ................................................... 211\nAppendix 12 Summary of included \neconomic evaluations ................................. 213\nAppendix 13 Markov model for the\nmanagement of arthritic disease of the \nhip .............................................................. 219\nAppendix 14 Balanced life table for general\nmortality (40% male, 60% female) ............. 221\nAppendix 15 Cohort analysis showing \n1000 patients as they progress through \nthe 40-year model for both standard and \nmini-incision THR  ..................................... 223\nHealth Technology Assessment reports\npublished to date ....................................... 225\nHealth Technology Assessment \nProgramme ................................................ 241\nContentsBMI body mass index\nBNF British National Formulary\nCEAC cost-effectiveness acceptability\ncurve\nCI confidence interval\nDVT deep vein thrombosis\nHES Hospital Episode Statistics\nHRG healthcare resource group\nICER incremental cost-effectiveness\nratio\nMI mini-incision\n2MI two mini-incision\nMIS minimally invasive surgery, \nmini-incision surgery\nNHS EED National Health Service Economic\nEvaluation Database\nNICE  National Institute for Health and\nClinical Excellence\nNJR National Joint Registry\nODEP Orthopaedic Device Evaluation\nPanel\nOR odds ratio\nQALY quality-adjusted life-year\nPE pulmonary embolism\nRCT randomised controlled trial\nSD standard deviation\nSF-6D Short Form with 6 Dimensions\nSF-12 Short Form with 12 Items\nSF-36 Short Form with 36 Items\nSI standard incision\nSIGN Scottish Intercollegiate Guidelines\nNetwork\nTHR  total hip replacement \nWMD weighted mean difference\nWOMAC Western Ontario and MacMaster\nUniversities\nHealth Technology Assessment 2008; Vol. 12: No. 26\nvii\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nList of abbreviations\nAll abbreviations that have been used in this report are listed here unless the abbreviation is well known (e.g. NHS), or \nit has been used only once, or it is a non-standard abbreviation used only in figures\/tables\/appendices in which case \nthe abbreviation is defined in the figure legend or at the end of the table.Health Technology Assessment 2008; Vol. 12: No. 26\nix\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nDescription of proposed service\nMinimal incision total hip replacement (THR) is\nperformed with significant variations between\nsurgeons but approaches fall into two main groups.\nOf these, the \u2018double-incision\u2019 or \u2018two-incision\u2019\napproach is novel and specific to minimally\ninvasive hip surgery, whereas the single mini-\nincision approach is a development of traditional\nanterolateral and posterior approaches. Minimal\nincision techniques can be used for all the main\ncategories of hip prostheses. Although shorter\nincisions may result in less muscle dissection, they\nmay also reduce visualisation at operation, leading\nto potential risks that the placement of the\nprosthesis will be sub-optimal and may, therefore,\nlead to a higher rate of revisions than might be\nexpected with standard THR. \nEpidemiology and background\nOsteoarthritis was the primary diagnosis in 94% of\nTHR operations in England and Wales in 2005. Its\nincidence increases with age, and consequently\nTHR is most common in older people (the\naverage age of patients is 68 years). With\nimprovements in implant design and longevity,\nyounger patients are also now considered for\nTHR. Over 55,000 primary THRs are recorded\nannually in the National Joint Registry, of which\n6\u201314% are reported to be mini-incision THR.\nMinimally invasive surgery (MIS) is thought to be\nless suitable for patients who are obese, very\nmuscular or with severe osteoporosis. \nObjective\nThis review aimed to assess the clinical\neffectiveness and cost-effectiveness of minimal\nincision approaches to THR for arthritis of the hip. \nMethods\nThe search strategy included electronic databases\n(covering 1966\u20132007) and relevant websites, contact\nwith experts in the field and scrutiny of retrieved\npapers to identify reports of published and ongoing\nstudies. Systematic reviews and selected conference\nproceedings were also searched. \nStudies of minimal (one or two) incision THR\ncompared with standard THR were assessed for\ninclusion for the review of clinical effectiveness.\nStudies of two-incision THR compared with one\nmini-incision THR were also eligible. Randomised\ncontrolled trials (RCTs), quasi-RCTs, prospective\nnon-randomised studies with concurrent\ncomparisons and matched-pair studies, and\nretrospective comparative studies with prospective\ndesign or total population recruitment were\nincluded. Additional long-term data were sought\nfrom national registries, and also single-surgeon\ncase series with a minimum follow-up of 3 years\nand multiple-surgeon case series with a minimum\nfollow-up of 1 year. Pre-specified subgroups were\nbased on age, gender, deformity, muscularity and\nbody mass index (BMI), and also operative\napproach (i.e. posterior, anterior).\nTwo reviewers independently extracted data and\nassessed methodological quality. Meta-analyses\nwere performed with the RCT data; dichotomous\ndata were combined using the Peto odds ratios\nand continuous data were combined using the\ninverse variance weighted mean differences. \nA systematic review of economic evaluations\ncomparing a minimal incision approach to\nstandard THR was performed and the estimates\nfrom the systematic review of clinical effectiveness\nwere incorporated into an economic model. This\nmodel estimated the cost\u2013utility of single mini-\nincision THR for time horizons of 1 and 40 years\n(although few long-term data relevant to the 40-\nyear time horizon were available). Many of the\noutcomes produced by the meta-analysis were\nimplausible and it was not possible to incorporate\nthem into the model. Data were suggestive of equal\noutcomes following standard and mini-incision\nTHR, hence the risks of revision, postoperative\ndislocation and infection, deep vein thrombosis\n(DVT) and pulmonary embolism (PE) were\nassumed to be equal but with wide confidence\nintervals (CIs) [relative risk (RR) 1, 95% CI 0.1 to\n1.89]. The key costs included in the model were\noperative costs in terms of hospital costs,\nequipment and staffing for the two procedures and\nhospital stay. Differences in hospital stay [weighted\nmean difference (WMD) \u20130.5 days, p \u0001 0.01] and\noperation duration (WMD \u20133.70 minutes, p \u0001 0.01)\nExecutive summaryx\nboth favoured single mini-incision THR and were\ntaken directly from the meta-analysis conducted as\npart of the review of effectiveness. The\nmanagement costs of postoperative complications\nwere also included, such as the cost of a revision\nsurgery (\u00a37858) after a subsequent failure, the cost\nof reoperations, due to both dislocations (\u00a31925)\nand infections (\u00a33365) and the cost associated with\nmanaging DVT (which varied depending on\nseverity) and non-fatal pulmonary embolisms\n(\u00a31326). Long-term costs of care included the\nfollow-up of patients in consultant-led outpatient\nvisits (\u00a3103 per visit) and the management costs of\nthose patients whose surgeries have failed and who,\ntherefore, are treated non-operatively for the\nremainder of their lives (annual cost \u00a3743).\nUtilities data were sourced to estimate quality-\nadjusted life-years (QALYs) and therefore utilities\nwere also assigned to the main quality of life\noutcomes included in the model, such as success\n(0.75), failure (0.33) and the utility associated with\nvarious complications. Due to lack of data, no\neconomic analysis was conducted for the two mini-\nincision surgical method. \nResults\nNumber and quality of studies, and\ndirection of evidence\nFifty-five reports describing 42 studies were\nidentified. Of these, 32 studies (nine RCTs, 17\nnon-randomised comparative studies and six case\nseries and one registry) were useful for the\ncomparison of single mini-incision THR with\nstandard THR. One RCT compared two mini-\nincision THR with standard THR and nine studies\n(two RCTs, five non-randomised comparative\nstudies and two case series) compared two mini-\nincision with single mini-incision THR. The RCTs\nwere of moderate quality. The majority had fewer\nthan 200 patients (range 20\u2013219). The majority \nof comparative studies comparing single \nmini-incision with standard THR (four RCTs, \n12 non-randomised) and those comparing the \ntwo mini-incision THR with single mini- or\nstandard THR (one RCT, three non-randomised)\nhad a follow-up period of less than 1 year. \nSummary of benefits\nThe single mini-incision THR may have some\nperioperative advantages, namely less blood loss\n(WMD \u201357.71 ml, p \u0001 0.01) and shorter operative\ntime, of uncertain practical significance. The mini-\nincision approach may also offer a shorter recovery\nperiod and greater patient satisfaction with the\noperation and scar appearance. Evidence on long-\nterm outcomes (especially revision) is too limited\nto be useful. Subgroup analysis was not possible\ndue to lack of suitable data.\nWith respect to the two-incision approach, data\nwere suggestive of shorter recovery compared with\nsingle-incision THR, although the data were not\nin a form amenable to meta-analysis. As data were\nsparse, conclusions must be treated with caution. \nCosts\nThe costs to the health service, per patient, of\nsingle mini-incision THR depends on the\nassumptions made, but are similar (\u00a37060) to\nstandard THR, which costs the NHS, on average,\n\u00a37350 per patient. In the base-case analysis, the\ncost difference between standard and single mini-\nincision THR for a 1-year time horizon was\napproximately \u00a3300 less per patient than standard\nTHR (for the 40-year time horizon the costs were\n\u00a311,618 for mini-incision and \u00a311,899 for\nstandard THR).\nCost-effectiveness\nTwo existing economic evaluations were identified,\nbut they added little, if any, value to the current\nevidence base owing to their limited quality. In the\neconomic model, mini-incision THR was less costly\nand provided slightly more QALYs and therefore\ndominated standard THR, in both the 1- and 40-\nyear analyses. The mean QALYs at 1 year were\n0.677 for standard THR and 0.695 for mini-incision\nTHR. At 40 years, the mean QALYs were 8.463 for\nstandard THR and 8.480 for mini-incision. The\nprobabilistic sensitivity analyses conducted indicate\nthat mini-incision THR has a 95% probability of\nbeing cost-effective at threshold values of up to\n\u00a350,000 for society\u2019s willingness to pay for a QALY.\nThis probability is reduced to approximately 55%\nfor the 40-year analyses. The cost-effectiveness\nresults were driven by the assumption of a 1-month\nearlier return to usual activities and a decreased\nhospital length of stay and operation duration\nfollowing mini-incision THR. \nSensitivity analyses\nAlthough it appeared that mini-incision THR was\nassociated with a shorter recovery, the precise\nreduction could not be estimated, so a threshold\nanalysis was performed around time to return to\nusual activities following mini-incision THR. This\nanalysis was conducted for the base-case model\nand a model assuming more intensive use of\nresources for mini-incision patients. In terms of\nthe base-case model, as mini-incision THR is less\nExecutive summarycostly than standard THR, mini-incision continued\nto dominate standard THR. When increased\nresource use was assumed for mini-incision\ncompared with standard THR (mini-incision THR\nis approximately \u00a3200 more expensive than\nstandard THR in this analysis), then provided that\nrecovery was 1.5 weeks faster, the incremental \ncost-effectiveness per QALY would be \u00a330,000 \nor less. \nOne major area of uncertainty is in risk of\nrevision. Initially it was assumed that revision rates\nin the long-term would be equal (with wide CIs). \nA threshold analysis around risk of revision\nshowed that if society would be willing to pay\n\u00a330,000 for a QALY, mini-incision THR would\nhave to be associated with a 7.5% increase in\nrevisions compared with standard THR for it to be\nno longer considered cost-effective (one more\nrevision for every 200 procedures performed). \nFurther sensitivity analysis involved relaxing\nassumptions of equal long-term outcomes where\npossible. Data produced by the meta-analysis in\nrelation to postoperative dislocation [odds ratio\n(OR) 1.72, 95% CI 0.43 to 6.92] favouring\nstandard THR, and DVT (OR 0.39, 95% CI 0.12\nto 1.30), favouring mini-incision THR, were\nutilised in this sensitivity analysis. Broadly similar\nresults to the base-case analysis were found in this\nand further sensitivity analyses. \nLimitations of the calculations\n(assumptions made)\nMuch of the information available was reported in\na form unsuitable for meta-analysis. Few data were\navailable for many outcomes, including revision\nrates. Lack of standardisation in outcome\nmeasures was also evident and some outcomes\nwere assessed in only one or two reports. The\nextent of the imprecision surrounding estimates\nwas such that many of the meta-analysis results\nwere not included in the base-case model (risk of\nrevision, postoperative dislocation, DVT and PE).\nConsequently, these outcomes in relation to mini-\nincision are assumed to have, on average, equal\nrelative effect sizes compared with standard THR\n(but with wide CIs). This represents an analyst\nassumption and is a limitation of the data inputs\nused by the model. Further limitations related to\nthe estimates of costs and the impact that minimal\nincision THR had on QALYs in both the short and\nlong term. In terms of utility, very few comparative\nand short-term data were available. Cost data\nwould be greatly enhanced if they were collected\nwithin a full economic evaluation, alongside a\nclinical trial, for example.\nOther important issues regarding\nimplications\nIf the use of MIS were increased from its current\nlevel of 6% of all THRs to 25% of all THRs, then\nNHS costs may reduce by \u00a34.1 million per year.\nThese savings depend on judgements made about\nthe relevance in reality of reductions in operation\ntime, length of stay, the need for little extra\nspecialised equipment and whether differences\nexist in longer term outcomes. \nThe increased adoption of mini-incision\ntechniques may allow an earlier return to usual\nactivities, which, in turn, reduces loss of income or\nneed for informal care by family and friends.\nHowever, few patients currently have access to\nminimal incision THR and more surgeons would\nneed training in this approach, which would be\ncostly and take time to achieve. Furthermore, not\nall patients are clinically suitable. \nNotes on the generalisability of the\nfindings\nOnly two of the nine trials were conducted in the\nUK. No data were available to conduct any\nworthwhile subgroup analysis. No UK economic\nstudies were identified. \nConclusions\nCompared with standard THR, minimal incision\nTHR has small perioperative advantages in terms\nof blood loss and operation time. It may offer a\nshorter hospital stay and quicker recovery. It\nappears to have a similar procedure cost to\nstandard THR, but evidence on its longer term\nperformance is very limited.\nFurther data are needed to assess long-term\noutcomes of single mini-incision or two mini-\nincision THR before robust decisions can be\nmade. Further long-term follow-up data are also\nrequired on costs and outcomes.\nRecommendations for further research\nNo useful data on long-term outcomes of single\nmini-incision or two mini-incision THR were\navailable. Such data are required before robust\ndecisions can be made. The sparse effectiveness\ndata limit subsequent economic analysis. Further\nlong-term follow-up data on costs and outcomes\nincluding analysis of subgroups of interest to the\nNHS (e.g. obese or muscular patients, patients\nwith significant bone deformity or severe\nosteoporosis and patients who present as\nemergency cases) would strengthen the current\nHealth Technology Assessment 2008; Vol. 12: No. 26\nxi\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.economic evaluation. The economic evaluation\nwould also be strengthened by the collection of\ncosts on long-term events and management, such\nas failure. In relation to utilities, short-term\ndifferences in recovery are required, in addition to\nlong-term differences in outcomes which depend\non both subsequent failures and differences in\nquality of life, caused by long-term implications of\ndifferent degrees of dissection. If a large RCT\naddressing long-term effectiveness is conducted in\nthe future, it is strongly recommended that a full\neconomic evaluation be incorporated as an\nintegral part of the study from design to\ndissemination. Further careful work would be\nrequired to explore the value of such a large RCT\nmore formally.\nExecutive summary\nxiiDescription of underlying health\nproblem\nIntroduction\nHip replacement has been described as \u201cthe\noperation of the (20th) century\u201d1 and it has\nbecome outstandingly successful in relieving pain\nand disability. It is estimated that over 80,000\nprimary hip replacements are now performed\nannually in the UK.2,3\nThe usual indication for the procedure is arthritis\nof the hip, most commonly osteoarthritis, but\ninflammatory arthropathies such as rheumatoid\narthritis may provide indications. Occasionally it\nmay also be undertaken for other pathologies \nsuch as fracture or tumour, or deformity \nsecondary to childhood hip disease. Osteoarthritis\naffects all the tissues in a joint, with the most\nmarked effects on the articular cartilage (which\nmay be damaged and destroyed) and the\nunderlying bone (which may become thickened\nand sclerotic). The joint surface becomes irregular\nand the joint space is reduced. Osteophytes (spurs\nof bone) form around the joint in an attempt at\nrepair. The result is pain, stiffness, deformity and\nloss of function, such as a reduced walking\ndistance and a limp. Total hip replacement (THR)\ninvolves exposing and dislocating the hip joint,\npreparing the cup-shaped acetabulum in the\npelvis by excising any osteophytes, reaming the\nsurface to remove remaining articular cartilage\ndown to subchondral bone and inserting an\nartificial cup with or without cement. The\nproximal femur is usually prepared by excising\nand discarding the head of the femur and\ninserting a metal stem with a ball top into the\nmedullary canal of the proximal femur, again with\nor without cement. \nMany variations of the operation exist, with\ndifferences in the design of the implants and their\ncomposition (metal, plastic, ceramic), and whether\nthey are inserted with bone cement or not\n(cementless THR). There are also different\ncombinations of the implants, producing different\nbearing surfaces (metal or ceramic-on-plastic;\nmetal-on-metal; ceramic-on-ceramic). Whatever\nimplant is chosen, the surgeon should follow the\nguidance from the National Institute for Health\nand Clinical Excellence (NICE)4,5 and the\nOrthopaedic Device Evaluation Panel (ODEP).6\nResurfacing arthroplasty has returned as a possible\noption. The head of the femur is prepared and a\nlarge-diameter metal cap is fitted, which\narticulates with a thin-walled metal cup implanted\nin the acetabulum. These methods were\nconsidered by NICE in 2001, but few data were\navailable.7 More recently, it has been reported that\nwith improved metallurgy and implant finishing,\nthese prostheses seem to be functioning well.8\nHowever, long-term results are awaited. It is\nreserved for more active younger patients with\ngood bone stock and has the attraction that\nsubsequent revision, if required, may be simpler. \nEpidemiology\nOsteoarthritis is the single biggest cause of\nlocomotor problems, and the commonest joint\ndisease, in the UK and was the diagnosis in 94%\nof THR operations in England and Wales in\n2005.3 Its incidence increases with age, and THR\nis more commonly performed on this older\npopulation (average age 68 years), approximately\n60% of whom are women.3 However, with\nimprovements in anaesthesia, older patients with\nmedical co-morbidities may have surgery. With\nimprovements in implant design and longevity,\nincreasing numbers of younger patients are also\nnow considered for hip replacement (in 2005 12%\nwere aged less than 55 years).3 The principal\nindication for surgery remains pain. \nCurrent service provision\nThe National Joint Registry (NJR) for England\nand Wales holds information on hip and knee\nreplacement procedures performed in the NHS\nand the independent sector in England and Wales\nsince 2003.3,9,10 In 2005, the NJR recorded an\nestimated 77% (124,036) of all hip and knee joint\nreplacement procedures carried out in England\nand Wales, compared with 60% (93,885) in 2004\nand 51% (46,798) in 2003. \nA total of 61,881 hip replacement procedures were\nrecorded on NJR in 2005. This represents a 1-year\nincrease of 26% from 48,987 in 2004 and a 2-year\nHealth Technology Assessment 2008; Vol. 12: No. 26\n1\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nChapter 1\nBackgroundincrease of 148% from 24,997 in 2003, which is\nlikely to reflect improved reporting to the registry\nrather than a true increase in the number of\nsurgical procedures. \nAbout 90% (55,812) of hip replacement\nprocedures recorded in 2005 were performed as\nprimary procedures and the majority of these\nprocedures used cement (Table 1). The other 10%\nwere revisions (5769) and re-operations (300).\nCurrently, only a very small subset of revisions and\nre-operations can be linked to the primary\noperation data captured by NJR. Since at least\n90% of hip implants are expected to last 10 years\nor more, fewer revision procedures are likely to\noccur before that time. \nUse of minimally invasive surgery (MIS) was\nreported in 6% of primary THRs in 2005, an\nincrease of 2% over 2003 (Table 2). It is worth\nnoting, however, that 14% of the procedures were\nalso recorded as having a short incision length of\n10 cm or less in the same year. Although not\nshown in the table, in 2005, 9% of those not\nclassified as minimally invasive had a short\nincision length (\u000210 cm), and 24% of those\nclassified as minimally invasive had a long incision\nlength (>10 cm). This reflects inconsistency in the\ndefinition of MIS. \nIn Scotland, the number of THRs recorded in the\nScottish Arthroplasty Project2 has been increasing\nsteadily over the last decade and especially since\n2002. In 2004\u20135, around 86% (4823) of Scottish\nTHRs were primary procedures, whereas 14%\n(753) were revision procedures. No data are\navailable on the number of MIS for THRs\nperformed in Scotland. \nOutside the UK, the Norwegian Arthroplasty\nRegister11 reported a lower rate of MIS (2% of\n6566 primary hip replacements) performed in\n2005, compared with that recorded in England\nand Wales. On the other hand, the Canadian Joint\nReplacement Registry12,13 recorded a higher rate\nof MIS for hip replacements: 9% of 12,474 hip\nreplacements (including revisions) in 2003\u20134 and\n12% of 14,307 hip replacements (including\nrevisions) in 2004\u20135. Almost all minimally invasive\nprocedures (99%) were primary procedures, rather\nthan revisions. The proportions of MIS were\nsignificantly higher among males than females\n[odds ratio (OR) 1.12, 95% confidence interval\n(CI) 1.02 to 1.24], but significantly lower among\npatients who were overweight and obese than\nthose who were underweight or normal weight\n(22% versus 34%). The use of a minimally invasive\nprocedure was not associated with patients\u2019 age.\nAfter adjusting for other factors, females and\noverweight or obese patients were still significantly\nless likely to receive MIS.\nDescription of new intervention\nOutline of the procedure\nMinimal incision hip arthroplasty continues a\ngeneral trend towards less invasive approaches,\nboth in orthopaedics14 and other surgical\nspecialties.15 Historically, the concept arose in\nNorth America, where the typical incision length\nhad perhaps been rather longer than in Europe.16\nMinimal incision THR is not a uniform procedure,\nbut is performed with significant variations\nBackground\n2\nTABLE 2 MIS in primary hip replacement procedures in England and Wales, 2003\u201320053,9,10\n2003 2004 2005\nPrimary hip replacement 22,672 44,262 55,812\nMinimally invasive\nYes 883 (4%) 2733 (6%) 3124 (6%)\nNo 21,779 (96%) 39,528 (94%) 47,437 (94%)\nIncision length\n\u000210 cm NR 4390 (17%) 6448 (14%)\n>10 cm NR 21,678 (83%) 40,605 (86%)\nNR, not reported.\nTABLE 1 Primary hip procedures in England and Wales, 20053\nProcedure type N %\nCemented THR 28,602 51\nCementless THR 13,955 25\nHybrid or reverse hybrid THR 8232 15\nPrimary resurfacing 2746 5\nOther 2277 4\nTotal 55,812 100between surgeons. Approaches, however, fall into\nthree main groups. Of these, the so-called \u2018double\nincision\u2019 or two-incision approach can be regarded\nas novel and specific to MIS, whereas the\nanterolateral and posterior approaches are\nessentially developments of traditional approaches\nperformed through smaller incisions. Further\nvariation within these groups will depend on the\nprecise surgical interval used, the extent of the\ndeep dissection (which may or may not be less\nthan with conventional surgery) and the use or\notherwise of instruments specially designed for\nminimally invasive procedures. Minimal incision\ntechniques can be used for the implantation of\ncemented, cementless or hybrid (cemented stem\nand cementless cup) prostheses.\nThe two-incision technique17 is performed with\nthe patient supine and, unlike other minimal\nincision approaches, X-ray fluoroscopy is required\nthroughout the procedure. A short incision is\nmade anterior to the femoral neck and the hip\napproached by means of medial retraction of the\nsartorius and rectus femoris muscles and lateral\nretraction of tensor fascia lata. The lateral\ncircumflex vessels are coagulated and the femoral\nhead and neck resected after a capsulotomy.\nLighted angled retractors are used to obtain\nacetabular exposure, allowing for preparation and\ncup implantation. A second incision is then made\nlaterally above the greater trochanter and\ndeepened to form a track through which the\nfemoral instrumentation can be inserted. After\nfemoral preparation and trial reduction, the\ndefinitive femoral component is implanted.\nThe posterior (or posterolateral) approach is a\nminimal incision adaptation of the approach\noriginally described by Moore.18 The patient is\npositioned laterally and an incision made along\nthe posterior edge of the greater trochanter and\ndeepened through the gluteal fascia. Obturator\ninternus and the gemelli muscles are divided close\nto their insertions, with or without piriformis\nsuperiorly and part of quadratus femoris inferiorly.\nCare is taken to avoid injury to the nearby sciatic\nnerve and a capsulotomy is performed, allowing\ndislocation and resection of the femoral head.\nWith appropriate retraction and positioning of the\nleg, acetabular and subsequently femoral\npreparation and implantation can be performed.\nMinimal incision anterolateral (or anterior)\napproaches are usually derivates of the \nHardinge approach,19 or sometimes the Watson-\nJones approach.20 The patient may be positioned\nsupine or more commonly laterally. A skin incision\nis made over the anterior part of the greater\ntrochanter and again deepened through fascia\nlata. With the Hardinge-type approach the\nanterior parts of gluteus medius\/minimus and\nvastus lateralis are reflected subperiosteally. The\nWatson-Jones variation is performed more\nanteriorly between tensor fascia lata and gluteus\nmedius. Capsulotomy and dislocation\/resection of\nthe femoral head allow acetabular and femoral\nexposure for the procedure to be performed. The\nanterior Smith Peterson approach has also been\nused in hip surgery, although perhaps it is\nrelatively rarely used in hip replacement.\nCriteria for treatment\nThe indications for minimal incision THR are the\nsame as that for standard THR, namely severe\npain due to primary or secondary degenerative\nconditions of the hip joint which does not respond\nto conservative treatment.21 Degenerative\nconditions necessitating hip replacement may\ninclude primary and secondary osteoarthritis,\ninflammatory arthritis and the consequences of\nosteonecrosis and metabolic bone conditions. Hip\nfracture and tumour are additional indications for\nTHR, but these conditions fall outside the scope\nof this review.\nIt has been claimed that the majority of patients\nsuitable for THR are theoretically suitable for\nminimal incision procedures,17 depending on the\nparticular expertise of the operating surgeon and\nthe facilities available. Contraindications suggested\nfor the use of minimal incision techniques,22\nhowever, include:\n\u25cf obese or excessively muscular patients\n\u25cf patients with abnormal anatomy requiring\ncomplex reconstruction (due, for example, to\nsevere developmental hip dysplasia, acetabular\nerosion or previous fracture)\n\u25cf previous hip surgery\n\u25cf bone weakness, such as osteoporosis.\nPersonnel involved\nFor a single minimal incision THR, substantially\nthe same staff are required for the operation. The\nprecise configuration of staff is described in more\ndetail in Chapter 5. However, it has been\nsuggested that an additional nurse may be\nrequired during the procedure. Additionally, a\nfurther outpatient appointment may be required\nduring patient follow-up, although the need for\nthis may decline, as experience and confidence\nwith the technique improve. Again, the impact of\nthe addition of an extra outpatient visit is\ndiscussed further in Chapter 5.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n3\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.For the two-incision approach, few data are\navailable to determine the staff required.\nNevertheless, it is likely that for the operation the\nsurgical team will be similar to that for standard\nTHR. However, additional personnel will be\nrequired to provide the additional imaging\nneeded for the two-incision approach.\nSetting and equipment required\nBoth the minimal incision and the standard\ntechniques can be performed in the same setting\nusing the same prostheses. The single minimal\nincision THR can be performed with the same\nequipment as a standard THR, although\nspecialised equipment such as angled retractors\nwith a light source and other customised\ninstruments are available to expose the hip, to\nprepare the socket and to insert prostheses. The\nlikely purchase cost for such equipment is\napproximately \u00a33000 but, as the equipment is\nreusable, this equates to an additional cost of\napproximately \u00a313 per patient (note: many\nmanufacturers will supply the instrumentation free\nof charge if their implant is being used). \nThe two-incision approach typically requires\nspecialised equipment and prostheses which are\nmarketed by specific manufacturers as a package.\nAs noted above, additional X-ray fluoroscopy\nguidance is recommended to aid positioning of\ninstruments and prostheses during the procedure.\nFurther, computer-assisted navigation tools may\nalso be used for both minimal incision (single or\ndouble) and standard THR. \nDegree of diffusion\nConcern has been raised that commercial\npressures and direct to consumer marketing rather\nthan clinical evidence were largely responsible for\nits initial spread in popularity.23,24 The current\nguidance by NICE on the safety and efficacy of\nsingle mini-incision surgery for THR states that it\n\u201cshould only be used in appropriately selected\npatients by clinicians with adequate training in this\ntechnique\u201d.5 The NICE guidance on the safety\nand efficacy of two-incision surgery for THR states\nthat, owing to lack of evidence of this procedure, it\nshould not be used \u201cwithout special arrangements\nfor consent and for audit or research\u201d.4 In this\nregard, the NICE guidance recommends clinicians\nundertaking two-incision surgery to \u201cinform the\nclinical governance leads in their Trusts\u201d and to\n\u201censure that patients understand the uncertainty\nabout the procedure\u2019s safety and efficacy and\nprovide them with clear written information\u201d and\nalso to \u201chave adequate training before performing\nthis procedure\u201d. \nAnticipated costs\nThe current use of mini-incision THR is low but\nthere is the potential for its use to increase\ndramatically. The anticipated costs of mini-incision\nTHR surgery based on different degrees of\ndiffusion are illustrated in Table 3. The total direct\ncosts to the NHS for a follow-up period of\n3 months after surgery are based on mean costs of\n\u00a37345 and \u00a37064 for standard and single mini-\nincision THR, respectively (the methods used to\nestimate these costs are described in Chapter 5).\nThe number of hip replacements per year is based\non the data for 2005 reported in Table 2.\nThese projections suggest that if the use of\nminimally invasive THR increased to a relatively\nmodest 10% from the 6% figure quoted in Table 2,\nthen the total cost to the NHS in England and\nWales would decrease by approximately \u00a3826,300\nper year. However, these estimates are subject to\nconsiderable uncertainty. First, the costs of both\nstandard and mini-incision THR are not known\nprecisely. Second, the calculations have assumed a\nfixed operation cost and therefore have not\nconsidered whether the unit cost of aspects such as\nspecialist instrumentation used for mini-incision\nTHR would change as diffusion increases. Finally,\nthese figures do not reflect the cost of training the\nincreased numbers of surgeons required to\nperform the additional operations.\nBackground\n4\nTABLE 3 Cost of surgery for primary THR\nProportion of total THRs performed  NHS cost  Reduction in cost below the cost \nminimally invasively (%) (\u00a3 million) of current provision (\u00a3000)\n5.0 431.1 826.3\n10.0 430.3 1,652.6\n15.0 429.5 2,478.9\n20.0 428.7 3,305.2\n25.0 427.8 4,131.5T\nhe aim of this study was to assess the relative\neffectiveness and cost-effectiveness of \n(1) single mini-incision THR compared with\nstandard THR and (2) two mini-incision THR\ncompared with standard THR or single mini-\nincision THR (as the quantity of data available was\nexpected to be limited). It was hypothesised that\nthe mini-incision approaches may involve less soft\ntissue dissection that would facilitate shorter\nrecovery. The smaller incision may lead to poorer\nvisualisation of the hip, however, and this may\nlead to higher revision rates.\nAs described in Chapter 1, patients receiving either\nminimal incision or standard THR follow a similar\npathway of care. However, there is uncertainty\nsurrounding minimal incision compared with\nstandard incision performance in terms of:\n\u25cf short- and long-term clinical performance\n\u25cf short- and long-term safety\n\u25cf resource use and costs\n\u25cf patient-centred measures such as quality of life\n\u25cf cost-effectiveness.\nFor single mini-incision THR, this study sought to\naddress the following questions:\n1. Short- and long-term clinical performance:\n(a) Does single minimal incision THR\ncompared with standard THR provide\nbetter outcomes\n(i) in terms of clinical effectiveness\nmeasures of surrogates for long-term\noutcomes (implant position, implant\nmigration, heterotopic ossification and\ncement quality)?\n(ii) in terms of long-term measures of\ntreatment success (revision rates, time\nto revision, dislocation rates and limb\nlength inequalities)? \n2. Short- and long-term safety\n(b) How does single minimal incision THR\ncompare with standard THR with respect to\nblood loss, intraoperative fractures,\nperiprosthetic fractures and various\ncomplications, such as wound infections,\nnerve injuries, vascular injuries and the risk\nof thrombosis [deep vein thrombosis (DVT)\nand pulmonary embolism (PE)]?\n3. Resource use and costs\n(c) Is single minimal incision THR compared\nwith standard THR:\n(i) associated with a shorter operation\ntime and length of stay? \n(ii) less costly when differences in\noperation time, length of stay, \nstaffing and equipment are taken into\naccount?\n(iii) less costly when differences in the \ncosts of treating revisions and other\nlong-term events are taken into\naccount?\n4. Patient-centred measures such as quality of life\n(d) Does single minimal incision THR\ncompared with standard THR improve:\n(i) the short-term quality of life \n(measured in terms of postoperative\npain, use of pain relief, return to usual\nactivities and formal measures of\nquality of life)?\n(ii) long-term quality of life (measured in\nterms of long-term pain, functional\nresults, mortality and formal measures\nof quality of life)?\n(iii) patient satisfaction?\n(iv) quality of life as measured by QALYs\nwhen differences in speed of recovery\nand longer term outcomes including\ncomplications are accounted for?\n5. Cost-effectiveness\n(e) Is single minimal incision THR compared\nwith standard THR cost-effective as judged\nagainst standard decision rules on how\nmuch an extra unit of outcome (i.e. a\nQALY) is worth to society?25\nIn addition to these questions, the performance of\nsingle minimal incision THR may vary according\nto the experience of the surgeon and by the\ncharacteristics of the patients selected for surgery.\nTherefore, if possible, the differences in the\noutcomes were reconsidered in the light of\nevidence on:\n\u25cf experience of the surgeon\n\u25cf characteristics of the patient (obese; muscular;\nhave significant bone deformity or severe\nosteoporosis; and who present as emergency\ncases).\nHealth Technology Assessment 2008; Vol. 12: No. 26\n5\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nChapter 2\nThe decision problemThese subgroups were chosen because, as\ndescribed in the section \u2018Criteria for treatment\u2019\n(p. 3), it has been argued that surgeon expertise\nmight influence outcomes and it has been\nsuggested that minimally invasive THR may be\ncontraindicated in these patients.\nFor the comparison of two mini-incisions THR\nwith standard or single mini-incision THR, an\nattempt was made to address the same questions\nas set out above. \nChapter 3 reports the methods used and results\nobtained for the questions on short- and long-\nterm clinical performance, short and long-term\nsafety, and question (c)(i) for \u2018resource use and\ncosts\u2019 and questions (d)(i) and (d)(ii) for \u2018patient-\ncentred measures\u2019. Chapters 4 and 5 address the\nremaining questions under \u2018resource use and costs\u2019\nand \u2018patient-centred measures\u2019 and address the\ncost-effectiveness question. The questions relating\nto the subgroups and the two incision approach\nwill be addressed where data will be available in\nthe relevant subsections of Chapters 3, 4 and 5. \nThe decision problem\n6Methods for reviewing\neffectiveness\nSearch strategy\nThe search strategy involved searching \nelectronic databases and relevant websites, \ncontact with experts in the field and scrutiny of\nbibliographies of retrieved papers. Extensive\nelectronic searches were conducted to identify\nreports of published and ongoing studies on \nthe effectiveness of minimal incision THR.\nSearches were carried out for both full papers \nand conference abstracts and there were no\nlanguage restrictions in this search of titles and\nabstracts. The databases searched were \nMEDLINE (1966\u2013February Week 3 2007),\nMEDLINE In-Process (1 March 2007), EMBASE\n(1980\u20132007 Week 8), BIOSIS (1985\u20131 March\n2007), Science Citation Index (1985\u20132 March\n2007), Cochrane Controlled Trials Register (The\nCochrane Library, Issue 1, 2007) and current\nresearch registers (National Research Register,\nIssue 4, 2006), Current Controlled Trials\n(December 2006) and Clinical Trials (December\n2006)). Additional databases searched for\nsystematic reviews and other background\ninformation included the Cochrane Database of\nSystematic Reviews (The Cochrane Library, Issue\n1, 2007), Database of Abstracts of Reviews of\nEffectiveness (December 2006), HTA Database\n(December 2006) and Health Management\nInformation Consortium (1979\u2013January 2007).\nFull-text searching of key surgical journals\n(American and British editions of the Journal of\nBone and Joint Surgery, Journal of Arthroplasty and\nClinical Orthopaedics and Related Research, all from\n2000 to February 2007) was also undertaken.\nRecent relevant conference proceedings and\nreference lists of all included studies were \nscanned to identify additional potentially relevant\nstudies. Websites of national orthopaedic \nregistries were searched, and also both key\nprofessional organisations (including the \nAmerican Association of Orthopaedic Surgeons,\nBritish Orthopaedic Association and British Hip\nSociety) and manufacturers (DePuy International,\nSmith and Nephew, Stryker Howmedica and\nZimmer). Full details of the search strategies \nused and websites consulted are documented in\nAppendix 1.\nAll titles and abstracts identified in these ways\nwere assessed to identify potentially eligible\nstudies. Two reviewers independently assessed\nthem for inclusion, using a study eligibility form\ndeveloped for this purpose (Appendix 2). Any\ndisagreements were resolved by discussion.\nInclusion and exclusion criteria\nTypes of studies\nAll randomised controlled trials (RCTs) and quasi-\nRCTs were included. Prospective non-randomised\nstudies with concurrent comparisons and matched-\npair studies, irrespective of duration of follow-up,\nwere also included. Retrospective comparative\nstudies were eligible only if there was clear\nevidence of prospective design, consecutive series\nor total population recruitment. Additionally, case\nseries or single cohort studies with two or more\nsurgeons with a minimum follow-up of 1 year, and\nsingle-surgeon case series with a minimum follow-\nup of 3 years, and where a report was available in\nfull text were included. We also included data from\nnational registries where these registries provided\nlong-term outcomes such as revision rates. Studies\nor reports reported in a language other than\nEnglish, Chinese or Japanese were excluded after\nfull-text copies of all potentially relevant reports\nwere obtained. \nTypes of participants\nAll adults eligible for standard THR for arthritis\nwere included. Studies that focused solely or\nprimarily on patients undergoing total hip\narthroplasty for other reasons, such as\nosteoporosis, fracture or tumour, were excluded. \nTypes of interventions\nWe included studies of single mini-incision\nprimary THR compared with standard primary\nTHR. Additionally, we also considered two-incision\nprimary THR compared with either standard\nprimary THR or single mini-incision primary\nTHR. Revision surgery, hip resurfacing or\ncomputer modelling surgery were excluded.\nTypes of outcomes\nThe following measures of outcomes were sought. \nClinical performance:\n1. revision rates\nHealth Technology Assessment 2008; Vol. 12: No. 26\n7\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nChapter 3\nEffectiveness2. time to revision \n3. dislocation\n4. surrogates for long-term outcomes\n(a) implant position (radiographic analysis)\n(b) implant migration (radiostereometric\nanalysis)\n(c) heterotopic ossification\n(d) cement quality\n5. limb length inequality.\nSafety:\n1. blood loss\n2. intraoperative fracture \n3. periprosthetic fracture \n4. wound infection\n5. nerve injury\n6. vascular injury\n7. DVT and PE.\nResource utilisation:\n1. duration of surgery \n2. length of hospital stay.\nPatient-centred measures:\n1. 30-day mortality \n2. long-term mortality\n3. pain relief \n4. postoperative pain\n5. long-term pain\n6. time to return to usual activities\n7. functional result, e.g. Harris Hip, Mayo,\nOxford Hip and Charnley Scores\n8. health-related quality of life\n9. patient satisfaction.\nOther:\n1. operating theatre throughput\n2. opposite method initiated (preoperatively)\n3. conversions to alternative procedure\n(intraoperatively) and reasons for conversion.\nOpposite method initiated was defined as a\nminimal incision THR initiated when a standard\nTHR was randomly allocated, or vice versa.\nDuration of operation was defined as time from\nfirst incision to last suture or, where this was not\navailable, time in theatre or duration of\nanaesthesia. Length of hospital stay was defined as\ntime from admission to discharge. Conversion was\ndefined as a procedure initiated as minimal\nincision but converted to a standard THR\nintraoperatively.\nData extraction strategy\nFull-text copies of all potentially relevant reports\nwere obtained. Two reviewers independently\nselected studies for inclusion and extracted data\nusing a standard data extraction form\n(Appendix 3). Discrepancies were solved by\ndiscussion, with involvement of a third reviewer\nwhen necessary. The reviewers were not blinded to\nauthors, institutions or publication details. Where\nthere was insufficient information in the published\nreport, attempt was made to contact the authors\nfor clarification (one case).\nQuality assessment strategy\nMethodological quality of RCTs, quasi-RCTs and\ncomparative studies of other designs was assessed\nusing the Delphi criteria list (Appendix 4).26 Each\nstudy was assessed independently by two reviewers.\nAny disagreements were resolved through\ndiscussion.\nData synthesis\nQuantitative data syntheses were performed with\nthe trial data only. For trials with multiple\npublications, only the most up-to-date or complete\ndata for each outcome were included. The data\nfrom the comparative studies were not formally\ncombined in data synthesis to avoid the risk of\naccentuating possible systematic bias inherent in\nany non-randomised studies. To estimate a\nsummary measure of effect on relevant outcomes\nin the trial data, dichotomous outcome data were\ncombined using the Peto OR method, since there\nwere relatively few events reported for many of \nthe dichotomous outcomes. Continuous outcomes\nwere combined using the inverse variance\nweighted mean difference (WMD) method; \n95% CIs and p-values were calculated for the\nestimates of OR and WMD. The results were\nreported using a fixed-effects model. To explore\nstatistical heterogeneity across studies \u00032 tests \nand I2 statistics were used. Where there was\nevidence of heterogeneity, a random effects \nmodel was applied for continuous outcomes \nand also possible reasons for heterogeneity \nwere explored. Quantitative syntheses were\nperformed using the standard Cochrane software\nRevMan 4.2. \nOwing to a lack of uniformity of the data present\nin many studies, a qualitative review looking for\nconsistency between studies was performed. For\ncontinuous variables, this was supplemented by\ntwo additional analyses. First, where standard\ndeviations (SDs) were not reported by the authors,\nthey were estimated on the basis of available\ninformation on p-values (calculated SDs). This\napproach made the assumption that SDs are the\nsame in both arms of the trial. Where studies only\nreported p-values less than a certain value (e.g.\np < 0.05), we calculated SDs on the basis of a \nEffectiveness\n8p-value equal to that value (i.e. p = 0.05). Second,\nwhere information on p-values was also\nunavailable, SDs were estimated as the weighted\nmeans of SDs reported in the other studies which\ndid report data on the same outcome (dummy\nSDs) or where they could be inputed from \np-values. A judgement was made for each \noutcome as to which of the three analyses, \nnamely (1) reported means and SDs, (2) reported\nmeans and SDs with calculated SDs, (3) reported\nmeans and SDs with calculated and dummy SDs,\nshould be used as the base case. This judgement\nwas based on consideration of the nature and\npattern of missing data. The other analyses are\nreported in appendices. Where a quantitative\nsynthesis was considered to be inappropriate or\nnot feasible, a narrative synthesis of results was\nprovided. \nResults\nQuantity and quality of research\navailable\nNumber of studies identified\nThe results of the searches are summarised in\nTables 4 and 5. The numbers retrieved from the\nsearches in Science Citation Index, BIOSIS,\nCENTRAL and full-text journal searches include\nonly the additional reports found after excluding\nthose identified from the MEDLINE\/EMBASE\nmulti-file search. A total of 887 reports were\nidentified, of which 186 were selected for full\nassessment. \nNumber and type of studies included\nFifty-four papers (43 full text papers17,27\u201368 and 11\nabstracts69\u201379) met the inclusion criteria for the\nreview. In addition, relevant data were\nsupplemented by a published registry report\n(Norwegian Arthroplasty Register)11 and extra\ninformation from the registry holders\n(Espehaug B, Norwegian Arthroplasty Register:\npersonal communication; 5 January 2007). In\ntotal, 55 reports describing 42 studies [12 trials,\n22 non-randomised comparative studies and eight\ncase series (including registry data)] were\nidentified as relevant to the review. Of these,\n32 studies were useful for the comparison of single\nmini-incision with standard incision, including\nnine trials,31,32,40,43,46,58,69,75,77 17 comparative\nstudies,28\u201330,33\u201336,42,44,45,48,52,54\u201356,74,78 and six case\nseries or registry;11,39,41,49\u201351 one was used for the\ncomparison of two mini-incision THR with\nstandard THR (one trial)57 and nine were relevant\nto the comparison of two mini-incision with single\nmini-incision THR, including two trials,72,73 five\ncomparative studies38,47,53,71,79 and two case\nHealth Technology Assessment 2008; Vol. 12: No. 26\n9\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 4 Search results\nDatabase No. retrieved No. selected for assessment\nMEDLINE\/EMBASE\/MEDLINE In-Process multi-file search 552 104\n(after de-duplication in Ovid)\nSCI 61 11\nBIOSIS 28 3\nCENTRAL 4 0\nFull-text journals 19 4\nNRR 22 8\nCCT 24 3\nClinical Trials 4 4\nDARE 35 7\nHTA database 35 11\nHMIC 0 0\nConference abstracts 96 24\nRegistry Reports 7 7\nTotal retrieved 887 186\nCCT, Current Controlled Trials; DARE, Database of Abstracts of Reviews of Effects; HMIC, Health Management Information\nConsortium; NRR, National Research Register; SCI, Science Citation Index.\nTABLE 5 Paper selected for full assessment \nAssessment No. of papers\nIncluded in review 55\nRetained for background information 42\nExcluded 81\nUnobtainable 8\nTotal 186series.27,37 The list of included studies and\nassociated references is given in Appendix 5. In\naddition, 14 ongoing trialists were identified and\ncontacted for information. The list of ongoing\ntrials identified is given in Appendix 6. \nNumber and type of studies excluded, with\nreasons for specific exclusions\nA total of 81 reports were also obtained but did\nnot meet the inclusion criteria and were\nsubsequently excluded. Of these, four studies did\nnot use concurrent comparisons (i.e. had historical\ncontrols), 10 were retrospective studies and 18\nwere descriptive studies. Five studies only included\nparticipants who received THR for reasons other\nthan arthritis (e.g. fracture) and five studies\nprimarily focused on revision surgery. Seventeen\ndid not report relevant outcomes or did not have a\nsufficient length of follow-up (1 year for multiple-\nsurgeon case series and 3 years for single-surgeon\ncase series were required). The remaining 22\nstudies were excluded because they were reported\nin languages other than English, Japanese or\nChinese.\nStudy quality, characteristics and evidence rating\nfor RCTs and comparative studies\nTable 6 provides a summary of the methodological\nquality of the 12 trials and 22 comparative studies\nby type of intervention and study design. Details\nof the quality assessment are given in Appendix 7. \nSingle mini-incision procedure\nWith respect to the studies examining the single\nmini-incision procedure, randomisation was\nperformed in nine studies. In only three of these\nEffectiveness\n10\nTABLE 6 Summary of the methodological quality of the included trials and comparative studies\nCriteria One incision Two incisions\nTrials Comparative Trials Comparative\n1a. Was a method of randomisation performed?  Y 9 0 3 0\nN0 1 7 0 5\nU0 0 0 0\n1b. Was a method of sequence generation adequate? Y 3 0 2 0\nN3 1 7 0 5\nU3 0 1 0\n2. Was the treatment allocation concealed? Y 1 0 0 0\nN5 1 7 0 5\nU3 0 3 0\n3. Were the groups similar at baseline regarding the  Y 6 6 3 3\nmost important prognostic indicators? N 1 7 0 1\nU2 4 0 1\n4. Were the eligibility criteria specified? Y 6 12 1 3\nN3 5 2 2\nU0 0 0 0\n5. Was the outcome assessor blinded? Y 8 6 0 1\nN0 5 0 1\nU1 6 3 3\n6. Was the care provider blinded? Y 5 1 0 0\nN2 7 0 2\nU2 9 3 3\n7. Was the patient blinded? Y 4 2 0 0\nN1 1 0 0 3\nU4 5 3 2\n8. Were point estimates and measures of  Y 4 10 1 1\nvariability presented for the primary outcome  N 4 7 2 4\nmeasures? U 1 0 0 0\n9. Did the analysis include an intention-to-treat  Y 4 9 0 1\nanalysis? N 1 0 0 0\nU4 8 3 4\nN, no; U, unclear; Y, yes.studies was this considered to be adequate (e.g. \na computer-generated sequence, random number\ntables or a card drawn by the anaesthetist at the\ntime of surgery).31,46,58 Methods used for\nallocation concealment were considered\ninadequate (e.g. alternation, sealed envelopes) in\nfive studies31,32,40,43,46 and unclear in a further\nthree (which were abstracts or poster).69,75,77\nSix of the nine randomised trials reported that the\nintervention and comparison groups were similar\nat baseline,31,43,46,58,69,75 although the two groups\nwere not balanced in one,77 and it was unclear for\nthe other two.32,40 The criteria by which patients\nwere assessed as eligible for inclusion was not\ndescribed in three trials.43,69,77 All but one trial75\nreported that the outcome assessors were blinded.\nIt is questionable whether blinding of care\nproviders and patients is possible, given the nature\nof the intervention. Nevertheless, four\ntrials43,46,69,77 reported that both care providers\nand patients were blinded, and one further trial\nalso suggested that care providers were unaware of\nthe incision length.58 One of these studies\nreported that blinding was achieved by means of a\nstandard-length wound dressing.46 Point estimates\nand measures of variability were presented for the\nprimary outcome measures in just under half of\nthe studies.31,32,46,58 Four trials included an\nintention-to-treat analysis31,32,46,58 but it was\nunclear if this was the case in four.43,46,75,77\nOf the 17 (non-randomised) comparative studies\nexamining the single mini-incision procedure,\nonly six reported that the intervention and\ncomparison groups were similar at\nbaseline.33\u201336,44,74 The groups were dissimilar in\nseven studies,28,42,45,48,52,55,56 and it was unclear in\na further four.29,30,54,78 The eligibility criteria \nwere not described in five studies.29,36,48,74,78 In\ntwo-thirds of the studies, either the outcome\nassessors were not blinded30,33,34,42,48 or it was\nunclear if they were blinded.29,36,45,56,74,78 Only\none study reported that both care providers \nand patients were blinded: this was done by means\nof a standard-length wound dressing.28 One\nfurther study also suggested that patients were\nunaware of the incision length.52 Point estimates\nand measures of variability were presented \nfor the primary outcome measures in\n10 studies.30,34,36,42,44,45,52,54\u201356 An intention-to-treat\nanalysis was included in nine.28,34\u201336,44,45,48,52,55\nTwo-incision procedure\nIn respect of the eight studies examining the two-\nincision procedure, an adequate method of\nrandom sequence generation (computerised\nrandomisation) was performed in only two\nstudies.72,73 One further study reported that\npatients were randomised but did not provide\ninformation on the method of randomisation\nused.57 No information was available as to whether\ntreatment allocation was concealed in these\nstudies. In all three randomised studies57,72,73 and\nthe majority of non-randomised studies,38,47,71 the\nintervention and comparison groups were similar\nat baseline, although this was not the case for\none53 and unclear in another.79 Only half of the\nstudies described the patient eligibility\ncriteria.38,47,53,57 One study reported that the\noutcome assessor was blinded53 but none of the\nstudies reported blinding of the care provider or\npatient. Point estimates and measures of variability\nfor the primary outcome measures were presented\nin two,53,57 and only one study included an\nintention-to-treat analysis.47\nCharacteristics of included studies\nTable 7 provides a summary of the baseline\ncharacteristics of the participants in the included\ntrials, comparative studies and case series and\nregistry. This is described in more detail in\nAppendix 8. \nWithin the nine trials and 17 comparative studies\ncomparing single mini-incision and standard\nincision, there were 27 comparisons, as one non-\nrandomised comparative study divided the\nparticipants into three groups postoperatively\naccording to the incision length, namely mini-\nincision (<10 cm), midi-incision (10\u201314 cm) and\nstandard incision (>14 cm).52 The results of this\nstudy are presented as two comparisons, mini-\nincision versus midi-incision and mini-incision\nversus standard incision. Hip replacements were\nperformed through several approaches, including\nanterolateral, lateral, posterolateral, anterior and\nposterior. It is worth noting that in three\ntrials58,75,77 and one comparative study,48 the mini-\nincision procedure and the standard incision\nprocedure were performed through different\napproaches (e.g. mini-incision anterior approach\nversus standard incision lateral approach). A\nfurther three comparative studies did not provide\ninformation on the operative approaches\nused.54,74,78 This is a possible confounder,\ncomparing the potential effects of different\nsurgical approaches and also length of incision. \nThe sample sizes ranged from 2048,78 to 219,46\nwith only one trial46 and one comparative study29\nhaving 200 or more participants. The total\nnumber of participants was 979 in the trials\n(recruited between November 1999 and June\nHealth Technology Assessment 2008; Vol. 12: No. 26\n11\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Effectiveness\n12\nTABLE 7 Summary of the baseline characteristics\nStudy Comparator (operative  No. of  Age Sex (M\/F) BMI Comments\napproach, average  partici- (years)a\nincision length) pants\nOne incision\nRCT and quasi-RCT\nCharles, 200669b MI lateral 20 66.6 NR 25.8\nSI lateral 20 70.8 NR 25.2\nChimento, 200531 MI posterolateral, 8 cm 28 67.2 16\/12 25.2\nSI posterolateral, 15 cm 32 65.6 13\/19 24.8\nChung, 200432 MI posterolateral, 9.2 cm 60 61.0 24\/36 NR\nSI posterior, 20.0 cm 60 64.0 28\/32 NR\nHart, 200540 MI posterolateral, 9\u201310 cm 60 72.4 40\/80 27.6\nSI posterolateral, 20 cm 60\nKim, 200643 MI posterolateral, 8 cm 70 55.6 53\/17 25.6 Bilateral THRs (MI on \nSI posterolateral, 15\u201320 cm 70 one hip, SI on the other)\nOgonda, 200546 MI posterior, 9.5 cm 109 67.4 49\/60 28.2\nSI posterior, 15.8 cm 110 65.9 58\/52 28.9\nRachbauer, 200675b MI anterior 60 NR NR NR\nSI lateral 60 NR NR NR\nSharma, 200677b MI posterior 20 67.0 NR 26.5\nSI posterolateral, 12 cm 20 68.6 NR 24.4\nZhang, 200658 MI anterior, 7.9 cm 60 61.0 25\/35 NR\nSI posterolateral, 16.3 cm 60 62.5 28\/32 NR\nComparative studies\nAsayama, 200628 MI lateral, 8\u201310 cm 52 64.3 24\/28 26.1\nSI lateral, 15\u201320 cm 50 65.1 25\/25 28.7\nBerger, 200429 MI anterolateral, 8.3 cm 100 57.0 NR NR\nSI anterolateral, 15\u201320 cm 100 59.0 NR NR\nChen, 200630 MI posterior, \u000410 cmc 51 68.1 28\/23 NR\nSI posterior, 15\u201320 cm 95 69.8 54\/41 NR\nCiminiello, 200633 MI anterolateral, <12.7 cm 60 69.8 15\/45 23.8 Matched-pair study\nSI anterolateral, \u000412.7 cm 60 70.2 15\/45 24.1\nde Beer, 200434 MI lateral, 7.7 cm 30 71.0 10\/20 32.4 Matched-pair study\nSI lateral, 13.9 cm 30 69.0 10\/20 31.7\nDiGioia, 200335 MI posterior, 11.7 cm 33 65.0 19\/14 27.0 With image navigation; \nSI posterior, 20.2 cm 33 65.0 19\/14 28.0 matched pairs\nDorr, 200736 MI posterior, 9.6 cm 109 63.5 52\/57 26.7\nSI posterior, 17.9 cm 56 65.6 26\/30 26.4\nHowell, 200442 MI anterolateral 46 59.8 34\/16 26.2\nSI anterolateral 56 62.3 27\/30 28.8\nLi, 200544 MI posterolateral, 9.3 cm 18 NR 13\/5 24.6\nSI posterolateral, 16.8 cm 18 NR 14\/4 26.1\nO\u2019Brien, 200545 MI lateral, 10cm 32 67.0 19\/13 27.0\nSI lateral, >10 cm 51 67.0 25\/26 30.0\nPanisello, 200674b Mini-incision 40 NR NR NR\nClassic approach 40 NR NR NR\nPilot, 200648 MI anterior, 8.6 cm 10 67.9 4\/6 29.1\nSI posterolateral, 17.4 cm 10 67.5 2\/8 26.4\nSzendr\u00f3i, 200652 MI lateral, 8.8 cm 38 64.0 NR 26.0\n(MI\/MD) MD lateral, 12.6 cm 43 62.0 NR 28.0\nSzendr\u00f3i 200652 MI lateral, 8.8 cm 38 64.0 NR 26.0\n(MI\/SI) SI lateral, 16.1 cm 21 57.0 NR 29.5\ncontinuedHealth Technology Assessment 2008; Vol. 12: No. 26\n13\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 7 Summary of the baseline characteristics (cont\u2019d)\nStudy Comparator (operative  No. of  Age Sex (M\/F) BMI Comments\napproach, average  partici- (years)a\nincision length) pants\nTakahira, 200678b MI 7.5 cm 10 NR 3\/7 NR\nSI 13.8 cm 10 NR 1\/9 NR\nTeet, 200654 MI 10 cm 73 NR NR NR\nSI 17\u201322 cm 54 NR NR NR\nWoolson, 200455 MI posterior, \u000210 cmd 50 60.0 29\/21 25.1\nSI posterior, 15\u201325 cmd 85 63.0 31\/54 28.2\nWright, 200456 MI posterolateral, 8.8 cm 42 64.2 NR 24.4\nSI posterolateral, 23 cm 42 65.0 NR 28.3\nCase series and registries\nFl\u00f6ren, 200639 MI posterior 79 73.0 31\/48 NR Participants with min. \n10-year FU only\nHartzband, 200641 MI posterolateral 100 M61, F65 41\/57 NR\nPipino, 200449 MI lateral, 8\u201310 or 12\u201315 cm 368 60.0 220\/148 NR Single surgeon in two \nlocations\nSiguier, 200450 MI anterior, <10 cm 926 67.8 336\/590 NR\nSwanson, 200551 MI posterior, 8.8 cm 759 62.3 415\/585 26.5\nNorwegian Mini-incision 200 NR NR NR\nArthroplasty \nRegister 200611\nTwo-incision\nRCT and quasi-RCT\nPagnano 2007a72b Two-incision 10 NR NR NR\nMI posterior 10 NR NR NR\nPagnano 2007b73b Two-incision 36 66 20\/16 NR\nMI posterior 36 20\/16 NR\nYan, 200557 Two-incision 15 63.0 6\/9 NR\nSI posterolateral, 12 cm 15 61.0 7\/8 NR\nComparative studies\nDuwelius, 200738 Two-incision 43 57.4 24\/19 NR Matched-pair study\nMI posterior 43 59.1 24\/19 NR\nGreidanus, 200671b Two-incision 66 NR NR NR\nMini-incision 99 NR NR NR\nPagnano, 200647 Two-incision 26 69.0 10\/16 NR Staged bilateral THRs \nMI posterior, 6\u20139 cm 26 (2MI on one hip, MI on\nthe other)\nTanavalee, 200653 Two-incision 35 53.0 8\/27 25.0\nMini-posterior, 9 cm 35 54.9 20\/15 24.2\nYoon, 200579b Two-incision 100 NR NR NR\nMini-incision, 7.5 cm 118 NR NR NR\nCase series\nArchibeck, 200427 Two-incision 831 61 435\/396 26 159 trainee surgeons\nDuwelius, 200337 Two-incision 375 30-76 188\/112 NR 4 centres (4 surgeons)\nFU, Follow-up; MD, midi-incision; MI, mini-incision; 2MI, two-incision; NR, not reported; SI, standard incision.\na Age is mean or as reported by individual studies.\nb Abstract only.\nc Includes two-incision surgeries in 29% of the mini-incision group.\nd Incision length measured before the operation began.2004) and 1686 in the comparative studies\n(recruited between October 1998 and January\n2005). The range of average age of participants\nwas comparable between the trials and\ncomparative studies, between 55.643 and\n72.4 years40 in the trials, and between 57.052 and\n71.0 years34 in the comparative studies. There\nwere more female than male participants across\nboth trials (334 males versus 375 females) and\ncomparative studies (510 males versus 567\nfemales), excluding those studies which did not\nprovide information about gender\ndistributions.29,30,52,54,69,74,75,77 Within the trials,\nparticipants\u2019 body mass index (BMI) was similar\nbetween the mini-incision group and the standard\nincision group, except in one trial where it was\nhigher for the mini-incision group.77 However, in\nnine comparative studies, the BMI in the mini-\nincision group was lower28,33,35,42,45,52,55,56 and all\nbut two reported this to be statistically\nsignificant.33,35\nThe nine trials were conducted in eight countries:\ntwo in the UK46,77 and one each in Canada,69 the\nUSA,31 Australia,32 Czech Republic,40 Korea,43\nAustria75 and China.58 Eight comparative studies\ntook place in the USA,28,29,33,35,36,54\u201356 three in\nCanada34,42,45 two in China30,44 and one each in\nHungary,52 Japan,78 The Netherlands48 and\nSpain.74 Five trials31,32,40,43,58 and five comparative\nstudies28,35,44,54,56 had a follow-up period of\n\u00041 year. In four trials31,32,43,46 and eight\ncomparative studies28,33,35,42,45,52,54,56 it was\nreported that all operations had been performed\nby or directly supervised by a single surgeon, and\nin two trials69,75 and four comparative\nstudies34,36,48,55 it was reported that two or more\nsurgeons performed operations in a single\ninstitution, and a further trial involved two\nsurgeons from two institutions.40\nFor case series and registries regarding the single\nmini-incision procedure, a total of 1175\nparticipants (551 males and 624 females) were\nidentified between 1988 and July 2004 with the\nsample size in each study ranging from under\n10039 to over 1000.50,51 Participants\u2019 average age\nwas between 6049 and 73 years.39 Information on\nparticipants\u2019 BMI was available from only one\nstudy,51 which gave a mean BMI of 26.5,\ncomparable to the value reported in the trials and\ncomparative studies examining the same mini-\nincision procedure. The case series and registry\ndata came from five countries: Germany,39 Italy,49\nFrance,50 the USA41,51 and Norway.11 All case\nseries were based on single surgeon experience,\nexcept for the French study, which involved two\nsurgeons,50 and the registry data.11 Duration of\nfollow-up ranged from 1 year,11 through 3 years,50,51\n6 years41 and 7 years49 to 10 years.39\nWith respect to eight studies comparing the two-\nincision procedure with either the single mini-\nincision38,47,53,71\u201373,79 or standard incision57\nprocedure, there were a total of 713 participants\n(122 in the trials and 591 in the comparative\nstudies) recruited between 2002 and 2004. The\nsample sizes ranged from 2072 to 218.79 Where\nreported, there were more females than males\n(139 versus 204 females) with the average age\nbetween 53 and 66 years. Information on\nparticipants\u2019 BMI was largely unavailable. Four\nstudies took place in the USA38,47,72,73 and one\neach in China,57 Canada,71 Thailand53 and\nKorea.79 Four studies had an average follow-up of\n\u00041 year.38,53,72,73 Three studies38,47,53 reported that\na single surgeon performed all operations.\nTwo case series also examined the two-incision\nprocedure.27,37 Both studies were multi-centred\nand conducted in the USA. The first study\ninvolved 159 surgeons who attended corporate-\nsponsored training on the two-incision THR and\nwho were asked to report to the company on their\nfirst 10 cases.27 A total of 851 cases from 831\npatients were reported between October 2002 and\nApril 2004. The second study involved four\nsurgeons in four different institutions performing\na total of 375 procedures followed for a period of\n1 year.37 In both studies, the number of male\nparticipants was higher than that of female\nparticipants (435 versus 396 and 188 versus 112,\nrespectively). \nDescription of surgery received\nIn one comparative study,29 one patient assigned\nto the mini-incision group received a standard\nincision THR due to retained hardware (dynamic\nhip screw). In no other included trials and\ncomparative studies was the opposite method\ninitiated to the one to which the patient was\nassigned or randomised. No information was\navailable on operating theatre throughput.\nTwo comparative studies reported conversions\nfrom single mini-incision surgery to single\nstandard incision surgery.52,56 The first of these\nstudies reported that two of the 42 participants\nwere converted to longer incisions in order to\nrelieve skin tension and increase acetabular\nexposure.56 In the second study, all participants\nwere started with a short incision (<10 cm) and\nincisions were extended as necessary during\nsurgery.52 Participants were then divided into three\nEffectiveness\n14groups according to incision length, namely, mini-\nincision (<10 cm, N = 38), midi-incision \n(10\u201314 cm, N = 43) and standard incision \n(>14 cm, N = 21). \nIn terms of surgeon experience in the single mini-\nincision procedure, four studies (three trials and\none comparative study) indicated that the\nsurgeons involved were experienced in this\nprocedure.31,40,46,56 Two further non-randomised\ncomparative studies did not report specifically on\nthe level of experience of the surgeon performing\nthe mini-incision procedure but reported that all\nprocedures took place in a high-volume\narthroplasty centre. In contrast, five studies (one\ntrial and four comparative studies) suggested that\nthe mini-incision procedure represented surgeons\u2019\nearly experience in this technique.32,42,48,52,55\nIn terms of surgeon experience in the two-incision\nprocedure, one study reported that the study did\nnot represent the surgeon\u2019s \u201cinitial learning\ncurve\u201d,38 whereas another study reported that the\nsurgeon performing all operations was\nexperienced in the standard single incision\nprocedure but the two-incision procedure\nrepresented the surgeon\u2019s learning curve.53\nTHRs may be combined with the accelerated\nrehabilitation programme and the refined\nanalgesic package. Although these may vary across\nstudies, none of the included studies indicated\nthat the programmes differed significantly\nbetween the groups.\nAssessment of effectiveness\nA full description of the selected outcomes\nreported in the included studies is given in\nAppendix 9. Detailed results of meta-analyses\nperformed are given in Appendix 10.\nOne mini-incision versus one standard incision\nClinical performance\nRevision rate\nTable 8 and Figure 1 show the number of patients\nrequiring revision operations in the single mini-\nHealth Technology Assessment 2008; Vol. 12: No. 26\n15\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 8 Revision rate (number having revision surgery)a\nStudy Mini-incision Standard incision Reported p-values\nn\/N % n\/N %\nRCT and quasi-RCT\nChimento, 200531 1\/27 0\/29\nHart, 200540 0\/60 0\/60\nOgonda, 200546 0\/110 0\/109\nSubtotal 1\/197 0.5 0\/198 0\nPeto OR (95% CI) 7.96 (0.16 to 402.02), p = 0.30\nComparative studies\nAsayama, 200628 2\/50 0\/52\nCiminiello, 200633 1\/60 0\/60\nLi, 200544 0\/18 1\/18\nSzendr\u00f3i 2006,52 MI\/MD 0\/38 0\/43\nSzendr\u00f3i 2006,52 MI\/SI 0\/38 0\/21\nWright, 200456 0\/37 0\/39\nSubtotal 3\/241 1.2 1\/233 0.4\nCase series\nFl\u00f6ren, 200639 8\/90\nPipino, 200449 2\/331\nSiguier, 200450 0\/926\nSwanson, 200551 21\/1000\nNorwegian Arthroplasty  2\/143\nRegister, 200611b\nNorwegian Arthroplasty  0\/57\nRegister (unpublished)c\nSubtotal 33\/2547 1.3\na Time to revision was not reported. \nb Based on the 2005 data collection period.\nc Based on the 2006 data collection period up to 19 December 2006 (Espehaug B, Norwegian Arthroplasty Register:\npersonal communication, 5 January 2007).incision group and the standard incision group by\nstudy type. Of the three trials (RCTs and quasi-\nRCTs) and six comparative studies reporting this\noutcome, the length of follow-up ranged from\n\u00023 months33,46,52 through <1 year44 and\n2 years28,31 to >3 years.40,56 In both trials and\ncomparative studies, a total of only five\nparticipants had a revision surgery. Given the\nlimited data available, the CIs are very wide and\ninclude differences that are not clinically plausible\n(Appendix 10, Comparison 01:01, Peto OR 7.96,\n95% CI 0.16 to 402.02, p = 0.30). Overall, revisions\noccurred in between 0.5 and 1.2% of minimal\nincision cases depending on the source of data,\nwith case series and registries showing a higher\npercentage, which probably reflects their relatively\nlonger follow-up (between 1 and 10 years).\nPostoperative dislocation rates\nDislocation was also uncommon, occurring in\nbetween 0.2 and 1.8% (the latter estimate being\nbased on case series data) of minimal incision\ncases depending on the source of data (Table 9 and\nFigure 2; Appendix 10, Comparison 01:02). The\ncorresponding rates for standard THR were 0.9\nand 1.1% based on data from trials and\ncomparative studies, respectively. There were no\nclear differences between groups and the CIs were\nwide, including differences that are not clinically\nplausible. There was a tendency in favour of the\nmini-incision groups in the comparative studies,\nbut this was not apparent in the randomised \ntrials.\nSurrogates for long-term outcomes\nImplant position (cup and stem) Three trials and six\ncomparative studies provided information\ndescribing poor placement of the acetabular\ncomponent (cup) using various definitions\n(Table 10 and Figure 3; Appendix 10, Comparison\n01:03). Compared with standard incision \nTHR, the proportion of cups poorly placed in\nEffectiveness\n16\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  01 Revision rate (number having revision surgery)\n01 RCT\n Chimento  2005  (RCT)  1\/27  0\/29\n  Hart 2005 (Q-RCT)  0\/60  0\/60\n  Ogonda 2005 (RCT)    0\/110    0\/109\nSubtotal (95% CI)       197       198\nTotal events: 1 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 1.04 (p = 0.30)\n02 Comparative studies\n Asayama  2006  2\/50  0\/52\n Ciminiello  2006  1\/60  0\/60\n Li  2005  0\/18  1\/18\n  Szendr\u00f3i 2006 MI\/MD  0\/38  0\/43\n  Szendr\u00f3i 2006 MI\/SI  0\/38  0\/21\n Wright  2004  0\/37  0\/39\nTotal events: 3 (Mini-incision), 1 (Standard incision)\n7.96 (0.16 to 402.02)\n        Not estimable\n        Not estimable\n7.96 (0.16 to 402.02)\n7.85 (0.48 to 127.30)\n7.39 (0.15 to 372.38)\n0.14 (0.00 to 6.82)\n        Not estimable\n        Not estimable\n        Not estimable\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n100.00\n49.74\n25.13\n25.13\n0.001 0.01 0.1 1 10\nMini-incision Standard incision\n100 1000\nFIGURE 1 Meta-analysis of revision ratesHealth Technology Assessment 2008; Vol. 12: No. 26\n17\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nT\nA\nB\nL\nE\n \n9\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nd\ni\ns\nl\no\nc\na\nt\ni\no\nn\n \nr\na\nt\ne\ns\nS\nt\nu\nd\ny\nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\nS\nt\na\nn\nd\na\nr\nd\n \ni\nn\nc\ni\ns\ni\no\nn\nR\ne\np\no\nr\nt\ne\nd\n \np\n-\nv\na\nl\nu\ne\ns\nn\n\/\nN\n%\nn\n\/\nN\n%\nR\nC\nT\n \na\nn\nd\n \nq\nu\na\ns\ni\n-\nR\nC\nT\nC\nh\ni\nm\ne\nn\nt\no\n,\n \n2\n0\n0\n5\n3\n1\n2\n\/\n2\n8\n0\n\/\n3\n2\n0\n.\n2\nC\nh\nu\nn\ng\n,\n \n2\n0\n0\n4\n3\n2\n0\n\/\n6\n0\n0\n\/\n6\n0\nH\na\nr\nt\n,\n \n2\n0\n0\n5\n4\n0\n1\n\/\n6\n0\n1\n\/\n6\n0\nK\ni\nm\n,\n \n2\n0\n0\n6\n4\n3\n1\n\/\n7\n0\n1\n\/\n7\n0\nO\ng\no\nn\nd\na\n,\n \n2\n0\n0\n5\n4\n6\n1\n\/\n1\n0\n9\n1\n\/\n1\n1\n0\nS\nh\na\nr\nm\na\n,\n \n2\n0\n0\n6\n7\n7\n0\n\/\n2\n0\n0\n\/\n2\n0\nS\nu\nb\nt\no\nt\na\nl\n5\n\/\n3\n4\n7\n1\n.\n4\n3\n\/\n3\n5\n2\n0\n.\n9\nP\ne\nt\no\n \nO\nR\n \n(\n9\n5\n%\n \nC\nI\n)\n1\n.\n7\n2\n \n(\n0\n.\n4\n3\n \nt\no\n \n6\n.\n9\n2\n)\n,\n \np\n=\n \n0\n.\n4\n5\nC\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ni\ne\ns\nA\ns\na\ny\na\nm\na\n,\n \n2\n0\n0\n6\n2\n8\n0\n\/\n5\n2\n1\n\/\n5\n0\nB\ne\nr\ng\ne\nr\n,\n \n2\n0\n0\n4\n2\n9\n0\n\/\n9\n9\n0\n\/\n1\n0\n0\nC\nh\ne\nn\n,\n \n2\n0\n0\n6\n3\n0\n0\n\/\n5\n1\n0\n\/\n9\n5\nC\ni\nm\ni\nn\ni\ne\nl\nl\no\n,\n \n2\n0\n0\n6\n3\n3\n0\n\/\n6\n0\n0\n\/\n6\n0\nD\ni\nG\ni\no\ni\na\n,\n \n2\n0\n0\n3\n3\n5\n0\n\/\n3\n3\n0\n\/\n3\n3\nO\n\u2019\nB\nr\ni\ne\nn\n,\n \n2\n0\n0\n5\n4\n5\n0\n\/\n3\n4\n0\n\/\n5\n3\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\nM\nI\n\/\nM\nD\n0\n\/\n3\n8\n0\n\/\n4\n3\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\nM\nI\n\/\nS\nI\n0\n\/\n3\n8\n0\n\/\n2\n1\nT\ne\ne\nt\n,\n \n2\n0\n0\n6\n5\n4\n1\n\/\n7\n3\n4\n\/\n5\n4\nW\no\no\nl\ns\no\nn\n,\n \n2\n0\n0\n4\n5\n5\n0\n\/\n5\n0\n1\n\/\n8\n5\nW\nr\ni\ng\nh\nt\n,\n \n2\n0\n0\n4\n5\n6\n0\n\/\n4\n2\n1\n\/\n4\n2\nS\nu\nb\nt\no\nt\na\nl\n1\n\/\n5\n7\n0\n0\n.\n2\n7\n\/\n6\n3\n6\n1\n.\n1\nC\na\ns\ne\n \ns\ne\nr\ni\ne\ns\nF\nl\n\u00f6\nr\ne\nn\n,\n \n2\n0\n0\n6\n3\n9\n0\n\/\n9\n0\nH\na\nr\nt\nz\nb\na\nn\nd\n,\n \n2\n0\n0\n6\n4\n1\n0\n\/\n1\n0\n0\nS\ni\ng\nu\ni\ne\nr\n,\n \n2\n0\n0\n4\n5\n0\n1\n0\n\/\n1\n0\n3\n7\nS\nw\na\nn\ns\no\nn\n,\n \n2\n0\n0\n5\n5\n1\n3\n0\n\/\n1\n0\n0\n0\nS\nu\nb\nt\no\nt\na\nl\n4\n0\n\/\n2\n2\n2\n7\n1\n.\n8mini-incision THR was similar based on the trial\ndata [22\/235 (9.4%) versus 24\/239 (10%), Peto OR\n0.93, 95% CI 0.50 to 1.74, p = 0.83] but slightly\nhigher based on data from comparative studies\n[23\/280 (8.2%) versus 18\/301 (6%)]. There were\nmarked differences between studies in their overall\nrates, which may be explained by the differences\nin definitions used.\nTable 11 and Figure 4 (Appendix 10, Comparison\n01:04) show the results of studies reporting the\nnumber of (variously defined) femoral component\n(stems) that were poorly placed in mini- and\nstandard incision THR. No trend was discernible\nfavouring either treatment group and again there\nwere wide differences between studies in their\noverall rates.\nImplant migration One trial40 and one comparative\nstudy33 provided information on implant\nmigration (Appendix 10, Comparison 01:05).\nThere was no case of implant migration \nobserved in the trial [mini-incision (MI) 0\/60\nversus standard incision (SI) 0\/60] and the\ncomparative study reported one case in the \nmini-incision group (MI 1\/60 versus SI 0\/60).\nEffectiveness\n18\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  02 Postoperative dislocation rates\n \n01 RCT\n  Chimento 2005 (RCT)  2\/28  0\/32\n  Chung 2004 (Q-RCT)  0\/60  0\/60\n  Hart 2005 (Q-RCT)  1\/60  1\/60\n  Kim 2006 (Q-RCT)  1\/70  1\/70\n  Ogonda 2005 (RCT)    1\/109    1\/110\n  Sharma 2006 (Q-RCT)  0\/20  0\/20\nSubtotal (95% CI)      347      352\nTotal events: 5 (Mini-incision), 3 (Standard incision)\nTest for heterogeneity: \u00032 = 1.75, df = 3 (p = 0.63), I2 = 0%\nTest for overall effect: z = 0.76 (p = 0.45)\n02 Comparative studies\n Asayama  2006  0\/52  1\/50\n  Berger 20  0\/99    0\/100\n Chen  2006  0\/51  0\/95\n Ciminiello  2006  0\/60  0\/60\n   DiGioia 2003  0\/33  0\/33\n O\u2019Brien  2005  0\/34  0\/53\n  Szendr\u00f3i 2006 MI\/MD  0\/38  0\/43\n  Szendr\u00f3i 2006 MI\/SI  0\/38  0\/21\n Teet  2006  1\/73  4\/54\n Woolson  2004  0\/50  1\/85\n Wright  2004  0\/42  1\/42\nTotal events: 1 (Mini-incision), 7 (Standard incision)\n8.84 (0.54 to 145.71)\n     Not estimable\n1.00 (0.06 to 16.18)\n1.00 (0.06 to 16.15)\n1.01 (0.06 to 16.24)\n        Not estimable\n1.72 (0.43 to 6.92)\n0.13 (0.00 to 6.56)\n     Not estimable\n     Not estimable\n     Not estimable\n     Not estimable\n     Not estimable\n     Not estimable\n     Not estimable\n0.21 (0.03 to 1.24)\n0.20 (0.00 to 11.83)\n0.14 (0.00 to 6.82)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n24.72\n25.05\n25.08\n25.15\n100.00\n13.04\n61.74\n12.17\n13.05\n0.01 0.1 1 10\nMini-incision Standard incision\n100\nFIGURE 2 Meta-analysis of postoperative dislocation ratesHealth Technology Assessment 2008; Vol. 12: No. 26\n19\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 10 Implant position (cup, number poorly placed)\nStudy Mini-incision Standard incision Reported p-values\nn\/N % n\/N %\nRCT and quasi-RCT\nChung, 200432 0\/60 0\/60 0\nKim, 200643 6\/70 5\/70\nOgonda, 200546 16\/105 19\/109 NS\nSubtotal 22\/235 9.4 24\/239 10.0\nPeto OR (95% CI) 0.93 (0.50 to 1.74), p = 0.83\nComparative studies\nAsayama ,200628 0\/52 0\/50\nCiminiello, 200633 0\/60 0\/60\nSzendr\u00f3i, 200652 MI\/MD 4\/38 2\/43 0.348\nSzendr\u00f3i, 200652 MI\/SI 4\/38 3\/21 0.686\nWoolson, 200455 15\/50 13\/85 0.04\nWright, 200456 0\/42 0\/42\nSubtotal 23\/280 8.2 18\/301 6.0\nCase series\nPipino, 200449 29\/353\nSwanson, 200551 30\/1000\nSubtotal 59\/1353 4.4\nNS, not significant.\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  03 Implant position (cup, number poorly placed)\n \n01 RCT\n  Chung 2004 (Q-RCT)    0\/60    0\/60\n  Kim 2006 (Q-RCT)    6\/70    5\/70\n  Ogonda 2005 (RCT)    16\/105    19\/109\nSubtotal (95% CI)         235         239\nTotal events: 22 (Mini-incision), 24 (Standard incision)\nTest for heterogeneity: \u00032 = 0.24, df = 1 (p = 0.62), I2 = 0%\nTest for overall effect: z = 0.21 (p = 0.83)\n02 Comparative studies\n  Asayama 2006    0\/52    0\/50\n  Ciminiello 2006    0\/60    0\/60\n  Szendr\u00f3i 2006 MI\/MD    4\/38    2\/43\n  Szendr\u00f3i 2006 MI\/SI    4\/38    3\/21\n Woolson  2004  15\/50  13\/85\n  Wright 2004    0\/42    0\/42\nTotal events: 23 (Mini-incision), 18 (Standard incision)\n     Not estimable\n1.22 (0.36 to 4.15)\n0.85 (0.41 to 1.76)\n0.93 (0.50 to 1.74)\n     Not estimable\n     Not estimable\n2.33 (0.44 to 12.21)\n0.70 (0.14 to 3.60)\n2.43 (1.03 to 5.73)\n     Not estimable \nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n25.77\n74.23\n100.00\n17.39\n17.86\n64.74\nMini-incision Standard incision\n0.1 0.2 0.5 1 2 5 10\nFIGURE 3 Meta-analysis of implant position (cup, number poorly placed)Effectiveness\n20\nT\nA\nB\nL\nE\n \n1\n1\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\ns\nt\ne\nm\n,\n \nn\nu\nm\nb\ne\nr\n \np\no\no\nr\nl\ny\n \np\nl\na\nc\ne\nd\n)\nS\nt\nu\nd\ny\nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\nS\nt\na\nn\nd\na\nr\nd\n \ni\nn\nc\ni\ns\ni\no\nn\nR\ne\np\no\nr\nt\ne\nd\n \np\n-\nv\na\nl\nu\ne\ns\nn\n\/\nN\n%\nn\n\/\nN\n%\nR\nC\nT\n \na\nn\nd\n \nq\nu\na\ns\ni\n-\nR\nC\nT\nC\nh\ni\nm\ne\nn\nt\no\n,\n \n2\n0\n0\n5\n3\n1\n1\n\/\n2\n8\n1\n\/\n3\n2\n0\n.\n9\n9\nC\nh\nu\nn\ng\n,\n \n2\n0\n0\n4\n3\n2\n0\n\/\n6\n0\n0\n\/\n6\n0\nH\na\nr\nt\n,\n \n2\n0\n0\n5\n4\n0\n6\n\/\n6\n0\n7\n\/\n6\n0\nK\ni\nm\n,\n \n2\n0\n0\n6\n4\n3\n4\n\/\n7\n0\n4\n\/\n7\n0\nO\ng\no\nn\nd\na\n,\n \n2\n0\n0\n5\n4\n6\n3\n\/\n1\n0\n5\n8\n\/\n1\n0\n9\nS\nu\nb\nt\no\nt\na\nl\n1\n4\n\/\n3\n2\n3\n4\n.\n3\n2\n0\n\/\n3\n3\n1\n6\n.\n0\nP\ne\nt\no\n \no\nd\nd\ns\n \nr\na\nt\ni\no\n \n[\n9\n5\n%\n \nC\nI\n]\n0\n.\n7\n0\n \n(\n0\n.\n3\n5\n \nt\no\n \n1\n.\n4\n0\n)\n,\n \np\n=\n \n0\n.\n3\n1\nC\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ni\ne\ns\nA\ns\na\ny\na\nm\na\n,\n \n2\n0\n0\n6\n2\n8\n0\n\/\n5\n2\n0\n\/\n5\n0\nC\ni\nm\ni\nn\ni\ne\nl\nl\no\n,\n \n2\n0\n0\n6\n3\n3\n0\n\/\n6\n0\n0\n\/\n6\n0\nd\ne\n \nB\ne\ne\nr\n,\n \n2\n0\n0\n4\n3\n4\n0\n\/\n3\n0\n0\n\/\n3\n0\nO\n\u2019\nB\nr\ni\ne\nn\n,\n \n2\n0\n0\n5\n4\n5\n1\n\/\n3\n4\n3\n\/\n5\n3\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\nM\nI\n\/\nM\nD\n2\n\/\n3\n8\n2\n\/\n4\n3\n0\n.\n5\n6\n8\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\nM\nI\n\/\nS\nI\n2\n\/\n3\n8\n1\n\/\n2\n1\n0\n.\n6\n8\n2\nT\ne\ne\nt\n,\n \n2\n0\n0\n6\n5\n4\n4\n\/\n7\n3\n4\n\/\n5\n4\n0\n.\n0\n0\n0\n9\nW\no\no\nl\ns\no\nn\n,\n \n2\n0\n0\n4\n5\n5\n6\n\/\n5\n0\n3\n\/\n8\n5\n0\n.\n0\n5\n6\nW\nr\ni\ng\nh\nt\n,\n \n2\n0\n0\n4\n5\n6\n0\n\/\n4\n2\n0\n\/\n4\n2\nS\nu\nb\nt\no\nt\na\nl\n1\n5\n\/\n4\n1\n7\n3\n.\n6\n1\n3\n\/\n4\n3\n8\n3\n.\n0\nC\na\ns\ne\n \ns\ne\nr\ni\ne\ns\nF\nl\n\u00f6\nr\ne\nn\n,\n \n2\n0\n0\n6\n3\n9\n1\n2\n\/\n7\n0\nP\ni\np\ni\nn\no\n,\n \n2\n0\n0\n4\n4\n9\n2\n1\n\/\n3\n5\n3\nS\nw\na\nn\ns\no\nn\n,\n \n2\n0\n0\n5\n5\n1\n7\n\/\n1\n0\n0\n0\nS\nu\nb\nt\no\nt\na\nl\n4\n0\n\/\n1\n4\n2\n3\n2\n.\n8Three further case series with 70, 100 and 331\nparticipants, respectively, reported no case of\nimplant migration.39,41,49\nHeterotopic ossification Two comparative studies\n(N = 86) reported a total of four cases of\nheterotopic ossification, all occurring in the\nstandard incision group (Appendix 10,\nComparison 01:06).35,78 Two further case series\nalso provided information on heterotopic\nossification. One of these studies with\n926 participants50 reported no incidents, \nwhereas the other study49 reported that it \noccurred in 44% (155\/353) of the participants. \nThe latter study is based on the Brooker\u2019s\nclassification grades (grade I = 106, \nII = 28, III = 21, IV = 0, where grade IV is \nthe worst).\nCement quality Table 12 (Appendix 10, Comparison\n01:07) shows the results of studies reporting the\nnumber of implants with poor cement quality\n(variously defined). The trial data show no\nstatistically significant differences in the average\nnumber of implants with poor cement quality [MI\n31\/192 (16.1%) versus SI 27\/197 (13.7%), Peto OR\n1.26, 95% CI 0.70 to 2.27, p = 0.45]. None of the\ncomparative studies reporting this outcome\nobserved any implants with poor cement quality.\nOne case series with 70 participants39 reported\nthat ten arthroplasties showed radiolucent lines in\none or more zone. \nLimb length inequality\nOne comparative study reported that there were\nno patients who had inequality in length across\ntheir limbs post-operation (MI 0\/52 versus SI\nHealth Technology Assessment 2008; Vol. 12: No. 26\n21\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  04 Implant position (stem, number poorly placed)\n \n01 RCT\n Chimento  2005  (RCT)  1\/28  1\/32\n  Chung 2004 (Q-RCT)  0\/60  0\/60\n  Hart 2005 (Q-RCT)  6\/60  7\/60\n  Kim 2006 (Q-RCT)  4\/70  4\/70\n  Ogonda 2005 (RCT)    3\/105    8\/109\nSubtotal (95% CI)       323       331\nTotal events: 14 (Mini-incision), 20 (Standard incision)\nTest for heterogeneity: \u00032 = 1.28, df = 3 (p = 0.73), I2 = 0%\nTest for overall effect: z = 0.76 (p = 0.45)\n02 Comparative studies\n Asayama  2006  0\/52  0\/50\n Ciminiello  2006  0\/60  0\/60\n   de Beer 2004  0\/30  0\/30\n O\u2019Brien  2005  1\/34  3\/53\n  Szendr\u00f3i 2006 MI\/MD  2\/38  2\/43\n  Szendr\u00f3i 2006 MI\/SI  2\/38  1\/21\n Teet  2006  4\/73  4\/54\n Woolson  2004  6\/50  3\/85\n Wright  2004  0\/42  0\/42\nTotal events: 15 (Mini-incision), 13 (Standard incision)\n1.15 (0.07 to 18.88)\n     Not estimable\n0.84 (0.27 to 2.65)\n1.00 (0.24 to 4.15)\n0.40 (0.12 to 1.34)\n0.70 (0.35 to 1.40)\n     Not estimable\n     Not estimable\n     Not estimable\n0.54 (0.07 to 4.19)\n1.14 (0.15 to 8.42)\n1.11 (0.10 to 12.27)\n0.72 (0.17 to 3.06)\n3.86 (0.96 to 15.59)\n     Not estimable\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n6.17\n36.85\n23.95\n33.04\n100.00\n14.45\n15.07\n10.44\n29.03\n31.02\nMini-incision Standard incision\n0.1 0.2 0.5 1 2 5 10\nFIGURE 4 Meta-analysis of implant position (stem, number poorly placed)Effectiveness\n22\nTABLE 13 Blood loss (intraoperative, ml)\nStudy Mini-incision Standard incision Reported p-values\nn\/N Valuea n\/N Valuea\nRCT and quasi-RCT\nCharles, 200669 20 460.0 20 462.5 0.966\nChimento, 200531 28 127 (48) 32 170 (65) 0.003\nChung, 200432 60 136.0 (41.1) 60 200.5 (65.2) <0.01\nHart ,200540 60 318.8 [200\u2013460] 60 544.4 [390\u2013880]\nKim, 200643 70 445.8 70 567.5 0.1687\nOgonda, 200546 109 314.0 [90\u20131310] 110 365.8 [100\u20131100] 0.03\nRachbauer 200675 60 Less 60 More <0.01\nSubtotal 407 412\nWMD (95% CI)b \u201356.59 (\u201371.63 to \u201341.55), \np < 0.00001\nComparative studies\nAsayama, 200628 52 217.0 [50\u2013600] 50 247.0 [100\u2013550]\nBerger, 200429 99 154 100 278 >0.05\nChen, 200630 51 175.49 (51.9) 95 293.68 (84.5)\nCiminiello, 200633 60 201.67 [40\u2013170] 60 191.73 [100\u2013400] 0.812\nde Beer, 200434 30 180.0 (69) 30 246.7 (99) 0.04\nHowell, 200442 50 387 (155) 57 469 (147) 0.007\nPilot, 200648 10 699 10 540 0.28\nSzendr\u00f3i, 200652 MI\/MD 38 244 (100) 43 265(114) 0.399\nSzendr\u00f3i, 200652 MI\/SI 38 244 (100) 43 304 (136) 0.098\nWoolson, 200455 50 603 85 507 0.12\nWright, 200456 42 151.8 (53.9) 42 173.2 (57.5) 0.08\nSubtotal 520 615\nCase series\nPipino 200449 368 150\nSwanson 200551 1000 317.3 (230.6)\nSubtotal 1368\na Values are reported as average (SD) [range].\nb Based on the analysis using estimated SDs from p-values where relevant data were not reported.\nTABLE 12 Cement quality (number with poor quality)\nStudy Mini-incision Standard incision Reported p-values\nn\/N % n\/N %\nRCT and quasi-RCT\nChimento, 200531 3\/27 1\/28 0.4\nHart, 200540 0\/60 0\/60\nOgonda, 200546 28\/105 26\/109 0.93\nSubtotal 31\/192 16.1 27\/197 13.7\nPeto OR [95% CI] 1.26 (0.70 to 2.27), p = 0.45\nComparative studies\nSzendr\u00f3i, 200652 MI\/MD 0\/24 0\/25\nSzendr\u00f3i, 200652 MI\/SI 0\/24 0\/11\nWoolson, 200455 0\/12 0\/21\nWright 200456 0\/42 0\/42\nSubtotal 0\/102 0 0\/99 00\/50).28 One case series reported that 8.5%\n(28\/331) of participants had a change in limb\nlength of up to 1 cm but none of the participants\nhad a change in limb length more than 1 cm.49\nAnother study reported that 8.8% (88\/1000) of\nparticipants had inequality in limb length of more\nthan 7 mm.51 In a further study, limb length\ninequality was noted in 7% (7\/100) of participants\nwith a maximum discrepancy of 5 mm.41\nSafety\nBlood loss\nTable 13 shows the results of studies that reported\nthe amount of blood loss for patients during the\noperation. The reported blood loss varied widely\nacross studies. Nevertheless, all seven trials, and\neight of the 11 comparative studies favoured the\nmini-incision group. The data from the case series\nfor mini-incision THR were consistent with data\nfrom the trials and comparative studies.\nOnly two trials31,32 reported SDs and were\ntherefore suitable for quantitative synthesis. \nThe results show that there was significantly less\nblood loss in the mini-incision group than in \nthe standard incision group (Appendix 10,\nComparison 01:09, WMD \u201358 ml, 95% CI \u201374 \nto \u201342, p < 0.00001). This result is broadly \nconsistent with further analyses supplemented\nwith SDs on the basis of reported p-values \n(Figure 5; Appendix 10, Comparison 02:09, \nWMD \u201357 ml, 95% CI \u201372 to \u201342, p < 0.00001).\nWhen supplemented further with dummy SDs \nfor the Hart study,40 significant differences\nremained, although there was significant\nstatistical heterogeneity (Appendix 10,\nComparison 03:09, WMD \u201399 ml, 95% CI \n\u2013112 to \u201386, p < 0.00001). Using a random\neffects model did not change this pattern \n(WMD \u201386 ml, 95% CI \u2013162 to \u201310, \np = 0.03).\nHealth Technology Assessment 2008; Vol. 12: No. 26\n23\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision (p-value)\nOutcome:  09 Blood loss (intraoperative, ml)\n \n01 RCT\n  Charles 2006 (RCT)  \n Chimento  2005  (RCT)\n  Chung 2004 (Q-RCT)\n  Hart 2005 (Q-RCT)\n  Kim 2006 (Q-RCT)\n Ogonda  2005  (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 2.94, df = 4 (p = 0.57), I2 = 0%\nTest for overall effect: z = 7.37 (p < 0.00001)\n02 Comparative  studies\n Asayama  2006\n Berger  20\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n Howell  2004\n Pilot  2006\n  Szendr\u00f3i 2006 MI\/MD\n  Szendr\u00f3i 2006 MI\/SI\n Woolson  2004\n Wright  2004\n  20  460.00 (184.25)  20  462.50 (184.25)\n  28  127.00 (48.00)  32  170.00 (65.00)\n  60  136.00 (41.10)  60  200.50 (65.20)\n  60  318.80 (0.00)  60  544.40 (0.00)\n  70   445.80 (521.95)  70  567.50 (521.95)\n109   314.20 (174.78)  110  365.80 (174.78)\n347   352\n  \n  52  217.50 (0.00)  50   247.00 (0.00)\n  99  154.00 (443.49)  100  278.00 (443.49)\n  51  175.49 (51.90)  95  293.68 (84.50)\n  60  201.67 (228.39)  60  191.73 (228.39)\n  30  180.00 (69.00)   30  246.70 (99.00)\n  50  387.00 (155.00)   57  469.00 (147.00)\n  10  699.00 (319.20)  10  540.00 (319.20)\n  38  244.00 (100.00)  43  265.00 (114.00)\n  38  244.00 (100.00)  43  304.00 (136.00)\n  50  603.00 (344.21)  85  507.00 (344.21)\n  42  151.80 (53.90)   42  173.20 (57.50)\n    \u20132.50 (\u2013116.70 to 111.70)\n  \u201343.00 (\u201371.69 to \u201314.31)\n  \u201364.50 (\u201384.00 to \u201345.00)\n              Not estimable\n\u2013121.70 (\u2013294.62 to \u201351.22)\n  \u201351.60 (\u201397.90 to \u20135.30)\n  \u201356.59 (\u201371.63 to \u201341.55)\n              Not estimable\n\u2013124.00 (\u2013247.24 to \u20130.76)\n\u2013118.19 (\u2013140.36 to \u201396.02)\n      9.94 (\u201371.79 to 91.67)\n  \u201366.70 (\u2013109.88 to \u201323.52)\n  \u201382.00 (\u2013139.46 to \u201324.54)\n  159.00 (\u2013120.79 to 438.79)\n  \u201321.00 (\u201367.60 to 25.60)\n  \u201360.00 (\u2013111.61 to \u20138.39)\n    96.00 (\u201324.24 to 216.24)\n  \u201321.40 (\u201345.24 to 2.44)\nStudy\nor subcategory NN Mean (SD) Mean (SD)\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n  1.73\n 27.48\n 59.48\n  0.76\n 10.55\n100.00\n  \n1.14\n 35.27\n  2.60\n  9.30\n  5.25\n  0.22\n  7.98\n  6.51\n  1.20\n 30.52\n\u2013100 \u201350 0 50\nMini-incision Standard incision\n100\n \nFIGURE 5 Meta-analysis of blood loss estimated using trial data supplemented by calculated standard deviations from reported \np-valuesTwo further comparative studies reported on \ntotal (rather than intraoperative) blood loss, \nwith one (N = 36) favouring mini-incision (318\nversus 523 ml, reported p-value <0.05)44 and \nthe other (N = 20) slightly favouring standard\nincision (796 versus 772 ml, p-value \nunknown).78\nFractures\nIntraoperative fractures occurred between 0 \nand 2.7% in the mini-incision group and \nbetween 0.5 and 1.2% in the standard group \n(Table 14; Appendix 10, Comparison 01:11). The\nrates varied depending on the source of data.\nThree trials (N = 339) reported no cases among\n169 in the mini-incision group compared with \nthe two among 170 in the standard incision \ngroup. In contrast, the comparative studies\nexamining this outcome (N = 790) tended to\nfavour the standard incision group. \nWith respect to postoperative fractures (Table 14;\nAppendix 10, Comparison 01:12), there were no\ncases reported in the trials examining this\noutcome (N = 160) but results from the\ncomparative studies (N = 326) again favoured the\nstandard incision group.\nOther adverse effects\nInfections Infections (including wound, superficial\nor deep infections) during the postoperative\nperiod appear to be uncommon in the included\nstudies with less than 1% across all data sources\nand surgical techniques (Table 15 and Figure 6) and\nEffectiveness\n24\nTABLE 14 Intraoperative and postoperative fractures\nStudy Mini-incision Standard incision Reported p-values\nn\/N % n\/N %\nIntra-operative fractures\nRCT and quasi-RCT\nHart, 200540 0\/60 0\/60\nOgonda, 200546 0\/109 2\/110\nSubtotal 0\/169 0 2\/170 1.2\nPeto OR (95% CI) 0.14 (0.01 to 2.18), p = 0.16\nComparative studies\nAsayama, 200628 2\/52 0\/50\nBerger, 200429 1\/99 1\/100\nHowell, 200442 2\/50 0\/57\nO\u2019Brien, 200545 2\/34 1\/53\nSzendr\u00f3i, 200652 MI\/MD 0\/38 0\/43\nSzendr\u00f3i 200652 MI\/SI 0\/38 0\/21\nTakahira, 200678 1\/10 0\/10\nWoolson, 200455 2\/50 0\/85\nSubtotal 10\/371 2.7 2\/419 0.5\nCase series\nSwanson, 200551 10\/1000 1.0\nPost-operative fractures\nRCT and quasi-RCT\nHart, 200540 0\/60 0\/60\nSharma, 200677 0\/20 0\/20\nSubtotal 0\/80 0 0\/80 0\nPeto OR (95% CI) Not estimable\nComparative studies\nChen, 200630 3\/51 4\/95\nCiminiello, 200633 0\/60 0\/60\nde Beer, 200434 1\/30 0\/30\nSubtotal 4\/141 2.8 4\/185 2.2\nCase series\nPipino, 200449 3\/331\nSiguier, 200450 1\/926\nSwanson, 200551 3\/1000\nSubtotal 7\/2257 0.3Health Technology Assessment 2008; Vol. 12: No. 26\n25\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nT\nA\nB\nL\nE\n \n1\n5\nI\nn\nf\ne\nc\nt\ni\no\nn\ns\nS\nt\nu\nd\ny\nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\nS\nt\na\nn\nd\na\nr\nd\n \ni\nn\nc\ni\ns\ni\no\nn\nR\ne\np\no\nr\nt\ne\nd\n \np\n-\nv\na\nl\nu\ne\ns\nn\n\/\nN\n%\nn\n\/\nN\n%\nR\nC\nT\n \na\nn\nd\n \nq\nu\na\ns\ni\n-\nR\nC\nT\nC\nh\ni\nm\ne\nn\nt\no\n,\n \n2\n0\n0\n5\n3\n1\n0\n\/\n2\n8\n0\n\/\n3\n2\nC\nh\nu\nn\ng\n,\n \n2\n0\n0\n4\n3\n2\n0\n\/\n6\n0\n0\n\/\n6\n0\nH\na\nr\nt\n,\n \n2\n0\n0\n5\n4\n0\n0\n\/\n6\n0\n0\n\/\n6\n0\nK\ni\nm\n,\n \n2\n0\n0\n6\n4\n3\n1\n\/\n7\n0\n0\n\/\n7\n0\nO\ng\no\nn\nd\na\n,\n \n2\n0\n0\n5\n4\n6\n2\n\/\n1\n0\n9\n0\n\/\n1\n1\n0\nS\nh\na\nr\nm\na\n,\n \n2\n0\n0\n6\n7\n7\n0\n\/\n2\n0\n0\n\/\n2\n0\nZ\nh\na\nn\ng\n,\n \n2\n0\n0\n6\n5\n8\n0\n\/\n6\n0\n0\n\/\n6\n0\nS\nu\nb\nt\no\nt\na\nl\n3\n\/\n4\n0\n7\n0\n.\n7\n0\n\/\n4\n1\n2\n0\nP\ne\nt\no\n \nO\nR\n \n(\n9\n5\n%\n \nC\nI\n)\n7\n.\n4\n8\n \n(\n0\n.\n7\n8\n \nt\no\n \n7\n2\n.\n1\n6\n)\n,\n \np\n=\n \n0\n.\n0\n8\nC\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ni\ne\ns\nA\ns\na\ny\na\nm\na\n,\n \n2\n0\n0\n6\n2\n8\n0\n\/\n5\n2\n1\n\/\n5\n0\nB\ne\nr\ng\ne\nr\n,\n \n2\n0\n0\n4\n2\n9\n0\n\/\n9\n9\n0\n\/\n1\n0\n0\nC\ni\nm\ni\nn\ni\ne\nl\nl\no\n,\n \n2\n0\n0\n6\n3\n3\n0\n\/\n6\n0\n0\n\/\n6\n0\nH\no\nw\ne\nl\nl\n,\n \n2\n0\n0\n4\n4\n2\n0\n\/\n5\n0\n1\n\/\n5\n7\nO\n\u2019\nB\nr\ni\ne\nn\n,\n \n2\n0\n0\n5\n4\n5\n0\n\/\n3\n4\n0\n\/\n5\n3\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\nM\nI\n\/\nM\nD\n0\n\/\n3\n8\n0\n\/\n4\n3\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\nM\nI\n\/\nS\nI\n0\n\/\n3\n8\n0\n\/\n2\n1\nW\no\no\nl\ns\no\nn\n,\n \n2\n0\n0\n4\n5\n5\n1\n\/\n5\n0\n0\n\/\n8\n5\nW\nr\ni\ng\nh\nt\n,\n \n2\n0\n0\n4\n5\n6\n0\n\/\n4\n2\n0\n\/\n4\n2\nS\nu\nb\nt\no\nt\na\nl\n1\n\/\n4\n6\n3\n0\n.\n2\n2\n\/\n5\n1\n1\n0\n.\n4\nC\na\ns\ne\n \ns\ne\nr\ni\ne\ns\nF\nl\n\u00f6\nr\ne\nn\n,\n \n2\n0\n0\n6\n3\n9\n0\n\/\n9\n0\nH\na\nr\nt\nz\nb\na\nn\nd\n,\n \n2\n0\n0\n6\n4\n1\n0\n\/\n1\n0\n0\nP\ni\np\ni\nn\no\n,\n \n2\n0\n0\n4\n4\n9\n1\n\/\n3\n3\n1\nS\ni\ng\nu\ni\ne\nr\n,\n \n2\n0\n0\n4\n5\n0\n5\n\/\n9\n2\n6\nS\nw\na\nn\ns\no\nn\n,\n \n2\n0\n0\n5\n5\n1\n8\n\/\n1\n0\n0\n0\nS\nu\nb\nt\no\nt\na\nl\n1\n4\n\/\n2\n4\n4\n7\n0\n.\n6Effectiveness\n26\nT\nA\nB\nL\nE\n \n1\n6\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\nS\nt\nu\nd\ny\nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\nS\nt\na\nn\nd\na\nr\nd\n \ni\nn\nc\ni\ns\ni\no\nn\nR\ne\np\no\nr\nt\ne\nd\n \np\n-\nv\na\nl\nu\ne\ns\nn\n\/\nN\n%\nn\n\/\nN\n%\nR\nC\nT\n \na\nn\nd\n \nq\nu\na\ns\ni\n-\nR\nC\nT\nC\nh\na\nr\nl\ne\ns\n,\n \n2\n0\n0\n6\n6\n9\n1\n\/\n2\n0\n0\n\/\n2\n0\nC\nh\ni\nm\ne\nn\nt\no\n,\n \n2\n0\n0\n5\n3\n1\n0\n\/\n2\n8\n0\n\/\n3\n2\nC\nh\nu\nn\ng\n,\n \n2\n0\n0\n4\n3\n2\n0\n\/\n6\n0\n0\n\/\n6\n0\nH\na\nr\nt\n,\n \n2\n0\n0\n5\n4\n0\n0\n\/\n6\n0\n0\n\/\n6\n0\nK\ni\nm\n,\n \n2\n0\n0\n6\n4\n3\n1\n\/\n7\n0\n1\n\/\n7\n0\nZ\nh\na\nn\ng\n,\n \n2\n0\n0\n6\n5\n8\n0\n\/\n6\n0\n0\n\/\n6\n0\nS\nu\nb\nt\no\nt\na\nl\n2\n\/\n2\n9\n8\n0\n.\n7\n1\n\/\n3\n0\n2\n0\n.\n3\nP\ne\nt\no\n \nO\nR\n \n(\n9\n5\n%\n \nC\nI\n)\n1\n.\n9\n5\n \n(\n0\n.\n2\n0\n \nt\no\n \n1\n8\n.\n8\n9\n)\n,\n \np\n=\n \n0\n.\n5\n6\nC\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ni\ne\ns\nA\ns\na\ny\na\nm\na\n \n2\n0\n0\n6\n2\n8\n0\n\/\n5\n2\n0\n\/\n5\n0\nC\nh\ne\nn\n \n2\n0\n0\n6\n3\n0\n0\n\/\n5\n1\n2\n\/\n9\n5\nD\ni\nG\ni\no\ni\na\n \n2\n0\n0\n3\n3\n5\n0\n\/\n3\n3\n0\n\/\n3\n3\nO\n\u2019\nB\nr\ni\ne\nn\n \n2\n0\n0\n5\n4\n5\n0\n\/\n3\n4\n0\n\/\n5\n3\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\nM\nI\n\/\nM\nD\n2\n\/\n3\n8\n3\n\/\n4\n3\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\nM\nI\n\/\nS\nI\n2\n\/\n3\n8\n0\n\/\n2\n1\nT\na\nk\na\nh\ni\nr\na\n,\n \n2\n0\n0\n6\n7\n8\n1\n\/\n1\n0\n0\n\/\n1\n0\nW\no\no\nl\ns\no\nn\n,\n \n2\n0\n0\n4\n5\n5\n1\n\/\n5\n0\n1\n\/\n8\n5\nW\nr\ni\ng\nh\nt\n \n2\n0\n0\n4\n5\n6\n0\n\/\n4\n2\n0\n\/\n4\n2\nS\nu\nb\nt\no\nt\na\nl\n6\n\/\n3\n4\n8\n1\n.\n7\n6\n\/\n4\n3\n2\n1\n.\n4\nC\na\ns\ne\n \ns\ne\nr\ni\ne\ns\nH\na\nr\nt\nz\nb\na\nn\nd\n,\n \n2\n0\n0\n6\n4\n1\n0\n\/\n1\n0\n0\nP\ni\np\ni\nn\no\n,\n \n2\n0\n0\n4\n4\n9\n0\n\/\n3\n3\n1\nS\nw\na\nn\ns\no\nn\n,\n \n2\n0\n0\n5\n5\n1\n6\n\/\n1\n0\n0\n0\nS\nu\nb\nt\no\nt\na\nl\n6\n\/\n1\n4\n3\n1\n0\n.\n4hence with wide confidence intervals around\nestimates of differences between the two\napproaches which are not clinically plausible.\nNerve injury Reports of postoperative nerve injury\nwere also rare. Data from the six trials and nine\ncomparative studies that reported the number of\npostoperative nerve injuries (Table 16;\nAppendix 10, Comparison 01:14) showed no\nstatistically significant differences between the\nmini-incision group and standard incision group,\nalthough with wide 95% CIs for the trials [Table 16;\nAppendix 10, Comparison 01:14, 2\/298 (0.7%)\nversus 1\/302 (0.3%), Peto OR 1.95, 95% CI 0.20 to\n18.89, p = 0.56].\nTwo case series49,51 also provided information on\nthe number of nerve injuries following mini-\nincision surgery at a slightly lower rate (0.4%),\ncompared with the data from the trials (0.7%) or\nthe comparative studies (1.7%). \nVascular injury One trial with 120 participants\nreported that there were no events of vascular\ninjury.58 Also, one case series with 331 participants\nwhich provided information on vascular injuries\nreported no events following mini-incision\nsurgery.49\nThrombosis Five trials and six comparative studies\nprovided information on DVT (Table 17 and\nFigure 7). In all studies where DVT occurred, \nthere were slightly fewer events in the mini-\nincision groups than in the standard groups \n(0.9% versus 2.5% in the trial, 2.1% versus 4.3%\nin the comparative studies), although meta-\nanalysis of the trial data found no statistically\nsignificant difference (Appendix 10, Comparison\nHealth Technology Assessment 2008; Vol. 12: No. 26\n27\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome: 13  Infections\n \n01 RCT\n Chimento  2005  (RCT)  0\/28  0\/32\n  Chung 2004 (Q-RCT)  0\/60  0\/60\n  Hart 2005 (Q-RCT)  0\/60  0\/60\n  Kim 2006 (Q-RCT)  1\/70  0\/70\n  Ogonda 2005 (RCT)    2\/109    0\/110\n Sharma  2006  (Q-RCT)  0\/20  0\/20\n  Zhang 2006 (RCT)  0\/60  0\/60\nSubtotal (95% CI)      407      412\nTotal events: 3 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: \u00032 = 0.00, df = 1 (p = 0.99), I2 = 0%\nTest for overall effect: z = 1.74 (p = 0.08)\n02 Comparative studies\n Asayama  2006  0\/52  1\/50\n  Berger 20  0\/99    0\/100\n Ciminiello  2006  0\/60  0\/60\n   Howell 2004  0\/50  1\/57\n O\u2019Brien  2005  0\/34  0\/53\n  Szendr\u00f3i 2006 MI\/MD  0\/38  0\/43\n  Szendr\u00f3i 2006 MI\/SI  0\/38  0\/21\n Woolson  2004  1\/50  0\/85\n Wright  2004  0\/42  0\/42\nTotal events: 1 (Mini-incision), 2 (Standard incision)\n        Not estimable\n        Not estimable\n        Not estimable\n  7.39 (0.15 to 372.38)\n  7.53 (0.47 to 121.10)\n        Not estimable\n        Not estimable\n  7.48 (0.78 to 72.16)\n  0.13 (0.00 to 6.56)\n        Not estimable\n        Not estimable\n  0.15 (0.00 to 7.78)\n        Not estimable\n        Not estimable\n        Not estimable\n14.88 (0.26 to 861.53)\n        Not estimable\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n33.44\n66.56\n100.00\n34.14\n34.01\n31.86\n0.01 0.1 1 10\nMini-incision Standard incision\n100\nFIGURE 6 Meta-analysis of infections01:16, Peto OR 0.39, 95% CI 0.12 to 1.30, \np = 0.12). \nThree further studies reported on PE (Table 17).\nOf these, one comparative study45 reported one\nepisode of PE in the mini-incision group. \nResource utilisation\nDuration of operation\nAll nine included trials provided information on\nthe duration of operation (Table 18). Of these,\nthree showed that the average duration was\nshorter in the mini-incision group,32,43,46 four\nshowed that it was shorter in the standard incision\ngroup,31,40,58,69 one reported no difference but did\nnot report any data75 and the ninth only provided\na (non-significant) p-value77 (Table 18). In the\ncomparative studies, eight30,33,44,45,52,55,56 of the 15\nstudies reporting this outcome found the\noperation shorter on average in the mini-incision\ngroup compared with seven in the standard\nincision group.28,29,34,35,42,48,78\nThe trials reporting SDs tended to be those that\nfavoured mini-incisions. For this reason, we chose\nto estimate SDs for the others using reported \np-values (calculated SDs). The results suggested a\nsmall difference in favour of mini-incisions for this\nanalysis (Table 18 and Figure 8; Appendix 10,\nComparison 02:18, WMD \u20133.70 minutes, 95% CI\n\u20135.67 to \u20131.74, p = 0.0002). Caution is required,\nas this analysis displayed statistical heterogeneity.\nEffectiveness\n28\nTABLE 17 DVT and PE\nStudy Mini-incision Standard incision Reported p-values\nn\/N % n\/N %\nRCT and quasi-RCT\nChimento, 200531 0\/28 0\/32\nChung, 200432 3\/60 5\/60\nHart, 200540 0\/60 0\/60\nOgonda, 200546 0\/109 1\/110\nZhang, 200658 0\/60 2\/60\nSubtotal 3\/317 0.9 8\/322 2.5\nPeto OR (95% CI) 0.39 (0.12 to 1.30), p = 0.12\nComparative studies\nAsayama, 200628 0\/52 1\/50\nDe Beer, 200434 0\/30 1\/30\nO\u2019Brien, 200545 0\/34 3\/53\nSzendr\u00f3i, 200652 MI\/MD 2\/38 3\/43\nSzendr\u00f3i, 200652 MI\/SI 2\/38 2\/21\nWoolson, 200455 1\/50 2\/85\nSubtotal 5\/242 2.1 12\/282 4.3\nCase series\nHartzband, 200641 4\/100 4.0\nPE\nRCT and quasi-RCT\nHart 200540 0\/60 0\/60\nSubtotal 0\/60 0 0\/60 0\nPeto OR (95% CI) Not estimable\nComparative studies\nBerger, 200429 0\/99 0\/100\nO\u2019Brien, 200545 1\/34 0\/53\nSubtotal 1\/133 0.8 0\/153 0\nCase series\nSwanson, 200551a 12\/1000 1.2\na Includes both DVT and PE.After applying random effects models, the\ndifferences between mini- and standard incision\nsurgery were no longer statistically significant\n(WMD \u20132.35, 95% CI \u20136.86 to 2.16, p = 0.31).\nAnalyses based on the published data and the \ndata supplemented with the dummy SDs are\nreported in Appendix 10, Comparisons 01: 18 \nand 03:18.\nOn the assumption that the trials are least biased,\noverall, there may be a small difference of around\n2\u20135 minutes in operating time favouring mini-\nincision. However, this is not certain and the\ndifference may not have any practical significance.\nLength of hospital stay\nThe reported length of hospital stay varied from 1\nto 23 days (Table 19). Compared with the standard\nincision group, five32,46,58,69,77 of the six trials and\nseven29,30,35,42,45,74,78 of the 12 comparative studies\nthat provided information on length of hospital\nstay reported shorter average hospital stay in the\nmini-incision group. The difference between the\ntwo groups tended to be small or for 1 or 2 days,\nexcept one trial by Zhang and colleagues\nreporting the largest difference of more than\n6 days.58 The length of stay reported in the case\nseries was generally consistent with the data on\nlength of stay for the mini-incision group in the\ntrials. \nMeta-analysis of the trial data supplemented by\ncalculated SDs from reported p-values resulted in \na mean length of stay that was statistically\nsignificantly shorter in the mini-incision group \nbut there was significant statistical heterogeneity \nat the 10% level (Figure 9; Appendix 10,\nComparison 02:19, WMD \u20130.50 days, 95% CI\n\u20130.83 to \u20130.18, p = 0.002). When a random effects\nmodel was applied, the difference between groups\nwas no longer statistically significant (WMD \u20130.34\ndays, 95% CI \u20130.94 to 0.25, p = 0.26). Further\nanalyses based on the published data and the \ndata supplemented with the dummy SDs are\nHealth Technology Assessment 2008; Vol. 12: No. 26\n29\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  16 DVT (deep venous thrombosis)\n01 RCT\n Chimento  2005  (RCT)  0\/28  0\/32\n  Chung 2004 (Q-RCT)  3\/60  5\/60\n  Hart 2005 (Q-RCT)  0\/60  0\/60\n  Ogonda 2005 (RCT)    0\/109    1\/110\n  Zhang 2006 (RCT)  0\/60  2\/60\nSubtotal (95% CI)      317       322\nTotal events: 3 (Mini-incision), 8 (Standard incision)\nTest for heterogeneity: \u00032 = 1.17, df = 2 (p = 0.56), I2 = 0%\nTest for overall effect: z = 1.54 (p = 0.12)\n02 Comparative studies\n Asayama  2006  0\/52  1\/50\n   de Beer 2004  0\/30  1\/30\n O\u2019Brien  2005  0\/34  3\/53\n  Szendr\u00f3i 2006 MI\/MD  2\/38  3\/43\n  Szendr\u00f3i 2006 MI\/SI  2\/38  2\/21\n Woolson  2004  1\/50  2\/85\nTotal events: 5 (Mini-incision), 12 (Standard incision)\n    Not estimable\n0.59 (0.14 to 2.45)\n    Not estimable\n0.14 (0.00 to 6.88)\n0.13 (0.01 to 2.15)\n0.39 (0.12 to 1.30)\n0.13 (0.00 to 6.56)\n0.14 (0.00 to 6.82)\n0.19 (0.02 to 1.95)\n0.75 (0.12 to 4.53)\n0.52 (0.06 to 4.22)\n0.85 (0.08 to 9.02)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n 71.62\n9.51\n 18.86\n100.00\n  6.34\n  6.35\n17.71\n30.03\n22.07\n17.49\n0.1 0.2 0.5 1 2 5\nMini-incision Standard incision\n10\nFIGURE 7 Meta-analysis of DVTEffectiveness\n30\nT\nA\nB\nL\nE\n \n1\n8\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nS\nt\nu\nd\ny\nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\nS\nt\na\nn\nd\na\nr\nd\n \ni\nn\nc\ni\ns\ni\no\nn\nR\ne\np\no\nr\nt\ne\nd\n \np\n-\nv\na\nl\nu\ne\ns\nn\n\/\nN\nV\na\nl\nu\ne\na\nn\n\/\nN\nV\na\nl\nu\ne\na\nS\nt\nu\nd\ny\nC\nh\na\nr\nl\ne\ns\n,\n \n2\n0\n0\n6\n6\n9\n2\n0\n9\n5\n.\n2\n2\n0\n8\n7\n.\n7\n0\n.\n3\n1\n5\nC\nh\ni\nm\ne\nn\nt\no\n,\n \n2\n0\n0\n5\n3\n1\n2\n8\n7\n0\n.\n3\n \n(\n1\n0\n.\n7\n)\n3\n2\n7\n0\n.\n0\n \n(\n8\n.\n5\n)\n0\n.\n4\nC\nh\nu\nn\ng\n,\n \n2\n0\n0\n4\n3\n2\n6\n0\n4\n9\n.\n0\n \n(\n9\n.\n4\n)\n6\n0\n5\n5\n.\n1\n \n(\n1\n7\n.\n9\n)\nH\na\nr\nt\n,\n \n2\n0\n0\n5\n4\n0\n6\n0\n7\n1\n \n[\n5\n5\n\u2013\n8\n4\n]\n6\n0\n7\n0\n \n[\n5\n1\n\u2013\n8\n6\n]\nN\nR\nK\ni\nm\n,\n \n2\n0\n0\n6\n4\n3\n7\n0\n5\n2\n \n[\n4\n8\n\u2013\n7\n0\n]\n7\n0\n6\n1\n \n[\n5\n1\n\u2013\n8\n0\n]\n<\n0\n.\n0\n0\n1\nO\ng\no\nn\nd\na\n,\n \n2\n0\n0\n5\n4\n6\n1\n0\n9\n6\n0\n.\n3\n \n(\n9\n.\n2\n)\n1\n1\n0\n6\n5\n.\n9\n \n(\n1\n3\n.\n2\n)\nR\na\nc\nh\nb\na\nu\ne\nr\n,\n \n2\n0\n0\n6\n7\n5\n6\n0\nN\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n6\n0\nN\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nN\nR\nS\nh\na\nr\nm\na\n,\n \n2\n0\n0\n6\n7\n7\n2\n0\nN\nR\n2\n0\nN\nR\n0\n.\n2\n0\n7\nZ\nh\na\nn\ng\n,\n \n2\n0\n0\n6\n5\n8\n6\n0\n7\n5\n6\n0\n6\n9\n>\n0\n.\n0\n5\nS\nu\nb\nt\no\nt\na\nl\n4\n8\n7\n4\n9\n2\nW\nM\nD\n \n(\n9\n5\n%\n \nC\nI\n)\nb\n\u2013\n3\n.\n7\n0\n \n(\n\u2013\n5\n.\n6\n7\n \nt\no\n \n\u2013\n1\n.\n7\n4\n)\n,\n \np\n=\n \n0\n.\n0\n0\n0\n2\nC\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ni\ne\ns\nA\ns\na\ny\na\nm\na\n,\n \n2\n0\n0\n6\n2\n8\n5\n0\n5\n8\n.\n6\n \n[\n3\n2\n\u2013\n8\n9\n]\n5\n0\n5\n7\n.\n9\n \n[\n3\n6\n-\n9\n0\n]\n0\n.\n7\n1\n5\nB\ne\nr\ng\ne\nr\n,\n \n2\n0\n0\n4\n2\n9\n9\n9\n7\n2\n1\n0\n0\n6\n6\nN\nR\n \nC\nh\ne\nn\n,\n \n2\n0\n0\n6\n3\n0\n5\n1\n8\n8\n.\n4\n1\n \n(\n1\n7\n.\n6\n0\n)\n9\n5\n9\n0\n.\n8\n5\n \n(\n1\n7\n.\n8\n1\n)\nC\ni\nm\ni\nn\ni\ne\nl\nl\no\n,\n \n2\n0\n0\n6\n3\n3\n6\n0\n5\n5\n.\n4\n5\n \n[\n4\n0\n\u2013\n1\n7\n0\n]\n6\n0\n5\n6\n.\n9\n5\n \n[\n3\n5\n\u2013\n9\n0\n]\n0\n.\n0\n9\n7\nd\ne\n \nB\ne\ne\nr\n,\n \n2\n0\n0\n4\n3\n4\n3\n0\n4\n6\n.\n6\n \n[\n2\n4\n\u2013\n9\n0\n]\n3\n0\n4\n4\n.\n5\n \n[\n1\n7\n\u2013\n7\n5\n]\n0\n.\n5\n7\n2\nD\ni\nG\ni\no\ni\na\n,\n \n2\n0\n0\n3\n3\n5\n3\n3\n1\n2\n0\n3\n3\n1\n0\n0\nN\nR\nH\no\nw\ne\nl\nl\n,\n \n2\n0\n0\n4\n4\n2\n5\n0\n9\n7\n \n(\n1\n9\n)\n5\n7\n8\n4\n \n(\n1\n5\n)\n0\n.\n0\n0\n1\nL\ni\n,\n \n2\n0\n0\n5\n4\n4\n1\n8\n9\n1\n \n(\n1\n6\n.\n4\n)\n1\n8\n9\n7\n \n(\n1\n5\n.\n6\n)\n>\n0\n.\n0\n5\nO\n\u2019\nB\nr\ni\ne\nn\n,\n \n2\n0\n0\n5\n4\n5\n3\n2\n7\n4\n \n(\n1\n5\n)\n5\n1\n8\n0\n \n(\n1\n0\n)\nP\ni\nl\no\nt\n,\n \n2\n0\n0\n6\n4\n8\n1\n0\n9\n9\n.\n5\n1\n0\n8\n1\n.\n0\n0\n.\n0\n5\n6\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\nM\nI\n\/\nM\nD\n3\n8\n8\n4\n \n(\n1\n6\n)\n4\n3\n9\n3\n \n(\n1\n8\n)\n0\n.\n0\n2\n0\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\nM\nI\n\/\nS\nI\n3\n8\n8\n4\n \n(\n1\n6\n)\n2\n1\n1\n0\n2\n \n(\n1\n2\n)\n<\n0\n.\n0\n0\n1\nT\na\nk\na\nh\ni\nr\na\n,\n \n2\n0\n0\n6\n7\n8\n1\n0\n1\n2\n6\n.\n5\n1\n0\n1\n1\n9\n.\n9\nN\nR\nW\no\no\nl\ns\no\nn\n,\n \n2\n0\n0\n4\n5\n5\n5\n0\n9\n7\n8\n5\n1\n0\n5\n0\n.\n1\n3\nW\nr\ni\ng\nh\nt\n,\n \n2\n0\n0\n4\n5\n6\n4\n2\n7\n1\n.\n4\n \n(\n1\n1\n.\n2\n)\n4\n2\n7\n7\n.\n7\n \n(\n1\n3\n.\n2\n)\n0\n.\n0\n2\nS\nu\nb\nt\no\nt\na\nl\n6\n1\n1\n7\n0\n5\nC\na\ns\ne\n \ns\ne\nr\ni\ne\ns\nH\na\nr\nt\nz\nb\na\nn\nd\n,\n \n2\n0\n0\n6\n4\n1\n1\n0\n0\n3\n7\n.\n5\n \n[\n2\n7\n\u2013\n9\n0\n]\nS\nw\na\nn\ns\no\nn\n,\n \n2\n0\n0\n5\n5\n1\n1\n0\n0\n0\n6\n1\n.\n2\n \n(\n2\n4\n.\n2\n)\nN\nR\n,\n \nn\no\nt\n \nr\ne\np\no\nr\nt\ne\nd\n.\na\n \nV\na\nl\nu\ne\ns\n \na\nr\ne\n \nr\ne\np\no\nr\nt\ne\nd\n \na\ns\n \na\nv\ne\nr\na\ng\ne\n \n(\nS\nD\n)\n \n[\nr\na\nn\ng\ne\n]\n.\nb\n \nB\na\ns\ne\nd\n \no\nn\n \nt\nh\ne\n \na\nn\na\nl\ny\ns\ni\ns\n \nu\ns\ni\nn\ng\n \nS\nD\ns\n \ne\ns\nt\ni\nm\na\nt\ne\nd\n \nf\nr\no\nm\n \np\n\u2013\nv\na\nl\nu\ne\ns\n \nw\nh\ne\nr\ne\n \nr\ne\nl\ne\nv\na\nn\nt\n \nd\na\nt\na\n \nw\ne\nr\ne\n \nn\no\nt\n \nr\ne\np\no\nr\nt\ne\nd\n.Health Technology Assessment 2008; Vol. 12: No. 26\n31\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision (p-value)\nOutcome:  28 Duration of operation (minutes)\n \n01 RCT\n  Charles 2006 (RCT)  \n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Hart 2005 (Q-RCT)\n  Kim 2006 (Q-RCT)\n  Ogonda 2005 (RCT)\n  Sharma 2006 (Q-RCT)\n  Zhang 2006 (RCT)    \nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 21.37, df = 5 (p = 0.0007), I2 = 76.6%\nTest for overall effect: z = 3.69 (p = 0.0002)\n02 Comparative  studies\n Asayama  2006\n Berger  20\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n DiGioia \n Howell  2004\n Li  2005\n O\u2019Brien  2005\n Pilot  2006\n  Szendr\u00f3i 2006 MI\/MD\n  Szendr\u00f3i 2006 MI\/SI\n Takahira  2006\n Woolson  2004\n Wright  2004\n  20    95.20 (23.29)  20    87.70 (23.29)\n  28    70.30 (10.70)  32    70.00 (8.50)\n  60    49.00 (9.40)  60     55.10 (17.90)\n  60    71.00 (0.00)  60    70.00 (0.00)\n  70    52.00 (15.84)  70    61.00 (15.84)\n109    60.30 (9.20)  110    65.90 (13.20)\n  20      0.00 (0.00)  20      0.00 (0.00)\n  60    75.00 (16.60)  60    69.00 (16.60)\n427                           432\n  50    58.60 (0.00)  50    57.90 (0.00)\n  99    72.00 (0.00)  100    66.00 (0.00)\n  51    88.41 (17.60)  95    90.85 (17.81)\n  60    55.45 (4.91)  60    56.95 (4.91)\n  30    46.60 (14.31)  30    44.50 (14.31)\n  33  120.00 (0.00)  33  100.00 (0.00)\n  50    97.00 (19.00)  57    84.00 (15.00)\n  18    91.00 (16.40)  18    97.00 (15.60)\n  32    74.00 (15.00)  51    80.00 (10.00)\n  10    99.50 (20.25)  10    81.00 (20.25)\n  38    84.00 (16.00)   43    93.00 (18.00)\n  38    84.00 (16.00)   21  102.00 (12.00)\n  10  126.50 (0.00)  10  119.90 (0.00)\n  50    97.00 (29.46)  85  105.00 (29.46)\n  42    71.40 (11.20)  42    77.70 (13.20)    \n    7.50 (\u20136.94 to 21.94)\n    0.30 (\u20134.64 to 5.24)\n  \u20136.10 (\u201311.22 to \u20130.98)\n          Not estimable\n  \u20139.00 (\u201314.25 to \u20133.75)\n  \u20135.60 (\u20138.61 to \u20132.59)\n           Not estimable\n    6.00 (0.06 to 11.94)\n  \u20133.70 (\u20135.67 to \u20131.74)\n           Not estimable\n           Not estimable\n  \u20132.44 (\u20138.45 to 3.57)\n  \u20131.50 (\u20133.26 to 0.26)\n    2.10 (\u20135.14 to 9.34)\n            Not estimable\n  13.00 (6.45 to 19.55)\n  \u20136.00 (\u201316.46 to 4.46)\n  \u20136.00 (\u201311.88 to \u20130.12)\n  18.50 (0.75 to 36.25)\n  \u20139.00 (\u201316.40 to \u20131.60)\n\u201318.00 (\u201325.23 to \u201310.77)\n           Not estimable\n  \u20138.00 (\u201318.29 to 2.29)\n  \u20136.30 (\u201311.54 to \u20131.06)\nStudy\nor subcategory NN Mean (SD) Mean (SD)\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n1.85\n15.84\n14.76\n14.02\n42.59\n10.94\n100.00\n5.33\n62.47\n3.68\n4.50\n1.76\n5.58\n0.61\n3.52\n3.69\n1.82\n7.04\n\u201310 \u20135 0 5\nMini-incision Standard incision\n10\nFIGURE 8 Meta-analysis of duration of operation time estimated using trial data supplemented by calculated SDs from reported \np-valuesreported in Appendix 10, Comparisons 01:19 \nand 03:19.\nCaution is required, since these differences may\nreflect the clinical policy of each hospital for\ndischarge rather than the clinical need of each\npatient. For this reason, it may not be appropriate\nto place much weight on these values.\nPatient-centred measures\nDeaths\nTwo trials31,46 and two comparative studies33,56\nprovided information on the number of\nparticipants who died during the first 30 days of\nthe study period (30-day mortality) and also\nduring the entire study period (long-term\nmortality) (Table 20). In terms of 30-day mortality,\none trial reported that two of the 110 patients\n(1.8%) in the standard incision group had died in\nthe early postoperative period (Appendix 10,\nComparison 01:20).46 No deaths were reported\nduring the early phase of the comparative\nstudies.33,56\nIn terms of long-term mortality, two of the 32 trial\nparticipants (6.3%) in the standard incision group\nhad died during the 2-year period but these\nevents were reported to be unrelated to surgery.31\nOne comparative study reported two deaths (2%)\nin each of the mini-incision and standard incision\ngroups over the period of 5 years but similarly\nreported that these were secondary to events\nEffectiveness\n32\nTABLE 19 Length of hospital stay (days)\nStudy Mini-incision Standard incision Reported p-values\nn\/N Valuea n\/N Valuea\nRCT and quasi-RCT\nCharles, 200669 20 5.35 20 5.70 0.501\nChimento, 200531 28 5.8 [4\u201313] 32 5.5 [3\u201315] 0.6\nChung, 200432 60 4.41 (1.1) 60 5.34 (1.4) <0.01\nOgonda, 200546 109 3.65 (2.04) 110 3.68 (2.45) 0.94\nSharma, 200677 20 Shorter 20 Longer 0.042\nZhang, 200658 60 7 [5\u20138] 60 13.5 [12\u201316] NR\nSubtotal 297 302\nWMD (95% CI)b \u20130.50 (\u20130.83 to \u20130.18), \np = 0.002\nComparative studies\nAsayama, 200628 52 2.96 (1\u20136) 50 2.94 (2\u20134) 0.858\nBerger, 200429 100 1.9 100 3.5 >0.05\nChen, 200630 51 11.16 (0.83) 95 12.83 (1.96)\nCiminiello, 200633 60 3.70 [2\u20137] 60 3.63 [2\u20135] 0.94\nde Beer, 200434 30 5.13 [3\u20138] 30 5.1 [4\u20138] 0.894\nDiGioia, 200335 33 3.8 33 3.9 0.6\nHowell, 200442 50 4.4 (2.9) 57 5.7 (3.1) 0.03\nO\u2019Brien, 200545 35 5.4 (2.1) 53 6.2 (2.8)\nPanisello, 200674 40 5.6 40 6.7 NR\nTakahira, 200678 10 22 10 23.4 NR\nWoolson, 200455 50 4.3 85 4.0 0.44\nWright, 200456 42 6.12 42 6.07 0.92\nSubtotal 553 655\nCase series\nFl\u00f6ren, 200639 79 4.7 (2.0)\nHartzband, 200641 100 2.89 [3\u20135]\nSwanson, 200551 1000 3.7 (1.8)\nSubtotal 1079\nNR, not reported.\na Values are reported as average (SD) [range].\nb Based on the analysis using SDs estimated from p-values where relevant data were not reported.unrelated to the hip arthroplasty.56 No deaths\nwere reported in another comparative study with a\nrelatively short (6-week) follow-up (Appendix 10,\nComparison 01:21).33\nPain\nPostoperative pain was reported using various\nmeasures, including analgesic requirements, pain\nscores and the number of patients reporting pain\n(Tables 21\u201323). The available data were mostly\nderived from short-term (\u00023 months) results. Five\nRCTs31,32,46,69,75 and three comparative\nstudies28,33,34 reported data on analgesic needs\n(Table 21). In all but two69,75 of these studies, the\naverage analgesic usage was slightly less in the\nmini-incision groups but these differences were\nsmall. This difference was not found to be\nstatistically significant in any of the studies which\nperformed a statistical test. As the outcome\nmeasures varied between studies and not all\nstudies reported data amenable to meta-analysis,\nonly limited quantitative synthesis was possible.\nThe meta-analyses that were conducted are\nreported in Appendix 10, Comparisons\n01:22\u201301:24, and none of these provided any\nevidence of a difference between mini- and\nstandard incision.\nIn terms of pain scores (short-term), results were\nsimilar with five46,52,75,77 of the six studies with\ndata favouring the mini-incision groups (Table 22;\nAppendix 10, Comparison 01:26). In three studies\nwhich performed a statistical test, this difference\nwas found to be statistically significant. Results in\nterms of the number of patients reporting short-\nterm pain, derived from three studies,28,33,34 were\nHealth Technology Assessment 2008; Vol. 12: No. 26\n33\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision (p-value)\nOutcome:  19 Length of hospital stay (days)\n \n01 RCT\n  Charles 2006 (RCT)  \n Chimento  2005  (RCT)\n  Chung 2004 (Q-RCT)\n Ogonda  2005  (RCT)\n Sharma  2006  (Q-RCT)\n  Zhang 2006 (RCT)    \nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 7.94, df = 3 (p = 0.05), I2 = 62.2%\nTest for overall effect: z = 3.03 (p = 0.002)\n02 Comparative  studies\n Asayama  2006\n Berger  20\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n DiGioia\n Howell  2004\n O\u2019Brien  2005\n Panisello  2006\n Takahira  2006\n Woolson  2004\n Wright  2004\n  20  5.35 (1.63)  20    5.70 (1.63)\n  28  5.80 (2.20)  32    5.50 (2.20)\n  60  4.41 (1.10)  60    5.34 (1.40)\n109  3.65 (2.04)  110    3.68 (2.45)\n  20  0.00 (0.00)  20    0.00 (0.00)\n  60  7.00 (0.00)  60  13.50 (0.00)\n297   302\n  52    2.96 (0.56)  50    2.94 (0.56)\n100    1.90 (5.74)  100    3.50 (5.74)\n  51  11.16 (0.83)  95  12.83 (1.96)\n  60    3.70 (5.08)  60    3.63 (5.08)\n  30    5.13 (0.87)  30    5.10 (0.87)\n  33    3.80 (0.77)  33    3.90 (0.77)\n  50    4.40 (2.90)  57    5.70 (3.10)\n  35    5.40 (2.10)  53    6.20 (2.80)\n  40    5.60 (0.00)  40    6.70 (0.00)\n  10  22.00 (0.00)  10  23.40 (0.00)\n  50    4.30 (2.17)  85    4.00 (2.17)\n  42    6.12 (2.27)  42    6.07 (2.27)\n\u20130.35 (\u20131.36 to 0.66)\n  0.30 (\u20130.82 to 1.42)\n\u20130.93 (\u20131.38 to \u20130.48)\n\u20130.03 (\u20130.63 to 0.57)\n       Not estimable\n       Not estimable\n\u20130.50 (\u20130.83 to \u20130.18)\n  0.02 (\u20130.20 to 0.24)\n\u20131.60 (\u20133.19 to \u20130.01)\n\u20131.67 (\u20132.13 to \u20131.21)\n  0.07 (\u20131.75 to 1.89)\n  0.03 (\u20130.14 to 0.47)\n\u20130.10 (\u20130.47 to 0.27)\n\u20131.30 (\u20132.44 to \u20130.16)\n\u20130.80 (\u20131.83 to 0.23)\n       Not estimable\n       Not estimable\n  0.30 (\u20130.46 to 1.06)\n  0.05 (\u20130.92 to 1.02)\nStudy\nor subcategory NN Mean (SD) Mean (SD)\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n 10.30\n  8.44\n 51.77\n 29.49\n100.00\n 48.52\n  0.91\n 11.07\n  0.69\n 11.83\n 16.61\n  1.77\n  2.18\n  3.99\n  2.43\n\u20134 \u20132 0 2\nMini-incision Standard incision\n4\nFIGURE 9 Meta-analysis of length of stay estimated using trial data supplemented by calculated SDs from reported p-valuesEffectiveness\n34\nTABLE 20 Mortality\nStudy Mini-incision Standard incision Reported p-values\nn\/N % n\/N %\n30-day mortality\nRCT\nOgonda, 200546 0\/109 2\/110\nSubtotal 0\/109 0 2\/110 1.8\nPeto OR (95% CI) 0.14 (0.01 to 2.18), p = 0.16\nComparative studies\nCiminiello, 200633 0\/60 0\/60\nWright, 200456 0\/42 0\/42\nSubtotal 0\/102 0 0\/102 0\nLong-term mortality\nRCT\nChimento, 200531 0\/28 2\/32\nSubtotal 0\/28 0 2\/32 6.3\nPeto OR (95% CI) 0.15 (0.01 to 2.45), p = 0.18\nComparative studies\nCiminiello, 200633 0\/60 0\/60\nWright, 200456 2\/42 2\/42\nSubtotal 2\/102 2.0 2\/102 2.0\nTABLE 21 Short-term pain \u2013 analgesic requirement\nStudy Measure Mini-incision Standard incision Reported p-value\nN Average (SD)  N Average (SD)\n[range] [range]\nRCT and quasi-RCT\nCharles, 200669 PCA narcotic  18 22.8 19 19.5 0.105\nconsumption (mg)\nChimento, 200531 Patient-controlled  28 285 (185) 32 319 (177) 0.3\nepidural anaesthesia (ml)\nChung, 200432 Narcotic use (days) 60 2.20 60 2.64 NS\nOgonda, 200546 Volume of morphine  109 42.9 (97.4) 110 45.0 (96.8) 0.89\nused (mg)\nRachbauer, 200675 Use of analgesic 60 No difference 60 No difference NR\nComparative studies\nAsayama, 200628 Total intravenous  52 92.7 [37\u2013180] 50 94.9 [38\u2013188] NS\nnarcotic received during \nhospitalisationa (mg)\nCiminiello, 200633 Equianalgesic  60 118 [10.5\u2013450.6] 60 121 [8.6\u2013390.5] 0.77\nrequirement up to \n6 weeks (mg)\nde Beer, 200434 Equianalgesic opioid  30 147.70 [18\u2013337.9] 30 169.3 [23.3\u2013413.3] 0.336\nconsumption (mg)\nNR, not reported; NS, not statistically significant; PCA, patient controlled analgesia.\na Equianalgesic equivalency to morphine.Health Technology Assessment 2008; Vol. 12: No. 26\n35\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 22 Other short-term pain\nStudy Measure Mini-incision Standard incision Reported p-value\nN Average (SD)  N Average (SD)\nPain score\nRCT and quasi-RCT\nCharles, 200669 Pain scorea  18 3.9 19 3.7 0.129\nKim, 200643 10-point analogous  70 NR 70 NR >0.05\nscale at 2 weeks and \n3 months\nOgonda, 200546 100-mm visual analogue  109 33 (18.0) 110 33.6 (19.6) 0.82\nscale in first 7 days \nfollowing discharge\nRachbauer, 200675 Postoperative pain in  60 Lower 60 Higher Sig.\nthe first week\nSharma, 200677 10-point visual analogue  20 4.05 20 6.25 0.0089\nscale at day 1\nComparative studies\nSzendr\u00f3i 200652 Visual analogue scale at  38 1.5 (1.15) 43 2.15 (1.2) 0.028\n(MI\/MD) day 3\nSzendr\u00f3i, 200652 Visual analogue scale at  38 1.5 (1.15) 21 2.1 (1.3) 0.112\n(MI\/SI) day 3\nNumber of patients reporting pain\nComparative studies\nAsayama, 200628 Mild pain 52 2 49 3\nCiminiello, 200633 Thigh pain 60 0 60 0\nDe Beer, 200434 Subcutaneous hematoma, \nmild sciatica and thigh pain 30 0 30 1\nCase series\nPipino, 200449 Thigh pain 331 7\nNR = not reported; Sig, statistically significant.\na Details unavailable.\nTABLE 23 Long-term pain\nStudy Measure Mini-incision Standard incision Reported p-value\nN Value N Value\nRCT and quasi-RCT\nKim, 200643 10-point analogous scale at  70 NR 70 NR >0.05\n6 months, 1 year and 2 years\nCase series\nFl\u00f6ren, 200639 Slight or mild pain (no. of patients) 90 10\nHartzband, 200641 Significant thigh pain \n(no. of patients) 100 0\nPipino, 200449 Persistent thigh pain at  331 1\n1 year (no. of patients)\nNR, not reported.also slightly better for the mini-incision group\n(Table 22; Appendix 10, Comparison 01:25).\nOnly one trial43 and three case series39,41,49\nincluded a measure of long-term pain (Table 23).\nThe trial did not report the actual pain score\nvalues at 6\u201324 months postoperatively but\nsuggested that the two groups did not differ\nsignificantly. The three case series recorded the\nnumber of patients reporting pain, although the\ndegree of reported pain varied between the\nstudies.\nReturn to usual activities\nOnly one trial75 and one comparative study30\nprovided information on time to return to usual or\ndaily activities (Table 24; Appendix 10,\nComparison 01:28). The average time in the mini-\nincision group was shorter in both studies. The\none case series reporting this outcome reported a\nshorter time to return to usual activities than\ncomparative study data. However, definitions and\ncase mix may have differed.\nTwo further trials31,32 and one comparative\nstudy28 recorded the number of participants\nrequiring a stick (cane) or other walking aid or\nthe duration for which participants used such\ndevices postoperatively (Table 24; Appendix 10,\nComparisons 01:29 and 01:30). Results were\ngenerally more favourable for the mini-incision\ngroup. The number of patients with a limp in \nthe mini-incision group within the first 3 months\nafter operation was significantly fewer in one\nstudy31 but non-significantly higher in another\n(Table 24; Appendix 10, Comparison 01:31).28\nEffectiveness\n36\nTABLE 24 Return to usual activities\nStudy Measure Mini-incision Standard incision Reported p-value\nN Value (SD) N Value (SD)\nTime to return to usual activities\nRCT and quasi-RCT\nRachbauer, 200675 Time to return to daily activities 60 Shorter 60 Longer NR\nComparative studies\nChen, 200630 Time to return to normal  51 60 (12) 95 116 (11)\nactivities (days)\nCase series\nPipino, 200449 Return to a full normal lifestyle  331 318\nat 1\u20137 years (no. of patients)\nSwanson, 200551 Time to begin unrestricted  1000 29.4\nnormal daily activities (days)\nUse of walking aids: short-term\nRCT and quasi-RCT\nChimento, 200531 Required a cane at 6 weeks  28 9 32 15 NS\n(no. of patients)\nChung, 200432 Use of walking aids (days) 60 21.4 (4.8) 60 24.8 (5.4)\nComparative studies\nAsayama, 200628 Use of walking aid at 3 months  52 4 49 4\n(no. of patients) \nLimp: short-term (no. of patients)\nRCT and quasi-RCT\nChimento, 200531 Persistent limp at 6 weeks 28 6 31 15 0.04\nComparative studies\nAsayama, 200628 Very slight limp at 3 months 52 19 49 16 NS\nCase series\nSiguier, 200450 Limp 926 0\nLimp: long-term (no. of patients)\nRCT and quasi-RCT\nChimento, 200531 Persistent limp at 1 year 27 0 29 0\nNR, not reported; NS, not statistically significant.Health Technology Assessment 2008; Vol. 12: No. 26\n37\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  33 Harris hip score (\u00023 months)\n01 RCT\n  Ogonda 2005 (RCT)\n  Zhang 2006 (RCT)    \nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 3.32, df = 1 (p = 0.07), I2 = 69.9%\nTest for overall effect: z = 0.98 (p = 0.33)\n02 Comparative  studies\n Ciminiello  2006\n  de Beer 2004\n DiGioia\n107  \u201384.15 (10.56)  108  \u201383.36 (8.33)    \n  60  \u201391.40 (35.68)  60  \u201378.50 (35.68)\n167   168\n  60  \u201391.02 (12.17)  60  \u201394.93 (12.17)\n  30  \u201371.10 (9.80)  30  \u201366.60 (12.20)\n  33  \u201386.29 (11.62)  33  \u201380.44 (11.62)\n  \u20130.79 (\u20133.33 to 1.75)\n\u201312.90 (\u201325.67 to \u20130.13)\n  \u20131.25 (\u20133.75 to 1.24)\n    3.91 (\u20130.44 to 8.26)\n  \u20134.50 (\u201310.10 to 1.10)\n  \u20135.85 (\u201311.46 to \u20130.24)\nStudy\nor subcategory NN Mean (SD) Mean (SD)\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n96.18\n3.82\n100.00\n45.29\n27.39\n27.31\n\u201310 \u20135 0 5\nMini-incision Standard incision\n10\nFIGURE 10 Meta-analysis of Harris hip score (\u00023 months) estimated using trial data supplemented by calculated SDs from reported\np-values\nTABLE 25 Condition-specific quality of life (\u00023 months)\nStudy Mini-incision Standard incision Reported p-value\nN Value (SD)  N Value (SD)\n[range] [range]\nHarris hip scorea\nRCT and quasi-RCT\nOgonda, 200546 107 84.15 (10.56) 108 83.36 (8.33) 0.54\nZhang, 200658  60 91.4 60 78.5 <0.05\nComparative studies\nCiminiello, 200633 60 91.02 [60\u2013100] 60 94.93 [70\u2013100] 0.081\nde Beer, 200434 30 71.1 (9.8) 30 66.6 (12.2) 0.193\nDiGioia, 200335 33 86.29 [63\u201396] 33 80.44 [63\u201395] 0.045\nWOMAC osteoarthritis indexb\nRCT and quasi-RCT\nCharles, 200669 16 91.99 19 89.60 0.690\nOgonda, 200546 107 74.40 (13.88) 108 73.95 (12.90)\nOxford hip scoreb\nRCT and quasi-RCT\nOgonda, 200546 107 24.97 (7.33) 108 25.88 (6.29)\nComparative studies\nde Beer, 200434 30 26.50 (8.40) 30 28.40 (7.50) 0.494\nMerle d\u2019Aubign\u00e9-Charnley Scoreb\nRCT and quasi-RCT\nHart, 200540 60 16.6 60 14.1 <0.02\na Higher scores reflect better quality of life.\nb Higher scores reflect poorer quality of life.Effectiveness\n38\nTABLE 26 Condition-specific quality of life (>3 months)\nStudy Mini-incision Standard incision Reported p-value\nN Value (SD)  N Value (SD)\n[range] [range]\nHarris hip score\nRCT and quasi-RCT\nChimento, 200531 27 94.5 29 94.5 NR\nChung, 200432 60 95.5 60 93.5 NS\nKim, 200643 70 93 [86\u2013100] 70 91 [85\u2013100] 0.7435\nZhang, 200658 60 95.1 60 95.6 >0.05\nComparative studies\nAsayama, 200628 52 96.2 50 96.2 NS\nChen, 200630 51 89.71 (3.62) 95 83.78 (8.03)\nDiGioia, 200335 33 96 [86\u2013100] 33 94 [79\u2013100] 0.08\nLi, 200544 18 92 18 90 >0.05\nWoolson, 200455 20 99 [89\u2013100] 14 97 [65\u2013100] 0.43\nWright, 200456 37 86.9 (4.1) 39 84.2 (6.4) 0.042\nCase series\nFl\u00f6ren, 200639 79 92.3 (7.9)\nSwanson, 200551 1000 92 (9)\nMerle d\u2019Aubign\u00e9-Charnley score\nRCT and quasi-RCT\nHart, 200540 60 17.4 60 17.3 NS\nNR, not reported; NS, not statistically significant.\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  34 Harris hip score (>3 months)\n01 RCT\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Kim 2006 (Q-RCT)\n  Zhang 2006 (RCT)    \nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 5.92, df = 2 (p = 0.05), I2 = 66.2%\nTest for overall effect: z = 1.43 (p = 0.152)\n02 Comparative  studies\n Asayama  2006\n Chen  2006\n DiGioia\n Li  2005\n Woolson  2004\n Wright  2004\n  27  \u201394.50 (0.00)  29  \u201394.50 (0.00)\n  60  \u201395.50 (5.53)  60  \u201393.50 (5.53)\n  70  \u201393.00 (35.58)  70  \u201391.00 (35.58)\n  60  \u201395.10 (1.38)  60  \u201395.60 (1.38)\n217   219\n  52  \u201396.20 (0.00)  50  \u201396.20 (0.00)\n  51  \u201389.71 (3.62)  95  \u201383.78 (8.03)\n  33  \u201396.00 (4.57)  33  \u201394.00 (4.57)\n  18  \u201392.00 (2.95)  18  \u201390.00 (2.95)\n  20  \u201399.00 (7.18)  14  \u201397.00 (7.18)\n  37  \u201386.90 (4.10)  39  \u201384.20 (6.40)\n       Not estimable\n\u20132.00 (\u20133.98 to \u20130.02)\n\u20132.00 (\u201313.79 to 9.79)\n  0.50 (0.01 to 0.99)\n  0.35 (\u20130.13 to 0.83)\n       Not  estimable\n\u20135.93 (\u20137.83 to \u20134.03)\n\u20132.00 (\u20134.21 to 0.21)\n\u20132.00 (\u20133.93 to \u20130.07)\n\u20132.00 (\u20136.90 to 2.90)\n\u20132.70 (\u20135.10 to \u20130.30)\nStudy\nor subcategory NN Mean (SD) Mean (SD)\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n5.85\n0.16\n93.98\n100.00\n28.75\n21.25\n27.82\n4.30\n17.88\n\u201310 \u20135 0 5\nMini-incision Standard incision\n10\nFIGURE 11 Meta-analysis of Harris hip score (>3 months) estimated using trial data supplemented by calculated SDs from reported\np-valuesNo studies measured resumption of normal\nactivities over a longer time span, except one\nstudy which reported no episodes of persistent\nlimp at 1 year after mini- or standard incision\nsurgery.31\nCondition-specific quality of life\nMeasurement of condition-specific quality of life\nfollowing surgery was assessed using a variety of\ninstruments, including the Harris hip score,\nWOMAC (Western Ontario and MacMaster\nUniversities Osteoarthritis Index), Oxford hip \nscore and Merle d\u2019Aubign\u00e9\u2013Charnley score. \nIn general, higher scores indicate better quality \nof life. However, for WOMAC and Oxford hip\nscores, higher scores indicate poorer quality \nof life. \nThe short-term (\u00023 months) results are\nsummarised in Table 25. Two trials46,58 and three\ncomparative studies33\u201335 utilised the Harris hip\nscore. All but one study33 favoured the mini-\nincision group but only two found this to be\nstatistically significant.35,58\nSince only one trial46 reported SDs, we estimated\nSDs for the other trial58 using the reported \np-value for the purpose of quantitative synthesis.\nThe results showed no statistically significant\ndifference between the mini- and standard incision\ngroups (Figure 10; Appendix 10, Comparison\n02:33, WMD \u20131.25, 95% CI \u20133.75 to 1.24,\np = 0.33). The average Harris hip scores varied\nwidely across studies, ranging from 67 to 95.\nAlthough not shown in the table, in one case series\nstudy 91% of the 353 participants had a Harris\nhip score of 90 or greater (the best possible score\nis 100).49\nOther studies that examined short-term quality of\nlife through the WOMAC index46,69 and the\nOxford hip score34,46 found no significant\ndifferences between groups (Table 25;\nAppendix 10, Comparisons 01:35 and 01:36).\nHowever, one trial examining the Merle\nd\u2019Aubign\u00e9\u2013Charnley score reported statistically\nsignificantly higher quality of life in the mini-\nincision group compared with the standard\nincision group (Table 25; Appendix 10,\nComparison 01:37).40\nWith respect to the long-term (>3 months) \nresults related to condition-specific quality of life\n(Table 26), eight of the 10 studies that examined\nthe Harris hip score tended to favour the mini-\nincision group, of which only one non-\nrandomised study reported a statistically\nsignificant difference.56 The average scores \nvaried across studies, although compared with \nthe short-term results the scores reported by\nstudies with longer follow-up appeared to be\nhigher (reflecting better quality of life), and the\ndifference between groups was smaller. Only\nlimited quantitative synthesis was possible due to\ninsufficient data. The trial data did not provide\nany evidence of a difference between groups \nafter supplementing with calculated SDs\n(Figure 11; Appendix 10, Comparison 02:34,\nWMD 0.35, 95% CI \u20130.13 to 0.83, p = 0.15) or\ncalculated and dummy SDs (Appendix 10,\nComparison 03:34, WMD 0.27, 95% CI \u20130.15 to\n0.69, p = 0.21). \nUsing an alternative measure of condition-specific\nquality of life (the Merle d\u2019Aubign\u00e9\u2013Charnley\nscore), one further trial again found no \nstatistically significant difference between groups\n(Table 26).40\nGeneral quality of life\nThree studies used components of Short Forms\nwith 12 (SF-12) and 36 Items (SF-36) to ascertain\ngeneral quality of life (Table 27; Appendix 10,\nComparisons 01:39\u201301:43). Overall, quality of life\nscores were similar in both the mini-incision and\nstandard incision groups. However, in one\ncomparative study the standard incision group\nscored higher (better) in the longer term\n(6 months to 1 year) on one test score (SF-36\nphysical function).36\nAlthough not analysed in the trial report by\nCharles and colleagues,69 further patient-level\nanalysis based on the completed SF-36 data\ncollected as part of this RCT was performed\n(Coyle D, Coyle K, University of Ottawa: \npersonal communication, May 2007). This\nanalysis calculated Short Form with 6 Dimensions\n(SF-6D) scores using the algorithm from Brazier\nand colleagues.80 Using an analysis of covariance\nand adjusting for baseline SF-6D scores, the\nresults showed no significant differences in the\nmean values between the mini-incision group \nand the standard incision group at 3 months \n[0.79 (SD 0.08) versus 0.76 (SD 0.10)] or 2 years\nafter operation [0.80 (SD 0.08) versus 0.82 (SD\n0.09)]. A full description of these analyses is\nreported in Appendix 11, including analyses\nusing different methods of handling missing\nvalues.\nPatient satisfaction and scar cosmesis\nSix studies using a variety of measures provided\ninformation on patient satisfaction and scar\nHealth Technology Assessment 2008; Vol. 12: No. 26\n39\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.cosmesis (Table 28; Appendix 10, Comparisons\n01:44\u201301:46). One trial69 reported that patient\nsatisfaction scores (details unknown) were slightly\nlower in the standard incision group than in the\nmini-incision group, although the difference was\nnot statistically significant. \nSimilarly, in three comparative studies36,55,56 the\nnumber of patients dissatisfied with the scar\nappearance of incision was higher in the standard\nincision group, and one study which performed a\nstatistical test found this to be significant. It is\nworth noting that one of the studies where no\nparticipants rated their scar as \u2018unacceptable\u201955\nreported that participants in the mini-incision\ngroup were significantly more likely to rate their\nscar as \u2018excellent\u2019 compared with the standard\ngroup (12\/20 versus 3\/14, p = 0.026), despite \nthe fact that more scars in the mini-incision \ngroup in the same study were rated \u2018poor\u2019 by\nplastic surgeons (MI 6\/20 scars versus \nSI 1\/14 scars). \nAlthough not shown in the table, one comparative\nstudy also reported that over 90% of patients were\nsatisfied with the outcomes irrespective of incision\nlength (<10, 10\u201314 or >14 cm), with the highest\nsatisfaction in the shortest incision (<10 cm)\ngroup, possibly due to less postoperative pain and\nbetter cosmetic appearance.52\nOne trial examined scar cosmesis in terms of\ncontraction.46 The results were similar for both\ngroups. \nTwo-incision THR versus single mini-incision or\nstandard THR\nClinical performance\nRevision rates\nTable 29 shows the revision rate after two-incision\noperations compared with single standard \nincision or single mini-incision operations. One\ncomparative study which examined this outcome\nreported no events after 1 year of follow-up.38\nIn two case series with 1\u20131.5 years of follow-up,\n0.6% of the participants received a revision\nsurgery following a two-incision surgery\n(5\/851;27;1\/20037). \nPostoperative dislocation rate\nOne trial with 30 participants recorded no\npostoperative dislocations in either the two-\nincision group or single standard incision group.57\nTwo case series with 1\u20131.5 years of follow-up\nreported that less than 2% of the participants had\npostoperative dislocations after a two-incision\nsurgery (8\/851;27 2\/10037).\nSurrogates for long-term outcomes\nTwo comparative studies38,53 provided information\non the number of acetabular components (cups)\nthat were poorly placed. There was no significant\ndifference between the two-incision group and the\nsingle mini-incision group (8\/78 versus 8\/78;\nAppendix 10, Comparison 04:03). In terms of the\nfemoral component (stem), there were no\ndifferences between two-incision and single\nstandard incision surgery based on one trial (0\/15\nversus 0\/15)57 or between two-incision and single\nEffectiveness\n40\nTABLE 27 General quality of life\nStudy Measure Mini-incision Standard incision Reported p-value\nN Value (SD)  N Value (SD)\n[range] [range]\nShort-term (\u0002 \u00023 months)\nRCT and quasi-RCT\nCharles, 200669 SF-36 physical component 16 40.8 19 40.4 0.583\nCoylea SF-6D 18 0.79 (0.08) 18 0.76 (0.10)\nOgonda, 200546 SF-12 physical component 107 38.48 (10.20) 108 37.73 (9.48) 0.58\nOgonda, 200546 SF-12 mental component 107 50.61 (11.05) 108 51.11 (10.54) 0.73\nLong-term (>3 months)\nComparative studies\nCoylea SF-6D 18 0.80 (0.08) 18 0.82 (0.09)\nDorr, 200736 SF-36 physical component 109 54.50 (4.29) 56 56.24 (3.87)\nDorr, 200736 SF-36 mental component 109 60.38 (3.84) 56 60.74 (3.42)\na Coyle D, Coyle K, University of Ottawa: personal communication, May 2007.mini-incision surgery based on the results from\ntwo comparative studies (8\/78 versus 7\/78;\nAppendix 10, Comparison 04:04).38,53 \nTwo comparative studies (N = 156) reported that\nthere were no incidents of implant migration.38,53\nIn one case series, implant migration was \nreported in two out of 175 (1%) and heterotopic \nossification in two out of 80 (2.5%).37\nLimb length inequality\nOnly one comparative study provided information\non this outcome.38 There was no significant\ndifference in the proportion of participants who\nhad inequality in limb length in the two-incision\ngroup compared with the single mini-incision\ngroup (6\/39 versus 6\/38; Appendix 10,\nComparison 04:06).\nSafety\nBlood loss\nOne study57 reported that there was significantly\nmore intraoperative blood loss in the two-incision\ngroup than in the single standard incision group\n(Table 30). In two comparative studies comparing\ntwo-incision surgery with single mini-incision\nsurgery, one reported significantly less blood loss\nin the two-incision group,38 whereas the other\nreported significantly more blood loss in the two-\nincision group.71 A further comparative study\nexamining total blood loss reported that there was\nsignificantly more blood loss in the two-incision\ngroup compared with the single mini-incision\ngroup (699 versus 603 ml, p = 0.02).53\nFracture\nTwo comparative studies reported that there were\nHealth Technology Assessment 2008; Vol. 12: No. 26\n41\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 28 Satisfaction\nStudy Measure Mini-incision Standard incision Reported p-value\nN Value (SD)  N Value (SD)\n[range] [range]\nRCT and quasi-RC\nCharles, 200669 Satisfaction (score) 18 15.222 19 14.579 0.341\nOgonda, 200546 Scar (cm) 107 8.44 (1.02) 108 13.95 (1.26)\nOgonda, 200546 Scar (mean contraction at  107 11% 108 12% 0.70\n6 weeks as % of total \nwound length at the end \nof surgery)\nComparative studies\nDorr, 200736 Not happy with cosmesis  109 0 56 21 0.000\n(no. of patients)\nWoolson, 200455 Opinion of scar  20 0 14 0 0.026\n(Mow, 2005)67 \u2018unacceptable\u2019 \n(no. of patients)\nWright, 200456 Disappointed with  37 0 37 5\nappearance of incision\n(no. of patients)\nTABLE 29 Revision rate (number having revision surgery)\nStudy Two incisions Single incision Reported p-values\nn\/N % n\/N %\nTwo-incision vs single standard incision\nNo studies\nTwo-incision vs single mini-incision\nDuwelius, 200738 0\/43 0 0\/43 0\nTwo-incision case series\nArchibeck, 200427 5\/851\nDuwelius, 200337 1\/200\nSubtotal 6\/1051 0.6slightly more intraoperative fractures in the two-\nincision group than in the single mini-incision\ngroup based on the data from two comparative\nstudies, but the difference was not statistically\nsignificant (5\/78 versus 1\/78; Appendix 10,\nComparison 04:09).38,53 In terms of postoperative\nfractures, one trial comparing two-incision with\nsingle standard incision surgery reported one case\nin each group (1\/15 versus 1\/15),57 whereas in\nanother study both postoperative fractures were in\nthe two-incision group (2\/35 versus 0\/35)\n(Appendix 10, Comparison 04:10).53\nTwo case series also reported on fractures.\nIntraoperative fractures were reported in 6% of\nthe samples (62\/851;27 3\/18037), whereas the\nproportion of postoperative fractures was less than\n1% (2\/851;37 3\/20027).\nInfections\nOne study reported that there were no incidents of\ninfections following two-incision or single standard\nincision surgery (0\/15 versus 0\/15).57 Two case\nseries reported infections in 0.8% of the sample\n(7\/851;37 1\/10027).\nNerve injury\nOne trial reported one case of nerve injury in the\ntwo-incision group, compared with none in the\nsingle standard incision group (1\/15 versus \n0\/15).57 Two further studies reported a total of \n10 cases of nerve injury in the two-incision group,\ncompared with none in the single mini-incision\ngroup (10\/78 versus 0\/78; Appendix 10,\nComparison 04:12).38,53 All nerve injuries\nappeared to relate to the lateral cutaneous nerve\nof the thigh, producing a degree of thigh\nnumbness which could be either temporary or\npermanent. Two case series reported that 5% of\nthe participants having two-incision surgery had\nnerve injuries (27\/851;37 18\/7527).\nResource utilisation\nDuration of operation\nDuration of operation was reported by one trial\ncomparing two-incision and single standard\nincision surgery57 and two further studies\ncomparing two-incision and single mini-incision\nsurgery38,79 (Table 31). Across all these studies the\nresults were consistently less favourable (longer\noperation time) for the two-incision group and\nthree studies found this to be statistically\nsignificant. Two case series (including one multi-\ncentre study) also provided information on\noperation time, as shown in Table 31.\nLength of hospital stay\nLength of hospital stay was reported in one trial\ncomparing two-incision and single standard\nincision surgery57 and another three studies\ncomparing two-incision and single mini-incision\nsurgery38,71,79 (Table 32). All studies reported\nshorter hospital stay for the two-incision group\nregardless of the comparator and in three studies\nthis was found to be statistically significant.\nAlthough not shown in the table, in one multi-\ncentre case series study where participants were\nmanaged with an accelerated critical pathway after\nhaving two-incision surgery, 69% (249\/363) were\ndischarged home within 24 hours after surgery.37\nPatient-centred measures\nPain\nThree studies comparing two-incision and single\nmini-incision surgery provided information on\npostoperative pain using various measures. One\ntrial with 72 participants reported that time to\ndiscontinue narcotics was shorter for the two-\nincision group (details not available).73 The \nsecond study with 165 participants reported that\nnarcotic use was significantly less for the two-\nincision group (p < 0.05; no further details\navailable).71 However, the third study reported\nEffectiveness\n42\nTABLE 30 Blood loss (intraoperative, ml)\nStudy Two incisions Single incision Reported p-value\nN Value (SD)  N Value (SD)\n[range] [range]\nTwo-incision vs single standard incision\nYan, 200557 15 760 [600\u20131200] 15 650 [500\u2013800] <0.05\nTwo-incision vs single mini-incision\nDuwelius, 200738 43 366 (215) 43 247 (90) 0.001\nGreidanus, 200671 66 Less 99 More <0.05\nTwo-incision case series\nNo studiesthat the number of patients using a prescription\nanti-inflammatory drug was significantly higher in\nthe two-incision group (20\/43 versus 10\/43,\np = 0.04).38 The same study also reported that\nWOMAC pain scores were lower for the two-\nincision group compared with the single mini-\nincision group 6 weeks after operation (2 versus\n2.5, from graph) but were the same between\ngroups 1 year after operation (1.6 versus 1.6, from\ngraph).38\nReturn to usual activities\nFour studies comparing two-incision with single\nmini-incision surgery provided information on\npatients\u2019 return to usual activities (functional\nrecovery) after surgery using various measures.\nOne trial with 72 participants reported that time\nto return to normal activities and time to\ndiscontinue ambulatory aids were both longer for\nthe two-incision group (details not available).73 A\ncomparative study with 52 participants reported\nthat there were no significant differences between\nthe groups in the duration of ambulatory aids use\n[28 (7\u201356) days versus 27 (5\u201349) days, p = 0.75] or\ntime to return to driving [32 (8\u201349) versus 34\n(20\u201356), p = 0.38].47 However, another study with\n86 participants reported that the two-incision\ngroup was significantly better in terms of time to\nresume driving [13 (2\u201331) days versus 24 (6\u201332)\ndays, p = 0.04] or time to resume shopping \n[14 (3\u201324) days versus 26 (6\u201337) days, p = 0.01].38\nThe fourth trial with 20 participants measured\noutcome at 1 year and reported that there was no\nsignificant difference between the groups in the\nresults of gait analysis performed 1 year after\nsurgery (details not available).72\nHealth Technology Assessment 2008; Vol. 12: No. 26\n43\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 31 Duration of operation (minutes)\nStudy Two incisions Single incision Reported p-value\nN Value (SD)  N Value (SD)\n[range] [range]\nTwo-incision vs single standard incision\nYan, 200557 15 100 [90\u2013220] 15 80 [60\u2013150] <0.05\nTwo-incision vs single mini-incision\nDuwelius, 200738 43 93.7 (90) 43 61.7 (60) 0.002\nTanavalee, 200653 35 168 [130\u2013210] 35 113 [90\u2013140] <0.01\nYoon, 200579 118 72 [50\u2013115] 100 52 [35\u201375] NR\nTwo-incision case series\nArchibeck, 200427 851 148\nDuwelius, 200337 \u2013 C1 100 90\nDuwelius, 200337 \u2013 C2 100 62\nDuwelius, 200337 \u2013 C3a 12 150\nDuwelius, 200337 \u2013 C3b 88 101\nDuwelius, 200337 \u2013 C4 75 85\nC, study centre; NR, not reported.\nTABLE 32 Length of hospital stay (days)\nStudy Two incisions Single incision Reported p-value\nN Value (SD)  N Value (SD)\n[range] [range]\nTwo-incision vs single standard incision\nYan, 200557 15 6 15 13 <0.001\nTwo-incision vs single mini-incision\nDuwelius, 200738 43 1.25 [0.5\u20132.3] 43 1.9 [0.5\u20134.3] <0.001\nGreidanus, 200671 66 Shorter 99 longer <0.05\nYoon, 200579 118 Shorter 100 longer NR\nTwo-incision case series\nNo studies\nNR, not reported.Condition-specific quality of life\nTable 33 shows results from studies reporting on\nthe Harris hip score. In terms of the short-term\n(\u00023 months) results, one study reported\nsignificantly higher scores (better health) for the\ntwo-incision group compared with the single\nstandard incision group.57 In another study, scores\nin the two-incision group were also better than in\nthe single mini-incision group, although the\ndifference appears to be relatively small. \nIn terms of the Harris hip scores over the longer\nterms (>3 months) (Table 33), the two-incision\ngroup did not differ from the single standard\nincision surgery57 or single mini-incision surgery,53\nwhereas in one study the two-incision group\nappeared to be better than the single mini-incision\ngroup.38\nGeneral quality of life\nOnly one study with 86 participants measured\ngeneral quality of life.38 This study used the SF-36\nphysical function and reported that the score in\nthe two-incision group was higher than that in the\nsingle mini-incision group 6 weeks postoperation\n(80 versus 70, estimated from a graph within the\nstudy report), although slightly lower at 1 year\nafter operation (80 versus 85, estimated from a\ngraph within the study report). \nPatient satisfaction\nOne comparative study carried out a self-\nadministered questionnaire survey to ascertain\nperceptions of 26 patients who underwent staged\nbilateral THRs with two-incision THR on one hip\nand single mini-incision THR (posterior) on the\nother hip.47 At a minimum of 6 months after the\nsecond operation, 62% (16\/26) of the patients\npreferred the single mini-incision approach to the\ntwo-incision approach with their reasons being a\nbetter early recovery (8\/16 participants), better\ncosmetic results (4\/16) or both (4\/16). Eight\npatients preferred the two-incision approach\nbecause of a better early recovery. None preferred\nthe cosmetic appearance of two-incision THR, as\nthey were not satisfied with the presence of the\nanterior incision, which was clearly visible during\nsimple daily activities such as bathing and\nchanging clothes.\nImportant subgroup differences for\nminimal incision versus standard\ntechniques\nOne trial reported subgroup analysis for grossly\nobese patients and muscular male patients, for\nwhom a mini-incision was thought to be more\ndifficult.46 The mean operative time was\n7.5 minutes longer for patients with a BMI of \n>35 (69.5 \u00b1 11.2 minutes) than that for patients\nwith a BMI of <30 (62.0 \u00b1 11.3 minutes). The\ndifference was statistically significant (p < 0.001),\nirrespective of the incision length. For the\nmuscular male patients with a mid-thigh\ncircumference of >55 cm, the mean operative\ntime (61.4 \u00b1 11.0 minutes) was not found to be\nsignificantly different from that for the less\nEffectiveness\n44\nTABLE 33 Harris hip score\nStudy Two incisions Single incision Reported p-value\nN Value (SD)  N Value (SD)\nShort-term (\u00023 months)\nTwo-incision vs single standard incision\nYan, 200557 15 89 15 86 <0.05\nTwo-incision vs single mini-incision\nDuwelius, 200738 43 89 43 88 From graph\nTwo-incision case series\nNo studies\nLong-term (>3 months)\nTwo-incision vs single standard incision\nYan, 200557 15 93 15 93 >0.05\nTwo-incision vs single standard incision\nDuwelius, 200738 43 94 43 88 From graph\nTanavalee, 200653 35 94.5 (4.7) 35 94.6 (4.5) 0.95\nTwo-incision case series\nDuwelius, 200337 100 90muscular male patients (66.9 \u00b1 13.2 minutes)\n(p = 0.17). Caution is required, however, as the\nnumber of patients was small.\nOne case series of the two-incision procedure also\nreported that the incidence of key complications\n(fractures, nerve deficits and dislocations) was\nnearly two times higher for patients with a BMI of\n\u000430 (16.3%) than that for patients with a BMI of\n<30 (8.3%) (p = 0.05).27\nThe same case series of the two-incision \nprocedure examined the possible effect of \nsurgeon experience on operative time, blood loss\nand the prevalence of key complications.27 This\nstudy was a prospective survey of trainee surgeons\nwho attended corporate-sponsored training on the\ntwo-incision THR. Results from 851 procedures\nperformed by 159 surgeons following training\nshow that the mean operative time was\nsignificantly decreased, as the surgeons progressed\nfrom their first case (168 \u00b1 49.6 minutes) to their\ntenth case (130 \u00b1 47.1 minutes) (p < 0.05). Blood\nloss also decreased non-significantly from the first\n(547 \u00b1 377 ml) to tenth (427 \u00b1 260 ml) cases\n(p > 0.05). No significant relationship was found\nbetween complication rates and surgeon\nexperience. Nevertheless, the prevalence of\ncomplications was significantly higher for surgeons\nwho reported performing less than 50 operations\nper year (26.5%), compared with surgeons\nperforming 50 or more operations per year \n(7.1% for surgeons performing 50\u2013100, 8.6% for\nsurgeons performing 100\u2013150 and 7.1% for\nsurgeons performing over 150 operations,\np = 0.0003).\nSummary and conclusions of the\nevidence for and against the\nintervention\nDespite the number of studies identified, there\nwas little evidence of any longer term differences\nbetween incision length. This is primarily due to\nthe lack of data available. Surrogates for longer\nterm outcomes also did not provide sufficient\ninformation with which to make judgements about\nlonger term performance. \nOverall, it appears likely that the mini-incision\napproach offers some perioperative advantages\nin terms of less blood loss and shorter operative\ntime, although these may be of limited practical\nsignificance. The mini-incision approach may\nalso offer a shorter recovery period as identified\nby the shorter length of hospital stay and time to\nreturn to usual activities. This quicker recovery is\na key issue in the economic evaluation, the\nmethods of which are discussed in Chapter 5,\nwhere the impact of this earlier recovery is\nmeasured using QALYs. Patients also appear to\nbe more satisfied with the operation and the\nappearance of the scar (although this latter\nfinding may be more influenced by the scar\u2019s\nlocation than its size). As indicated above, \nlimited data are available for other outcomes \nand the level of uncertainty is such that \nclinically important differences may exist\nfavouring either treatment. Nevertheless, until\nnew data become available, it may be sensible to\nassume that the two methods are comparable. \nA summary of the effect sizes based on \nmeta-analyses of trial data is given in \nTable 34. \nWith respect to the two-incision procedure, it is\nnot possible to draw firm conclusions due to the\nsmall number of studies identified from our\nsearches and also the poor quality of the data\nreported. At best, the data suggest that the \ntwo-incision procedure may offer a possible\nshort-term benefit in terms of earlier discharge\nfrom hospital and better quality of life (Harris\nhip score) (Table 35). Although there were more\ncases of nerve injuries with the two-incision\noperation, the CIs were wide and did not rule\nout clinically important differences that could\nfavour either two-incision or single incision\nprocedures. It is also worth noting that blood loss\nand operation time tended to favour single\nincision rather than two-incision surgery. As is\nthe case for single mini-incision THR, any\nobserved differences in operation duration\nfollowing the two-incision procedure, compared\nwith standard THR, are not likely to be large and\nmay be of limited practical significance. For\nlonger term outcomes, there was no discernible\ndifference by the type of surgical procedures\nwithin the available data. \nHealth Technology Assessment 2008; Vol. 12: No. 26\n45\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Effectiveness\n46\nTABLE 34 Summary of the effect size from meta-analysis of the trial data for single mini-incision THR versus standard THR \nOutcome (WMD and Peto OR based on trials) [95% CI] No. of trials \n(No. of comparative studies)\nFavours mini-incision\nBlood lossa\nWMD \u201356.59 [\u201371.63 to \u201341.55], p < 0.00001 7 (11)\nDuration of operationa\nWMD \u20133.70 [\u20135.67 to \u20131.74], p = 0.0002 9 (15)\nLength of hospital staya\nWMD \u20130.50 [\u20130.83 to \u20130.18], p = 0.002 6 (12)\nReturn to usual activities after operation\nTime to return to normal activities: no trial data 0 (1)\nUse of walking aids (days): WMD \u20133.40 [\u20135.23 to \u20131.57], p = 0.0003 1 (0)\nUse of walking aids (N of patients): Peto OR 0.55 [0.20 to 1.53], p = 0.25 1 (1)\nLimp: Peto OR 0.31 [0.11 to 0.91], p = 0.03 1 (1)\nPatient satisfaction\nWMD not estimable 1 (3)\nNo evidence of a difference or insufficient information\nRevision rates\nPeto OR 7.96 [0.16 to 402.02], p = 0.30 3 (6)\nPostoperative dislocation rates\nPeto OR 1.72 [0.43 to 6.92], p = 0.45 6 (11)\nSurrogates for long-term outcomes\nImplant position (cup): Peto OR 0.93 [0.50 to 1.74], p = 0.83 3 (6)\nImplant position (stem): Peto OR 0.70 [0.35 to 1.40], p = 0.31 5 (9)\nImplant migration: Peto OR not estimable 1 (1)\nHeterotopic ossification: no trial data 0 (2)\nCement quality: Peto OR 1.26 [0.70 to 2.27], p = 0.45 3 (4)\nLimb length inequality (number of patients with unequal length)\nNo trial data 0 (1)\nIntraoperative fractures\nPeto OR 0.14 [0.01 to 2.18], p = 0.16 2 (3)\nPostoperative fractures\nPeto OR not estimable 2 (3)\nInfections\nPeto OR 7.48 [0.78 to 72.16], p = 0.08 7 (9)\nNerve injury\nPeto OR 1.95 [0.20 to 18.89], p = 0.56 6 (9)\nVascular injuries\nPeto OR not estimable 1 (0)\nDVT\nPeto OR 0.39 [0.12 to 1.30], p = 0.12 5 (6)\nPulmonary embolism\nPeto OR not estimable 1 (2)\n30-day mortality\nPeto OR 0.14 [0.01 to 2.18], p = 0.16 1 (2)\nLong-term mortality\nPeto OR 0.15 [0.01 to 2.45], p = 0.18 1 (2)\nAnalgesic use\nNarcotic (days): WMD not estimable 1 (0)\nPatient-controlled anaesthesia (mg): WMD \u20134.41 [\u201329.18 to 20.36], p = 0.73 3 (0)\nTotal narcotic received (mg): no trial data 0 (3)\ncontinuedHealth Technology Assessment 2008; Vol. 12: No. 26\n47\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 34 Summary of the effect size from meta-analysis of the trial data for single mini-incision THR versus standard THR (cont\u2019d)\nOutcome (WMD and Peto OR based on trials) [95% CI] No. of trials \n(No. of comparative studies)\nShort-term pain\nPain (no. of patients): no trial data 0 (3)\nPain score: WMD \u20130.06 [\u20130.56 to 0.44],p = 0.81 4 (2)\nLong-term pain\nPain score: WMD not estimable 1 (0)\nLong-term difference in usual activities\nLimp: Peto OR not estimable 1 (0)\nShort-term condition-specific quality of life\nHarris hip scorea: WMD \u20131.25 [\u20133.75 to 1.24], p = 0.33 2 (3)\nWOMAC: WMD 0.45 [\u20133.13 to 4.03], p = 0.81 2 (0)\nOxford hip score: WMD \u20130.91 [\u20132.74 to 0.92], p = 0.33 1 (1)\nMerle d\u2019Aubign\u00e9\u2013Charnley score: WMD not estimable 1 (0)\nLong-term condition-specific quality of life\nHarris hip scorea: WMD 0.35 [\u20130.13 to 0.83], p = 0.15 4 (6)\nMerle d\u2019Aubign\u00e9-Charnley score: WMD not estimable 1 (0)\nShort-term general quality of life\nSF-12 physical component: WMD \u20130.75 [\u20133.38 to 1.88], p = 0.58 1 (0)\nSF-12 mental component: WMD 0.50 [\u20132.39 to 3.39], p = 0.73 1 (0)\nSF-36 physical function WMD: not estimable 1 (0) \nLong-term general quality of life\nSF-36 physical function: no trial data 0 (1)\nSF-36 mental function: no trial data 0 (1)\nFavours standard incision\nNo outcomes\na Based on published data supplemented with calculated standard deviations. All other values (WMD and Peto OR) are\nbased on published data.\nTABLE 35 Summary of evidence for two-incisions THR versus single mini-incision or standard THR\nOutcome No. of studies\nFavours two incisions\nLength of hospital stay\n2MI vs SI: 1 favours two incisions (significant difference) 1\n2MI vs MI: 3 favour two incisions (2 significant difference) 3\nShort-term condition-specific quality of life (Harris hip score)\n2MI vs SI: 1 favours two incisions (significant difference) 1\n2MI vs MI: 1 favours two incisions (no significant difference) 1\nNo evidence of a difference or insufficient information\nRevision rates\n2MI vs SI: no studies 1\n2MI vs MI: no events 1\nPostoperative dislocation rates\n2MI vs SI: no events 1\n2MI vs MI: no studies 0\nSurrogates for long-term outcomes\nImplant position (cup):\n2MI vs SI: no studies 0\n2MI vs MI: 8\/78 cases vs 8\/78 cases  2\ncontinuedEffectiveness\n48\nTABLE 35 Summary of evidence for two incisions THR versus single mini-incision or standard THR (cont\u2019d)\nOutcome No. of studies\nImplant position (stem): \n2MI vs SI: no events  1\n2MI vs MI: 8\/78 cases vs 7\/78 cases  2\nImplant migration:\n2MI vs SI: no studies 0\n2MI vs MI: no events 2\nLimb length inequality\n2MI vs SI: no studies 0\n2MI vs MI: 6\/39 cases vs 6\/38 cases 1\nIntraoperative fractures\n2MI vs SI: no studies 0\n2MI vs MI: 5\/78 cases vs 1\/78 cases 2\nPostoperative fractures\n2MI vs SI: 1\/15 cases vs 1\/15 cases 1\n2MI vs MI: 2\/35 cases vs 0\/35 cases 1\nInfections\n2MI vs SI: no events 1\n2MI vs MI: no studies 0\nShort-term pain\nNarcotics use: \n2MI vs SI, no studies 0\n2MI vs MI: 2 favour 2MI (1 significant difference), 1 favours MI (significant difference) 3\nPain score: \n2MI vs SI, no studies 0\n2MI vs MI, 1 favours two incisions (no significant difference) 1\nLong-term pain (pain score)\n2MI vs SI: no studies 0\n2MI vs MI: no significant difference 1\nReturn to usual activities after operation (various measures)\n2MI vs SI: no studies 0\n2MI vs MI: 1 favours 2MI (significant difference), 1 favours SI (no significant difference), 1 no difference 3\nLong-term difference in usual activities (gait analysis)\n2MI vs SI: no studies 0\n2MI vs MI: no significant difference 1\nLong-term condition specific quality of life (Harris hip score)\n2MI vs SI: no significant difference 1\n2MI vs MI: no significant difference 2\nShort-term general quality of life (SF-36)\n2MI vs SI: no studies 0\n2MI vs MI: 1 favours 2MI (no significant difference) 1\nLong-term general quality of life (SF-36)\n2MI vs SI: no studies 0\n2MI vs MI: 1 favours MI (no significant difference) 1\nFavours single incision\nBlood loss\n2MI vs SI: 1 favours SI (significant difference) 1\n2MI vs MI: 1 favours 2MI (significant difference); 1 favours MI (significant difference) 2\nNerve injury\n2MI vs SI: 1\/15 cases vs 0\/15 cases 1\n2MI vs MI: 10\/78 cases vs 0\/78 cases 2\nDuration of operation\n2MI vs SI: 1 favours SI (significant difference) 1\n2MI vs MI: 3 favour MI (2 significant difference) 3 Methods\nSearch strategies\nStudies that reported both costs and outcomes of\nsingle mini-incision and\/or two mini-incision\ntechniques compared with standard THR surgery\nfor the treatment of arthritis of the hip were\nsought from a systematic review of the literature.\nNo language restrictions to searches were\nimposed.\nDatabases searched were MEDLINE\n(1996\u2013February Week 3 2007), EMBASE\n(1980\u2013Week 8 2007), MEDLINE In-Process \n(1 March 2007), Science Citation Index \n(1985\u20132 March 2007), NHS Economic Evaluation\nDatabase (NHS EED) (December 2006), HTA\nDatabase (December 2006) and Health\nManagement Information Consortium\n(1979\u2013March 2006). In addition, recent\nconference proceedings and reference lists of all\nincluded studies were scanned to identify\nadditional potentially relevant studies. Other\nsources of information consulted included\nreferences in relevant articles and selected experts\nin the field. Full details of the search strategies\nused are documented in Appendix 1.\nInclusion and exclusion criteria\nTo be included, studies had to compare, in terms\nof both costs and outcomes, strategies involving\nsingle and\/or two mini-incision surgical techniques\nwith standard THR for the treatment of arthritis\nof the hip. Studies were included even if they\nmade no formal attempt to relate cost to outcome\ndata in a cost-effectiveness or cost\u2013utility analysis.\nOne reviewer assessed all abstracts for relevance\nand full papers were obtained for those that\nappeared potentially relevant.\nData extraction strategy\nThe following data were extracted for each\nincluded primary study using the framework\nprovided for abstracts prepared for the NHS\nEED:81\n1. Study identification information\n(a) Author and year.\n(b) The interventions studied.\n(c) The type of economic evaluation.\n(d) The country of origin and currency\nreported.\n2. The intervention, study design and main outcomes\n(a) Fuller description of treatment.\n(b) Numbers receiving or randomised to each\nintervention.\n(c) Outcomes studied.\n3. Sources of data\n(a) Effectiveness data.\n(b) Mortality and co-morbidity (if measured).\n(c) Cost data.\n(d) Quality of life (if measured).\n4. Methods and study perspective\n5. Results\n(a) Costs.\n(b) Benefits.\n(c) Incremental cost-effectiveness ratio\n(ICER)\/cost\u2013utility.\n(d) Sensitivity analyses.\n6. Additional comments relating to the design and\nreporting of the economic evaluation\nFor reviews of economic evaluations, data were\nextracted on the nature of the review\nmethodology used, the inclusion criteria for\nstudies, the number of studies identified, the\nmethod of quality assessment for individual\neconomic evaluations and the conclusions\ndrawn on the relative efficiency of the\nalternative methods.\nQuality assessment strategy\nOne economist assessed included studies using the\nNHS EED guidelines for reviewers.81\nData synthesis\nNo attempt was made to synthesise quantitatively\nthe primary studies that were identified. Data from\nall included studies were instead summarised and\nappraised in order to identify common results,\nvariations and weaknesses between studies. \nResults\nNumber of studies identified\nThe results of the literature search are presented\nin Table 36. The number of reports retrieved from\nthe search in the Science Citation Index is the\ntotal after deduplication against the results of the\nMEDLINE\/EMBASE multi-file search.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n49\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nChapter 4\nSystematic review of economic evaluationsTwenty-three papers were selected from the\nsearches, four of which were assessed for the\nsystematic review. The remaining 19 papers were\nselected for background information or for\npossible utilities data. Of the four studies, one82\nmet the inclusion criteria. One additional\nunpublished paper was obtained from a\nmanufacturer of hip prostheses (Duwelius and\ncolleagues, Providence St Vincent Medical Center,\nPortland, OR, 2006) (henceforth Duwelius, 2006).\nReasons for exclusion of the remaining three were\nthat one contained no cost information,62 in the\nsecond the procedures followed a care pathway\ndissimilar to usual care in the UK NHS \n(standard THR was treated as an inpatient\nprocedure, whereas minimal incision THR was an\noutpatient procedure)83 and the final study\ncompared standard THR with a \u2018do nothing\u2019\napproach and not a minimal incision THR\ntechnique.84\nStudy identification and key elements\nComparators, type of study, dates for collection\nand prospective study from sample\nThe unpublished paper by Duwelius and\ncolleagues compared single mini-incision and two\nmini-incision THR with standard THR on a group\nof non-randomised patients in the USA. The study\nby Straumann and colleagues, set in Switzerland,\nused a model based analysis to assess\nconsequences to Switzerland of MIS THR\ncompared with standard THR at the aggregate\nlevel. For the Swiss study, MIS THR was assumed\nto include both the single mini-incision and two\nmini-incision surgical techniques.82\nThe unpublished study was classified as a\ncost\u2013utility analysis, that is, when the\nconsequences of programmes are adjusted by\ngeneric health state preference scores to allow the\nQALYs gained to be assessed as opposed to the\ncrude number of years.85 The Swiss study was\nclassified as a modelling study with a retrospective\ncosting exercise of standard THR. Effectiveness\ndata and cost difference between standard and\nMIS THR were based on the unpublished US\nstudy by Duwelius and colleagues. Both papers\ntook a societal perspective, that is, in addition to\nhospital and community costs they both took into\naccount the cost of productivity losses. The\ncharacteristics of the included studies are\npresented in Table 37.\nThe unpublished US study collected effectiveness\ndata prospectively over the period from 2002 to\n2005. The costing was undertaken retrospectively\non the same sample as that used for the\neffectiveness study (Duwelius, 2006). In relation to\nthe Swiss study, the baseline costs were estimated\nfor the year 2003.\nSystematic review of economic evaluations\n50\nTABLE 36 Results of searching for studies on cost-effectiveness\nDatabase Hits Selected  for \nscreened full assessment\nMEDLINE\/EMBASE\/MEDLINE In-Process multi-file search (after deduplication in Ovid) 56 16\nSCI 12 1\nNHS NEED 55\nHTA database 35 1\nHMIC 10 0\nSelected from conference abstracts 0 0\nTotal 118 23\nTABLE 37 Characteristics of the included studies\nStudy Design Sample Follow-up Perspective\nDuwelius, 2006  Multi-centre prospective  Two-incision THR: 235 6 weeks Societal\n(unpublished) (USA) non-randomised, unmatched  Mini-incision THR: 325\ncohort study Standard THR: 31 \nStraumann, 200682 Modelling with retrospective  13,101 primary THRs  NA Societal\n(Switzerland) costing exercise of standard  performed in Switzerland \nTHR in 2003\nNA, not applicable.Patient group, study sample and study\ndesign\nThe sample size of the US study was 591 patients,\nalthough patients were not distributed equally\nbetween the three interventions: 235 patients were\ntreated using the two mini-incision technique, \n325 using the single mini-incision technique and\n31 using standard THR. The study was a multi-\ncentre unmatched cohort study. Fourteen surgeons\nat 10 hospitals provided data on the 591 patients.\nIt appears that no eligibility criteria were specified\nand patients were recruited to each intervention\nbased on surgeon preference. As a consequence,\nsignificantly different (p \u0002 0.05) demographic\ncharacteristics between groups at time of\noperation were identified. That is, a trend in\npatient selection tending towards younger and\nhealthier patients was apparent for the two mini-\nincision and single mini-incision techniques\n(Duwelius, 2006). Patients were followed up for a\nmaximum of 6 weeks.\nIn terms of patient groups and study sample, the\npaper by Straumann and colleagues is difficult to\nquantify.82 This study was a simple model-based\nanalysis which utilised a retrospective costing\nexercise of standard THR. It is assumed, from\npublished literature, that 13,101 primary THR\noperations were performed in Switzerland in\n2003. The average hospital cost of a primary THR\nwas estimated from a single hospital in Zurich.\nFrom the total number of primary THRs\nperformed, it was assumed that, potentially, 30%\n(conservative) or up to 50% (optimistic) of these\nmight have been performed as an MIS technique.\nTherefore, the costs (and potential cost savings) of\nthe MIS techniques were calculated at the\naggregate level, for rates of 30 and 50%, by\nmultiplying the cost difference in percentage\nterms between standard and MIS THR from the\nunpublished US study with the cost of standard\nTHR (Duwelius, 2006).\nThe main clinical outcome measures for the\nincluded studies are presented in Table 38.\nMethods of economic analysis\nBoth papers provided details on which items were\nincluded in cost calculations, although no unit cost\ndata were presented for either. What is not clear is\nwhether a consistent base-year has been applied to\nall costs (Duwelius, 2006). Indirect costs were\ncalculated for both studies using the human\ncapital approach (time off paid work). In terms of\nsummary measures of health benefits, none were\npresented for the study by Straumann and\ncolleagues, which assumed that outcomes were\nequal,82 whereas the unpublished US paper\npresented QALYs as its main measure of health\nbenefit (Duwelius, 2006).\nTwo-way sensitivity analysis was performed in the\npaper by Duwelius and colleagues for all costs and\nutility values. Further, community costs such as the\ncost of an inpatient rehabilitations facility, skilled\nnursing facility, home health care, home only (no\nrehabilitation) and physician costs were all varied\nby +30% and \u201330% of the base-case values. Wages\nand hospital cost-to-charge ratios were also varied\nby +10% or \u201310% of base-case values. Inflation\nrates were varied by +5% to \u20135% of base-case\nvalues to see what effect this might have on results\n(Duwelius, 2006). The only sensitivity analysis\nperformed in relation to the Swiss paper was\nchanges to the indication rate of minimally\ninvasive techniques from 30% (assumed to be\nconservative) to 50% (optimistic).82\nResults\nThe results of the included studies are shown in\nTable 39. In the unpublished US study by Duwelius\nand colleagues, total costs including productivity\ncosts were lowest for the two mini-incision\ntechnique and highest for the standard technique\n(two mini-incision, $16,085; single mini-incision,\n$16,615; and standard incision, $21,705)\n(Duwelius, 2006). When the total cost was broken\ndown into hospital costs, rehabilitation costs and\nindirect costs, the cost for the two mini-incision\nand single mini-incision techniques were\nconsistently lower than standard THR with two\nHealth Technology Assessment 2008; Vol. 12: No. 26\n51\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 38 Outcome measures used in the included studies\nStudy End-points\nDuwelius, 2006 (unpublished) (USA) Time to walking without support (WWOS)\nPsychometric health status (SF-36)\nPostoperative recovery (approximated by WWOS, Harris hip score and \nhealth-related quality of life)\nVarious complications\nStraumann, 200682 None specified (assumed equal)mini-incision remaining the least costly option. It\nis unclear whether the differences in costs were\ntested for significance and no CIs were reported.\nIn terms of benefits, 6-week QALYs were\ncalculated for the three interventions and the\nreported incremental effectiveness of the two mini-\nincision and single mini-incision techniques\ncompared with standard incision were 0.037 and\n0.023 QALYs gained respectively. The authors\nreported that the same patterns of outcomes and\ncosts were observed after varying input parameters\nto test the sensitivity of the base-case assumptions.\nNo measure of health benefit was included in the\nstudy by Straumann and colleagues.82 Average\nhospital costs per patient were higher for standard\nTHR compared with MIS THR (\u20ac13,511 versus\n\u20ac11,534.40 per patient). At the aggregate level, it\nwas assumed that by employing MIS in place of\nstandard THR for 30 or 50% of cases, hospital and\nrehabilitation costs would reduce dramatically and\nthat many millions of euros would be saved over\nthe 1-year time horizon. In terms of indirect costs,\nit was assumed that 36 fewer work days were lost\nper employed patient with MIS THR as opposed\nto standard THR. From this, it was estimated that\nthe effective reduction of productivity losses\nranged between \u20ac23.8 million and \u20ac39.7 million.\nSummary of results and discussion\nThe two studies that met the inclusion criteria of\nthe review of economics estimated that MIS THR\n(including both single and double mini-incision) is\nlikely to be less costly than standard THR. This is\ndue to the fact that the unpublished US study\nfound that length of stay was statistically\nsignificantly shorter for the MIS procedures\n(p \u0002 0.05). The study also found that the need for\ncommunity rehabilitation was also reduced for the\nMIS procedures in comparison to standard THR.\nSystematic review of economic evaluations\n52\nTABLE 39 Cost and outcome data reported in the included studiesa\nStudy Finding Two Single  Standard\nmini-incision mini-incision\nDuwelius, 2006  Total cost $16,085 $16,615 $21,705\n(unpublished) [\u00a38,042.50] [\u00a38,307.50] [\u00a310,852.50]\n(USA)\nPrice year 2003 Total costs, excluding productivity losses $14,651 $14,825 $19,451\n[\u00a37,325.50] [\u00a37,412.50] [\u00a39,725.50]\n6-week QALYs 0.053 0.039 0.016\nMIS (both single and \ntwo mini-incision)\nStraumann,  Total cost per patient \u20ac13,511 \u20ac11,534.40\n200682 Switzerland [\u00a39,187.48] [\u00a37,843.39]\nPrice year not  Aggregate hospital cost savings assuming  \u20ac7.8 million saving  NA\nstated 30% MIS indication rate [\u00a35.3 million saving]\nAggregate hospital cost savings assuming  \u20ac12.9 million saving  NA\n50% MIS indication rate [\u00a38.8 million saving]\nAggregate community cost savings \u20ac10.9 million saving [\u00a37.4 million saving] NA\nassuming 50% MIS indication rate for two mini-incision and \n\u20ac10.1 million saving [\u00a36.9 million saving] \nfor single mini-incision \nAggregate community cost savings \u20ac18.1 million saving [\u00a312.3 million saving]  NA\nassuming 50% MIS indication rate for and two mini-incision and \n\u20ac16.9 million saving [\u00a311.5 million saving] \nfor single mini-incision\nAggregate indirect cost savings assuming  \u20ac23.8 million saving NA\n30% MIS indication rate [\u00a316.2 million saving]\nAggregate indirect cost savings assuming  \u20ac39.7 million saving\n50% MIS indication rate [\u00a327 million saving] NA\nNA, not applicable.\na Figures in brackets are conversions in UK \u00a3 sterling using rates of US$1 \u2248 \u00a30.5 and \u20ac1 \u2248 \u00a30.68.Furthermore, it was reported that short-term\noutcomes were improved for the MIS techniques\nin comparison with standard THR, although\ndifferences in 6-week QALYs were not statistically\nsignificant (Duwelius, 2006). It should be noted\nthat a statistically significant difference in terms of\ncase mix between the groups in the unpublished\nUS study was found, that is, a trend in patient\nselection saw younger and healthier patients being\nselected for the two mini-incision and single mini-\nincision approaches compared with standard\nTHR. The authors attempted to compensate for\nthis bias by using propensity scoring (Duwelius,\n2006). As the relative differences in costs and\neffects were taken from the unpublished US paper\n(Duwelius, 2006) and applied to Swiss data in the\nstudy by Straumann and colleagues,82 it is\nunsurprising that the same conclusions in terms of\ncosts were found. Both studies concluded that the\nadoption of MIS techniques in the field of THR\nwould likely reduce healthcare costs and provide\nbetter short-term outcomes. \nThere are numerous issues that should be taken\ninto account when interpreting the results of the\ntwo described studies, which are, at best,\ncontentious. In relation to the unpublished US\nstudy, the single most important limitation related\nto the case mix of patients recruited to the three\nsurgical approaches. Patients were non-\nrandomised and unmatched and, as a result, all\nreductions in necessity for postoperative care and\nimproved outcomes are likely to be affected by the\nfact that younger and healthier people were\nconsistently selected to receive the MIS\ntechniques. As a result, the fact that these patients\nwere discharged from hospital sooner, were less\nlikely to use rehabilitation facilities in the\ncommunity and had higher quality of life in terms\nof QALYs gained is what one might have expected\nif the same patient group were treated using the\nstandard method. The authors used propensity\nscoring when calculating health-related quality of\nlife to counteract the potential biases that might\narise from differences in case mix, although it is\nunclear if this approach would have corrected\npossible selection biases. Further limitations of this\nstudy related to the costing method. A\nretrospective costing exercise took place which\nestimated surgeon costs from the Medicare\nunadjusted national average rates for primary\nTHR, hospital costs from charge data converted to\ncosts using a hospital cost-to-charge ratio and\nrehabilitation costs from inpatient hospital\ndischarge and Medicare reimbursement schedules.\nBearing in mind the methods used to collect cost\ndata, it is unknown whether such costs would be\nappropriate to the UK and, indeed, to THR\nsurgery, as charges were converted using \nhospital-level cost-to-charge ratios. Furthermore,\nno attempt was made to correct for possible\nselection biases and it is unclear whether a\nconsistent base year was applied to all costs as is\nusual good practice when conducting an economic\nevaluation. \nIn relation to the paper by Straumann and\ncolleagues,82 little useful information is presented\nand this study is not a typical costing exercise. The\npaper assumes equal effectiveness in terms of\noutcomes and only considers the potential cost\nsavings from the introduction of minimally\ninvasive techniques. By applying the definitive cost\ndifference between minimally invasive THR and\nstandard THR to the average cost of a standard\nTHR in Switzerland, the authors are making\nseveral extremely strong assumptions. First, the\nauthors assume that data from the unpublished US\nstudy are valid, even for the US, and that MIS\nTHR is likely to have equal or better outcomes\nthan standard THR. The authors also assume that\nUS data are likely to be applicable to Switzerland,\ndespite the vast difference in standard surgical\npractice across healthcare systems.\nConclusions\nThis chapter presents the overall evidence\navailable on the cost-effectiveness of single mini-\nincision and two mini-incision THR compared\nwith standard THR in the treatment of arthritis of\nthe hip, based on a systematic review of the\nliterature. The two cost studies that met the\ninclusion criteria for the review of economic\nevaluations add little, if any, value to the current\nevidence base. Although results claim that MIS\ntechniques are likely to be cost saving and provide\nbetter outcomes in the immediate postoperative\nperiod, the strong assumptions made by the\nauthors of the two included studies have probably\nproduced biased, unreliable results with limited\napplicability to the UK. The conclusions drawn\nwithin the two studies are very strong given their\nlimitations in quality. The measurement and\ninclusion of such costs (indirect costs) in an\neconomic evaluation, however, are contentious. A\nwell-designed UK-based economic evaluation with\nlong-term follow-up of costs and outcomes is\nwarranted to answer questions over the potential\ncost-effectiveness of single and two mini-incision\nTHR in the NHS (even after we consider the\naddition to the evidence base of the economic\nevaluation conducted as part of this report).\nHealth Technology Assessment 2008; Vol. 12: No. 26\n53\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Economic model\nIn this chapter, the data available on costs and\neffects are combined in an economic model to\nestimate the cost-effectiveness of minimal incision\nTHR compared with standard THR for the\ntreatment of arthritic disease of the hip. The results\nshould be treated with caution, as the model is\nconstrained by the paucity of data available for\nestimating some model parameters. It was not\npossible to include the two mini-incision technique\nin the model analysis owing to the limited and\npoor-quality data available. Conceivably, expert\nopinion might have been used to provide some\nestimates of the necessary parameters to guide an\neconomic analysis of the two incision method. This\napproach was not adopted, however, as it is believed\nthat the two mini-incision technique has fallen out\nof favour within the orthopaedic community\n(Hutchison JD, Department of Surgery, University\nof Aberdeen and Munro N, NHS Grampian:\npersonal communication, April 2007).\nThe economic evaluation was conducted using a\nMarkov Model (constructed in TreeAge Pro 2007).\nThe model estimated the short-term (1-year) long-\nterm costs and benefits of a cohort of typical\npatients for the different surgical procedures. The\nlong-term model followed a cohort of patients\nfrom their initial operation through their\nconvalescence (operation state) to their return to\nusual activities (defined in the model as a\n\u2018Successful THR state\u2019). The patients may remain\nin this state until they die or they suffer a\ncomplication and therefore have a revision\noperation or some other form of long-term\npatient management if surgery is no longer\nconsidered a viable option. Conceptually, the\npatients could move between states within the\nmodel until they all eventually die. For the\npurposes of the analysis, however, the cohort of\npatients was modelled for a maximum of 40 years\nfollowing the initial operation, which represents\nthe maximum survival for the majority of the\npatients. An illustrative representation of the\nMarkov model can be seen in Figure 12.\nDeterministic sensitivity analysis to explore\nchanges in parameter values or threshold values\nwas conducted. Many of these deterministic\nanalyses were combined with partial probabilistic\nsensitivity analyses where many, but not all,\nparameters within the model were described by a\nHealth Technology Assessment 2008; Vol. 12: No. 26\n55\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nChapter 5\nEconomic evaluation\nPrimary THR\nSuccessful THR Non-operative\nmanagement\nSuccessful\nrevision\nRevision\nAll health states\ncan progress\nto Death state\nFIGURE 12 Markov model for standard and mini-incision THRprobability distribution. The methods used to\nassign these distributions are described below.\nWhere no distribution was attached to a\nparameter, this was because the estimates were\nrelatively precise or a standard value was used or\ninsufficient information was available to estimate a\ndistribution.\nFollowing their initial surgery, patients could move\ninto one of following states:\n\u25cf Successful THR state.\n\u25cf Revision state: where a patient has revision\nsurgery.\n\u25cf Successful THR revision state: where patients\nfollowing a successful revision operation remain\nuntil they die or have further complications\nwarranting surgery and\/or non-operative\nmanagement.\n\u25cf Non-operative management state: resulting in\nlong-term non-operative management of the\ndisease, as surgery is no longer a viable option.\n\u25cf Death.\nA cost per patient for each health state in the\nMarkov model was calculated using the methods\noutlined below. The main cost components in the\nmodel are the initial operative procedure and the\ncosts of any subsequent revision operation or long-\nterm non-operative management. It was assumed\nthat if a patient suffered a complication requiring\na revision procedure, the patient would be\noperated on using standard THR regardless of the\nmethod of THR they originally received. Death is\nthe only state within the model that a patient\ncannot leave (i.e. it is an absorbing state). As \nall orthopaedic surgical procedures carry some\nrisk of complications, the costs of postoperative\ncomplications were included where it was felt likely\nthat the impact on quality of life or costs would be\nsubstantial. \nThe cycle length (the minimum period between\ntransitions) of the model was set at 1 year, and the\nmodel was run for a maximum of 40 cycles\nalthough analyses using a 1-year time horizon are\nalso presented as a base case as the most reliable\ndata related to this period. For the base-case\nanalysis, it is only the costs and consequences that\npatients incur in the first cycle of the model that\nwere estimated. An outline of the tree structure is\nshown in Appendix 13. It was assumed that the\nstarting age for the model cohort is 68 years based\non the mean age of patients undergoing primary\nTHR from the National Joint Registry for England\nand Wales.3\nEstimation of model parameters\nBaseline parameters\nAll baseline parameter values are given in Table 40\nand their source and methods used to derive them\nare described below. Although many analyses were\nconducted for a 1-year time horizon, it is\nnecessary to explain the methods used in relation\nto those analyses where a 40-year time horizon was\nconsidered. For the remainder of this section,\ntherefore, all model inputs for both the 1- and \n40-year analysis are described. Where quantitative\nsynthesis was possible, the outputs of the\nsystematic review of effectiveness (Chapter 3) were\nEconomic evaluation\n56\nTABLE 40 Baseline parameter values used in the model\nBaseline parameter Value Distribution Values of distribution\nTransition probabilities\nOperative mortality 0.0091 Log-normal 95% CI 0.0055 to 0.0142\nAll-cause mortality See sex and age-adjusted UK life table in Appendix 13\nRevision rate See 24-year risk of revision in Table 41\nRate of non-operative management following failed THR 0\nOther probabilities\nRe-operation rate for dislocation 0.01 No distribution\nRe-operation rate for deep infection (risk only  0.011 No distribution\nincluded for first 5 years postoperation)\nDVT rate 0.0189 Normal 95% CI 0.0111 to 0.0276\nPE rate 0.012 Log-normal 95% CI 0.0065 to 0.0202\nOperation duration 120 minutes No distribution\nLength of stay 8.7 days Log-normal Mean 8.7 days, median 7 dayspresented as Peto ORs for dichotomous variables\nand WMDs for continuous variables. For these\ndata to be incorporated into the model they\nneeded to be combined with estimates of baseline\nrates for one of the interventions. Furthermore,\nalthough it might be argued that such relative\neffect sizes are transferable between settings,86 it\nwas important to ensure that they were applied to\nbaseline rates that are applicable to the UK, so\nthat the resultant absolute differences between\ninterventions were more likely to be applicable to\nthe UK. \nThe baseline annual rate of revision following\nstandard THR was taken from data provided by\nthe Swedish National Joint Registry database.87\nThese data were utilised, as opposed to data from\nthe UK National Joint Registry database, as they\nprovided the most precise estimates of long-term\nsurvival of prostheses with the greatest number of\nobservations. Estimation of the risk of revision was\nbased on the survival curve for \u2018all implants\u2019.\nThese data provided estimates of the survival of\nhip implants up to 24 years post-surgery. The\noverall survival of the hip prostheses for standard\nTHR for each 1-year time period up to 24 years\nwas estimated from these curves. From these data,\na revision rate for each 1-year cycle length was\ncalculated. Details of the revision risks for each\nyear are shown in Table 41. It should be noted that\nfor those sensitivity analyses that used a 40-year\ntime horizon, an assumption was made that the\nrisk of revision after year 24 is constant for the\nremaining years at 1.802% per year, the transition\nprobability at 24 years. For the 1-year time horizon\nanalysis, it is only the baseline risk of revision at\none year post-surgery and the relative effectiveness\nat 1 year that are considered.\nNo distribution was assigned to the baseline risk of\nrevision as the number of observations used to\ncalculate this risk is taken from a very large\nnational database and the CIs around the point\nestimates were narrow. \nIn the event that a patient\u2019s THR failed, the\nmodel allowed patients to be treated non-\noperatively for the rest of their lives if further\nrevision surgery is deemed inappropriate. For the\nbase-case model, however, it was assumed that all\nfailed THRs will receive revision surgery. The\nimpact of relaxing this assumption was explored in\nlater sensitivity analyses. It should be noted that\nwhen patients do enter the non-operative\nmanagement state, they are unable to leave this\nstate unless they die.\nAs with all surgical procedures requiring general\nanaesthetic, death due to complications in the\nintraoperative period is a potential risk. The risk\nof operative mortality was based on data from the\nTrent regional replacement register88 shown in\nTable 40. Based on these data, a mortality rate of\n0.91% was assumed. The CIs around the point\nestimate reported by Fender and colleagues88\nassumed a log-normal distribution; therefore,\nthese data were used to estimate a similar\ndistribution around this baseline risk. \nAs patients progress through the model over time,\nannual rates of age-specific general or all-cause\nmortality were required. These were taken from\npublished UK life tables for the years 2003 to\n2005.89 The National Joint Registry reports that\n60% of all primary THRs are performed on\nwomen; therefore, the all-cause mortality for the\nmodel cohort was weighted to reflect this. Data\nrelating to the rate of all-cause mortality can be\nseen in Appendix 14. As the number of\nobservations used to calculate this risk is very\nlarge, no distribution was assigned to these rates.\nCertain postoperative complications other than\nrevision have been allowed for within the model\nowing to their importance in terms of resource use\nand quality of life. These complications have been\nsubsumed within the initial operation and\nsuccessful THR states and, once rectified, patients\nwould still be classed as successful. The following\nHealth Technology Assessment 2008; Vol. 12: No. 26\n57\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 41 Cumulative risk of revision estimated from survival curves\nTime  Absolute  Time Absolute Time Absolute Time  Absolute Time Absolute \n(years) rate of  (years) rate of  (years) rate of  (years) rate of  (years) rate of \nrevision revision revision revision revision\n0 0 5 0.028 10 0.073 15 0.136 20 0.197\n1 0.007 6 0.035 11 0.085 16 0.147 21 0.204\n2 0.013 7 0.042 12 0.097 17 0.163 22 0.211\n3 0.017 8 0.05 13 0.113 18 0.174 23 0.218\n4 0.02 9 0.06 14 0.124 19 0.186 24 0.222complications have been explicitly included in the\nmodel: risk of re-operation (i.e. not revision) due\nto dislocation or wound infection, risk of DVT and\nrisk of non-fatal PE. The risks of DVT and non-\nfatal PE are only factored into the initial operation\nand revision states as these complications are only\nrelevant in the immediate postoperative period.\nThe Swedish National Joint Registry provided\ndata on the rate of re-operations and revisions due\nto various complications.87 From this, it was\npossible to calculate the rate of re-operations on\nthe hip joint (not including revision procedures).\nTwo of the most important complications which\nmight require a re-operation are dislocation and\ndeep infection. From the Swedish Registry data, \nan annual constant risk of re-operation for\ndislocation was estimated as the yearly rates\nremained similar over time. Similarly, a constant\nrate of re-operation for infection was calculated\nfrom the Swedish data, although this risk was only\nincluded for the first 5 years postoperatively, as\nthe data suggested that this risk became negligible\nafter this time point. Again, as with the risk of\nrevision, no distribution was assigned to these risks\ndue to the large number of observed events in the\nregistry data.87 The associated probability, cost and\ndisutility associated with these complications were\nfactored into the \u2018Initial operation\u2019, \u2018Revision\u2019 and\n\u2018Successful THR\u2019 states.\nThe risks of DVT and non-fatal PE were included\nin the model\u2019s operation states (primary THR and\nrevision) as it was felt that these risks might differ\nbetween standard and mini-incision THR surgery.\nThe baseline risks of DVT and PE were taken from\nthe Scottish Intercollegiate Guidelines Network\n(SIGN) guidelines for the prophylaxis of venous\nthromboembolism (see Table 40).90 From this, a\nbaseline risk of 1.9% for DVT and a risk of 1.2%\nfor non-fatal PE were assumed. The CIs around\nthe point estimate for DVT were based on a\nnormal distribution and a similar distribution\naround this baseline risk was used in the model.\nFor the PE rate, the CIs suggested a log-normal\ndistribution, which was therefore used to express\nthe uncertainty around this point estimate.\nOther baseline parameters required for the model\nrelated to operation duration and length of stay.\nFor standard THR, the baseline length of\noperation was assumed to be 120 minutes based\non a previous HTA monograph.91 Average length\nof hospital stay was taken from the Hospital\nEpisodes Statistics Database for the operation code\nW37.1 and was assumed to be 8.7 days based on\n\u2018Total prosthetic replacement of the hip joint\nusing cement, Primary total prosthetic\nreplacement of hip joint using cement\u2019. This\nparticular operation code was chosen as it is the\nmost frequently recorded operation code for THR\n(Table 40).92 A distribution for this parameter was\nconstructed using the median and mean length of\nstay for this operation code. Using these two items\nof data, the use of alternative distributions was\ninvestigated and a log-normal distribution was\nchosen, as it provided a plausible lower estimate of\nlength of stay and also allowed the possibility of\nsubstantially greater length of stay.\nDerivation of relative effect sizes\nData on the relative effect sizes were derived from\nthe systematic review of effectiveness where\npossible. All relative effect sizes are given in\nTable 42. It was assumed that the relative effect size\nof operative mortality and of all-cause morality for\nmini-incision THR compared with standard THR\nEconomic evaluation\n58\nTABLE 42 Relative effect sizes used in the model\nParameter Point estimate Limits of 95% CI Distribution\nLower Upper\nTransition probabilities \nOperative mortality 1 1 1\nAll-cause mortality 1 1 1\nRevision rate 1 0.1 1.9 Uniform\nRate of non-operative management following failed THR 1 1 1\nOther probabilities\nRe-operation rate for dislocation 1 0.1 1.9 Uniform\nRe-operation rate for deep infection 1 0.1 1.9 Uniform\nDVT rate 1 0.1 1.9 Uniform\nPE rate 1 0.1 1.9 Uniform\nOperation duration (minutes) \u20133.70 \u20135.67 \u20131.74 Normal\nLength of stay (days) \u20130.5 \u20130.83 \u20130.18 Normalwas one (Table 42). This assumption was made as it\nis unlikely that these risks would differ between\nthe two operative techniques (Hutchison JD,\nDepartment of Surgery, University of Aberdeen\nand Munro N, NHS Grampian: personal\ncommunication, February 2007).\nThe conclusions that can be drawn from the meta-\nanalysis reported in Chapter 3 are tenuous, as\ndata for some outcomes were sparse and the CIs\nwere implausibly wide. For the base-case model,\ntherefore, the relative effect sizes from the meta-\nanalysis were not utilised for several model\nparameters. Reliable data relating to the annual\nrisk of revision, rate of re-operation for both\ndislocation and deep infection and risk of DVT\nand non-fatal PE were not available but\ninterpretation of the few data from Chapter 3\nsuggests a relative effect size of one but with\nconsiderable uncertainty, which was reflected by\nthe adoption of a uniform distribution for these\nparameters (Table 42). This assumption was based\non the interpretation of the findings of the review\nof effectiveness and on advice of the\nmethodological and clinical members of the\nresearch team. The approach was deemed more\nappropriate than surveying expert opinion as such\ndata are themselves arbitrary and may reflect the\nbiases of those surveyed. \nOther relative effect sizes required for the model\nrelate to operation duration and length of stay,\nwhich were obtained from data reported in\nChapter 3 (Table 42). Data were suggestive of a\nstatistically significant reduction in operation time\nand length of stay and this was therefore reflected\nin the initial operation costs for the two\nprocedures. For both parameters, a normal\ndistribution was assigned to represent statistical\nuncertainty of the point estimates based on the\n95% CIs.\nResource use and costs\nThe derivations of selected individual resource use\nparameters are shown in Tables 43 and 44. A\nsummary of all resource use parameter values\nincluded in the model can be found in Table 45.\nThe main cost component included in the model\nis the costs associated with the primary THR\noperation and the costs of any subsequent revision\noperations or re-operations for complications (i.e.\ndislocation and\/or infection). It is likely that the\nmain cost differences between standard and mini-\nincision THR might result from any extra\nspecialist equipment or instrumentation required\nfor mini-incision techniques, any difference in the\nduration of surgery and as the possibility of a\nshorter hospitalisation period which may be\nassociated with the mini-incision technique. \nFor the primary operation, the cost of a cemented\nprosthesis, assumed to be used for both\nprocedures, was estimated from a number of\nmanufacturers\u2019 price lists. A cemented prosthesis\nwas chosen, as data from the Hospital Episodes\nStatistics showed that a greater number of THRs\nwere performed with cemented rather than\nuncemented prostheses.92 In relation to\ninstrumentation costs, it was assumed for standard\nTHR that this cost would be subsumed in the cost\nof the prosthesis based on usual NHS practice. To\nperform mini-incision THR, however, an extra\nadditional instrumentation kit would be necessary.\nThe one-off cost of this was taken from\nmanufacturers\u2019 price lists and an estimate of the\nlifespan of the instruments, and also an\napproximation of the number of times these\ninstruments would be used in a year was\ndetermined following expert opinion \n(Hutchison JD, Department of Surgery, University\nof Aberdeen and Munro N, NHS Grampian:\npersonal communication, March 2007). An annual\nequivalent cost was estimated using a discount rate\nHealth Technology Assessment 2008; Vol. 12: No. 26\n59\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 43 Cost of management of DVT during initial hospitalisation period\nManagement Cost (\u00a3) Dose Source\nTests\nUltrasound 38 NRC banding code RBB3 \nOther ultrasound\nFibrin D-dimer 1 NRC Speciality code DAP 841 \u2013 biochemistry test\nDrugs\nHeparin 0.36 5000 units\/ml BNF\n13.68 1000 units\/ml\/hour for 72 hours BNF\nWarfarin 0.11 10 mg on first day BNF\n8.10 6 mg warfarin for a further 3 months BNF\nTotal 61.25of 3.5% which, given expected annual usage, gave\na cost per patient of \u00a312.58. Other costs associated\nwith the initial operation related to staffing,\noverheads (length of stay and theatre costs),\nconsumables and capital costs. The staff mixes for\nboth methods of replacement were estimated and\nassumed to be the same for the base-case analysis\nfollowing clinical opinion (Hutchison JD,\nDepartment of Surgery, University of Aberdeen\nand Munro N, NHS Grampian: personal\ncommunication, 2007). The various staff unit costs\nwere estimated from published sources,93 as were\nthe unit costs of theatre time and a stay on an\northopaedic ward.94\nThe cost of surgery would be incurred in the first\ncycle of the model. Other costs would also be\nincurred in this cycle related to follow-up visits\nand the cost of complications which may occur\nfollowing discharge. \nFollowing guidance from the British Orthopaedic\nAssociation, a patient would attend a consultant\noutpatient appointment at 8 weeks and at 1 year.\nAt this time, both antero-posterior and lateral X-\nrays would be performed.95 Following consultation\nwith clinical experts, the same follow-up for mini-\nincision patients was assumed for the base-case\nanalysis (Hutchison JD, Department of Surgery,\nUniversity of Aberdeen and Munro N, NHS\nGrampian: personal communication, March 2007).\nThe cost of an outpatient appointment was\nassumed to be \u00a3103, taken from published\nsources.94 The costs of antero-posterior and lateral\nX-rays were assumed to be the same and were\ntaken from the NHS reference costs. A triangular\ndistribution was defined for this cost based on the\ninterquartile range of costs reported for this\nimaging modality.96\nThe costs of complications which might have a\nlarge impact on resource use and quality of life\nwere also allowed for within the first cycle of the\nmodel. These include the cost of re-operation for\ndislocation and deep infection as well as\nadmissions to hospital as a result of a DVT and\/or\nPE. Costs for a re-operation (i.e. not revision), for\nboth dislocation and infection, and the cost of\ntreatment for PE were taken from NHS reference\ncosts and, using the methods outlined above in\nrelation to the cost of an X-ray, triangular\ndistributions assigned to these costs.96 For a DVT,\nit was assumed, based on clinical opinion, that\napproximately 5% of those suffering from DVT\nwould be readmitted to hospital for further\ntreatment (Hutchison JD, Department of Surgery,\nUniversity of Aberdeen and Munro N, NHS\nGrampian: personal communication, April 2007).\nFor these patients, the cost of management was\nbased on NHS reference costs and a triangular\ndistribution was defined around the point estimate\nto reflect statistical uncertainty.96 For the\nremaining patients with a DVT, it was assumed\nthat they would principally be treated using the\ntreatment regime recommended by SIGN\n(Table 43).97 The cost of tests and medications\nrequired were estimated from NHS reference costs\nand the BNF (Table 43).96,98\nFollowing a successful THR operation, regular\nreviews past 1 year would be performed. These\ninclude consultant-led outpatient visits including\nX-rays (as described above for outpatient\nappointments within the first year after surgery) at\n5 years following surgery and every subsequent\n5 years thereafter.95 These follow-up visits are\nassumed to cost the same as those incurred in the\nfirst cycle. The risk and management cost of\ncomplications which may impact on resource use\nand quality of life (not including revision) were\nsubsumed within the relevant states. As described\nabove for the operation state, these included the\ncosts of re-operation for both dislocation and deep\ninfection.\nEconomic evaluation\n60\nTABLE 44 Cost of non-operative management for patients following failed THR\nArea of resource use Quantity of  Unit cost (\u00a3) Annual cost per  Source\nresource use patient (\u00a3)\nPhysiotherapy sessions \u2013 outpatient Eight sessions per annum 32 256.00 PSSRU\nPhysiotherapy in the community Three sessions per annum 14 42.00 PSSRU\nMedication (assume 270 days  1.2 g daily 0.6 g \u00d7 84 tablets = 3.79 24.36 BNF\nper year): ibuprofen\nGP visits Two per annum 18 36.00 PSSRU\nNSAID events 385.00\nTotal 743.36\nNSAID, non-steroidal anti-inflammatory drug; PSSRU, Personal Social Services Research Unit.Health Technology Assessment 2008; Vol. 12: No. 26\n61\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 45 Cost estimates for each element of total cost \nParameter Value Distribution Values for  Source\ndistribution\nEstimation of theatre costs (per minute)\nConsultant surgeon \u00a31.30 NA NA PSSRU\nConsultant anaesthetist \u00a31.32 NA NA PSSRU\nSpecialist registrar  \u00a30.57 NA NA PSSRU\nNurse \u2013 Grade F  \u00a30.40 NA NA PSSRU\nNurse \u2013 Grade F \u00a30.40 NA NA PSSRU\nNurse \u2013 Grade E  \u00a30.32 NA NA PSSRU\nTheatre overheads \u00a319.47 NA NA ISD\nDuration of operation for  120 NA NA Hip resurfacing HTA \nstandard (minutes) review\nEquipment and instrumentation\nCost cemented prosthesis \u00a3558.13 NA NA Manufacturer\nCost for MI instrumentation  \u00a312.58 Manufacturer\nper patient\nCost of standard instrumentation Subsumed in  NA NA\nprosthesis cost\nFollow-up cost\nCost of inpatient hospital stay  \u00a3411.79 NA NA ISD Scotland\nper day\nCost of outpatient visit \u00a3103.00 NA NA ISD Scotland\nCost of X-ray \u00a319.00 Triangular IQR: \u00a315\u201323 NRC Band A (RBA1)\nCost of complications\nRevision \u00a37858.00 Triangular IQR: \u00a36129\u20139121 NRC HRG H71 \u2013\nRevisional procedure\nto hip\nRe-operation for dislocation \u00a31925.00 Triangular IQR: \u00a31263\u20132304 NRC HRG H40 \u2013\nClosed upper limb\nfractures or\ndislocation\nRe-operation for infection \u00a33365.00 Triangular IQR: \u00a31034\u20134352 NRC HRG H30 \u2013\nInfections of bones or\njoints\nCost of non-admitted DVT \u00a361.25\nCost of admitted DVT \u00a3789.00 Triangular IQR: \u00a3612\u20131610 NRC HRG E21 \u2013\nDeep vein thrombosis\n<70 without\ncomplications\nCost PE \u00a31326.00 Triangular IQR: \u00a3979\u20132090 NRC HRG D11 \u2013\nPulmonary embolism\nwithout complications\nCost of non-operative  \u00a3743.36 NA NA Hip resurfacing HTA \nmanagement review\nHRG, Healthcare Resource Group; HTA, Health Technology Assessment; IQR, interquartile range; ISD, Information Services\nDivision; NA, not applicable; NRC, National Health Service reference costs; PSSRU, Personal Social Services Research Unit.The cost of care for patients who might have a\nfailed operation would, of course, be dependent\nupon the nature of the failure. For those patients\nwho require a revision surgery, the cost of this was\ntaken from the NHS reference costs for Healthcare\nResource Group (HRG) H71 (a revisional\nprocedure to hip). A distribution for this cost was\ndefined using the same methods described above.\nThe follow-up of patients after a revision would be\nsimilar to follow-up following primary THR. It was\nassumed, however, that during the first year\nfollowing revision surgery, an extra outpatient\nappointment including X-rays would be performed.\nAgain, the risk and costs of complications were\nfactored into the revision state and were assumed\nto be the same as after primary THR.\nIn addition to the cost of revision, a patient might\nreceive medications and non-operative treatments\nfor the control and management of hip disease if,\nafter a failed primary or revision surgery, further\nrevision surgery is no longer viable, for example as\na result of being unfit for surgery. The cost for a\ntypical regime of care was defined based on a\nprevious HTA monograph,91 which identified the\nmanagement cost for those people who were\nwaiting for a THR. The resource usage was used\nand costs were updated to 2006 prices (Table 44).\nNo distributions were assigned to these costs and\nthis represents a caveat of the costs associated with\nthe non-operative management state. It should be\nnoted, however, that the number of patients\nentering this state is likely to be extremely small;\ntherefore, failing to assign distributions to each\ncomponent is unlikely to alter the conclusions\nbetween mini-incision and standard THR.\nTable 45 outlines cost estimates for each element of\nresource use used in the model.\nEstimation of quality-adjusted life-years (QALYs)\nThis section and Table 46 describe the source and\nmethods used to obtain utility values. All utility\nvalues used for the base-case model are shown in\nTable 47. No suitable utility data, required to\nestimate QALYs, were identified in either of the\neconomic evaluations reported in Chapter 4.\nPotential utility data were sought from focused\nsearches of the Harvard Cost Utility Database and\nof the literature of quality of life estimates\nEconomic evaluation\n62\nTABLE 46 Main findings from papers in relation to quality of life following THR\nStudy Type of  Baseline Scores for treatment success\nTHR\n3 months 1 year\nDawson, 200199 Revision 0.32 (95% CI 0.29 to 0.36) 0.62 (95% CI 0.59 to 0.65)\nRobinson, 1999100 Primary NR 0.99 (IQR 0.006)\nMalchau, 2005101 Primary 0.38 (no SD reported) 0.75 (no SD reported)\nOstendorf, 2004a102  Primary 0.35 (SD 0.31) 0.76 (SD 0.27)\nOstenforf, 2004b103 Primary 0.33 (SD 0.32) 0.71 (SD 0.26) 0.75 (SD 0.28)\nIQR, interquartile range; NR, not reported; SD, standard deviation.\nTABLE 47 Utility values used in the model to estimate QALYs\nUtility scores used in the economic model Utility value (SD) Distribution\nPrimary THR\nPreoperative 0.33 (0.32) Beta\nSuccess at 3 months 0.71 (0.26) Beta\nSuccess at 1 year 0.75 (0.28) Beta\nSuccessful THR\nSuccess at 1 year 0.75 (0.28) Beta\nRevision\nFailure of THR up to 3 months 0.33 (0.32) Beta\nSuccessful revision at 1 year 0.62 (0.015) Beta\nSuccessful THR after revision\nSuccess at 1 year 0.62 (0.015) Beta\nNon-operative management  0.33 (0.32) Beta\nDead 0 Nonefollowing standard THR. From these searches, a\nnumber of studies with potentially relevant utility\nvalues which could be used to estimate QALYs\nwere found. Five European studies with relevant\ndata were identified as having potentially useful\nquality of life data. The results of these studies are\nsummarised in Table 46.\nResults at baseline and 1 year for utility scores\nfollowing standard THR were similar across all the\nstudies apart from one study which based its sample\non revision THR patients.99 Based on the above\ndata, utilities data were taken from two papers.99,103\nThe data reported by Ostendorf and colleagues103\nwas chosen because preoperative and 1-year utility\nscores were similar to results from other studies\nand also because this was the only study that\nreported a utility value at 3 months following\nsurgery. This paper analysed a prospective cohort\nof patients in The Netherlands (n = 161) whose\nquality of life was measured at the time when the\npatient was placed on a waiting list for THR,\npreoperatively and at 3 and 12 months after\nsurgery. The values used in the model are\nreported in Table 47. For the 40-year model, the\nutility associated with success post-1 year (for the\nsuccessful THR and successful THR after revision\nstates, respectively) were assumed to be equal to\nthe 1-year values reported in Table 47. It should be\nnoted that the disutility associated with a failed\nTHR requiring revision and also the disutility\nassociated with re-operations for dislocation were\nallowed for within the model. It was assumed that\npatients suffering any of these complications would\nhave a utility score equal to the preoperative score\nfor 3 months before progressing to the quality of\nlife score associated with the successful THR or\nsuccessful THR after a revision. Following\nsuccessful revision surgery, patients were assumed\nto have a utility score equal to 0.62 at 1 year (for\nthe revision state and successful THR after\nrevision state) (Table 47). This figure was obtained\nfrom a paper by Dawson and colleagues,99 which\nanalysed the outcomes of 601 revision patients in\nthe UK using the EQ-5D. For those patients who\nprogress to the non-operative management state\nin the model following failed surgery, it was\nassumed that they would have a utility score equal\nto the pre-operative quality of life estimate. All\nutility scores defined in the model were assigned a\nbeta distribution in order to reflect uncertainty of\nthe point estimate (Table 47).\nWithin the base-case analysis, the above utilities\nwere applied to both mini-incision THR and\nstandard THR. The results presented in Chapter 3\nindicate that mini-incision THR is associated with\na shorter recovery. Therefore, it was assumed that\npatients would return to a utility of 0.71 at\n2 months rather than the 3 months assumed for\nstandard THR. This assumption of a 1-month\nearlier recovery represents analyst assumption as it\nwas not possible to quantify the available data in\nrelation to \u2018time to return to usual activities\u2019. \nA 1-month quicker recovery was a reasonable\nstarting point given findings from the review of\neffectiveness (see Table 24, p. 36) and the\nimplication of this assumption has been addressed\nin a threshold analysis around this estimate (see\nthe section \u2018Results\u2019, p. 65).\nFinally, utilities data were also sought from the\nHarvard Cost Utility Database in relation to the\ndisutility associated with DVT and non-fatal PE\nfollowing surgery. No suitable data were found and\nthe effects of these complications on quality of life,\ntherefore, have not been factored into the\nestimation of QALYs.\nAssessment of cost-effectiveness\nThe base-case analysis is based on the costs and\noutcomes faced by a cohort of 68-year-old THR\npatients (the mean age of patients receiving THR as\nstated in the most recent National Joint Registry for\nEngland and Wales report)3 over two time horizons\n(1 year and 40 years). For the 40-year model, costs\nand effects were discounted at a rate of 3.5%\nfollowing current national guidelines.104 Within the\neconomic model, outcomes are presented as\nincremental cost per QALY. Data on these outcomes\nare presented in two ways. First, mean costs and\nQALYs for the alternative interventions are\npresented and incremental cost per additional\nQALYs calculated where appropriate. The second\nway in which the cost-effectiveness of the alternative\ninterventions is presented is in terms of cost-\neffectiveness acceptability curves (CEACs).105\nCEACs have been used to illustrate the effect of\nstatistical uncertainty caused by the statistical\nvariability in the model\u2019s parameter estimates.\nThese curves illustrate the likelihood that an\nintervention is cost-effective at various threshold\nvalues for society\u2019s willingness to pay for a QALY. \nSensitivity analysis and subgroup\nanalysis\nSensitivity analysis focused on varying assumptions\nor parameter values in the base-case model.\nIncreased resource use associated with mini-\nincision THR (1-year time horizon)\nIt was assumed for the base-case analysis that the\nmanagement of patients following mini-incision\nHealth Technology Assessment 2008; Vol. 12: No. 26\n63\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.THR would be similar to that for standard THR\npatients. Following consultation with clinical\nexperts, it is possible that mini-incision patients\nmight be followed up more closely than standard\nTHR patients (Hutchison JD, Department of\nSurgery, University of Aberdeen and Munro N,\nNHS Grampian: personal communication, March\n2007). This sensitivity analysis assumes that an\nextra Grade E nurse would be required for the\nduration of surgery for mini-incision patients and\nalso assumes that patients would have an extra\nconsultant-led outpatient appointment during the\nfirst year after surgery. At this time the usual\nantero-posterior and lateral X-rays would be\nperformed. \nFor the base-case analysis, the impact on cost\nassociated with a shorter hospitalisation period\nand reduced operation time was included in the\nmodel. As these differences are very small and\ntheir relevance is uncertain, this sensitivity analysis\nalso makes the assumption that any differences\nwere not economically important. \nUse of Peto ORs for dislocation and DVT\nreported in review of effectiveness (1- and \n40-year time horizons)\nDifferences in short- and long-term outcomes\nfollowing the two forms of surgery are assumed to\nbe the same for the base-case analysis (but with\nwide CIs) due to the limited data around estimates\nproduced in the meta-analysis reported in \nChapter 3. Estimates surrounding the odds of\ndislocation and DVT following mini-incision THR\ncompared with standard THR, although not\nstatistically significant, were not wholly\nimplausible, so these were included in this\nsensitivity analysis to relax slightly the assumptions\nof equal outcomes. The meta-analysis reports a\nPeto OR of 1.72 (95% CI 0.43 to 6.92) in relation\nto the risk of postoperative dislocation and a Peto\nOR of 0.39 (95% CI 0.12 to 1.30) in relation to\nDVT (a Peto OR <1 can be interpreted as a lower\nodds of a particular event occurring for mini-\nincision THR and, conversely, a Peto OR >1\nrepresents a greater likelihood of an event\noccurring for mini-incision THR). Log-normal\ndistributions were assigned to these risks to reflect\nuncertainty of point estimates. The analysis was\nconducted for a 1- and 40-year time horizons.\nUse of alternative utilities data to estimate\nQALYs (1- and 40-year time horizons)\nAlternative utilities data were identified to\nestimate QALYs from a study conducted by\nCharles and colleagues.69 Details of the reanalysis\nthat was performed on the trial results can be\nfound in detail in Appendix 11. Three analyses\nwere performed on the data to account for missing\nvalues. For this sensitivity analysis, the reported\nutility scores using the \u2018last value carried forward\u2019\napproach to missing data was used. Utilities data\nat baseline, 3 months, 6 months and 1 year were\nused to estimate QALYs for standard THR\npatients. For mini-incision THR, the mean scores\nat each time point for standard THR were\ncompared in an analysis of covariance adjusting\nfor baseline SF-6D scores. Table 48 shows the data\nused for this analysis, as required by the model. To\nestimate results for a 40-year time horizon, it was\nnecessary to consider the utility that might apply\nfor revision THR as the utilities data were for\nprimary THR only. It was assumed for the 40-year\nmodel, therefore, that patients who underwent\nrevision surgery would have 76% of the utility of\nprimary THR patients (based on the difference\nbetween a successful primary and revision THR at\n1 year from the base-case utility values used). As\nfor the base-case models, the disutility associated\nwith re-operations for dislocation was also allowed\nfor within the model. In the calculation of QALYs,\nall utility values were given a beta distribution to\nreflect uncertainty of the point estimates and the\nreported coefficients of difference for mini-\nincision compared with standard THR were\nassigned normal distributions to reflect\nuncertainty (Table 48).\nAssumption that all failed primary THRs go to\nnon-operative management state and are not\nallowed the chance of revision surgery (40-year\ntime horizon)\nThis sensitivity analysis assumed that all patients\nwho failed their initial primary surgery would not\nbe allowed the opportunity for further surgical\nmanagement. These patients were instead treated\nnon-operatively for the rest of their lives.\n50% of failed THRs (primary and revision) go to\nnon-operative management state and are not\nallowed the chance of revision surgery (40-year\ntime horizon)\nSimilarly to the above, 50% of those patients who\nfailed their THR surgery would not be allowed the\nopportunity for further surgical management.\nThese patients were instead treated non-\noperatively for the rest of their lives.\n25% of failed THRs (primary and revision) go to\nnon-operative management state and are not\nallowed the chance of revision surgery (40-year\ntime horizon)\nThis sensitivity analysis assumed that 25% of all\npatients who failed their THR surgery would not\nEconomic evaluation\n64be allowed the opportunity for further surgical\nmanagement. These patients were instead treated\nnon-operatively for the rest of their lives.\nThreshold analysis for revision rates for a 40-year\ntime horizon\nA threshold analysis in the form of an implied\nvaluation was performed around the relative effect\nsize associated with revision following mini-\nincision THR for a 40-year time horizon. The\nrange of values of the relative effect size for\nrevision following mini-incision THR were varied\nfrom 1.0 (no difference in relative difference in\nrevision) to 1.2 (20% relative increase in revision\nfollowing mini-incision THR in comparison with\nstandard THR). In this way, it is possible to\ndetermine the relative increase in revision rates\nthat mini-incision THR would have to be\nassociated with to make it the least cost-effective\nalternative.\nSubgroup analysis\nThere were no data available on which to conduct\na subgroup analysis.\nResults\nThe results of the deterministic analysis which\nreports incremental cost per QALY for the 1-year\nanalysis are shown in Table 49 and Figure 13.\nThe ICER is not reported in Table 49 because\nstandard THR is dominated by mini-incision THR\nover a 1-year time horizon (Table 49). To give an\nindication as to the flow of the patients through\nthe model, in a cohort of 1000 patients, for both\nstandard and mini-incision THR, 967 patients\nwould move to the successful THR states at the\nend of the first cycle whereas seven would move to\nthe revision states and a total of 26 deaths would\noccur within the 1-year time horizon. The results\nare the same for both forms of replacement given\nthe assumptions made around the rates of\ncomplications for the base-case analysis. A cohort\nanalysis showing how patients move through the\nmodel over the 40-year time horizon for the base-\ncase analysis is shown in Appendix 15. When\nexamining the deterministic results for the 1-year\ntime horizon analysis displayed in Table 49, the\npoint estimates of the incremental cost-\neffectiveness do not provide any indication of the\nuncertainty that surrounds the model parameters.\nThe uncertainty surrounding the precision of\nmany of the parameter estimates is reflected in the\nlikelihood that the two surgical interventions are\ncost-effective at different threshold values for\nsociety\u2019s willingness to pay for a QALY. Figures 13\nand 14 report the CEACs comparing standard and\nmini-incision THR in terms of QALYs and the\nassociated cost-effectiveness plane, respectively.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n65\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 48 Alternative utility values\nTime period Group Mean SD Adjusted difference (SE)\nPreoperation Standard 0.61235 0.15764\nMini-incision 0.61235 0.15764\n3 months postoperation Standard  0.7632 0.10304\nMini-incision 0.7924 0.08298\nDifference 0.045 (0.31)\n6 months postoperation Standard  0.8014 0.09470\nMini-incision 0.8001 0.07565\nDifference 0.001 (0.030)\n1 year postoperation Standard  0.8139 0.11936\nMini-incision 0.7895 0.06912\nDifference \u20130.011 (0.033)\nSE, standard error.\nTABLE 49 Results of the deterministic model for a 1-year time horizon (QALYs)\nScenario Procedure Cost (\u00a3) QALYs Incremental  Incremental  Incremental \ncost (\u00a3) QALYs cost per QALY\nBase-case (1 year) Mini-incision THR 7064 0.695\nStandard THR 7345 0.677 281 \u20130.018 DominatedEconomic evaluation\n66\n0\n0\n10\n20\n30\n40\n50\n60\n70\n80\n90\n100\n5 10 15 20 25\nCeiling ratio (\u00a3000)\n30 35 40 45 50\nP\nr\no\nb\na\nb\ni\nl\ni\nt\ny\n \nc\no\ns\nt\n-\ne\nf\nf\ne\nc\nt\ni\nv\ne\n \n(\n%\n)\nMI THA\nStandard THA\nFIGURE 13 CEAC showing society\u2019s willingness to pay for a QALY for the comparison of mini-incision with standard THR surgery\n(base-case analysis)\n35  \u2013\n30  \u2013\n25  \u2013\n20  \u2013\n15  \u2013\n10  \u2013\n5  \u2013\n0  \u2013\n0 0.2 0.4 0.6\nEffectiveness (QALYs)\n0.8 1.0 1.2\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n \nc\no\ns\nt\n \n(\n\u00a3\n0\n0\n0\n)\nStandard THA\nMI THA\nFIGURE 14 Cost-effectiveness plane for base-case analysisAlthough patients flow through the model in the\nsame way, it is the decreased cost of mini-incision\nTHR in comparison with standard THR and the\nutility associated with a 1-month quicker recovery\nthat drives the results. As can be seen from\nFigure 13, for the 1-year time horizon analysis\nmini-incision THR has >90% chance of being\nconsidered cost-effective for every willingness to\npay threshold presented. The base-case results\nshow that the reduced cost associated with the\nshorter operation and duration of hospital stay is\nenough to offset the cost of the extra\ninstrumentation required for mini-incision THR.\nThe difference in QALYs is also caused by the\nassumption that mini-incision THR patients would\nrecover from surgery 1 month earlier than standard\nTHR patients. This is expanded on further in the\nsensitivity analyses in the next section. \nTable 50 shows the deterministic results of the\nbase-case model when it was repeated for a \n40-year time horizon. As can be seen, the results\nare similar to those for the 1-year analysis. It is\nonly when we look at the stochastic analysis,\nhowever, that the importance of the 40-year\nanalysis becomes apparent. The 40-year analysis\nallows a greater amount of uncertainty into the\nmodel and, although many outcomes assume no\ndifference in effects, the extremely wide CIs\naround the point estimates reduce the probability\nthat mini-incision THR is the most cost-effective\nalternative from around 95% to 55% for all\nthreshold values considered.\nSensitivity analyses\nThreshold analysis around time to return to usual\nactivities (base-case model)\nThe base-case analysis assumed a 4-week quicker\nrecovery following mini-incision THR, although\nthe absolute difference is unknown. A threshold\nanalysis was performed to explore the impact of\nquicker return to usual activities following mini-\nincision THR (Table 51). From Table 51, it can be\nseen that even if there was no difference in time to\nreturn to usual activities following mini-incision\nTHR in relation to standard THR, standard THR\nis still dominated because of the higher cost\nassociated with it.\nIncreased resource use associated with mini-\nincision THR (1-year time horizon)\nThe first sensitivity analysis focused on increasing\nthe hospital resource usage of mini-incision\nsurgery in comparison with standard THR surgery\nand by relaxing assumptions on cost savings in\nrelation to the slightly shorter length of stay and\noperation time estimates (Figures 15 and 16). \nHere mini-incision THR is, again, more effective\nthen standard THR, due to the assumption of\nearlier recovery for these patients, but is also more\ncostly by approximately \u00a3200 with an ICER of\napproximately \u00a311,000.\nThreshold analysis around time to return to usual\nactivities (1-year time horizon and increased\nresource use model)\nIn a further sensitivity analysis, for the scenario\nwhere mini-incision THR is associated with\nincreased resource use, a threshold analysis around\ntime to return to usual activities was performed.\nThis analysis showed that if mini-incision THR\nwas associated with a 2-week reduction in time to\nreturn to usual activities, as opposed to the 4-week\nquicker recovery assumed for the base-case\nanalysis, then the ICER is approximately \u00a322,000.\nWhen time to return to usual activities is reduced\nfurther to 1 week, the ICER increases to \u00a344,000\n(Table 52 and Figure 17).\nHealth Technology Assessment 2008; Vol. 12: No. 26\n67\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 50 Results of the deterministic model for a 40-year time horizon (QALYs)\nScenario Procedure Cost (\u00a3) QALYs Incremental  Incremental  Incremental \ncost (\u00a3) QALYs cost per QALY\nBase-case (40 years) Mini-incision THR 11,618 8.480\nStandard THR 11,899 8.463 281 \u20130.017 Dominated\nTABLE 51 Threshold analysis of impact of earlier return to usual activities following mini-incision THR (base-case analysis)\nReduction in time to return to usual activities following minimal-incision THR (weeks)\n0123456\nChange in QALYs 0 0.00436 0.0087 0.0131 0.0175 0.0218 0.0262\nChange in costs (\u00a3) \u2013281 \u2013281 \u2013281 \u2013281 \u2013281 \u2013281 \u2013281\nICER Dominated Dominated Dominated Dominated Dominated Dominated DominatedEconomic evaluation\n68\n100\n90\n80\n70\n60\n50\n40\n30\n20\n10\n0\n0 5 10 15 20 25\nCeiling ratio (\u00a3000)\n30 35 40 45 50\nMI THA\nStandard THA\nP\nr\no\nb\na\nb\ni\nl\ni\nt\ny\n \nc\no\ns\nt\n-\ne\nf\nf\ne\nc\nt\ni\nv\ne\n \n(\n%\n)\nFIGURE 15 CEAC showing society\u2019s willingness to pay for a QALY for the comparison of mini-incision with standard THR surgery\n(increased resource use with mini-incision THR, 1-year time horizon)\n35  \u2013\n30  \u2013\n25  \u2013\n20  \u2013\n15  \u2013\n10  \u2013\n5  \u2013\n0  \u2013\n0 0.2 0.4 0.6\nEffectiveness (QALYs)\n0.8 1.0 1.2\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n \nc\no\ns\nt\n \n(\n\u00a3\n0\n0\n0\n)\nStandard THA\nMI THA\nFIGURE 16 Cost-effectiveness plane for increased resource usage analysisUse of Peto ORs reported for dislocation and\nDVT from review of effectiveness\nThis analysis used the point estimates of the Peto\nOR for DVT and re-operation due to dislocation\nfrom the meta-analysis conducted as part of the\nsystematic review of effectiveness in Chapter 3. As\nis apparent in Table 53, the results did not differ\ngreatly from the base-case analysis. Although there\nis a high management cost associated with\ndislocation, the baseline risk is small, hence the\nincrease in the rate of dislocation apparent for\nmini-incision THR patients impacts little on\nresults. Further, as the Peto OR for DVT favoured\nmini-incision THR, some of the increased cost\nassociated with an increase in re-operations for\ndislocations would be offset by the reduction in\ncost for the treatment of patients suffering from\nDVT. As would be expected, the QALY gain\nfollowing mini-incision surgery is slightly reduced\ndue to the assumptions made around quality of\nlife following a dislocation. Again, this reduction\nin quality of life is small because of the low\nbaseline risk of dislocation and because of the\nshort time horizon of this analysis. At all threshold\nvalues for society\u2019s willingness to pay for a QALY,\nmini-incision THR still has >95% chance of being\nconsidered cost-effective. \nWhen this analysis was repeated for the 40-year\ntime horizon, standard THR is still dominated by\nmini-incision THR (Table 54) but the magnitude of\nthe difference in cost and QALYs is reduced. This\nis because the longer time horizon allows more\nuncertainty into the model and also allows a\ngreater number of mini-incision patients to suffer\nthe costs and consequences associated with a re-\noperation for dislocation in comparison with\nstandard THR. This would be as expected given\nthe point estimates of the OR for re-operation due\nto dislocation used for this analysis which slightly\nHealth Technology Assessment 2008; Vol. 12: No. 26\n69\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTABLE 52 Threshold analysis of impact of earlier return to usual activities following mini-incision THR (increased resource usage\nanalysis)\nReduction in time to return to usual activities following minimal-incision THR (weeks)\n0123456\nChange in QALYs 0 0.00436 0.0087 0.0131 0.0175 0.0218 0.0262\nChange in costs (\u00a3) 192 192 192 192 192 192 192\nICER (\u00a3) Dominated 43,991 21,996 14,664 10,998 8,798 7,331\n45\n50\n40\n35\n30\n25\n20\n15\n10\n5\n0\nI\nC\nE\nR\n \n(\n\u00a3\n0\n0\n0\n)\n123\nDifference in time to return to usual activities following MI THR (weeks)\n456\nFIGURE 17 Threshold analysis of impact of earlier return to usual activities (increased resource usage analysis)favours standard THR. As the baseline risk of\ndislocation is low, however, it is not enough to\noffset the benefits of mini-incision surgery in\nterms of earlier return to usual activities in the\nimmediate postoperative period, the driver of\nQALY results. The important point to note in\nrelation to the probabilistic sensitivity analysis\nresults for the 40-year model is that the probability\nthat mini-incision THR would be considered cost-\neffective is approximately 55% for all threshold\nvalues (markedly reduced from the 95% chance in\nthe 1-year analysis). This is because this model\nallows a much greater amount of uncertainty into\nthe analysis. \nUse of alternative utilities data to estimate\nQALYs (1- and 40-year analysis)\nAlternative utilities data were identified from a\nstudy by Charles and colleagues.69 Again, standard\nTHR is dominated by mini-incision THR in this\nanalysis which differs little from the base-case\nresults (Table 53). The difference in cost between\nthe two interventions remained the same as the\nbase-case analysis; however, QALYs following mini-\nincision THR were slightly higher at 1 year. This is\nbecause the utility scores reported at 3 and\n6 months were slightly higher for mini-incision\nTHR than standard THR (Table 48) and the net\neffect of this was that QALYs at 1 year following\nmini-incision THR were higher. \nThis analysis was repeated for the 40-year time\nhorizon and is one of the few analyses where\nstandard THR is not dominated by mini-incision\nTHR, although the ICER reported is extremely\nhigh (approximately \u00a3259,000). The difference in\ncost between the two interventions remained the\nsame as in the base-case analysis; however, on\naverage, QALYs following standard THR were\nvery slightly higher at 40 years. This is because the\ndifference in utilities at 1 year reported in the data\nfrom Charles and colleagues69 (Table 48) was\nslightly lower for mini-incision and it was this\ndifference in utility that was applied to the\nsuccessful THR and successful THR after revision\nstates, the states in the model in which patients\nwould likely spend the most amount of time. The\nmean utility for standard THR was, therefore,\nhigher than that for minimally invasive THR,\nleading to a greater number of QALYs following\nstandard THR over the 40-year time horizon.\nFinally, the point estimate of QALYs for both\nstandard and mini-incision THR for the \n40-year analysis using alternative utility data are\nhigher than those reported in the 1-year base-case\nanalysis because the utility score associated with\nfailure from the alternative utilities data was\nhigher than (approximately double) that of the\nbase-case utility score for failed THRs (Table 54). \nAssumptions around the number of failed THR\npatients (primary and revision) moving to the\nnon-operative management state and not being\nallowed the chance of revision surgery (40-year\ntime horizon)\nResults of the sensitivity analyses that made\nassumptions around the number of failed THR\npatients going to the non-operative management\nstate for the rest of their lives, as opposed to being\ngiven the chance of revision surgery, did not differ\ngreatly from those of the base-case analysis. As\nwould be expected, patients in both arms of the\nmodel experienced reduced QALYs over the \n40-year time horizon, compared with the 1-year\ntime horizon base-case analysis, for each of the\nthree sensitivity analyses that were performed (one\nassuming all failed patients went to the non-\noperative management state, one assuming 50%\nand one assuming 25%). This is as would be\nexpected given the low quality of life associated\nwith the model\u2019s non-operative management state.\nSimilarly in relation to cost, although patients\nincurred costs in terms of long-term pain and\nnon-operative management over the 40-year\nperiod, the high costs associated with revision\nsurgery were more likely to be avoided and, as a\nresult, reduced the cost estimates for both forms of\nsurgery for each of the analyses (Table 54).\nThreshold analysis for revision rates for a 40-year\ntime horizon\nA threshold analysis was conducted on the relative\ndifference in revisions following mini-incision\nTHR compared with standard THR. This analysis\nshowed that if society were willing to pay \u00a330,000\nfor a QALY, mini-incision THR would have to be\nassociated with a 7.5% increase in revisions for it\nto be no longer considered cost-effective. \nSummary of evidence on \ncost-effectiveness\nAvailable data on the effectiveness of single mini-\nincision THR in comparison with standard THR\nwere explicitly synthesised in an economic model.\nSynthesised data from the systematic review of\neffectiveness in relation to revision, risk of\ndislocation and infection and the risks of DVT and\nPE were extremely tenuous and were therefore not\nincluded in the model owing to the implausibly\nwide CIs reported. In general, however, the results\nsuggested a relative effect size of one. It was\nassumed, therefore, that these outcomes would be\nEconomic evaluation\n70Health Technology Assessment 2008; Vol. 12: No. 26\n71\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nT\nA\nB\nL\nE\n \n5\n3\nB\na\ns\ne\n-\nc\na\ns\ne\n \na\nn\nd\n \ns\ne\nn\ns\ni\nt\ni\nv\ni\nt\ny\n \na\nn\na\nl\ny\ns\ni\ns\n \nr\ne\ns\nu\nl\nt\ns\n \n(\n1\n-\ny\ne\na\nr\n \nt\ni\nm\ne\n \nh\no\nr\ni\nz\no\nn\n)\nS\ne\nn\ns\ni\nt\ni\nv\ni\nt\ny\n \na\nn\na\nl\ny\ns\ni\ns\nP\nr\no\nb\na\nb\ni\nl\ni\nt\ny\n \nc\no\ns\nt\n-\ne\nf\nf\ne\nc\nt\ni\nv\ne\n \nf\no\nr\n \nd\ni\nf\nf\ne\nr\ne\nn\nt\n \nt\nh\nr\ne\ns\nh\no\nl\nd\n \nv\na\nl\nu\ne\ns\n \nf\no\nr\n \ns\no\nc\ni\ne\nt\ny\n\u2019\ns\n \nw\ni\nl\nl\ni\nn\ng\nn\ne\ns\ns\n \nt\no\n \np\na\ny\n \nf\no\nr\n \na\n \nQ\nA\nL\nY\n \n(\n%\n)\nP\nr\no\nc\ne\nd\nu\nr\ne\nC\no\ns\nt\n \n(\n\u00a3\n)\nQ\nA\nL\nY\ns\nI\nC\nE\nR\n \n(\n\u00a3\n)\n\u00a3\n1\n0\n,\n0\n0\n0\n\u00a3\n2\n0\n,\n0\n0\n0\n\u00a3\n3\n0\n,\n0\n0\n0\n\u00a3\n5\n0\n,\n0\n0\n0\nB\na\ns\ne\n-\nc\na\ns\ne\n \n(\n1\n-\ny\ne\na\nr\n \nt\ni\nm\ne\n \nh\no\nr\ni\nz\no\nn\n)\nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n7\n,\n0\n6\n4\n0\n.\n6\n9\n5\n9\n9\n.\n4\n9\n7\n.\n2\n9\n5\n.\n3\n9\n3\n.\n0\nS\nt\na\nn\nd\na\nr\nd\n7\n,\n3\n4\n5\n0\n.\n6\n7\n7\nD\no\nm\ni\nn\na\nt\ne\nd\n0\n.\n6\n2\n.\n8\n4\n.\n7\n7\n.\n0\nH\ni\ng\nh\n \nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nc\no\ns\nt\nS\nt\na\nn\nd\na\nr\nd\n7\n,\n3\n4\n5\n0\n.\n6\n7\n7\n4\n8\n.\n5\n2\n9\n.\n8\n2\n3\n.\n7\n1\n7\n.\n9\nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n7\n,\n5\n3\n7\n0\n.\n6\n8\n1\n1\n0\n,\n9\n9\n8\n5\n1\n.\n5\n7\n0\n.\n2\n7\n6\n.\n3\n8\n2\n.\n1\nP\ne\nt\no\n \nO\nR\n \nf\no\nr\n \nd\ni\ns\nl\no\nc\na\nt\ni\no\nn\n \na\nn\nd\n \nD\nV\nT\n \nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n7\n,\n0\n7\n6\n0\n.\n6\n9\n4\n9\n9\n.\n2\n9\n6\n.\n9\n9\n4\n.\n7\n9\n2\n.\n7\nt\na\nk\ne\nn\n \nf\nr\no\nm\n \nm\ne\nt\na\n-\na\nn\na\nl\ny\ns\ni\ns\nS\nt\na\nn\nd\na\nr\nd\n7\n,\n3\n4\n5\n0\n.\n6\n7\n7\nD\no\nm\ni\nn\na\nt\ne\nd\n0\n.\n8\n3\n.\n1\n5\n.\n3\n7\n.\n3\nA\nl\nt\ne\nr\nn\na\nt\ne\n \nu\nt\ni\nl\ni\nt\ni\ne\ns\n \nv\na\nl\nu\ne\ns\nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n7\n,\n0\n6\n4\n0\n.\n7\n9\n2\n9\n3\n.\n2\n8\n7\n.\n3\n8\n4\n.\n7\n8\n1\n.\n0\nS\nt\na\nn\nd\na\nr\nd\n7\n,\n3\n4\n5\n0\n.\n7\n7\n1\nD\no\nm\ni\nn\na\nt\ne\nd\n6\n.\n8\n1\n2\n.\n7\n1\n5\n.\n3\n1\n9\n.\n0\nT\nA\nB\nL\nE\n \n5\n4\nB\na\ns\ne\n-\nc\na\ns\ne\n \na\nn\nd\n \ns\ne\nn\ns\ni\nt\ni\nv\ni\nt\ny\n \na\nn\na\nl\ny\ns\ne\ns\n \nc\no\nn\nd\nu\nc\nt\ne\nd\n \nu\ns\ni\nn\ng\n \na\n \n4\n0\n-\ny\ne\na\nr\n \nt\ni\nm\ne\n \nh\no\nr\ni\nz\no\nn\nS\ne\nn\ns\ni\nt\ni\nv\ni\nt\ny\n \na\nn\na\nl\ny\ns\ni\ns\nP\nr\no\nb\na\nb\ni\nl\ni\nt\ny\n \nc\no\ns\nt\n-\ne\nf\nf\ne\nc\nt\ni\nv\ne\n \nf\no\nr\n \nd\ni\nf\nf\ne\nr\ne\nn\nt\n \nt\nh\nr\ne\ns\nh\no\nl\nd\n \nv\na\nl\nu\ne\ns\n \nf\no\nr\n \ns\no\nc\ni\ne\nt\ny\n\u2019\ns\n \nw\ni\nl\nl\ni\nn\ng\nn\ne\ns\ns\n \nt\no\n \np\na\ny\n \nf\no\nr\n \na\n \nQ\nA\nL\nY\n \n(\n%\n)\nP\nr\no\nc\ne\nd\nu\nr\ne\nC\no\ns\nt\n \n(\n\u00a3\n)\nQ\nA\nL\nY\ns\nI\nC\nE\nR\n \n(\n\u00a3\n)\n\u00a3\n1\n0\n,\n0\n0\n0\n\u00a3\n2\n0\n,\n0\n0\n0\n\u00a3\n3\n0\n,\n0\n0\n0\n\u00a3\n5\n0\n,\n0\n0\n0\nB\na\ns\ne\n-\nc\na\ns\ne\n \n(\n4\n0\n-\ny\ne\na\nr\n \nt\ni\nm\ne\n \nh\no\nr\ni\nz\no\nn\n)\nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n1\n1\n,\n6\n1\n8\n8\n.\n4\n8\n0\n5\n9\n.\n0\n5\n7\n.\n5\n5\n6\n.\n3\n5\n6\n.\n1\nS\nt\na\nn\nd\na\nr\nd\n1\n1\n,\n8\n9\n9\n8\n.\n4\n6\n3\nD\no\nm\ni\nn\na\nt\ne\nd\n4\n1\n.\n0\n4\n2\n.\n5\n4\n3\n.\n7\n4\n3\n.\n9\nO\nR\n \nf\no\nr\n \nd\ni\ns\nl\no\nc\na\nt\ni\no\nn\n \na\nn\nd\n \nD\nV\nT\n \nt\na\nk\ne\nn\n \nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n1\n1\n,\n7\n3\n5\n8\n.\n4\n7\n6\n5\n5\n.\n8\n5\n4\n.\n9\n5\n4\n.\n9\n5\n4\n.\n3\nf\nr\no\nm\n \nm\ne\nt\na\n-\na\nn\na\nl\ny\ns\ni\na\nS\nt\na\nn\nd\na\nr\nd\n1\n1\n,\n8\n9\n9\n8\n.\n4\n6\n3\nD\no\nm\ni\nn\na\nt\ne\nd\n4\n4\n.\n2\n4\n5\n.\n1\n4\n5\n.\n1\n4\n5\n.\n7\nA\nl\nt\ne\nr\nn\na\nt\ne\n \nu\nt\ni\nl\ni\nt\ny\n \nv\na\nl\nu\ne\ns\nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n1\n1\n,\n6\n1\n8\n9\n.\n1\n2\n3\n5\n2\n.\n5\n5\n1\n.\n8\n5\n1\n.\n6\n5\n1\n.\n7\nS\nt\na\nn\nd\na\nr\nd\n1\n1\n,\n8\n9\n9\n9\n.\n1\n2\n4\n2\n5\n8\n,\n6\n0\n9\n4\n7\n.\n5\n4\n8\n.\n2\n4\n8\n.\n4\n4\n8\n.\n3\nA\nl\nl\n \nf\na\ni\nl\ne\nd\n \nT\nH\nR\n \np\na\nt\ni\ne\nn\nt\ns\n \ng\no\n \nt\no\n \nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n9\n,\n8\n1\n9\n7\n.\n6\n7\n1\n5\n5\n.\n8\n5\n4\n.\n7\n5\n4\n.\n1\n5\n3\n.\n8\nn\no\nn\n-\no\np\ne\nr\na\nt\ni\nv\ne\n \nm\na\nn\na\ng\ne\nm\ne\nn\nt\n \ns\nt\na\nt\ne\nS\nt\na\nn\nd\na\nr\nd\n1\n0\n,\n1\n0\n1\n7\n.\n6\n5\n4\nD\no\nm\ni\nn\na\nt\ne\nd\n4\n4\n.\n2\n4\n5\n.\n3\n4\n5\n.\n9\n4\n6\n.\n2\n5\n0\n%\n \nf\na\ni\nl\ne\nd\n \nT\nH\nR\n \np\na\nt\ni\ne\nn\nt\ns\n \ng\no\n \nt\no\n \nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n1\n0\n,\n6\n0\n4\n8\n.\n0\n4\n5\n5\n6\n.\n2\n5\n4\n.\n6\n5\n4\n.\n2\n5\n4\n.\n0\nn\no\nn\n-\no\np\ne\nr\na\nt\ni\nv\ne\n \nm\na\nn\na\ng\ne\nm\ne\nn\nt\n \ns\nt\na\nt\ne\nS\nt\na\nn\nd\na\nr\nd\n1\n0\n,\n8\n8\n5\n8\n.\n0\n2\n7\nD\no\nm\ni\nn\na\nt\ne\nd\n4\n3\n.\n8\n4\n5\n.\n4\n4\n5\n.\n8\n4\n6\n.\n0\n2\n5\n%\n \nf\na\ni\nl\ne\nd\n \nT\nH\nR\n \np\na\nt\ni\ne\nn\nt\ns\n \ng\no\n \nt\no\n \nM\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n1\n1\n,\n0\n8\n0\n8\n.\n2\n5\n4\n5\n7\n.\n0\n5\n4\n.\n8\n5\n4\n.\n5\n5\n4\n.\n2\nn\no\nn\n-\no\np\ne\nr\na\nt\ni\nv\ne\n \nm\na\nn\na\ng\ne\nm\ne\nn\nt\n \ns\nt\na\nt\ne\nS\nt\na\nn\nd\na\nr\nd\n1\n1\n,\n3\n6\n1\n8\n.\n2\n3\n7\nD\no\nm\ni\nn\na\nt\ne\nd\n4\n3\n.\n0\n4\n5\n.\n2\n4\n5\n.\n5\n4\n5\n.\n8equal but with considerable uncertainty around\nthe point estimates. In the base case of this model,\nand most of the sensitivity analyses, standard THR\nwas dominated (i.e. no more effective but more\ncostly by approximately \u00a3300) by mini-incision\nTHR (with approximately a 95% likelihood of\nbeing cost-effective depending on the cost per\nQALY threshold considered for the 1-year base-\ncase analysis). Standard THR only appeared to be\nless costly when it was assumed that follow-up after\nmini-incision THR would be more intensive than\nafter standard THR. Nevertheless, if society were\nwilling to pay \u00a330,000 for an additional QALY, the\nlikelihood that mini-incision surgery would be the\nmost cost-effective alternative was still high at\napproximately 75%. The use of alternative utility\nvalues were explored for both a 1- and 40-year\ntime horizons. The analysis conducted over a \n40-year time horizon was one of the few analyses\nwhere standard THR was not dominated by mini-\nincision THR. The slight added effectiveness of\nstandard THR in relation to mini-incision THR\ndid not, however, alter the probabilistic sensitivity\nanalysis results significantly. Relaxing assumptions\nwith regard to equal long- and short-term\ncomplications following surgery, and increasing\nthe time horizon of the analysis to 40 years, did\nnot alter the deterministic results significantly but\ndid make results of the stochastic analyses more\nuncertain as, when employing the 40-year time\nhorizon, the likelihood that mini-incision THR\nwould be considered cost-effective varied between\n50 and 60% for threshold values for society\u2019s\nwillingness to pay of up to \u00a350,000. The exception\nto this was the analysis that used alternative utility\nvalues, where standard THR was more costly but\nmore effective than mini-incision THR. The\nincremental cost per QALY for standard THR\ncompared with mini-incision THR, however, was\nnearly \u00a3260,000. Furthermore, the likelihood that\nmini-incision THR would be considered cost-\neffective was over 50% for all threshold values for\nsociety\u2019s willingness to pay for a QALY up to\n\u00a350,000. A threshold analysis around revisions for\nthe 40-year time horizon model showed that if\nsociety were willing to pay \u00a330,000 for a QALY,\nmini-incision THR would have to be associated\nwith a 7.5% increase in revisions for it to be no\nlonger considered cost-effective. \nResults of the economic evaluation should be\ntreated with caution because very few useable and\nreliable data were available in relation to costs for\nthe two modes of surgery and the risk of long-\nterm complications following mini-incision THR\nin comparison with standard THR.\nEconomic evaluation\n72Quality of life for the family and\ncarers\nQuality of life issues related to THR relate to pain,\nmobility (e.g. limp, use of walking aids) and return\nto normal activities. There are a number of\nspecific scores which measure condition-specific\nquality of life, encapsulating a range of issues,\nsuch as the Harris hip score. Finally, there are\ngeneral quality of life measures such as the SF-12,\nthe SF-36 and the EQ-5D. \nThe information on pain (either short-term within\n3 months of the operation or long-term pain\nresulting in disability) was not well reported, but\nthere were no overall differences between patients\nreceiving a mini-incision or a standard incision.\nThere were either no differences in mobility or\ntime to return to normal activities or the data\nfavoured mini-incision. \nSimilarly, few studies reported significant\ndifferences between the two groups in condition-\nspecific measures, but where there were such\ndifferences, they favoured the mini-incision group\nboth in the short term (less than 3 months) and\nover a longer period (e.g. 1\u20135 years). Measures of\ngeneral quality of life did not favour either group. \nPatients also preferred the shorter scars resulting\nfrom MIS.\nIn summary, it seems reasonable to conclude that\npatients had a marginally better quality of life\nafter MIS, but long-term information is not\navailable. This conclusion might also be\noverturned if there was evidence of a higher need\nfor revision surgery in the long term. \nAlthough no information was available on the\nquality of life of family and carers, better quality of\nlife for the individual with hip disease would most\nlikely reduce the burden of care for their carers\nand hence improve their own quality of life. \nFinancial impact for the patient\nand others\nAn earlier return to mobility and normal activity\nfollowing MIS would be expected to result in\neconomic benefits both for themselves (e.g. earlier\nreturn to work) and for carers in reducing the\nneed for time spent caring for the patient.\nHowever, there were no data available to support\nthis inference. \nIt is unlikely that minimal incision approaches will\nbe employed in all patients due to variations in\nindividual patients\u2019 habitus, the variable\ncomplexity of reconstruction between cases and\nthe variable experience of different surgeons. \nHealth Technology Assessment 2008; Vol. 12: No. 26\n73\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nChapter 6\nImplications for other partiesTraining\nRelatively few orthopaedic surgeons in the UK are\ncurrently undertaking formal mini-incision THR.\nHowever, there is a trend to reduce incision size,\nwhich could be seen as a development of standard\npractice rather than a new technique which\nrequires specific training. \nNevertheless, it would be prudent to advise that\nwidespread adoption of this technique should be\nin the context of ongoing quality assurance\nprocesses relating to individual surgeons\u2019 practices.\nThese might include audit and feedback from the\nNational Joint Registry\/Scottish Arthroplasty\nProject. Several studies addressed the issue of a\nlearning curve for surgeons not familiar with this\ntechnique,32,42,48,52,55 whereas others only included\npatients from surgeons who were considered to be\nexperienced.31,40,46,56 However, there was no\nconsensus as to how many procedures would be\nsufficient to ensure a reasonable level of skill. It\nseems reasonable to propose, however, that initial\ntraining in mini-incision operations should occur in\nhigh-volume orthopaedic centres, and that surgeons\nperforming THRs should perform a minimum\nnumber annually to maintain their expertise. \nA further point to note is that if the use of MIS\nincreases, this may reduce the number of cases of\nstandard THRs available for the training of junior\nsurgeons. Proficiency in mini-incision is achieved\nby performing the procedure and is, generally, not\namenable to being taught on a training course\n(Hutchison JD, Department of Surgery, University\nof Aberdeen and Munro N, NHS Grampian:\npersonal communication, April 2007). Generally,\nan orthopaedic surgeon would need to be\nproficient in the standard technique before\nmodifying it to a mini-incision technique. We\nestimate that around two in five patients may be\nsuitable for the mini-incision procedure (see the\nnext section) and therefore not available for\ntraining in standard THR techniques. In addition,\ntraining in computer-aided navigation and robotic\nguidance might further reduce the necessary\nnumber of standard THRs available for the\ntraining of junior surgeons. \nTraining may also be provided by companies who\nare commercially motivated to sell their own \nTHR appliances, and who may also supply THR\n\u2018kits\u2019 consisting of specially adapted retractors,\nlight sources and so on in order to boost their\nsales. The desirability of this for the NHS is\nunclear. \nFair access and equity issues\nCurrently, MIS is variably utilised within the NHS,\ndue to uncertainty about its safety and efficacy and\nthe potential need for special training. However, it\nshould be remembered that this operation is not\nsuitable for all patients, particularly those who are\nobese, very muscular or with severe osteoporosis.\nThis is for technical reasons related to operative\ndifficulty, need for adequate operative access and a\nhigher chance of complications in certain\npopulations. \nEstimates of the proportion of THR patients who\nmight be suitable for this operation are not\navailable, but around 6% of all THRs are currently\nperformed via a mini-incision. Three studies\nincluded information about the proportions of\npatients potentially suitable for MIS. In one study,\npatients were selected for MIS based on their\nupper thigh or hip girdle girth:45 32\/51 patients\n(63%) were considered to be small enough to be\nsuitable for mini-incision THR. In another study,55\nwhere patients were selected for mini-incision\nTHR based on body habitus (lower BMI), 50\/135\npatients (37%) received mini-incision THR.\nFinally, in a third study,52 where the surgeons\nintended to use mini-incision THR, but then\nextended the incision length if required during\nthe operation, 38\/102 (37%) were successfully\nrestricted to an incision of less than 10 cm, 43\/102\n(42%) had an intermediate incision length of\n10\u201314 cm and 21\/102 (21%) finally had an incision\nlength of more than 14 cm. Interestingly, the final\nincision length correlated with increasing body\nhabitus (mean BMI 26, 28 and 29.5, respectively).\nHence, in an unselected population, just under\n40% might be found to be suitable for mini-\nincision THR. \nHealth Technology Assessment 2008; Vol. 12: No. 26\n75\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nChapter 7\nImplications for the NHSSecond, the need for training and a need to\nmaintain professional competence by performing\na minimum number of operations may restrict the\ncentres providing this technique to those with\nspecialised hip surgeons. This may limit access to\nmini-incision operations by patients served by\nother centres. \nBudgetary impact on the NHS\nGiven that the NHS operation costs of a mini-\nincision THR may be similar to those of standard\nincision, it would seem likely that increasing the\nnumbers of THRs carried out via mini-incisions\nwould not result in any appreciable change in\nNHS costs. However, this would depend on there\nbeing no significant increase in the need for\nrevision surgery: long-term data for this outcome\nare lacking. It would be important to obtain long-\nterm follow-up data for all THRs performed in the\nNHS, for example through the National Joint\nRegistry.3\nThe use of two-incision\napproaches\nLittle evidence was available on the effectiveness\nof the two-incision approaches to minimal incision\nTHR and it was not possible to estimate cost-\neffectiveness or budget impact of adopting these\napproaches. The generally accepted view among\nsurgeons is that they have never been widely used\nand the conflicting evidence from the current\nreport supports this stance.\nImplications for the NHS\n76M\ninimal incision THR continues a general\ntrend towards the use of less invasive\napproaches in other surgical specialities. This\nstudy aimed to examine the clinical and cost-\neffectiveness of single mini-incision and two mini-\nincision procedures for THR compared with\nstandard THR. The rationale behind the need for\nthis research is that shorter incisions (usually\n10 cm or less) may result in less muscle dissection,\nwhich may in turn lead to reduced morbidity and\nquicker recovery. On the other hand, shorter\nincisions may reduce visualisation at operation,\nleading to a potential risk of suboptimal\nplacement of the prostheses, which may then lead\nto a higher rate of revisions than might be\nexpected with standard THR. Failure of THR\nrequiring replacement (revision) carries serious\nimplications and so longer term performance is a\nmajor factor in the choice of method for THR. In\naddition to uncertainty about the relative\neffectiveness (including their effect on\ncomplication rates) of these minimally invasive\ntechniques, there is also uncertainty about the\nrelative costs of these procedures. In particular it\nwas unclear whether the potential reduction in\nlength of hospital stay would compensate for any\nincreased cost of equipment. \nMain results\nThe results of the review of clinical effectiveness\nsuggest that single mini-incision procedures\nappear comparable to single standard incision\nprocedures in terms of safety and quality of life\nfollowing surgery. Single mini-incision surgery\nappeared to be associated with a small reduction\nin the loss of blood and operation time. The\nclinical and economic relevance of these results is\nuncertain and a matter for judgement. Recovery\nappears more rapid after MIS (although the\nmagnitude of the reduction in time to return to\nusual activities is uncertain). This is reflected in a\nreduced hospital stay and quicker return to usual\nactivities. \nHowever, comparisons of longer term data and, in\nparticular, revision rates, were inconclusive\nbecause of the small amount of data available and\nthe limited duration of follow-up. The number of\nrevisions observed during the follow-up periods\nwas very small. For example, revision rates derived\nfrom the trial data were 0.5% (1\/197) for mini-\nincision procedures compared with 0% (0\/198) for\nstandard incision procedures. The corresponding\nPeto OR was, as a result, 7.96 (95% CI 0.16 to\n402.02). Clearly, such a wide CI is beyond the\nlimits of clinical plausibility.\nWith respect to the two-incision procedure, the\nresults are inconclusive and conflicting. Two-\nincision surgery is technically more complex than\nsingle-incision surgery and this may be reflected in\na higher mean intraoperative blood loss and\nlonger operation time (two of the three studies\nreporting on blood loss and all four studies\nreporting on operation time, found this difference\nto be statistically significant). On the other hand,\nthe procedure may offer a shorter hospital stay\nand higher postoperative quality of life, compared\nwith single mini-incision or standard incision\nprocedures. However, data are sparse so these\nfindings must be treated with caution. This\noperation has not been taken up with any\nenthusiasm by orthopaedic surgeons in the UK\n(Hutchison JD, Department of Surgery, University\nof Aberdeen and Munro N, NHS Grampian:\npersonal communication, May 2007). After a\nfurther focused search of the most recent\nliterature, there is little sign that the two-incision\napproach is being taken up any further than the\ncurrent very small proportion in the UK. Further,\nthere appears to be a decreasing trend in\nenthusiasm in the international literature.\nOnly two economic evaluations were identified\nthat considered a comparison of minimally\ninvasive approaches (Duwelius, 2006).82 One of\nthese, the unpublished US study, involved a\ncomparison of two mini-incisions with single mini-\nincision and standard THR (Duwelius, 2006). The\nsecond study was a crude modelling exercise based\non the results of the first study.82 Neither study\nwas methodologically robust and their results are\nunlikely to inform decision-makers.\nResults of the economic evaluation conducted\nsuggest similar costs and effects for mini-incision\nTHR and standard incision THR. On average,\nmini-incision THR was found to be slightly less\nHealth Technology Assessment 2008; Vol. 12: No. 26\n77\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nChapter 8\nDiscussioncostly than standard incision THR. This result is\ndriven by the assumption that operation time and,\nmore importantly, length of stay, are reduced and\nthat little additional specialised equipment and\ninstrumentation are required. In addition, an\nassumption around quicker return to usual\nactivities following mini-incision THR results in\nthe new intervention being slightly more effective\nthan standard THR. Analyses were conducted over\ntwo time horizons (1 and 40 years). For both the\nshort- and long-term analyses, the deterministic\nresults were similar. It is only when we look at the\nstochastic analysis, however, that the importance\nof the 40-year analysis becomes apparent. The \n40-year model allows a greater amount of\nuncertainty into the models\u2019 input parameters and\nwhen this is translated into the probability that\nmini-incision THR might be cost-effective, a\nreduction is seen in this rate from 95% to\napproximately 55% for all threshold values\nconsidered for society\u2019s willingness to pay for a\nQALY. Only here does the current huge level of\nuncertainty in relation to long-term outcomes\nbecome apparent. It was not possible to\nincorporate data to estimate the cost-effectiveness\nof two mini-incision THR as data are too sparse to\nallow any meaningful analysis to be conducted.\nFurthermore, no analysis by subgroup was\nperformed due to the lack of data available.\nTable 50 (p. 67) shows the deterministic results of\nthe base-case model when it was repeated for a \n40-year time horizon. As can be seen, the results\nare similar to those of the 1-year analysis. \nThe published results on subgroup differences do\nappear to indicate longer operation time for\ngrossly obese patients (BMI >35) compared with\npatients with a BMI of <30 for the single incision\nprocedures (irrespective of incision length).46\nAnother study for the two-incision procedure also\nappears to indicate higher complication rates for\nobese patients (BMI >30) and also a training\neffect whereby operative time, blood loss and\ncomplication rates are higher with low-volume\nsurgeons.27\nAssumptions, limitations and\nuncertainties\nThe relatively small differences found between\nminimal and standard incision THR may be\nexplained by a number of factors. First, THR with\nstandard-length incision (usually 25\u201340 cm) has\nalready been proved to be very successful in\nrelieving pain and disability.106 Moreover, some\nsurgeons may have been using a progressively\nshorter incision in standard THR for many\nyears.107 Indeed, most of the included studies\nreported using average incision length of around\n20 cm or less for the standard incision group.\nHence measurable improvements with further\nshortening of incisions to less than 10 cm might\nbe expected to be relatively small. \nNevertheless, given that minimal incision THR is\na relatively new technique compared with standard\nTHR, it is possible that the number of\ncomplications may increase, as minimal incision\nTHR is generalised from surgeons with a special\ninterest in this area to the wider community of\nsurgeons who have a relatively low annual activity\nlevel for THR. It may also be possible that clinical\nperformance of minimal incision THR will\nimprove, as more surgeons gain proficiency in this\ntechnique. Further consideration is therefore\nrequired regarding the potential impact of this\nlearning effect. Our searches identified 14\nongoing trials (of which four had been\nabandoned) and their results would represent a\nsignificant contribution to the area (Appendix 6). \nSecond, there is no consensus as to what\nconstitutes a minimally invasive THR. The\nNational Joint Registry has used a definition of\nincision length of \u000210 cm. However, it has been\nargued by some that reduction in the dissection of\nsoft tissue is more important with the less invasive\napproaches rather than incision length itself.107,108\nYet it is not always clear within the included\nstudies whether the deep dissection was\nsufficiently different between the mini-incision and\nstandard incision groups. Of note, the cadaver\nstudy by Mardones and colleagues109 comparing\nthe two-incision technique with a single mini-\nincision technique reported that the degree of\ndamage to the abductor muscle was actually\ngreater with the two-incision incision technique.\nThird, for most of the complications specified in\nthe review, events were rare, while the sample size\nof the trials tended to be relatively small.\nTherefore, there was little information available.\nMost often, there were no clear differences, but\nconfidence intervals were wide.\nThere is little research into the predictors of long-\nterm success from short-term measures. We chose\nimplant position (poor placement of cup or stem)\nand cement quality. It is possible that\nradiostereometry may be useful in this respect, but\nlong-term research will be required to assess its\nvalue. The hypothesis is that if radiostereometry\nshows that the implant is stable at 2 years, it\nDiscussion\n78should remain so. If the implant is moving, long-\nterm surveillance may be required. If this\nhypothesis is proven, radiostereometry could be\nused to identify those patients whose implants are\nunstable (and hence require long-term\nsurveillance) and discharge the rest from follow-\nup. This is a researchable question. \nThe study has largely been concerned with THR\nfor patients with osteoarthritis. Since the incidence\nof osteoarthritis increases with age, the majority of\nparticipants in the studies included in the\nsystematic review of effectiveness were in the older\nage groups. Therefore, the applicability of\nfindings to younger age groups is uncertain.\nAlthough it might be expected that apart from\nyounger patients possibly being more muscular or\nhaving previous trauma or childhood hip disease\nwith subsequent deformity, and hence being less\nsuitable for minimal incision approaches, there is\nno reason to expect the relative performance of\nthe two approaches to be different in younger\npatients. The study also did not consider hip\nresurfacing. This operation is gaining popularity\nand is more commonly performed on a younger\npopulation.3 The review also excluded studies that\nfocused solely on patients with trauma and\nosteoporosis, who are also likely to have\nsignificantly different characteristics. \nBecause minimally invasive THR may be\ncontraindicated in some patients (e.g. obese,\nmuscular or having severe osteoporosis), it is\nplausible to expect a difference in the outcome of\nthe THR on the basis of the type of patients. We\nhad therefore planned analysis within subgroups\nas specified in Chapter 2. In the event, this was\nnot performed due to the lack of data available.\nThis is a common problem with any subgroup\nanalyses and we acknowledge that the initial\nspecification of subgroups represents an ideal.\nIndeed, amongst six31,32,40,46,58,75 of the nine\nincluded trials that reported inclusion and\nexclusion criteria, patients were excluded from the\ntrials for reasons such as weight, BMI, age,\nanaemia, neurological deficits and having\n\u2018difficult\u2019 hips requiring complex reconstruction\n(e.g. post-fracture). \nThe review of effectiveness and the subsequent\neconomic evaluation were limited by the amount\nand quality of research on mini-incision THR. Our\nsearches identified few high-quality RCTs. In most\nof the studies identified, the sample sizes were\nsmall and the duration of follow-up was short.\nAlthough the results from the review appear to\nshow some short-term benefits for minimal\nincision THR, many of the complications arising\nfrom THR occur over a longer time span and, for\nthese outcomes, data are lacking. Further expert\nopinion might have been used but it is unclear if\nestimates of relative effectiveness would be any\nmore robust than those used here. Nevertheless,\nthis might represent a potential weakness of the\nreport. According to current NICE guidance on\nthe selection of prostheses for primary THR,106\nthe most recent available evidence shows that the\nbest prostheses have revision rates of 10% or less\nat 10 years after surgery. Based on this evidence,\nNICE recommended that, wherever possible, the\nNHS should use implants and techniques that can\nbe expected to last for 10 years or more. \nDue to the small number of RCTs identified, the\nreview of effectiveness included a number of non-\nrandomised prospective comparative studies. The\ndata from these comparative studies and the trials\nwere not formally combined in the meta-analyses\nbut their data were broadly consistent with those\nfrom the trials. However, in terms of dislocation\nrates, the results from the comparative studies\nsuggested a trend towards lower rates following\nminimal incision as opposed to a trend towards\nstandard THR based on data from the trials. In\nneither case was the difference statistically\nsignificant.\nData identified as part of the review of\neffectiveness were not always reported in a form\namenable to meta-analysis. For continuous\nvariables, means and SDs for both minimally\ninvasive and standard THR were not always\nreported. More importantly, there seemed to be a\ntendency for these to be provided where the\nestimate was in a particular direction (e.g.\nduration of operation). For this reason, we chose\nto estimate missing data by imputing the standard\nerror of the mean difference for individual studies\non the basis of available information on p-values.\nThis approach made the assumption that SDs are\nthe same in both arms of the trial. Where\ninformation on p-values was also unavailable,\n\u2018dummy\u2019 SDs were imputed as the weighted means\nof SDs reported in the other studies which did\nreport data on the same outcome or where they\ncould be imputed from p-values.\nIn addition to problems with obtaining data\namenable to meta-analysis, there are also some\nconcerns about the usefulness of some of the\nmeta-analyses that could be conducted. There was\nevidence of statistical heterogeneity in the trial\ndata on length of hospital stay. As reported above,\nwhen using a fixed effects approach length of stay\nHealth Technology Assessment 2008; Vol. 12: No. 26\n79\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.was shorter for the mini-incision approach\ncompared with standard THR. When data were\nreanalysed using a random effects model instead\nof a fixed effects model the difference in length of\nhospital stay was no longer statistically significant.\nIt also needs to be borne in mind that length of\nhospital stay may be influenced by hospital policy\nfor discharge rather than the clinical needs of\neach patient. Statistical heterogeneity was also\nevident in the trial data on operation time. The\nresults from a fixed effects approach favoured the\nmini-incision approach but when a random effects\nmodel was applied, the difference in operation\ntime was no longer statistically significant. Caution\nis therefore required in interpreting these\nfindings. \nThe studies included in the review of effectiveness\nalso varied in terms of surgeon experience\n(learning curve effect) and operative approach\nused (e.g. posterior, anterior). Lack of\nstandardisation in outcome measurements was also\nevident, particularly in terms of quality of life such\nas postoperative pain and functional recovery, and\nsome outcomes were assessed in only one or two\nreports. This made comparison across studies\ndifficult.\nThere are also possible uncontrolled factors\ninfluencing the outcomes of THR. For example,\naggressive rehabilitation programmes may offer a\nshorter recovery period regardless of incision\nlength.110 Patients\u2019 awareness of incision length\nmay be another factor influencing outcomes:\nalthough blinding the patients to the incision size\nis difficult, patients who are aware of a smaller\nincision may recover slightly more quickly than\nthose who are not.111\nAs with any economic evaluation, a number of\nassumptions have been made, mostly in response\nto the very limited data available. For example,\nresults from the meta-analysis conducted as part of\nthe review of effectiveness in relation to long-term\noutcomes such as revision were so limited that they\nwere not used in the economic evaluation. As a\nresult, it has been assumed for the base-case\nanalysis that differences in complications are equal\nfollowing both forms of surgery (but with wide\nCIs). Although this is a strong assumption to\nmake, it was deemed appropriate given that no\nstatistically significant differences were found in\nthe outcomes of interest and that any differences\nthat did exist would likely be small. Nevertheless,\nfurther long-term data following mini-incision\nTHR are essential. This being said, the baseline\nrisks of complications from long-term Swedish\nRegistry data are so small that only large\ndifferences in relative complications following\nmini-incision THR in comparison with standard\nTHR would greatly alter the cost-effectiveness\nresults. A threshold analysis around revisions\nshowed that if society were willing to pay \u00a330,000\nfor a QALY, mini-incision THR would have to be\nassociated with a 7.5% increase in revisions for it\nto be no longer considered cost-effective. Given\nthe likely absolute rate of revisions for standard\nTHR, this is approximately equal to one more\nrevision for every 200 procedures performed.\nIn the economic model, estimates of the absolute\neffectiveness of minimal incision THR for many\nparameters were based on combining relative\neffect sizes for the differences between minimal\nincision THR with estimates for the absolute\neffectiveness of standard THR. One of the main\nsources of data on the relative effectiveness of\nstandard THR was the Swedish Registry. Although\nit is true that there are likely to be some\ndifferences between Scandinavian and UK\npopulations, long-term UK specific data are\nlacking, The National Joint Registry for England\nand Wales is a recent innovation and their most\nrecent report contains, for the main, a maximum\nfollow-up of 3 years, and only a crude calculation\nof the risk of revision can be calculated.\nFurthermore, there is little information about\npostoperative complications. The Swedish Registry\nis internationally recognised as being the original\nand most respected database reporting the\noutcomes for THR. It is applicable to this study in\nthat it covers a north European population with a\npredominantly public healthcare system.\nTraditionally, implant choice was more similar to\nthat in the UK than in some countries with an\nemphasis on cemented implants (although this is\nstarting to change a little in the UK). The\nadvantage of such registry data in comparison with\nstudies from individual hospitals or surgeons is\nthat they may be more representative, and the\nlarge number of patients included, allow estimates\nfor outcomes to be identified with greater\nprecision. Unfortunately, at this time we are not\naware of any formal publication comparing the\ntwo populations covered by the National Joint\nRegistry for England and Wales and the Swedish\nRegistry. \nOne area where data are lacking relates to the rate\nat which failed primary and revision THR patients\nmight receive non-operative treatment as opposed\nto further revision surgery. It was assumed that\nthere would be no difference in this rate following\nboth modes of surgery. If, in the future,\nDiscussion\n80differences are found to lie in this area, then the\ncosts and consequences of this will have to be\naddressed. \nThe main cost drivers in the model are the\nreduced hospital length of stay and operation\nduration assumed to be associated with minimal\nincision THR. These estimates were taken from\nthe review of effectiveness and, as stated\npreviously, these estimates are uncertain. When\nthe analysis was repeated but with the alternative\nassumption that there were no economically\nimportant differences in operation time or length\nof stay, mini-incision THR became more costly\nthan standard THR by approximately \u00a3200 per\npatient. Further data relevant to the UK are\nneeded to judge whether any differences in length\nof hospitalisation and operation exist and, if they\ndo exist, whether they are economically important. \nIn addition to limitations in estimates of the\nrelative effect sizes, there are also concerns about\nthe limited cost and utilities data available. In the\ncase of costs, no high-quality economic evaluations\nhave been conducted, so a bottom-up costing of\nthe two forms of surgery was attempted. However,\nit was not possible to include all relevant elements\nof the operation cost. For example, certain cost\nelements in relation to hospital resource use, such\nas consumables, instrumentation and equipment\ncosts, were not available and therefore not\nincluded in the calculation of operation cost.\nNonetheless, it is likely that such elements would\nbe similar for both mini-incision and standard\nTHR procedures and that their inclusion would\nnot greatly alter the estimated difference in cost\nbetween the two procedures. Furthermore, in\nterms of operating room instrumentation, it has\nbeen assumed in this report that only a specialised\nminimally invasive instrumentation kit would be\nrequired in addition to the standard THR\ninstrumentation kit. Nevertheless, it is plausible\nthat further additional instrumentation and\nequipment might be used depending on the\npreference of the surgeon and the particular\nsurgical centre. In such instances, these elements\nof cost would need to be accounted for. With\nrespect to utilities few useable data were available\nrelevant to the comparison of mini-incision to\nstandard THR, although data from one RCT were\nused for a sensitivity analyses. The trial, however,\nwas very small, so estimates are subject to\nconsiderable imprecision. Some exploration of the\nlikely importance of any difference in health state\nutilities was provided by the threshold analysis\nwhich was conducted. For the base-case analysis,\nmini-incision THR remained a less costly but more\neffective alternative than standard THR provided\nthat it was assumed that it was associated with a\nquicker recovery. In the analysis which assumed\nthat mini-incision THR is associated with more\nintensive resource usage, then recovery would\nneed to be on average 1.5 weeks sooner before the\nincremental cost per QALY was \u00a330,000. \nIt was not possible to conduct any subgroup\nanalysis around model estimates. Consequently, it\nis not possible to assess the suitability of minimal\nincision THR techniques to particular patient\ndemographics and operative approaches and\nhence the applicability of results to all groups is\nlimited.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n81\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Implications for the NHS\n\u25cf Compared with standard THR, minimal\nincision THR has small perioperative\nadvantages in terms of blood loss and operation\ntime. It may offer a shorter hospital stay and\nquicker recovery. It appears to have a similar\nprocedure cost to standard THR, but evidence\non its longer term performance is very limited. \n\u25cf There is no evidence of differences between\npatients receiving minimal incision and\nstandard incision THRs in postoperative\ncomplication rates and self-reported quality of\nlife.\n\u25cf The use of single mini-incision THR continues\na trend within the NHS towards the use of\nminimally invasive procedures. Given the\nsimilarities between minimal incision and\nstandard THR, the adoption of minimal\nincision THR would involve relatively small\nchanges compared with the adoption of other\nminimally invasive procedures.\n\u25cf The main uncertainty is the related long-term\nperformance of minimal incision THR.\n\u25cf A 7.5% difference in revision rates would be\nrequired for minimal incision THR for it no\nlonger to be considered cost-effective at a\n\u00a330,000 threshold.\n\u25cf It is plausible that the longer term outcomes\nfollowing minimal incision THR will be similar\nto those of standard THR. Therefore, there is\nno current evidence to suggest that its use\nshould be restricted.\n\u25cf Due to the difficulty in obtaining adequate\nvisualisation of the hip, minimal incision THR\nmay be technically more difficult. It is this lack\nof visualisation that has led to concerns that the\nrisk of revision and dislocation may be higher\nthan with standard THR. Appropriate training\nis needed for both patient selection and\ntechnical aspects of the procedure.\n\u25cf Few data were identified relevant to the two\nminimal incision THR approach. Given its\ncurrent low use within the NHS, these data\nprovide no basis to suggest that this approach\nshould be further adopted. \n\u25cf Standard THR remains an effective treatment.\nAs the apparent short-term benefits of minimal\nincision THR are modest, the quality of an\nindividual operation should not be\ncompromised purely to conform to an arbitrary\nlimit in terms of wound size.\n\u25cf The increase in minimal incision THRs\nperformed may reduce the number of cases of\nstandard THRs available for the training of\njunior surgeons. Generally, an orthopaedic\nsurgeon would need to be proficient in the\nstandard technique before modifying it to a\nmini-incision technique and, when it is taken\ninto account that further training might be\nrequired in computer aided navigation and\nrobotic guidance, this might reduce still further\nthe necessary number of standard THRs\nrequired for training. \nImplications for patients and\ncarers\n\u25cf The use of minimal incision THR could provide\nadvantages to patients in terms of reduced time\nunder anaesthetic and possibly less time in\nhospital. The shorter incision and reduced\nmuscle dissection also result in a quicker\nrecovery. It would be natural for patients to\nwant to obtain these benefits but they should be\naware that the longer term outcomes are\nuncertain. \n\u25cf The use of minimal incision THR is not suitable\nfor all patients. It is generally not\nrecommended for those who are obese or\nheavily muscled and for those with significant\ndeformity or severe osteoporosis.\n\u25cf Compared with standard THR, minimal\nincision THR is a relatively new and evolving\ntechnique. As a consequence, the procedure\nmay not be practised by all surgeons who\nperform THR.\nImplications for research\n\u25cf An important issue that needs to be addressed\nformally by the orthopaedic community relates\nto definitional issues around minimally invasive\ntechniques. Currently, there is little consensus\nacross studies, making the evaluation of such\ntechniques especially difficult. \n\u25cf The main difficulty about making a decision to\nuse minimal incision THR is lack of reliable\nHealth Technology Assessment 2008; Vol. 12: No. 26\n83\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nChapter 9\nConclusionsinformation on longer term outcomes,\nespecially revision and other long-term\ncomplications. \n\u25cf Securing reliable information on longer term\noutcomes is not straightforward. The ideal\ndesign would be a sufficiently large RCT with\nfollow-up for at least 5 years. However,\ndifferences in long-term performance are not\nlikely to be large and so a big trial would be\nneeded to provide sufficiently precise estimates,\nand this may not be feasible and\/or worth the\ncost. If such a trial were to be conducted,\nhowever, it would be recommended that an\neconomic evaluation be conducted as part of it.\n\u25cf Data from national registers, such as the\nNational Joint Registry and the Scottish\nArthroplasty Project, would certainly be useful\nfor assessing short-term complications and\noperator issues, such as related to training and\nlearning. Registers can include large numbers\nof procedures and hence give relatively precise\nestimates; however, registers would be less\nsatisfactory than large RCTs for assessing\ndifferences in long-term outcome because the\nselection bias inherent in a register is likely to\nobscure or exaggerate any true differences\nbetween minimal incision THR and standard\nTHR.\n\u25cf This lack of understanding of long-term\noutcomes translates into uncertainty about\nlonger term costs. Such costs related to minimal\nincision and standard THRs, therefore, would\nlikely be enhanced by reliable data from high-\nquality RCTs.\n\u25cf The need for long-term observation is a major\nimpediment for assessing developments in hip\nand other joint replacement; research to fund\nreliable surrogate outcomes that can be\nmeasured earlier should therefore be\nencouraged, for example collection of data in\nrelation to implant position, cement quality and\nradiostereometry.\n\u25cf Further research around the use of robotic\nguidance and computer navigation techniques\nto improve positioning of the implants may also\nbe worthwhile. \n\u25cf Further research is required in relation to the\noperative approach from different locations (i.e.\nposterior, anterior).\n\u25cf Direct measurements of health state utilities to\nreflect potential differences in pain, mobility,\nreturn to normal activities and general quality\nof life are required to supplement the available\nevidence base from RCTs so that the economic\nevaluation of minimal incision THR can be\nmade more robust.\n\u25cf If two minimal incision THR is to be adopted\nwidely, high-quality RCTs comparing two\nminimal incision with standard THR are\nnecessary. Given that this technique has\ngenerally fallen out of favour within the UK\northopaedic community and, as a consequence,\nhas a low use within the NHS, such trials are\nunlikely to be considered worthwhile.\nConclusions\n84W\ne thank all those researchers from\nthroughout the world who provided\nadditional information on the trials and registries.\nWe also thank Bronwyn Davidson and Kathleen\nMcIntosh for secretarial support. The Health\nServices Research Unit and the Health Economics\nResearch Unit are both core funded by the Chief\nScientist Office of the Scottish Government Health\nDirectorates. The views expressed are those of the\nauthors.\nThis report was commissioned by the NIHR \nHTA Programme. The views expressed in this\npublication are those of the authors and not\nnecessarily those of the NIHR HTA Programme.\nAny errors are the responsibility of the \nauthors.\nContribution of authors\nMari Imamura (Research Fellow), Shihua Zhu\n(Research Fellow) and Cathryn Glazener (Reader)\ncompleted the review of effectiveness. Robyn de\nVerteuil (Research Assistant) conducted the review\nof economic evaluations and the economic\nmodelling. Cynthia Fraser (Information Officer)\ndeveloped and ran the search strategies and was\nresponsible for obtaining papers and for reference\nmanagement. Niall Munro (Consultant in\nOrthopaedics) and James Hutchison (Regius\nProfessor of Surgery) drafted the background\nchapter and along with Douglas Coyle (Associate\nProfessor), Kathryn Coyle (Consultant) and Adrian\nGrant (Professor of Health Services Research)\nprovided advice and commented on drafts of the\nreview. Luke Vale (Professor of Health Technology\nAssessment) led the review team.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n85\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAcknowledgements1. Coventry MB. Foreword. In: Amutz HC, editor.\nHip arthroplasty. New York: Churchill Livingstone;\n1991.\n2. NHS Scotland. Scottish Arthroplasty Project Annual\nReport 2006. Edinburgh: NHS Scotland; 2006.\nURL: http:\/\/www.arthro.scot.nhs.uk\/Reports\/\nArthro_Report_2006.pdf. Accessed April 2007.\n3. National Joint Registry Centre. National Joint\nRegistry Annual Report 2005\u20132006. Hemel\nHempstead: National Joint Registry Centre; 2006.\nURL: http:\/\/www.njrcentre.org.uk\/documents\/\nreports\/annual\/3rd\/NJR_AR2.pdf. Accessed April\n2007.\n4. NICE. Minimally invasive two-incision surgery for total\nhip replacement. Interventional Procedure Guidance\nIPG112. London: National Institute for Health and\nClinical Excellence; 2005. URL: http:\/\/guidance.\nnice.org.uk\/IPG112\/?template=ipcat.aspx.\nAccessed April 2007.\n5. NICE. Single mini-incision surgery for total hip\nreplacement. Interventional Procedure Guidance\nIPG152. London: National Institute for Health\nand ClinicalExcellence; 2006. URL:\nhttp:\/\/guidance.nice.org.uk\/IPG152\/?template=\nipcat.aspx. Accessed April 2007.\n6. Department of Health. Orthopaedic Device\nEvaluation Panel Database. London: Department of\nHealth, NHS Purchasing and Supply Agency;\n2007. URL: http:\/\/www.pasa.nhs.uk\/. Accessed\nApril 2007.\n7. NICE. Hip disease \u2013 metal-on-metal hip resurfacing.\nGuidance Number TA44. London: National Institute\nfor Health and Clinical Excellence; 2001.URL:\nhttp:\/\/guidance.nice.org.uk\/TA44\/guidance\/pdf\/\nEnglish. Accessed April 2007.\n8. Daniel J, Pynsent PB, McMinn DJ. Metal-on-metal\nresurfacing of the hip in patients under the age of\n55 years with osteoarthritis. J Bone Joint Surg Br\n2004;86:177\u201384.\n9. National Joint Registry Centre. National Joint\nRegistry for England & Wales. 1st Annual Report.\nHemel Hempstead: National Joint Registry\nCentre. 2004. URL: http:\/\/www.njrcentre.org.uk\/\ndocuments\/reports\/annual\/1st\/fullreport04.pdf.\nAccessed April 2007.\n10. National Joint Registry Centre. National Joint\nRegistry for England and Wales. 2nd Annual Report.\nHemel Hempstead: National Joint Registry\nCentre; 2005. URL: http:\/\/www.njrcentre.org.uk\/\ndocuments\/reports\/annual\/2nd\/NJR2_fullreport.\npdf. Accessed April 2007.\n11. Haukeland University Hospital. Centre for\nExcellence for Joint Replacement: the Norwegian\nArthroplasty Register, the Norwegian Cruiate Ligament\nRegister, the Norwegian Hip Fracture Register.\nBergen: Haukeland University Hospital,\nDepartment of Orthopedic Surgery; 2006. \nURL: http:\/\/www.haukeland.no\/nrl\/Report2006.pdf.\nAccessed April 2007.\n12. Canadian Institute for Health Information. 2005\nCJRR Report: Total Hip and Total Knee Replacements\nin Canada. Ottawa: Canadian Institute for Health\nInformation; 2005. URL: http:\/\/secure.cihi.ca\/\ncihiweb\/dispPage.jsp?cw_page=AR_30_E. Accessed\nApril 2007.\n13. Canadian Institute for Health Information. 2006\nCJRR Report: Total Hip and Total Knee Replacements\nin Canada. Ottawa: Canadian Institute for Health\nInformation; 2006. URL: http:\/\/secure.cihi.ca\/\ncihiweb\/dispPage.jsp?cw_page=AR_30_E. Accessed\nApril 2007.\n14. Hunt D. Minimal access orthopaedics. Oxford:\nRadcliffe Medical Press; 1995.\n15. Darzi A, Mackay S. Recent advances in minimal\naccess surgery. BMJ 2002;324:31\u20134.\n16. Lukoschek M, Breusch SJ. Minimal incision\napproaches to the hip. In: Breusch SJ, Malchau H,\neditors. The well-cemented total hip arthroplasty: theory\nand practice. Heidelberg: Springer; 2005. pp. 2\u201315.\n17. Berger RA, Duwelius PJ. The two-incision\nminimally invasive total hip arthroplasty:\ntechnique and results. Orthop Clin North Am\n2004;3:163\u201372.\n18. Moore AT. The self-locking metal hip prosthesis.\nJ Bone Joint Surg Am 1957;39A:811\u201327.\n19. Hardinge K. The direct lateral approach to the\nhip. J Bone Joint Surg Br 1982;64:17\u201319.\n20. Watson-Jones R. Fractures of the neck of the\nfemur. Br J Surg 1936;23:787\u2013808.\n21. Harkness JW. Arthroplasty of hip. In: Canale ST,\neditor. Campbell\u2019s operative orthopaedics. St Louis,\nMO: Mosby; 1998. pp. 296\u2013471.\n22. Ranawat CS, Ranawat AS. Minimally invasive total\njoint arthroplasty: where are we going? J Bone Joint\nSurg Am 2003;85:2070\u20131.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n87\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nReferences23. Hungerford DS. Minimally invasive total hip\narthroplasty: in opposition. J Arthroplasty\n2004;19:81\u20132.\n24. Ranawat CS, Ranawat AS. A common sense\napproach to minimally invasive total hip\nreplacement. Orthopedics 2005;28:937\u20138.\n25. NICE: Guide to the methods of technology appraisal.\nLondon: National Institute for Clinical Excellence;\n2004. URL: http:\/\/www.nice.org.uk\/page.aspx?o=\n201974. Accessed September 2005.\n26. Verhagen AP, de Vet HC, de Bie RA, Kessels AG,\nBoers M, Bouter LM, et al. The Delphi list: a\ncriteria list for quality assessment of randomized\nclinical trials for conducting systematic reviews\ndeveloped by Delphi consensus. J Clin Epidemiol\n1998;51:1235\u201341.\n27. Archibeck MJ, White RE Jr. Learning curve for the\ntwo-incision total hip replacement. Clin Orthop\n2004;429:232\u20138.\n28. Asayama I, Kinsey TL, Mahoney OM. Two-year\nexperience using a limited-incision direct lateral\napproach in total hip arthroplasty. J Arthroplasty\n2006;21:1083\u201391.\n29. Berger RA. Mini-incision total hip replacement\nusing an anterolateral approach: technique and\nresults. Orthop Clin North Am 2004;35:143\u201351.\n30. Chen J, Chen W, Zhou J, Huang H. Clinical\nresearch and following results on the minimal\nincision and traditional total hip arthroplasty.\nFudan Xuebao (Yixueban) 2006;33:257\u201382.\n31. Chimento GF, Pavone V, Sharrock N, Kahn B,\nCahill J, Sculco TP. Minimally invasive total hip\narthroplasty: a prospective randomized study.\nJ Arthroplasty 2005;20:139\u201344.\n32. Chung WK, Liu D, Foo LS. Mini-incision total hip\nreplacement \u2013 surgical technique and early results.\nJ Orthop Surg 2004;12:19\u201324.\n33. Ciminiello M, Parvizi J, Sharkey PF, Eslampour A,\nRothman RH. Total hip arthroplasty: is small\nincision better? J Arthroplasty 2006;21:484\u20138.\n34. de Beer J, Petruccelli D, Zalzal P, Winemaker MJ.\nSingle-incision, minimally invasive total hip\narthroplasty: length doesn\u2019t matter. J Arthroplasty\n2004;19:945\u201350.\n35. DiGioia AM III, Plakseychuk AY, Levison TJ,\nJaramaz B. Mini-incision technique for total hip\narthroplasty with navigation. J Arthroplasty\n2003;18:123\u20138.\n36. Dorr L, Thomas D, Long W, Polatin P, Sirianni L.\nPsychologic reasons for patients preferring\nminimally invasive total hip arthroplasty. Clin\nOrthop 2007;458:94\u2013100.\n37. Duwelius PJ, Berger RA, Hartzband MA, \nMears DC. Two-incision minimally invasive total\nhip arthroplasty: operative technique and early\nresults from four centers. J Bone Joint Surg Am\n2003;85A:2240\u20132.\n38. Duwelius PJ, Burkhart RL, Hayhurst JO,\nMoller H, Butler JB. Comparison of the 2-incision\nand mini-incision posterior total hip arthroplasty\ntechnique. J Arthroplasty 2007;22:48\u201356.\n39. Fl\u00f6ren M, Lester DK. Durability of implant\nfixation after less-invasive total hip arthroplasty.\nJ Arthroplasty 2006;21:783\u201390.\n40. Hart R, Stipcak V, Janecek M, Visna P. \nComponent position following total hip\narthroplasty through a miniinvasive posterolateral\napproach. Acta Orthop Belg 2005;71:60\u20134.\n41. Hartzband MA. Posterolateral mini-incision total\nhip arthroplasty. Oper Tech Orthop 2006;16:93\u2013101.\n42. Howell JR, Masri BA, Duncan CP. Minimally\ninvasive versus standard incision anterolateral hip\nreplacement: a comparative study. Orthop Clin\nNorth Am 2004;35:153\u201362.\n43. Kim Y-H. Comparison of primary total hip\narthroplasties performed with a minimally invasive\ntechnique or a standard technique. J Arthroplasty\n2006;21:1092\u20138.\n44. Li Z, Shi Z, Guo W, Zhang N, Sun W. Preliminary\nexperiences in minimally invasive and mini-\nincision surgery total hip arthroplasty for late\nosteonecrosis of the femoral head. Chung Kuo Hsiu\nFu Chung Chien Wai Ko Tsa Chih 2005;19:710\u201313\n(in Chinese).\n45. O\u2019Brien DA, Rorabeck CH. The mini-incision\ndirect lateral approach in primary total hip\narthroplasty. Clin Orthop 2005;441:99\u2013103.\n46. Ogonda L, Wilson R, Archbold P, Lawlor M,\nHumphreys P, O\u2019Brien S, et al. A minimal-incision\ntechnique in total hip arthroplasty does not\nimprove early postoperative outcomes. A\nprospective, randomized, controlled trial. J Bone\nJoint Surg Am 2005;87:701\u201310.\n47. Pagnano MW, Trousdale RT, Meneghini RM,\nHanssen AD. Patients preferred a mini-posterior\nTHA to a contralateral two-incision THA. Clin\nOrthop 2006;453:156\u20139.\n48. Pilot P, Kerens B, Draijer WF, Kort NP, ten Kate J,\nBuurman WA, et al. Is minimally invasive surgery\nless invasive in total hip replacement? A pilot\nstudy. Injury 2006;37:S17\u201323.\n49. Pipino F. CFP prosthetic stem in mini-invasive\ntotal hip arthroplasty. J Orthop Traumatol\n2004;5:165\u201371.\n50. Siguier T, Siguier M, Brumpt B. Mini-incision\nanterior approach does not increase dislocation\nrate: a study of 1037 total hip replacements. Clin\nOrthop 2004;426:164\u201373.\nReferences\n8851. Swanson TV. Early results of 1000 consecutive,\nposterior, single-incision minimally invasive\nsurgery total hip arthroplasties. J Arthroplasty\n2005;7:26\u201332.\n52. Szendr\u00f3i M, Sztrinkai G, Vass R, Kiss J. The\nimpact of minimally invasive total hip arthroplasty\non the standard procedure. Int Orthop\n2006;30:167\u201371.\n53. Tanavalee A, Jaruwannapong S, Yuktanandana P,\nItiravivong P. Early outcomes following minimally\ninvasive total hip arthroplasty using a two-incision\napproach versus a mini-posterior approach. Hip\nInt 2006;16:S17\u201322.\n54. Teet JS, Skinner HB, Khoury L. The effect of the\n\u201cmini\u201d incision in total hip arthroplasty on\ncomponent position. J Arthroplasty 2006;21:503\u20137.\n55. Woolson ST, Mow CS, Syquia JF, Lannin JV,\nSchurman DJ. Comparison of primary total hip\nreplacements performed with a standard incision\nor a mini-incision. J Bone Joint Surg Am\n2004;86A:1353\u20138.\n56. Wright JM, Crockett HC, Delgado S, Lyman S,\nMadsen M, Sculco TP. Mini-incision for total hip\narthroplasty: a prospective, controlled\ninvestigation with 5-year follow-up evaluation. \nJ Arthroplasty 2004;19:538\u201345.\n57. Yan Z-Q, Chen Y-S, Yang Y, Li W-J, Chen Z-R,\nZhang G-J. Two-incision minimal invasive\napproach for total hip replacement. Acta Acad Med\nShanghai 2005;32:557\u201360 (in Chinese).\n58. Zhang XL, Wang Q, Jiang Y, Zeng BF. Minimally\ninvasive total hip arthroplasty with anterior\nincision. Chung Hua Wai Ko Tsa Chih 2006;\n44:512\u201315 (in Chinese).\n59. Bennett D, Ogonda L, Elliott D, Humphreys L,\nBeverland DE. Comparison of gait kinematics in\npatients receiving minimally invasive and\ntraditional hip replacement surgery: a prospective\nblinded study. Gait Posture 2006;23:374\u201382.\n60. Berger RA. Total hip arthroplasty using the\nminimally invasive two-incision approach. Clin\nOrthop 2003;417:232\u201341.\n61. Duwelius PJ, Berger RA. The two-incision\nminimally invasive total hip arthroplasty:\ntechnique and results. Semin Arthroplasty\n2004;15:99\u2013107.\n62. Duwelius PJ. Two-incision minimally invasive total\nhip arthroplasty: techniques and results to date.\nInstr Course Lect 2006;55:215\u201322.\n63. Hafez MA, Seel MJ, Jaramaz B, DiGioia AM III.\nNavigation in minimally invasive total knee\narthroplasty and total hip arthroscopy. Oper Tech\nOrthop 2006;16:207\u201310.\n64. Hart R, Stipcak V, Janecek M, Visna P.\nRadiological study of THA after mini-incision\ntechnique. Hip Int 2005;15:98\u2013101.\n65. Inaba Y, Dorr LD, Wan Z, Sirianni L, Boutary M.\nOperative and patient care techniques for\nposterior mini-incision total hip arthroplasty. \nClin Orthop 2005;441:104\u201314.\n66. Lawlor M, Humphreys P, Morrow E, Ogonda L,\nBennett D, Elliott D, et al. Comparison of early\npostoperative functional levels following total hip\nreplacement using minimally invasive versus\nstandard incisions. A prospective randomized\nblinded trial. Clin Rehabil 2005;19:465\u201374.\n67. Mow CS, Woolson ST, Ngarmukos SG, Park EH,\nLorenz HP. Comparison of scars from total hip\nreplacements done with a standard or a mini-\nincision. Clin Orthop 2005;441:80\u20135.\n68. Sculco TP, Jordan LC, Walter WL. Minimally\ninvasive total hip arthroplasty: the Hospital for\nSpecial Surgery experience. Orthop Clin North Am\n2004;35:137\u201342.\n69. Charles MN, Fejbel RJ, Kim P. Minimally invasive\nsurgery of the hip \u2013 a randomized pilot study.\nAnnual Meeting of the Canadian Orthopaedic\nAssociation, Toronto, June 2006. Poster 88.\n70. DiGioia AM III. Mini incision supported by\nnavigation. Annual Meeting of the American\nAcademy of Orthopaedic Surgeons, San Fransisco,\nMarch 2003. Symposia (ORS1).\n71. Greidanus NV, Garbuz DS, Masri BA, Duncan CP,\nCallaghan JJ, Hozack WJ. Comparative cohort\nstudy of 2-incision versus 1-incision MIS THA.\nAnnual Meeting of the American Academy of\nOrthopaedic Surgeons, Chicago, March 2006.\nPaper No. 200.\n72. Pagnano MW, Meneghini RM, Kaufman K,\nColemam-Wood K, Berg E, Hanssen AD. No\nbenefit of the 2-incision technique over\nminiposterior total hip arthroplasty: a\ncomprehensive gait analysis and strength testing\nstudy. J Arthroplasty 2007;22:301.\n73. Pagnano MW, Leone J, Hanssen AD, \nTrousdale RTM, Berg E. A prospective\nrandomized clinical trial shows that 2-incision total\nhips do not recover quicker than miniposterior\ntotal hips. J Arthroplasty 2007;22:303.\n74. Panisello JJ, Canales V, Herrera A, Mateo J,\nPeguero A. Effectiveness of mini-incision technique\nin primary hip replacement. J Bone Joint Surg Br\n2006;88B:63.\n75. Rachbauer F, Rosiek R, Nogler M, Kessler O. \nThe benefits of the direct anterior approach in\nminimally invasive THA. Annual Meeting of the\nAmerican Academy of Orthopaedic Surgeons,\nChicago, March 2006. Paper No. 202.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n89\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.76. Rothman RH, Ciminiello M, Parvizi J. Total hip\narthroplasty: does incision length matter. Annual\nMeeting of the American Academy of Orthopaedic\nSurgeons, Washington, DC, March 2005.\nPaper No. 137.\n77. Sharma S, Bharma MS. A prospective randomised\npilot study to compare early post-operative\nrecovery after conventional versus minimal\nincision posterior approach for total hip joint\nreplacement. J Bone Joint Surg Br 2006;88B:243.\n78. Takahira N, Uchiyama K, Takasi S, Katano M,\nItoman M. Prospective comparison study of\nclinical data between the minimal incision and\nconventional incision in total hip arthroplasty.\n19th Annual Symposium of the International\nSociety for Technology in Arthroplasty, New York,\nOctober 2006. Abstract A9-3.\n79. Yoon TR, Moon E, Rowe SM, Jung ST, Seo HY,\nLee JY. Minimally invasive total hip arthroplasty:\ncomparison between one-incision and two-incision\ntechnique. Annual Meeting of the American\nAcademy of Orthopaedic Surgeons, Washington,\nDC, March 2005. Paper No. 147.\n80. Brazier J, Roberts J, Deverill M. The estimation of\na preference-based measure of health from the \nSF-36. J Health Econ 2002;21:271\u201392.\n81. NHS Centre for Reviews and Dissemination. \nNHS Economic Evaluation Database Handbook. York:\nNHS Centre for Reviews and Dissemination; 2007.\nURL: http:\/\/www.york.ac.uk\/inst\/crd\/pdf\/\nnhseeed-handb07.pdf. Accessed April 2007.\n82. Straumann D, Valderrabano V, Eckstein M, Dick W,\nDora C. Cost\u2013benefit analysis of MIS THA: model-\nbased analysis of the consequences for Switzerland.\nHip Int 2006;16:S54\u20137.\n83. Bertin KC. Minimally invasive outpatient total hip\narthroplasty: a financial analysis. Clin Orthop\n2005;435:154\u201363.\n84. Chang RW, Pellissier JM, Hazen GB. A cost-\neffectiveness analysis of total hip arthroplasty for\nosteoarthritis of the hip. JAMA 1996;275:858\u201365.\n85. Drummond MF, Sculpher MJ, Torrance GW,\nO\u2019Brien BJ, Stoddart GL. Methods for the economic\nevaluation of health care programmes. New York:\nOxford University Press; 2005.\n86. Mulrow CD. Rationale for systematic reviews. In:\nChalmers I, Alvarez G, editors. Systematic reviews.\nLondon: BMJ Publishing Group; 1995.\n87. Sahlgrenska University Hospital. Swedish Hip\nArthroplasty Register. annual report 2004. Goteborg:\nSahlgrenska University Hospital, Department of\nOthropaedics; 2005. URL: http:\/\/www.jru.\northop.gu.se\/. Accessed January 2007.\n88. Fender D, Harper WM, Gregg PJ. The Trent\nregional arthroplasty study. Experiences with a hip\nregister. J Bone Joint Surg Br 2000;82:944\u20137.\n89. Government Actuary\u2019s Department. Interim life\ntables. London: United Kingdom Government\nActuary\u2019s Department; 2007. URL: http:\/\/www.gad.\ngov.uk\/Life_Tables\/Interim_life_tables.htm.\nAccessed January 2007.\n90. SIGN. Prophylaxis of venous thromboembolism. SIGN\nGuideline No. 62. Edinburgh: Scottish\nIntercollegiate Guidelines Network; 2002. URL:\nhttp:\/\/www.sign.ac.uk\/guidelines\/fulltext\/62\/index.\nhtml. Accessed January 2007. \n91. Vale L, Wyness L, McCormack K, McKenzie L,\nBrazzelli M, Stearns SC. A systematic review of the\neffectiveness and cost-effectiveness of metal-on-\nmetal hip resurfacing arthoplasty for treatment of\nhip disease. Health Technol Assess 2002;6(15).\n92. NHS: The Information Centre. Hospital Episode\nStatistics. London: NHS: The Information Centre;\n2006. URL: http:\/\/www.hesonline.nhs.uk\/Ease\/\nservlet\/ContentServer?siteID=1937&categoryID=537.\nAccessed January 2007.\n93. Curtis L, Netten, A. Unit costs of health and social\ncare. University of Kent: Personal Social Services\nResearch Unit; 2006. URL: http:\/\/www.pssru.ac.uk\/\npdf\/uc\/uc2006\/uc2006.pdf. Accessed January 2007.\n94. ISD Scotland. Scotttish Health Services costs.\nEdinburgh: ISD Scotland; 2006. URL:\nhttp:\/\/www.isdscotland.org\/isd\/797.html. Accessed\nJanuary 2007.\n95. British Orthopaedic Association. Primary total hip\nreplacement: a guide to good practice. London: \nBritish Orthopaedic Association; 2006. URL:\nhttp:\/\/www.boa.ac.uk\/. Accessed January 2007.\n96. Department of Health. NHS reference costs.\nLondon: Department of Health; 2007. URL:\nhttp:\/\/www.dh.gov.uk\/en\/Policyandguidance\/\nOrganisationpolicy\/Financeandplanning\/\nNHSreferencecosts\/index.htm. Accessed January\n2007.\n97. SIGN. Antithrombotic therapy. SIGN Guideline No. 36.\nEdinburgh: Scottish Intercollegiate Guidelines\nNetwork; 1999. URL: http:\/\/www.sign.ac.uk\/\nguidelines\/fulltext\/36\/index.html. Accessed January\n2007. \n98. BMJ Publishing Group. British National Formulary\n53. London: BMJ Publishing Group; 2007. URL:\nhttp:\/\/www.bnf.org\/bnf\/. Accessed January 2007. \n99. Dawson J, Fitzpatrick R, Frost S, Gundle R,\nMcLardy-Smith P, Murray D. Evidence for the\nvalidity of a patient-based instrument for\nassessment of outcome after revision hip\nreplacement. J Bone Joint Surg Br 2001;83:1125\u20139.\nReferences\n90100. Robinson AH, Palmer CR, Villar RN. Is revision as\ngood as primary hip replacement? A comparison\nof quality of life. J Bone Joint Surg Br 1999;81:\n42\u20135.\n101. Malchau H, Garellick G, Eisler T, Karrholm J,\nHerberts P. Presidential guest address: the Swedish\nHip Registry: increasing the sensitivity by patient\noutcome data. Clin Orthop 2005;441:19\u201329.\n102. Ostendorf M, van Stel HF, Buskens E, Schrijvers AJ,\nMarting LN, Verbout AJ, et al. Patient-reported\noutcome in total hip replacement. A comparison\nof five instruments of health status. J Bone Joint\nSurg Br 2004;86:801\u20138.\n103. Ostendorf M, Buskens E, van Stel H, Schrijvers A,\nMarting L, Dhert W, et al. Waiting for total hip\narthroplasty: avoidable loss in quality time and\npreventable deterioration. J Arthroplasty 2004;19:\n302\u20139.\n104. NICE. Guidance on the methods of technology appraisal\n(reference N0515). London: National Institute for\nClinical Excellence; 2004. URL:\nhttp:\/\/www.nice.org.uk\/page.aspx?o=201973.\nAccessed September 2006.\n105. Van Hout B, Al M, Gordon G. Costs, effects and\nC\/E ratios alongside a clinical trial. Health Econ\n1994;3:309\u201319.\n106. NICE. Guidance on the selection of prostheses for\nprimary total hip replacement. Technology Appraisal\nGuidance No 2. London: National Institute for\nClinical Excellence; 2000. URL:\nhttp:\/\/guidance.nice.org.uk\/TA2\/guidance\/pdf\/\nEnglish. Accessed April 2007.\n107. White SP, Smith EJ. Minimal access surgery for\ntotal hip arthroplasty \u2013 current beliefs and activity\nprofile in the UK. Ann R Coll Surg Engl\n2007;89:36\u201340.\n108. Khan RJK, Fick D, Khoo P, Yao F, Nivbrant B,\nWood D. Less invasive total hip arthroplasty.\nDescription of a new technique. J Arthroplasty\n2006;21:1038\u201346.\n109. Mardones R, Pagnano MW, Nemanich JP,\nTrousdale RT. Muscle damage after total hip\narthroplasty done with the two-incision and \nmini-posterior techniques. Clin Orthop 2005;441:\n63\u20137.\n110. Parvizi J, Pour AE, Sharkey PF, Rothman RH,\nCallaghan JJ, Hozack WJ. Minimally invasive hip\narthroplasty: what role does patient\npreconditioning play. Annual Meeting of the\nAmerican Academy of Orthopaedic Surgeons,\nChicago, March 2006. Paper No. 201.\n111. Wright JM, Rosse D, Rosse S. A prospective\nrandomized patient-blinded comparison of mini\nversus standard incision THA. Annual Meeting of\nthe American Academy of Orthopaedic Surgeons,\nWashington, DC, March 2005. Paper No. 139.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n91\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Clinical effectiveness\nSearch strategies used to identify\nreports of clinical effectiveness of\nminimally invasive hip arthroplasty\nMEDLINE (1966\u2013February Week 3 2007),\nEMBASE (1980\u20132007 Week 8) \n(MEDLINE In-Process 1 March 2007)\nOvid multi-file search. \nURL: http:\/\/gateway.ovid.com\/athens\n1 Arthroplasty, Replacement, Hip\/\n2 Total Hip Prosthesis\/ use emez \n3 Hip Prosthesis\/ \n4 (hip adj3 (arthroplast$ or replace$ or\nprosthes$ or implant$)).tw. \n5 or\/1-4 \n6 Osteoarthritis,Hip\/su\n7 exp Arthritis\/su \n8 (osteoarthritis or arthritis).tw. \n9 hip.tw,hw. \n10 (7 or 8) and 9 \n11 or\/6,10 \n12 Hip Joint\/su use mesz\n13 Hip\/su use mesz \n14 Hip Surgery\/ use emez \n15 (arthroplast$ or replace$ or prosthes$ or\nimplant$).tw. \n16 (12 or 13 or 14) and 15 \n17 5 or 11 or 16 \n18 Surgical procedures,minimally invasive\/ \n19 Robotics\/ \n20 Video-assisted Surgery\/ \n21 (minimal$ adj3 (invasiv$ or access$ or\nsurg$)).tw. \n22 ((small or single or double or mini or one or\ntwo) adj3 incision$).tw. \n23 computer aid$.tw. \n24 robotic$.tw.\n25 (key hole or keyhole).tw. \n26 (less adj5 invasiv$).tw. \n27 or\/18-26\n28 17 and 27 \n29 humans\/ \n30 animals\/ or nonhuman\/ \n31 30 not (29 and 30) \n32 28 not 31 \n33 remove duplicates from 32 \nScience Citation Index (1985\u20132 March 2007),\nBiosis (1985\u20131 March 2007)\nWeb of Knowledge. URL:\nhttp:\/\/wok.mimas.ac.uk\/ \n#1 TS=(hip SAME arthroplast*)\n#2 TS=(hip SAME replace*)\n#3 TS=(hip SAME prosthes*)\n#4 TS=(hip SAME implant*)\n#5 TS=(hip SAME (surgery or surgical))\n#6 #1 or #2 or #3 or #4 or #5\n#7 TS=(minimal* SAME (invasiv* or access* or\nsurg*))\n#8 TS=((small or single or double or mini or\none or two) SAME incision*)\n#9 TS=(robotic* or computer-aid*)\n#10 #7 or #8 or #9\n#11 #6 and #10\nCochrane Library (Issue 1, 2007)\nURL: http:\/\/www3.interscience.wiley.com\/\ncgi-bin\/mrwhome\/106568753\/HOME\n#1 MeSH descriptor Arthroplasty, Replacement,\nHip, this term only \n#2 MeSH descriptor Hip Prosthesis, this term\nonly \n#3 MeSH descriptor Osteoarthritis, Hip, this\nterm only with qualifier: SU \n#4 MeSH descriptor Arthritis explode all trees\nwith qualifier: SU \n#5 MeSH descriptor Hip Joint, this term only\nwith qualifier: SU \n#6 MeSH descriptor Hip, this term only with\nqualifier: SU \n#7 (arthroplast* or replace* or prosthes* or\nimplant*) \n#8 (((#5 OR #6 ) AND #7)\n#9 (hip near\/3 (arthroplast* or replace* or\nprosthes* or implant*)) \n#10 (osteoarthritis or arthritis) and (hip) \n#11 (hip) \n#12 (#4 AND #11) \n#13 (#1 OR #2 OR #3 OR #8 OR #9 OR #10\nOR #12) \n#14 MeSH descriptor Surgical Procedures,\nMinimally Invasive, this term only \n#15 MeSH descriptor Robotics, this term \nHealth Technology Assessment 2008; Vol. 12: No. 26\n93\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 1\nSearch strategies#16 MeSH descriptor Video-Assisted Surgery,\nthis term only \n#17 (minimal* near\/3 (invasiv* or access* or\nsurg*)) or ((small or single or double or\nmini or one or two) near\/3 incision*) or\n(computer aid*) or (robotic* or key hole or\nkeyhole) or (less near\/3 invasiv*) \n#18 (#14 OR #15 OR #16 OR #17) \n#19 (#13 AND #18) \nNational Research Register (Issue 4, 2006)\nURL: http:\/\/www.update-software.com\/National\/\n1 MeSH Arthroplasty, Replacement, Hip\n2 MeSH Hip Prosthesis\n3 MeSH Osteoarthritis, Hip QUALIFIERS SU\n4 MeSH Arthritis QUALIFIERS SU EXPLODE 1\n5 MeSH Hip Joint QUALIFIERS SU\n6 MeSH Hip QUALIFIERS SU\n7 (arthroplast* or replace* or prosthes* or\nimplant*)\n8 ((#5 or #6) and #7)\n9 (hip near\/3 (arthroplast* or replace* or\nprosthes* or implant*)) \n10 ((osteoarthritis OR arthritis) AND hip)\n11 hip\n12 (#4 and #11)\n13 (#1 OR #2 OR #3 OR #8 OR #9 OR #10\nOR #12)\n14 MeSH Surgical Procedures, Minimally Invasive\n15 MeSH Robotics\n16 MeSH Video-Assisted Surgery\n17 (minimal* near (invasiv* or access* or surg*)\n18 (small or single or double or mini or one or\ntwo) near incision*) \n19 (computer aid*) \n20 (robotic* or key hole or keyhole) \n21 (less near invasiv*)\n22 #14 or #15 or #16 or #17 or #18 or #19 or\n#20 or #21\n23 #13 and #22\nClinical Trials (December 2006)\nURL: http:\/\/clinicaltrials.gov\/ct\/gui\/c\/r\nHip and minimally and (arthroplasty or\nreplacement)\nCurrent Controlled Trials (December 2006) \nURL: http:\/\/www.controlled-trials.com\/\nHip and Minimal% and (arthroplast% or replac%\nor implant% or prosthes% or surg%)\nCost-effectiveness and economic\nevaluations\nSearch strategies used to identify\nreports of cost-effectiveness and\neconomic evaluations of minimally\ninvasive hip arthroplasty\nMEDLINE (1966\u2013February Week 3 2007),\nEMBASE (1980\u2013Week 8 2007) \n(MEDLINE In-Process 1 March 2007)\nOvid multi-file search. URL:\nhttp:\/\/gateway.ovid.com\/\n1 Arthroplasty, Replacement, Hip\/ \n2 Total Hip Prosthesis\/ use emez \n3 Hip Prosthesis\/ \n4 (hip adj3 (arthroplast$ or replace$ or\nprosthes$ or implant$)).tw. \n5 or\/1-4 \n6 Osteoarthritis,Hip\/su \n7 exp Arthritis\/su \n8 (osteoarthritis or arthritis).tw. \n9 hip.tw,hw. \n10 (7 or 8) and 9 \n11 or\/6,10 \n12 Hip Joint\/su use mesz \n13 Hip\/su use mesz \n14 Hip Surgery\/ use emez \n15 (arthroplast$ or replace$ or prosthes$ or\nimplant$).tw. \n16 (12 or 13 or 14) and 15 \n17 5 or 11 or 16 \n18 Surgical procedures,minimally invasive\/ \n19 Robotics\/ \n20 Video-assisted Surgery\/ \n21 (minimal$ adj3 (invasiv$ or access$ or\nsurg$)).tw. \n22 ((small or single or double or mini or one or\ntwo) adj3 incision$).tw. \n23 computer aid$.tw. \n24 robotic$.tw. \n25 (key hole or keyhole).tw. \n26 (less adj5 invasiv$).tw. \n27 or\/18-26 \n28 17 and 27 \n29 exp \"costs and cost analysis\"\/ \n30 economics\/ \n31 exp economics,hospital\/\n32 exp economics,medical\/ \n33 economic,pharmaceutical\/ \n34 exp budgets\/\n35 exp models, economic\/ \n36 exp decision theory\/ \n37 ec.fs. use mesz \n38 monte carlo method\/ \n39 markov chains\/ \n40 exp quality of life\/ \n41 \"Value of Life\"\/ \nAppendix 1\n9442 cost of illness\/ \n43 exp health status indicators\/ \n44 cost$.ti.\n45 (cost$ adj2 (effective$ or utilit$ or benefit$ or\nminimis$)).ab\n46 economics model$.tw. \n47 (economics$ or pharmacoeconomic$ or\npharmo-economic$).ti. \n48 (price$ or pricing$).tw. \n49 (financial or finance or finances or financed).tw.\n50 (value adj2 (money or monetary)).tw. \n51 quality adjusted life.tw. \n52 disability adjusted life.tw. \n53 (qaly? or qald? or qale? or qtime? or daly?).tw. \n54 (euroqol or euro qol or eq5d or eq 5d).tw. \n55 (hql or hqol or h qol or hrqol or hr qol).tw. \n56 (hye or hyes).tw. \n57 (health adj3 (indicator? or status or utilit?)).tw. \n58 markov$.tw. \n59 monte carlo.tw. \n60 (decision$ adj2 (tree? or analy$ or model$)).tw. \n61 or\/29-60 \n62 28 and 61\n63 Remove duplicates from 62\nScience Citation Index (1985\u20132 March 2007)\nWeb of Knowledge URL: http:\/\/wok.mimas.ac.uk\/ \n#1 TS=(hip SAME arthroplast*)\n#2 TS=(hip SAME replace*)\n#3 TS=(hip SAME prosthes*)\n#4 TS=(hip SAME implant*)\n#5 TS=(hip SAME (surgery or surgical))\n#6 #1 or #2 or #3 or #4 or #5\n#7 TS=(minimal* SAME (invasiv* or access* or\nsurg*))\n#8 TS=((small or single or double or mini or\none or two) SAME incision*)\n#9 TS=(robotic* or computer-aid*)\n#10 #7 or #8 or #9\n#11 #6 and #10\n#12 TS=economic*\n#13 TS=cost*\n#14 TS=(price* OR pricing*)\n#15 TS=(financial or finance*)\n#16 TS=(decision* SAME (tree* OR analy* or\nmodel*))\n#17 TS=markov*\n#18 TS=monte carlo\n#19 TS=(health SAME (indicator* or status or\nutilit*))\n#20 TS=quality of life\n#21 TS=quality adjusted life\n#22 TS=disability adjusted life\n#22 TS=(qaly* or qald* or qale* or qtime* or\ndaly*)\n#23 TS=(euroqol* or euro qol* or eq5d or eq 5d)\n#24 TS=(hql or hqol or h qol or hrqol or hr qol)\n#25 TS=(hye or hyes)\n#26 #12 or #13 or #14 or #15 or #16 or #17\nor #18 or #19 or #20 or #21 or #22 or\n#23 or #24 or #25\n#17 #11 and #26\nNHS EED (December 2006)\nURL: http:\/\/www.york.ac.uk\/inst\/crd\/nhsdhp.htm\n#1 MeSH Arthroplasty, Replacement, Hip\nEXPLODE 1 2\n#2 MeSH Hip Prosthesis EXPLODE 1\n#3 hip\n#4 arthroplasty OR replac* OR prosthes* OR\nimplant*\n#5 #3 And #4\n#6 #1 OR #2 OR #5\nSearch strategy for additional search\nfor utilities, cost data and revision rates\nfor total hip arthroplasty\nMEDLINE (1995\u2013January Week 5 2007),\nEMBASE (1995\u20132007 Week 5) (MEDLINE \nIn-Process 8 February 2007)\nOvid multi-file search URL:\nhttp:\/\/gateway.ovid.com\/athens\n1 Arthroplasty, Replacement, Hip\/\n2 Total Hip Prosthesis\/ use emez \n3 Hip Prosthesis\/ \n4 (hip adj3 (arthroplast$ or replace$ or\nprosthes$ or implant$)).tw. \n5 or\/1-4 \n6 Hip Joint\/su use mesz \n7 Hip\/su use mesz \n8 Hip Surgery\/ use emez \n9 (arthroplast$ or replace$ or prosthes$ or\nimplant$).tw. \n10 (6 or 7 or 8) and 9\n11 5 or 10 \n12 exp quality of life\/\n13 \"Value of Life\"\/ \n14 cost of illness\/ \n15 exp health status indicators\/ \n16 quality adjusted life.tw.\n17 disability adjusted life.tw. \n18 (qaly? or qald? or qale? or qtime? or \ndaly?).tw. \n19 (euroqol or euro qol or eq5d or eq 5d).tw. \n20 (hql or hqol or h qol or hrqol or hr qol).tw. \n21 (hye or hyes).tw. (70)\n22 (health adj3 (indicator? or status or \nutilit?)).tw. \n23 markov$.tw. \n24 monte carlo.tw. \n25 (decision$ adj2 (tree? or analy$ or \nmodel$)).tw. \n26 or\/12-24\n27 11 and 26\nHealth Technology Assessment 2008; Vol. 12: No. 26\n95\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.28 27 and eng.la. (1076)\n29 limit 28 to yr=\"1995 - 2007\" \n30 remove duplicates from 29\n31 (case reports or letter).pt. \n32 30 not 31 \n33 exp \"costs and cost analysis\"\/ \n34 economics\/ \n35 exp economics,hospital\/ \n36 exp economics,medical\/ \n37 economics,pharmaceutical\/ \n38 exp budgets\/ \n39 exp models, economic\/ \n40 exp decision theory\/ \n41 ec.fs. use mesz \n42 monte carlo method\/ \n43 markov chains\/ \n44 cost$.ti. \n45 (cost$ adj2 (effective$ or utilit$ or benefit$ or\nminimis$)).ab. \n46 economics model$.tw. (16)\n47 (economics$ or pharmacoeconomic$ or\npharmo-economic$).ti. \n48 (price$ or pricing$).tw. \n49 (financial or finance or finances or\nfinanced).tw. \n50 (value adj2 (money or monetary)).tw.\n51 or\/33-50\n52 11 and 51\n53 united kingdom\/ use emez \n54 exp great britain\/ use mesz \n55 53 or 54\n56 52 and 55\n57 remove duplicates from 56\n58 exp prosthesis failure\/ \n59 prosthesis-related infection\/ use mesz \n60 prosthesis infection\/ use emez \n61 hip prosthesis\/ae \n62 follow-up studies\/ use mesz \n63 follow-up\/ use emez \n64 10 year$.ti. \n65 ten year$.ti. \n66 (11 year$ or eleven year$).ti\n67 (12 year$ or twelve year$).ti. \n68 (13 year$ or thirteen year$).ti. \n69 (14 year$ or fourteen year$).ti. \n70 (15 year$ or fifteen year$).ti. \n71 (20 year$ or twenty year$).ti. \n72 cohort studies\/ \n73 or\/58-63,72\n74 11 and 73\n75 ((failed or failure) adj3 (prosthes$ or\narthroplast$ or operat$)).tw. \n76 ((re operat$ or reoperat$ or revision) adj\nrate$).tw. \n77 (follow up or long term or longterm).ti. \n78 or\/64-71,75-77\n79 74 and 78\n80 79 not 31\n81 limit 80 to english language \n82 limit 181to yr=\"1995 - 2007\" \n83 remove duplicates from 82\n84 32 or 57 or 83\nGeneral searches\nSearch strategies used to identify\nreports of clinical or cost effectiveness\nof minimally invasive hip arthroplasty \nHMIC (1979\u2013January 2007)\nURL: http:\/\/gateway.ovid.com\/\n1 joint replacement surgery\/ \n2 arthroplasty\/ \n3 hip.tw,hw. \n4 (1 or 2) and 3 \n5 (hip adj3 (arthroplast$ or replac$ or\nprosthes$)).tw. \n6 4 or 5 \n7 hip joint replacement\/ \n8 6 or 7 \n9 minimally invasive therapy\/ \n10 (minimal$ adj3 (invasiv$ or access$ or\nsurg$)).tw. \n11 ((small or single or double or mini or one or\ntwo) adj3 incision$).tw. \n12 or\/9-11 \n13 8 and 12\nDARE and HTA Databases (December 2006)\nNHS Centre for Reviews and Dissemination \nURL: http:\/\/nhscrd.york.ac.uk\/welcome.htm\n#1 MeSH Arthroplasty, Replacement, Hip\nEXPLODE 1 2\n#2 MeSH Hip Prosthesis EXPLODE 1\n#3 hip\n#4 arthroplasty OR replac* OR prosthes* OR\nimplant*\n#5 #3 And #4\n#6 #1 OR #2 OR #5\nNational Registries consulted\nAOA National Joint Replacement Registry\n(Australian). URL:\nhttp:\/\/www.dmac.adelaide.edu.au\/aoanjrr\/index.j\nsp\nCanadian Joint Replacement Registry. URL:\nhttp:\/\/secure.cihi.ca\/cihiweb\/dispPage.jsp?cw_pag\ne=services_cjrr_about_e\nDanish Hip Arthroplasty Registry. URL:\nhttp:\/\/www.dhr.dk\/ENGLISH.htm\nEuropean Arthroplasty Register. URL:\nhttp:\/\/www.ear.efort.org\/\nFinnish Arthroplasty Registry. URL:\nhttp:\/\/www.nam.fi\/english\/publications\/\nAppendix 1\n96Norwegian Arthroplasty Register. URL:\nhttp:\/\/www.haukeland.no\/nrl\/\nRomanian Arthroplasty Register. URL:\nhttp:\/\/www.rne.ro\/site\/\nScottish Arthroplasty Project. URL:\nhttp:\/\/www.arthro.scot.nhs.uk\/\nSwedish National Hip Arthroplasty Regstry. \nURL: http:\/\/www.jru.orthop.gu.se\/\nNew Zealand National Joint Registry. \nURL: http:\/\/www.cdhb.govt.nz\/NJR\/\nUK National Joint Registry. URL:\nhttp:\/\/www.njrcentre.org.uk\/\nConference Proceedings Abstracts:\nAmercian Academy of Orthopaedic Surgeons\n(AAOS)\n2003 Annual Meeting, San Fransisco, CA, \nMarch 2003.\n2004 Annual Meeting, New Orleans, LA, \nMarch 2004.\n2005 Annual Meeting, Washington, DC, \nFebruary 2006.\n2006 Annual Meeting, Chicago, IL, March 2006.\nAmerican Association of Hip and Knee Surgeons\n(AAHKS)\n15th Annual Meeting, Dallas,TX, November 2005.\n16th Annual Meeting, Dallas,TX, November 2006.\nAmerican Orthopaedic Assocation (AOA)\n117th Annual Meeting, Boston, MA, June 2004.\n118th Annual Meeting, Huntington Beach, CA,\nJune 2005.\n119th Annual Meeting, San Antonio, TX, June\n2006.\nAssociation of Bone and Joint Surgery (ABJS): \n57th Annual Meeting, Carmel, CA, June 2005\n58th Annual Meeting, Buenos Aires, April 2006\nBritish Hip Society\nAnnual Meeting, Belfast, February 2003.\nAnnual Meeting, Sheffield, March 2004.\nAnnual Meeting, Wrightington Hospital, \nMarch 2005.\nAnnual Meeting, Edinburgh, March 2006.\nBritish Orthopaedic Association (BOA)\nAnnual Congress, Manchester, September 2004.\nAnnual Congress, Birmingham, September 2005.\nAnnual Congress, Glasgow, September 2006.\nHip Society and AAHKS\n9th Annual Combined Open Meeting, \nNew Orleans, LA, February 2003.\n10th Annual Combined Open Meeting 2004 \nSan Fransisco, CA, March 2004.\n11th Annual Combined Open Meeting 2005\nWashington, DC, February 2005.\n12th Annual Combined Open Meeting 2006\nChicago, IL, March 2006. \nInternational Society for Technology in\nArthoplasty (ISTA)\n18th Annual Symposium, Kyoto, October 2005.\n19th Annual Symposium,Washington,DC, October\n2006.\nMid-American Orthopaedic Association\n22nd Annual Meeting, La Quinta April 2004.\n23rd Annual Meeting, Amelia Island, FL, April\n2005.\n24th Annual Meeting, San Antonio, TX, April\n2006.\nJournals (full-text search)\nJournal of Arthroplasty (2000\u2013February 2007)\nScience Direct. URL: www.sciencedirect.com\/\nJournal of Bone and Joint Surgery, American\nVolume (2000\u2013March 2007)\nURL: http:\/\/www.ejbjs.org\/\nJournal of Bone and Joint Surgery, British Volume\n(2000\u2013February 2007)\nURL: www.jbjs.org.uk\/\nClinical Orthopaedics and Related Research\n(2000\u2013February 2007) \nOvid Journals. URL:\nhttp:\/\/gateway.ovid.com\/athens\nHip* and (minimal* or MIS or incision*)\nWebsites searched for other evidence-based\nreports and background information\nAmerican Academy of Orthopaedic Surgeons.\nURL: http:\/\/www.aaos.org\/\nAmerican Association of Hip and Knee Surgeons.\nURL: http:\/\/www.aahks.org\/\nBritish Hip Society. URL:\nhttp:\/\/www.britishhipsociety.com\/\nBritish Orthopaedic Association. URL:\nhttp:\/\/www.boa.ac.uk\/\nDepuy International (Johnson & Johnson). URL:\nhttp:\/\/jnjgateway.com\/\nSmith and Nephew. URL:\nhttp:\/\/www.smithnephew.com\/\nStyker. URL: http:\/\/www.stryker.com\/\nZimmer. URL: http:\/\/www.zimmer.co.uk\/ \nHealth Technology Assessment 2008; Vol. 12: No. 26\n97\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Minimally invasive hip arthroplasty versus conventional hip arthroplasty\nfor the treatment of arthritic disease of the hip\nAssessor initials: __________ Date assessed: __________\nStudy identifier \n(surname of first author + year of publication)\nType of study\nQ1. Is the study (circle one number) Yes Unclear No\n1. a randomised controlled trial, or \n2. a comparative study (at least 2 groups) or \n3. a case series\/cohort study?\n4. other Go to\nDesign: FU: next question Exclude\nParticipants in the study Yes Unclear No\nQ2. Are some or all of the participants in the study adults with \narthritis (excluding osteoporosis, fracture or tumour)?\nGo to\nnext question Exclude\nInterventions in the study Yes Unclear No\nQ3. Did some or all of the participants receive minimally \ninvasive primary total hip replacement (and not revision \nsurgery or hip resurfacing or computer modelling surgery)?\nGo to\nnext question Exclude\nOutcomes in the study Yes Unclear No\nQ4. Does the study report short-term and\/or long-term \noutcome data on the patients that underwent the \nintervention(s)?\nFor case series\/cohort studies only rare complications and long-term  Include Exclude\noutcomes are to be collected.\nFinal decision (subject to clarification of \u2018unclear\u2019 points) Include Unclear Exclude\nHealth Technology Assessment 2008; Vol. 12: No. 26\n99\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 2\nStudy eligibility formMinimally invasive hip arthroplasty versus conventional hip arthroplasty\nfor the treatment of arthritic disease of the hip\nReviewer ID: Date: __________________\nStudy\nStudy ID: Country: RCT \u0001\nQuasi-RCT \u0001\nFunding: government\/private\/manufacturer\/other (specify) Cohort study (Comparative) \u0001\nAdditional information on study design (e.g. prospective\/ Cohort study (one-group) \u0001\nretrospective, method of randomisation): Unclear \u0001\nParticipants\nRecruitment dates: ___________________________\nNumber of eligible patients: __________________Number of patients randomised: _____________\nCriteria for Inclusion:\nCriteria for Exclusion: \nIntervention\nSurgical technique No of Patients\nIntervention 1\nIntervention 2\nIntervention 3\nComments: (i.e. operator information, specialised equipment used, length of incision)\nHealth Technology Assessment 2008; Vol. 12: No. 26\n101\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 3\nData extraction formPatient Characteristics\nSpecify Intervention 1 Intervention 2 Intervention 3 Overall\nAge (years)\nSex (M\/F)\nBody weight (kg)\nHeight\nBMI\nMuscular patient* (%)\nSignificant bone deformity* (%)\nSevere osteoporosis* (%)\nEmergency case (%)\nFollow-up period: __________________________ Number of patients lost to follow-up: _______________\nComments:\n* Note details on how assessed\nIndications for total hip replacement \nSpecify Intervention 1 Intervention 2 Intervention 3 Overall\nTotal (No.)\nArthritis\n\u2022 Degenerative arthritis \n(osteoarthritis)\n\u2022 Rheumatoid arthritis\nDeformity\nAppendix 3\n102Operative approach \nSpecify Intervention 1 Intervention 2 Intervention 3 Overall\nTotal (No.)\nOperative method performed?\n\u2022 Anterolateral\n\u2022 Lateral\n\u2022 Posterolateral\n\u2022 Transtrochanteric\nType and name of \nprosthesis used?\nCemented or uncemented \nprocedure?\nShort-term Outcomes \nIntra-operative Intervention 1 Intervention 2 Intervention 3\nDuration of operation (min)\nOperating theatre throughput\nBlood loss\nOpposite method initiated (pre-operative) \nIntra-operative fracture\nConversion (intra-operative)\nPost-operative\nDislocation\nInfection (specify, e.g. wound)\nNerve injury\nVascular injury\nDeep vein thrombosis\nPeri-prosthetic fracture\n30 day mortality\nLength of hospital stay\nHealth Technology Assessment 2008; Vol. 12: No. 26\n103\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Post-operative pain (specify)\nTime to return to usual activities (days)\nImplant position (radiographic analysis)\nOther\nLong-term Outcomes Intervention 1 Intervention 2 Intervention 3\nFunctional result (Harris hip, Mayo and \nCharnley scores)\nPain relief\nRevision rates\nTime to revision (months)\nHealth related quality of life\nLong term pain\nLimb length inequality\nMortality\nSurrogates for long-term outcomes\n\u2022 Implant migration (radiostereometry anal)\n\u2022 Heterotopic ossification\n\u2022 Component orientation\n\u2022 Cement quality\nOther (e.g. patient perception\/satisfaction)\nAdditional information\/Other comments\nContact with Author\nDate: \u2026\u2026\u2026\/\u2026\u2026\u2026\/\u2026\u2026\u2026 Signature: \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\nAppendix 3\n104Minimally invasive hip arthroplasty versus conventional hip arthroplasty\n(Verhagen et al., 1998)26\nReviewer ID: Date:\nQuestion Yes No Unclear\n1. Was a method of randomisation performed? \nAdequate approaches to sequence generation\n\u2022 Computer-generated random tables\n\u2022 Random number tables\nInadequate approaches to sequence generation\n\u2022 Use of alternation, case record numbers, birth dates or week days\n2. Was the treatment allocation concealed?\nAdequate approaches to concealment of randomisation\n\u2022 Centralised or pharmacy-controlled randomisation\n\u2022 Serially numbered identical containers\n\u2022 On-site computer based system with a randomisation sequence \nthat is not readable until allocation\n\u2022 Other approaches with robust methods to prevent foreknowledge \nof the allocation sequence to clinicians and patients\nInadequate approaches to concealment of randomisation\n\u2022 Use of alternation, case record numbers, birth dates or week days\n\u2022 Open random number lists\n\u2022 Serially numbered envelopes\n3. Were the groups similar at baseline regarding the most important \nprognostic indicators?\n4. Were the eligibility criteria specified?\n5. Was the outcome assessor blinded?\n6. Was the care provider blinded?\n7. Was the patient blinded?\n8. Were point estimates and measures of variability presented for \nthe primary outcome measures?\n9. Did the analysis include an intention-to-treat analysis?\nHealth Technology Assessment 2008; Vol. 12: No. 26\n105\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 4\nQuality assessment form \u2013 RCTsIncluded studies (full-text papers)\nArchibeck, 2004\nArchibeck MJ, White RE Jr. Learning curve for the \ntwo-incision total hip replacement. Clin Orthop 2004;\n429:232\u20138.\nAsayama, 2006\nAsayama I, Kinsey TL, Mahoney OM. Two-year\nexperience using a limited-incision direct lateral\napproach in total hip arthroplasty. J Arthroplasty 2006;\n21:1083\u201391.\nBerger, 2004\nBerger RA. Mini-incision total hip replacement using an\nanterolateral approach: technique and results. Orthop\nClin North Am 2004;35:143\u201351.\nChen, 2006\nChen J, Chen W, Zhou J, Huang H. Clinical research\nand following results on the minimal incision and\ntraditional total hip arthroplasty. Fudan Xuebao\n(Yixueban) 2006;33:257\u201382.\nChimento, 2005\nPrimary reference\nChimento GF, Pavone V, Sharrock N, Kahn B, Cahill J,\nSculco TP. Minimally invasive total hip arthroplasty: \na prospective randomized study. J Arthroplasty 2005;\n20:139\u201344.\nSecondary reference\nSculco TP, Jordan LC, Walter WL. Minimally invasive\ntotal hip arthroplasty: the Hospital for Special Surgery\nexperience. Orthop Clin North Am 2004;35:137\u201342.\nChung, 2004\nChung WK, Liu D, Foo LS. Mini-incision total hip\nreplacement \u2013 surgical technique and early results.\nJ Orthop Surg 2004;12:19\u201324.\nCiminiello, 2006\nPrimary reference\nCiminiello M, Parvizi J, Sharkey PF, Eslampour A,\nRothman RH. Total hip arthroplasty: is small incision\nbetter? J Arthroplasty 2006;21:484\u20138.\nSecondary reference\nRothman RH, Ciminiello M, Parvizi J. Total hip\narthroplasty: does incision length matter. Annual\nMeeting of the American Academy of Orthopaedic\nSurgeons, Washington, DC, March 2005. Paper No. 137.\nDe Beer, 2004\nde Beer J, Petruccelli D, Zalzal P, Winemaker MJ.\nSingle-incision, minimally invasive total hip\narthroplasty: length doesn't matter. J Arthroplasty 2004;\n19:945\u201350.\nDiGioia, 2003\nPrimary reference\nDiGioia AM III, Plakseychuk AY, Levison TJ, \nJaramaz B. Mini-incision technique for total hip\narthroplasty with navigation. J Arthroplasty 2003;\n18:123\u20138.\nSecondary references\nDiGioia AM III. Mini incision supported by navigation.\nAnnual Meeting of the American Academy of\nOrthopaedic Surgeons, San Francisco, March 2003.\nSymposia (ORS1).\nHafez MA, Seel MJ, Jaramaz B, DiGioia AM III.\nNavigation in minimally invasive total knee arthroplasty\nand total hip arthroscopy. Oper Tech Orthop 2006;\n16:207\u201310.\nDorr, 2007\nPrimary reference\nDorr L, Thomas D, Long W, Polatin P, Sirianni L.\nPsychologic reasons for patients preferring minimally\ninvasive total hip arthroplasty. Clin Orthop 2007;\n458:94\u2013100.\nSecondary reference\nInaba Y, Dorr LD, Wan Z, Sirianni L, Boutary M.\nOperative and patient care techniques for posterior\nmini-incision total hip arthroplasty. Clin Orthop 2005;\n441:104\u201314.\nDuwelius, 2007\nPrimary reference\nDuwelius PJ, Burkhart RL, Hayhurst JO, Moller H,\nButler JB. Comparison of the 2-incision and mini-\nincision posterior total hip arthroplasty technique.\nJ Arthroplasty 2007;22:48\u201356.\nSecondary reference\nDuwelius PJ. Two-incision minimally invasive total hip\narthroplasty: techniques and results to date. Instr Course\nLect 2006;55:215\u201322.\nDuwelius, 2003\nPrimary reference\nDuwelius PJ, Berger RA, Hartzband MA, Mears DC.\nTwo-incision minimally invasive total hip arthroplasty:\noperative technique and early results from four centers.\nJ Bone Joint Surg Am 2003;85A:2240\u20132.\nSecondary references\nBerger RA, Duwelius PJ. The two-incision minimally\ninvasive total hip arthroplasty: technique and results.\nOrthop Clin North Am 2004;3:163\u201372.\nBerger RA. Total hip arthroplasty using the minimally\ninvasive two-incision approach. Clin Orthop 2003;\n417:232\u201341.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n107\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 5\nList of included studiesDuwelius PJ, Berger RA. The two-incision minimally\ninvasive total hip arthroplasty: technique and results.\nSemin Arthroplasty 2004;15:99\u2013107.\nDuwelius PJ. Two-incision minimally invasive total hip\narthroplasty: techniques and results to date. Instr Course\nLect 2006;55:215\u201322.\nFl\u00f6ren, 2006\nFl\u00f6ren M, Lester DK. Durability of implant fixation\nafter less-invasive total hip arthroplasty. J Arthroplasty\n2006;21:783\u201390.\nHart, 2005\nPrimary reference\nHart R, Stipcak V, Janecek M, Visna P. Component\nposition following total hip arthroplasty through a\nminiinvasive posterolateral approach. Acta Orthop Belg\n2005;71:60\u20134.\nSecondary reference\nHart R, Stipcak V, Janecek M, Visna P. Radiological\nstudy of THA after mini-incision technique. Hip Int\n2005;15:98\u2013101.\nHartzband, 2006\nHartzband MA. Posterolateral mini-incision total hip\narthroplasty. Oper Tech Orthop 2006;16:93\u2013101.\nHowell, 2004\nHowell JR, Masri BA, Duncan CP. Minimally invasive\nversus standard incision anterolateral hip replacement:\na comparative study. Orthop Clin North Am 2004;\n35:153\u201362.\nKim, 2006\nKim Y-H. Comparison of primary total hip\narthroplasties performed with a minimally invasive\ntechnique or a standard technique. J Arthroplasty\n2006;21:1092\u20138.\nLi, 2005\nLi Z, Shi Z, Guo W, Zhang N, Sun W. Preliminary\nexperiences in minimally invasive and mini-incision\nsurgery total hip arthroplasty for late osteonecrosis of\nthe femoral head. Chung Kuo Hsiu Fu Chung Chien Wai\nKo Tsa Chih 2005;19:710\u201313 (in Chinese).\nO\u2019Brien, 2005\nO\u2019Brien DA, Rorabeck CH. The mini-incision direct\nlateral approach in primary total hip arthroplasty. \nClin Orthop 2005;441:99\u2013103.\nOgonda, 2005\nPrimary reference\nOgonda L, Wilson R, Archbold P, Lawlor M, \nHumphreys P, O\u2019Brien S, et al. A minimal-incision\ntechnique in total hip arthroplasty does not improve\nearly postoperative outcomes. A prospective, randomized,\ncontrolled trial. J Bone Joint Surg Am 2005;87:701\u201310.\nSecondary references\nLawlor M, Humphreys P, Morrow E, Ogonda L,\nBennett D, Elliott D, et al. Comparison of early\npostoperative functional levels following total hip\nreplacement using minimally invasive versus standard\nincisions. A prospective randomized blinded trial. \nClin Rehabil 2005;19:465\u201374.\nBennett D, Ogonda L, Elliott D, Humphreys L,\nBeverland DE. Comparison of gait kinematics in\npatients receiving minimally invasive and traditional hip\nreplacement surgery: a prospective blinded study. Gait\nPosture 2006;23:374\u201382.\nPagnano, 2006\nPagnano MW, Trousdale RT, Meneghini RM, \nHanssen AD. Patients preferred a mini-posterior THA\nto a contralateral two-incision THA. Clin Orthop 2006;\n453:156\u20139.\nPilot, 2006\nPilot P, Kerens B, Draijer WF, Kort NP, ten Kate J,\nBuurman WA, et al. Is minimally invasive surgery less\ninvasive in total hip replacement? A pilot study. Injury\n2006;37:S17\u201323.\nPipino, 2004\nPipino F. CFP prosthetic stem in mini-invasive total hip\narthroplasty. J Orthop Traumatol 2004;5:165\u201371.\nSiguier, 2004\nSiguier T, Siguier M, Brumpt B. Mini-incision anterior\napproach does not increase dislocation rate: a study of\n1037 total hip replacements. Clin Orthop 2004;\n426:164\u201373.\nSwanson, 2005\nSwanson TV. Early results of 1000 consecutive, posterior,\nsingle-incision minimally invasive surgery total hip\narthroplasties. J Arthroplasty 2005:20:26\u201332.\nSzendr\u00f3i, 2006\nSzendr\u00f3i M, Sztrinkai G, Vass R, Kiss J. The impact of\nminimally invasive total hip arthroplasty on the\nstandard procedure. Int Orthop 2006;30:167\u201371.\nTanavalee, 2006\nTanavalee A, Jaruwannapong S, Yuktanandana P,\nItiravivong P. Early outcomes following minimally\ninvasive total hip arthroplasty using a two-incision\napproach versus a mini-posterior approach. Hip Int\n2006;16:S17\u201322.\nTeet, 2006\nTeet JS, Skinner HB, Khoury L. The effect of the \n\u201cmini\u201d incision in total hip arthroplasty on component\nposition. J Arthroplasty 2006;21:503\u20137.\nWoolson, 2004\nPrimary reference\nWoolson ST, Mow CS, Syquia JF, Lannin JV,\nSchurman DJ. Comparison of primary total hip\nreplacements performed with a standard incision \nor a mini-incision. J Bone Joint Surg Am 2004;86A:\n1353\u20138.\nSecondary reference\nMow CS, Woolson ST, Ngarmukos SG, Park EH, \nLorenz HP. Comparison of scars from total hip\nreplacements done with a standard or a mini-incision.\nClin Orthop 2005;441:80\u20135.\nWright, 2004\nWright JM, Crockett HC, Delgado S, Lyman S, \nMadsen M, Sculco TP. Mini-incision for total hip\nAppendix 5\n108arthroplasty: a prospective, controlled investigation with\n5-year follow-up evaluation. J Arthroplasty 2004;\n19:538\u201345.\nYan, 2005\nYan Z-Q, Chen Y-S, Yang Y, Li W-J, Chen Z-R, \nZhang G-J. Two-incision minimal invasive approach for\ntotal hip replacement. Acta Acad Med Shanghai 2005;\n32:557\u201360 (in Chinese).\nZhang, 2006\nZhang XL, Wang Q, Jiang Y, Zeng BF. Minimally\ninvasive total hip arthroplasty with anterior incision.\nChung Hua Wai Ko Tsa Chih 2006;44:512\u201315 \n(in Chinese). \nIncluded studies (abstracts only)\nCharles, 2006\nCharles MN, Fejbel RJ, Kim P. Minimally invasive\nsurgery of the hip \u2013 a randomized pilot study. Annual\nMeeting of the Canadian Orthopaedic Association,\nToronto, June 2006. Poster 88.\nGreidanus, 2006\nGreidanus NV, Garbuz DS, Masri BA, Duncan CP,\nCallaghan JJ, Hozack WJ. Comparative cohort study of\n2-incision versus 1-incision MIS THA. Annual Meeting\nof the American Academy of Orthopaedic Surgeons,\nChicago, March 2006. Paper No. 200.\nPagnano, 2007a\nPagnano MW, Meneghini RM, Kaufman K, Colemam-\nWood K, Berg E, Hanssen AD. No benefit of the \n2-incision technique over miniposterior total hip\narthroplasty: a comprehensive gait analysis and strength\ntesting study. J Arthroplasty 2007;22:301.\nPagnano, 2007b\nPagnano MW, Leone J, Hanssen AD, Trousdale RTM,\nBerg E. A prospective randomized clinical trial shows\nthat 2-incision total hips do not recover quicker than\nminiposterior total hips. J Arthroplasty 2007;22:303.\nPanisello, 2006\nPanisello JJ, Canales V, Herrera A, Mateo J, Peguero A.\nEffectiveness of mini-incision technique in primary hip\nreplacement. J Bone Joint Surg Br 2006;88B:63.\nRachbauer, 2006\nRachbauer F, Rosiek R, Nogler M, Kessler O. \nThe benefits of the direct anterior approach in\nminimally invasive THA. Annual Meeting of the\nAmerican Academy of Orthopaedic Surgeons, Chicago,\nMarch 2006. Paper No. 202.\nSharma, 2006\nSharma S, Bharma MS. A prospective randomised pilot\nstudy to compare early post-operative recovery after\nconventional versus minimal incision posterior\napproach for total hip joint replacement. J Bone Joint\nSurg Br 2006;88B:243.\nTakahira, 2006\nTakahira N, Uchiyama K, Takasi S, Katano M, \nItoman M. Prospective comparison study of clinical data\nbetween the minimal incision and conventional incision\nin total hip arthroplasty. 19th Annual Symposium of the\nInternational Society for Technology in Arthroplasty,\nNew York, October 2006. Abstract A9-3.\nYoon, 2005\nYoon TR, Moon E, Rowe SM, Jung ST, Seo HY, Lee JY.\nMinimally invasive total hip arthroplasty: comparison\nbetween one-incision and two-incision technique.\nAnnual Meeting of the American Academy of\nOrthopaedic Surgeons, Washington, DC, March 2005.\nPaper No. 147.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n109\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Health Technology Assessment 2008; Vol. 12: No. 26\n111\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 6\nList of ongoing trials\nTitle of trial Contact Project details\nMinimally invasive surgery\nof the hip: a randomised\nstudy\nDr Paul Kim\nDivision of Orthopedics\n501 Smyth Road \nOttawa\nOntario K1H 8L6, Canada\nEmail: pkim@Ottawahospital.on.ca\nA pilot trial compares minimally invasive THR via a\nmodified lateral approach with a standard lateral\n(Hardinge) approach with 12-week follow-up. Variables\nmeasured included in-hospital length of stay, incidence of\nsurgical complications and validated pain and function\nscores\nIntended number of participants: 40\nPoster presented at the Canadian Orthopaedic\nAssociation meeting, June 2006, Ontario:\nCharles MN, Feibel RJ and Kim P , Minimally invasive\nsurgery of the hip \u2013 a randomised pilot study\nClinical evaluation\ncomparing minimally\ninvasive and standard skin\nincisions in cementless total\nhip arthroplasty using the\nBimetric Hip System with\nthe 38 mm M2A cup.\nClinical evaluation of\nincision size in total hip\nreplacement\nMr James Calder\nNorth Hampshire Hospital NHS\nTrust\nAldermaston Road\nBasingstoke\nHants RG24 9NA, UK\nEmail: james.calder@imperial.ac.uk\nThe trial has now ended recruiting and is evaluating\ngeneral health scores, hip scores, patient satisfaction,\nblood loss, length of stay, time to discharge and\npostoperative X-rays. Follow-up is still ongoing\nMinimally invasive surgery\nin total hip arthroplasty: the\n2-incision technique versus\nconventional total hip\narthroplasty. A prospective,\nrandomised, controlled trial\nDr Dr Jakob van Oldenrijk\nAcademic Medical Center (AMC)\nDepartment of Orthopedics\nP .O. Box 22660\nMeibergdreef 9\n1100 DD Amsterdam\nThe Netherlands\nEmail: J.vanoldenrijk@amc.uva.nl\nThe trial is in progress, without any substantial evidence\nto publish yet. Switched from a two-incision technique to\nthe anterolateral (Rottinger) MIS in March 2006 and\nconducting a prospective non-blinded RCT comparing\nthis technique with the lateral transgluteal technique\nThe patient recruitment period was planned from March\n2006 to March 2008, with 1-year follow-up. Planned\noutcome measures include operation time, blood loss,\nfractures, dislocation, perioperative complications, length\nof hospital stay, short- and long-term pain, radiographic\nevaluation, function scores (e.g. Harris hip score,\nWOMAC), revision rates, health-related quality of life\n(e.g. SF-36) and patient satisfaction\nIntended number of participants: 100\ncontinuedAppendix 6\n112\nTitle of trial Contact Project details\nEffectiveness of computer-\nnavigated minimally invasive\ntotal hip surgery compared\nwith conventional total hip\narthroplasty: design of a\nrandomised controlled trial\nInge Reininga\nUniversity Medical Centre\nGroningen \nDepartment of Orthopaedic\nSurgery\nP .O. Box 30001\n9700 RB Groningen\nThe Netherlands\nEmail: i.reininga@orth.umcg.nl\nThe trial compares computer-navigated minimally\ninvasive THR (the Smith\u2013Petersen anterior approach)\nwith a conventional technique (the posterolateral\napproach). Patient recruitment was planned from March\n2007 to May 2008. The main focus is cost-effectiveness\nanalysis besides the clinical follow-up for 6 months.\nPlanned outcome measures include perioperative\ncomplications, gait analysis, implant position\n(radiographic analysis) and self-reported functional status\nand health-related quality of life\nIntended number of participants: 110\nThe trial protocol was recently published:\nReininga IHF, Wagenmakers R, van den Akker-Scheek J,\nStant AD, Groothoff JW, Bulstra SK, et al., Effectiveness\nof computer-navigated minimally invasive total hip\nsurgery compared to conventional total hip arthroplasty:\ndesign of a randomised controlled trial\u2019 (protocol), BMC\nMusculoskeletal Disorders 2007;8:4(11 January 2007)\nA randomized controlled\ntrial utilising RSA for a\ncomparison of minimally\ninvasive surgery (MIS) vs\nstandard exposure in\nprimary total hip\narthroplasty with the\nProfemurZ modular\nfemoral stem\nDr Michael Gross\nQEII Health Sciences Centre\nHalifax\nNova Scotia B3H 3A7\nCanada\nTel. 902-473-6811\nEmail: mgross@eastlink.ca\nThe trial compares minimally invasive and standard THR\nusing the direct lateral approach. It is recruiting patients\nand will have preliminary clinical results in 1 year from\nJanuary 2007. Hip function will be assessed using Harris\nhip score, Oxford-12 and WOMAC. The primary\noutcome will be implant micromotion (RSA analysis).\nThe RSA part of the study has a 2-year follow-up \nIntended number of participants: 100\nProtocol: Dr Michael Gross (Principal Investigator), \nA randomised controlled trial utilising RSA for a\ncomparison of Minimally Invasive Surgery (MIS) vs\nstandard exposure in primary total hip arthroplasty with\nthe ProfemurZ modular femoral stem\nRandomised, prospective,\npost-market surveillance\nstudy comparing the\noutcomes of minimally\ninvasive and conventional\nsurgical procedures in\nsubjects requiring primary\ntotal hip arthroplasty\n(THA) for osteoarthritis\nDr S Young\nSouth Warwickshire General\nHospitals NHS Trust\nLakin Road\nWarwich CV34 5BW, UK\nEmail: skyoung@uk-\nconsultants.co.uk\nThe project is in its very early stages and there are no\nresults available; being coordinated at DePuy\nComparison of two\nminimally invasive hip\narthroplasties in a\nrandomised trial\nAssociate Professor Per Rotb\u00f8ll\nNielsen \nH:S Tv\u00e6rfaglige Smertecenter\nNeurocentret\nH:S Rigshospitalet\nBlegdamsvej 9\nDK-2100 K\u00f8benhavn \u00d8 \nDenmark\nEmail: rotboell@rh.dk\nThe trial has just started and will be collecting data for\nnext 15 months. The research team has a contract that\nforbids them from providing further information\ncontinuedHealth Technology Assessment 2008; Vol. 12: No. 26\n113\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nTitle of trial Contact Project details\nSingle versus dual incision\nminimally invasive hip\narthroplasty\nProfessor Bo Nibvrant\nPerth Orthpaedic Institute\nGate 3, Verdun Street\nNedlands\nPerth 6009, Australia\nEmail: bo.nivbrant@uwa.edu.au\nThe trial data are still in process; no further information\navailable\nMinimally invasive total hip\nreplacement (prospective\nrandomised, multi-centre\nstudy of synergy total hip\nsystem comparing the\neffectiveness and safety of\nminimally invasive THR\narthroplasty vs standard\nsurgery)\nMr Simon Scott\nAintree Trust\nUniversity Hospital Aintree\nLower Lane\nLiverpool L9 7AL, UK\nEmail: wicksyontour@hotmail.com\nThe trial has had the funding withdrawn by the company\nIs minimally invasive total\nhip replacement clinically\nadvantageous, safe and cost\neffective compared to\nconventional total hip\narthroplasty?\nDr David Beard\nNuffield Department of\nOrthopaedic Surgery (NDOS)\nUniversity of Oxford\nWindmill Road\nOxford OX3 7LD, UK\nEmail: david.beard@orthopaedic-\nsurgery.oxford.ac.uk\nThe trial was suspended before it became live (in the\npilot stage) because the two incision method proposed\nfor one arm of the trial was found to have an obvious\nand unacceptable complication rate (four out of 10\npatients); it is no longer performed in the hospital;\nfunding was returned\nDoes a small incision at the\ntime of total hip\nreplacement surgery confer\nany advantage to patients\nby comparison to a\nstandard incision?\nMr John Timperley\nExeter Hip Unit\nPrincess Elizabeth Orthopaedic\nHospital\nRA & E\nBarrack Road\nExeter EX2 5DW, UK\nEmail: john.timperley@virgin.net\nThe trial was abandoned at an early stage, as the\nresearch team felt there were sufficient data available in\nthe world literature that proves that the size of incision\nis not the important factor in determining outcome or\ncost-effectiveness\nA prospective randomised\ncontrol trial comparing two\ndifferent surgical\napproaches for minimally\ninvasive total hip\nreplacement\nMr H Apthorp\nConquest Hospital\nThe Ridge\nSt Leonard\u2019s on Sea\nEast Sussex TN37 7RD, UK\nThe trial has been put on hold, as the research team are\nworried that they are getting significantly better results\nwith their posterior approaches compared with anterior\napproaches\nImage guidance for\nminimally invasive hip\nreplacement\nProfessor Dave Hawkes\nRadiological Sciences\n5th Floor, Thomas Guy House\nGuy\u2019s Hospital\nSt Thomas\u2019 Hospital\nLondon SE1 9RT, UK\nEmail: david.hawkes@kcl.ac.uk\nNo available data at the time of writing\nComparison of the clinical\neffectiveness and cost-\neffectiveness of the MIS\nanterolateral approach \n(MIS Watson Jones, G3)\nversus anterolateral mini or\nposterolateral mini\napproaches in primary total\nhip arthroplasty\nJames Latteier\nVancouver General Hospital\nVancouver\nBritish Colombia V5Z 1L8\nCanada\nEmail: jlatteier@arthritisresearch.ca\nNo available data at the time of writingHealth Technology Assessment 2008; Vol. 12: No. 26\n115\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 7\nDetailed quality assessment score for the \nincluded trials and comparative studies (see Table 6)\nStudy Q1a Q1b Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9\nOne incision\nRCT and quasi-RCT\nCharles, 200669a YUUY NYYYNN\nChimento, 200531 YYN Y YYUUYY\nChung, 200432 YNN U YYNNYY\nHart, 200540 YNN U YYNUNY\nKim, 200643 YNNY NY YYNU\nOgonda, 200546 YYN Y YYYYYU\nRachbauer, 200675a YUUY YUUUNU\nSharma, 200677a YUU NNYYYUU\nZhang, 200658 YYYY YYYUYY\nComparative studies\nAsayama, 200628 NNNN YY YYNY\nBerger, 200429 NNNU NUUUNU\nChen, 200630 NNNU YNUUYU\nCiminiello, 200633 NNNY YNNNNU\nde Beer, 200434 NNNY YNNNY Y\nDiGioia, 200335 NNNY YY NNNY\nDorr, 200736 NNNY NUNNY Y\nHowell, 200442 NNNN YNNNYU\nLi, 200544 NNNY YY UNY Y\nO\u2019Brien, 200545 NNNN YUUNY Y\nPanisello, 200674a NNNY NUUUNU\nPilot, 200648 NNNN NNNNNY\nSzendr\u00f3i, 200652 NNNN YY NYY Y\nTakahira, 200678a NNNU NUUUNU\nTeet, 200654 NNNU YY UUYU\nWoolson, 200455 NNNN YY UNY Y\nWright, 200456 NNNN YUUNYU\nTwo incisions\nRCT and quasi-RCT\nPagnano, 2007a72a YYU YN UUU NU\nPagnano, 2007b73a YYU YN UUU NU\nYan, 200557 YUUY YUUUYU\nComparative studies\nDuwelius, 200738 NNNY YNNNNU\nGreidanus, 200671a NNNY NUUUNU\nPagnano, 200647 NNNY YUNNNY\nTanavalee, 200653 NNNN YY UNYU\nYoon, 200579a NNNU NUUUNU\nN, no; U, unclear; Y, yes.\na Abstract only.In the following tables:\n\u2022 continuous data: total N, mean (SD), [range]\n\u2022 dichotomous data: n\/N\n\u2022 abbreviations: FU, follow-up; MD, midi-incision; MI, mini-incision; 2MI, 2 mini-incision; NR, not\nreported; NS, not statistically significant; SI, standard incision.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n117\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 8\nCharacteristics of included studiesAppendix 8\n118\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nO\nn\ne\n \nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\nR\nC\nT\ns\n \na\nn\nd\n \nq\nu\na\ns\ni\n-\nR\nC\nT\ns\nC\nh\na\nr\nl\ne\ns\n,\n \n2\n0\n0\n6\n6\n9\n \nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\ni\nl\no\nt\nb\nl\ni\nn\nd\ne\nd\n \nR\nC\nT\nL\no\nc\na\nt\ni\no\nn\n:\nC\na\nn\na\nd\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\nF\nu\nn\nd\ni\nn\ng\n:\nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n1\n2\nw\ne\ne\nk\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n4\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nN\nR\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n,\n \nS\nD\n)\n:\n \nM\nI\n \n6\n6\n.\n6\n,\n \nS\nI\n \n7\n0\n.\n8\n,\np\n=\n \n0\n.\n0\n9\n4\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\nI\n \n7\n2\n.\n7\n,\n \nS\nI\n \n7\n2\n.\n \n6\n5\n,\n \np\n=\n \n0\n.\n9\n2\n6\nH\ne\ni\ng\nh\nt\n \n(\nc\nm\n)\n:\n \nM\nI\n \n1\n6\n6\n.\n6\n,\n \nS\nI\n \n1\n6\n9\n.\n7\n,\n \np\n=\n \n0\n.\n3\n1\n0\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n5\n.\n8\n,\n \nS\nI\n \n2\n5\n.\n2\n,\n \np\n=\n \n0\n.\n5\n1\n3\nA\nm\ne\nr\ni\nc\na\nn\n \nS\no\nc\ni\ne\nt\ny\n \no\nf\nA\nn\ne\ns\nt\nh\ne\ns\ni\no\nl\no\ng\ni\ns\nt\ns\n \n(\nA\nS\nA\n)\n \ns\nt\na\nt\nu\ns\n:\n \nM\nI\n \n1\n.\n8\n9\n,\n \nS\nI\n \n2\n.\n1\n6\n,\n \np\n=\n \n0\n.\n1\n0\n2\nM\nI\n:\n \nN\n=\n \n2\n0\nS\nI\n:\n \nN\n=\n \n2\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nS\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n2\ns\nu\nr\ng\ne\no\nn\ns\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n2\n0\n,\n \n9\n5\n.\n2\n,\n \nS\nI\n \n2\n0\n,\n \n8\n7\n.\n7\n,\n \np\n=\n \n0\n.\n3\n1\n5\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n4\n6\n0\n.\n0\n,\n \nS\nI\n \n4\n6\n2\n.\n5\n,\n \np\n=\n \n0\n.\n9\n6\n6\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n \n(\nt\nr\na\nn\ns\ni\ne\nn\nt\n \nf\ne\nm\no\nr\na\nl\n \nn\ne\nr\nv\ne\np\na\nl\ns\ny\n)\n:\n \nM\nI\n \n1\n\/\n2\n0\n,\n \nS\nI\n \n0\n\/\n2\n0\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n2\n0\n,\n \n5\n.\n3\n5\n,\n \nS\nI\n \n2\n0\n,\n \n5\n.\n7\n0\n,\n \np\n=\n \n0\n.\n5\n0\n1\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\nP\nC\nA\n \nn\na\nr\nc\no\nt\ni\nc\n \nc\no\nn\ns\nu\nm\np\nt\ni\no\nn\n \n(\nm\ng\n)\n:\n \nM\nI\n \n1\n8\n,\n2\n2\n.\n8\n,\n \nS\nI\n \n1\n9\n,\n \n1\n9\n.\n5\n,\n \np\n=\n \n0\n.\n1\n0\n5\nP\na\ni\nn\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n1\n8\n,\n \n3\n.\n9\n4\n,\n \nS\nI\n \n1\n9\n,\n \n3\n.\n6\n8\n,\n \np\n=\n \n0\n.\n1\n2\n9\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\nD\na\ny\ns\n \nt\no\n \ni\nn\nd\ne\np\ne\nn\nd\ne\nn\nt\n \na\nm\nb\nu\nl\na\nt\ni\no\nn\n:\n \nM\nI\n \n1\n.\n2\n5\n,\nS\nI\n \n1\n.\n1\n5\n,\n \np\n=\n \n0\n.\n6\n3\n2\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nW\nO\nM\nA\nC\n:\n \nM\nI\n \n1\n6\n,\n \n9\n1\n.\n9\n9\n,\n \nS\nI\n \n1\n9\n,\n \n8\n9\n.\n6\n0\n,\n \np\n=\n \n0\n.\n6\n9\n0\nH\ne\na\nl\nt\nh\n-\nr\ne\nl\na\nt\ne\nd\n \nq\nu\na\nl\ni\nt\ny\n \no\nf\n \nl\ni\nf\ne\nS\nF\n-\n3\n6\n:\n \nM\nI\n \n1\n6\n,\n \n4\n0\n.\n8\n,\n \nS\nI\n \n1\n9\n,\n \n4\n0\n.\n4\n,\n \np\n=\n \n0\n.\n5\n8\n3\n \nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n1\n8\n,\n \n1\n5\n.\n2\n2\n2\n,\n \nS\nI\n \n1\n9\n,\n \n1\n4\n.\n5\n7\n9\n,\n \np\n=\n \n0\n.\n3\n4\n1\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n119\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nC\nh\ni\nm\ne\nn\nt\no\n,\n \n2\n0\n0\n5\n3\n1\n,\n6\n8\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nR\nC\nT\nL\no\nc\na\nt\ni\no\nn\n:\n \nN\ne\nw\n \nY\no\nr\nk\n,\nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\n \nN\no\nv\ne\nm\nb\ne\nr\n1\n9\n9\n9\n\u2013\nJ\nu\nl\ny\n \n2\n0\n0\n0\nF\nu\nn\nd\ni\nn\ng\n:\n \nn\no\nn\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n2\ny\ne\na\nr\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nB\nM\nI\n \n<\n3\n0\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \np\nr\ni\no\nr\n \nh\ni\np\ns\nu\nr\ng\ne\nr\ny\n;\n \nh\ni\np\n \np\na\nt\nh\no\nl\no\ng\ny\n \nr\ne\nq\nu\ni\nr\ni\nn\ng\ne\nx\nt\ne\nn\ns\ni\nl\ne\n \ne\nx\np\no\ns\nu\nr\ne\n \n(\nN\n=\n \n0\n)\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n2\n6\n5\n \n(\n2\n5\n1\n \ns\no\nl\ni\nc\ni\nt\ne\nd\n \nf\no\nr\ns\nt\nu\nd\ny\n)\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n6\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nM\nI\n \n1\n,\n \nS\nI\n \n3\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \n2\n \nd\ne\na\nt\nh\ns\n)\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \nM\nI\n \n2\n8\n\/\n2\n8\n,\n \nS\nI\n \n3\n2\n\/\n3\n2\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n7\n.\n2\n \n(\n8\n.\n6\n)\n,\n \nS\nI\n \n6\n5\n.\n6\n(\n1\n0\n.\n5\n)\n,\n \nN\nS\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n1\n6\n\/\n1\n2\n,\n \nS\nI\n \n1\n3\n\/\n1\n9\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\nI\n \n7\n1\n.\n7\n \n(\n1\n2\n.\n8\n)\n,\nS\nI\n \n7\n3\n.\n0\n \n(\n1\n3\n.\n0\n)\n,\n \nN\nS\nH\ne\ni\ng\nh\nt\n \n(\nc\nm\n)\n:\n \nM\nI\n \n1\n6\n8\n \n(\n9\n.\n3\n)\n,\n \nS\nI\n \n1\n7\n1\n(\n1\n0\n.\n9\n)\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n5\n.\n2\n \n(\n3\n.\n1\n)\n,\n \nS\nI\n \n2\n4\n.\n8\n \n(\n2\n.\n5\n)\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n5\n4\n.\n2\n \n(\n9\n.\n4\n)\n,\n \nS\nI\n \n5\n3\n.\n4\n \n(\n7\n.\n9\n)\nM\nI\n:\n \nN\n=\n \n2\n8\nS\nI\n:\n \nN\n=\n \n3\n2\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n8\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\nm\no\nd\ni\nf\ni\ne\nd\n \np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\n2\n7\n \nh\ny\nb\nr\ni\nd\n \n(\nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \nc\nu\np\n+\n \nc\ne\nm\ne\nn\nt\ne\nd\n \ns\nt\ne\nm\n)\n,\n \n1\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\nS\nI\n:\n \n1\n5\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\n2\n8\n \nh\ny\nb\nr\ni\nd\n \n(\nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \nc\nu\np\n+\n \nc\ne\nm\ne\nn\nt\ne\nd\n \ns\nt\ne\nm\n)\n,\n \n4\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \no\nr\ns\nu\np\ne\nr\nv\ni\ns\ne\nd\n \nb\ny\n \nt\nh\ne\n \ns\ne\nn\ni\no\nr\na\nu\nt\nh\no\nr\n \n(\nS\nc\nu\nl\nc\no\n)\nS\nm\na\nl\nl\n \ns\np\ne\nc\ni\na\nl\ni\ns\ne\nd\n \nr\ne\nt\nr\na\nc\nt\no\nr\ns\nf\no\nr\n \nM\nI\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n2\n8\n,\n \n7\n0\n.\n3\n \n(\n1\n0\n.\n7\n)\n,\n \nS\nI\n \n3\n2\n,\n \n7\n0\n.\n0\n \n(\n8\n.\n5\n)\n,\n \np\n=\n \n0\n.\n4\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n2\n8\n,\n \n1\n2\n7\n \n(\n4\n8\n)\n,\n \nS\nI\n \n3\n2\n,\n \n1\n7\n0\n \n(\n6\n5\n)\n,\n \np\n=\n \n0\n.\n0\n0\n3\nC\no\nn\nv\ne\nr\ns\ni\no\nn\n:\n \nM\nI\n:\n \n0\n\/\n2\n8\n \n(\nn\no\n \ni\nn\nc\ni\ns\ni\no\nn\ns\n \nn\ne\ne\nd\ne\nd\ne\nx\nt\ne\nn\ns\ni\no\nn\n)\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n2\n\/\n2\n8\n,\n \nS\nI\n \n0\n\/\n3\n2\n,\n \nN\nS\nI\nn\nf\ne\nc\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n2\n8\n,\n \nS\nI\n \n0\n\/\n3\n2\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n:\n \nM\nI\n \n0\n\/\n2\n8\n,\n \nS\nI\n \n0\n\/\n3\n2\nD\nV\nT\n:\n \nM\nI\n \n0\n\/\n2\n8\n,\n \nS\nI\n \n0\n\/\n3\n2\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n2\n8\n,\n \n5\n.\n8\n \n[\n4\n\u2013\n1\n3\n]\n,\n \nS\nI\n \n3\n2\n,\n \n5\n.\n5\n \n[\n3\n\u2013\n1\n5\n]\n,\n \nN\nS\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n \nP\na\nt\ni\ne\nn\nt\n-\nc\no\nn\nt\nr\no\nl\nl\ne\nd\n \ne\np\ni\nd\nu\nr\na\nl\n \na\nn\na\ne\ns\nt\nh\ne\ns\ni\na\n \n(\nm\nl\n)\n:\nM\nI\n \n2\n8\n,\n \n2\n8\n5\n \n(\n1\n8\n5\n)\n,\n \nS\nI\n \n3\n2\n,\n \n3\n1\n9\n \n(\n1\n7\n7\n)\n,\n \nN\nS\nO\nr\na\nl\n \nn\na\nr\nc\no\nt\ni\nc\ns\n \n(\nn\n)\n:\n \nM\nI\n \n2\n8\n,\n \n3\n.\n2\n7\n \n(\n1\n.\n9\n)\n,\n \nS\nI\n \n3\n2\n,\n3\n.\n1\n3\n \n(\n2\n.\n6\n)\n,\n \nN\nS\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\nD\na\ny\ns\n \nt\no\n \nr\ne\na\nc\nh\n \nr\ne\nh\na\nb\ni\nl\ni\nt\na\nt\ni\no\nn\n \ng\no\na\nl\ns\n(\nF\ni\ng\nu\nr\ne\n2\n)\n,\n \nN\nS\n \nT\ni\nm\ne\n \nt\no\n \nt\nr\na\nn\ns\nf\ne\nr\n \ni\nn\nd\ne\np\ne\nn\nd\ne\nn\nt\nl\ny\nT\ni\nm\ne\n \nt\no\n \na\nm\nb\nu\nl\na\nt\ne\n \nw\ni\nt\nh\n \na\n \nw\na\nl\nk\ne\nr\nT\ni\nm\ne\n \nt\no\n \na\nm\nb\nu\nl\na\nt\ne\n \nw\ni\nt\nh\n \na\n \nc\na\nn\ne\nT\ni\nm\ne\n \nt\no\n \nn\ne\ng\no\nt\ni\na\nt\ne\n \ns\nt\na\ni\nr\ns\n \nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n)\n \nS\nt\ne\nm\n \ni\nn\n \nv\na\nr\nu\ns\n:\n \nM\nI\n \n1\n\/\n2\n8\n,\n \nS\nI\n \n1\n\/\n3\n2\n,\n \nN\nS\nA\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \na\nn\ng\nl\ne\n:\n \nM\nI\n \n2\n8\n,\n \n3\n6\n.\n6\n\u00b0\n(\nR\n3\n0\n\u2013\n4\n5\n)\n,\n \nS\nI\n \n3\n2\n,\n \n3\n6\n.\n5\n\u00b0\n(\nR\n3\n0\n\u2013\n4\n7\n)\n,\n \nN\nS\nG\na\np\n \n>\n2\n \nm\nm\n \ni\nn\n \nd\no\nm\ne\n \no\nf\n \na\nc\ne\nt\na\nb\nu\nl\nu\nm\n \n(\n=\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n)\n:\n \nM\nI\n \n2\n,\n \nS\nI\n \n2\n,\n \nN\nS\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\na\nt\n \n2\n \ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n2\n7\n,\n \n9\n4\n.\n5\n,\n \nS\nI\n \n2\n9\n,\n \n9\n4\n.\n5\nR\ne\nq\nu\ni\nr\ne\nd\n \na\n \nc\na\nn\ne\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n:\n \nM\nI\n \n9\n\/\n2\n8\n,\n \nS\nI\n \n1\n5\n\/\n3\n2\n,\n \nN\nS\nP\ne\nr\ns\ni\ns\nt\ne\nn\nt\n \nl\ni\nm\np\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n:\n \nM\nI\n \n6\n\/\n2\n8\n,\n \nS\nI\n \n1\n5\n\/\n3\n1\n,\n \np\n=\n \n0\n.\n0\n4\nP\ne\nr\ns\ni\ns\nt\ne\nn\nt\n \nl\ni\nm\np\n \na\nt\n \n1\n \ny\ne\na\nr\n:\n \nM\nI\n \n0\n\/\n2\n7\n,\n \nS\nI\n \n0\n\/\n2\n9\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \nM\nI\n \n1\n\/\n2\n7\n,\n \nS\nI\n \n0\n\/\n2\n9\nM\no\nr\nt\na\nl\ni\nt\ny\n \n(\na\nt\n \n2\n \ny\ne\na\nr\ns\n)\nM\nI\n \n0\n\/\n2\n8\n,\n \nS\nI\n \n2\n\/\n3\n2\n \n(\nu\nn\nr\ne\nl\na\nt\ne\nd\n \nt\no\n \ns\nu\nr\ng\ne\nr\ny\n)\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\n \no\nu\nt\nc\no\nm\ne\ns\nC\ne\nm\ne\nn\nt\n \nq\nu\na\nl\ni\nt\ny\n:\n \nM\nI\n \nA\n \n=\n \n4\n\/\n2\n7\n,\n \nB\n \n=\n \n2\n0\n\/\n2\n7\n,\nC\n \n=\n \n3\n\/\n2\n7\n;\n \nS\nI\n \nA\n \n=\n \n8\n\/\n2\n8\n,\n \nB\n \n=\n \n1\n9\n\/\n2\n8\n,\n \nC\n \n=\n \n1\n\/\n2\n8\n;\n \nN\nS\n \nf\no\nr\n \no\nv\ne\nr\na\nl\nl\n \ng\nr\na\nd\ni\nn\ng\n \no\nr\n \nf\no\nr\n \nN\no\nf\n \ng\nr\na\nd\ne\n \nC\nO\nt\nh\ne\nr\n\u2022\nt\no\nt\na\nl\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\n:\n \nM\nI\n \n2\n8\n,\n \n3\n7\n8\n \n(\n1\n5\n1\n)\n,\n \nS\nI\n \n3\n2\n,\n \n5\n0\n4\n \n(\n2\n0\n5\n)\n,\n \np\n=\n \n0\n.\n0\n0\n9\n\u2022\nd\ni\ns\nc\nh\na\nr\ng\ne\n \nt\no\n \nh\no\nm\ne\n\/\nf\na\nc\ni\nl\ni\nt\ny\n\u2022\ns\ne\nr\nu\nm\n \nI\nL\n-\n6\n \nl\ne\nv\ne\nl\ns\n\/\nc\ny\nt\no\nk\ni\nn\ne\n\u2022\na\nt\nr\ni\na\nl\n \nf\nl\nu\nt\nt\ne\nr\n\u2022\nv\ni\ns\nu\na\nl\n \nh\na\nl\nl\nu\nc\ni\nn\na\nt\ni\no\nn\n \nw\nh\ni\nl\ne\n \no\nn\n \nt\nh\ne\n \nP\nC\nE\nA\np\nu\nm\np\n\u2022\nd\ne\nv\ne\nl\no\np\ne\nd\n \na\n \nr\na\ns\nh\n\u2022\ne\nx\np\ne\nr\ni\ne\nn\nc\ne\nd\n \na\nn\na\nl\ng\ne\ns\ni\nc\n-\nr\ne\nl\na\nt\ne\nd\n \nc\no\nn\nf\nu\ns\ni\no\nn\n\u2022\ns\nc\ni\na\nt\ni\nc\n \np\na\ni\nn\n \ni\nn\n \nt\nh\ne\n \nc\no\nn\nt\nr\na\nl\na\nt\ne\nr\na\nl\n \nl\ne\ng\n(\np\ne\nr\ni\no\np\ne\nr\na\nt\ni\nv\ne\n \nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\n)\n?\n:\n \nM\nI\n \n1\n\/\n2\n8\n,\n \nS\nI\n \n0\n\/\n3\n2\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n120\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nC\nh\nu\nn\ng\n,\n \n2\n0\n0\n4\n3\n2\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nq\nu\na\ns\ni\n-\nR\nC\nT\n \n(\na\nl\nt\ne\nr\nn\na\nt\ne\na\nl\nl\no\nc\na\nt\ni\no\nn\n)\nL\no\nc\na\nt\ni\no\nn\n:\n \nA\nu\ns\nt\nr\na\nl\ni\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \n1\n.\n2\n \n[\n0\n.\n8\n\u2013\n2\n.\n2\n]\n \ny\ne\na\nr\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nw\ne\ni\ng\nh\nt\n>\n1\n0\n0\nk\ng\n;\n \ns\ne\nm\ni\n-\na\nn\nk\ny\nl\no\ns\ne\nd\n \nj\no\ni\nn\nt\ns\n;\ns\ne\nv\ne\nr\ne\n \np\nr\no\nt\nr\nu\ns\ni\no\n;\n \nd\ny\ns\np\nl\na\ns\ni\na\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n1\n2\n0\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n1\n2\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nn\no\nn\ne\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \nM\nI\n6\n0\n\/\n6\n0\n,\n \nS\nI\n \n6\n0\n\/\n6\n0\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n1\n \n[\n4\n1\n\u2013\n8\n3\n]\n,\n \nS\nI\n \n6\n4\n \n[\n4\n8\n\u2013\n8\n1\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n2\n4\n\/\n3\n6\n,\n \nS\nI\n \n2\n8\n\/\n3\n2\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\nI\n \n8\n4\n,\n \nS\nI\n \n8\n6\n.\n5\nM\nI\n:\n \nN\n=\n \n6\n0\nS\nI\n:\n \nN\n=\n \n6\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n9\n.\n2\n \n[\n6\n\u2013\n1\n1\n]\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nP\no\nr\no\nu\ns\n-\nc\no\na\nt\ne\nd\n \nc\nu\np\n \n+\nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \ns\nt\ne\nm\nS\nI\n:\n \n2\n0\n.\n0\n \n[\n1\n5\n\u2013\n2\n8\n]\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\nP\no\nr\no\nu\ns\n-\nc\no\na\nt\ne\nd\n \nc\nu\np\n \n+\nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \ns\nt\ne\nm\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \no\nn\ne\ns\nu\nr\ng\ne\no\nn\n \nw\ni\nt\nh\n \nn\no\n \ns\np\ne\nc\ni\na\nl\ni\ns\ne\nd\ne\nq\nu\ni\np\nm\ne\nn\nt\n;\n \ne\na\nr\nl\ny\n \nr\ne\ns\nu\nl\nt\ns\n \no\nf\nM\nI\n \nf\nr\no\nm\n \nf\ni\nr\ns\nt\n \n6\n0\n \nc\na\ns\ne\ns\n \nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n6\n0\n,\n \n4\n9\n \n(\n9\n.\n4\n)\n \n[\n3\n5\n\u2013\n6\n5\n]\n,\n \nS\nI\n \n6\n0\n,\n \n5\n5\n.\n1\n \n(\n1\n7\n.\n9\n)\n[\n3\n0\n\u2013\n9\n0\n]\n,\n \nN\nS\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n6\n0\n,\n \n1\n3\n6\n \n(\n4\n1\n.\n1\n)\n \n[\n7\n5\n\u2013\n2\n5\n0\n]\n,\n \nS\nI\n \n6\n0\n,\n \n2\n0\n0\n.\n5\n(\n6\n5\n.\n2\n)\n \n[\n9\n5\n\u2013\n3\n0\n0\n]\n,\n \np\n<\n0\n.\n0\n1\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nI\nn\nf\ne\nc\nt\ni\no\nn\n \n(\nw\no\nu\nn\nd\n)\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nD\nV\nT\n:\n \nM\nI\n \n3\n\/\n6\n0\n,\n \nS\nI\n \n5\n\/\n6\n0\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n6\n0\n,\n \n4\n.\n4\n1\n \n(\n1\n.\n1\n)\n \n[\n3\n\u2013\n7\n]\n.\n \nS\nI\n \n6\n0\n,\n \n5\n.\n3\n4\n \n(\n1\n.\n4\n)\n[\n4\n\u2013\n9\n]\n,\n \np\n<\n0\n.\n0\n1\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\nN\na\nr\nc\no\nt\ni\nc\n \nu\ns\ne\n \n(\nd\na\ny\ns\n)\n:\n \nM\nI\n \n6\n0\n,\n \n2\n.\n2\n,\n \nS\nI\n \n6\n0\n,\n \n2\n.\n6\n4\n,\nN\nS\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\nU\ns\ne\n \no\nf\n \nw\na\nl\nk\ni\nn\ng\n \na\ni\nd\ns\n \n(\nd\na\ny\ns\n)\n:\n \nM\nI\n \n6\n0\n,\n \n2\n1\n.\n4\n \n(\n4\n.\n8\n)\n[\n1\n4\n\u2013\n3\n0\n]\n,\n \nS\nI\n \n6\n0\n,\n \n2\n4\n.\n8\n \n(\n5\n.\n4\n)\n \n[\n1\n4\n\u2013\n3\n0\n]\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n \n\u2013\nt\ni\nm\ni\nn\ng\n \nu\nn\nc\nl\ne\na\nr\n)\nI\nm\np\nl\na\nn\nt\n \ni\nn\ns\ne\nr\nt\ni\no\nn\n \ne\nr\nr\no\nr\ns\n \no\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\nm\na\nl\na\nl\ni\ng\nn\nm\ne\nn\nt\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nA\nl\nl\n \nf\ne\nm\no\nr\na\nl\n \ns\nt\ne\nm\ns\n \nw\ni\nt\nh\ni\nn\n \n3\n\u00b0\no\nf\n \nn\ne\nu\nt\nr\na\nl\na\nl\ni\ng\nn\nm\ne\nn\nt\n \nw\ni\nt\nh\n \nr\ne\ns\np\ne\nc\nt\n \nt\no\n \nt\nh\ne\n \nf\ne\nm\no\nr\na\nl\n \ns\nh\na\nf\nt\na\nx\ni\ns\nA\nl\nl\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\ns\n \nw\ni\nt\nh\ni\nn\n \nt\nh\ne\n \n4\n0\n \nt\no\n5\n0\n\u00b0\na\nb\nd\nu\nc\nt\ni\no\nn\n \na\nn\ng\nl\ne\n \nr\na\nn\ng\ne\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \nl\na\ns\nt\n \nf\no\nl\nl\no\nw\n-\nu\np\n:\n \nM\nI\n \n9\n5\n.\n5\n,\nS\nI\n \n9\n3\n.\n5\n,\n \nN\nS\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n121\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nH\na\nr\nt\n,\n \n2\n0\n0\n5\n4\n0\n,\n6\n4\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nq\nu\na\ns\ni\n-\nR\nC\nT\n \n(\na\nl\nt\ne\nr\nn\na\nt\ne\na\nl\nl\no\nc\na\nt\ni\no\nn\n \n\u2013\n \na\nu\nt\nh\no\nr\nc\no\nn\nt\na\nc\nt\ne\nd\n)\nL\no\nc\na\nt\ni\no\nn\n:\n \nC\nz\ne\nc\nh\nR\ne\np\nu\nb\nl\ni\nc\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\n \nS\ne\np\nt\ne\nm\nb\ne\nr\n2\n0\n0\n0\n\u2013\nF\ne\nb\nr\nu\na\nr\ny\n \n2\n0\n0\n2\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \n3\n.\n2\n5\n[\n2\n.\n7\n\u2013\n3\n.\n8\n]\n \ny\ne\na\nr\ns\n \nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \na\ng\ne\n \n>\n6\n5\n \ny\ne\na\nr\ns\n;\nB\nM\nI\n \n<\n3\n5\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nc\no\na\ng\nu\nl\na\nt\ni\no\nn\nd\ni\ns\no\nr\nd\ne\nr\ns\n;\n \na\nn\na\ne\nm\ni\nc\n \n(\nh\na\ne\nm\no\ng\nl\no\nb\ni\nn\nl\ne\nv\ne\nl\n \n<\n1\n2\n \ng\n\/\nd\nl\n)\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n1\n2\n0\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n1\n2\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nn\no\nn\ne\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \np\nr\ni\nm\na\nr\ny\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\ng\nr\na\nd\ne\n \n3\n \no\nr\n \n4\n \nM\nI\n \n6\n0\n\/\n6\n0\n,\n \nS\nI\n \n6\n0\n\/\n6\n0\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \n7\n2\n.\n4\n \n[\n6\n6\n\u2013\n7\n8\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n4\n0\n\/\n8\n0\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \n7\n2\n.\n1\n \n[\n6\n1\n\u2013\n8\n7\n]\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \n2\n7\n.\n6\n \n[\n2\n2\n.\n6\n\u2013\n3\n4\n.\n9\n]\nM\ne\nr\nl\ne\n \nd\n\u2019\nA\nu\nb\ni\ng\nn\n\u00e9\n-\nC\nh\na\nr\nn\nl\ne\ny\n \ns\nc\no\nr\ne\n:\nM\nI\n \n1\n0\n.\n6\n,\n \nS\nI\n \n1\n0\n.\n6\nM\nI\n:\n \nN\n=\n \n6\n0\nS\nI\n:\n \nN\n=\n \n6\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n9\n\u2013\n1\n0\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\n6\n0\n \nC\ne\nm\ne\nn\nt\ne\nd\n \nc\nu\np\n \na\nn\nd\n \ns\nt\ne\nm\nS\nI\n:\n \n2\n0\n-\nc\nm\n \ns\nt\na\nn\nd\na\nr\nd\np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\n6\n0\n \nC\ne\nm\ne\nn\nt\ne\nd\n \nc\nu\np\n \na\nn\nd\n \ns\nt\ne\nm\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \nT\nH\nR\ns\np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \n2\n \ns\ne\nn\ni\no\nr\ns\nu\nr\ng\ne\no\nn\ns\n \nw\ni\nt\nh\n \ns\nt\na\nn\nd\na\nr\nd\ni\nn\ns\nt\nr\nu\nm\ne\nn\nt\ns\n \n(\nb\nu\nt\n \na\n \ns\nl\ni\ng\nh\nt\nl\ny\nm\no\nd\ni\nf\ni\ne\nd\n \nb\nr\no\na\nd\n \nM\n\u00fc\nl\nl\ne\nr\nr\ne\nt\nr\na\nc\nt\no\nr\n)\n \na\nn\nd\n \nw\ni\nt\nh\no\nu\nt\nf\nl\nu\no\nr\no\ns\nc\no\np\ny\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n6\n0\n,\n \n7\n1\n \n[\n5\n5\n\u2013\n8\n4\n]\n,\n \nS\nI\n \n6\n0\n,\n \n7\n0\n \n[\n5\n1\n\u2013\n8\n6\n]\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n6\n0\n,\n \n3\n1\n8\n.\n8\n \n[\n2\n0\n0\n\u2013\n4\n6\n0\n]\n,\n \nS\nI\n \n6\n0\n,\n \n5\n4\n4\n.\n4\n[\n3\n9\n0\n\u2013\n8\n8\n0\n]\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n1\n\/\n6\n0\n,\n \nS\nI\n \n1\n\/\n6\n0\nI\nn\nf\ne\nc\nt\ni\no\nn\n \n(\nd\ne\ne\np\n)\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n \n(\nl\ne\ng\ni\no\nn\n \no\nf\n \nt\nh\ne\n \ns\nc\ni\na\nt\ni\nc\n \nn\ne\nr\nv\ne\n)\n:\nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nD\nV\nT\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n3\nd\na\ny\ns\n \na\nf\nt\ne\nr\n \ns\nu\nr\ng\ne\nr\ny\n \na\nn\nd\n \na\nt\n \nt\nh\ne\n \nl\na\ns\nt\n \nf\no\nl\nl\no\nw\n-\nu\np\n \nc\no\nn\nt\nr\no\nl\n \ni\nn\n \nJ\nu\nl\ny\n \n2\n0\n0\n4\n)\nF\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \nv\na\nr\nu\ns\n \na\nl\ni\ng\nn\nm\ne\nn\nt\n \no\nf\n \n<\n3\n\u00b0\n[\nr\na\nn\ng\ne\n \n4\n\u2013\n6\n\u00b0\n]\n:\n \nM\nI\n \n6\n\/\n6\n0\n,\n \nS\nI\n \n7\n\/\n6\n0\nF\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \nc\no\nr\no\nn\na\nl\n \na\nl\ni\ng\nn\nm\ne\nn\nt\nw\ni\nt\nh\ni\nn\n \n3\n\u00b0\no\nf\n \nn\ne\nu\nt\nr\na\nl\n \np\no\ns\ni\nt\ni\no\nn\n:\n \nM\nI\n \n5\n4\n\/\n6\n0\n,\n \nS\nI\n \n5\n3\n\/\n6\n0\nC\nu\np\n \ni\nn\nc\nl\ni\nn\na\nt\ni\no\nn\n \na\nn\ng\nl\ne\n:\n \nM\nI\n \n6\n0\n,\n \n4\n2\n.\n3\n\u00b0\n[\n3\n6\n\u2013\n5\n2\n\u00b0\n]\n,\n \nS\nI\n \n6\n0\n,\n \n4\n2\n.\n4\n\u00b0\n[\n3\n5\n\u2013\n5\n0\n\u00b0\n]\nC\nu\np\n \na\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n \na\nn\ng\nl\ne\n:\n \nM\nI\n \n6\n0\n,\n \n1\n3\n.\n6\n\u00b0\n[\n6\n\u2013\n2\n9\n\u00b0\n]\n,\n \nS\nI\n \n6\n0\n,\n \n1\n3\n.\n6\n\u00b0\n[\n8\n\u2013\n2\n4\n\u00b0\n]\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nM\ne\nr\nl\ne\n \nd\n\u2019\nA\nu\nb\ni\ng\nn\n\u00e9\n\u2013\nC\nh\na\nr\nn\nl\ne\ny\n \ns\nc\no\nr\ne\n \na\nt\n6\nw\ne\ne\nk\ns\n \n(\no\nv\ne\nr\na\nl\nl\n,\n \nm\na\nx\n.\n \n1\n8\n \np\no\ni\nn\nt\ns\n)\n:\n \nM\nI\n \n1\n6\n.\n6\n,\nS\nI\n \n1\n4\n.\n1\n,\n \np\n<\n \n0\n.\n0\n2\nM\ne\nr\nl\ne\n \nd\n\u2019\nA\nu\nb\ni\ng\nn\n\u00e9\n\u2013\nC\nh\na\nr\nn\nl\ne\ny\n \ns\nc\no\nr\ne\n \na\nt\n1\n2\nm\no\nn\nt\nh\ns\n \n(\no\nv\ne\nr\na\nl\nl\n)\n:\n \nM\nI\n6\n0\n,\n \n1\n7\n.\n4\n,\n \nS\nI\n6\n0\n,\n1\n7\n.\n3\n,\n \nN\nS\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\n \no\nu\nt\nc\no\nm\ne\ns\nI\nm\np\nl\na\nn\nt\n \nm\ni\ng\nr\na\nt\ni\no\nn\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nC\ne\nm\ne\nn\nt\n \nq\nu\na\nl\ni\nt\ny\n \n(\nn\no\n \nd\ne\nf\ne\nc\nt\ns\n)\n:\n \nM\nI\n \n6\n0\n\/\n6\n0\n,\n \nS\nI\n \n6\n0\n\/\n6\n0\nO\nt\nh\ne\nr\n\u2022\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \ni\nn\nt\no\n \nd\nr\na\ni\nn\na\ng\ne\n:\nM\nI\n \n6\n0\n,\n \n6\n1\n3\n.\n3\n \n[\n3\n5\n0\n\u2013\n1\n1\n8\n0\n]\n,\n \nS\nI\n \n6\n0\n,\n \n8\n5\n3\n.\n7\n[\n5\n1\n0\n\u2013\n1\n3\n9\n0\n]\n\u2022\np\nu\nl\nm\no\nn\na\nr\ny\n \ne\nm\nb\no\nl\ni\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\n\u2022\na\ns\ne\np\nt\ni\nc\n \nl\no\no\ns\ne\nn\ni\nn\ng\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\n\u2022\nh\na\ne\nm\na\nt\no\nm\na\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\n\u2022\ns\ne\nr\no\nm\na\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n122\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nK\ni\nm\n,\n \n2\n0\n0\n6\n4\n3\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nq\nu\na\ns\ni\n-\nR\nC\nT\n;\n \nb\ni\nl\na\nt\ne\nr\na\nl\ns\ni\nm\nu\nl\nt\na\nn\ne\no\nu\ns\n \nT\nH\nR\ns\n(\nM\nI\n \no\nn\n \no\nn\ne\n \nh\ni\np\n \na\nn\nd\nS\nI\n \no\nn\n \nt\nh\ne\n \no\nt\nh\ne\nr\n \nh\ni\np\n)\nL\no\nc\na\nt\ni\no\nn\n:\n \nK\no\nr\ne\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\n \nF\ne\nb\nr\nu\na\nr\ny\n2\n0\n0\n2\n\u2013\nF\ne\nb\nr\nu\na\nr\ny\n \n2\n0\n0\n3\nF\nu\nn\nd\ni\nn\ng\n:\n \nn\no\nn\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \n2\n6\n.\n4\n(\n2\n4\n\u2013\n3\n6\n)\n \nm\no\nn\nt\nh\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n7\n5\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n7\n0\n \n(\n1\n4\n0\n \nh\ni\np\ns\n)\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nn\no\nn\ne\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \n1\n0\n\/\n7\n0\n(\n1\n4\n%\n)\n;\n \no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n:\n \n5\n6\n\/\n7\n0\n(\n8\n0\n%\n)\n;\n \na\nn\nk\ny\nl\no\ns\ni\nn\ng\n \ns\np\no\nn\nd\ny\nl\ni\nt\ni\ns\n:\n \n4\n\/\n7\n0\n \n(\n6\n%\n)\n \nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \n5\n5\n.\n6\n \n[\n4\n3\n\u2013\n6\n8\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n5\n3\n\/\n1\n7\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \n6\n5\n.\n8\n \n[\n5\n4\n\u2013\n9\n8\n]\nH\ne\ni\ng\nh\nt\n \n(\nc\nm\n)\n:\n \n1\n6\n7\n.\n3\n \n[\n1\n4\n8\n\u2013\n1\n8\n8\n]\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \n2\n5\n.\n6\n \n[\n1\n8\n.\n7\n\u2013\n3\n5\n.\n6\n]\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \nS\nc\no\nr\ne\n:\n \nM\nI\n \n4\n6\n,\n \nS\nI\n \n4\n5\n,\np\n=\n0\n.\n2\n8\n9\n9\nM\nI\n:\n \nN\n=\n \n7\n0\n \nh\ni\np\ns\nS\nI\n:\n \nN\n=\n \n7\n0\n \nh\ni\np\ns\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n8\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\nm\no\nd\ni\nf\ni\ne\nd\n \np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nC\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \nc\nu\np\n \na\nn\nd\n \ns\nt\ne\nm\nS\nI\n:\n \n1\n5\n\u2013\n2\n0\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\ns\nt\na\nn\nd\na\nr\nd\n \np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nC\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \nc\nu\np\n \na\nn\nd\n \ns\nt\ne\nm\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \no\nn\ne\ns\nu\nr\ng\ne\no\nn\n \nw\ni\nt\nh\n \ns\np\ne\nc\ni\na\nl\ni\ns\ne\nd\nr\ne\nt\nr\na\nc\nt\no\nr\ns\n,\n \nr\ne\na\nm\ne\nr\ns\n,\n \nc\nu\np\ni\nn\ns\ne\nr\nt\ne\nr\ns\n \na\nn\nd\n \nc\ne\nr\na\nm\ni\nc\n \nb\ne\na\nr\ni\nn\ng\nh\no\nl\nd\ne\nr\n \ni\nn\n \nM\nI\nM\nI\n \nr\na\nn\nd\no\nm\ni\ns\ne\nd\n \nt\no\n \nl\ne\nf\nt\n \no\nr\nr\ni\ng\nh\nt\n \nh\ni\np\n;\n \nt\nh\ne\n \no\nr\nd\ne\nr\n \no\nf\n \nu\ns\ni\nn\ng\nM\nI\n \na\nn\nd\n \nS\nI\n \na\ns\ns\ni\ng\nn\ne\nd\na\nl\nt\ne\nr\nn\na\nt\ne\nl\ny\n,\n \ni\n.\ne\n.\n \nM\nI\n \nf\ni\nr\ns\nt\n \no\nn\n \n1\ns\nt\np\na\nt\ni\ne\nn\nt\n \na\nn\nd\n \nS\nI\n \nf\ni\nr\ns\nt\n \no\nn\n \n2\nn\nd\np\na\nt\ni\ne\nn\nt\n \ne\nt\nc\n.\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n7\n0\n,\n \n5\n2\n \n[\n4\n8\n\u2013\n7\n0\n]\n,\n \nS\nI\n \n7\n0\n,\n \n6\n1\n \n[\n5\n1\n\u2013\n8\n0\n]\n,\n \np\n<\n0\n.\n0\n0\n1\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n7\n0\n,\n \n4\n4\n5\n.\n8\n,\n \nS\nI\n \n7\n0\n,\n \n5\n6\n7\n.\n5\n,\n \np\n=\n0\n.\n1\n6\n8\n7\n \nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n1\n\/\n7\n0\n,\n \nS\nI\n \n1\n\/\n7\n0\nI\nn\nf\ne\nc\nt\ni\no\nn\n \n(\nd\ne\ne\np\n \nw\no\nu\nn\nd\n)\n:\n \nM\nI\n \n1\n\/\n7\n0\n,\n \nS\nI\n \n0\n\/\n7\n0\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n \n(\np\ne\nr\no\nn\ne\na\nl\n \nn\ne\nr\nv\ne\n \np\na\nl\ns\ny\n)\n:\n \nM\nI\n \n1\n\/\n7\n0\n,\n \nS\nI\n \n1\n\/\n7\n0\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\n:\n \nM\nI\n \na\nn\nd\n \nS\nI\n \n1\n2\n.\n8\n \n[\n9\n\u2013\n1\n4\n]\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n1\n0\n-\np\no\ni\nn\nt\n \na\nn\na\nl\no\ng\no\nu\ns\n \ns\nc\na\nl\ne\n \n(\n0\n \n=\n \nn\no\n \np\na\ni\nn\n)\n:\n \nn\no\nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \nb\ne\nt\nw\ne\ne\nn\n \ng\nr\no\nu\np\ns\n \n(\np\n>\n0\n.\n0\n5\n)\n \na\nt\n \n2\nw\ne\ne\nk\ns\n,\n \n3\n \nm\no\nn\nt\nh\ns\n,\n \n6\n \nm\no\nn\nt\nh\ns\n,\n \n1\n \ny\ne\na\nr\n \na\nn\nd\n \n2\ny\ne\na\nr\ns\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n)\nC\nu\np\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \n(\nN\no\nf\n \no\nu\nt\nl\ni\ne\nr\ns\n,\n \ng\no\na\nl\n \n=\n \n3\n5\n\u2013\n4\n5\n\u00b0\n)\n:\n \nM\nI\n \n6\n\/\n7\n0\n,\n \nS\nI\n \n5\n\/\n7\n0\n,\n \np\n=\n \n0\n.\n3\n7\n1\nC\nu\np\n \na\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n \n(\nN\no\nf\n \no\nu\nt\nl\ni\ne\nr\ns\n,\n \ng\no\na\nl\n \n=\n \n2\n0\n\u2013\n3\n0\n\u00b0\n)\n:\n \nM\nI\n \n7\n\/\n7\n0\n,\n \nS\nI\n \n6\n\/\n7\n0\n,\n \np\n=\n \n0\n.\n3\n5\n4\nS\nt\ne\nm\n \nv\na\nr\nu\ns\n\/\nv\na\nl\ng\nu\ns\n:\n \nM\nI\n \n4\n\/\n7\n0\n,\n \nS\nI\n \n4\n\/\n7\n0\n,\n \np\n=\n \n0\n.\n1\n8\n2\nS\nt\ne\nm\n \na\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n \n(\nN\no\nf\n \no\nu\nt\nl\ni\ne\nr\ns\n)\n:\n \nM\nI\n \n8\n\/\n7\n0\n,\n \nS\nI\n \n7\n\/\n7\n0\n,\n \np\n=\n \n0\n.\n3\n6\n8\nA\nn\nt\ne\nr\no\np\no\ns\nt\ne\nr\ni\no\nr\n \nv\ni\ne\nw\n \ns\nt\ne\nm\n \n(\nd\ne\ng\nr\ne\ne\n)\n:\n \nM\nI\n \n1\n.\n8\n \n(\n1\n.\n6\n)\n[\n\u2013\n2\n,\n \n7\n]\n,\n \nS\nI\n \n1\n.\n3\n \n(\n1\n.\n3\n)\n \n[\n\u2013\n2\n,\n \n5\n]\nA\nn\nt\ne\nr\no\np\no\ns\nt\ne\nr\ni\no\nr\n \nv\ni\ne\nw\n \nc\nu\np\n \n(\nd\ne\ng\nr\ne\ne\n)\n:\n \nM\nI\n \n4\n4\n.\n3\n \n(\n5\n.\n8\n)\n \n[\n3\n0\n,\n \n5\n7\n]\n,\n \nS\nI\n \n4\n1\n.\n9\n \n(\n7\n)\n \n[\n2\n5\n,\n \n5\n5\n]\nL\na\nt\ne\nr\na\nl\n \nv\ni\ne\nw\n \ns\nt\ne\nm\n \n(\na\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n,\n \nd\ne\ng\nr\ne\ne\n)\n \nM\nI\n \n1\n5\n.\n1\n(\n4\n.\n9\n)\n \n[\n2\n,\n \n2\n6\n]\n,\n \nS\nI\n \n1\n2\n.\n5\n \n(\n1\n6\n)\n \n[\n0\n,\n \n2\n3\n]\nL\na\nt\ne\nr\na\nl\n \nv\ni\ne\nw\n \nc\nu\np\n \n(\nd\ne\ng\nr\ne\ne\n)\n:\n \nM\nI\n \n3\n1\n.\n1\n \n(\n7\n.\n1\n)\n \n[\n9\n,\n \n4\n6\n]\n,\n \nS\nI\n \n2\n6\n.\n9\n \n(\n4\n)\n \n[\n1\n7\n,\n \n3\n8\n]\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n9\n3\n \n[\n8\n6\n\u2013\n1\n0\n0\n]\n,\n \nS\nI\n \n9\n1\n \n[\n8\n5\n\u2013\n1\n0\n0\n]\n,\n \np\n=\n \n0\n.\n7\n4\n3\n5\nP\na\ni\nn\n \nr\ne\nl\ni\ne\nf\n:\n \ns\ne\ne\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\nL\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ni\nn\ne\nq\nu\na\nl\ni\nt\ny\n \n(\nc\nm\n)\n:\n \nM\nI\n \n0\n.\n6\n(\n0\n.\n5\n9\n)\n \n[\n0\n\u2013\n0\n.\n8\n]\n \nl\no\nn\ng\ne\nr\n \nt\nh\na\nn\np\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\n \nl\ne\nn\ng\nt\nh\n,\n \nS\nI\n \n0\n.\n7\n \n(\n0\n.\n7\n9\n)\n[\n0\n\u2013\n0\n.\n9\n]\n \nl\no\nn\ng\ne\nr\n \nt\nh\na\nn\n \np\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\nl\ne\nn\ng\nt\nh\n,\n \nN\nS\nO\nt\nh\ne\nr\n\u2022\n\u201c\na\nt\n \nt\nh\ne\n \nf\ni\nn\na\nl\n \nf\no\nl\nl\no\nw\n-\nu\np\n,\n \na\nl\nl\na\nc\ne\nt\na\nb\nu\nl\na\nr\n \na\nn\nd\n \nf\ne\nm\no\nr\na\nl\nc\no\nm\np\no\nn\ne\nn\nt\ns\n \nw\ne\nr\ne\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\na\nl\nl\ny\n \ns\nt\na\nb\nl\ne\n\u201d\n \n(\nn\no\n \nl\no\no\ns\ne\nn\ni\nn\ng\n)\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n123\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nO\ng\no\nn\nd\na\n,\n \n2\n0\n0\n5\n4\n6\n,\n5\n9\n,\n6\n6\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nR\nC\nT\nL\no\nc\na\nt\ni\no\nn\n:\n \nB\ne\nl\nf\na\ns\nt\n,\n \nU\nK\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nD\ne\nc\ne\nm\nb\ne\nr\n2\n0\n0\n3\n\u2013\nJ\nu\nn\ne\n \n2\n0\n0\n4\nF\nu\nn\nd\ni\nn\ng\n:\n \nn\no\nn\ne\n \nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \n6\n \nw\ne\ne\nk\ns\n \nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nu\nn\ni\nl\na\nt\ne\nr\na\nl\n \nh\ni\np\na\nr\nt\nh\nr\no\np\nl\na\ns\nt\ny\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \np\nr\ne\nv\ni\no\nu\ns\n \nh\ni\np\ns\nu\nr\ng\ne\nr\ny\n;\n \ns\ne\nv\ne\nr\ne\n \ni\nn\nf\nl\na\nm\nm\na\nt\no\nr\ny\np\no\nl\ny\na\nr\nt\nh\nr\ni\nt\ni\ns\n \nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n2\n1\n9\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nS\nI\n \n2\n \n(\nd\ne\na\nt\nh\ns\n)\n;\n \na\nn\no\nt\nh\ne\nr\n2\n \nc\no\nu\nl\nd\n \nn\no\nt\n \nb\ne\n \ns\ne\ne\nn\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n(\ng\nr\no\nu\np\n \nn\no\nt\n \ns\np\ne\nc\ni\nf\ni\ne\nd\n)\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \nM\nI\n \n1\n0\n7\n\/\n1\n0\n9\n,\n \nS\nI\n \n1\n0\n7\n\/\n1\n1\n0\n;\nr\nh\ne\nu\nm\na\nt\no\ni\nd\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n \nM\nI\n \n2\n\/\n1\n0\n9\n,\n \nS\nI\n \n1\n\/\n1\n1\n0\n;\n \no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n \nM\nI\n \n0\n\/\n1\n0\n9\n,\nS\nI\n \n2\n\/\n1\n1\n0\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n7\n.\n4\n \n(\n9\n.\n8\n)\n,\n \nS\nI\n \n6\n5\n.\n9\n(\n1\n0\n.\n3\n)\n,\n \np\n=\n \n0\n.\n2\n5\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n4\n9\n\/\n6\n0\n,\n \nS\nI\n \n5\n8\n\/\n5\n2\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n8\n.\n2\n \n(\n4\n.\n3\n3\n)\n,\n \nS\nI\n \n2\n8\n.\n9\n4\n \n(\n4\n.\n3\n3\n)\n,\n \np\n=\n \n0\n.\n2\n1\nM\nu\ns\nc\nu\nl\na\nr\n \np\na\nt\ni\ne\nn\nt\nM\ni\nd\n-\nt\nh\ni\ng\nh\n \nc\ni\nr\nc\nu\nm\nf\ne\nr\ne\nn\nc\ne\n \n(\nc\nm\n)\n:\n \nM\nI\n \n4\n9\n.\n3\n \n(\n5\n.\n3\n)\n,\n \nS\nI\n \n5\n0\n \n(\n5\n.\n7\n)\n,\n \np\n=\n0\n.\n3\n3\nT\nh\ni\ng\nh\n \nc\ni\nr\nc\nu\nm\nf\ne\nr\ne\nn\nc\ne\n \na\nt\nt\nr\no\nc\nh\na\nn\nt\ne\nr\ni\nc\n \nr\ni\nd\ng\ne\n \n(\nc\nm\n)\n:\n \nM\nI\n \n6\n0\n.\n7\n3\n(\n5\n.\n7\n)\n,\n \nS\nI\n \n6\n1\n.\n5\n3\n \n(\n4\n.\n6\n)\n,\n \np\n=\n \n0\n.\n2\n5\nD\ne\np\nt\nh\n \no\nf\n \ns\nu\nb\nc\nu\nt\na\nn\ne\no\nu\ns\n \nf\na\nt\n \nl\na\ny\ne\nr\n(\nc\nm\n)\n:\n \nM\nI\n \n2\n.\n7\n2\n \n(\n1\n.\n5\n9\n)\n,\n \nS\nI\n \n2\n.\n8\n3\n(\n1\n.\n2\n7\n)\n,\n \np\n=\n \n0\n.\n5\n9\nM\na\nl\ne\n \nw\ni\nt\nh\n \na\n \nm\ni\nd\n-\nt\nh\ni\ng\nh\nc\ni\nr\nc\nu\nm\nf\ne\nr\ne\nn\nc\ne\n \n>\n5\n5\n \nc\nm\n:\n \nM\nI\n \n1\n6\n\/\n4\n9\n,\nS\nI\n \n2\n6\n\/\n5\n8\nM\nI\n:\n \nN\n=\n \n1\n0\n9\nS\nI\n:\n \nN\n=\n \n1\n1\n0\nB\ne\nn\nn\ne\nt\nt\n,\n \n2\n0\n0\n6\n5\n9\nM\nI\n \nN\n=\n \n9\n,\n \nS\nI\n \nN\n=\n \n8\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n \n9\n.\n5\n \n(\n0\n.\n9\n5\n)\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\n \nH\ny\nb\nr\ni\nd\n \n(\nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \nc\nu\np\n \n+\nc\ne\nm\ne\nn\nt\ne\nd\n \ns\nt\ne\nm\n)\nS\nI\n \n1\n5\n.\n8\n1\n \n(\n0\n.\n9\n3\n)\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\nH\ny\nb\nr\ni\nd\n \n(\nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \nc\nu\np\n \n+\nc\ne\nm\ne\nn\nt\ne\nd\n \ns\nt\ne\nm\n)\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \na\nn\ne\nx\np\ne\nr\ni\ne\nn\nc\ne\nd\n \ns\nu\nr\ng\ne\no\nn\n \ne\nx\nc\ne\np\nt\ne\nx\np\no\ns\nu\nr\ne\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\na\nr\nt\nh\nr\no\np\nl\na\ns\nt\ny\n \nf\ne\nl\nl\no\nw\n \ni\nn\n \n1\n5\n%\n \no\nf\nS\nI\n \ng\nr\no\nu\np\n;\n \nn\no\n \ns\np\ne\nc\ni\na\nl\ni\ns\ne\nd\ne\nq\nu\ni\np\nm\ne\nn\nt\n \nu\ns\ne\nd\n.\n \nP\na\nt\ni\ne\nn\nt\ns\nr\ne\nc\nr\nu\ni\nt\ne\nd\n \nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\nl\ny\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n1\n0\n9\n,\n \n6\n0\n.\n3\n \n(\n9\n.\n2\n)\n,\n \nS\nI\n \n1\n1\n0\n,\n \n6\n5\n.\n9\n \n(\n1\n3\n.\n2\n)\n \nO\nf\n \nt\nh\ne\n \nt\nh\nr\ne\ne\n \np\nh\na\ns\ne\ns\n,\n \ni\n.\ne\n.\n \ni\nn\nc\ni\ns\ni\no\nn\n \nt\no\n \ni\nn\ns\ne\nr\nt\ni\no\nn\n \no\nf\n \nt\nh\ne\na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nl\ni\nn\ne\nr\n,\n \ni\nn\ns\ne\nr\nt\ni\no\nn\n \no\nf\n \nt\nh\ne\n \nl\ni\nn\ne\nr\n \nt\no\n \nr\ne\nd\nu\nc\nt\ni\no\nn\no\nf\n \nt\nh\ne\n \nh\ni\np\n \na\nn\nd\n \nr\ne\nd\nu\nc\nt\ni\no\nn\n \nt\no\n \nc\nl\no\ns\nu\nr\ne\n \no\nf\n \nt\nh\ne\n \ns\nk\ni\nn\n,\ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \ni\nn\n \nf\ni\nr\ns\nt\n \na\nn\nd\n \nl\na\ns\nt\n \np\nh\na\ns\ne\ns\n \no\nf\ns\nu\nr\ng\ne\nr\ny\n \n(\np\n=\n \n0\n.\n0\n0\n1\n \na\nn\nd\n \np\n<\n0\n.\n0\n0\n1\n,\n \nr\ne\ns\np\ne\nc\nt\ni\nv\ne\nl\ny\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n1\n0\n9\n,\n \n3\n1\n4\n.\n2\n \n[\n9\n0\n\u2013\n1\n3\n1\n0\n]\n,\n \nS\nI\n \n1\n1\n0\n,\n \n3\n6\n5\n.\n8\n[\n1\n0\n0\n\u2013\n1\n1\n0\n0\n]\n,\n \np\n=\n0\n.\n0\n3\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\nM\nI\n \n0\n\/\n1\n0\n9\n,\n \nS\nI\n \n2\n\/\n1\n1\n0\nC\no\nn\nv\ne\nr\ns\ni\no\nn\nM\nI\n \n0\n\/\n1\n0\n9\n \n(\n2\n \ni\nn\n \nS\nI\n \ng\nr\no\nu\np\n \nw\no\nu\nl\nd\n \nh\na\nv\ne\n \nb\ne\ne\nn\n \nd\ni\nf\nf\ni\nc\nu\nl\nt\nw\ni\nt\nh\n \nM\nI\n)\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n1\n\/\n1\n0\n9\n,\n \nS\nI\n \n1\n\/\n1\n1\n0\nI\nn\nf\ne\nc\nt\ni\no\nn\nD\ne\ne\np\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n:\n \nM\nI\n \n1\n\/\n1\n0\n9\n,\n \nS\nI\n \n0\n\/\n1\n1\n0\nS\nu\np\ne\nr\nf\ni\nc\ni\na\nl\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n:\n \nM\nI\n \n1\n\/\n1\n0\n9\n,\n \nS\nI\n \n0\n\/\n1\n1\n0\nD\nV\nT\n:\n \nM\nI\n \n0\n\/\n1\n0\n9\n,\n \nS\nI\n \n1\n\/\n1\n1\n0\n3\n0\n-\nd\na\ny\n \nm\no\nr\nt\na\nl\ni\nt\ny\n \n(\nb\ne\nf\no\nr\ne\n \nd\ni\ns\nc\nh\na\nr\ng\ne\n)\nM\nI\n \n0\n\/\n1\n0\n9\n,\n \nS\nI\n \n2\n\/\n1\n1\n0\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n1\n0\n9\n,\n \n3\n.\n6\n5\n \n(\n2\n.\n0\n4\n)\n,\n \n[\n2\n\u2013\n1\n3\n]\nS\nI\n \n1\n1\n0\n,\n \n3\n.\n6\n8\n \n(\n2\n.\n4\n5\n)\n,\n \n[\n2\n\u2013\n2\n2\n]\n,\n \nN\nS\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n \nN\no\n \ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \ni\nn\n \np\na\ni\nn\n \ns\nc\no\nr\ne\n \n(\nr\ne\nc\no\nr\nd\ne\nd\nw\ni\nt\nh\n \nv\ni\ns\nu\na\nl\n \na\nn\na\nl\no\ng\nu\ne\n \ns\nc\na\nl\ne\n)\n \ni\nn\n \nf\ni\nr\ns\nt\n \n3\n6\n \nh\no\nu\nr\ns\n(\nO\ng\no\nn\na\nd\na\n \nT\na\nb\nl\ne\n \nI\nV\n)\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\n(\na\nt\n \n6\n \nw\ne\ne\nk\ns\n)\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n:\n \nM\nI\n \n1\n0\n7\n,\n \n8\n4\n.\n1\n5\n \n(\n1\n0\n.\n5\n6\n)\n,\n \nS\nI\n \n1\n0\n8\n,\n \n8\n3\n.\n3\n6\n(\n8\n.\n3\n3\n)\n,\n \np\n=\n \n0\n.\n5\n4\nW\nO\nM\nA\nC\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n:\n \nM\nI\n \n1\n0\n7\n,\n \n7\n4\n.\n4\n(\n1\n3\n.\n8\n8\n)\n,\n \nS\nI\n \n1\n0\n8\n,\n \n7\n3\n.\n9\n5\n \n(\n1\n2\n.\n9\n0\n)\n,\n \np\n=\n \n0\n.\n8\n1\nO\nx\nf\no\nr\nd\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n:\n \nM\nI\n \n1\n0\n7\n,\n \n2\n4\n.\n9\n7\n \n(\n7\n.\n3\n3\n)\n,\n \nS\nI\n \n1\n0\n8\n,\n \n2\n5\n.\n8\n8\n(\n6\n.\n2\n9\n)\n,\n \np\n=\n \n0\n.\n3\n3\nT\ni\nm\ne\nd\n \n1\n0\n-\nm\n \nw\na\nl\nk\n \na\nt\n \n6\nw\ne\ne\nk\ns\n(\ns\ne\nc\no\nn\nd\ns\n)\n:\n \nM\nI\n \n1\n0\n7\n,\n \n1\n3\n.\n5\n2\n \n(\n7\n.\n1\n)\n,\n \nS\nI\n \n1\n0\n8\n,\n \n1\n2\n.\n3\n6\n \n(\n4\n.\n6\n9\n)\n,\n \np\n=\n0\n.\n1\n6\nN\no\n \ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \ni\nn\n \nu\ns\ne\n \no\nf\nw\na\nl\nk\ni\nn\ng\n \na\ni\nd\ns\n \na\nt\n \n6\nw\ne\ne\nk\ns\n \n(\nL\na\nw\nl\no\nr\nT\na\nb\nl\ne\n \n5\n)\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \nn\no\n \nr\ne\nv\ni\ns\ni\no\nn\ns\nH\ne\na\nl\nt\nh\n-\nr\ne\nl\na\nt\ne\nd\n \nq\nu\na\nl\ni\nt\ny\n \no\nf\n \nl\ni\nf\ne\nS\nF\n-\n1\n2\n \np\nh\ny\ns\ni\nc\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \na\nt\n \n6\nw\ne\ne\nk\ns\n:\n \nM\nI\n \n1\n0\n7\n,\n \n3\n8\n.\n4\n8\n \n(\n1\n0\n.\n2\n)\n,\n \nS\nI\n \n1\n0\n8\n,\n3\n7\n.\n7\n3\n \n(\n9\n.\n4\n8\n)\n,\n \np\n=\n \n0\n.\n5\n8\n \nS\nF\n-\n1\n2\n \nm\ne\nn\nt\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \na\nt\n6\nw\ne\ne\nk\ns\n:\n \nM\nI\n \n1\n0\n7\n,\n \n5\n0\n.\n6\n1\n \n(\n1\n1\n.\n0\n5\n)\n,\n \nS\nI\n \n1\n0\n8\n,\n \n5\n1\n.\n1\n1\n \n(\n1\n0\n.\n5\n4\n)\n,\n \np\n=\n \n0\n.\n7\n3\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\nS\nc\na\nr\n \nm\ne\na\ns\nu\nr\ne\nm\ne\nn\nt\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n \n(\nc\nm\n)\n:\nM\nI\n1\n0\n7\n,\n \n8\n.\n4\n4\n \n(\n1\n.\n0\n2\n)\n,\n \nS\nI\n1\n0\n8\n,\n \n1\n3\n.\n9\n5\n(\n1\n.\n2\n6\n)\nM\ne\na\nn\n \nc\no\nn\nt\nr\na\nc\nt\ni\no\nn\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n \na\ns\n \n%\no\nf\n \nt\no\nt\na\nl\n \nw\no\nu\nl\nd\n \nl\ne\nn\ng\nt\nh\ne\nn\n \na\nt\n \nt\nh\ne\n \ne\nn\nd\no\nf\n \ns\nu\nr\ng\ne\nr\ny\n:\n \nM\nI\n \n1\n0\n7\n,\n \n1\n1\n%\n \n(\n1\n.\n0\n6\n\/\n9\n.\n5\nc\nm\n)\n,\nS\nI\n \n1\n0\n8\n,\n \n1\n2\n%\n \n(\n1\n.\n8\n6\n\/\n1\n5\n.\n8\n1\n \nc\nm\n)\n,\n \np\n=\n \n0\n.\n7\n0\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n124\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nP\na\ni\nn\n \ns\nc\no\nr\ne\n \ni\nn\n \nf\ni\nr\ns\nt\n \n7\n \nd\na\ny\ns\n \nf\no\nl\nl\no\nw\ni\nn\ng\n \nd\ni\ns\nc\nh\na\nr\ng\ne\n:\n \nM\nI\n \n1\n0\n9\n,\n \n3\n3\n \n(\n1\n8\n)\n,\n \nS\nI\n \n1\n1\n0\n,\n \n3\n3\n.\n6\n \n(\n1\n9\n.\n6\n)\n \np\n \n=\n \n0\n.\n8\n2\nV\no\nl\nu\nm\ne\n \no\nf\n \nm\no\nr\np\nh\ni\nn\ne\n \nu\ns\ne\nd\n \n(\nm\ng\n)\n:\n \nM\nI\n \n1\n0\n9\n,\n \n4\n2\n.\n9\n(\n9\n7\n.\n4\n)\n,\n \nS\nI\n \n1\n1\n0\n,\n \n4\n5\n.\n0\n \n(\n9\n6\n.\n8\n)\n,\n \np\n=\n \n0\n.\n8\n9\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\nN\no\n \ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \ni\nn\n \nI\no\nw\na\n \nl\ne\nv\ne\nl\n-\no\nf\n-\na\ns\ns\ni\ns\nt\na\nn\nc\ne\ns\nc\na\nl\ne\n \n(\nf\nr\no\nm\n \ns\nu\np\ni\nn\ne\n \nt\no\n \ns\ni\nt\n,\n \ns\ni\nt\n \nt\no\n \ns\nt\na\nn\nd\n \na\nn\nd\nm\no\nb\ni\nl\ni\ns\na\nt\ni\no\nn\n \nw\ni\nt\nh\n \na\ni\nd\n)\n \no\nn\n \nd\na\ny\n \n2\n \n(\nN\n=\n \n1\n0\n4\n \nf\no\nr\n \nM\nI\n,\n1\n0\n5\n \nf\no\nr\n \nS\nI\n)\nN\no\n \ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \ni\nn\n \n1\n0\n-\nm\n \nw\na\nl\nk\ni\nn\ng\n \nt\ni\nm\ne\n \no\nr\ns\nt\na\ni\nr\n \nc\nl\ni\nm\nb\ni\nn\ng\n \nt\ni\nm\ne\n \n(\nN\n=\n \n1\n0\n4\n \nf\no\nr\n \nM\nI\n,\n \n1\n0\n5\n \nf\no\nr\n \nS\nI\n;\nO\ng\no\nn\nd\na\n \nT\na\nb\nl\ne\n \nV\n)\nN\no\n \ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \ni\nn\n \ns\nt\nr\ni\nd\ne\n \na\nn\na\nl\ny\ns\ni\ns\n \n(\n1\n0\n0\np\na\nt\ni\ne\nn\nt\ns\n \nr\na\nn\nd\no\nm\nl\ny\n \ns\ne\nl\ne\nc\nt\ne\nd\n \nf\nr\no\nm\n \nt\nh\ne\n \ns\na\nm\np\nl\ne\n;\n \nN\ni\nn\ne\na\nc\nh\n \ng\nr\no\nu\np\n \nn\no\nt\n \nr\ne\np\no\nr\nt\ne\nd\n)\n \nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n \ni\nm\nm\ne\nd\ni\na\nt\ne\nl\ny\np\no\ns\nt\n-\no\np\ne\nr\na\nt\ni\nv\ne\n)\nC\nu\np\n \no\nu\nt\nl\ni\ne\nr\ns\n \n(\n<\n3\n0\n\u00b0\no\nr\n \n>\n5\n0\n\u00b0\n)\n:\n \nM\nI\n \n1\n6\n\/\n1\n0\n5\n,\n \nS\nI\n \n1\n9\n\/\n1\n0\n9\n,\nN\nS\nF\ne\nm\no\nr\na\nl\n \ns\nt\ne\nm\n \na\nl\ni\ng\nn\nm\ne\nn\nt\n \no\nn\n \nl\na\nt\ne\nr\na\nl\n \nr\na\nd\ni\no\ng\nr\na\np\nh\n:\n \nM\nI\n \np\no\ns\nt\ne\nr\ni\no\nr\n \n=\n \n2\n5\n\/\n1\n0\n5\n,\n \na\nn\nt\ne\nr\ni\no\nr\n \n4\n\/\n1\n0\n5\n,\n \nn\ne\nu\nt\nr\na\nl\n \n=\n7\n6\n\/\n1\n0\n5\n,\n \nS\nI\n \np\no\ns\nt\ne\nr\ni\no\nr\n \n=\n \n3\n4\n\/\n1\n0\n9\n,\n \na\nn\nt\ne\nr\ni\no\nr\n \n=\n \n1\n\/\n1\n0\n9\n,\nn\ne\nu\nt\nr\na\nl\n \n=\n \n7\n4\n\/\n1\n0\n9\nF\ne\nm\no\nr\na\nl\n \ns\nt\ne\nm\n \na\nl\ni\ng\nn\nm\ne\nn\nt\n \no\nn\n \na\nn\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\nr\na\nd\ni\no\ng\nr\na\np\nh\n:\n \nM\nI\n:\n \nv\na\nr\nu\ns\n \n=\n \n3\n\/\n1\n0\n5\n,\n \nv\na\nl\ng\nu\ns\n \n=\n \n0\n\/\n1\n0\n5\n,\nn\ne\nu\nt\nr\na\nl\n \n=\n \n1\n0\n2\n\/\n1\n0\n5\n,\n \nS\nI\n:\n \nv\na\nr\nu\ns\n \n=\n \n8\n\/\n1\n0\n9\n,\n \nv\na\nl\ng\nu\ns\n \n=\n0\n\/\n1\n0\n9\n,\n \nn\ne\nu\nt\nr\na\nl\n \n=\n \n1\n0\n1\n\/\n1\n0\n9\nC\nu\np\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \na\nn\ng\nl\ne\n:\n \nM\nI\n \n1\n0\n5\n,\n \n4\n5\n.\n8\n5\n\u00b0\n(\n5\n.\n0\n)\n,\n \nS\nI\n \n1\n0\n9\n,\n4\n6\n.\n6\n5\n\u00b0\n(\n5\n.\n6\n)\n,\n \nN\nS\nS\nt\ne\nm\n \na\nn\ng\nl\ne\n:\n \nM\nI\n1\n0\n5\n,\n \n0\n.\n8\n1\n\u00b0\n(\n1\n.\n2\n5\n)\n \no\nf\n \nv\na\nr\nu\ns\n,\n \nS\nI\n \n1\n0\n9\n,\n1\n.\n0\n2\n\u00b0\n(\n1\n.\n4\n9\n)\n \no\nf\n \nv\na\nr\nu\ns\n,\n \nN\nS\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\no\nu\nt\nc\no\nm\ne\ns\nC\ne\nm\ne\nn\nt\n \nq\nu\na\nl\ni\nt\ny\n \n(\na\nt\n \ni\nm\nm\ne\nd\ni\na\nt\ne\n \np\no\ns\nt\n-\no\np\ne\nr\na\nt\ni\nv\ne\n \np\ne\nr\ni\no\nd\n)\n:\n \nM\nI\n \nA\n \n=\n \n3\n2\n\/\n1\n0\n5\n,\n \nB\n=\n \n4\n5\n\/\n1\n0\n5\n,\n \nC\n1\n=\n \n2\n3\n\/\n1\n0\n5\n,\n \nC\n2\n \n=\n \n5\n\/\n1\n0\n5\n,\n \nD\n \n=\n \n0\n\/\n1\n0\n5\n,\n \nS\nI\n \nA\n \n=\n \n2\n9\n\/\n1\n0\n9\n,\n \nB\n \n=\n \n5\n4\n\/\n1\n0\n9\n,\n \nC\n1\n=\n \n2\n2\n\/\n1\n0\n9\n,\n \nC\n2\n \n=\n \n4\n\/\n1\n0\n9\n,\n \nD\n \n=\n \n0\n\/\n1\n0\n9\n,\n \np\n=\n \n0\n.\n9\n3\nB\ne\nn\nn\ne\nt\nt\n,\n \n2\n0\n0\n6\n5\n9\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\n \n(\np\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\nl\ny\n,\n2\nd\na\ny\ns\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nl\ny\n \na\nn\nd\n \n6\n \nw\ne\ne\nk\ns\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nl\ny\n)\nT\ne\nm\np\no\nr\na\nl\n\u2013\ns\np\na\nt\ni\na\nl\n \nv\na\nr\ni\na\nb\nl\ne\ns\n:\n \nN\no\ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \nb\ne\nt\nw\ne\ne\nn\ng\nr\no\nu\np\ns\n \ne\nx\nc\ne\np\nt\n \nf\no\nr\n \nc\na\nd\ne\nn\nc\ne\n \no\nn\n \nd\na\ny\n \n2\nw\ni\nt\nh\n \nM\nI\n \ng\nr\no\nu\np\n \ns\nh\no\nw\ni\nn\ng\n \na\n \ng\nr\ne\na\nt\ne\nr\nr\ne\nd\nu\nc\nt\ni\no\nn\n \nt\nh\na\nn\n \nS\nI\nK\ni\nn\ne\nm\na\nt\ni\nc\n \nv\na\nr\ni\na\nb\nl\ne\ns\n:\n \nN\no\n \ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \na\nt\n \nD\na\ny\n \n2\n;\n \nb\ne\nt\nw\ne\ne\nn\n \nw\ne\ne\nk\n6\n \na\nn\nd\n \nd\na\ny\n \n2\n,\n \nS\nI\n \nh\na\nd\n \na\n \ng\nr\ne\na\nt\ne\nr\ni\nm\np\nr\no\nv\ne\nm\ne\nn\nt\n \ni\nn\n \nh\ni\np\nf\nl\ne\nx\ni\no\nn\n\/\ne\nx\nt\ne\nn\ns\ni\no\nn\n \na\nn\nd\n \na\n \ng\nr\ne\na\nt\ne\nr\nr\ne\nd\nu\nc\nt\ni\no\nn\n \ni\nn\n \ne\nx\nt\ne\nr\nn\na\nl\n \nr\no\nt\na\nt\ni\no\nn\n,\n \nt\nh\na\nn\nM\nI\n;\n \nb\ne\nt\nw\ne\ne\nn\n \nw\ne\ne\nk\n \n6\n \na\nn\nd\np\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\nl\ny\n,\n \nS\nI\n \nh\na\nd\n \na\n \ng\nr\ne\na\nt\ne\nr\nr\ne\nd\nu\nc\nt\ni\no\nn\n \ni\nn\n \np\ne\nl\nv\ni\nc\n \nt\ni\nl\nt\n \na\nn\nd\n \ni\nn\ne\nx\nt\ne\nr\nn\na\nl\n \nh\ni\np\n \nr\no\nt\na\nt\ni\no\nn\n \nt\nh\na\nn\n \nM\nI\nO\nt\nh\ne\nr\n\u2022\ns\ne\nr\nu\nm\n \nl\ne\nv\ne\nl\ns\n \no\nf\n \nC\n-\nr\ne\na\nc\nt\ni\nv\ne\n \np\nr\no\nt\ne\ni\nn\n\u2022\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \ns\nw\ne\nl\nl\ni\nn\ng\n \n(\ni\nn\nc\nr\ne\na\ns\ne\ni\nn\n \nm\ni\nd\n-\nt\nh\ni\ng\nh\n \nc\ni\nr\nc\nu\nm\nf\ne\nr\ne\nn\nc\ne\n \na\nt\n4\n8\nh\no\nu\nr\ns\n)\n\u2022\nd\ni\ns\nc\nh\na\nr\ng\ne\n \nt\no\n \nh\no\nm\ne\n\u2022\ns\nu\nb\ng\nr\no\nu\np\n \na\nn\na\nl\ny\ns\ni\ns\n \nb\ny\n \nm\nu\ns\nc\nu\nl\na\nr\n \no\nr\no\nb\ne\ns\ne\n \np\na\nt\ni\ne\nn\nt\ns\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n125\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nR\na\nc\nh\nb\na\nu\ne\nr\n,\n \n2\n0\n0\n6\n7\n5\n(\na\nb\ns\nt\nr\na\nc\nt\n \no\nn\nl\ny\n)\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nR\nC\nT\nL\no\nc\na\nt\ni\no\nn\n:\n \nA\nu\ns\nt\nr\ni\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \nN\nR\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nB\nM\nI\n \n>\n3\n5\n,\np\nr\ne\nv\ni\no\nu\ns\n \nh\ni\np\n \ns\nu\nr\ng\ne\nr\ny\n,\n \np\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\nn\ne\nu\nr\no\nl\no\ng\ni\nc\na\nl\n \nd\ne\nf\ni\nc\ni\nt\ns\n,\n \na\ng\ne\n>\n8\n0\ny\ne\na\nr\ns\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n1\n2\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nN\nR\nP\na\nt\ni\ne\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\n:\n\u201c\nD\ne\nm\no\ng\nr\na\np\nh\ni\nc\na\nl\nl\ny\n \ne\nq\nu\na\nl\nl\ny\nd\ni\ns\nt\nr\ni\nb\nu\nt\ne\nd\n\u201d\nM\nI\n:\n \nN\n=\n \n6\n0\nS\nI\n:\n \nN\n=\n \n6\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \na\nn\nt\ne\nr\ni\no\nr\na\np\np\nr\no\na\nc\nh\nS\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nl\na\nt\ne\nr\na\nl\nt\nr\na\nn\ns\ng\nl\nu\nt\nt\na\nl\n \na\np\np\nr\no\na\nc\nh\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \n2\ns\nu\nr\ng\ne\no\nn\ns\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\n:\n \nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \nl\ne\ns\ns\n,\n \nS\nI\n \nm\no\nr\ne\n,\n \np\n<\n \n0\n.\n0\n1\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n \nU\ns\ne\n \no\nf\n \na\nn\na\nl\ng\ne\ns\ni\nc\n:\n \nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n \ni\nn\n \nt\nh\ne\n \nf\ni\nr\ns\nt\n \nw\ne\ne\nk\n:\n \nM\nI\n \nl\no\nw\ne\nr\n,\n \nS\nI\n \nh\ni\ng\nh\ne\nr\n,\n \ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\nM\nI\n \ns\nh\no\nr\nt\ne\nr\n,\n \nS\nI\n \nl\no\nn\ng\ne\nr\n,\n \ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nS\nh\na\nr\nm\na\n,\n \n2\n0\n0\n6\n7\n7\n(\na\nb\ns\nt\nr\na\nc\nt\n \no\nn\nl\ny\n)\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nq\nu\na\ns\ni\n-\nR\nC\nT\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nK\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\ne\na\nr\nl\ny\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\np\ne\nr\ni\no\nd\n \no\nn\nl\ny\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n4\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nN\nR\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n6\n.\n9\n5\n,\n \nS\nI\n \n6\n8\n.\n5\n5\n,\n \np\n=\n \n0\n.\n5\n1\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n6\n.\n5\n,\n \nS\nI\n \n2\n4\n.\n4\n,\n \np\n=\n \n0\n.\n0\n2\n9\nO\nx\nf\no\nr\nd\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n4\n1\n.\n7\n5\n,\n \nS\nI\n \n4\n2\n.\n1\n5\n,\n \np\n=\n \n0\n.\n8\n7\nM\nI\n:\n \nN\n=\n \n2\n0\nS\nI\n:\n \nN\n=\n \n2\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \np\no\ns\nt\ne\nr\ni\no\nr\na\np\np\nr\no\na\nc\nh\nS\nI\n:\n \n1\n2\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \nn\no\nn\ne\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \nN\nR\n,\n \nS\nI\n \nN\nR\n,\n \np\n=\n \n0\n.\n2\n0\n7\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n2\n0\n,\n \nS\nI\n \n0\n\/\n2\n0\nI\nn\nf\ne\nc\nt\ni\no\nn\n \n(\ns\nu\np\ne\nr\nf\ni\nc\ni\na\nl\n \no\nr\n \nw\no\nu\nn\nd\n)\n:\n \nM\nI\n \n0\n\/\n2\n0\n,\n \nS\nI\n \n0\n\/\n2\n0\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \nM\nI\n \n0\n\/\n2\n0\n,\n \nS\nI\n \n0\n\/\n2\n0\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n1\n.\n6\n5\n \nd\na\ny\ns\n \ne\na\nr\nl\ni\ne\nr\n \nt\nh\na\nn\n \nS\nI\n,\n \np\n=\n \n0\n.\n0\n4\n2\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n1\n0\n-\np\no\ni\nn\nt\n \nv\ni\ns\nu\na\nl\n \na\nn\na\nl\no\ng\nu\ne\n \ns\nc\na\nl\ne\n \na\nt\n \nd\na\ny\n \n1\n:\n \nM\nI\n \n4\n.\n0\n5\n,\n \nS\nI\n \n6\n.\n2\n5\n,\n \np\n \n=\n \n0\n.\n0\n0\n9\nS\ni\nm\ni\nl\na\nr\n \nr\ne\ns\nu\nl\nt\ns\n \no\nn\n \nd\na\ny\n \n2\n \na\nn\nd\n \nd\na\ny\n \no\nf\n \nd\ni\ns\nc\nh\na\nr\ng\ne\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n126\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nZ\nh\na\nn\ng\n,\n \n2\n0\n0\n6\n5\n8\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nR\nC\nT\nL\no\nc\na\nt\ni\no\nn\n:\n \nC\nh\ni\nn\na\n \nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nA\nu\ng\nu\ns\nt\n2\n0\n0\n2\n\u2013\nF\ne\nb\nr\nu\na\nr\ny\n \n2\n0\n0\n4\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\n \nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \n1\n.\n7\n[\n1\n\u2013\n2\n.\n5\n]\n \ny\ne\na\nr\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \ng\no\no\nd\n \nh\ne\na\nl\nt\nh\n(\nB\nM\nI\n \n\u0002\n2\n7\n)\n \nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nB\nM\nI\n \n>\n2\n7\n,\no\ns\nt\ne\no\np\no\nr\no\ns\ni\ns\n,\n \nf\nr\na\nc\nt\nu\nr\ne\n,\n \nt\nu\nm\no\nu\nr\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n1\n2\n0\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n1\n2\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nn\no\nn\ne\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \nM\nI\n \n3\n6\n,\nS\nI\n \n3\n5\n;\n \nr\nh\ne\nu\nm\na\nt\no\ni\nd\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \nM\nI\n \n3\n,\nS\nI\n \n2\n;\n \no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n:\n \nM\nI\n \n2\n1\n,\n \nS\nI\n \n2\n3\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n1\n \n[\n4\n8\n\u2013\n7\n2\n]\n,\n \nS\nI\n \n6\n2\n.\n5\n \n[\n5\n2\n\u2013\n7\n7\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n2\n5\n\/\n3\n5\n,\n \nS\nI\n \n2\n8\n\/\n3\n2\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n5\n1\n.\n3\n,\n \nS\nI\n \n5\n1\n.\n6\n,\nN\nS\nM\nI\n:\n \nN\n=\n6\n0\n \nS\nI\n:\n \nN\n=\n \n6\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n7\n.\n9\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\na\nn\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\nS\nI\n:\n \n1\n6\n.\n3\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \nn\no\nn\ne\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n7\n5\n,\n \nS\nI\n \n6\n9\n,\n \np\n \n>\n \n0\n.\n0\n5\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nI\nn\nf\ne\nc\nt\ni\no\nn\nD\ne\ne\np\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\n \nS\nu\np\ne\nr\nf\ni\nc\ni\na\nl\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\n \nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nV\na\ns\nc\nu\nl\na\nr\n \ni\nn\nj\nu\nr\ny\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\n \nD\nV\nT\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n2\n\/\n6\n0\n \nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n7\n \n[\n5\n\u2013\n8\n]\n,\n \nS\nI\n \n1\n3\n.\n5\n \n[\n1\n2\n\u2013\n1\n6\n]\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n3\n \nm\no\nn\nt\nh\ns\n:\n \nM\nI\n \n9\n1\n.\n4\n,\n \nS\nI\n \n7\n8\n.\n5\n,\n \np\n<\n \n0\n.\n0\n5\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \nf\ni\nn\na\nl\n \nv\ni\ns\ni\nt\n:\n \nM\nI\n \n9\n5\n.\n1\n,\n \nS\nI\n \n9\n5\n.\n6\n,\n \np\n>\n0\n.\n0\n5Health Technology Assessment 2008; Vol. 12: No. 26\n127\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nA\ns\na\ny\na\nm\na\n,\n \n2\n0\n0\n6\n2\n8\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\na\nt\ni\nv\ne\n \nc\no\nh\no\nr\nt\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\n \na\nn\nd\nJ\na\np\na\nn\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nS\ne\np\nt\ne\nm\nb\ne\nr\n2\n0\n0\n1\n\u2013\nM\na\nr\nc\nh\n \n2\n0\n0\n3\nF\nu\nn\nd\ni\nn\ng\n:\nm\na\nn\nu\nf\na\nc\nt\nu\nr\ne\nr\n(\nS\nt\nr\ny\nk\ne\nr\nO\nr\nt\nh\no\np\na\ne\nd\ni\nc\ns\n,\nM\na\nh\nw\na\nh\n,\n \nN\nJ\n,\n \nU\nS\nA\n)\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\nm\ni\nn\ni\nm\nu\nm\n \n2\n \ny\ne\na\nr\ns\n(\nd\na\nt\na\n \nr\ne\np\no\nr\nt\ne\nd\n \nu\np\n \nt\no\n4\n2\n \nm\no\nn\nt\nh\ns\n)\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nn\no\nn\n-\nc\no\nm\np\nl\ne\nx\n,\nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n,\n \nu\nn\ni\nl\na\nt\ne\nr\na\nl\n \nc\na\ns\ne\ns\n \nw\ni\nt\nh\nn\no\n \np\nr\ni\no\nr\n \ns\nu\nr\ng\ne\nr\ni\ne\ns\n \nt\no\n \nt\nh\ne\n \na\nf\nf\ne\nc\nt\ne\nd\nh\ni\np\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nc\no\nm\np\nl\ne\nx\n \nc\na\ns\ne\ns\n(\nN\n=\n \n4\n8\n)\n,\n \ni\nn\nc\nl\nu\nd\ni\nn\ng\n \nm\nu\nl\nt\ni\np\nl\ne\n \nj\no\ni\nn\nt\np\nr\no\nc\ne\nd\nu\nr\ne\ns\n \nu\nn\nd\ne\nr\n \nt\nh\ne\n \ns\na\nm\ne\na\nn\ne\ns\nt\nh\ne\nt\ni\nc\n,\n \np\nr\ne\nv\ni\no\nu\ns\n \nf\nr\na\nc\nt\nu\nr\ne\ns\n \no\nr\ns\nu\nr\ng\ne\nr\ni\ne\ns\n,\n \ns\ne\nv\ne\nr\ne\n \np\ne\nl\nv\ni\nc\nd\ne\nf\no\nr\nm\ni\nt\ni\ne\ns\n,\n \no\nt\nh\ne\nr\n \ns\nu\nr\ng\ni\nc\na\nl\na\np\np\nr\no\na\nc\nh\n,\n \nc\ne\nm\ne\nn\nt\ne\nd\n \nf\ni\nx\na\nt\ni\no\nn\n,\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\n \n(\nN\n=\n1\n)\n,\nh\ne\nm\ni\na\nr\nt\nh\nr\no\np\nl\na\ns\nt\ny\n;\n \no\nb\ne\ns\ni\nt\ny\n \n(\nB\nM\nI\n \n>\n3\n9\n.\n1\n)\n;\n \nc\no\n-\nm\no\nr\nb\ni\nd\nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\ns\n \n(\nn\n=\n \n3\n)\n,\n \ni\nn\nc\nl\nu\nd\ni\nn\ng\nc\na\nr\nd\ni\no\nv\na\ns\nc\nu\nl\na\nr\n,\n \ng\na\ns\nt\nr\no\ni\nn\nt\ne\ns\nt\ni\nn\na\nl\nb\nl\ne\ne\nd\ni\nn\ng\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n1\n3\n8\n \n(\n1\n4\n8\n \nT\nH\nR\ns\n)\nN\ns\ne\nl\ne\nc\nt\ne\nd\n:\n \n9\n6\n \np\na\nt\ni\ne\nn\nt\ns\n \n(\n1\n0\n2\nc\na\ns\ne\ns\n)\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \nM\nI\n \n4\n1\n,\nS\nI\n \n3\n6\n;\n \nr\nh\ne\nu\nm\na\nt\no\ni\nd\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \nM\nI\n \n1\n,\nS\nI\n \n2\n;\n \na\nv\na\ns\nc\nu\nl\na\nr\n \nn\ne\nc\nr\no\ns\ni\ns\n:\n \nM\nI\n \n7\n,\n \nS\nI\n \n9\n;\na\nn\nk\ny\nl\no\ns\ni\nn\ng\n \ns\np\no\nn\nd\ny\nl\ni\nt\ni\ns\n:\n \nM\nI\n \n0\n,\n \nS\nI\n \n2\n;\nd\ne\nv\ne\nl\no\np\nm\ne\nn\nt\na\nl\n \nd\ny\ns\np\nl\na\ns\ni\na\n:\n \nM\nI\n \n0\n,\n \nS\nI\n \n1\n;\n \np\no\ns\nt\nt\nr\na\nu\nm\na\nt\ni\nc\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \nM\nI\n \n1\n,\nS\nI\n \n2\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n4\n.\n3\n \n[\n1\n9\n\u2013\n8\n3\n]\n,\n \nS\nI\n:\n \n6\n5\n.\n1\n \n[\n3\n7\n\u2013\n8\n9\n]\n,\n \nN\nS\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n2\n4\n\/\n2\n8\n,\n \nS\nI\n \n2\n5\n\/\n2\n5\n,\n \nN\nS\nM\nI\n:\n \nN\n=\n \n5\n2\n \nc\na\ns\ne\ns\nS\nI\n:\n \nN\n=\n \n5\n0\n \nc\na\ns\ne\ns\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n8\n\u2013\n1\n0\n \nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\nd\ni\nr\ne\nc\nt\n \nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\nU\nn\nc\ne\nm\ne\nn\nt\ne\nd\nS\nI\n:\n \n1\n5\n\u2013\n2\n0\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\nt\nr\na\nd\ni\nt\ni\no\nn\na\nl\n \nd\ni\nr\ne\nc\nt\n \nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nU\nn\nc\ne\nm\ne\nn\nt\ne\nd\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \na\ns\ni\nn\ng\nl\ne\n \ns\nu\nr\ng\ne\no\nn\n \nw\ni\nt\nh\no\nu\nt\ns\np\ne\nc\ni\na\nl\n \ni\nn\ns\nt\nr\nu\nm\ne\nn\nt\na\nt\ni\no\nn\nM\nI\nS\n \n=\n \nl\ni\nm\ni\nt\ne\nd\n \ni\nn\nc\ni\ns\ni\no\nn\n \n+\nl\ni\nm\ni\nt\ni\nn\ng\n \nt\nh\ne\n \ni\nn\nv\no\nl\nv\ne\nm\ne\nn\nt\n \no\nf\nt\nh\ne\n \ng\nl\nu\nt\ne\nu\ns\n \nm\na\nx\ni\nm\nu\ns\n \nm\nu\ns\nc\nl\ne\nb\ne\nl\nl\ny\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nO\np\ne\nr\na\nt\ni\no\nn\n \nt\ni\nm\ne\n:\n \nM\nI\n \n5\n0\n,\n \n5\n8\n.\n6\n \n[\n3\n2\n\u2013\n8\n9\n]\n,\n \nS\nI\n \n5\n0\n,\n \n5\n7\n.\n9\n[\n3\n6\n\u2013\n9\n0\n]\n,\n \np\n=\n \n0\n.\n7\n1\n5\nA\nn\na\ne\ns\nt\nh\ne\nt\ni\nc\n \nt\ni\nm\ne\n:\n \nM\nI\n \n5\n0\n,\n \n1\n0\n0\n \n[\n6\n2\n\u2013\n1\n3\n3\n]\n,\n \nS\nI\n \n5\n2\n,\n \n9\n8\n[\n7\n1\n\u2013\n1\n4\n0\n]\n,\n \nN\nS\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nR\ne\nc\no\nr\nd\ne\nd\n \nb\ny\n \ns\nu\nr\ng\ne\no\nn\n:\n \nM\nI\n \n5\n2\n,\n \n2\n1\n7\n.\n5\n \n[\n5\n0\n\u2013\n6\n0\n0\n]\n,\n \nS\nI\n \n5\n0\n,\n \n2\n4\n7\n \n[\n1\n0\n0\n\u2013\n5\n5\n0\n]\nR\ne\nc\no\nr\nd\ne\nd\n \nb\ny\n \na\nn\na\ne\ns\nt\nh\ne\ns\ni\no\nl\no\ng\ny\n:\n \nM\nI\n \n2\n2\n7\n.\n9\n \n[\n7\n5\n\u2013\n7\n0\n0\n]\n,\n \nS\nI\n \n2\n7\n6\n \n[\n5\n0\n\u2013\n6\n0\n0\n]\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\n \n(\nf\ne\nm\no\nr\na\nl\n)\n:\nM\nI\n \n2\n\/\n5\n2\n,\n \nS\nI\n \n0\n\/\n5\n0\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n5\n2\n,\n \nS\nI\n \n1\n\/\n5\n0\n \nI\nn\nf\ne\nc\nt\ni\no\nn\nI\nn\nf\ne\nc\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n5\n2\n,\n \nS\nI\n \n1\n\/\n5\n0\nA\ns\ne\np\nt\ni\nc\n \nw\no\nu\nn\nd\n \np\nr\no\nb\nl\ne\nm\ns\n:\n \nM\nI\n \n0\n\/\n5\n2\n,\n \nS\nI\n \n0\n\/\n5\n0\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n \n(\nn\ne\nr\nv\ne\n \np\na\nl\ns\ny\n)\n:\n \nM\nI\n \n0\n\/\n5\n2\n,\n \nS\nI\n \n0\n\/\n5\n0\nD\nV\nT\n:\n \nM\nI\n \n0\n\/\n5\n2\n,\n \nS\nI\n \n1\n\/\n5\n0\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \ns\ne\ne\n \ne\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n5\n2\n,\n \n2\n.\n9\n6\n \n[\n1\n\u2013\n6\n]\n,\n \nS\nI\n \n5\n0\n,\n \n2\n.\n9\n4\n \n[\n2\n\u2013\n4\n]\n,\n \np\n=\n \n0\n.\n8\n5\n8\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\nT\no\nt\na\nl\n \ni\nn\nt\nr\na\nv\ne\nn\no\nu\ns\n \nn\na\nr\nc\no\nt\ni\nc\n \nr\ne\nc\ne\ni\nv\ne\nd\n \nd\nu\nr\ni\nn\ng\nh\no\ns\np\ni\nt\na\nl\ni\ns\na\nt\ni\no\nn\n \n(\ne\nq\nu\ni\na\nn\na\nl\ng\ne\ns\ni\nc\n \ne\nq\nu\ni\nv\na\nl\ne\nn\nc\ny\n \nt\no\nm\no\nr\np\nh\ni\nn\ne\n)\n \n(\nm\ng\n)\n:\n \nM\nI\n \n5\n2\n,\n \n9\n2\n.\n7\n \n[\n3\n7\n\u2013\n1\n8\n0\n]\n,\n \nS\nI\n \n5\n0\n,\n \n9\n4\n.\n9\n[\n3\n8\n\u2013\n1\n8\n8\n]\n,\n \nN\nS\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n2\n \ny\ne\na\nr\ns\n:\n \n9\n6\n.\n2\n \nf\no\nr\nb\no\nt\nh\n,\n \nN\nS\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \nM\nI\n \n0\n\/\n5\n2\n,\n \nS\nI\n \n2\n\/\n5\n0\nT\ni\nm\ne\n \nt\no\n \nr\ne\nv\ni\ns\ni\no\nn\n \n(\nm\no\nn\nt\nh\ns\n)\n:\n1\n\/\n2\nr\ne\nv\ni\ns\ni\no\nn\n \na\nt\n \nl\ne\ns\ns\n \nt\nh\na\nn\n \n1\n \nm\no\nn\nt\nh\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\nA\nt\n \n2\n \nw\ne\ne\nk\ns\nN\no\n \np\na\ni\nn\n:\n \nM\nI\n \n7\n\/\n5\n2\n,\n \nS\nI\n \n5\n\/\n5\n0\nM\ni\nl\nd\n \np\na\ni\nn\n:\n \nM\nI\n \n3\n7\n\/\n5\n2\n,\n \nS\nI\n \n4\n0\n\/\n5\n0\nM\no\nd\ne\nr\na\nt\ne\n \np\na\ni\nn\n:\n \nM\nI\n \n8\n\/\n5\n2\n,\n \nS\nI\n \n5\n\/\n5\n0\n,\n \nN\nS\nA\nt\n \n6\n \nw\ne\ne\nk\ns\nN\no\n \np\na\ni\nn\n:\n \nM\nI\n \n3\n8\n\/\n5\n2\n,\n \nS\nI\n \n3\n8\n\/\n4\n9\n,\n \nN\nS\nW\na\nl\nk\n \nw\ni\nt\nh\no\nu\nt\n \nl\ni\nm\np\n:\n \nM\nI\n \n1\n5\n\/\n5\n2\n,\n \nS\nI\n \n1\n3\n\/\n4\n9\n,\n \nN\nS\nW\na\nl\nk\n \nw\ni\nt\nh\no\nu\nt\n \na\ni\nd\n:\n \nM\nI\n \n3\n9\n\/\n5\n2\n,\n \nS\nI\n \n3\n7\n\/\n4\n9\n,\n \nN\nS\nA\nt\n \n3\n \nm\no\nn\nt\nh\ns\nM\ni\nl\nd\n \np\na\ni\nn\n:\n \nM\nI\n \n2\n\/\n5\n2\n,\n \nS\nI\n \n3\n\/\n4\n9\nU\ns\ne\n \no\nf\n \nw\na\nl\nk\ni\nn\ng\n \na\ni\nd\n:\n \nM\nI\n \n4\n\/\n5\n2\n,\n \nS\nI\n \n4\n\/\n4\n9\nV\ne\nr\ny\n \ns\nl\ni\ng\nh\nt\n \nl\ni\nm\np\n:\n \nM\nI\n \n1\n9\n\/\n5\n2\n,\n \nS\nI\n \n1\n6\n\/\n4\n9\n,\nN\nS\nL\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ni\nn\ne\nq\nu\na\nl\ni\nt\ny\n:\n \nM\nI\n \n0\n\/\n5\n2\n,\n \nS\nI\n \n0\n\/\n5\n0\nO\nt\nh\ne\nr\n\u2022\nu\nr\ni\nn\na\nr\ny\n \nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\ns\n \na\nt\nm\ni\nn\ni\nm\nu\nm\n \n2\n.\n3\n \ny\ne\na\nr\n \nf\no\nl\nl\no\nw\n-\nu\np\n:\n \nM\nI\n \n3\n\/\n5\n2\n,\n \nS\nI\n \n0\n\/\n5\n0\n\u2022\ns\nh\no\nr\nt\nn\ne\ns\ns\n \no\nf\n \nb\nr\ne\na\nt\nh\n \na\nt\n \nm\ni\nn\ni\nm\nu\nm\n2\n.\n3\n \ny\ne\na\nr\n \nf\no\nl\nl\no\nw\n-\nu\np\n:\n \nM\nI\n \n1\n\/\n5\n2\n,\n \nS\nI\n \n0\n\/\n5\n0\nc\no\nn\nt\ni\nn\nu\ne\nd\nC\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ni\ne\nsAppendix 8\n128\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\nI\n \n7\n5\n.\n8\n[\n4\n6\n\u2013\n1\n2\n0\n]\n,\n \nS\nI\n \n8\n6\n.\n5\n \n[\n5\n2\n\u2013\n1\n3\n2\n]\n,\n \np\n=\n \n0\n.\n0\n0\n5\nH\ne\ni\ng\nh\nt\n \n(\nc\nm\n)\n:\n \nM\nI\n \n1\n6\n9\n.\n4\n \n[\n1\n5\n2\n\u2013\n1\n9\n3\n]\n,\nS\nI\n \n1\n7\n2\n.\n8\n \n[\n1\n5\n2\n\u2013\n1\n9\n8\n]\n,\n \nN\nS\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n6\n.\n1\n2\n[\n1\n8\n.\n6\n\u2013\n3\n9\n.\n1\n]\n,\n \nS\nI\n \n2\n8\n.\n6\n7\n \n[\n1\n7\n.\n9\n\u2013\n3\n8\n.\n3\n]\n,\np\n=\n \n0\n.\n0\n0\n7\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\n \n(\nb\ne\nf\no\nr\ne\n \nd\ni\ns\nc\nh\na\nr\ng\ne\n)\nF\ni\nr\ns\nt\n \na\nm\nb\nu\nl\na\nt\ni\no\nn\n \n(\nd\na\ny\ns\n)\n:\n \nM\nI\n \n5\n1\n,\n \n1\n.\n0\n6\n \n[\n1\n\u2013\n2\n]\n,\n \nS\nI\n \n4\n9\n,\n1\n.\n1\n0\n \n[\n1\n\u2013\n2\n]\n,\n \nN\nS\nT\no\nt\na\nl\n \nd\ni\ns\nt\na\nn\nc\ne\n \na\nt\n \nd\na\ny\n \n2\n \n(\nf\nt\n)\n:\n \nM\nI\n \n5\n1\n,\n \n3\n5\n2\n \n[\n1\n0\n\u2013\n8\n7\n0\n]\n,\n \nS\nI\n \n4\n9\n,\n \n3\n7\n9\n \n[\n4\n8\n\u2013\n2\n0\n0\n0\n]\n,\n \nN\nS\nM\na\nx\n.\n \nd\ni\ns\nt\na\nn\nc\ne\n \ni\nn\n \na\n \ns\ne\ns\ns\ni\no\nn\n \n(\nf\nt\n)\n:\n \nM\nI\n \n5\n1\n,\n \n1\n9\n3\n \n[\n5\n6\n\u2013\n3\n0\n0\n]\n,\nS\nI\n \n4\n9\n,\n \n1\n9\n1\n \n[\n3\n0\n\u2013\n8\n0\n0\n]\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\na\nn\na\nl\ny\ns\ni\ns\n)\n \nC\no\nm\np\no\nn\ne\nn\nt\ns\n \nw\ne\nl\nl\n-\np\nl\na\nc\ne\nd\n;\n \nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \ni\nn\n \nq\nu\na\nl\ni\nt\ny\n \no\nf\nc\no\nm\np\no\nn\ne\nn\nt\n \np\nl\na\nc\ne\nm\ne\nn\nt\n \nA\nv\ne\nr\na\ng\ne\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \no\nf\n \nt\nh\ne\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\nu\np\n:\n \n4\n1\n.\n1\n\u00b0\n[\n2\n2\n\u2013\n5\n2\n]\nC\nu\nt\n \na\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n:\n \n4\n.\n8\n\u00b0\n[\n0\n\u2013\n1\n0\n.\n8\n]\nF\ne\nm\no\nr\na\nl\n \no\nf\nf\ns\ne\nt\n \n(\nm\nm\n)\n:\n \n4\n1\n.\n3\n \n[\n2\n7\n\u2013\n6\n0\n]\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \nl\ne\nv\ne\nr\n \na\nr\nm\n \nd\ni\ns\nt\na\nn\nc\ne\n \n(\nm\nm\n)\n:\n \n1\n0\n6\n.\n1\n[\n8\n2\n\u2013\n1\n2\n4\n]\n\u2022\nd\ni\ns\nc\nh\na\nr\ng\ne\n \nd\ni\ns\np\no\ns\ni\nt\ni\no\nn\n(\nh\no\nm\ne\n\/\ni\nn\np\na\nt\ni\ne\nn\nt\n \nr\ne\nh\na\nb\ni\nl\ni\nt\na\nt\ni\no\nn\n)\n \n\u2013\nT\na\nb\nl\ne\n \n4\n\u2022\n\u201c\nn\no\n \nu\nn\ns\nt\na\nb\nl\ne\n \nf\ni\nx\na\nt\ni\no\nn\n \na\nt\n2\n4\n\u2013\n4\n2\nm\no\nn\nt\nh\ns\n\u201d\n \n(\nn\no\n \na\ns\ne\np\nt\ni\nc\nl\no\no\ns\ne\nn\ni\nn\ng\n)\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n129\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nB\ne\nr\ng\ne\nr\n,\n \n2\n0\n0\n4\n2\n9\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\na\nt\ni\nv\ne\nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \ns\ne\nr\ni\ne\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\ni\nn\ni\nt\ni\na\nl\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\np\ne\nr\ni\no\nd\n \no\nn\nl\ny\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \np\nr\ni\nm\na\nr\ny\n \nT\nH\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n2\n0\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nN\nR\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n5\n7\n,\n \nS\nI\n \n5\n9\nM\nI\n:\n \nN\n=\n \n1\n0\n0\nS\nI\n:\n \nN\n=\n \n1\n0\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n3\n.\n2\n5\n \n[\n2\n.\n7\n5\n\u2013\n3\n.\n7\n5\n]\n-\ni\nn\nc\nh\ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \na\nn\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nC\ne\nm\ne\nn\nt\ne\nd\n\/\nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n:\n \nN\nR\nS\nI\n:\n \n6\n\u2013\n8\n-\ni\nn\nc\nh\n \ns\ni\nn\ng\nl\ne\n \ni\nn\nc\ni\ns\ni\no\nn\n,\ns\nt\na\nn\nd\na\nr\nd\n \na\nn\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nC\ne\nm\ne\nn\nt\ne\nd\n\/\nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n:\n \nN\nR\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\ns\np\ne\nc\ni\na\nl\ni\ns\ne\nd\n \nr\ne\nt\nr\na\nc\nt\no\nr\ns\n \na\nn\nd\nr\ne\na\nm\ne\nr\ns\n \ni\nn\n \nM\nI\n;\n \ns\np\ne\nc\ni\na\nl\nl\ny\nd\ne\ns\ni\ng\nn\ne\nd\n \np\nr\no\nv\ni\ns\ni\no\nn\na\nl\n \nn\ne\nc\nk\na\nn\nd\n \nh\ne\na\nd\n \n(\nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\ni\nn\ns\nt\nr\nu\nm\ne\nn\nt\n \ns\ne\nt\n)\n;\n \ns\np\ne\nc\ni\na\nl\nr\ne\nt\nr\na\nc\nt\no\nr\ns\n \nw\ni\nt\nh\n \nb\nu\ni\nl\nt\n-\ni\nn\n \nf\ni\nb\nr\ne\n-\no\np\nt\ni\nc\n \nl\ni\ng\nh\nt\ns\n \nm\na\ny\n \na\nl\ns\no\n \nb\ne\nu\ns\ne\nd\n \ni\nn\n \nM\nI\n \nM\nI\n \n=\n \ns\nm\na\nl\nl\n \ni\nn\nc\ni\ns\ni\no\nn\n \n+\nr\ne\nm\no\nv\ni\nn\ng\n \n2\n0\n\u2013\n2\n5\n%\n \no\nf\n \nt\nh\ne\na\nb\nd\nu\nc\nt\no\nr\n \no\nf\nf\n \nt\nh\ne\n \nt\nr\no\nc\nh\na\nn\nt\ne\nr\nS\nI\n \n=\n \n6\n\u2013\n8\n-\ni\nn\nc\nh\n \ni\nn\nc\ni\ns\ni\no\nn\n \n+\nr\ne\nm\no\nv\ni\nn\ng\n \n5\n0\n%\n \no\nf\n \nt\nh\ne\na\nb\nd\nu\nc\nt\no\nr\n \no\nf\nf\n \nt\nh\ne\n \nt\nr\no\nc\nh\na\nn\nt\ne\nr\n \nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n9\n9\n,\n \n7\n2\n,\n \nS\nI\n \n1\n0\n0\n,\n \n6\n6\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n9\n9\n,\n \n1\n5\n4\n,\n \nS\nI\n \n1\n0\n0\n,\n \n2\n7\n8\n,\n \np\n>\n \n0\n.\n0\n5\nO\np\np\no\ns\ni\nt\ne\n \nm\ne\nt\nh\no\nd\n \ni\nn\ni\nt\ni\na\nt\ne\nd\nM\nI\n \n1\n\/\n1\n0\n0\n,\n \nS\nI\n \n0\n\/\n1\n0\n0\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\nM\nI\n \n1\n\/\n9\n9\n,\n \nS\nI\n \n1\n\/\n1\n0\n0\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n9\n9\n,\n \nS\nI\n \n0\n\/\n1\n0\n0\nI\nn\nf\ne\nc\nt\ni\no\nn\n \no\nr\n \ns\nk\ni\nn\n \nb\nr\ne\na\nk\nd\no\nw\nn\n:\n \nM\nI\n \n0\n\/\n9\n9\n,\n \nS\nI\n \n0\n\/\n1\n0\n0\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\n:\n \nM\nI\n \n1\n0\n0\n,\n \n1\n.\n9\n.\n \nS\nI\n \n1\n0\n0\n,\n \n3\n.\n5\n,\n \np\n>\n \n0\n.\n0\n5\nO\nt\nh\ne\nr\n\u2022\nP\nE\n:\n \nM\nI\n \n0\n\/\n9\n9\n,\n \nS\nI\n \n0\n\/\n1\n0\n0\n\u2022\nm\ny\no\nc\na\nr\nd\ni\na\nl\n \ni\nn\nf\na\nr\nc\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n9\n9\n,\n \nS\nI\n \n0\n\/\n1\n0\n0\n\u2022\n\u201c\no\nt\nh\ne\nr\n \ns\ne\nr\ni\no\nu\ns\n \np\nr\no\nb\nl\ne\nm\ns\n\u201d\n:\n \nM\nI\n \n0\n\/\n9\n9\n,\n \nS\nI\n \n0\n\/\n1\n0\n0\n\u2022\nt\nr\na\nn\ns\nf\ne\nr\n \nr\na\nt\ne\n \nt\no\n \na\n \nr\ne\nh\na\nb\ni\nl\ni\nt\na\nt\ni\no\nn\nf\na\nc\ni\nl\ni\nt\ny\n:\n \nM\nI\n \n1\n2\n\/\n9\n9\n,\n \nS\nI\n \n2\n8\n\/\n1\n0\n0\n,\np\n>\n0\n.\n0\n5\n\u2022\nr\ne\na\nd\nm\ni\ns\ns\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n9\n9\n,\n \nS\nI\n \n0\n\/\n1\n0\n0\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n130\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nC\nh\ne\nn\n,\n \n2\n0\n0\n6\n3\n0\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\na\nt\ni\nv\ne\n \nc\no\nh\no\nr\nt\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nC\nh\ni\nn\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nJ\nu\nn\ne\n \n2\n0\n0\n2\n\u2013\nJ\na\nn\nu\na\nr\ny\n2\n0\n0\n5\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n0\n.\n5\n\u2013\n2\n.\n2\n \ny\ne\na\nr\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n1\n4\n6\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \nM\nI\n \n1\n2\n,\n \nS\nI\n \n1\n9\n;\n \no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n \nM\nI\n \n8\n,\n \nS\nI\n \n1\n5\n;\nd\ne\nf\no\nr\nm\ni\nt\ny\n \nM\nI\n \n0\n,\n \nS\nI\n \n8\n;\n \nf\ne\nm\no\nr\na\nl\n \nn\ne\nc\nk\nf\nr\na\nc\nt\nu\nr\ne\n \nM\nI\n \n3\n1\n,\n \nS\nI\n \n5\n3\n \nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n8\n.\n0\n6\n \n(\n5\n.\n9\n2\n)\n,\n \nS\nI\n \n6\n9\n.\n7\n8\n \n(\n8\n.\n5\n7\n)\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n2\n8\n\/\n2\n3\n,\n \nS\nI\n \n5\n4\n\/\n4\n1\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\nI\n \n6\n8\n.\n0\n8\n \n(\n4\n.\n6\n)\n,\nS\nI\n \n7\n0\n.\n5\n9\n \n(\n5\n.\n1\n7\n)\n \nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n2\n6\n.\n1\n6\n \n(\n1\n6\n.\n4\n8\n)\n,\nS\nI\n \n2\n2\n.\n5\n1\n \n(\n1\n6\n.\n7\n5\n)\nP\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n:\n \nM\nI\n \n8\n3\n.\n7\n8\n(\n8\n.\n0\n3\n)\n,\n \nS\nI\n \n8\n3\n.\n3\n9\n \n(\n8\n.\n3\n3\n)\n \nP\no\ns\ns\ni\nb\nl\ny\n \nb\na\ns\ne\nd\n \no\nn\n \nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\nC\no\n-\nm\no\nr\nb\ni\nd\ni\nt\ny\nC\na\nr\nd\ni\no\np\na\nt\nh\ny\n:\n \nM\nI\n \n2\n\/\n5\n1\n,\n \nS\nI\n \n5\n\/\n9\n5\nH\ny\np\ne\nr\nt\ne\nn\ns\ni\no\nn\n:\n \nM\nI\n \n5\n\/\n5\n1\n,\n \nS\nI\n \n9\n\/\n9\n5\nD\ni\na\nb\ne\nt\ne\ns\n:\n \nM\nI\n \n1\n1\n\/\n5\n1\n,\n \nS\nI\n \n2\n1\n\/\n9\n5\nO\nt\nh\ne\nr\n:\n \nM\nI\n \n2\n\/\n5\n1\n,\n \nS\nI\n \n3\n\/\n9\n5\nM\nI\n:\n \nN\n=\n \n5\n1\n \n(\n3\n6\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \n1\n5\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n)\n \nS\nI\n:\n \nN\n=\n \n9\n5\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n(\n1\n)\n \n\u0001\n1\n0\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \np\no\ns\nt\ne\nr\ni\no\nr\n \n(\nG\ni\nb\ns\no\nn\n)\na\np\np\nr\no\na\nc\nh\n;\n \n(\n2\n)\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\nM\nI\nS\n \n2\n9\n \nc\ne\nm\ne\nn\nt\ne\nd\n,\n \n2\n2\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\nS\nI\n:\n \n1\n5\n\u2013\n2\n0\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\np\no\ns\nt\ne\nr\ni\no\nr\n \n(\nG\ni\nb\ns\no\nn\n)\n \na\np\np\nr\no\na\nc\nh\n5\n6\n \nc\ne\nm\ne\nn\nt\ne\nd\n,\n \n3\n9\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \nn\no\nn\ne\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n5\n1\n,\n \n8\n8\n.\n4\n1\n \n(\n1\n7\n.\n6\n0\n)\n,\n \nS\nI\n \n9\n5\n,\n \n9\n0\n.\n8\n4\n \n(\n1\n7\n.\n8\n1\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n5\n1\n,\n \n1\n7\n5\n.\n4\n9\n \n(\n5\n1\n.\n9\n0\n)\n,\n \nS\nI\n \n9\n5\n,\n \n2\n9\n3\n.\n6\n8\n \n(\n8\n4\n.\n5\n0\n)\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n5\n1\n,\n \nS\nI\n \n0\n\/\n9\n5\n \nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\nL\na\nt\ne\nr\na\nl\n \nt\nh\ni\ng\nh\n \nn\ne\nr\nv\ne\n \np\na\nr\na\nl\ny\ns\ni\ns\n:\n \nM\nI\n \n0\n\/\n5\n1\n,\n \nS\nI\n \n2\n\/\n9\n5\n \nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \nM\nI\n \n3\n\/\n5\n1\n,\n \nS\nI\n \n4\n\/\n9\n5\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\n:\n \nM\nI\n \n5\n1\n,\n \n1\n1\n.\n1\n6\n \n(\n0\n.\n8\n3\n)\n,\nS\nI\n \n9\n5\n,\n \n1\n2\n.\n8\n3\n \n(\n1\n.\n9\n6\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\n \n(\nw\ne\ne\nk\ns\n)\n:\n \nM\nI\n \n8\n.\n0\n6\n(\n1\n.\n8\n)\n,\n \nS\nI\n \n1\n6\n.\n4\n3\n \n(\n1\n.\n5\n3\n)\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n6\n \nm\no\nn\nt\nh\ns\n:\n \nM\nI\n \n8\n9\n.\n7\n1\n \n(\n3\n.\n6\n2\n)\n,\n \nS\nI\n \n8\n3\n.\n7\n8\n \n(\n8\n.\n0\n3\n)\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n:\n \nM\nI\n \n3\n0\n \n(\n1\n5\n.\n2\n6\n)\n,\n \nS\nI\n \n4\n9\n.\n5\n8\n \n(\n1\n6\n.\n3\n8\n)\n,\n \np\n<\n \n0\n.\n0\n5\nP\no\ns\ns\ni\nb\nl\ny\n \nb\na\ns\ne\nd\n \no\nn\n \nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\nP\na\nt\ni\ne\nn\nt\n \ns\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \nh\ni\ng\nh\ne\nr\n \ni\nn\n \nM\nI\ng\nr\no\nu\np\n \nt\nh\na\nn\n \ni\nn\n \nS\nI\n \ng\nr\no\nu\np\nO\nt\nh\ne\nr\n\u2022\nt\no\nt\na\nl\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\no\np\ne\nr\na\nt\ni\no\nn\n \n+\n1\n\u2013\n3\nd\na\ny\ns\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n)\n \n(\nm\nl\n)\n:\n \nM\nI\n \n3\n6\n9\n.\n5\n1\n \n(\n6\n5\n.\n0\n5\n)\n,\n \nS\nI\n \n5\n0\n9\n.\n6\n3\n(\n1\n1\n7\n.\n3\n9\n)\n \nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n131\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nC\ni\nm\ni\nn\ni\ne\nl\nl\no\n,\n \n2\n0\n0\n6\n3\n3\n,\n7\n6\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nm\na\nt\nc\nh\ne\nd\n-\np\na\ni\nr\n \ns\nt\nu\nd\ny\n;\nt\nh\ne\n \nt\nw\no\n \ng\nr\no\nu\np\ns\nm\na\nt\nc\nh\ne\nd\n \nf\no\nr\n \na\ng\ne\n,\ns\ne\nx\n,\n \nB\nM\nI\n,\n \nA\nm\ne\nr\ni\nc\na\nn\nS\no\nc\ni\ne\nt\ny\n \no\nf\nA\nn\ne\ns\nt\nh\ne\ns\ni\no\nl\no\ng\ni\ns\nt\ns\n(\nA\nS\nA\n)\n \ns\nc\no\nr\ne\n,\nd\ni\na\ng\nn\no\ns\ni\ns\n,\n \np\nr\no\ns\nt\nh\ne\ns\ni\ns\n,\nt\ny\np\ne\n \no\nf\n \nf\ni\nx\na\nt\ni\no\nn\n,\na\nn\na\ne\ns\nt\nh\ne\ns\ni\na\n,\n \ns\nu\nr\ng\ni\nc\na\nl\na\np\np\nr\no\na\nc\nh\n \na\nn\nd\ni\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\np\na\nt\ni\ne\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\ni\nn\ng\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\n \n(\n8\n-\nm\no\nn\nt\nh\np\ne\nr\ni\no\nd\n)\nF\nu\nn\nd\ni\nn\ng\n:\n \nn\no\nn\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n6\nw\ne\ne\nk\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \ne\nn\nd\n-\ns\nt\na\ng\ne\no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\n \nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n1\n2\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \nM\nI\n \n6\n0\n,\nS\nI\n6\n0\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n9\n.\n8\n \n[\n3\n9\n\u2013\n8\n9\n]\n,\nS\nI\n7\n0\n.\n2\n \n[\n4\n2\n\u2013\n7\n9\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n1\n5\n\/\n4\n5\n,\n \nS\nI\n \n1\n5\n\/\n4\n5\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n3\n.\n8\n1\n[\n2\n0\n.\n1\n\u2013\n3\n4\n.\n8\n]\n,\n \nS\nI\n \n2\n4\n.\n1\n1\n \n[\n2\n1\n.\n2\n\u2013\n3\n5\n.\n1\n]\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n4\n9\n.\n2\n6\n[\n2\n0\n\u2013\n7\n5\n]\n,\n \nS\nI\n \n5\n6\n.\n1\n3\n \n[\n3\n0\n\u2013\n8\n0\n]\nO\nt\nh\ne\nr\n:\n \nA\nS\nA\n \ns\nc\no\nr\ne\nM\nI\n:\n \nN\n=\n \n6\n0\nS\nI\n:\n \nN\n=\n \n6\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \n(\n<\n5\n \ni\nn\nc\nh\n)\n,\na\nn\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\n6\n0\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \nT\nH\nR\n \n(\ns\nt\ne\nm\n+\n \nc\no\nm\np\no\nn\ne\nn\nt\n)\nS\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \n(\n\u0005\n5\n \ni\nn\nc\nh\n)\n,\na\nn\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\n6\n0\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \nT\nH\nR\n \n(\ns\nt\ne\nm\n+\n \nc\no\nm\np\no\nn\ne\nn\nt\n)\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \no\nr\ns\nu\np\ne\nr\nv\ni\ns\ne\nd\n \nb\ny\n \na\n \ns\ni\nn\ng\nl\ne\ns\nu\nr\ng\ne\no\nn\n \na\nt\n \na\n \nh\ni\ng\nh\n-\nv\no\nl\nu\nm\ne\nj\no\ni\nn\nt\n \na\nr\nt\nh\nr\no\np\nl\na\ns\nt\ny\n \nc\ne\nn\nt\nr\ne\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n6\n0\n,\n \n5\n5\n.\n4\n5\n \n[\n4\n0\n\u2013\n1\n7\n0\n]\n,\n \nS\nI\n \n6\n0\n,\n \n5\n6\n.\n9\n5\n \n[\n3\n5\n\u2013\n9\n0\n]\n,\n \nN\nS\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n6\n0\n,\n \n2\n0\n1\n.\n6\n7\n \n[\n4\n0\n\u2013\n1\n7\n0\n]\n,\n \nS\nI\n \n6\n0\n,\n \n1\n9\n1\n.\n7\n3\n \n[\n1\n0\n0\n\u2013\n4\n0\n0\n]\n,\nN\nS\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nI\nn\nf\ne\nc\nt\ni\no\nn\n \n(\nd\ne\ne\np\n \no\nr\n \ns\nu\np\ne\nr\nf\ni\nc\ni\na\nl\n)\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\n3\n0\n-\nd\na\ny\n \nm\no\nr\nt\na\nl\ni\nt\ny\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n6\n0\n,\n \n3\n.\n7\n \n[\n2\n\u2013\n7\n]\n;\n \nS\nI\n \n6\n0\n,\n \n3\n.\n6\n3\n \n[\n2\n\u2013\n5\n]\n,\n \nN\nS\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\nE\nq\nu\ni\na\nn\na\nl\ng\ne\ns\ni\nc\n \nr\ne\nq\nu\ni\nr\ne\nm\ne\nn\nt\n \nu\np\n \nt\no\n \n6\n \nw\ne\ne\nk\ns\n \n(\nm\ng\n)\n:\n \nM\nI\n \n6\n0\n,\n \n1\n1\n8\n \n[\n1\n0\n.\n5\n\u2013\n4\n5\n0\n.\n6\n]\n,\n \nS\nI\n \n6\n0\n,\n \n1\n2\n1\n \n[\n8\n.\n6\n\u2013\n3\n9\n0\n.\n5\n]\n,\nN\nS\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n)\nA\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n \no\np\nt\ni\nm\na\nl\nl\ny\n \np\no\ns\ni\nt\ni\no\nn\ne\nd\n \n(\ni\n.\ne\n.\na\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n \nb\ne\nt\nw\ne\ne\nn\n \n1\n0\n\u2013\n2\n0\n\u00b0\na\nn\nd\n \na\nn\n \na\nb\nd\nu\nc\nt\ni\no\nn\na\nn\ng\nl\ne\n \nb\ne\nt\nw\ne\ne\nn\n \n3\n0\n\u2013\n5\n0\n\u00b0\n)\n:\n \nM\nI\n \n6\n0\n\/\n6\n0\n,\n \nS\nI\n \n6\n0\n\/\n6\n0\nF\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \no\np\nt\ni\nm\na\nl\nl\ny\n \np\no\ns\ni\nt\ni\no\nn\ne\nd\n \n(\ni\n.\ne\n.\n \nt\nh\ne\nv\na\nr\nu\ns\n \no\nr\n \nv\na\nl\ng\nu\ns\n \na\nn\ng\nl\ne\n \nw\na\ns\n \nl\ne\ns\ns\n \nt\nh\na\nn\n \n5\n\u00b0\n)\n:\n \nM\nI\n \n6\n0\n\/\n6\n0\n,\nS\nI\n6\n0\n\/\n6\n0\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n:\n \nM\nI\n \n9\n1\n.\n0\n2\n \n[\n6\n0\n\u2013\n1\n0\n0\n]\n,\n \nS\nI\n \n9\n4\n.\n9\n3\n[\n7\n0\n\u2013\n1\n0\n0\n]\nI\nm\np\nr\no\nv\ne\nm\ne\nn\nt\n \nf\nr\no\nm\n \np\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n4\n1\n.\n7\n6\n \n(\n1\n1\n.\n0\n6\n)\nS\nI\n \n3\n8\n.\n8\n0\n \n(\n1\n1\n.\n2\n5\n)\n,\n \nN\nS\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \nM\nI\n \n1\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nT\ni\nm\ne\n \nt\no\n \nr\ne\nv\ni\ns\ni\no\nn\n \n(\nm\no\nn\nt\nh\ns\n)\n:\n \nM\nI\n8\nm\no\nn\nt\nh\ns\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\nt\nh\ni\ng\nh\n \np\na\ni\nn\n)\n:\nM\nI\n0\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\nM\no\nr\nt\na\nl\ni\nt\ny\n \n(\na\nt\n \n6\n \nw\ne\ne\nk\ns\n)\n:\n \nM\nI\n \n0\n\/\n6\n0\n,\nS\nI\n0\n\/\n6\n0\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\no\nu\nt\nc\no\nm\ne\ns\nI\nm\np\nl\na\nn\nt\n \nm\ni\ng\nr\na\nt\ni\no\nn\n:\n \nM\nI\n \n1\n\/\n6\n0\n,\n \nS\nI\n \n0\n\/\n6\n0\n \nO\nt\nh\ne\nr\n\u2022\nd\ni\ns\nc\nh\na\nr\ng\ne\n \nt\no\n \nr\ne\nh\na\nb\ni\nl\ni\nt\na\nt\ni\no\nn\n \nf\na\nc\ni\nl\ni\nt\ny\n:\nM\nI\n \n4\n9\n\/\n6\n0\n \n(\n8\n1\n%\n)\n,\n \nS\nI\n \n4\n6\n\/\n6\n0\n \n(\n7\n6\n%\n)\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n132\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nd\ne\n \nB\ne\ne\nr\n,\n \n2\n0\n0\n4\n3\n4\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nm\na\nt\nc\nh\ne\nd\n \np\na\ni\nr\n \ns\nt\nu\nd\ny\n;\nm\na\nt\nc\nh\ne\nd\n \nf\no\nr\n \na\ng\ne\n,\ng\ne\nn\nd\ne\nr\n,\n \nB\nM\nI\n,\nd\ni\na\ng\nn\no\ns\ni\ns\n \na\nn\nd\nA\nm\ne\nr\ni\nc\na\nn\n \nS\no\nc\ni\ne\nt\ny\n \no\nf\nA\nn\ne\ns\nt\nh\ne\ns\ni\no\nl\no\ng\ni\ns\nt\ns\n(\nA\nS\nA\n)\n \ns\nc\no\nr\ne\n,\ns\nt\nr\na\nt\ni\nf\ni\ne\nd\n \nb\ny\n \ns\nu\nr\ng\ne\no\nn\n;\np\ni\nl\no\nt\n \ns\nt\nu\nd\ny\nD\na\nt\na\n \ng\na\nt\nh\ne\nr\ne\nd\n \nf\nr\no\nm\na\n \np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nl\ny\ng\na\nt\nh\ne\nr\ne\nd\na\nr\nt\nh\nr\no\np\nl\na\ns\nt\ny\nd\na\nt\na\nb\na\ns\ne\n \no\nf\n \n4\n0\n0\np\nr\ni\nm\na\nr\ny\n \nT\nH\nR\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nO\nn\nt\na\nr\ni\no\n,\nC\na\nn\na\nd\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\n1\n6\n-\nm\no\nn\nt\nh\n \np\ne\nr\ni\no\nd\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\n \nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n6\nw\ne\ne\nk\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n;\np\nr\ni\nm\na\nr\ny\n \nT\nH\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n4\n0\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nn\no\nn\ne\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \nM\nI\n \n3\n0\n,\nS\nI\n3\n0\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n7\n1\n \n(\n8\n.\n9\n)\n \n[\n4\n5\n\u2013\n8\n6\n]\n,\nS\nI\n \n6\n9\n \n(\n1\n2\n.\n3\n)\n \n[\n3\n9\n\u2013\n8\n5\n]\n,\n \nN\nS\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n1\n0\n\/\n2\n0\n,\n \nS\nI\n \n1\n0\n\/\n2\n0\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n3\n2\n.\n4\n \n(\n5\n.\n0\n)\n[\n2\n1\n.\n6\n\u2013\n4\n1\n.\n7\n]\n,\n \nS\nI\n \n3\n1\n.\n7\n \n(\n5\n.\n9\n)\n[\n1\n9\n.\n6\n\u2013\n4\n3\n.\n4\n]\n,\n \np\n=\n \n0\n.\n5\n7\n9\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n3\n6\n.\n8\n \n(\n1\n2\n)\n[\n2\n1\n\u2013\n5\n9\n]\n,\n \nS\nI\n \n3\n6\n.\n4\n \n(\n6\n.\n8\n)\n \n[\n2\n3\n\u2013\n4\n8\n]\n,\n \nN\nS\nO\nx\nf\no\nr\nd\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n4\n3\n.\n6\n \n(\n6\n.\n2\n)\n[\n3\n1\n\u2013\n5\n4\n]\n,\n \nS\nI\n \n4\n0\n.\n9\n \n(\n6\n.\n6\n)\n \n[\n3\n1\n\u2013\n5\n3\n]\n,\n \nN\nS\nF\nl\ne\nx\ni\no\nn\n:\n \ns\ne\ne\n \nT\na\nb\nl\ne\n \n1\nA\nl\nl\n \np\na\nt\ni\ne\nn\nt\ns\n \nh\na\nd\n \na\nn\n \na\nv\ne\nr\na\ng\ne\n \nA\nS\nA\nr\na\nn\ng\ne\n \no\nf\n \n2\n,\n \ni\nn\nd\ni\nc\na\nt\ni\nn\ng\n \nm\ni\nl\nd\ns\ny\ns\nt\ne\nm\na\nt\ni\nc\n \nd\ni\ns\ne\na\ns\ne\nM\nI\n:\n \nN\n=\n3\n0\n \nS\nI\n:\n \nN\n=\n3\n0\n \nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n7\n.\n7\n \n[\n6\n\u2013\n1\n0\n]\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \nd\ni\nr\ne\nc\nt\n \nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\n2\n6\n\/\n3\n0\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \ns\nt\ne\nm\n4\n\/\n3\n0\n \nc\ne\nm\ne\nn\nt\ne\nd\n \ns\nt\ne\nm\n3\n0\n\/\n3\n0\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\nc\nl\nu\ns\nt\ne\nr\nS\nI\n:\n \n1\n3\n.\n9\n \n[\n1\n1\n\u2013\n2\n2\n]\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \ns\nt\na\nn\nd\na\nr\nd\n \nd\ni\nr\ne\nc\nt\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\n2\n6\n\/\n3\n0\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \ns\nt\ne\nm\n4\n\/\n3\n0\n \nc\ne\nm\ne\nn\nt\ne\nd\n \ns\nt\ne\nm\n3\n0\n\/\n3\n0\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\nc\nl\nu\ns\nt\ne\nr\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \no\np\ne\nr\na\nt\ne\nd\n \nb\ny\n \no\nr\ns\nu\np\ne\nr\nv\ni\ns\ne\nd\n \nb\ny\n \n2\n \ns\nu\nr\ng\ne\no\nn\ns\n \na\nt\n \na\nh\ni\ng\nh\n-\nv\no\nl\nu\nm\ne\n \na\nr\nt\nh\nr\no\np\nl\na\ns\nt\ny\nc\ne\nn\nt\nr\ne\n \nw\ni\nt\nh\n \ns\nt\na\nn\nd\na\nr\nd\ni\nn\ns\nt\nr\nu\nm\ne\nn\nt\na\nt\ni\no\nn\n \na\nn\nd\nr\ne\nt\nr\na\nc\nt\no\nr\ns\n \n\u201c\nT\nh\ne\n \nd\ni\ns\ns\ne\nc\nt\ni\no\nn\n \nd\ne\ne\np\n \nt\no\n \nt\nh\ne\nf\na\ns\nc\ni\na\n \nl\na\nt\na\n \nw\na\ns\n \ni\nd\ne\nn\nt\ni\nc\na\nl\n \nf\no\nr\nb\no\nt\nh\n \nM\nI\n \na\nn\nd\n \nS\nI\n \ng\nr\no\nu\np\ns\n\u201d\n(\np\n.\n9\n4\n6\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n3\n0\n,\n \n4\n6\n.\n6\n \n[\n2\n4\n\u2013\n9\n0\n]\n,\n \nS\nI\n \n3\n0\n,\n \n4\n4\n.\n5\n \n[\n1\n7\n\u2013\n7\n5\n]\n,\n \np\n=\n \n0\n.\n5\n7\n2\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n3\n0\n,\n \n1\n8\n0\n \n(\n6\n9\n)\n \n[\n1\n0\n0\n\u2013\n3\n0\n0\n]\n,\n \nS\nI\n \n3\n0\n,\n \n2\n4\n6\n.\n7\n \n(\n9\n9\n)\n[\n1\n0\n0\n\u2013\n6\n0\n0\n]\n,\n \np\n=\n \n0\n.\n0\n4\n \nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\nV\nT\n:\n \nM\nI\n \n0\n\/\n3\n0\n,\n \nS\nI\n \n1\n\/\n3\n0\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \nM\nI\n \n1\n\/\n3\n0\n \n(\nf\na\nl\nl\n \na\nt\n \nh\no\nm\ne\n)\n,\n \nS\nI\n \n0\n\/\n3\n0\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n3\n0\n,\n \n5\n.\n1\n3\n \n[\n3\n\u2013\n8\n]\n,\n \nS\nI\n \n3\n0\n,\n \n5\n.\n1\n0\n \n[\n4\n\u2013\n8\n]\n,\n \np\n=\n \n0\n.\n8\n9\n4\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n \nE\nq\nu\ni\na\nn\na\nl\ng\ne\ns\ni\nc\n \no\np\ni\no\ni\nd\n \nc\no\nn\ns\nu\nm\np\nt\ni\no\nn\n \n(\nm\ng\n)\n:\n \nM\nI\n \n3\n0\n,\n1\n4\n7\n.\n7\n \n[\n1\n8\n\u2013\n3\n3\n7\n.\n9\n]\n,\n \nS\nI\n \n3\n0\n,\n \n1\n6\n9\n.\n3\n \n[\n2\n3\n.\n3\n\u2013\n4\n1\n3\n.\n3\n]\n,\np\n=\n0\n.\n3\n3\n6\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n)\n \nF\ne\nm\no\nr\na\nl\n \ns\nt\ne\nm\n \nn\ne\nu\nt\nr\na\nl\n \na\nl\ni\ng\nn\nm\ne\nn\nt\n:\n \nM\nI\n \n3\n0\n\/\n3\n0\n,\n \nS\nI\n \n3\n0\n\/\n3\n0\nC\nu\np\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nl\na\nt\ne\nr\na\nl\n \no\np\ne\nn\ni\nn\ng\n \n(\nc\nu\np\n \na\nb\nd\nu\nc\nt\ni\no\nn\na\nn\ng\nl\ne\n)\n:\n \nM\nI\n \n3\n9\n.\n0\n3\n\u00b0\n(\n6\n.\n5\n)\n \n[\n2\n2\n\u2013\n5\n2\n]\n,\n \nS\nI\n \n3\n7\n.\n7\n\u00b0\n(\n5\n.\n6\n)\n[\n2\n4\n\u2013\n5\n0\n]\n,\n \np\n=\n0\n.\n4\n1\n4\nC\nu\np\n \na\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n \na\nn\ng\nl\ne\n:\n \nM\nI\n \n1\n8\n.\n5\n\u00b0\n(\n6\n.\n8\n)\n \n[\n4\n\u2013\n3\n0\n]\n,\nS\nI\n1\n6\n.\n5\n\u00b0\n(\n7\n.\n3\n)\n \n[\n0\n\u2013\n3\n0\n]\n,\n \np\n=\n \n0\n.\n2\n8\nC\no\nm\nb\ni\nn\ne\nd\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\n \na\nn\ng\nl\ne\n:\n \nM\nI\n \n5\n7\n.\n6\n\u00b0\n(\n9\n.\n6\n)\n \n[\n3\n8\n\u2013\n8\n0\n]\n,\nS\nI\n \n5\n4\n.\n2\n\u00b0\n(\n7\n.\n6\n)\n \n[\n4\n0\n\u2013\n8\n6\n]\n,\n \np\n=\n0\n.\n1\n4\n6\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n:\n \nM\nI\n \n7\n1\n.\n1\n \n(\n9\n.\n8\n)\n \n[\n4\n1\n\u2013\n8\n7\n]\n,\n \nS\nI\n \n6\n6\n.\n6\n \n(\n1\n2\n.\n2\n)\n[\n3\n2\n\u2013\n8\n4\n]\n,\n \np\n=\n \n0\n.\n1\n9\n3\nO\nx\nf\no\nr\nd\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n:\nM\nI\n2\n6\n.\n5\n \n(\n8\n.\n4\n)\n \n[\n1\n3\n\u2013\n4\n0\n]\n,\n \nS\nI\n \n2\n8\n.\n4\n \n(\n7\n.\n5\n)\n[\n1\n9\n\u2013\n3\n9\n]\n,\n \np\n=\n \n0\n.\n4\n9\n4\n \nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \nS\nu\nb\nc\nu\nt\na\nn\ne\no\nu\ns\n \nh\ne\nm\na\nt\no\nm\na\n,\n \nm\ni\nl\nd\ns\nc\ni\na\nt\ni\nc\na\n \na\nn\nd\n \nt\nh\ni\ng\nh\n \np\na\ni\nn\n:\n \nM\nI\n \n0\n\/\n3\n0\n,\nS\nI\n1\n\/\n3\n0\nO\nt\nh\ne\nr\n\u2022\ni\nn\nf\ne\nr\ni\no\nr\n \ni\ns\nc\nh\na\ne\nm\ni\nc\n \nc\nh\na\nn\ng\ne\nr\ne\nq\nu\ni\nr\ni\nn\ng\n \na\nd\nm\ni\ns\ns\ni\no\nn\n \nt\no\n \nc\na\nr\nd\ni\na\nc\nu\nn\ni\nt\n:\n \nM\nI\n \n0\n\/\n3\n0\n,\n \nS\nI\n \n1\n\/\n3\n0\n \nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n133\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nD\ni\nG\ni\no\ni\na\n,\n \n2\n0\n0\n3\n3\n5\n,\n6\n3\n,\n7\n0\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nm\na\nt\nc\nh\ne\nd\n-\np\na\ni\nr\n \ns\nt\nu\nd\ny\n;\nm\na\nt\nc\nh\ne\nd\n \nb\ny\nd\ni\na\ng\nn\no\ns\ni\ns\n,\n \ng\ne\nn\nd\ne\nr\n,\na\ng\ne\n \na\nn\nd\n \nH\na\nr\nr\ni\ns\n \nh\ni\np\ns\nc\no\nr\ne\nL\no\nc\na\nt\ni\no\nn\n:\nP\ne\nn\nn\ns\ny\nl\nv\na\nn\ni\na\n,\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nO\nc\nt\no\nb\ne\nr\n \n1\n9\n9\n8\n\u2013\n \n(\ne\nn\nd\nd\na\nt\ne\n \nN\nR\n)\nF\nu\nn\nd\ni\nn\ng\n:\n \nn\no\nn\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n1\ny\ne\na\nr\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \ns\ne\nl\ne\nc\nt\ne\nd\n \nf\nr\no\nm\n \nc\no\nh\no\nr\nt\ns\no\nf\n \n1\n2\n1\n \n(\nM\nI\n)\n \n+\n \n1\n2\n0\n \n(\nS\nI\n)\n \np\na\nt\ni\ne\nn\nt\ns\nN\nm\na\nt\nc\nh\ne\nd\n:\n \n6\n6\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\nM\nI\n3\n3\n\/\n3\n3\n,\n \nS\nI\n \n3\n3\n\/\n3\n3\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n5\n \n[\n4\n9\n\u2013\n8\n0\n]\n,\n \nS\nI\n6\n5\n[\n4\n9\n\u2013\n7\n6\n]\n,\n \np\n=\n \n0\n.\n8\n6\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n1\n9\n\/\n1\n4\n,\n \nS\nI\n \n1\n9\n\/\n1\n4\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\nI\n \n7\n9\n.\n8\n,\n \nS\nI\n \n7\n9\n.\n5\nH\ne\ni\ng\nh\nt\n \n(\nc\nm\n)\n:\n \nM\nI\n \n1\n7\n0\n.\n6\n,\n \nS\nI\n \n1\n6\n7\n.\n8\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n7\n,\n \nS\nI\n \n2\n8\n,\n \np\n>\n \n0\n.\n5\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n5\n2\n.\n2\n9\n[\n2\n4\n\u2013\n7\n4\n]\n,\n \nS\nI\n \n5\n3\n.\n4\n4\n \n[\n2\n2\n\u2013\n7\n6\n]\n,\np\n=\n0\n.\n8\n8\nM\nI\n:\n \nN\n=\n \n3\n3\n \n(\n3\n5\n \nh\ni\np\ns\n)\nS\nI\n:\n \nN\n=\n \n3\n3\n \n(\n3\n5\n \nh\ni\np\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n \n1\n1\n.\n7\n \n[\n7\n.\n3\n\u2013\n1\n3\n]\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nm\no\nd\ni\nf\ni\ne\nd\n \np\no\ns\nt\ne\nr\ni\no\nr\na\np\np\nr\no\na\nc\nh\n \nw\ni\nt\nh\n \ni\nm\na\ng\ne\n-\ng\nu\ni\nd\ne\nd\nn\na\nv\ni\ng\na\nt\ni\no\nn\n3\n3\n \np\nr\ne\ns\ns\n-\nf\ni\nt\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\nc\no\nm\np\no\nn\ne\nn\nt\n;\n \n2\n7\n \nc\ne\nm\ne\nn\nt\ne\nd\na\nn\nd\n \n6\n \nn\no\nn\n-\nc\ne\nm\ne\nn\nt\ne\nd\n \nf\ne\nm\no\nr\na\nl\ni\nm\np\nl\na\nn\nt\nS\nI\n \n2\n0\n.\n2\n \n[\n1\n4\n.\n8\n\u2013\n2\n6\n]\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \ns\nt\na\nn\nd\na\nr\nd\n \np\no\ns\nt\ne\nr\ni\no\nr\na\np\np\nr\no\na\nc\nh\n \nw\ni\nt\nh\n \ni\nm\na\ng\ne\n-\ng\nu\ni\nd\ne\nd\nn\na\nv\ni\ng\na\nt\ni\no\nn\n3\n3\n \np\nr\ne\ns\ns\n-\nf\ni\nt\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\nc\no\nm\np\no\nn\ne\nn\nt\n;\n \n2\n7\n \nc\ne\nm\ne\nn\nt\ne\nd\na\nn\nd\n \n6\n \nn\no\nn\n-\nc\ne\nm\ne\nn\nt\ne\nd\n \nf\ne\nm\no\nr\na\nl\ni\nm\np\nl\na\nn\nt\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \no\nn\ne\ns\nu\nr\ng\ne\no\nn\n \nw\ni\nt\nh\n \ns\nt\na\nn\nd\na\nr\nd\nr\ne\nt\nr\na\nc\nt\no\nr\ns\nM\nI\nS\n \n=\n \nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n \n+\nm\ni\nn\ni\nm\ni\ns\ni\nn\ng\n \ns\no\nf\nt\n \nt\ni\ns\ns\nu\ne\nd\ni\ns\ns\ne\nc\nt\ni\no\nn\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n3\n3\n,\n \n1\n2\n0\n,\n \nS\nI\n \n3\n3\n,\n \n1\n0\n0\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n \na\nt\n \n1\n \ny\ne\na\nr\n:\n \nM\nI\n \n0\n\/\n3\n3\n,\n \nS\nI\n \n0\n\/\n3\n3\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n \na\nt\n \n1\n \ny\ne\na\nr\n:\n \nM\nI\n \n0\n\/\n3\n3\n,\n \nS\nI\n \n0\n\/\n3\n3\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n3\n3\n,\n \n3\n.\n8\n,\n \nS\nI\n \n3\n3\n,\n \n3\n.\n9\n,\n \np\n=\n \n0\n.\n6\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\nS\ne\ne\n \nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\ns\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\na\nn\na\nl\ny\ns\ni\ns\n)\nA\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\nu\np\n \na\nl\ni\ng\nn\nm\ne\nn\nt\n \nf\no\nr\n \nb\no\nt\nh\n \ng\nr\no\nu\np\ns\n \nw\na\ns\nw\ni\nt\nh\ni\nn\n \n5\n\u00b0\no\nf\n \nt\nh\ne\n \np\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\nl\ny\n \np\nl\na\nn\nn\ne\nd\n \np\no\ns\ni\nt\ni\no\nn\n,\n \ni\n.\ne\n.\n \n4\n5\n\u00b0\no\nf\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \na\nn\nd\n \n2\n0\n\u00b0\no\nf\n \nf\nl\ne\nx\ni\no\nn\nA\nv\ne\nr\na\ng\ne\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \na\nf\nt\ne\nr\n \nf\ni\nn\na\nl\n \nc\nu\np\n \np\nl\na\nc\ne\nm\ne\nn\nt\n:\n \n4\n6\n\u00b0\n[\n4\n2\n\u2013\n4\n8\n\u00b0\n]\nA\nv\ne\nr\na\ng\ne\n \nf\nl\ne\nx\ni\no\nn\n \n(\nc\nu\np\n \na\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n)\n:\n \n2\n2\n\u00b0\n[\n1\n8\n\u2013\n2\n5\n\u00b0\n]\n \nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\ny\n \n3\n \nm\no\nn\nt\nh\ns\n:\nM\nI\n3\n3\n,\n \ni\nn\nc\nr\ne\na\ns\ne\n \nb\ny\n \n3\n4\n \np\no\ni\nn\nt\ns\n[\n6\n3\n\u2013\n9\n6\n]\n,\n \nS\nI\n \n3\n3\n,\n \ni\nn\nc\nr\ne\na\ns\ne\n \nb\ny\n \n2\n7\n \np\no\ni\nn\nt\ns\n \n[\n6\n3\n\u2013\n9\n5\n]\n,\n \np\n=\n \n0\n.\n0\n4\n5\n,\n \ni\n.\ne\n.\n \nM\nI\n8\n6\n.\n2\n9\n,\n \nS\nI\n \n8\n0\n.\n4\n4\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \nb\ny\n \n6\n \nm\no\nn\nt\nh\ns\n:\nM\nI\n3\n3\n,\n \ni\nn\nc\nr\ne\na\ns\ne\n \nb\ny\n \n4\n1\n \np\no\ni\nn\nt\ns\n[\n8\n4\n\u2013\n1\n0\n0\n]\n,\n \nS\nI\n \n3\n3\n,\n \ni\nn\nc\nr\ne\na\ns\ne\n \nb\ny\n \n3\n4\n \np\no\ni\nn\nt\ns\n \n[\n7\n1\n\u2013\n1\n0\n0\n]\n,\n \np\n=\n \n0\n.\n0\n1\n7\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n1\n \ny\ne\na\nr\n:\n \nM\nI\n \n3\n3\n,\n9\n6\n \n[\n8\n6\n\u2013\n1\n0\n0\n]\n,\n \nS\nI\n \n3\n3\n,\n \n9\n4\n \n[\n7\n9\n\u2013\n1\n0\n0\n]\n,\np\n=\n0\n.\n0\n8\n \n(\nN\nS\n)\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\nS\ne\ne\n \nd\ne\nt\na\ni\nl\ne\nd\n \nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \nr\ne\ns\nu\nl\nt\ns\na\nb\no\nv\ne\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\no\nu\nt\nc\no\nm\ne\ns\nH\ne\nt\ne\nr\no\nt\no\np\ni\nc\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n3\n3\n,\nS\nI\n3\n\/\n3\n3\n \n(\nt\ny\np\ne\n \nI\n)\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n134\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nD\no\nr\nr\n,\n \n2\n0\n0\n7\n3\n6\n,\n6\n5\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nc\no\nn\nt\nr\no\nl\nl\ne\nd\n \nb\ne\nf\no\nr\ne\n-\na\nn\nd\n-\na\nf\nt\ne\nr\n \ns\nu\nr\nv\ne\ny\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\nF\nu\nn\nd\ni\nn\ng\n:\n \nr\ne\ns\ne\na\nr\nc\nh\nf\no\nu\nn\nd\na\nt\ni\no\nn\n \na\nn\nd\nm\na\nn\nu\nf\na\nc\nt\nu\nr\ne\nr\n(\nZ\ni\nm\nm\ne\nr\n)\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n0\n.\n5\n\u2013\n1\n \ny\ne\na\nr\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \ne\nn\nr\no\nl\nl\ne\nd\n \ni\nn\n \na\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n \ns\nt\nu\nd\ny\n \n(\nN\n=\n \n2\n3\n)\n;\n \nl\ni\nv\ne\nd\no\nu\nt\ns\ni\nd\ne\n \ns\nt\na\nt\ne\n \na\nn\nd\n \nd\ni\nd\n \nn\no\nt\n \nr\ne\nt\nu\nr\nn\nf\no\nr\n \n6\n-\nw\ne\ne\nk\n \nF\nU\n \n(\nN\n=\n \n1\n1\n,\n \n1\n2\n \nh\ni\np\ns\n)\n;\np\nr\no\nb\nl\ne\nm\n \nw\ni\nt\nh\n \nl\na\nn\ng\nu\na\ng\ne\n \n(\nN\n=\n \n4\n)\n;\ny\no\nu\nn\ng\ne\nr\n \nt\nh\na\nn\n \n1\n8\n \ny\ne\na\nr\ns\n \n(\nN\n=\n \n1\n)\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n2\n0\n4\nN\nf\no\nl\nl\no\nw\ne\nd\n-\nu\np\n:\n \n1\n6\n5\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \n0\n\/\n1\n6\n5\n \n(\nb\nu\nt\n \ns\ne\ne\ne\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n)\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nN\nR\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n3\n.\n5\n \n(\n1\n2\n.\n3\n)\n,\nS\nI\n6\n5\n.\n6\n \n(\n1\n3\n.\n3\n)\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n5\n2\n\/\n5\n7\n,\n \nS\nI\n \n2\n6\n\/\n3\n0\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n6\n.\n6\n7\n \n(\n4\n.\n3\n)\n,\nS\nI\n2\n6\n.\n4\n \n(\n4\n.\n7\n)\nE\nm\np\nl\no\ny\ne\nd\n\/\nr\ne\nt\ni\nr\ne\nd\n:\n \nM\nI\n \n7\n0\n\/\n3\n9\n,\nS\nI\n3\n6\n\/\n2\n0\nP\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\n \ne\nx\np\ne\nc\nt\na\nt\ni\no\nn\ns\n \nf\no\nr\n \na\nl\nl\n1\n4\n \nq\nu\ne\ns\nt\ni\no\nn\ns\n \nf\na\nv\no\nu\nr\ne\nd\n \nt\nh\ne\n \ns\nm\na\nl\nl\n-\ni\nn\nc\ni\ns\ni\no\nn\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \nN\n=\n \n1\n0\n9\n \n(\n1\n3\n1\n \nh\ni\np\ns\n)\nS\nI\n:\n \nN\n=\n \n5\n6\n \n(\n5\n6\n \nh\ni\np\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n9\n.\n6\n \n(\n1\n.\n5\n)\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\nT\ny\np\ne\n \no\nf\n \np\nr\no\ns\nt\nh\ne\ns\ni\ns\n:\n \nN\nR\nS\nI\n:\n \n1\n7\n.\n9\n \n(\n3\n.\n5\n-\nc\nm\n)\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\nT\ny\np\ne\n \no\nf\n \np\nr\no\ns\nt\nh\ne\ns\ni\ns\n:\n \nN\nR\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \n2\ns\nu\nr\ng\ne\no\nn\ns\n;\n \nr\ne\ns\ne\na\nr\nc\nh\n \nt\no\no\nl\ns\ni\nn\nc\nl\nu\nd\ne\n \n(\n1\n)\n \ns\np\ne\nc\ni\na\nl\nl\ny\n \nd\ne\ns\ni\ng\nn\ne\nd\n1\n4\n-\ni\nt\ne\nm\n \nq\nu\ne\ns\nt\ni\no\nn\nn\na\ni\nr\ne\n,\n \n(\n2\n)\n \nS\nF\n-\n3\n6\n \nv\n2\n,\n \n(\n3\n)\n \n8\n-\ni\nt\ne\nm\nt\ne\nl\ne\np\nh\no\nn\ne\n \ns\nu\nr\nv\ne\ny\nq\nu\ne\ns\nt\ni\no\nn\nn\na\ni\nr\ne\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\nV\nT\n:\n \n1\n\/\n1\n6\n5\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \n1\n\/\n1\n6\n5\nH\ne\na\nl\nt\nh\n-\nr\ne\nl\na\nt\ne\nd\n \nq\nu\na\nl\ni\nt\ny\n \no\nf\n \nl\ni\nf\ne\nS\nF\n-\n3\n6\n \np\nh\ny\ns\ni\nc\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n:\n \nM\nI\n \n1\n0\n9\n,\n5\n4\n.\n5\n \n(\n4\n.\n2\n9\n)\n,\n \nS\nI\n \n5\n6\n,\n \n5\n6\n.\n2\n4\n \n(\n3\n.\n8\n7\n)\n,\ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \nS\nF\n-\n3\n6\n \nm\ne\nn\nt\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n:\n \nM\nI\n \n1\n0\n9\n,\n6\n0\n.\n3\n8\n \n(\n3\n.\n8\n4\n)\n,\n \nS\nI\n \n5\n6\n,\n \n6\n0\n.\n7\n4\n \n(\n3\n.\n4\n2\n)\n,\ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \n(\n8\n-\ni\nt\ne\nm\n \nt\ne\nl\ne\np\nh\no\nn\ne\ns\nu\nr\nv\ne\ny\n \na\nt\n \n6\n \nm\no\nn\nt\nh\ns\n \nt\no\n \n1\n \ny\ne\na\nr\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n)\nQ\n4\n.\n \nI\ns\n \nc\no\ns\nm\ne\ns\ni\ns\n \ns\nt\ni\nl\nl\n \ni\nm\np\no\nr\nt\na\nn\nt\n?\n(\ny\ne\ns\n\/\nn\no\n\/\nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n)\n \n(\n%\n)\n:\nM\nI\n7\n6\n\/\n2\n0\n\/\n3\n.\n7\n,\n \nS\nI\n \n0\n\/\n7\n0\n\/\n3\n0\n,\n \np\n=\n \n0\n.\n0\n0\n0\nQ\n5\n.\n \nH\na\np\np\ny\n \nw\ni\nt\nh\n \nc\no\ns\nm\ne\ns\ni\ns\n?\n(\ny\ne\ns\n\/\nn\no\n\/\nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n)\n \n(\n%\n)\n:\nM\nI\n1\n0\n0\n\/\n0\n\/\n0\n,\n \nS\nI\n \n3\n9\n\/\n3\n8\n\/\n2\n3\n,\n \np\n=\n \n0\n.\n0\n0\n0\nO\nt\nh\ne\nr\n\u2022\nP\na\nt\ni\ne\nn\nt\ns\n\u2019\n \ne\nx\np\ne\nc\nt\na\nt\ni\no\nn\ns\n \na\ns\nm\ne\na\ns\nu\nr\ne\nd\n \nb\ny\n \n1\n4\n-\ni\nt\ne\nm\nq\nu\ne\ns\nt\ni\no\nn\nn\na\ni\nr\ne\n \nf\no\nc\nu\ns\ni\nn\ng\n \no\nn\n \nt\nh\nr\ne\ne\nd\no\nm\na\ni\nn\ns\n \no\nf\n \np\na\ni\nn\n,\n \nf\nu\nn\nc\nt\ni\no\nn\n \na\nn\nd\np\ne\nr\nc\ne\np\nt\ni\no\nn\n:\n \n\u201c\nD\no\n \ny\no\nu\n \nf\ne\ne\nl\n \nt\nh\na\nt\n \na\np\na\nt\ni\ne\nn\nt\n \nw\nh\no\n \nh\na\ns\n \nh\na\nd\n \na\n \ns\nm\na\nl\nl\n \nh\ni\np\ni\nn\nc\ni\ns\ni\no\nn\n \n(\n2\n\u2013\n4\n \ni\nn\nc\nh\ne\ns\n \nl\no\nn\ng\n)\n \ni\ns\n \nm\no\nr\ne\nl\ni\nk\ne\nl\ny\n \nt\no\n \nh\na\nv\ne\n \nt\nh\ne\n \nf\no\nl\nl\no\nw\ni\nn\ng\n \nt\nh\na\nn\n \na\np\na\nt\ni\ne\nn\nt\n \nw\nh\no\n \nh\na\ns\n \nh\na\nd\n \na\n \nt\nr\na\nd\ni\nt\ni\no\nn\na\nl\ni\nn\nc\ni\ns\ni\no\nn\n \n(\n1\n0\n\u2013\n1\n2\n \ni\nn\nc\nh\ne\ns\n \nl\no\nn\ng\n)\n?\n\u201d\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n135\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nH\no\nw\ne\nl\nl\n,\n \n2\n0\n0\n4\n4\n2\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nn\nc\nu\nr\nr\ne\nn\nt\nc\no\nm\np\na\nr\ni\ns\no\nn\nL\no\nc\na\nt\ni\no\nn\n:\n \nC\na\nn\na\nd\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nJ\nu\nn\ne\n \n2\n0\n0\n2\n\u2013\nJ\nu\nn\ne\n2\n0\n0\n3\nF\nu\nn\nd\ni\nn\ng\n:\n \nl\ne\na\nd\n \na\nu\nt\nh\no\nr\n(\nH\no\nw\ne\nl\nl\n)\n \nw\na\ns\ns\nu\np\np\no\nr\nt\ne\nd\n \nb\ny\n \na\n \ng\nr\na\nn\nt\nf\nr\no\nm\n \nt\nh\ne\n \nJ\no\nh\nn\nC\nh\na\nr\nn\nl\ny\n \nT\nr\nu\ns\nt\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\nn\no\nn\ne\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n \n(\nf\no\nr\n \nc\no\nn\nt\nr\no\nl\n \ng\nr\no\nu\np\n,\n \nN\n=\n \n1\n6\n)\n:\n \nt\nh\ne\nc\no\nm\np\nl\ne\nx\ni\nt\ny\n \no\nf\n \nt\nh\ne\n \np\nr\ni\nm\na\nr\ny\n \nT\nH\nR\n \nw\na\ns\n \na\nf\nf\ne\nc\nt\ne\nd\n \nb\ny\np\nr\ne\nv\ni\no\nu\ns\n \ns\nu\nr\ng\ne\nr\ny\n \no\nr\n \nb\ny\n \na\n \nc\no\nn\ng\ne\nn\ni\nt\na\nl\n \nc\no\nn\nd\ni\nt\ni\no\nn\n;\n \nd\nu\nr\ni\nn\ng\nt\nh\ne\n \no\np\ne\nr\na\nt\ni\no\nn\n \nr\ne\nq\nu\ni\nr\ne\nd\n \na\nn\n \na\nd\nd\ni\nt\ni\no\nn\na\nl\n \np\nr\no\nc\ne\nd\nu\nr\ne\n;\n \nt\nh\ne\na\nn\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\n \nw\na\ns\n \nn\no\nt\n \nu\ns\ne\nd\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n1\n1\n8\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nA\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \np\nr\ni\nm\na\nr\ny\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n(\nO\nA\n)\n \nM\nI\n \n3\n9\n,\n \nS\nI\n \n3\n5\n;\nO\nA\n \ns\ne\nc\no\nn\nd\na\nr\ny\n \nt\no\n \nd\ny\ns\np\nl\na\ns\ni\na\n \nM\nI\n \n5\n,\n \nS\nI\n \n9\n;\n \np\no\ns\nt\n-\nt\nr\na\nu\nm\na\nt\ni\nc\nO\nA\n \nM\nI\n \n1\n,\n \nS\nI\n \n4\n;\n \na\nn\nk\ny\nl\no\ns\ni\nn\ng\n \ns\np\no\nn\nd\ny\nl\ni\nt\ni\ns\n \nM\nI\n \n0\n,\n \nS\nI\n \n3\n;\no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n \nM\nI\n \n2\n,\n \nS\nI\n \n1\n;\n \nd\ne\nv\ne\nl\no\np\nm\ne\nn\nt\na\nl\n \np\nr\no\nt\nr\nu\ns\ni\no\nn\nM\nI\n \n1\n,\n \nS\nI\n \n2\n;\n \nr\nh\ne\nu\nm\na\nt\no\ni\nd\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \nM\nI\n \n0\n,\n \nS\nI\n2\n;\n \nm\nu\nl\nt\ni\np\nl\ne\ne\np\ni\np\nh\ny\ns\ne\na\nl\n \nd\ny\ns\np\nl\na\ns\ni\na\n \nM\nI\n \n2\n,\n \nS\nI\n \n0\n;\n \nS\nC\nF\nE\n \nw\ni\nt\nh\n \ns\ne\nc\no\nn\nd\na\nr\ny\nd\ne\ng\ne\nn\ne\nr\na\nt\ni\no\nn\n \nM\nI\n \n0\n,\n \nS\nI\n \n1\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n5\n9\n.\n8\n \n(\n1\n1\n.\n7\n)\n,\n \nS\nI\n6\n2\n.\n3\n \n(\n1\n3\n.\n5\n)\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n3\n4\n\/\n1\n6\n,\n \nS\nI\n \n2\n7\n\/\n3\n0\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n6\n.\n2\n \n(\n3\n.\n7\n)\n,\n \nS\nI\n2\n8\n.\n8\n \n(\n5\n.\n8\n)\n,\n \np\n=\n \n0\n.\n0\n0\n7\nC\no\n-\nm\no\nr\nb\ni\nd\ni\nt\ny\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n0\n.\n5\n \n(\n1\n.\n0\n1\n)\n,\n \nS\nI\n \n0\n.\n5\n \n(\n0\n.\n6\n8\n)\nM\nI\n:\n \nN\n=\n \n4\n6\n \n(\n5\n0\n \nh\ni\np\ns\n)\nS\nI\n:\n \nN\n=\n \n5\n6\n \n(\n5\n7\n \nh\ni\np\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\na\nn\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\n3\n6\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n,\n \n1\n4\n \nh\ny\nb\nr\ni\nd\nS\nI\n:\n \ns\nt\na\nn\nd\na\nr\nd\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\na\nn\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\n3\n5\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n,\n \n2\n2\n \nh\ny\nb\nr\ni\nd\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \nb\ny\n \na\n \ns\ni\nn\ng\nl\ne\n \ns\nu\nr\ng\ne\no\nn\n(\ns\ne\nn\ni\no\nr\n \na\nu\nt\nh\no\nr\n)\n;\n \ns\nt\nu\nd\ny\nr\ne\np\nr\ne\ns\ne\nn\nt\ns\n \ne\na\nr\nl\ny\n \ne\nx\np\ne\nr\ni\ne\nn\nc\ne\no\nf\n \nt\nh\ne\n \ns\nu\nr\ng\ne\no\nn\n \nw\ni\nt\nh\n \nM\nI\nS\n(\ni\nn\ni\nt\ni\na\nl\n \nl\ne\na\nr\nn\ni\nn\ng\n \nc\nu\nr\nv\ne\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n5\n0\n,\n \n9\n7\n \n(\n1\n9\n)\n,\n \nS\nI\n \n5\n7\n,\n \n8\n4\n \n(\n1\n5\n)\n,\np\n=\n0\n.\n0\n0\n0\n1\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n5\n0\n,\n \n3\n8\n7\n \n(\n1\n5\n5\n)\n,\n \nS\nI\n \n5\n7\n,\n \n4\n6\n9\n(\n1\n4\n7\n)\n,\n \np\n=\n \n0\n.\n0\n0\n7\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \nM\nI\n \n2\n\/\n5\n0\n,\n \nS\nI\n \n0\n\/\n5\n7\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nI\nn\nf\ne\nc\nt\ni\no\nn\nC\nl\no\ns\nt\nr\ni\nd\ni\nu\nm\n \nd\ni\nf\nf\ni\nc\ni\nl\ne\ne\nn\nt\ne\nr\no\nc\no\nl\ni\nt\ni\ns\n:\nM\nI\n \n0\n\/\n5\n0\n,\n \nS\nI\n \n1\n\/\n5\n7\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n5\n0\n,\n \n4\n.\n4\n \n(\n2\n.\n9\n)\n,\n \nS\nI\n \n5\n7\n,\n \n5\n.\n7\n \n(\n3\n.\n1\n)\n,\np\n=\n \n0\n.\n0\n3\nL\ni\n \n2\n0\n0\n5\n4\n4\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nP\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\ni\ns\no\nn\n \no\nf\nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \ns\ne\nr\ni\ne\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nC\nh\ni\nn\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nM\na\nr\nc\nh\n \n2\n0\n0\n3\n\u2013\n \n(\ne\nn\nd\nd\na\nt\ne\n \nN\nR\n)\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \n0\n.\n9\n[\n0\n.\n5\n\u2013\n1\n.\n7\n]\n \ny\ne\na\nr\ns\n \nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nl\na\nt\ne\nr\n \no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n \no\nf\n \nf\ne\nm\no\nr\na\nl\n \nh\ne\na\nd\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n3\n6\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nn\no\nn\ne\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \nM\nI\n \n0\n,\n \nS\nI\n \n6\n;\n \no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\nM\nI\n \n1\n8\n,\n \nS\nI\n \n7\n;\n \nf\ne\nm\no\nr\na\nl\n \nn\ne\nc\nk\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \nM\nI\n \n0\n,\n \nS\nI\n \n5\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n[\n2\n4\n\u2013\n5\n7\n]\n,\n \nS\nI\n \n[\n3\n1\n\u2013\n7\n1\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n1\n3\n\/\n5\n,\n \nS\nI\n \n1\n4\n\/\n4\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n4\n.\n6\n \n[\n1\n7\n.\n1\n\u2013\n3\n0\n.\n1\n]\n,\n \nS\nI\n \n2\n6\n.\n1\n \n[\n1\n8\n.\n4\n\u2013\n3\n2\n.\n5\n]\nM\nu\ns\nc\nu\nl\na\nr\n \np\na\nt\ni\ne\nn\nt\n \n(\n%\n)\n:\n \nM\nI\n \n6\n1\n%\n,\n \nS\nI\n \nN\nR\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n4\n6\n,\n \nS\nI\n \n4\n6\nM\nI\n:\n \nN\n=\n1\n8\n \n(\n2\n2\n \nT\nH\nR\ns\n)\nS\nI\n:\n \nN\n=\n \n1\n8\n \n(\n2\n2\n \nT\nH\nR\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n9\n.\n3\n \n(\n0\n.\n4\n)\n \n[\n8\n.\n7\n\u2013\n1\n0\n.\n5\n]\n-\nc\nm\ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nC\ne\nm\ne\nn\nt\ne\nd\nS\nI\n:\n \n1\n6\n.\n8\n \n(\n2\n.\n3\n)\n \n[\n1\n4\n\u2013\n2\n0\n]\n-\nc\nm\ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nC\ne\nm\ne\nn\nt\ne\nd\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \nn\no\nn\ne\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n1\n8\n,\n \n9\n1\n.\n0\n \n(\n1\n6\n.\n4\n)\n \n[\n6\n5\n\u2013\n1\n2\n0\n]\n,\nS\nI\n1\n8\n,\n \n9\n7\n.\n0\n \n(\n1\n5\n.\n6\n)\n \n[\n7\n5\n\u2013\n1\n5\n0\n]\n,\np\n>\n0\n.\n0\n5\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n6\n \nm\no\nn\nt\nh\ns\n:\n \nM\nI\n9\n2\n,\nS\nI\n \n9\n0\n,\n \np\n>\n \n0\n.\n0\n5\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \nM\nI\n \n0\n\/\n1\n8\n,\n \nS\nI\n \n1\n\/\n1\n8\nO\nt\nh\ne\nr\n\u2022\nt\no\nt\na\nl\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\n:\n \nM\nI\n \n3\n1\n8\n(\n2\n2\n3\n.\n1\n)\n \n[\n1\n5\n0\n\u2013\n1\n1\n0\n0\n]\n,\n \nS\nI\n \n5\n2\n3\n(\n2\n1\n0\n.\n7\n)\n \n[\n2\n0\n0\n\u2013\n1\n0\n0\n0\n]\n,\n \np\n<\n \n0\n.\n0\n5\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n136\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nO\n\u2019\nB\nr\ni\ne\nn\n,\n \n2\n0\n0\n5\n4\n5\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nr\ne\nt\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\ni\ns\no\nn\n \no\nf\nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \ns\ne\nr\ni\ne\ns\n \no\nf\np\na\nt\ni\ne\nn\nt\ns\n \nL\no\nc\na\nt\ni\no\nn\n:\n \nC\na\nn\na\nd\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nM\na\ny\n \n2\n0\n0\n3\n\u2013\nS\ne\np\nt\ne\nm\nb\ne\nr\n \n2\n0\n0\n4\nF\nu\nn\nd\ni\nn\ng\n:\n \nn\no\nn\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n6\nw\ne\ne\nk\ns\n \nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nd\ni\nr\ne\nc\nt\n \nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\n;\n \np\nr\ni\nm\na\nr\ny\n \nT\nH\nR\ns\n,\n \np\na\nt\ni\ne\nn\nt\ns\nw\ne\nr\ne\n \ng\ni\nv\ne\nn\n \nM\nI\nS\n \nb\na\ns\ne\nd\n \no\nn\n \nt\nh\ne\no\nv\ne\nr\na\nl\nl\n \ng\ni\nr\nt\nh\n \no\nf\n \nt\nh\ne\n \np\na\nt\ni\ne\nn\nt\ns\n \nu\np\np\ne\nr\nt\nh\ni\ng\nh\n\/\nh\ni\np\n \ng\ni\nr\nd\nl\ne\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \np\no\ns\nt\ne\nr\ni\no\nr\na\np\np\nr\no\na\nc\nh\n \n(\nN\n=\n \n2\n)\n \nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n8\n5\n \n(\n8\n9\n \nh\ni\np\ns\n)\n \nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nn\no\nn\ne\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \np\nr\ni\nm\na\nr\ny\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\nM\nI\n \n2\n8\n,\n \nS\nI\n \n3\n9\n;\n \nr\nh\ne\nu\nm\na\nt\no\ni\nd\n \na\nr\nt\nh\nr\ni\nt\ni\ns\nM\nI\n \n0\n,\n \nS\nI\n \n3\n;\n \np\no\ns\nt\nt\nr\na\nu\nm\na\no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \nM\nI\n \n0\n,\n \nS\nI\n \n3\n;\no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \ns\ne\nc\no\nn\nd\na\nr\ny\n \nt\no\nd\ny\ns\np\nl\na\ns\ni\na\n \nM\nI\n \n2\n,\n \nS\nI\n \n5\n;\n \na\nv\na\ns\nc\nu\nl\na\nr\nn\ne\nc\nr\no\ns\ni\ns\n \nM\nI\n \n4\n,\n \nS\nI\n \n1\n;\n \na\nn\nk\ny\nl\no\ns\ni\nn\ng\ns\np\no\nn\nd\ny\nl\ni\nt\ni\ns\n \nM\nI\n \n0\n,\n \nS\nI\n \n1\n;\n \np\ns\no\nr\ni\na\nt\ni\nc\nM\nI\n0\n,\n \nS\nI\n \n1\n \nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n7\n,\n \nS\nI\n \n6\n7\n,\n \nN\nS\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n1\n9\n\/\n1\n3\n,\n \nS\nI\n \n2\n5\n\/\n2\n6\n,\n \nN\nS\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\nI\n \n7\n9\n.\n2\n,\n \nS\nI\n \n9\n0\n.\n9\n,\nN\nS\nH\ne\ni\ng\nh\nt\n \n(\nc\nm\n)\n:\n \nM\nI\n \n1\n7\n0\n,\n \nS\nI\n \n1\n6\n8\n,\n \nN\nS\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n7\n \n(\n4\n)\n,\n \nS\nI\n \n3\n0\n \n(\n9\n)\nA\nm\ne\nr\ni\nc\na\nn\n \nS\no\nc\ni\ne\nt\ny\n \no\nf\nA\nn\ne\ns\nt\nh\ne\ns\ni\no\nl\no\ng\ni\ns\nt\ns\n \n(\nA\nS\nA\n)\n \ns\nc\no\nr\ne\n(\n%\n)\n:\n \nM\nI\n \n2\n,\n \nS\nI\n \n2\n,\n \nN\nS\nM\nI\n:\n \nN\n=\n3\n2\n \n(\n3\n4\n \nh\ni\np\ns\n)\nS\nI\n:\n \nN\n=\n \n5\n1\n \n(\n5\n3\n \nh\ni\np\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n1\n0\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\nd\ni\nr\ne\nc\nt\n \nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\nC\no\nm\np\no\nn\ne\nn\nt\n \nf\ni\nx\na\nt\ni\no\nn\n:\n \n9\n7\n%\nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n,\n \n3\n%\n \nh\ny\nb\nr\ni\nd\n;\n \n2\n6\n%\na\nc\ne\nt\na\nb\nl\nu\nl\na\nr\n \ns\nc\nr\ne\nw\n \nf\ni\nx\na\nt\ni\no\nn\nS\nI\n:\n \n>\n1\n0\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\nd\ni\nr\ne\nc\nt\n \nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\nC\no\nm\np\no\nn\ne\nn\nt\n \nf\ni\nx\na\nt\ni\no\nn\n:\n \n8\n7\n%\nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n,\n \n1\n3\n%\n \nh\ny\nb\nr\ni\nd\n;\n1\n5\n%\n \na\nc\ne\nt\na\nb\nl\nu\nl\na\nr\n \ns\nc\nr\ne\nw\nf\ni\nx\na\nt\ni\no\nn\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \no\nn\ne\ns\nu\nr\ng\ne\no\nn\n.\n \nF\ne\na\ns\ni\nb\ni\nl\ni\nt\ny\n \ns\nt\nu\nd\ny\n \nf\no\nr\nR\nC\nT\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n3\n2\n,\n \n7\n4\n \n(\n1\n5\n)\n,\n \nS\nI\n \n5\n3\n,\n \n8\n0\n \n(\n1\n0\n)\n,\n \np\n=\n \n0\n.\n0\n4\n8\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\nM\nI\n \n2\n\/\n3\n4\n,\n \nS\nI\n \n1\n\/\n5\n3\n,\n \nN\nS\nC\no\nn\nv\ne\nr\ns\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n3\n4\n,\n \nS\nI\n \n0\n\/\n5\n3\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nE\na\nr\nl\ny\n \nd\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n3\n4\n,\n \nS\nI\n \n0\n\/\n5\n3\nI\nn\nf\ne\nc\nt\ni\no\nn\nI\nn\nf\ne\nc\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n3\n4\n,\n \nS\nI\n \n0\n\/\n5\n3\nW\no\nu\nn\nd\n \nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n3\n4\n,\n \nS\nI\n \n0\n\/\n5\n3\n \nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\nN\ne\nu\nr\no\nl\no\ng\ni\nc\na\nl\n \ni\nn\nj\nu\nr\ny\n:\n \nM\nI\n \n0\n\/\n3\n4\n,\n \nS\nI\n \n0\n\/\n5\n3\n \nD\nV\nT\n:\n \nM\nI\n \n0\n\/\n3\n4\n,\n \nS\nI\n \n3\n\/\n5\n3\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\n:\n \nM\nI\n \n5\n.\n4\n \n(\n2\n.\n1\n)\n,\n \nS\nI\n \n6\n.\n2\n(\n2\n.\n8\n)\n,\n \np\n=\n \n0\n.\n0\n1\n4\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n)\nF\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \nv\na\nr\nu\ns\n \n>\n5\n\u00b0\n:\n \nM\nI\n \n3\n%\n(\n1\n\/\n3\n4\n)\n,\n \nS\nI\n \n4\n%\n \n(\n2\n\/\n5\n3\n)\nF\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \nv\na\nl\ng\nu\ns\n \n>\n5\n\u00b0\n:\n \nM\nI\n \n0\n%\n(\n0\n\/\n3\n4\n)\n,\n \nS\nI\n \n2\n%\n \n(\n1\n\/\n5\n3\n)\nF\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \nn\ne\nu\nt\nr\na\nl\n \no\nr\n \nw\ni\nt\nh\ni\nn\n \n5\n\u00b0\nv\na\nr\nu\ns\n\/\nv\na\nl\ng\nu\ns\n:\n \nM\nI\n \n9\n7\n%\n,\n \nS\nI\n \n9\n4\n%\nN\nB\n:\n \no\nu\nt\nl\ni\ne\nr\ns\n \n=\n \n>\n5\n5\n\u00b0\na\nn\nd\n \n<\n3\n5\n\u00b0\nA\nb\nd\nu\nc\nt\ni\no\nn\n \na\nn\ng\nl\ne\n:\n \nM\nI\n \n4\n5\n\u00b0\n[\n3\n4\n\u2013\n5\n8\n]\n,\n \nS\nI\n \n4\n5\n\u00b0\n[\n2\n5\n\u2013\n6\n5\n]\n,\np\n=\n0\n.\n9\n3\n3\n \nO\nt\nh\ne\nr\n\u2022\nP\nE\n:\n \nM\nI\n \n1\n,\n \nS\nI\n \n0\n\u2022\nm\ny\no\nc\na\nr\nd\ni\na\nl\n \ni\nn\nf\na\nr\nc\nt\ni\no\nn\n:\n \nM\nI\n \n0\n,\n \nS\nI\n \n3\n\u2022\ng\na\ns\nt\nr\no\ni\nn\nt\ne\ns\nt\ni\nn\na\nl\n \nb\nl\ne\ne\nd\ni\nn\ng\n:\n \nM\nI\n \n0\n,\nS\nI\n1\n\u2022\nd\ni\ns\nc\nh\na\nr\ng\ne\nd\n \nh\no\nm\ne\n:\n \nM\nI\n \n9\n4\n%\n,\nS\nI\n7\n7\n%\n,\n \np\n=\n0\n.\n0\n3\n8\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n137\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nP\na\nn\ni\ns\ne\nl\nl\no\n,\n \n2\n0\n0\n6\n7\n4\n(\na\nb\ns\nt\nr\na\nc\nt\n \no\nn\nl\ny\n)\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\na\nt\ni\nv\ne\n \nc\no\nh\no\nr\nt\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nS\np\na\ni\nn\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\ns\nh\no\nr\nt\n-\nt\ne\nr\nm\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n8\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nN\nR\nM\nI\n:\n \nN\n=\n \n4\n0\nS\nI\n:\n \nN\n=\n \n4\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \ns\ni\nn\ng\nl\ne\n \nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\nC\ne\nm\ne\nn\nt\nl\ne\ns\ns\nS\nI\n:\n \nc\nl\na\ns\ns\ni\nc\n \na\np\np\nr\no\na\nc\nh\nC\ne\nm\ne\nn\nt\nl\ne\ns\ns\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n5\n.\n6\n,\n \nS\nI\n \n6\n.\n7\nP\ni\nl\no\nt\n,\n \n2\n0\n0\n6\n4\n8\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nc\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ny\n;\np\ni\nl\no\nt\n \ns\nt\nu\nd\ny\nL\no\nc\na\nt\ni\no\nn\n:\n \nT\nh\ne\nN\ne\nt\nh\ne\nr\nl\na\nn\nd\ns\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\no\nv\ne\nm\nb\ne\nr\n \n2\n0\n0\n4\n\u2013\nJ\na\nn\nu\na\nr\ny\n \n2\n0\n0\n5\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\nn\no\nn\ne\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nu\nn\ni\nl\na\nt\ne\nr\na\nl\n \nT\nH\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n2\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nA\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nN\nR\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n7\n.\n9\n,\n \nS\nI\n \n6\n7\n.\n5\n,\n \nN\nS\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n4\n\/\n6\n,\n \nS\nI\n \n2\n\/\n8\nH\ne\ni\ng\nh\nt\n \n(\nc\nm\n)\n:\n \nM\nI\n \n1\n6\n9\n,\n \nS\nI\n \n1\n6\n7\n,\n \nN\nS\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n9\n.\n1\n,\n \nS\nI\n \n2\n6\n.\n4\n,\np\n=\n0\n.\n0\n4\n8\nA\nm\ne\nr\ni\nc\na\nn\n \nS\no\nc\ni\ne\nt\ny\n \no\nf\nA\nn\ne\ns\nt\nh\ne\ns\ni\no\nl\no\ng\ni\ns\nt\ns\n \n(\nA\nS\nA\n)\n \ng\nr\na\nd\ni\nn\ng\n(\n1\n\/\n2\n\/\n3\n\/\n4\n)\n:\n \nM\nI\n \n4\n\/\n5\n\/\n1\n\/\n0\n,\n \nS\nI\n \n3\n\/\n7\n\/\n0\n\/\n0\nM\nI\n:\n \nN\n=\n \n1\n0\nS\nI\n:\n \nN\n=\n \n1\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n8\n.\n6\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\na\nn\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\nU\nn\nc\nl\ne\na\nr\n \nw\nh\ne\nt\nh\ne\nr\n \nc\ne\nm\ne\nn\nt\ne\nd\no\nr\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\nS\nI\n:\n \n1\n7\n.\n4\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\nU\nn\nc\nl\ne\na\nr\n \nw\nh\ne\nt\nh\ne\nr\n \nc\ne\nm\ne\nn\nt\ne\nd\no\nr\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n5\ns\nu\nr\ng\ne\no\nn\ns\n \ne\nx\np\ne\nr\ni\ne\nn\nc\ne\nd\n \ni\nn\nc\no\nn\nv\ne\nn\nt\ni\no\nn\na\nl\n \nT\nH\nR\n;\n \na\nl\nl\na\nt\nt\ne\nn\nd\ne\nd\n \na\n \nc\na\nd\na\nv\ne\nr\n \nc\no\nu\nr\ns\ne\n \no\nn\nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nT\nH\nR\n \n(\nl\ne\na\nr\nn\ni\nn\ng\nc\nu\nr\nv\ne\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n1\n0\n,\n \n9\n9\n.\n5\n,\n \nS\nI\n \n1\n0\n,\n \n8\n1\n.\n0\n,\n \np\n=\n \n0\n.\n0\n5\n6\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n1\n0\n,\n \n6\n9\n9\n,\n \nS\nI\n \n1\n0\n,\n \n5\n4\n0\n,\n \np\n=\n \n0\n.\n2\n8\n \nO\nt\nh\ne\nr\n\u2022\nm\nu\ns\nc\nl\ne\n \nd\na\nm\na\ng\ne\n \na\nn\nd\n \ni\nn\nf\nl\na\nm\nm\na\nt\ni\no\nn\n\u2022\nh\ne\na\nr\nt\n-\nt\ny\np\ne\n \nf\na\nt\nt\ny\n \na\nc\ni\nd\n \nb\ni\nn\nd\ni\nn\ng\np\nr\no\nt\ne\ni\nn\n \n(\nH\n-\nF\nA\nR\nB\n)\n\u2022\ni\nn\nt\ne\nr\nl\ne\nu\nk\ni\nn\n-\n6\n \n(\nI\nL\n-\n6\n)\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n138\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\ni\ns\no\nn\n \no\nf\nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \nc\no\nh\no\nr\nt\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nH\nu\nn\ng\na\nr\ny\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nJ\na\nn\nu\na\nr\ny\n \n2\n0\n0\n3\n\u2013\nD\ne\nc\ne\nm\nb\ne\nr\n \n2\n0\n0\n4\nF\nu\nn\nd\ni\nn\ng\n:\n \nn\no\nn\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n3\nm\no\nn\nt\nh\ns\n \nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \np\nr\ni\nm\na\nr\ny\n \nT\nH\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \ns\ne\nv\ne\nr\ne\n \nf\no\nr\nm\ns\n \no\nf\nc\no\nn\ng\ne\nn\ni\nt\na\nl\n \nd\ni\ns\nl\no\nc\na\nt\ni\no\nn\ns\n \no\nf\n \nt\nh\ne\n \nh\ni\np\nr\ne\nv\ni\ns\ni\no\nn\n \nT\nH\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n1\n0\n2\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nn\no\nn\ne\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n \n(\na\nl\nl\n \ng\nr\no\nu\np\ns\n)\n:\n \np\nr\ni\nm\na\nr\ny\no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n7\n6\n\/\n1\n0\n2\n;\n \ns\ne\nc\no\nn\nd\na\nr\ny\no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \n1\n7\n\/\n1\n0\n2\n;\n \na\ns\ne\np\nt\ni\nc\nn\ne\nc\nr\no\ns\ni\ns\n \no\nf\n \nt\nh\ne\n \nf\ne\nm\no\nr\na\nl\n \nh\ne\na\nd\n:\n6\n\/\n1\n0\n2\n;\n \np\no\ns\nt\n-\nt\nr\na\nu\nm\na\nt\ni\nc\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n3\n\/\n1\n0\n2\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n4\n \n(\n1\n2\n)\n \n[\n4\n4\n\u2013\n8\n8\n]\n,\nM\nD\n \n6\n2\n \n(\n1\n3\n)\n \n[\n3\n8\n\u2013\n8\n5\n]\n,\n \nS\nI\n \n5\n7\n \n(\n1\n3\n)\n[\n3\n0\n\u2013\n8\n0\n]\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\nI\n \n7\n0\n \n(\n1\n3\n.\n5\n)\n[\n4\n8\n\u2013\n1\n0\n2\n]\n,\n \nM\nD\n \n7\n8\n \n(\n1\n3\n)\n \n[\n6\n1\n\u2013\n1\n0\n4\n]\nS\nI\n7\n8\n \n(\n1\n9\n.\n5\n)\n \n[\n5\n0\n\u2013\n1\n1\n6\n]\n,\n \np\n=\n \n0\n.\n0\n0\n9\n(\nM\nI\n\u2013\nM\nD\n)\n,\n \np\n=\n \nN\nS\n \n(\nM\nD\n\u2013\nS\nI\n)\n,\np\n=\nN\nS\n \n(\nM\nI\n\u2013\nS\nI\n)\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n6\n \n(\n3\n.\n3\n)\n[\n2\n0\n\u2013\n3\n5\n.\n4\n]\n,\n \nM\nD\n \n2\n8\n \n(\n4\n.\n2\n)\n[\n1\n7\n.\n8\n\u2013\n3\n7\n.\n1\n]\n,\n \nS\nI\n \n2\n9\n.\n5\n \n(\n7\n)\n[\n2\n0\n.\n3\n\u2013\n4\n4\n.\n2\n]\n,\n \np\n=\n \n0\n.\n0\n2\n6\n \n(\nM\nI\n\u2013\nM\nD\n)\n,\np\n=\n \nN\nS\n \n(\nM\nD\n\u2013\nS\nI\n)\n,\n \np\n=\n \n0\n.\n0\n4\n8\n(\nM\nI\n\u2013\nS\nI\n)\nM\nI\n:\n \nN\n=\n \n3\n8\nM\nD\n:\n \nN\n=\n \n4\n3\nS\nI\n:\n \nN\n=\n \n2\n1\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n \n8\n.\n8\n \n(\n0\n.\n9\n8\n)\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \nd\ni\nr\ne\nc\nt\n \nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\n2\n4\n \nc\ne\nm\ne\nn\nt\ne\nd\n,\n1\n4\nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\nM\nD\n:\n \n1\n2\n.\n6\n \n(\n1\n.\n2\n1\n)\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \nd\ni\nr\ne\nc\nt\n \nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\n2\n5\n \nc\ne\nm\ne\nn\nt\ne\nd\n,\n1\n8\nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\nS\nI\n:\n \n1\n6\n.\n1\n \n(\n1\n.\n8\n8\n)\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \nd\ni\nr\ne\nc\nt\n \nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\n1\n1\n \nc\ne\nm\ne\nn\nt\ne\nd\n,\n1\n0\nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \nt\nh\ne\ns\ne\nn\ni\no\nr\n \na\nu\nt\nh\no\nr\n;\n \nf\ne\nm\no\nr\na\nl\n \ns\nh\na\nf\nt\n,\nb\ne\nn\nt\n \nH\no\nh\nm\na\nn\n \nr\ne\nt\nr\na\nc\nt\no\nr\ns\n \na\nn\nd\ns\np\ni\nk\ne\n \nr\ne\nt\nr\na\nc\nt\no\nr\n \na\nr\ne\n \nu\ns\ne\nd\n.\n \nN\no\nf\nl\nu\no\nr\no\ns\nc\no\np\ne\nT\nH\nR\n \na\nl\nw\na\ny\ns\n \ns\nt\na\nr\nt\ns\n \na\ns\n \na\n \ns\nh\no\nr\nt\ni\nn\nc\ni\ns\ni\no\nn\n \n(\n<\n1\n0\nc\nm\n)\n \na\nn\nd\n \nt\nh\ne\nn\ne\nx\nt\ne\nn\nd\ne\nd\n \na\ns\n \nn\ne\nc\ne\ns\ns\na\nr\ny\n \nd\nu\nr\ni\nn\ng\ns\nu\nr\ng\ne\nr\ny\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n3\n8\n,\n \n8\n4\n \n(\n1\n6\n)\n \n[\n5\n0\n\u2013\n1\n2\n0\n]\n,\n \nM\nD\n \n4\n3\n,\n \n9\n3\n \n(\n1\n8\n)\n[\n6\n0\n\u2013\n1\n3\n0\n]\n,\nS\nI\n \n2\n1\n,\n \n1\n0\n2\n \n(\n1\n2\n)\n \n[\n8\n0\n\u2013\n1\n2\n0\n]\n,\n \np\n=\n \n0\n.\n0\n2\n0\n \n(\nM\nI\n\u2013\nM\nD\n)\n,\np\n=\n0\n.\n0\n2\n8\n \n(\nM\nD\n\u2013\nS\nI\n)\n,\n \np\n<\n \n0\n.\n0\n0\n1\n \n(\nM\nI\n\u2013\nS\nI\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n3\n8\n,\n \n2\n4\n4\n \n(\n1\n0\n0\n)\n \n[\n1\n0\n0\n\u2013\n5\n5\n0\n]\n,\n \nM\nD\n \n4\n3\n,\n \n2\n6\n5\n \n(\n1\n1\n4\n)\n[\n7\n0\n\u2013\n6\n0\n0\n]\n,\n \nS\nI\n \n2\n1\n,\n \n3\n0\n4\n \n(\n1\n3\n6\n)\n \n[\n1\n5\n0\n\u2013\n6\n0\n0\n]\n,\n \np\n=\n \n0\n.\n3\n9\n9\n(\nM\nI\n\u2013\nM\nD\n)\n,\n \np\n=\n \n0\n.\n2\n7\n8\n \n(\nM\nD\n\u2013\nS\nI\n)\n,\n \np\n=\n \n0\n.\n0\n9\n8\n \n(\nM\nI\n\u2013\nS\nI\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\n \n(\nf\ne\nm\no\nr\na\nl\n \ns\nh\na\nf\nt\n)\n:\n \nM\nI\n \n0\n\/\n3\n8\n,\nM\nD\n \n0\n\/\n4\n3\n,\n \nS\nI\n \n0\n\/\n2\n1\nC\no\nn\nv\ne\nr\ns\ni\no\nn\nM\nI\n \n0\n\/\n3\n8\n,\n \nM\nD\n \n4\n3\n\/\n4\n3\n,\n \nS\nI\n \n2\n1\n\/\n2\n1\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n3\n8\n,\n \nM\nD\n \n0\n\/\n4\n3\n,\n \nS\nI\n \n0\n\/\n2\n1\nI\nn\nf\ne\nc\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n3\n8\n,\n \nM\nD\n \n0\n\/\n4\n3\n,\n \nS\nI\n \n0\n\/\n2\n1\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\nC\no\nm\np\nl\ne\nt\ne\n \ns\nc\ni\na\nt\ni\nc\n \nn\ne\nr\nv\ne\n \np\na\nl\ns\ny\n:\n \nM\nI\n \n0\n\/\n3\n8\n,\n \nM\nD\n \n0\n\/\n4\n3\n,\n \nS\nI\n0\n\/\n2\n1\nT\nr\na\nn\ns\ni\ne\nn\nt\n \nf\ne\nm\no\nr\na\nl\n \nn\ne\nr\nv\ne\n \np\na\nl\ns\ny\n:\n \nM\nI\n \n2\n\/\n3\n8\n,\n \nM\nD\n \n3\n\/\n4\n3\n,\nS\nI\n0\n\/\n2\n1\nD\nV\nT\n:\n \nM\nI\n \n2\n\/\n3\n8\n,\n \nM\nD\n \n3\n\/\n4\n3\n,\n \nS\nI\n \n2\n\/\n2\n1\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n \n(\nb\ny\n \nt\nh\ne\n \ni\nn\nd\ni\nv\ni\nd\nu\na\nl\n \nv\ni\ns\nu\na\nl\n \na\nn\na\nl\no\ng\nu\ne\ns\nc\na\nl\ne\n \na\nt\n \nd\na\ny\n \n3\n)\n:\n \nM\nI\n \n3\n8\n,\n \n1\n.\n5\n \n(\n1\n.\n1\n5\n)\n \n[\n0\n\u2013\n5\n]\n,\n \nM\nD\n \n4\n3\n,\n2\n.\n1\n5\n \n(\n1\n.\n2\n)\n \n[\n0\n\u2013\n4\n]\n,\n \nS\nI\n \n2\n1\n,\n \n2\n.\n1\n \n(\n1\n.\n3\n)\n \n[\n0\n\u2013\n4\n]\n,\n \np\n=\n \n0\n.\n0\n2\n8\n \n(\nM\nI\n\u2013\nM\nD\n)\n,\n \np\n=\n \n0\n.\n8\n7\n6\n \n(\nM\nD\n\u2013\nS\nI\n)\n,\np\n=\n0\n.\n1\n1\n2\n \n(\nM\nI\n\u2013\nS\nI\n)\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\na\nn\na\nl\ny\ns\ni\ns\n)\nC\nu\np\n:\n \n%\n \nh\ni\np\ns\n \nw\ni\nt\nh\ni\nn\n \nn\no\nr\nm\na\nl\n \nr\na\nn\ng\ne\n \n(\n3\n5\n\u00b0\n\u2013\n5\n0\n\u00b0\n)\n:\n \nM\nI\n \n8\n9\n%\n \n(\n3\n4\n\/\n3\n8\n)\n,\n \nM\nD\n \n9\n5\n%\n \n(\n4\n1\n\/\n4\n3\n)\n,\n \nS\nI\n \n8\n5\n%\n \n(\n1\n8\n\/\n2\n1\n)\n,\np\n=\n \n0\n.\n3\n4\n8\n \n(\nM\nI\n\u2013\nS\nI\n)\n,\n \np\n=\n \n0\n.\n2\n0\n9\n \n(\nM\nD\n\u2013\nS\nI\n)\n,\n \np\n=\n \n0\n.\n6\n8\n6\n(\nM\nI\n\u2013\nS\nI\n)\n \nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\n:\n \n\u201c\nd\ne\np\ne\nn\nd\ne\nd\n \nm\no\nr\ne\no\nn\n \nt\nh\ne\n \ng\ne\nn\ne\nr\na\nl\n \nc\no\nn\nd\ni\nt\ni\no\nn\n,\n \na\ng\ne\n,\nc\no\ne\nx\ni\ns\nt\ne\nn\nt\n \nd\ni\ns\ne\na\ns\ne\ns\n \no\nf\n \nt\nh\ne\n \np\na\nt\ni\ne\nn\nt\nr\na\nt\nh\ne\nr\n \nt\nh\na\nn\n \nt\nh\ne\n \nl\ne\nn\ng\nt\nh\n \no\nf\n \ni\nn\nc\ni\ns\ni\no\nn\n\u201d\n \nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \nM\nI\n \n0\n\/\n3\n8\n,\n \nM\nD\n \n0\n\/\n4\n3\n,\nS\nI\n0\n\/\n2\n1\nP\na\nt\ni\ne\nn\nt\n \ns\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n:\n \nM\nI\n \nh\ni\ng\nh\ne\ns\nt\n,\nM\nD\nh\ni\ng\nh\n,\n \nS\nI\n \nh\ni\ng\nh\n \n(\no\nv\ne\nr\n \n9\n0\n%\n \ni\nn\n \na\nl\nl\ng\nr\no\nu\np\ns\n)\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\no\nu\nt\nc\no\nm\ne\ns\nC\ne\nm\ne\nn\nt\n \nq\nu\na\nl\ni\nt\ny\n \n\u201c\np\no\no\nr\n\u201d\n:\n \nM\nI\n \n0\n\/\n2\n4\n,\nM\nD\n \n0\n\/\n2\n5\n,\n \nS\nI\n \n0\n\/\n1\n1\n \n(\nc\ne\nm\ne\nn\nt\ne\nd\np\nr\no\ns\nt\nh\ne\ns\ni\ns\n \no\nn\nl\ny\n)\nO\nt\nh\ne\nr\n\u2022\nt\no\nt\na\nl\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n:\n \nM\nI\n \n7\n4\n4\n \n(\n2\n6\n0\n)\n,\nM\nD\n \n7\n0\n8\n \n(\n2\n2\n1\n)\n,\n \nS\nI\n \n7\n7\n1\n \n(\n2\n3\n5\n)\n;\n \nl\ne\ns\ns\nb\nl\no\no\nd\n \nl\no\ns\ns\n \nf\no\nr\n \nc\ne\nm\ne\nn\nt\ne\nd\n \n(\nn\n=\n6\n0\n,\n6\n4\n2\n \nm\nl\n)\n \nv\ns\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \n(\nn\n=\n \n4\n2\n,\n8\n6\n8\n \nm\nl\n)\n \np\nr\no\ns\nt\nh\ne\ns\ne\ns\n \n(\np\n=\n \n0\n.\n0\n1\n1\n)\n\u2022\np\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n:\n \nM\nI\n \n7\n.\n8\n \n(\n1\n.\n3\n)\n[\n5\n\u2013\n1\n0\n]\n,\n \nM\nD\n \n7\n.\n9\n \n(\n1\n.\n3\n)\n \n[\n5\n\u2013\n1\n0\n]\n,\nS\nI\n8\n.\n5\n \n(\n1\n.\n4\n)\n \n[\n5\n\u2013\n1\n0\n]\n;\n \nd\nr\no\np\n \ni\nn\n \np\na\ni\nn\nf\nr\no\nm\n \nt\nh\ne\n \np\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\n \nt\no\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nl\ne\nv\ne\nl\n \nh\ni\ng\nh\ne\nr\n \ni\nn\n \nM\nI\ng\nr\no\nu\np\n \n(\np\n=\n \n0\n.\n0\n2\n8\n)\n\u2022\nl\no\no\ns\ne\n \na\nn\nd\n \nu\nn\ns\nt\na\nb\nl\ne\n \nc\no\nm\np\no\nn\ne\nn\nt\n:\nM\nI\n \n0\n\/\n3\n8\n,\n \nM\nD\n \n0\n\/\n4\n3\n,\n \nS\nI\n \n0\n\/\n2\n1\n\u2022\ns\nw\ne\nl\nl\ni\nn\ng\n \na\nr\no\nu\nn\nd\n \nt\nh\ne\n \nw\no\nu\nn\nd\n:\nM\nI\ns\no\nm\ne\n,\n \nM\nD\n \n0\n\/\n4\n3\n,\n \nS\nI\n \n0\n\/\n2\n1\n\u2022\nw\no\nu\nn\nd\n \nn\ne\nc\nr\no\ns\ni\ns\n:\n \nM\nI\n \n0\n\/\n3\n8\n,\nM\nD\n0\n\/\n4\n3\n,\n \nS\nI\n \n0\n\/\n2\n1\n \nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n139\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nC\nu\np\n:\n \n%\n \no\nf\n \nc\no\nm\np\no\nn\ne\nn\nt\ns\n \nt\nh\na\nt\n \nw\ne\nr\ne\n \no\nu\nt\nl\ni\ne\nr\ns\n:\nM\nI\n8\n.\n2\n5\n%\n \n(\n<\n3\n5\n\u00b0\n)\n,\n \n2\n.\n7\n5\n%\n \n(\n>\n5\n0\n\u00b0\n)\n,\n \nM\nD\n \n5\n%\n \n(\n>\n5\n0\n\u00b0\n)\n,\nS\nI\n \n5\n%\n \n(\n<\n3\n5\n\u00b0\n)\n,\n \n>\n5\n0\n\u00b0\n(\n1\n0\n%\n)\nC\nu\np\n \ni\nn\nc\nl\ni\nn\na\nt\ni\no\nn\n:\n \nM\nI\n \n4\n4\n.\n2\n\u00b0\n(\n5\n.\n3\n)\n,\n \nM\nD\n \n4\n4\n.\n8\n\u00b0\n(\n3\n.\n5\n)\n,\nS\nI\n4\n4\n.\n8\n\u00b0\nS\nt\ne\nm\n \na\nl\ni\ng\nn\nm\ne\nn\nt\n \n(\nn\no\nr\nm\na\nl\n \nr\na\nn\ng\ne\n \n\u00b1\n5\n\u00b0\nt\no\n \nt\nh\ne\n \nv\ne\nn\nt\nr\na\nl\na\nx\ni\ns\n \no\nf\n \nt\nh\ne\n \nf\ne\nm\nu\nr\n)\n:\n \nM\nI\n \n8\n%\n \n(\n2\n\/\n3\n8\n)\n \nv\na\nr\nu\ns\n,\n \n9\n2\n%\n \nn\no\nr\nm\na\nl\n,\n \nM\nD\n \n5\n%\n \n(\n2\n\/\n4\n3\n)\nv\na\nr\ng\nu\ns\n,\n \n9\n5\n%\n \nn\no\nr\nm\na\nl\n,\n \nS\nI\n \n5\n%\n \n(\n1\n\/\n2\n1\n)\n \nv\na\nr\nu\ns\n,\n \n9\n5\n%\nn\no\nr\nm\na\nl\n,\n \np\n=\n \n0\n.\n5\n6\n8\n \n(\nM\nI\n\u2013\nS\nI\n)\n,\n \np\n=\n \n0\n.\n9\n6\n9\n \n(\nM\nD\n\u2013\nS\nI\n)\n,\np\n=\n0\n.\n6\n8\n2\n \n(\nM\nI\n\u2013\nS\nI\n)\nT\na\nk\na\nh\ni\nr\na\n,\n \n2\n0\n0\n6\n7\n8\n(\na\nb\ns\nt\nr\na\nc\nt\n \no\nn\nl\ny\n)\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\na\nt\ni\nv\ne\n \nc\no\nh\no\nr\nt\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nJ\na\np\na\nn\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nM\na\ny\n \n2\n0\n0\n3\n\u2013\nJ\na\nn\nu\na\nr\ny\n \n2\n0\n0\n4\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \nN\nR\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\nw\ni\nt\nh\no\nu\nt\n \nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\ns\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n3\n\/\n7\n,\n \nS\nI\n \n1\n\/\n9\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\nI\n \n6\n6\n.\n4\n[\n5\n5\n\u2013\n7\n6\n]\n,\n \nS\nI\n \n6\n3\n.\n1\n \n[\n5\n6\n\u2013\n7\n5\n]\nM\nI\n:\n \nN\n=\n \n1\n0\nS\nI\n:\n \nN\n=\n \n1\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n7\n.\n5\n \n[\n6\n\u2013\n9\n]\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n \na\np\np\nr\no\na\nc\nh\nC\ne\nm\ne\nn\nt\nl\ne\ns\ns\nS\nI\n:\n \n1\n3\n.\n8\n \n[\n1\n1\n\u2013\n1\n7\n]\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \nc\no\nn\nv\ne\nn\nt\ni\no\nn\na\nl\na\np\np\nr\no\na\nc\nh\nC\ne\nm\ne\nn\nt\nl\ne\ns\ns\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n1\n2\n6\n.\n5\n,\n \nS\nI\n \n1\n1\n9\n.\n9\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\nM\nI\n \n1\n\/\n1\n0\n,\n \nS\nI\n \n0\n\/\n1\n0\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n \n(\nf\ne\nm\no\nr\na\nl\n \nn\ne\nr\nv\ne\n \np\na\nl\ns\ny\n)\n:\n \nM\nI\n \n1\n\/\n1\n0\n,\n \nS\nI\n \n0\n\/\n1\n0\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n2\n2\n,\n \nS\nI\n \n2\n3\n.\n4\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nJ\nO\nA\n \n(\nJ\na\np\na\nn\ne\ns\ne\n \nO\nr\nt\nh\no\np\na\ne\nd\ni\nc\nA\ns\ns\no\nc\ni\na\nt\ni\no\nn\n)\n \ns\nc\no\nr\ne\n \na\nt\n \nd\ni\ns\nc\nh\na\nr\ng\ne\n:\nM\nI\n7\n9\n.\n5\n,\n \nS\nI\n \n7\n9\n.\n4\n,\n \nN\nS\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\no\nu\nt\nc\no\nm\ne\ns\nH\ne\nt\ne\nr\no\nt\no\np\ni\nc\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n1\n0\n,\nS\nI\n1\n\/\n1\n0\nO\nt\nh\ne\nr\n\u2022\n \nt\no\nt\na\nl\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\n:\n \nM\nI\n \n7\n9\n6\n,\nS\nI\n7\n7\n2\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n140\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nT\ne\ne\nt\n,\n \n2\n0\n0\n6\n5\n4\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nr\ne\nt\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ny\n \no\nf\nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \np\na\nt\ni\ne\nn\nt\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\n1\n9\n9\n9\n\u2013\n2\n0\n0\n3\nF\nu\nn\nd\ni\nn\ng\n:\n \nn\no\nn\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n1\n.\n5\ny\ne\na\nr\ns\n \n[\n6\n \nw\ne\ne\nk\ns\nt\no\n \n4\n.\n5\n \ny\ne\na\nr\ns\n]\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \np\nr\ni\nm\na\nr\ny\n \nT\nH\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \np\na\nt\ni\ne\nn\nt\ns\n \nw\ni\nt\nh\nl\ne\ns\ns\n \nt\nh\na\nn\n \n6\n-\nw\ne\ne\nk\n \nF\nU\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n1\n2\n7\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nN\nR\nM\nI\n:\n \nN\n=\n \n7\n3\nS\nI\n:\n \nN\n=\n \n5\n4\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n\u0001\n1\n2\n \nc\nm\n \n(\na\np\np\nr\no\nx\n.\n \n1\n0\n \nc\nm\n)\n \n7\n3\n\/\n7\n3\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n,\n \n3\n9\n\/\n7\n3\n \nc\ne\nm\ne\nn\nt\ne\nd\n,\n \n3\n4\n\/\n7\n3\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\nS\nI\n:\n \n>\n1\n2\n \nc\nm\n \n(\na\np\np\nr\no\nx\n.\n1\n7\n\u2013\n2\n2\nc\nm\n)\n5\n4\n\/\n5\n4\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n,\n \n3\n1\n\/\n5\n4\n \nc\ne\nm\ne\nn\nt\ne\nd\n,\n \n2\n3\n\/\n5\n4\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \nb\ny\n \no\nn\ne\n \ns\nu\nr\ng\ne\no\nn\n \nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n1\n\/\n7\n3\n,\n \nS\nI\n \n4\n\/\n5\n4\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n \na\nt\n \nt\nh\ne\n \nm\no\ns\nt\nr\ne\nc\ne\nn\nt\n \nF\nU\n;\n \nm\ni\nn\ni\nm\nu\nm\n \n6\n \nw\ne\ne\nk\ns\n)\nF\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n>\n2\n\u00b0\nv\na\nr\nu\ns\n:\n \nM\nI\n \n3\n0\n.\n5\n%\n \n(\n4\n\/\n7\n3\n)\n,\nS\nI\n \n7\n.\n4\n%\n \n(\n4\n\/\n5\n4\n)\n,\n \np\n=\n \n0\n.\n0\n0\n0\n9\nF\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \ni\nn\n \nn\ne\nu\nt\nr\na\nl\n \np\no\ns\ni\nt\ni\no\nn\n:\n \nM\nI\n \n2\n1\n.\n9\n%\n,\nS\nI\n \n2\n5\n.\n9\n%\n,\n \nN\nS\nA\nc\ne\nt\na\nb\nl\nu\nl\na\nr\n \na\nn\ng\nl\ne\n \no\nf\n \na\nb\nd\nu\nc\nt\ni\no\nn\n:\n \nM\nI\n \n4\n0\n.\n8\n\u00b0\n(\n7\n.\n3\n)\n,\nS\nI\n4\n1\n.\n6\n6\n\u00b0\n(\n7\n.\n2\n5\n)\n,\n \np\n=\n \n0\n.\n5\n1\nA\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n \na\nn\ng\nl\ne\n \no\nf\n \nt\nh\ne\n \nc\nu\np\n:\n \nM\nI\n \n1\n2\n.\n2\n9\n\u00b0\n(\n7\n.\n0\n3\n)\n,\nS\nI\n1\n6\n.\n2\n1\n\u00b0\n(\n7\n.\n0\n1\n)\n,\n \np\n=\n \n0\n.\n0\n0\n1\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\no\nu\nt\nc\no\nm\ne\ns\nH\ne\nt\ne\nr\no\nt\no\np\ni\nc\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n:\n \n\u201c\nn\no\nh\ne\nt\ne\nr\no\nt\no\np\ni\nc\n \nb\no\nn\ne\n \ni\nn\n \n2\n\/\n3\n \no\nf\n \nb\no\nt\nh\ng\nr\no\nu\np\ns\n\u201d\nC\ne\nm\ne\nn\nt\n \nq\nu\na\nl\ni\nt\ny\n \n(\nB\na\nr\nr\na\nc\nk\n \nc\ne\nm\ne\nn\nt\ng\nr\na\nd\ni\nn\ng\n \no\nf\n \nt\nh\ne\n \nc\ne\nm\ne\nn\nt\ne\nd\n \nf\ne\nm\no\nr\na\nl\ns\nt\ne\nm\ns\n,\n \nm\na\nx\n.\n \np\no\ni\nn\nt\ns\n \n7\n)\n:\n \nM\nI\n \n1\n.\n7\n2\n(\n0\n.\n6\n5\n)\n,\n \nS\nI\n \n1\n.\n6\n3\n \n(\n0\n.\n7\n2\n)\n,\n \nN\nS\nO\nt\nh\ne\nr\n\u2022\nf\na\ni\nl\nu\nr\ne\n \no\nf\n \ni\nn\ng\nr\no\nw\nt\nh\n \n(\nr\na\nd\ni\no\nl\nu\nc\ne\nn\nc\ny\n)\n\u2013\n \nf\no\nr\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \nc\no\nm\np\no\nn\ne\nn\nt\ns\n\u2022\nf\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \ni\nn\ng\nr\no\nw\nt\nh\n(\nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n)\n\/\nc\ne\nm\ne\nn\nt\n \nt\ne\nc\nh\nn\ni\nq\nu\ne\n(\nc\ne\nm\ne\nn\nt\ne\nd\n \nc\no\nm\np\no\nn\ne\nn\nt\ns\n \no\nn\nl\ny\n;\ng\no\no\nd\n \ni\nn\n \nb\no\nt\nh\n \ng\nr\no\nu\np\ns\n)\n\u2022\ns\nu\nb\ng\nr\no\nu\np\n \na\nn\na\nl\ny\ns\ni\ns\n:\n \nc\ne\nm\ne\nn\nt\ne\nd\n \nv\ns\nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\nW\no\no\nl\ns\no\nn\n,\n \n2\n0\n0\n4\n5\n5\n,\n6\n7\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nr\ne\nt\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\ni\ns\no\nn\n \no\nf\nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \np\na\nt\ni\ne\nn\nt\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nS\ne\np\nt\ne\nm\nb\ne\nr\n2\n0\n0\n1\n\u2013\nM\na\nr\nc\nh\n \n2\n0\n0\n3\nF\nu\nn\nd\ni\nn\ng\n:\n \nn\no\nn\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\nW\no\no\nl\ns\no\nn\n,\n \n2\n0\n0\n4\n(\nN\n=\n1\n3\n5\n)\n:\n \nm\ni\nn\ni\nm\nu\nm\n6\n \nm\no\nn\nt\nh\ns\n;\n \nM\no\nw\n,\n2\n0\n0\n5\n \n(\nN\n=\n \n3\n2\n)\n:\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \np\nr\ni\nm\na\nr\ny\nu\nn\ni\nl\na\nt\ne\nr\na\nl\n \nT\nH\nR\n;\n \nM\nI\n \ng\nr\no\nu\np\n \ns\ne\nl\ne\nc\nt\ne\nd\np\nr\ni\nm\na\nr\ni\nl\ny\n \nb\na\ns\ne\nd\n \no\nn\n \nb\no\nd\ny\n \nh\na\nb\ni\nt\nu\ns\n,\ne\n.\ng\n.\n \nl\no\nw\ne\nr\n \nB\nM\nI\n \nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n1\n3\n5\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \nM\nI\n \n4\n3\n,\nS\nI\n6\n6\n;\n \no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n \nM\nI\n \n2\n,\n \nS\nI\n \n8\n;\nc\no\nn\ng\ne\nn\ni\nt\na\nl\n \nd\ny\ns\np\nl\na\ns\ni\na\n \nM\nI\n \n2\n,\n \nS\nI\n \n6\n;\no\nt\nh\ne\nr\n \nM\nI\n \n3\n,\n \nS\nI\n \n5\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n0\n \n[\n2\n0\n\u2013\n8\n1\n]\n,\n \nS\nI\n \n6\n3\n[\n3\n5\n\u2013\n9\n1\n]\n,\n \nN\nS\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n2\n9\n\/\n2\n1\n,\n \nS\nI\n \n3\n1\n\/\n5\n4\n,\np\n=\n0\n.\n0\n1\nM\nI\n:\n \nN\n=\n \n5\n0\nS\nI\n:\n \nN\n=\n \n8\n5\nM\no\nw\n,\n \n2\n0\n0\n5\n:\n6\n7\nM\nI\n \nN\n=\n \n1\n9\n(\n2\n0\nh\ni\np\ns\n)\n,\n \nS\nI\n \nN\n=\n \n1\n3\n \n(\n1\n4\n \nh\ni\np\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n\u0001\n1\n0\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\n4\n8\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n,\n \n2\n \nh\ny\nb\nr\ni\nd\n(\nc\ne\nm\ne\nn\nt\ne\nd\n \nf\ne\nm\no\nr\na\nl\nc\no\nm\np\no\nn\ne\nn\nt\n \n+\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n)\nS\nI\n:\n \n1\n5\n\u2013\n2\n5\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\n6\n4\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n,\n \n2\n1\n \nh\ny\nb\nr\ni\nd\n(\nc\ne\nm\ne\nn\nt\ne\nd\n \nf\ne\nm\no\nr\na\nl\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n5\n0\n,\n \n9\n7\n,\n \nS\nI\n \n8\n5\n,\n \n1\n0\n5\n,\n \np\n=\n \n0\n.\n1\n3\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n5\n0\n,\n \n6\n0\n3\n,\n \nS\nI\n \n8\n5\n,\n \n5\n0\n7\n,\n \np\n=\n \n0\n.\n1\n2\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\nM\nI\n \n2\n\/\n5\n0\n,\n \nS\nI\n \n0\n\/\n8\n5\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n5\n0\n,\n \nS\nI\n \n1\n\/\n8\n5\nI\nn\nf\ne\nc\nt\ni\no\nn\nS\nu\np\ne\nr\nf\ni\nc\ni\na\nl\n \nw\no\nu\nn\nd\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n:\n \nM\nI\n \n1\n\/\n5\n0\n,\n \nS\nI\n \n0\n\/\n8\n5\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\nP\na\nr\nt\ni\na\nl\n \np\ne\nr\no\nn\ne\na\nl\n \nn\ne\nr\nv\ne\n \np\na\nl\ns\ny\n:\n \nM\nI\n \n0\n\/\n5\n0\n,\n \nS\nI\n \n1\n\/\n8\n5\nC\no\nm\np\nl\ne\nt\ne\n \ns\nc\ni\na\nt\ni\nc\n \nn\ne\nr\nv\ne\n \np\na\nl\ns\ny\n:\n \nM\nI\n:\n \n1\n\/\n5\n0\n,\n \nS\nI\n:\n \n0\n\/\n8\n5\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \ns\ne\ne\n \nM\no\nw\n,\n \n2\n0\n0\n5\n,\nb\ne\nl\no\nw\nL\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ni\nn\ne\nq\nu\na\nl\ni\nt\ny\n \n(\nm\nm\n)\n:\n \nM\nI\n5\n0\n,\n0\n.\n6\n \n(\n5\n)\n,\n \nS\nI\n \n8\n5\n,\n \n\u2013\n0\n.\n2\n \n(\n6\n)\n,\n \np\n=\n \n0\n.\n4\n2\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\no\nu\nt\nc\no\nm\ne\ns\nC\ne\nm\ne\nn\nt\n \nq\nu\na\nl\ni\nt\ny\n \n(\nC\n2\n \no\nr\n \nD\n)\n:\n \nM\nI\n \n0\n\/\n1\n2\n,\nS\nI\n \n0\n\/\n2\n1\nP\na\nt\ni\ne\nn\nt\n \ns\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n:\n \ns\ne\ne\n \nM\no\nw\n,\n \n2\n0\n0\n5\n,\nb\ne\nl\no\nw\nO\nt\nh\ne\nr\n\u2022\nN\no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n \nd\ni\ns\nc\nh\na\nr\ng\ne\nd\n \nh\no\nm\ne\n\/\nN\nd\ni\ns\nc\nh\na\nr\ng\ne\nd\n \nt\no\n \na\n \ns\nk\ni\nl\nl\ne\nd\n \nn\nu\nr\ns\ni\nn\ng\n \no\nr\nr\ne\nh\na\nb\ni\nl\ni\nt\na\nt\ni\no\nn\n \nf\na\nc\ni\nl\ni\nt\ny\n:\n \nM\nI\n \n2\n4\n\/\n2\n6\n,\nS\nI\n3\n0\n\/\n5\n5\n,\n \np\n=\n \n0\n.\n1\n5\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n141\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nm\ni\nn\ni\nm\nu\nm\n1\n7\nm\no\nn\nt\nh\ns\n;\n \na\nv\ne\nr\na\ng\ne\n2\n3\n \nm\no\nn\nt\nh\ns\n \n(\nM\nI\n)\n,\n2\n5\nm\no\nn\nt\nh\ns\n \n(\nS\nI\n)\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\nI\n \n7\n8\n \n[\n5\n3\n\u2013\n1\n1\n3\n]\n,\nS\nI\n \n8\n2\n \n[\n4\n4\n\u2013\n1\n4\n0\n]\n,\n \nN\nS\nH\ne\ni\ng\nh\nt\n \n(\nc\nm\n)\n:\n \nM\nI\n \n1\n7\n4\n,\n \nS\nI\n \n1\n7\n0\n,\np\n=\n0\n.\n0\n1\n9\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n5\n.\n1\n,\n \nS\nI\n \n2\n8\n.\n2\n,\n \np\n=\n \n0\n.\n0\n0\n8\nN\no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n \nw\nh\no\n \nw\ne\nr\ne\n \no\nb\ne\ns\ne\n(\nB\nM\nI\n \n\u0005\n3\n0\n)\n:\n \nM\nI\n \n3\n\/\n5\n0\n,\n \nS\nI\n \n3\n0\n\/\n8\n5\n,\n \np\n=\n \n0\n.\n0\n0\n0\n1\nO\nt\nh\ne\nr\n:\n \nA\nm\ne\nr\ni\nc\na\nn\n \nS\no\nc\ni\ne\nt\ny\n \no\nf\nA\nn\ne\ns\nt\nh\ne\ns\ni\no\nl\no\ng\ni\ns\nt\ns\n \n(\nA\nS\nA\n)\n \ns\nc\no\nr\ne\n:\nM\nI\n1\n.\n7\n6\n,\n \nS\nI\n \n2\n.\n1\n4\n,\n \np\n=\n \n0\n.\n0\n0\n6\nN\no\nf\n \nh\ni\np\ns\n \ni\nn\n \nA\nS\nA\n \nc\nl\na\ns\ns\ne\ns\n \n3\n \na\nn\nd\n \n4\n:\nM\nI\n \n4\n\/\n5\n0\n,\n \nS\nI\n \n2\n1\n\/\n8\n5\n,\n \np\n=\n \n0\n.\n0\n1\n6\nN\no\nf\n \np\nr\no\nc\ne\nd\nu\nr\ne\ns\n \nd\no\nn\ne\n \nw\ni\nt\nh\nr\ne\ng\ni\no\nn\na\nl\n \na\nn\na\ne\ns\nt\nh\ne\ns\ni\na\n\/\nN\nw\ni\nt\nh\ng\ne\nn\ne\nr\na\nl\n \na\nn\na\ne\ns\nt\nh\ne\ns\ni\na\n:\n \nM\nI\n \n4\n5\n\/\n5\n,\nS\nI\n6\n5\n\/\n2\n0\nc\no\nm\np\no\nn\ne\nn\nt\n \n+\n \nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n)\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \n3\nf\ne\nl\nl\no\nw\ns\nh\ni\np\n \nt\nr\na\ni\nn\ne\nd\n \ns\nu\nr\ng\ne\no\nn\ns\n;\nM\nI\n \ns\nu\nr\ng\ne\nr\ni\ne\ns\n \nr\ne\np\nr\ne\ns\ne\nn\nt\n \nt\nh\ne\ni\nn\ni\nt\ni\na\nl\n \ne\nx\np\ne\nr\ni\ne\nn\nc\ne\n \no\nf\n \nt\nh\ne\ns\ne\ns\nu\nr\ng\ne\no\nn\ns\n \nw\ni\nt\nh\n \nt\nh\ni\ns\n \nt\ne\nc\nh\nn\ni\nq\nu\ne\n;\nM\nI\n \ns\nu\nr\ng\ne\nr\ni\ne\ns\n \nd\no\nn\ne\n \nw\ni\nt\nh\ns\np\ne\nc\ni\na\nl\ni\ns\ne\nd\n \nr\ne\nt\nr\na\nc\nt\no\nr\ns\n;\n \nl\ne\nn\ng\nt\nh\no\nf\n \ni\nn\nc\ni\ns\ni\no\nn\n \nm\ne\na\ns\nu\nr\ne\nd\n \nb\ne\nf\no\nr\ne\nt\nh\ne\n \no\np\ne\nr\na\nt\ni\no\nn\n \nb\ne\ng\na\nn\nD\nV\nT\n:\n \nM\nI\n \n1\n\/\n5\n0\n,\n \nS\nI\n \n2\n\/\n8\n5\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n5\n0\n,\n \n4\n.\n3\n,\n \nS\nI\n \n8\n5\n,\n \n4\n.\n0\n,\n \np\n=\n \n0\n.\n4\n4\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\na\nn\na\nl\ny\ns\ni\ns\n)\nN\no\nf\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n \nt\nh\na\nt\n \nw\ne\nr\ne\n \no\nu\nt\nl\ni\ne\nr\ns\n(\n\u0001\n3\n0\n\u00b0\no\nr\n \n\u0005\n5\n0\n\u00b0\no\nf\n \na\nb\nd\nu\nc\nt\ni\no\nn\n)\n:\n \nM\nI\n \n1\n5\n\/\n5\n0\n,\n \nS\nI\n \n1\n3\n\/\n8\n5\n,\n \np\n=\n \n0\n.\n0\n4\nA\nb\nd\nu\nc\nt\ni\no\nn\n \na\nn\ng\nl\ne\n \no\nf\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n:\n \nM\nI\n \n5\n0\n,\n4\n0\n.\n5\n\u00b0\n(\n8\n)\n \n[\n2\n1\n\u2013\n5\n6\n]\n,\n \nS\nI\n \n8\n5\n,\n \n4\n0\n\u00b0\n(\n7\n)\n \n[\n2\n6\n\u2013\n6\n0\n]\n,\n \np\n=\n \n0\n.\n6\n4\nN\no\nf\n \ns\nt\ne\nm\ns\n \ni\nn\n \nv\na\nr\nu\ns\n \na\nl\ni\ng\nn\nm\ne\nn\nt\n:\n \nM\nI\n \n6\n\/\n5\n0\n,\n \nS\nI\n \n3\n\/\n8\n5\n,\np\n=\n0\n.\n0\n5\n6\nN\no\nf\n \nh\ni\np\ns\n \nw\ni\nt\nh\n \np\no\no\nr\n \nf\ni\nx\na\nt\ni\no\nn\n \ng\nr\na\nd\ne\n \no\nr\n \ni\nn\n \nv\na\nr\nu\ns\na\nl\ni\ng\nn\nm\ne\nn\nt\n \n(\nd\ne\nf\ni\nn\ni\nt\ni\no\nn\n \n=\n \nt\nh\ne\n \nf\ni\nt\n \na\nn\nd\n \nf\ni\nl\nl\n \no\nf\n \nh\ni\np\ns\n \nw\ni\nt\nh\nc\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \nf\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\ns\n \nw\na\ns\n \np\no\no\nr\n,\n \nt\nh\ne\nc\ne\nm\ne\nn\nt\ni\nn\ng\n \nw\na\ns\n \ng\nr\na\nd\ne\n \nC\n2\n\/\nD\n \nf\no\nr\n \nh\ni\np\ns\n \nw\ni\nt\nh\n \nc\ne\nm\ne\nn\nt\nf\ni\nx\na\nt\ni\no\nn\n,\n \no\nr\n \nt\nh\ne\n \ns\nt\ne\nm\n \nw\na\ns\n \ni\nn\n \nv\na\nr\nu\ns\n \na\nl\ni\ng\nn\nm\ne\nn\nt\n)\n:\nM\nI\n7\n\/\n5\n0\n,\n \nS\nI\n \n3\n\/\n8\n5\n,\n \np\n=\n \n0\n.\n0\n2\nN\no\nf\n \nh\ni\np\ns\n \na\nc\nc\no\nr\nd\ni\nn\ng\n \nt\no\n \ng\nr\na\nd\ne\n \n(\ng\no\no\nd\n\/\nf\na\ni\nr\n\/\np\no\no\nr\n)\n \no\nf\n \nf\ni\nt\na\nn\nd\n \nf\ni\nl\nl\n \no\nf\n \nc\no\nm\np\no\nn\ne\nn\nt\ns\n \ni\nn\ns\ne\nr\nt\ne\nd\n \nw\ni\nt\nh\no\nu\nt\n \nc\ne\nm\ne\nn\nt\n:\nM\nI\n2\n6\n\/\n1\n6\n\/\n6\n,\n \nS\nI\n4\n2\n\/\n2\n2\n\/\n0\n,\n \np\n=\n \n0\n.\n0\n0\n3\n6\n\u2022\nP\nr\no\nl\no\nn\ng\ne\nd\n \nw\no\nu\nn\nd\n \nd\nr\na\ni\nn\na\ng\ne\n:\nM\nI\n0\n\/\n5\n0\n,\n \nS\nI\n2\n\/\n8\n5\nM\no\nw\n,\n \n2\n0\n0\n5\n6\n7\nE\nx\na\nm\ni\nn\na\nt\ni\no\nn\n \nb\ny\n \np\nl\na\ns\nt\ni\nc\n \ns\nu\nr\ng\ne\no\nn\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \nm\ni\nn\n.\n \n1\n7\n \nm\no\nn\nt\nh\ns\n:\nM\nI\n \n2\n0\n,\n \n9\n9\n \n[\n8\n9\n\u2013\n1\n0\n0\n]\n,\n \nS\nI\n \n1\n4\n,\n \n9\n7\n[\n6\n5\n\u2013\n1\n0\n0\n]\n,\n \np\n=\n \n0\n.\n4\n3\nW\no\nu\nn\nd\n \np\nr\no\nb\nl\ne\nm\n:\n \nM\nI\n \n2\n\/\n2\n0\n,\n \nS\nI\n \n0\n\/\n1\n4\n,\n \np\n=\n \n0\n.\n2\n2\nA\np\np\ne\na\nr\na\nn\nc\ne\n \n(\ng\no\no\nd\n\/\nf\na\ni\nr\n\/\np\no\no\nr\n)\n:\nM\nI\n4\n\/\n1\n0\n\/\n6\n,\n \nS\nI\n7\n\/\n6\n\/\n1\nC\no\nl\no\nu\nr\n \n\u2013\n \nT\na\nb\nl\ne\n \n2\nC\no\nn\nt\no\nu\nr\n \n\u2013\n \nT\na\nb\nl\ne\n \n2\nD\ni\ns\nt\no\nr\nt\ni\no\nn\n \n\u2013\n \nT\na\nb\nl\ne\n \n2\nF\ni\nz\np\na\nt\nr\ni\nc\nk\n \nc\nl\na\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n \n\u2013\n \nT\na\nb\nl\ne\n \n2\nR\ne\nc\no\nm\nm\ne\nn\nd\n \ns\nc\na\nr\n \nr\ne\nv\ni\ns\ni\no\nn\n \n\u2013\n \nT\na\nb\nl\ne\n \n2\nS\nu\nb\nc\nu\nt\na\nn\ne\no\nu\ns\n \nt\ni\ns\ns\nu\ne\n \nn\ne\nc\nr\no\ns\ni\ns\n \n\u2013\nT\na\nb\nl\ne\n \n2\nP\na\nt\ni\ne\nn\nt\ns\n \np\ne\nr\nc\ne\np\nt\ni\no\nn\nO\np\ni\nn\ni\no\nn\n \no\nf\n \ns\nc\na\nr\n \n(\ne\nx\nc\ne\nl\nl\ne\nn\nt\n\/\na\nv\ne\nr\na\ng\ne\n\/\nu\nn\na\nc\nc\ne\np\nt\na\nb\nl\ne\n)\n:\n \nM\nI\n \n1\n2\n\/\n8\n\/\n0\n,\n \nS\nI\n \n3\n\/\n1\n1\n\/\n0\n,\np\n=\n \n0\n.\n0\n2\n6\nS\nc\na\nr\n \na\np\np\ne\na\nr\na\nn\nc\ne\n \n(\na\ns\ne\nx\np\ne\nc\nt\ne\nd\n\/\nb\ne\nt\nt\ne\nr\n \nt\nh\na\nn\ne\nx\np\ne\nc\nt\ne\nd\n\/\nw\no\nr\ns\ne\n \nt\nh\na\nn\n \ne\nx\np\ne\nc\nt\ne\nd\n)\n:\nM\nI\n8\n\/\n1\n2\n\/\n0\n,\n \nS\nI\n8\n\/\n6\n\/\n0\n,\n \np\n=\n \n0\n.\n3\n2\nO\nu\nt\nc\no\nm\ne\n \ni\nm\np\no\nr\nt\na\nn\nc\ne\n:\n \ns\nc\na\nr\n \nf\no\nu\nn\nd\n \nt\no\nb\ne\n \nl\no\nw\n \no\nn\n \nt\nh\ne\n \np\na\nt\ni\ne\nn\nt\ns\n\u2019\n \np\nr\ni\no\nr\ni\nt\ny\n;\nf\nr\no\nm\n \nm\no\ns\nt\n \ni\nm\np\no\nr\nt\na\nn\nt\n \nt\no\n \nl\ne\na\ns\nt\ni\nm\np\no\nr\nt\na\nn\nt\n \n(\nb\no\nt\nh\n \ng\nr\no\nu\np\ns\n)\n:\n \nn\no\n \nh\ni\np\np\na\ni\nn\n,\n \nh\no\nw\n \nl\no\nn\ng\n \nT\nH\nR\n \nw\ni\nl\nl\n \nl\na\ns\nt\n,\n \nh\no\nw\nl\no\nn\ng\n \nw\ni\nt\nh\n \nc\nr\nu\nt\nc\nh\ne\ns\n,\n \nl\ne\nn\ng\nt\nh\n \no\nf\ni\nn\nc\ni\ns\ni\no\nn\n,\n \na\n \np\ne\nr\nf\ne\nc\nt\n \ns\nc\na\nr\n \nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n142\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nW\nr\ni\ng\nh\nt\n,\n \n2\n0\n0\n4\n5\n6\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\ni\ns\no\nn\n \no\nf\n \nt\nw\no\nc\no\nh\no\nr\nt\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\no\nv\ne\nm\nb\ne\nr\n \n1\n9\n9\n6\n\u2013\nD\ne\nc\ne\nm\nb\ne\nr\n \n1\n9\n9\n7\n(\nM\nI\n)\n;\n \nN\no\nv\ne\nm\nb\ne\nr\n1\n9\n9\n6\n\u2013\nF\ne\nb\nr\nu\na\nr\ny\n \n1\n9\n9\n7\n(\nS\nI\n)\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\nM\nI\n5\n.\n0\n8\n \n(\n0\n.\n3\n3\n)\n \ny\ne\na\nr\ns\n,\nS\nI\n \n5\n.\n1\n7\n \n(\n0\n.\n3\n7\n)\n \ny\ne\na\nr\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nn\no\n \ns\np\ne\nc\ni\nf\ni\nc\nc\nr\ni\nt\ne\nr\ni\na\n;\n \nd\ne\nc\ni\ns\ni\no\nn\n \nt\no\n \nu\ns\ne\n \nM\nI\nd\ne\np\ne\nn\nd\ne\nd\n \no\nn\n \nt\nh\ne\n \np\nr\ne\ns\ne\nn\nc\ne\n \no\nr\na\nb\ns\ne\nn\nc\ne\n \no\nf\n \na\n \np\na\nr\nt\ni\nc\nu\nl\na\nr\n \ng\nr\no\nu\np\n \no\nf\na\ns\ns\ni\ns\nt\na\nn\nt\n \ns\nu\nr\ng\ne\no\nn\ns\n \n(\nM\nI\n,\n \nn\no\nn\n-\nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \nT\nH\nR\ns\n;\n \nS\nI\n,\n \nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\nT\nH\nR\ns\n)\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nd\ne\nv\ne\nl\no\np\nm\ne\nn\nt\na\nl\nh\ni\np\n \nd\ny\ns\np\nl\na\ns\ni\na\n \n(\nN\n=\n \n6\n)\n;\n \na\n \nd\ne\nf\ni\nn\ni\nt\ne\nt\ne\nn\nd\ne\nn\nc\ny\n \nt\no\n \na\nv\no\ni\nd\n \nM\nI\n \ni\nn\n \no\nb\ne\ns\ne\np\na\nt\ni\ne\nn\nt\ns\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n3\n3\n6\n \nT\nH\nR\ns\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nM\nI\n \n5\n \n(\n2\n \nd\ni\ne\nd\n \na\nn\nd\n \n3\nl\no\ns\nt\n \nt\no\n \nF\nU\n)\n,\n \nS\nI\n \n3\n \n(\n2\n \nd\ni\ne\nd\n \na\nn\nd\n \n1\n \nl\no\ns\nt\nt\no\n \nF\nU\n)\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\nM\nI\n3\n7\n\/\n4\n2\n,\n \nS\nI\n3\n9\n\/\n4\n2\n;\n \nr\nh\ne\nu\nm\na\nt\no\ni\nd\na\nr\nt\nh\nr\ni\nt\ni\ns\n \nM\nI\n \n1\n\/\n4\n2\n,\n \nS\nI\n \n0\n\/\n4\n2\n;\no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n \nM\nI\n \n4\n\/\n4\n2\n,\n \nS\nI\n \n3\n\/\n4\n2\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n4\n.\n2\n \n(\n1\n5\n.\n1\n)\n,\nS\nI\n6\n5\n.\n0\n \n(\n8\n.\n2\n)\n,\n \np\n=\n \n0\n.\n7\n6\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\nI\n \n7\n1\n.\n4\n \n(\n2\n0\n.\n6\n)\n,\nS\nI\n \n8\n0\n.\n9\n \n(\n1\n8\n.\n7\n)\n,\n \np\n=\n \n0\n.\n0\n3\nH\ne\ni\ng\nh\nt\n \n(\nc\nm\n)\n:\n \nM\nI\n \n1\n6\n8\n.\n9\n \n(\n1\n1\n.\n5\n)\n,\nS\nI\n1\n6\n7\n.\n8\n \n(\n8\n.\n2\n)\n,\n \np\n=\n \n0\n.\n6\n2\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nM\nI\n \n2\n4\n.\n4\n \n(\n5\n.\n7\n)\n,\n \nS\nI\n2\n8\n.\n3\n(\n6\n.\n1\n)\n,\n \np\n<\n0\n.\n0\n1\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n3\n9\n.\n1\n \n(\n1\n2\n.\n9\n)\n,\nS\nI\n4\n0\n.\n6\n \n(\n1\n0\n.\n8\n)\n,\n \np\n=\n \n0\n.\n6\n0\nM\nI\n:\n \nN\n=\n \n4\n2\n \nh\ni\np\ns\nS\nI\n:\n \nN\n=\n \n4\n2\n \nh\ni\np\ns\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n8\n.\n8\n \n(\n1\n.\n5\n)\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nm\no\nd\ni\nf\ni\ne\nd\np\no\ns\nt\ne\nr\no\nl\no\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\nH\ny\nb\nr\ni\nd\n \n(\np\nr\ne\ns\ns\n-\nf\ni\nt\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\nc\no\nm\np\no\nn\ne\nn\nt\n \nw\ni\nt\nh\n \nn\no\ns\nu\np\np\nl\ne\nm\ne\nn\nt\n \ns\nc\nr\ne\nw\n \nf\ni\nx\na\nt\ni\no\nn\n \n+\nc\ne\nm\ne\nn\nt\ne\nd\n \nf\ne\nm\no\nr\na\nl\nc\no\nm\np\no\nn\ne\nn\nt\ns\n)\nS\nI\n:\n \n2\n3\n.\n0\n \n(\n2\n.\n1\n)\n-\nc\nm\n \nm\no\nd\ni\nf\ni\ne\nd\np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \na\np\np\nr\no\na\nc\nh\nH\ny\nb\nr\ni\nd\n \n(\np\nr\ne\ns\ns\n-\nf\ni\nt\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\nc\no\nm\np\no\nn\ne\nn\nt\n \nw\ni\nt\nh\n \nn\no\ns\nu\np\np\nl\ne\nm\ne\nn\nt\n \ns\nc\nr\ne\nw\n \nf\ni\nx\na\nt\ni\no\nn\n \n+\nc\ne\nm\ne\nn\nt\ne\nd\n \nf\ne\nm\no\nr\na\nl\nc\no\nm\np\no\nn\ne\nn\nt\ns\n)\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \no\nn\ne\ns\ne\nn\ni\no\nr\n \ns\nu\nr\ng\ne\no\nn\n \n(\nS\nc\nu\nl\nc\no\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n4\n2\n,\n \n7\n1\n.\n4\n \n(\n1\n1\n.\n2\n)\n,\n \nS\nI\n \n4\n2\n,\n \n7\n7\n.\n7\n \n(\n1\n3\n.\n2\n)\n,\n \np\n=\n \n0\n.\n0\n2\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n4\n2\n,\n \n1\n5\n1\n.\n8\n \n(\n5\n3\n.\n9\n)\n,\n \nS\nI\n \n4\n2\n,\n \n1\n7\n3\n.\n2\n \n(\n5\n7\n.\n5\n)\n,\n \np\n=\n \n0\n.\n0\n8\nC\no\nn\nv\ne\nr\ns\ni\no\nn\n:\n \nM\nI\n \n2\n\/\n4\n2\n,\n \nS\nI\n \n0\n\/\n4\n2\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n4\n2\n,\n \nS\nI\n \n1\n\/\n4\n2\nI\nn\nf\ne\nc\nt\ni\no\nn\n \n(\ns\ne\np\nt\ni\nc\n \na\nn\nd\n \na\ns\ne\np\nt\ni\nc\n)\n:\n \nM\nI\n \n0\n\/\n4\n2\n,\n \nS\nI\n \n0\n\/\n4\n2\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n \n(\nn\ne\nr\nv\ne\n \np\na\nl\ns\ny\n)\n:\n \nM\nI\n \n0\n\/\n4\n2\n,\n \nS\nI\n \n0\n\/\n4\n2\n3\n0\n-\nd\na\ny\n \nm\no\nr\nt\na\nl\ni\nt\ny\n:\n \nM\nI\n \n0\n\/\n4\n2\n,\n \nS\nI\n \n0\n\/\n4\n2\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nM\nI\n \n4\n2\n,\n \n6\n.\n1\n2\n,\n \nS\nI\n \n4\n2\n,\n \n6\n.\n0\n7\n,\n \np\n=\n \n0\n.\n9\n2\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\ni\nn\ni\nt\ni\na\nl\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\na\nn\na\nl\ny\ns\ni\ns\n)\n \nA\nc\nc\ne\np\nt\na\nb\nl\ne\n \na\nl\ni\ng\nn\nm\ne\nn\nt\n \nf\no\nr\n \n1\n0\n0\n%\n \no\nf\n \nb\no\nt\nh\n \nf\ne\nm\no\nr\na\nl\na\nn\nd\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\ns\n \n(\ni\n.\ne\n.\n \nn\no\n \no\nu\nt\nl\ni\ne\nr\ns\n)\n \nA\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n \ni\nn\nc\nl\ni\nn\na\nt\ni\no\nn\n \nb\ne\nt\nw\ne\ne\nn\n \n3\n5\n\u00b0\na\nn\nd\n5\n0\n\u00b0\nw\na\ns\n \nc\no\nn\ns\ni\nd\ne\nr\ne\nd\n \n\u201c\nw\ne\nl\nl\n-\na\nl\ni\ng\nn\ne\nd\n\u201d\nF\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \na\nn\ng\nu\nl\na\nt\ni\no\nn\n \nb\ne\nt\nw\ne\ne\nn\n \n3\n\u00b0\nv\na\nr\nu\ns\na\nn\nd\n \n3\n\u00b0\nv\na\nl\ng\nu\ns\n \nr\ne\nl\na\nt\ni\nv\ne\n \nt\no\n \nt\nh\ne\n \nf\ne\nm\no\nr\na\nl\n \ns\nh\na\nf\nt\n \na\nx\ni\ns\nc\no\nn\ns\ni\nd\ne\nr\ne\nd\n \n\u201c\nw\ne\nl\nl\n-\na\nl\ni\ng\nn\ne\nd\n\u201d\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n5\n \ny\ne\na\nr\ns\n:\n \nM\nI\n \n3\n7\n,\n8\n6\n.\n9\n \n(\n4\n.\n1\n)\n,\n \nS\nI\n \n3\n9\n,\n \n8\n4\n.\n2\n \n(\n6\n.\n4\n)\n,\np\n=\n0\n.\n0\n4\n2\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \nM\nI\n \n0\n\/\n3\n7\n,\n \nS\nI\n \n0\n\/\n3\n9\nM\no\nr\nt\na\nl\ni\nt\ny\n \na\nt\n \n5\n \ny\ne\na\nr\ns\n \n(\ns\ne\nc\no\nn\nd\na\nr\ny\n \nt\no\ne\nv\ne\nn\nt\ns\n \nu\nn\nr\ne\nl\na\nt\ne\nd\n \nt\no\n \nt\nh\ne\n \nh\ni\np\na\nr\nt\nh\nr\no\np\nl\na\ns\nt\ny\n)\n:\n \nM\nI\n \n2\n\/\n4\n2\n,\n \nS\nI\n \n2\n\/\n4\n2\n \nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \nw\ni\nt\nh\n \na\np\np\ne\na\nr\na\nn\nc\ne\n \no\nf\ni\nn\nc\ni\ns\ni\no\nn\n \n(\nT\na\nb\nl\ne\n \n4\n)\n:\n \nE\nn\nt\nh\nu\ns\ni\na\ns\nt\ni\nc\n:\n \nM\nI\n \n1\n6\n\/\n3\n7\n,\n \nS\nI\n \n3\n\/\n3\n7\nS\na\nt\ni\ns\nf\ni\ne\nd\n:\n \nM\nI\n \n1\n5\n\/\n3\n7\n,\n \nS\nI\n \n1\n7\n\/\n3\n7\nI\nn\nd\ni\nf\nf\ne\nr\ne\nn\nt\n:\n \nM\nI\n \n6\n\/\n3\n7\n,\n \nS\nI\n \n1\n4\n\/\n3\n7\nD\ni\ns\na\np\np\no\ni\nn\nt\ne\nd\n:\n \nM\nI\n \n0\n\/\n3\n7\n,\n \nS\nI\n \n5\n\/\n3\n7\nW\no\nu\nl\nd\n \nb\ne\n \nm\no\nr\ne\n \np\nl\ne\na\ns\ne\nd\n \ni\nf\n \ni\nn\nc\ni\ns\ni\no\nn\n \ni\ns\n \ns\nh\no\nr\nt\ne\nr\n:\n \nM\nI\n \n4\n1\n%\n \n(\n1\n5\n\/\n3\n7\n)\n,\n \nS\nI\n \n6\n7\n%\n(\n2\n5\n\/\n3\n7\n)\nW\no\nu\nl\nd\n \nb\ne\n \nl\ne\ns\ns\n \np\nl\ne\na\ns\ne\nd\n \ni\nf\n \ni\nn\nc\ni\ns\ni\no\nn\n \ni\ns\nl\no\nn\ng\ne\nr\n:\n \nM\nI\n \n7\n3\n%\n \n(\n2\n7\n\/\n3\n7\n)\n,\n \nS\nI\n \n4\n9\n%\n(\n1\n8\n\/\n3\n7\n)\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\no\nu\nt\nc\no\nm\ne\ns\nC\ne\nm\ne\nn\nt\n \nq\nu\na\nl\ni\nt\ny\n:\n \nM\nI\n \nA\n \n=\n \n3\n8\n\/\n4\n2\n,\nB\n=\n4\n\/\n4\n2\n,\n \nS\nI\n \nA\n \n=\n \n3\n7\n\/\n4\n2\n,\n \nB\n \n=\n \n5\n\/\n4\n2\nO\nt\nh\ne\nr\n\u2022\np\nr\no\ng\nr\ne\ns\ns\ni\nv\ne\n \nr\na\nd\ni\no\nl\nu\nc\ne\nn\nc\ni\ne\ns\n:\nM\nI\n0\n\/\n3\n7\n,\n \nS\nI\n0\n\/\n3\n9\n\u2022\nc\na\nv\ni\nt\ny\n \no\ns\nt\ne\no\nl\ny\ns\ni\ns\n:\n \nM\nI\n \n0\n\/\n3\n7\n,\n \nS\nI\n \n0\n\/\n3\n9C\na\ns\ne\n \ns\ne\nr\ni\ne\ns\nHealth Technology Assessment 2008; Vol. 12: No. 26\n143\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nF\nl\n\u00f6\nr\ne\nn\n,\n \n2\n0\n0\n6\n3\n9\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \nc\no\nh\no\nr\nt\ns\nt\nu\nd\ny\nL\no\nc\na\nt\ni\no\nn\n:\n \nG\ne\nr\nm\na\nn\ny\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\n1\n9\n8\n8\n\u2013\n1\n9\n9\n1\nF\nu\nn\nd\ni\nn\ng\n:\n \nn\no\nn\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \n1\n0\n.\n9\n(\n1\n.\n1\n)\n \ny\ne\na\nr\ns\n \n[\nr\na\nn\ng\ne\n1\n0\n\u2013\n1\n3\n \ny\ne\na\nr\ns\n]\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \ni\nn\ni\nt\ni\na\nl\n \nc\no\nh\no\nr\nt\n \n(\nN\n=\n \n1\n2\n2\n)\n \nr\ne\np\nr\ne\ns\ne\nn\nt\ns\n \nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\ns\ne\nr\ni\ne\ns\n \nn\no\nt\n \ns\ne\nl\ne\nc\nt\ne\nd\n \nf\no\nr\n \na\ng\ne\n,\n \ns\ne\nx\n,\nb\no\nn\ne\n \nt\ny\np\ne\n,\n \nb\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \no\nr\nd\ni\na\ng\nn\no\ns\ni\ns\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \np\na\nt\ni\ne\nn\nt\ns\n \nw\ni\nt\nh\nl\ne\ns\ns\n \nt\nh\na\nn\n \n1\n0\n-\ny\ne\na\nr\n \nF\nU\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n1\n2\n2\n \n(\n1\n3\n7\n \nh\ni\np\ns\n)\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \n4\n3\n \n(\no\nf\n \nw\nh\no\nm\n \n3\n2\n \nd\ni\ne\nd\n;\na\nl\nl\n \n3\n2\n \nw\nh\no\n \nh\na\nd\n \nd\ni\ne\nd\n \nh\na\nd\n \na\nn\nn\nu\na\nl\n \nF\nU\na\nn\nd\n \nn\no\nn\ne\n \nn\ne\ne\nd\ne\nd\n \nr\ne\nv\ni\ns\ni\no\nn\n)\n1\n0\n-\nY\ne\na\nr\n \nf\no\nl\nl\no\nw\n-\nu\np\n \ng\nr\no\nu\np\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n7\n4\n;\nr\nh\ne\nu\nm\na\nt\no\ni\nd\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n \n5\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \n7\n3\n \n(\n1\n2\n.\n9\n)\n \n[\n3\n2\n\u2013\n9\n7\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n3\n1\n\/\n4\n8\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \n8\n0\n.\n9\n \n(\n1\n8\n.\n3\n)\nH\ne\ni\ng\nh\nt\n \n(\nc\nm\n)\n:\n \n1\n6\n2\n \n(\n9\n.\n5\n)\nI\nn\ni\nt\ni\na\nl\n \ng\nr\no\nu\np\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n1\n1\n5\n;\nr\nh\ne\nu\nm\na\nt\no\ni\nd\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n \n7\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \n6\n4\n \n(\n1\n3\n.\n4\n)\n \n[\n1\n9\n\u2013\n9\n1\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n5\n0\n\/\n7\n2\nM\nI\n:\n \nN\n=\n \n7\n9\n \n(\n9\n0\n \nh\ni\np\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\nC\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \nc\nu\np\n \na\nn\nd\n \ns\nt\ne\nm\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \na\ns\ni\nn\ng\nl\ne\n \ns\nu\nr\ng\ne\no\nn\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \n0\n\/\n9\n0\nI\nn\nf\ne\nc\nt\ni\no\nn\n:\n \n0\n\/\n9\n0\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\n:\n7\n9\n,\n \n4\n.\n7\n \n(\n2\n.\n0\n)\n \n[\n1\n\u2013\n1\n3\n]\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\na\nn\na\nl\ny\ns\ni\ns\n,\n \nm\ne\na\nn\n \nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \nF\nU\n1\n0\n.\n9\n \n\u00b1\n1\n.\n0\n \n[\nr\na\nn\ng\ne\n \n1\n0\n\u2013\n1\n3\n]\n \ny\ne\na\nr\ns\n)\nS\nt\ne\nm\ns\n \ni\nn\n \nv\na\nr\nu\ns\n:\n \n1\n2\n\/\n7\n0\nS\nt\ne\nm\ns\n \ni\nn\n \nn\ne\nu\nt\nr\na\nl\n \np\no\ns\ni\nt\ni\no\nn\n:\n \n5\n8\n\/\n7\n0\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\n \n(\na\nt\n \n>\n1\n0\n \ny\ne\na\nr\ns\n)\nM\ne\na\nn\n \nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \n7\n9\n,\n \n9\n2\n.\n3\n \n(\n7\n.\n9\n)\n \n[\n6\n6\n\u2013\n9\n9\n]\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\nE\nx\nc\ne\nl\nl\ne\nn\nt\n,\n \n9\n0\n\u2013\n9\n9\n\/\nG\no\no\nd\n,\n \n8\n0\n\u2013\n8\n9\n\/\nF\na\ni\nr\n,\n7\n0\n\u2013\n7\n9\n\/\nP\no\no\nr\n,\n \n<\n7\n0\n)\n:\n \n6\n5\n\/\n1\n8\n\/\n6\n\/\n1\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \ns\nu\nb\ns\nc\na\nl\ne\n:\n \ng\na\ni\nt\n\u2022\nl\ni\nm\np\n \n(\nn\no\nn\ne\n\/\ns\nl\ni\ng\nh\nt\n\/\nm\no\nd\ne\nr\na\nt\ne\n\/\n \ns\ne\nv\ne\nr\ne\n)\n:\n \n6\n7\n\/\n2\n0\n\/\n3\n\/\n0\n\u2022\ns\nu\np\np\no\nr\nt\n \n(\nn\no\nn\ne\n\/\nc\na\nn\ne\n \nf\no\nr\n \nl\no\nn\ng\n \nw\na\nl\nk\ns\n\/\nc\na\nn\ne\n \nm\no\ns\nt\n \no\nf\n \nt\nh\ne\nt\ni\nm\ne\n\/\n1\n \nc\nr\nu\nt\nc\nh\n\/\n2\n \nc\nr\nu\nt\nc\nh\ne\ns\n\/\nn\no\nt\n \na\nb\nl\ne\n \nt\no\n \nw\na\nl\nk\n)\n:\n7\n2\n\/\n5\n\/\n9\n\/\n4\n\/\n0\n\/\n0\n\u2022\nd\ni\ns\nt\na\nn\nc\ne\n \nw\na\nl\nk\ne\nd\n \n(\nu\nn\nl\ni\nm\ni\nt\ne\nd\n\/\n6\n \nb\nl\no\nc\nk\ns\n\/\n2\n \no\nr\n \n3\nb\nl\no\nc\nk\ns\n\/\ni\nn\nd\no\no\nr\ns\n \no\nn\nl\ny\n\/\nb\ne\nd\n \na\nn\nd\n \nc\nh\na\ni\nr\n)\n:\n \n6\n6\n\/\n4\n\/\n2\n0\n\/\n0\n\/\n0\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \ns\nu\nb\ns\nc\na\nl\ne\n:\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\n\u2022\ns\nt\na\ni\nr\ns\n \n(\nn\no\nr\nm\na\nl\nl\ny\n \nw\ni\nt\nh\no\nu\nt\n \nu\ns\ni\nn\ng\n \na\n \nr\na\ni\nl\ni\nn\ng\n\/\nn\no\nr\nm\na\nl\nl\ny\nu\ns\ni\nn\ng\n \na\n \nr\na\ni\nl\ni\nn\ng\n\/\ni\nn\n \na\nn\ny\n \nm\na\nn\nn\ne\nr\n\/\nu\nn\na\nb\nl\ne\n \nt\no\n \nd\no\n \ns\nt\na\ni\nr\ns\n)\n:\n2\n9\n\/\n5\n7\n\/\n2\n\/\n2\n\u2022\ns\nh\no\ne\ns\n \na\nn\nd\n \ns\no\nc\nk\ns\n \n(\nw\ni\nt\nh\n \ne\na\ns\ne\n\/\nw\ni\nt\nh\n \nd\ni\nf\nf\ni\nc\nu\nl\nt\ny\n\/\nu\nn\na\nb\nl\ne\n)\n:\n6\n9\n\/\n2\n0\n\/\n1\n\u2022\ns\ni\nt\nt\ni\nn\ng\n \n(\nc\no\nm\nf\no\nr\nt\na\nb\nl\ny\n \ni\nn\n \no\nr\nd\ni\nn\na\nr\ny\n \nc\nh\na\ni\nr\n \nf\no\nr\n \n1\n \nh\n\/\no\nn\n \na\nh\ni\ng\nh\n \nc\nh\na\ni\nr\n \nf\no\nr\n \n0\n.\n5\n \nh\n\/\nu\nn\na\nb\nl\ne\n \nt\no\n \ns\ni\nt\n \nc\no\nm\nf\no\nr\nt\na\nb\nl\ny\n \ni\nn\n \na\nn\ny\nc\nh\na\ni\nr\n)\n:\n \n8\n6\n\/\n2\n\/\n2\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \n8\n\/\n9\n0\nT\ni\nm\ne\n \nt\no\n \nr\ne\nv\ni\ns\ni\no\nn\n \n(\ny\ne\na\nr\ns\n)\n:\n \n9\n0\n,\n \n6\n.\n8\n \n(\n1\n.\n8\n)\n \n[\n4\n\u2013\n1\n0\n]\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\nM\ne\na\nn\ns\n \ns\nc\no\nr\ne\n \nf\no\nr\n \nH\na\nr\nr\ni\ns\n \nh\ni\np\n \np\na\ni\nn\n \ns\nu\nb\ns\nc\na\nl\ne\n:\n \n9\n0\n,\n \n4\n3\n.\n2\n(\n2\n.\n7\n)\n \n[\n3\n0\n\u2013\n4\n4\n]\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \np\na\ni\nn\n \ns\nu\nb\ns\nc\na\nl\ne\n \n(\nn\no\nn\ne\n \no\nr\n \ni\ng\nn\no\nr\ne\n \ni\nt\n\/\ns\nl\ni\ng\nh\nt\n,\no\nc\nc\na\ns\ni\no\nn\na\nl\n,\n \nn\no\n \nc\no\nm\np\nr\no\nm\ni\ns\ne\n \ni\nn\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\n\/\nm\ni\nl\nd\n \np\na\ni\nn\n,\n \nn\no\ne\nf\nf\ne\nc\nt\n \no\nn\n \na\nv\ne\nr\na\ng\ne\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\n\/\nm\no\nd\ne\nr\na\nt\ne\n \np\na\ni\nn\n,\n \nt\no\nl\ne\nr\na\nb\nl\ne\n,\ns\no\nm\ne\n \nl\ni\nm\ni\nt\na\nt\ni\no\nn\n \no\nf\n \nm\no\nt\ni\no\nn\n \na\nc\nt\ni\nv\ni\nt\ny\n \no\nr\n \nw\no\nr\nk\n\/\nm\na\nr\nk\ne\nd\np\na\ni\nn\n,\n \ns\ne\nr\ni\no\nu\ns\n \nl\ni\nm\ni\nt\na\nt\ni\no\nn\n \no\nf\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\n\/\nt\no\nt\na\nl\nl\ny\n \nd\ni\ns\na\nb\nl\ne\nd\n,\nc\nr\ni\np\np\nl\ne\nd\n,\n \np\na\ni\nn\n \ni\nn\n \nb\ne\nd\n,\n \nb\ne\nd\nr\ni\nd\nd\ne\nn\n)\n:\n \n8\n0\n\/\n7\n\/\n3\n\/\n0\n\/\n0\n\/\n0\nM\no\nr\nt\na\nl\ni\nt\ny\n:\n \n3\n2\n\/\n1\n2\n2\n \n(\ns\ne\ne\n \nL\no\ns\nt\n \nt\no\n \nF\nU\n)\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n144\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\no\nu\nt\nc\no\nm\ne\ns\nI\nm\np\nl\na\nn\nt\n \nm\ni\ng\nr\na\nt\ni\no\nn\n:\n \n0\n\/\n7\n0\n \n(\nn\no\ns\nu\nb\ns\ni\nd\ne\nn\nc\ne\n \no\nf\n \ns\nt\ne\nm\n)\nC\ne\nm\ne\nn\nt\n \nq\nu\na\nl\ni\nt\ny\n:\n \n2\n \nc\nu\np\ns\n \nh\na\nd\np\no\nl\ny\ne\nt\nh\ny\nl\ne\nn\ne\n-\ni\nn\nd\nu\nc\ne\nd\n \no\ns\nt\ne\no\nl\ny\ns\ni\ns\n \ni\nn\nz\no\nn\ne\n \n2\n,\n \na\nn\nd\n \n3\n \na\nr\nt\nh\nr\no\np\nl\na\ns\nt\ni\ne\ns\n \nh\na\nd\nr\na\nd\ni\no\nl\nu\nc\ne\nn\nt\n \nl\ni\nn\ne\ns\n \n(\n\u0005\n2\n \nm\nm\n)\n \ni\nn\n \nz\no\nn\ne\ns\n1\n \na\nn\nd\n \n2\n;\n \n5\n \nc\nu\np\ns\n \nd\ne\nm\no\nn\ns\nt\nr\na\nt\ne\nd\nr\na\nd\ni\no\nl\nu\nc\ne\nn\nt\n \nl\ni\nn\ne\ns\n \n(\n\u0001\n1\n \nm\nm\n)\n \ni\nn\n \na\nl\nl\nz\no\nn\ne\ns\nO\nt\nh\ne\nr\n\u2022\nd\ni\ns\nc\nh\na\nr\ng\ne\nd\n \nh\no\nm\ne\n:\n \n6\n9\n%\n\u2022\nd\ni\ns\nc\nh\na\nr\ng\ne\nd\n \nt\no\n \nf\na\nc\ni\nl\ni\nt\ny\n:\n \n3\n1\n%\n\u2022\na\ns\ne\np\nt\ni\nc\n \nl\no\no\ns\ne\nn\ni\nn\ng\n:\n \n0\n\/\n7\n0\n\u2022\na\nt\nr\no\np\nh\ni\nc\n \nb\no\nn\ne\n \nc\nh\na\nn\ng\ne\ns\n:\n \n4\n0\n\/\n7\n0\n\u2022\nr\na\nd\ni\no\nl\nu\ns\nc\ne\nn\nt\n \nl\ni\nn\ne\ns\n \n(\n\u0001\n2\n \nm\nm\n)\n:\n1\n0\n\/\n7\n0\n\u2022\no\ns\nt\ne\no\nl\ny\ns\ni\ns\n:\n \n8\n\/\n7\n0\n\u2022\nc\nl\ni\nn\ni\nc\na\nl\n \nl\no\no\ns\ne\nn\ni\nn\ng\n:\n \n\u2022\np\no\nl\ny\ne\nt\nh\ny\nl\ne\nn\ne\n \nw\ne\na\nr\n:\n \n\u2022\ns\nc\nl\ne\nr\no\nt\ni\nc\n \nc\nh\na\nn\ng\ne\ns\n \na\nr\no\nu\nn\nd\n \nt\nh\ne\ns\nt\ne\nm\n:\n \n3\n\/\n7\n0\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n145\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nH\na\nr\nt\nz\nb\na\nn\nd\n,\n \n2\n0\n0\n6\n4\n1\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \nc\na\ns\ne\ns\ne\nr\ni\ne\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nJ\na\nn\nu\na\nr\ny\n\u2013\nM\na\ny\n \n2\n0\n0\n0\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \n5\n.\n7\n5\n[\n5\n.\n6\n\u2013\n6\n]\n \ny\ne\na\nr\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n9\n8\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n7\n6\n\/\n1\n0\n0\n;\nd\ne\nv\ne\nl\no\np\nm\ne\nn\nt\na\nl\n \nd\ny\ns\np\nl\na\ns\ni\na\n \no\nf\n \nt\nh\ne\n \nh\ni\np\n8\n\/\n1\n0\n0\n;\n \na\nv\na\ns\nc\nu\nl\na\nr\n \nn\ne\nc\nr\no\ns\ni\ns\n \n9\n\/\n1\n0\n0\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\n \n6\n1\n \n[\n3\n0\n\u2013\n9\n3\n]\n,\n \nF\n \n6\n5\n[\n4\n0\n\u2013\n8\n7\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n4\n1\n\/\n5\n7\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nM\n \n9\n2\n.\n6\n[\n6\n7\n.\n2\n\u2013\n1\n3\n1\n.\n5\n]\n,\n \nF\n \n7\n2\n.\n6\n \n[\n3\n8\n.\n6\n\u2013\n1\n0\n8\n.\n0\n]\nM\nI\n:\n \nN\n=\n \n9\n8\n \n(\n1\n0\n0\n \nc\na\ns\ne\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n7\n.\n2\n6\n \n[\n6\n\u2013\n8\n]\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \nt\nh\ne\na\nu\nt\nh\no\nr\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \na\nl\nl\np\nr\no\nc\ne\nd\nu\nr\ne\ns\n \nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\n:\n \n3\n7\n.\n5\n[\n2\n7\n\u2013\n9\n0\n]\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \n0\n\/\n1\n0\n0\nI\nn\nf\ne\nc\nt\ni\no\nn\n \n(\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \ni\nn\nf\ne\nc\nt\ni\no\nn\ns\n)\n:\n \n0\n\/\n1\n0\n0\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n \n(\nn\ne\nr\nv\ne\n \np\na\nl\ns\ny\n)\n:\n \n0\n\/\n1\n0\n0\nD\nV\nT\n:\n \n4\n\/\n1\n0\n0\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\n:\n \n1\n0\n0\n,\n \n2\n.\n8\n9\n[\n3\n\u2013\n5\n]\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n)\nA\nv\ne\nr\na\ng\ne\n \nc\nu\np\n \na\nb\nd\nu\nc\nt\ni\no\nn\n:\n \n1\n0\n0\n,\n \n4\n5\n.\n2\n\u00b0\n[\n3\n0\n\u00b0\n\u2013\n5\n6\n\u00b0\n]\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n:\n \nn\no\n \ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \np\na\ni\nn\nL\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ni\nn\ne\nq\nu\na\nl\ni\nt\ny\n \n(\nN\no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\n:\n7\n\/\n1\n0\n0\n,\n \nw\ni\nt\nh\n \na\n \nm\na\nx\ni\nm\nu\nm\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nl\ne\nn\ng\nt\nh\n \nd\ni\ns\nc\nr\ne\np\na\nn\nc\ny\n \no\nf\n \n0\n.\n5\n \nc\nm\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\n \no\nu\nt\nc\no\nm\ne\ns\nI\nm\np\nl\na\nn\nt\n \nm\ni\ng\nr\na\nt\ni\no\nn\n:\n \nn\no\n \nc\no\nm\np\no\nn\ne\nn\nt\ns\nu\nb\ns\ni\nd\ne\nn\nc\ne\n \no\nr\n \nl\no\no\ns\ne\nn\ni\nn\ng\n \no\nc\nc\nu\nr\nr\ne\nd\nP\ni\np\ni\nn\no\n,\n \n2\n0\n0\n4\n4\n9\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \ns\ni\nn\ng\nl\ne\nc\no\nh\no\nr\nt\nL\no\nc\na\nt\ni\no\nn\n:\n \nI\nt\na\nl\ny\n(\nG\ne\nn\no\na\n \na\nn\nd\n \nM\no\nn\nz\na\n)\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nA\np\nr\ni\nl\n \n1\n9\n9\n7\n\u2013\nJ\nu\nl\ny\n \n2\n0\n0\n4\n(\nu\nn\nt\ni\nl\n \nD\ne\nc\ne\nm\nb\ne\nr\n2\n0\n0\n2\n \ni\nn\n \nG\ne\nn\no\na\n,\nM\no\nn\nz\na\n \nt\nh\ne\nr\ne\na\nf\nt\ne\nr\n)\n \nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n1\n\u2013\n7\ny\ne\na\nr\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \ng\ne\nn\ne\nr\na\nl\nl\ny\n \ng\no\no\nd\nq\nu\na\nl\ni\nt\ny\n \no\nf\n \nt\nh\ne\n \nr\ne\nm\na\ni\nn\ni\nn\ng\n \nh\ne\na\nl\nt\nh\ny\nf\ne\nm\no\nr\na\nl\n \nb\no\nn\ne\n,\n \ne\ns\np\ne\nc\ni\na\nl\nl\ny\n \na\ns\nt\nr\nu\nc\nt\nu\nr\na\nl\nl\ny\n \ni\nn\nt\na\nc\nt\n \nf\ne\nm\no\nr\na\nl\n \nn\ne\nc\nk\nw\ni\nt\nh\n \nn\ne\na\nr\n-\nn\no\nr\nm\na\nl\n \ni\nn\nc\nl\ni\nn\na\nt\ni\no\nn\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n3\n6\n8\n \n(\n3\n0\n3\n \ni\nn\n \nG\ne\nn\no\na\n,\n \n6\n5\n \ni\nn\n \nM\no\nn\nz\na\n)\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \n3\n7\n \n(\n3\n7\n \nh\ni\np\ns\n)\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nc\no\nx\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n3\n0\n2\n;\nn\ne\nc\nr\no\ns\ni\ns\n \no\nf\n \nf\ne\nm\no\nr\na\nl\n \nn\ne\nc\nk\n \n2\n9\n;\nc\no\nx\na\nr\nt\nh\nr\ni\nt\ni\ns\n \na\nn\nd\n \nd\ny\ns\np\nl\na\ns\ni\na\n \n2\n2\n;\no\nt\nh\ne\nr\n \n1\n5\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \n6\n0\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n2\n2\n0\n\/\n1\n4\n8\nM\nI\n:\n \nN\n=\n \n3\n6\n8\n \n(\n3\n9\n0\n \nh\ni\np\ns\n)\n \na\nt\nb\na\ns\ne\nl\ni\nn\ne\nN\n=\n \n3\n3\n1\n \n(\n3\n5\n3\n \nh\ni\np\ns\n)\n \na\nt\n1\n\u2013\n7\ny\ne\na\nr\ns\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \nt\nr\na\nn\ns\ng\nl\nu\nt\nt\ne\na\nl\n \nd\ni\nr\ne\nc\nt\n \nl\na\nt\ne\nr\na\nl\na\nc\nc\ne\ns\ns\n;\n \n1\n2\n\u2013\n1\n5\n-\nc\nm\n \ni\nn\nc\ni\ns\ni\no\nn\n \ni\nn\nG\ne\nn\no\na\n;\n \n8\n\u2013\n1\n0\n-\nc\nm\n \ni\nn\nc\ni\ns\ni\no\nn\n \ni\nn\nM\no\nn\nz\na\n3\n9\n0\n \nC\nF\nP\n \ns\nt\ne\nm\ns\n,\n \nd\ne\ns\ni\ng\nn\ne\nd\n \nf\no\nr\n\u201c\nc\no\nl\nl\nu\nm\n \nf\ne\nm\no\nr\ni\ns\n-\np\nr\ne\ns\ne\nr\nv\ni\nn\ng\n\u201d\nt\ne\nc\nh\nn\ni\nq\nu\ne\n,\n \na\n \nm\ni\nn\ni\n-\ni\nn\nv\na\ns\ni\nv\ne\ns\nu\nr\ng\ne\nr\ny\n \nt\nh\na\nt\n \np\nr\ne\ns\ne\nr\nv\ne\ns\n \na\nn\nd\nr\ne\ns\np\ne\nc\nt\ns\n \na\ns\n \nm\nu\nc\nh\n \na\ns\n \np\no\ns\ns\ni\nb\nl\ne\nt\nh\ne\n \nj\no\ni\nn\nt\n \ns\nt\nr\nu\nc\nt\nu\nr\ne\n \n(\nb\no\nn\ne\ns\nt\no\nc\nk\n \na\nn\nd\n \ns\no\nf\nt\n \nt\ni\ns\ns\nu\ne\ns\n)\n3\n8\n8\n\/\n3\n9\n0\n \nc\nu\np\ns\n \np\no\ns\ni\nt\ni\no\nn\ne\nd\n \nb\ny\np\nr\ne\ns\ns\n-\nf\ni\nt\nt\ni\nn\ng\n;\n \n2\n\/\n3\n9\n0\n \nc\nu\np\ns\n \nw\ni\nt\nh\ns\nc\nr\ne\nw\ns\n \n(\nd\nu\ne\n \nt\no\n \nf\nr\na\nc\nt\nu\nr\ne\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\n:\n \n3\n6\n8\n,\n \n1\n5\n0\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nI\nn\nf\ne\nc\nt\ni\no\nn\n \n(\nd\ne\ne\np\n \nS\n.\n \na\nu\nr\ne\nu\ns\ni\nn\nf\ne\nc\nt\ni\no\nn\n)\n:\n \n1\n\/\n3\n3\n1\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n:\n \n0\n\/\n3\n3\n1\nV\na\ns\nc\nu\nl\na\nr\n \ni\nn\nj\nu\nr\ny\n:\n \n0\n\/\n3\n3\n1\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \n3\n\/\n3\n3\n1\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\ni\nm\nm\ne\nd\ni\na\nt\ne\nl\ny\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n)\nC\nu\np\n \ns\nl\no\np\ne\n \n(\nc\nu\np\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \no\nu\nt\ns\ni\nd\ne\n \nn\no\nr\nm\na\nl\nr\na\nn\ng\ne\n)\n:\n \n<\n5\n0\n\u00b0\n1\n8\n\/\n3\n5\n3\n,\n \n>\n6\n0\n\u00b0\n1\n1\n\/\n3\n5\n3\n;\n \n5\n0\n\u2013\n6\n0\n\u00b0\n(\nn\no\nr\nm\na\nl\n)\n \n3\n2\n4\n\/\n3\n5\n3\nS\nt\ne\nm\n \na\nl\ni\ng\nn\ne\nd\n \ni\nn\n \nv\na\nr\nu\ns\n \n1\n8\n\/\n3\n5\n3\n,\n \ni\nn\n \nv\na\nl\ng\nu\ns\n3\n\/\n3\n5\n3\n,\n \nc\no\nr\nr\ne\nc\nt\nl\ny\n \n3\n3\n2\n\/\n3\n5\n3\nC\nu\np\n \ns\na\nt\n \nc\no\nr\nr\ne\nc\nt\nl\ny\n \ni\nn\n \nt\nh\ne\n \nc\no\nt\ny\nl\no\ni\nd\n \nc\na\nv\ni\nt\ny\n3\n4\n2\n\/\n3\n5\n3\n,\n \nt\no\no\n \nd\ne\ne\np\n \n4\n\/\n3\n5\n3\n,\n \nt\no\no\n \ns\nh\na\nl\nl\no\nw\n7\n\/\n3\n5\n3\n,\n \ns\nm\na\nl\nl\n \ng\na\np\n \nb\ne\nn\ne\na\nt\nh\n \nt\nh\ne\n \np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nr\ni\nm\n2\n\/\n3\n5\n3\n \nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n1\n\u2013\n7\n \ny\ne\na\nr\ns\n:\nE\nx\nc\ne\nl\nl\ne\nn\nt\n,\n \n9\n0\n\u2013\n1\n0\n0\n:\n \n3\n2\n1\n\/\n3\n5\n3\nG\no\no\nd\n,\n \n8\n0\n\u2013\n8\n9\n:\n \n2\n0\n\/\n3\n5\n3\nF\na\ni\nr\n,\n \n7\n0\n\u2013\n7\n9\n:\n \n8\n\/\n3\n5\n3\nP\no\no\nr\n,\n \n<\n7\n0\n:\n \n4\n\/\n3\n5\n3\nR\ne\nt\nu\nr\nn\n \nt\no\n \na\n \nf\nu\nl\nl\n \nn\no\nr\nm\na\nl\n \nl\ni\nf\ne\ns\nt\ny\nl\ne\n \na\nt\n \n1\n\u2013\n7\n \ny\ne\na\nr\ns\n:\n9\n6\n%\n \n(\n3\n1\n8\n\/\n3\n3\n1\n)\nA\nb\nl\ne\n \nt\no\n \nt\na\nk\ne\n \nu\np\n \ns\np\no\nr\nt\ns\n \na\nt\n \na\n \ng\no\no\nd\n \na\nm\na\nt\ne\nu\nr\nl\ne\nv\ne\nl\n \na\nt\n \n1\n\u2013\n7\n \ny\ne\na\nr\ns\n:\n \n1\n2\n%\n \n(\n4\n0\n\/\n3\n3\n1\n)\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \n2\n\/\n3\n3\n1\nT\ni\nm\ne\n \nt\no\n \nr\ne\nv\ni\ns\ni\no\nn\n \n(\nm\no\nn\nt\nh\ns\n)\n:\n \na\nf\nt\ne\nr\n \n2\n \nm\no\nn\nt\nh\ns\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\nT\nh\ni\ng\nh\n \np\na\ni\nn\n \na\nt\n \n2\n \nm\no\nn\nt\nh\ns\n:\n \n7\n\/\n3\n3\n1\nP\ne\nr\ns\ni\ns\nt\ne\nn\nt\n \nt\nh\ni\ng\nh\n \np\na\ni\nn\n \na\nt\n \n1\n\u2013\n7\n \ny\ne\na\nr\ns\n:\n \n1\n\/\n3\n3\n1\nL\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ni\nn\ne\nq\nu\na\nl\ni\nt\ny\nC\nh\na\nn\ng\ne\n \nl\ne\ns\ns\n \nt\nh\na\nn\n \n1\n \nc\nm\n:\n \n2\n8\n\/\n3\n3\n1\nC\nh\na\nn\ng\ne\n \nm\no\nr\ne\n \nt\nh\na\nn\n \n1\n \nc\nm\n:\n \n0\n\/\n3\n3\n1\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n146\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \ns\ni\nn\ng\nl\ne\ns\nu\nr\ng\ne\no\nn\n \n(\ni\nn\n \nt\nw\no\n \nl\no\nc\na\nt\ni\no\nn\ns\n)\nM\nI\nS\n \n=\n \ns\nh\no\nr\nt\n \ni\nn\nc\ni\ns\ni\no\nn\n \n+\np\nr\ne\ns\ne\nr\nv\na\nt\ni\no\nn\n \no\nf\n \nt\nh\ne\n \nf\ne\nm\no\nr\na\nl\nn\ne\nc\nk\nS\nt\ne\nm\n \ns\ni\nz\ne\n \nc\no\nr\nr\ne\nc\nt\n \n3\n2\n8\n\/\n3\n5\n3\n,\n \no\nv\ne\nr\ns\ni\nz\ne\nd\n1\n4\n\/\n3\n5\n3\n,\n \nu\nn\nd\ne\nr\ns\ni\nz\ne\nd\n:\n \n1\n1\n\/\n3\n5\n3\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\n \no\nu\nt\nc\no\nm\ne\ns\nI\nm\np\nl\na\nn\nt\n \nm\ni\ng\nr\na\nt\ni\no\nn\n \n(\na\nt\n \n1\n\u2013\n7\n \ny\ne\na\nr\ns\n)\n:\n \n0\n\/\n3\n3\n1\n \n(\nt\nh\ne\ni\nm\np\nl\na\nn\nt\ne\nd\n \nc\nu\np\ns\n \nd\ni\nd\n \nn\no\nt\n \nd\ne\nt\na\nc\nh\n,\n \nm\ni\ng\nr\na\nt\ne\n \no\nr\nm\no\nb\ni\nl\ni\ns\ne\n,\n \na\nn\nd\n \nn\no\nn\ne\n \np\nr\ne\ns\ne\nn\nt\ne\nd\n \no\ns\nt\ne\no\nl\ny\ns\ni\ns\n \no\nr\nr\na\nd\ni\no\nl\nu\nc\ne\nn\nt\n \nl\ni\nn\ne\ns\n;\n \n2\n \ns\nt\ne\nm\ns\n \nh\na\nd\n \na\ns\ne\np\nt\ni\nc\nl\no\no\ns\ne\nn\ni\nn\ng\n,\n \nw\nh\ni\nl\ne\n \nt\nh\ne\n \ni\nn\nt\ne\ng\nr\na\nt\ni\no\nn\n \no\nf\n \nt\nh\ne\ni\nm\np\nl\na\nn\nt\ne\nd\n \ns\nt\ne\nm\n \ni\nn\nt\no\n \nt\nh\ne\n \nb\no\nn\ne\n \nw\na\ns\n \ng\ne\nn\ne\nr\na\nl\nl\ny\ng\no\no\nd\n \ni\nn\n \nt\nh\ne\n \nr\ne\nm\na\ni\nn\ni\nn\ng\n \n3\n5\n1\n \nc\na\ns\ne\ns\n)\n \nH\ne\nt\ne\nr\no\nt\no\np\ni\nc\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n:\n \n1\n5\n5\n\/\n3\n5\n3\n(\nB\nr\no\no\nk\ne\nr\n\u2019\ns\n \nc\nl\na\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n \ng\nr\na\nd\ne\n \nI\n\/\nI\nI\n\/\nI\nI\nI\n\/\nI\nV\n:\n1\n0\n6\n\/\n2\n8\n\/\n2\n1\n\/\n0\n,\n \nw\nh\ne\nr\ne\n \nI\nV\n \n=\n \nw\no\nr\ns\nt\n)\nO\nt\nh\ne\nr\n\u2022\nm\na\ns\ns\ni\nv\ne\n \nd\ne\nt\na\nc\nh\nm\ne\nn\nt\n \no\nf\n \nt\nh\ne\n \ns\nt\ne\nm\n,\n \ns\ne\nv\ne\nr\na\nl\nm\no\nn\nt\nh\ns\n \na\nf\nt\ne\nr\n \ns\nu\nr\ng\ne\nr\ny\n:\n \n1\n\/\n3\n5\n3\n \n(\np\na\nt\ni\ne\nn\nt\nd\ni\na\ng\nn\no\ns\ne\nd\n \nw\ni\nt\nh\n \ng\na\ns\nt\nr\ni\nc\n \nc\na\nr\nc\ni\nn\no\nm\na\n2\nm\no\nn\nt\nh\ns\n \na\nf\nt\ne\nr\n \ns\nu\nr\ng\ne\nr\ny\n)\n\u2022\na\nl\nt\ne\nr\ne\nd\n \nb\no\nn\ne\n \nr\ne\nm\no\nd\ne\nl\nl\ni\nn\ng\n \na\nr\no\nu\nn\nd\n \nt\nh\ne\ns\nt\ne\nm\n \n(\ni\nn\ng\nr\no\nw\nt\nh\n)\n\u2022\ns\np\no\nt\n-\nw\ne\nl\nd\ns\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n147\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nS\ni\ng\nu\ni\ne\nr\n,\n \n2\n0\n0\n4\n5\n0\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nr\ne\nt\nr\no\ns\np\ne\nc\nt\ni\nv\ne\n \ns\nt\nu\nd\ny\no\nf\n \nc\no\nn\nt\ni\nn\nu\no\nu\ns\n \ns\ne\nr\ni\ne\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nP\na\nr\ni\ns\n,\nF\nr\na\nn\nc\ne\n \nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nJ\nu\nn\ne\n \n1\n9\n9\n3\n\u2013\nJ\nu\nn\ne\n2\n0\n0\n0\nF\nu\nn\nd\ni\nn\ng\n:\n \nn\no\nn\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\nu\nn\nc\nl\ne\na\nr\n.\n \nS\no\nm\ne\n \nd\na\nt\na\nr\ne\np\no\nr\nt\ne\nd\n \nu\np\n \nt\no\n3\ny\ne\na\nr\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nn\no\n \np\nr\ne\nv\ni\no\nu\ns\n \nh\ni\np\ns\nu\nr\ng\ne\nr\ny\n \nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \no\nb\ne\ns\ne\n \np\na\nt\ni\ne\nn\nt\ns\nr\ne\nq\nu\ni\nr\ni\nn\ng\n \nl\no\nn\ng\ne\nr\n \ni\nn\nc\ni\ns\ni\no\nn\n \n(\nN\n=\n1\n5\n)\n;\nm\nu\ns\nc\nu\nl\na\nr\n \nm\ne\nn\n \n(\nN\n=\n \n8\n)\n;\n \nc\no\nn\ng\ne\nn\ni\nt\na\nl\np\no\ns\nt\ne\nr\ni\no\nr\n \nd\ni\ns\nl\no\nc\na\nt\ne\nd\n \nh\ni\np\ns\n;\nd\ny\ns\np\nl\na\ns\nt\ni\nc\n \nh\ni\np\ns\n;\n \nf\nr\na\nc\nt\nu\nr\ne\nd\n \nn\ne\nc\nk\n \no\nf\nt\nh\ne\n \nf\ne\nm\nu\nr\n \no\nr\n \na\nc\ne\nt\na\nb\nu\nl\nu\nm\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \n4\n5\n \np\na\nt\ni\ne\nn\nt\ns\n \na\nf\nt\ne\nr\n \n1\ns\nt\nv\ni\ns\ni\nt\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n9\n5\n0\n;\nc\no\nn\ng\ne\nn\ni\nt\na\nl\n \nd\ny\ns\np\nl\na\ns\nt\ni\nc\n \nh\ni\np\n \n4\n6\n;\na\nv\na\ns\nc\nu\nl\na\nr\n \nn\ne\nc\nr\no\ns\ni\ns\n \n2\n0\n;\ni\nn\nf\nl\na\nm\nm\na\nt\no\nr\ny\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n \n1\n1\n;\n \np\no\ns\nt\n-\nt\nr\na\nu\nm\na\nt\ni\nc\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n5\n;\nL\ne\ng\ng\n\u2013\nC\na\nl\nv\n\u00e9\n\u2013\nP\ne\nr\nt\nh\ne\ns\n \nd\ni\ns\ne\na\ns\ne\n \n3\n;\nd\ni\ns\na\nb\ni\nl\ni\nt\ny\n \na\nf\nt\ne\nr\n \ne\np\ni\np\nh\ny\ns\ni\no\nl\ny\ns\ni\ns\n \n2\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \n6\n7\n.\n8\n \n[\n2\n3\n\u2013\n9\n3\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n3\n3\n6\n\/\n5\n9\n0\n \nM\nI\n:\n \nN\n=\n \n9\n2\n6\n \n(\n1\n0\n3\n7\n \nT\nH\nR\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n<\n1\n0\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\na\nn\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\n,\n \nw\ni\nt\nh\no\nu\nt\nm\nu\ns\nc\nl\ne\n \no\nr\n \nt\ne\nn\nd\no\nn\n \ns\ne\nc\nt\ni\no\nn\ni\nn\ng\n \n1\n0\n3\n7\n \nc\ne\nm\ne\nn\nt\ne\nd\n \np\nr\no\nc\ne\nd\nu\nr\ne\ns\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \n2\ns\nu\nr\ng\ne\no\nn\ns\n \nw\ni\nt\nh\no\nu\nt\n \nn\na\nv\ni\ng\na\nt\ni\no\nn\no\nr\n \ni\nm\na\ng\ne\n \ni\nn\nt\ne\nn\ns\ni\nf\ni\ne\nr\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \n1\n0\n\/\n1\n0\n3\n7\n \n(\n0\n.\n9\n6\n%\n)\n \nI\nn\nf\ne\nc\nt\ni\no\nn\n \n(\ns\ne\np\nt\ni\nc\n \nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\n)\n:\n \n5\n\/\n9\n2\n6\n \n=\n \n5\n\/\n1\n0\n3\n7\nh\ni\np\ns\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \nM\nI\n \n1\n\/\n9\n2\n6\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nL\ni\nm\np\n \n(\np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\ne\nr\ni\no\nd\n,\np\no\ns\ns\ni\nb\nl\ny\n \n<\n3\n \nm\no\nn\nt\nh\ns\n)\n:\n \n0\n\/\n9\n2\n6\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n \n(\nf\no\nr\n \nh\na\ne\nm\na\nt\no\nm\na\n)\n:\n0\n\/\n9\n2\n6\n \nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\no\nu\nt\nc\no\nm\ne\ns\nH\ne\nt\ne\nr\no\nt\no\np\ni\nc\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n9\n2\n6\nO\nt\nh\ne\nr\n\u2022\nr\ne\n-\no\np\ne\nr\na\nt\ni\no\nn\n \na\nf\nt\ne\nr\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \n2\n\/\n9\n2\n6\n\u2022\nr\ne\nf\nu\ns\ne\nd\n \nr\ne\n-\no\np\ne\nr\na\nt\ni\no\nn\n \na\nf\nt\ne\nr\nf\nr\na\nc\nt\nu\nr\ne\n \na\nt\n \n3\n \nm\no\nn\nt\nh\ns\n,\n \n8\n \nm\no\nn\nt\nh\ns\na\nn\nd\n \n3\n \ny\ne\na\nr\ns\n:\n \n1\n\/\n9\n2\n6\n\u2022\nf\ne\nm\no\nr\na\nl\n \np\na\nr\ne\ns\ni\ns\n:\n \n2\n\/\n9\n2\n6\n\u2022\na\ns\nc\ne\np\nt\ni\nc\n \nl\no\no\ns\ne\nn\ni\nn\ng\n:\n \n3\n\/\n9\n2\n6\n\u2022\nl\no\no\ns\ne\nn\ni\nn\ng\n \no\nf\n \ns\ne\np\nt\ni\nc\n \no\nr\ni\ng\ni\nn\n:\n \n3\n\/\n9\n2\n6\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n148\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nS\nw\na\nn\ns\no\nn\n,\n \n2\n0\n0\n5\n5\n1\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \nc\na\ns\ne\ns\ne\nr\ni\ne\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nM\na\ny\n \n1\n9\n9\n7\n\u2013\nF\nu\nn\nd\ni\nn\ng\n:\nm\na\nn\nu\nf\na\nc\nt\nu\nr\ne\nr\n;\n \np\na\nr\nt\ni\na\nl\no\nr\n \ni\nn\n \nt\no\nt\na\nl\n \ns\nu\np\np\no\nr\nt\n \no\nf\nt\nh\ne\n \nr\ne\ns\ne\na\nr\nc\nh\nm\na\nt\ne\nr\ni\na\nl\n \n(\nP\nl\nu\ns\nO\nr\nt\nh\no\np\ne\nd\ni\nc\ns\n,\n \nS\na\nn\n \nD\ni\ne\ng\no\n,\n \nC\nA\n,\nc\no\nn\ns\nu\nl\nt\ni\nn\ng\n \nf\ne\ne\n)\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \n3\n.\n1\n[\n2\n\u2013\n5\n.\n2\n]\n \ny\ne\na\nr\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nm\ni\nn\ni\nm\nu\nm\n \n2\n-\ny\ne\na\nr\nF\nU\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nd\ne\na\nt\nh\n \no\nr\n \nl\no\ns\ns\n \nt\no\nF\nU\n \ni\nn\n \nf\ni\nr\ns\nt\n \n2\n \ny\ne\na\nr\ns\n \n(\nN\n=\n \n8\n3\n)\n;\np\na\nt\ni\ne\nn\nt\ns\n \nr\ne\nq\nu\ni\nr\ni\nn\ng\n \ne\nx\nt\ne\nn\ns\ni\nv\ne\nh\na\nr\nd\nw\na\nr\ne\n \nr\ne\nm\no\nv\na\nl\n,\n \nh\na\nv\ni\nn\ng\ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\n \nd\ne\nf\no\nr\nm\ni\nt\ny\n,\n \nr\ne\nq\nu\ni\nr\ni\nn\ng\ns\nt\nr\nu\nc\nt\nu\nr\na\nl\n \nb\no\nn\ne\n \ng\nr\na\nf\nt\ns\n \no\nr\nu\nn\nd\ne\nr\ng\no\ni\nn\ng\n \nf\ne\nm\no\nr\na\nl\n \no\ns\nt\ne\no\nt\no\nm\ny\n;\nn\no\n \np\na\nt\ni\ne\nn\nt\ns\n \nw\ne\nr\ne\n \ne\nx\nc\nl\nu\nd\ne\nd\nb\ne\nc\na\nu\ns\ne\n \no\nf\n \nw\ne\ni\ng\nh\nt\n \no\nr\n \nB\nM\nI\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n8\n4\n2\n \n(\n1\n1\n1\n5\n \nT\nH\nR\ns\n)\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \n8\n3\n \n(\nn\no\nt\n \ni\nn\nc\nl\nu\nd\ne\nd\n \ni\nn\nt\nh\ne\n \ns\nt\nu\nd\ny\n;\n \ns\ne\ne\n \na\nb\no\nv\ne\n)\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n8\n1\n2\n\/\n1\n0\n0\n0\n;\n \nr\nh\ne\nu\nm\na\nt\no\ni\nd\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n1\n9\n\/\n1\n0\n0\n0\n;\n \no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n \n6\n8\n\/\n1\n0\n0\n0\n;\nd\ne\nv\ne\nl\no\np\nm\ne\nn\nt\na\nl\n \nd\ny\ns\np\nl\na\ns\ni\na\n \no\nf\n \nt\nh\ne\n \nh\ni\np\n2\n2\n\/\n1\n0\n0\n0\n;\n \no\nt\nh\ne\nr\n \n7\n9\n\/\n1\n0\n0\n0\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \n6\n2\n.\n3\n \n(\n1\n3\n.\n5\n)\n \n[\n2\n3\n\u2013\n9\n3\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n4\n1\n5\n\/\n5\n8\n5\n \n(\nb\na\ns\ne\nd\n \no\nn\n \nN\no\nf\nh\ni\np\ns\n)\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \n7\n6\n.\n7\n \n(\n1\n9\n.\n2\n)\n[\n4\n3\n\u2013\n1\n6\n3\n]\nH\ne\ni\ng\nh\nt\n \n(\nc\nm\n)\n:\n \n1\n6\n9\n \n(\n1\n0\n)\n \n[\n1\n2\n6\n\u2013\n1\n9\n8\n]\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \n2\n6\n.\n5\n \n(\n5\n.\n7\n)\n[\n1\n4\n.\n3\n\u2013\n5\n6\n.\n5\n]\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \n3\n4\n \n(\n1\n2\n)\n \n[\n2\n5\n\u2013\n4\n5\n]\nO\nt\nh\ne\nr\nD\no\nr\nr\n \nb\no\nn\ne\n \nt\ny\np\ne\ns\nC\nh\na\nr\nn\nl\ne\ny\n \nf\nu\nn\nc\nt\ni\no\nn\na\nl\n \nc\nl\na\ns\ns\ne\ns\nM\nI\n:\n \nN\n=\n \n7\n5\n9\n \n(\n1\n0\n0\n0\n \nT\nH\nR\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n8\n.\n8\n \n(\n2\n.\n0\n)\n \n[\n6\n\u2013\n1\n6\n]\n-\nc\nm\ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \np\no\ns\nt\ne\nr\ni\no\nr\na\np\np\nr\no\na\nc\nh\nT\na\np\ne\nr\ne\nd\n \nt\ni\nt\na\nn\ni\nu\nm\n \nf\ne\nm\no\nr\na\nl\nc\no\nm\np\no\nn\ne\nn\nt\n \n+\n \nh\ne\nm\ni\ns\np\nh\ne\nr\ni\nc\na\nl\np\nr\ne\ns\ns\n-\nf\ni\nt\n \ni\nn\ng\nr\no\nw\nt\nh\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\nc\no\nm\np\no\nn\ne\nn\nt\n;\n \ns\nu\np\np\nl\ne\nm\ne\nn\nt\na\nl\na\nc\ne\nt\na\nb\nu\nl\na\nr\n \ns\nc\nr\ne\nw\ns\n \nw\ne\nr\ne\n \nu\ns\ne\nd\ni\nn\n \nm\no\ns\nt\n \np\na\nt\ni\ne\nn\nt\ns\n \nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\np\nr\no\nc\ne\nd\nu\nr\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\no\nn\ne\n \ns\nu\nr\ng\ne\no\nn\n \n(\na\nu\nt\nh\no\nr\n)\n \nw\ni\nt\nh\n \na\nC\nh\na\nr\nn\nl\ne\ny\n \nr\ne\nt\nr\na\nc\nt\no\nr\n \n(\nm\no\nd\ni\nf\ni\ne\nd\nt\no\n \nm\ni\nn\ni\nm\ni\ns\ne\n \ns\nk\ni\nn\n \nt\ne\nn\ns\ni\no\nn\n)\n \na\nn\nd\ns\nt\na\nn\nd\na\nr\nd\n \nh\ne\nm\ni\ns\np\nh\ne\nr\ni\nc\na\nl\np\no\nw\ne\nr\n \nr\ne\na\nm\ne\nr\ns\n,\n \nl\ne\nn\ng\nt\nh\n \no\nf\ni\nn\nc\ni\ns\ni\no\nn\n \nl\na\nr\ng\ne\nl\ny\n \nd\ne\np\ne\nn\nd\ne\nn\nt\n \no\nn\np\na\nt\ni\ne\nn\nt\ns\n\u2019\n \nB\nM\nI\n \n\u201c\nM\ni\nn\ni\nm\na\nl\nl\ny\n \ni\nn\nv\na\ns\ni\nv\ne\n\u201d\n \ns\nu\nr\ng\ne\nr\ny\nd\ne\nf\ni\nn\ne\nd\n \na\ns\n \nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n \n+\nm\ni\nn\ni\nm\ni\ns\ne\n \ns\no\nf\nt\n \nt\ni\ns\ns\nu\ne\nd\ni\ns\ns\ne\nc\nt\ni\no\nn\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\n:\n \n1\n0\n0\n0\n,\n \n6\n1\n.\n2\n \n(\n2\n4\n.\n2\n)\n[\n2\n3\n\u2013\n2\n7\n4\n]\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\n1\n0\n0\n0\n,\n \n3\n1\n7\n.\n3\n \n(\n2\n3\n0\n.\n6\n)\n \n[\n1\n0\n0\n\u2013\n2\n0\n0\n0\n]\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\n \n(\nf\ne\nm\no\nr\na\nl\n \ns\nh\na\nf\nt\n)\n:\n \n7\n\/\n1\n0\n0\n0\nT\nr\no\nc\nh\na\nn\nt\ne\nr\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \n3\n\/\n1\n0\n0\n0\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \n3\n0\n\/\n1\n0\n0\n0\nI\nn\nf\ne\nc\nt\ni\no\nn\nD\ne\ne\np\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n:\n \n3\n\/\n1\n0\n0\n0\n \nS\nu\np\ne\nr\nf\ni\nc\ni\na\nl\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n:\n \n5\n\/\n1\n0\n0\n0\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n \n(\nt\nr\na\nn\ns\ni\ne\nn\nt\n \nn\ne\nr\nv\ne\n \np\na\nl\ns\ny\n)\n:\n \n6\n\/\n1\n0\n0\n0\n \nD\nV\nT\n \na\nn\nd\n\/\no\nr\n \nP\nE\n:\n \n1\n2\n\/\n1\n0\n0\n0\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n \n(\nf\ne\nm\no\nr\na\nl\n \ns\nh\na\nf\nt\n)\n:\n \n3\n\/\n1\n0\n0\n0\n(\na\nf\nt\ne\nr\n \nf\na\nl\nl\ns\n \ni\nn\n \nt\nh\ne\n \ne\na\nr\nl\ny\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\ne\nr\ni\no\nd\n)\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\n:\n \n1\n0\n0\n0\n,\n \n3\n.\n7\n \n(\n1\n.\n8\n)\n[\n2\n\u2013\n1\n8\n]\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\nT\ni\nm\ne\n \nt\no\n \nb\ne\ng\ni\nn\n \nu\nn\nr\ne\ns\nt\nr\ni\nc\nt\ne\nd\n \nn\no\nr\nm\na\nl\n \nd\na\ni\nl\ny\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\n(\ns\ne\nl\nf\n-\nr\ne\np\no\nr\nt\n)\n:\n \n4\n.\n2\n \n[\n1\n\u2013\n1\n1\n]\n \nw\ne\ne\nk\ns\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n \na\nt\n \ne\na\nc\nh\n \nF\nU\nv\ni\ns\ni\nt\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n,\n \n3\n \na\nn\nd\n \n6\n \nm\no\nn\nt\nh\ns\n,\n \n1\n \ny\ne\na\nr\n \na\nn\nd\n \ny\ne\na\nr\nl\ny\nt\nh\ne\nr\ne\na\nf\nt\ne\nr\n)\nF\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\ns\n \ni\nn\n \n<\n5\n\u00b0\no\nf\n \nv\na\nr\nu\ns\n:\n \n7\n\/\n1\n0\n0\n0\nC\nu\np\n \ni\nn\nc\nl\ni\nn\na\nt\ni\no\nn\n \n<\n3\n0\n\u00b0\no\nr\n \n>\n5\n0\n\u00b0\n:\n \n3\n0\n\/\n1\n0\n0\n0\nC\nu\np\n \na\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n \n<\n0\n\u00b0\no\nr\n \n>\n3\n0\n\u00b0\n:\n \n1\n0\n\/\n1\n0\n0\n0\nC\nu\np\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \na\nn\ng\nl\ne\n:\n \n4\n1\n.\n2\n\u00b0\nC\nu\np\n \na\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n:\n \n1\n4\n.\n6\n\u00b0\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \n1\n0\n0\n0\n,\n \n9\n2\n \n(\n9\n)\n[\n6\n7\n\u2013\n1\n0\n0\n]\n \nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \n2\n1\n\/\n1\n0\n0\n0\nL\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ni\nn\ne\nq\nu\na\nl\ni\nt\ny\n \n(\nw\ni\nt\nh\ni\nn\n \n7\n \nm\nm\no\nf\n \ne\na\nc\nh\n \no\nt\nh\ne\nr\n)\n:\n \n9\n1\n2\n\/\n1\n0\n0\n0\n,\n \ni\n.\ne\n.\n8\n8\n\/\n1\n0\n0\n0\n \nn\no\nt\n \ne\nq\nu\na\nl\nM\no\nr\nt\na\nl\ni\nt\ny\n:\n \ns\ne\ne\n \ne\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\nO\nt\nh\ne\nr\n\u2022\nd\ne\nl\na\ny\ne\nd\n \nw\no\nu\nn\nd\n \nh\ne\na\nl\ni\nn\ng\n:\n \n1\n0\n\/\n1\n0\n0\n0\n\u2022\n\u201c\na\nc\nu\nt\ne\n \nm\ne\nd\ni\nc\na\nl\n \nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\ns\n\u201d\n:\n4\n1\n\/\n1\n0\n0\n0\nc\no\nn\nt\ni\nn\nu\ne\ndT\nw\no\n \ni\nn\nc\ni\ns\ni\no\nn\ns\nR\nC\nT\ns\n \na\nn\nd\n \nq\nu\na\ns\ni\n-\nR\nC\nT\ns\nHealth Technology Assessment 2008; Vol. 12: No. 26\n149\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nP\na\ng\nn\na\nn\no\n,\n \n2\n0\n0\n7\na\n7\n2\n(\na\nb\ns\nt\nr\na\nc\nt\n \no\nn\nl\ny\n)\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nR\nC\nT\n,\nm\na\nt\nc\nh\ne\nd\n \nb\ny\nc\no\nm\np\nu\nt\ne\nr\ni\ns\ne\nd\nr\na\nn\nd\no\nm\ni\ns\na\nt\ni\no\nn\n \nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n1\ny\ne\na\nr\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n2\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nN\nR\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \n6\n6\n,\n \nm\na\nt\nc\nh\ne\nd\n \nb\ny\nc\no\nm\np\nu\nt\ne\nr\ni\ns\ne\nd\n \nr\na\nn\nd\no\nm\ni\ns\na\nt\ni\no\nn\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nm\na\nt\nc\nh\ne\nd\n \nb\ny\nc\no\nm\np\nu\nt\ne\nr\ni\ns\ne\nd\n \nr\na\nn\nd\no\nm\ni\ns\na\nt\ni\no\nn\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nm\na\nt\nc\nh\ne\nd\n \nb\ny\nc\no\nm\np\nu\nt\ne\nr\ni\ns\ne\nd\n \nr\na\nn\nd\no\nm\ni\ns\na\nt\ni\no\nn\n2\nM\nI\n:\n \nN\n=\n \n1\n0\nM\nI\n:\n \nN\n=\n \n1\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\n2\nM\nI\n:\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \na\np\np\nr\no\na\nc\nh\n(\nM\ne\na\nr\ns\n\/\nB\ne\nr\ng\ne\nr\n \nt\ne\nc\nh\nn\ni\nq\nu\ne\n)\n,\nf\nl\nu\no\nr\no\ns\nc\no\np\ny\n \na\ns\ns\ni\ns\nt\ne\nd\nM\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nm\ni\nn\ni\n-\np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nG\na\ni\nt\n \na\nn\na\nl\ny\ns\ni\ns\n \na\nt\n \n1\n \ny\ne\na\nr\n:\n \nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nP\na\ng\nn\na\nn\no\n,\n \n2\n0\n0\n7\nb\n7\n3\n(\na\nb\ns\nt\nr\na\nc\nt\n \no\nn\nl\ny\n)\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nR\nC\nT\n,\nm\na\nt\nc\nh\ne\nd\n \nb\ny\nc\no\nm\np\nu\nt\ne\nr\ni\ns\ne\nd\nr\na\nn\nd\no\nm\ni\ns\na\nt\ni\no\nn\n \nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n1\ny\ne\na\nr\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n7\n2\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nN\nR\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nm\na\nt\nc\nh\ne\nd\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n2\n0\n\/\n1\n6\n,\n \nS\nI\n \n2\n0\n\/\n1\n6\n(\nm\na\nt\nc\nh\ne\nd\n)\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nm\na\nt\nc\nh\ne\nd\n2\nM\nI\n:\n \nN\n=\n \n3\n6\nM\nI\n:\n \nN\n=\n \n3\n6\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\n2\nM\nI\n:\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \na\np\np\nr\no\na\nc\nh\n(\nM\ne\na\nr\ns\n\/\nB\ne\nr\ng\ne\nr\n \nt\ne\nc\nh\nn\ni\nq\nu\ne\n)\n,\nf\nl\nu\no\nr\no\ns\nc\no\np\ny\n \na\ns\ns\ni\ns\nt\ne\nd\nM\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n,\n \nm\ni\nn\ni\n-\np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n \nT\ni\nm\ne\n \nt\no\n \nd\ni\ns\nc\no\nn\nt\ni\nn\nu\ne\n \nn\na\nr\nc\no\nt\ni\nc\ns\n:\n \ns\nh\no\nr\nt\ne\nr\n \nf\no\nr\n \n2\nM\nI\n \nt\nh\na\nn\nM\nI\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nn\no\nr\nm\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\n:\n \ns\nh\no\nr\nt\ne\nr\n \nf\no\nr\n \nM\nI\nt\nh\na\nn\n \n2\nM\nI\nT\ni\nm\ne\n \nt\no\n \nd\ni\ns\nc\no\nn\nt\ni\nn\nu\ne\n \na\nm\nb\nu\nl\na\nt\no\nr\ny\n \na\ni\nd\ns\n:\n \ns\nh\no\nr\nt\ne\nr\n \nf\no\nr\n \nM\nI\nT\ni\nm\ne\n \nt\no\n \nc\nl\ni\nm\nb\n \ns\nt\na\ni\nr\ns\n:\n \ns\nh\no\nr\nt\ne\nr\n \nf\no\nr\n \nM\nI\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n150\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nY\na\nn\n,\n \n2\n0\n0\n5\n5\n7\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nq\nu\na\ns\ni\n-\nR\nC\nT\n;\n \nr\na\nn\nd\no\nm\ni\ns\na\nt\ni\no\nn\nm\ne\nt\nh\no\nd\n \nn\no\nt\nd\ne\ns\nc\nr\ni\nb\ne\nd\nL\no\nc\na\nt\ni\no\nn\n:\n \nC\nh\ni\nn\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nD\ne\nc\ne\nm\nb\ne\nr\n \n2\n0\n0\n3\n\u2013\nJ\nu\nn\ne\n \n2\n0\n0\n4\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n6\nm\no\nn\nt\nh\ns\n \nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \ng\no\no\nd\n \nh\ne\na\nl\nt\nh\n(\nb\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n<\n1\n0\n0\n \nk\ng\n)\n,\n \nn\no\no\ns\nt\ne\no\np\no\nr\no\ns\ni\ns\n \na\nn\nd\n \nn\no\n \nd\ne\nf\no\nr\nm\ni\nt\ny\n,\nl\no\nw\n \nl\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ns\nh\no\nr\nt\ni\nn\ng\n \n\u0001\n2\nc\nm\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n3\n0\nN\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n:\n \n3\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \nM\nI\n \n6\n,\nS\nI\n7\n;\n \no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n \no\nf\n \nf\ne\nm\no\nr\na\nl\nh\ne\na\nd\n \nM\nI\n \n8\n,\n \nS\nI\n \n6\n;\n \nf\ne\nm\no\nr\na\nl\n \nf\nr\na\nc\nt\nu\nr\ne\nM\nI\n \n1\n,\n \nS\nI\n \n3\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nM\nI\n \n6\n3\n \n[\n5\n1\n\u2013\n6\n9\n]\n,\n \nS\nI\n \n6\n1\n[\n5\n0\n\u2013\n7\n0\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nM\nI\n \n6\n\/\n9\n,\n \nS\nI\n \n7\n\/\n8\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nM\nI\n \n5\n7\n,\n \nS\nI\n \n6\n2\n2\nM\nI\n:\n \nN\n=\n1\n5\n \nS\nI\n:\n \nN\n=\n \n1\n5\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nT\nH\nR\n \nw\ni\nt\nh\n3\n.\n6\n \n[\n3\n.\n0\n\u2013\n4\n.\n5\n]\n \na\nn\nd\n \n5\n.\n7\n[\n5\n.\n4\n\u2013\n6\n.\n5\n]\n-\nc\nm\n \ni\nn\nc\ni\ns\ni\no\nn\ns\n \nS\nI\n:\n \n1\n2\n.\n0\n \n[\n9\n\u2013\n1\n4\n]\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \np\no\ns\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\na\np\np\nr\no\na\nc\nh\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nM\nI\n \n1\n5\n,\n \n1\n0\n0\n \n[\n9\n0\n\u2013\n2\n2\n0\n]\n,\n \nS\nI\n \n1\n5\n,\n \n8\n0\n \n[\n6\n0\n\u2013\n1\n5\n0\n]\n,\n \np\n<\n0\n.\n0\n5\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\nM\nI\n \n1\n5\n,\n \n7\n6\n0\n \n[\n6\n0\n0\n\u2013\n1\n2\n0\n0\n]\n,\n \nS\nI\n \n1\n5\n,\n \n6\n5\n0\n \n[\n5\n0\n0\n\u2013\n8\n0\n0\n]\n,\np\n<\n0\n.\n0\n5\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n1\n5\n,\n \nS\nI\n \n0\n\/\n1\n5\nI\nn\nf\ne\nc\nt\ni\no\nn\n:\n \nM\nI\n \n0\n\/\n1\n5\n,\n \nS\nI\n \n0\n\/\n1\n5\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n \n(\nt\nh\ni\ng\nh\n)\n:\n \nM\nI\n \n1\n\/\n1\n5\n,\n \nS\nI\n \n0\n\/\n1\n5\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \nM\nI\n \n1\n\/\n1\n5\n,\n \nS\nI\n \n1\n\/\n1\n5\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\n:\n \nM\nI\n \n6\n,\n \nS\nI\n \n1\n3\n,\np\n<\n0\n.\n0\n0\n1\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n)\nF\ne\nm\no\nr\na\nl\n \ns\nt\ne\nm\n:\n \na\nl\nl\n \nn\ne\nu\nt\nr\na\nl\n \np\no\ns\ni\nt\ni\no\nn\nA\nb\nd\nu\nc\nt\ni\no\nn\n \no\nf\n \nt\nh\ne\n \nc\nu\np\n:\n \nM\nI\n \n[\n4\n1\n\u2013\n4\n7\n\u00b0\n]\n,\n \nS\nI\n \n[\n4\n0\n\u2013\n5\n3\n\u00b0\n]\n,\np\n<\n0\n.\n0\n5\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nA\nt\n \n1\n \nw\ne\ne\nk\n:\n \nM\nI\n \n8\n1\n,\n \nS\nI\n \n7\n2\n,\n \np\n<\n0\n.\n0\n5\n \nA\nt\n \n6\n \nw\ne\ne\nk\ns\n:\n \nM\nI\n \n8\n9\n,\n \nS\nI\n \n8\n6\n,\n \np\n<\n \n0\n.\n0\n5\n \nA\nt\n \n3\n \nm\no\nn\nt\nh\ns\n:\n \nM\nI\n \n9\n2\n,\n \nS\nI\n \n9\n1\n,\n \np\n>\n \n0\n.\n0\n5\nA\nt\n \n6\n \nm\no\nn\nt\nh\ns\n:\n \nM\nI\n \n9\n3\n,\n \nS\nI\n \n9\n3\n,\n \np\n>\n \n0\n.\n0\n5\nL\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ni\nn\ne\nq\nu\na\nl\ni\nt\ny\n \n(\nc\nm\n)\n:\n \nM\nI\n \n0\n,\n \n0\n.\n3\n \n[\n0\n.\n2\n\u2013\n0\n.\n5\n]\n,\n \nS\nI\n \n1\n5\n,\n \n0\n.\n5\n[\n0\n.\n3\n\u2013\n0\n.\n9\n]\n,\n \np\n<\n0\n.\n0\n5C\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ni\ne\ns\nHealth Technology Assessment 2008; Vol. 12: No. 26\n151\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nD\nu\nw\ne\nl\ni\nu\ns\n,\n \n2\n0\n0\n7\n3\n8\n,\n6\n2\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nm\na\nt\nc\nh\ne\nd\n \np\na\ni\nr\ns\n;\nm\na\nt\nc\nh\ne\nd\n \nf\no\nr\n \na\ng\ne\n,\ng\ne\nn\nd\ne\nr\n,\n \nB\nM\nI\n,\nd\ni\na\ng\nn\no\ns\ni\ns\n,\n \nf\no\nl\nl\no\nw\n-\nu\np\nl\ne\nn\ng\nt\nh\n \na\nn\nd\n \nW\nO\nM\nA\nC\ns\nc\no\nr\ne\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nD\ne\nc\ne\nm\nb\ne\nr\n \n2\n0\n0\n2\n\u2013\nJ\nu\nn\ne\n \n2\n0\n0\n4\nF\nu\nn\nd\ni\nn\ng\n:\nm\na\nn\nu\nf\na\nc\nt\nu\nr\ne\nr\n(\nZ\ni\nm\nm\ne\nr\n)\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n:\n \n1\n.\n2\n[\n0\n.\n5\n\u2013\n2\n.\n0\n]\n \ny\ne\na\nr\ns\n;\n \no\nn\ne\nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n:\n \n1\n.\n1\n[\n0\n.\n5\n\u2013\n2\n.\n0\n]\n \ny\ne\na\nr\ns\n;\n1\n3\n\/\n4\n3\n \ni\nn\n \ne\na\nc\nh\n \ng\nr\no\nu\np\nh\na\nd\n \n1\n-\ny\ne\na\nr\n \nF\nU\n \nd\na\nt\na\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nb\no\nt\nh\n \nt\nw\no\n-\n \na\nn\nd\no\nn\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nM\nI\nS\n:\n \np\na\nt\ni\ne\nn\nt\ns\n \na\ng\ne\nd\n1\n8\ny\ne\na\nr\ns\n \no\nr\n \no\nl\nd\ne\nr\n \na\nt\n \nt\nh\ne\n \nt\ni\nm\ne\n \no\nf\nT\nH\nR\n \na\nn\nd\n \nw\nh\no\n \nc\no\nm\np\nl\ne\nt\ne\nd\n \nt\nh\ne\nw\ne\ne\nk\nl\ny\n \np\na\nt\ni\ne\nn\nt\n \nd\ni\na\nr\ny\nF\no\nr\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n:\n \na\ng\ne\n \n<\n7\n0\ny\ne\na\nr\ns\n;\nB\nM\nI\n<\n4\n0\n;\n \np\na\nt\ni\ne\nn\nt\ns\n \nw\nh\no\n \nd\no\n \nn\no\nt\nh\na\nv\ne\n \na\n \nC\nr\no\nw\ne\n \nd\ny\ns\np\nl\na\ns\ni\na\nc\nl\na\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n \no\nf\n \nc\nl\na\ns\ns\n \nI\nI\nI\n \no\nr\n \nI\nV\n \na\nn\nd\nd\no\n \nn\no\nt\n \nh\na\nv\ne\n \na\nn\n \ne\nx\nc\ne\ns\ns\ni\nv\ne\na\nn\nt\ne\nr\ni\no\nr\n\u2013\np\no\ns\nt\ne\nr\ni\no\nr\n \nb\no\nw\n \no\nf\n \nt\nh\ne\nf\ne\nm\nu\nr\n;\n \nt\nh\ne\n \nd\ni\na\nm\ne\nt\ne\nr\n \no\nf\n \nt\nh\ne\ni\nn\nt\nr\na\nm\ne\nd\nu\na\nl\nl\ny\n \nc\na\nn\na\nl\n \no\nf\n \nt\nh\ne\n \nf\ne\nm\nu\nr\nd\no\n \nn\no\nt\n \ne\nx\nc\ne\ne\nd\n \n1\n8\n \nm\nm\n \na\nn\nd\n \nt\nh\ne\ns\ni\nz\ne\n \no\nf\n \nt\nh\ne\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\nu\np\n \nd\no\n \nn\no\nt\ne\nx\nc\ne\ne\nd\n \n6\n4\n \nm\nm\nN\no\n \ns\ne\nl\ne\nc\nt\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n \nf\no\nr\n \no\nn\ne\n \nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n;\n \na\nn\ny\n \np\na\nt\ni\ne\nn\nt\ns\n \nw\nh\no\n \nd\ni\nd\n \nn\no\nt\nf\ni\nt\n \nt\nh\ne\n \nc\nr\ni\nt\ne\nr\ni\na\n \nf\no\nr\n \nt\nh\ne\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\np\nr\no\nc\ne\nd\nu\nr\ne\n \nw\ne\nr\ne\n \ni\nn\nc\nl\nu\nd\ne\nd\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n2\n8\n4\n \nN\nm\na\nt\nc\nh\ne\nd\n:\n \n8\n6\nL\no\ns\nt\n \nt\no\n \nF\nU\n \n(\na\nt\n \n1\n2\n \nm\no\nn\nt\nh\ns\n)\n:\n \n2\nM\nI\n \n6\n,\nM\nI\n \n1\n3\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n2\nM\nI\n4\n3\n\/\n4\n3\n,\n \nM\nI\n \n4\n3\n\/\n4\n3\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \n2\nM\nI\n \n5\n7\n.\n4\n \n(\n6\n.\n3\n)\n[\n4\n0\n\u2013\n6\n8\n]\n,\n \nM\nI\n \n5\n9\n.\n1\n \n(\n8\n.\n2\n)\n \n[\n4\n3\n\u2013\n7\n4\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n2\nM\nI\n \n2\n4\n\/\n1\n9\n,\n \nM\nI\n \n2\n4\n\/\n1\n9\n2\nM\nI\n:\n \nN\n=\n \n4\n3\nM\nI\n:\n \nN\n=\n \n4\n3\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\n2\nM\nI\n:\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nm\ni\nn\ni\nm\na\nl\nl\ny\ni\nn\nv\na\ns\ni\nv\ne\n \ns\nu\nr\ng\ne\nr\ny\n4\n3\n\/\n4\n3\n \nt\nr\ni\nl\no\ng\ny\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n+\n \n1\n \no\nr\n \n2\ns\nc\nr\ne\nw\ns\n)\n,\n \n4\n3\n\/\n4\n3\n \nf\nu\nl\nl\ny\n \nc\no\na\nt\ne\nd\nf\ne\nm\no\nr\na\nl\n \ns\nt\ne\nm\n \nM\nI\n:\n \ns\ni\nn\ng\nl\ne\n \np\no\ns\nt\ne\nr\ni\no\nr\n \nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nm\ni\nn\ni\nm\na\nl\nl\ny\n \ni\nn\nv\na\ns\ni\nv\ne\ns\nu\nr\ng\ne\nr\ny\n4\n3\n\/\n4\n3\n \nt\nr\ni\nl\no\ng\ny\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\nc\no\nm\np\no\nn\ne\nn\nt\n1\n1\n\/\n4\n3\n \nV\ne\nr\nS\ny\ns\n \nF\nu\nl\nl\nC\no\na\nt\n \ns\nt\ne\nm\n,\n3\n2\n\/\n4\n3\n \nV\ne\nr\nS\ny\ns\n \nF\ni\nb\ne\nr\n \nM\ne\nt\na\nl\nM\ni\nd\nC\no\na\nt\n \ns\nt\ne\nm\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \nb\ny\n \ne\nx\np\ne\nr\ni\ne\nn\nc\ne\nd\ns\nu\nr\ng\ne\no\nn\n(\ns\n)\n \n\u2013\n \nn\no\nt\n \np\na\nr\nt\n \no\nf\n \nt\nh\ne\ni\nn\ni\nt\ni\na\nl\n \n\u2018\nl\ne\na\nr\nn\ni\nn\ng\n \nc\nu\nr\nv\ne\n\u2019\n \n\u2013\n \nw\ni\nt\nh\ni\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nl\nu\no\nr\no\ns\nc\no\np\ny\n;\ns\nu\nr\ng\ni\nc\na\nl\n \nt\ne\nc\nh\nn\ni\nq\nu\ne\n \nd\ne\ns\nc\nr\ni\nb\ne\nd\ne\nl\ns\ne\nw\nh\ne\nr\ne\n \n(\ns\ne\ne\n \np\n.\n5\n0\n \ni\nn\nr\ne\nf\n.\n3\n8\n \nf\no\nr\n \nr\ne\nf\ne\nr\ne\nn\nc\ne\n)\n \nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\n2\nM\nI\n \n4\n3\n,\n \n9\n3\n.\n7\n \n(\n9\n0\n)\n \n[\n7\n2\n\u2013\n1\n3\n5\n]\n,\n \nM\nI\n \n4\n3\n,\n \n6\n1\n.\n7\n(\n6\n0\n)\n \n[\n3\n9\n\u2013\n1\n1\n1\n]\n,\n \np\n=\n \n0\n.\n0\n0\n2\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\na\ns\n \nc\no\nl\nl\ne\nc\nt\ne\nd\n \ni\nn\n \na\nc\ne\nl\nl\n \ns\na\nv\ne\nr\n)\n \n(\nm\nl\n)\n2\nM\nI\n \n4\n3\n,\n \n3\n6\n6\n \n(\n2\n1\n5\n)\n \n[\n1\n5\n0\n\u2013\n1\n4\n0\n0\n]\n,\n \nM\nI\n \n4\n3\n,\n \n2\n4\n7\n(\n9\n0\n)\n \n[\n1\n0\n0\n\u2013\n4\n5\n0\n]\n,\n \np\n=\n \n0\n.\n0\n0\n1\n \nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\n \n(\nf\ne\nm\no\nr\na\nl\n \nn\ne\nc\nk\n)\n:\n2\nM\nI\n3\n\/\n4\n3\n,\n \nM\nI\n \n1\n\/\n4\n3\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\nS\nc\ni\na\nt\ni\nc\n,\n \np\ne\nr\no\nn\ne\na\nl\n \no\nr\n \nc\no\nm\nm\no\nn\n \nf\ne\nm\no\nr\na\nl\n \nn\ne\nr\nv\ne\ni\nn\nj\nu\nr\ny\n:\n \n2\nM\nI\n \n0\n\/\n4\n3\n,\n \nM\nI\n \n0\n\/\n4\n3\nS\no\nm\ne\n \nn\nu\nm\nb\nn\ne\ns\ns\n \ni\nn\n \nt\nh\ne\n \na\nn\nt\ne\nr\no\nl\na\nt\ne\nr\na\nl\n \nt\nh\ni\ng\nh\n:\n2\nM\nI\n \n6\n\/\n4\n3\n \n,\n \nM\nI\n \n0\n\/\n4\n3\n \nN\ne\nr\nv\ne\n \np\na\ni\nn\n:\n \n2\nM\nI\n \n0\n\/\n4\n3\n,\n \nM\nI\n \n0\n\/\n4\n3\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nh\no\nu\nr\ns\n)\n:\n \n2\nM\nI\n \n4\n3\n,\n \n3\n0\n.\n7\n[\n1\n2\n.\n9\n\u2013\n5\n5\n.\n7\n]\n,\n \nM\nI\n \n4\n3\n,\n \n4\n4\n.\n6\n \n[\n1\n3\n\u2013\n1\n0\n2\n]\n,\np\n<\n0\n.\n0\n0\n1\n,\n \ni\n.\ne\n.\n \nM\nI\n \n1\n.\n2\n5\n \n[\n0\n.\n5\n\u2013\n2\n.\n3\n]\n \nd\na\ny\ns\n,\n \nS\nI\n1\n.\n9\n[\n0\n.\n5\n\u2013\n4\n.\n3\n]\n \nd\na\ny\ns\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\nP\nr\ne\ns\nc\nr\ni\np\nt\ni\no\nn\n \na\nn\nt\ni\n-\ni\nn\nf\nl\na\nm\nm\na\nt\no\nr\ny\n \nu\ns\ne\n:\n \n2\nM\nI\n4\n7\n%\n \n(\n2\n0\n\/\n4\n3\n)\n,\n \nM\nI\n \n2\n3\n%\n \n(\n1\n0\n\/\n4\n3\n)\n,\n \np\n=\n \n0\n.\n0\n4\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\n \nT\ni\nm\ne\n \nt\no\n \nr\ne\ns\nu\nm\ne\n \nd\nr\ni\nv\ni\nn\ng\n \n(\nd\na\ny\ns\n)\n:\n \n2\nM\nI\n \n4\n3\n,\n \n1\n3\n[\n2\n\u2013\n3\n1\n]\n,\n \nM\nI\n \n4\n3\n,\n \n2\n4\n \n[\n6\n\u2013\n3\n2\n]\n,\n \np\n=\n \n0\n.\n0\n4\nT\ni\nm\ne\n \nt\no\n \nr\ne\ns\nu\nm\ne\n \ns\nh\no\np\np\ni\nn\ng\n \n(\nd\na\ny\ns\n)\n:\n \n2\nM\nI\n \n4\n3\n,\n1\n4\n \n[\n3\n\u2013\n2\n4\n]\n,\n \nM\nI\n \n4\n3\n,\n \n2\n6\n \n[\n6\n\u2013\n3\n7\n]\n,\n \np\n=\n \n0\n.\n0\n1\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n \na\nt\n6\nw\ne\ne\nk\ns\n \no\nr\n \n3\n \nm\no\nn\nt\nh\ns\n)\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\nf\nr\no\nm\n \ng\nr\na\np\nh\n)\n:\n \n6\n \nw\ne\ne\nk\ns\n:\n \n2\nM\nI\n \n8\n4\n,\n \nM\nI\n \n8\n4\n3\n \nm\no\nn\nt\nh\ns\n:\n \n2\nM\nI\n \n8\n9\n,\n \nM\nI\n \n8\n8\n6\n \nm\no\nn\nt\nh\ns\n:\n \n2\nM\nI\n \n9\n4\n,\n \nM\nI\n \n8\n8\n1\n \ny\ne\na\nr\n:\n \n2\nM\nI\n \n9\n4\n,\n \nM\nI\n \n8\n8\n2\nM\nI\n \nb\ne\nt\nt\ne\nr\n \nt\nh\na\nn\n \nM\nI\n:\n \nn\no\n \na\ns\ns\ni\ns\nt\ni\nv\ne\n \nd\ne\nv\ni\nc\ne\nn\ne\ne\nd\ne\nd\n \na\nt\n \n2\n \nw\ne\ne\nk\ns\n \n(\np\n=\n \n0\n.\n0\n0\n1\n)\n \na\nn\nd\nn\ne\ng\no\nt\ni\na\nt\ni\nn\ng\n \ns\nt\na\ni\nr\ns\n \nw\ni\nt\nh\no\nu\nt\n \na\n \nr\na\ni\nl\ni\nn\ng\n \na\nt\n5\nw\ne\ne\nk\ns\n \n(\np\n=\n \n0\n.\n0\n0\n4\n)\nA\nl\ns\no\n \ni\nn\n \nF\ni\ng\nu\nr\ne\n \n1\n:\n \nW\nO\nM\nA\nC\n \np\nh\ny\ns\ni\nc\na\nl\n \nf\nu\nn\nc\nt\ni\no\nn\n,\nW\nO\nM\nA\nC\n \ns\nt\ni\nf\nf\nn\ne\ns\ns\n.\n \nT\nh\ne\ns\ne\n \nd\no\n \nn\no\nt\n \na\np\np\ne\na\nr\n \nt\no\nb\ne\n \ns\ni\ng\nn\ni\nf\ni\nc\na\nn\nt\nl\ny\n \nd\ni\nf\nf\ne\nr\ne\nn\nt\n \nb\ne\nt\nw\ne\ne\nn\n \ng\nr\no\nu\np\ns\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \n2\nM\nI\n \n0\n\/\n4\n3\n,\n \nM\nI\n \n0\n\/\n4\n3\nH\ne\na\nl\nt\nh\n-\nr\ne\nl\na\nt\ne\nd\n \nq\nu\na\nl\ni\nt\ny\n \no\nf\n \nl\ni\nf\ne\nS\nF\n-\n3\n6\n \np\nh\ny\ns\ni\nc\na\nl\n \nf\nu\nn\nc\nt\ni\no\nn\n \n(\nF\ni\ng\nu\nr\ne\n \n1\n)\n:\n \n2\nM\nI\n \n8\n0\n,\nM\nI\n \n7\n0\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\nW\nO\nM\nA\nC\n \np\na\ni\nn\n \ns\nc\no\nr\ne\n \n(\nf\nr\no\nm\n \ng\nr\na\np\nh\n)\n6\n \nw\ne\ne\nk\ns\n:\n \n2\nM\nI\n \n2\n,\n \nM\nI\n \n2\n.\n5\n6\n \nm\no\nn\nt\nh\ns\n:\n \n2\nM\nI\n \n1\n.\n8\n,\n \nM\nI\n \n1\n.\n6\n1\n \ny\ne\na\nr\n:\n \n2\nM\nI\n \n1\n.\n6\n,\n \nM\nI\n \n1\n.\n6\nT\no\nt\na\nl\n \nW\nO\nM\nA\nC\n \np\na\ni\nn\n \ns\nu\nb\ns\nc\na\nl\ne\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n:\n2\nM\nI\n \n3\n.\n3\n1\n \n[\n0\n\u2013\n1\n1\n]\n,\n \nM\nI\n \n1\n.\n2\n2\n \n[\n0\n\u2013\n1\n0\n]\n,\n \np\n=\n \n0\n.\n0\n0\n3\n \nM\nI\n \nb\ne\nt\nt\ne\nr\n \nt\nh\na\nn\n \n2\nM\nI\n:\n \nn\no\n \np\na\ni\nn\n \na\nt\n \nn\ni\ng\nh\nt\n \na\nt\n6\nw\ne\ne\nk\ns\n \n(\np\n=\n \n0\n.\n0\n0\n2\n8\n)\n \na\nn\nd\n \np\na\ni\nn\n \na\nt\n \nn\ni\ng\nh\nt\n \ni\nn\nb\ne\nd\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n \n(\np\n=\n \n0\n.\n0\n0\n4\n)\nS\nF\n-\n3\n6\n \nb\no\nd\ni\nl\ny\n \np\na\ni\nn\n \n(\nf\nr\no\nm\n \ng\nr\na\np\nh\n)\n:\n6\n \nw\ne\ne\nk\ns\n:\n \n2\nM\nI\n \n6\n8\n,\n \nM\nI\n \n7\n6\n6\n \nm\no\nn\nt\nh\ns\n:\n \n2\nM\nI\n \n7\n5\n,\n \nM\nI\n \n7\n5\n1\n \ny\ne\na\nr\n:\n \n2\nM\nI\n \n7\n6\n,\n \nM\nI\n \n7\n5\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n152\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\nN\no\nr\nm\na\nl\n \n(\n<\n2\n5\n)\n:\n \n2\nM\nI\n \n2\n1\n\/\n4\n3\n,\nM\nI\n2\n1\n\/\n4\n3\nO\nv\ne\nr\nw\ne\ni\ng\nh\nt\n \n(\n2\n5\n\u2013\n3\n0\n)\n:\n \n2\nM\nI\n \n1\n5\n\/\n4\n3\n,\nM\nI\n \n1\n5\n\/\n4\n3\nO\nb\ne\ns\ne\n \n(\n>\n3\n0\n)\n:\n \n2\nM\nI\n \n7\n\/\n4\n3\n,\n \nM\nI\n \n7\n\/\n4\n3\nW\nO\nM\nA\nC\n \np\na\ni\nn\n:\n \n2\nM\nI\n \n9\n.\n1\n \n(\n2\n.\n8\n)\n[\n4\n\u2013\n1\n5\n]\n,\n \nM\nI\n \n9\n.\n0\n \n(\n2\n.\n9\n)\n \n[\n2\n\u2013\n1\n4\n]\n \nW\nO\nM\nA\nC\n \np\nh\ny\ns\ni\nc\na\nl\n \nf\nu\nn\nc\nt\ni\no\nn\n:\n \n2\nM\nI\n2\n8\n.\n4\n \n(\n9\n.\n6\n)\n \n[\n5\n\u2013\n4\n5\n]\n,\n \nM\nI\n \n2\n9\n.\n8\n \n(\n9\n.\n8\n)\n[\n8\n\u2013\n4\n5\n]\nW\nO\nM\nA\nC\n \nf\ni\nt\nn\ne\ns\ns\n:\n \n2\nM\nI\n \n3\n.\n9\n \n(\n1\n.\n6\n)\n[\n1\n\u2013\n8\n]\n,\n \nM\nI\n \n4\n.\n4\n \n(\n1\n.\n4\n)\n \n[\n2\n\u2013\n8\n]\n \nS\nt\ne\nm\n \ni\nn\n \n\u0005\n3\n\u00b0\nv\na\nr\nu\ns\n:\n \n2\nM\nI\n \n1\n\/\n4\n3\n,\n \nM\nI\n \n1\n\/\n4\n3\n;\n \na\nl\nl\n \no\nt\nh\ne\nr\n \ns\nt\ne\nm\ns\n \ni\nn\n \nn\ne\nu\nt\nr\na\nl\n \na\nl\ni\ng\nn\nm\ne\nn\nt\nC\nu\np\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \n(\nN\no\nf\n \no\nu\nt\nl\ni\ne\nr\ns\n;\n \nt\na\nr\ng\ne\nt\n \n4\n5\n\u00b0\n)\n:\n2\nM\nI\n \n4\n\/\n4\n3\n \n(\n>\n5\n0\n\u00b0\n)\n,\n \nM\nI\n \n2\n\/\n4\n3\n \nC\nu\np\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \na\nn\ng\nl\ne\n:\n \n2\nM\nI\n \n4\n3\n,\n \n4\n9\n.\n4\n\u00b0\n(\n4\n.\n2\n)\n[\n4\n1\n\u2013\n6\n0\n]\n,\n \nM\nI\n \n4\n3\n,\n \n4\n5\n.\n6\n\u00b0\n(\n5\n.\n3\n)\n \n[\n3\n5\n\u2013\n5\n7\n]\n,\np\n=\n0\n.\n0\n0\n0\n3\nC\nu\np\n \na\nn\nt\ne\nv\ne\nr\ns\ni\no\nn\n:\n \n2\nM\nI\n \n4\n3\n,\n \n2\n0\n.\n2\n\u00b0\n(\n5\n.\n3\n)\n \n[\n5\n\u2013\n2\n5\n]\n,\nM\nI\n \n4\n3\n,\n \n1\n8\n.\n4\n \n(\n7\n.\n9\n)\n \n[\n0\n\u2013\n3\n5\n]\n,\n \np\n=\n \n0\n.\n2\n6\n2\n4\nN\nB\n:\n \nr\na\nd\ni\no\ng\nr\na\np\nh\ns\n \nw\ne\nr\ne\n \np\ne\nr\nf\no\nr\nm\ne\nd\ni\nm\nm\ne\nd\ni\na\nt\ne\nl\ny\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n,\n \na\nt\n \n6\n \nw\ne\ne\nk\ns\n,\n3\nm\no\nn\nt\nh\ns\n,\n \n6\n \nm\no\nn\nt\nh\ns\n \na\nn\nd\n \na\nn\nn\nu\na\nl\n \nv\ni\ns\ni\nt\ns\n \nM\ne\nd\ni\nc\na\nl\n \nO\nu\nt\nc\no\nm\ne\ns\n \nS\nt\nu\nd\ny\n \n(\nM\nO\nS\n)\n \ns\nl\ne\ne\np\n \ns\nc\na\nl\ne\n:\nM\nI\n \nb\ne\nt\nt\ne\nr\n \nt\nh\na\nn\n \nS\nI\n:\n \nn\no\n \nt\nr\no\nu\nb\nl\ne\n \nf\na\nl\nl\ni\nn\ng\n \na\ns\nl\ne\ne\np\n(\np\n=\n0\n.\n0\n0\n0\n4\n)\n \na\nn\nd\n \nn\no\n \nt\nr\no\nu\nb\nl\ne\n \nf\na\nl\nl\ni\nn\ng\n \nb\na\nc\nk\n \nt\no\ns\nl\ne\ne\np\n \n(\np\n=\n0\n.\n0\n0\n3\n)\nL\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ni\nn\ne\nq\nu\na\nl\ni\nt\ny\n \n(\na\nt\n \n6\n \nw\ne\ne\nk\ns\n)\n:\n2\nM\nI\n6\n\/\n3\n9\n,\n \nM\nI\n6\n\/\n3\n8\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\n \no\nu\nt\nc\no\nm\ne\ns\nI\nm\np\nl\na\nn\nt\n \nm\ni\ng\nr\na\nt\ni\no\nn\n \n(\nf\nr\no\nm\n \nt\nh\ne\n \nr\na\nd\ni\no\ng\nr\na\np\nh\n \nw\ni\nt\nh\nt\nh\ne\n \nl\no\nn\ng\ne\ns\nt\n \nf\no\nl\nl\no\nw\n-\nu\np\n)\n:\n \n2\nM\nI\n \n0\n\/\n4\n3\n,\n \nM\nI\n \n0\n\/\n4\n3\n(\nn\no\n \nc\no\nm\np\no\nn\ne\nn\nt\ns\n \ns\nu\nb\ns\ni\nd\ne\nd\n)\nO\nt\nh\ne\nr\nP\na\nt\ni\ne\nn\nt\n \nc\no\nm\np\nl\ni\na\nn\nc\ne\n \n(\nd\ni\na\nr\ny\n \na\nn\nd\n \na\nt\nt\ne\nn\nd\na\nn\nc\ne\n \na\nt\ns\nc\nh\ne\nd\nu\nl\ne\nd\n \ne\nx\na\nm\ni\nn\na\nt\ni\no\nn\n)\n:\n1\n \nw\ne\ne\nk\n:\n \n2\nM\nI\n \n9\n1\n%\n \n[\n8\n6\n\u2013\n9\n5\n]\n,\n \nM\nI\n \n8\n8\n%\n[\n7\n7\n\u2013\n9\n5\n]\n,\n \nN\nS\n6\n \nw\ne\ne\nk\ns\n:\n \n2\nM\nI\n \n4\n1\n\/\n4\n3\n,\n \nM\nI\n \n4\n1\n\/\n4\n3\n6\n \nm\no\nn\nt\nh\ns\n:\n \n2\nM\nI\n \n3\n3\n\/\n4\n3\n,\n \nM\nI\n \n2\n8\n\/\n4\n3\n,\n \nN\nS\n1\n2\n \nm\no\nn\nt\nh\ns\n:\n \n2\nM\nI\n \n2\n6\n\/\n3\n7\n,\n \nM\nI\n \n2\n6\n\/\n3\n0\n,\n \np\n=\n \n0\n.\n0\n9\nG\nr\ne\ni\nd\na\nn\nu\ns\n,\n \n2\n0\n0\n6\n7\n1\n(\na\nb\ns\nt\nr\na\nc\nt\n \no\nn\nl\ny\n)\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\na\nt\ni\nv\ne\n \nc\no\nh\no\nr\nt\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nC\na\nn\na\nd\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\n2\n0\n0\n2\n\u2013\n4\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \nN\nR\n \nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nN\nR\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nC\no\n-\nm\no\nr\nb\ni\nd\n \ns\nt\na\nt\nu\ns\n:\n \nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nW\nO\nM\nA\nC\n:\n \nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nO\nx\nf\no\nr\nd\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\nS\nF\n-\n1\n2\n:\n \nn\no\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n2\nM\nI\n:\n \nN\n=\n \n6\n6\nM\nI\n:\n \nN\n=\n \n9\n9\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\n2\nM\nI\n:\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \na\np\np\nr\no\na\nc\nh\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nS\nh\no\nr\nt\ne\nr\n \nf\no\nr\n \n2\nM\nI\n,\n \np\n<\n \n0\n.\n0\n5\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\nA\nn\na\nl\ng\ne\ns\ni\nc\n \nu\ns\ne\n:\n \nl\ne\ns\ns\n \nf\no\nr\n \n2\nM\nI\n,\n \np\n<\n \n0\n.\n0\n5\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n153\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nP\na\ng\nn\na\nn\no\n,\n \n2\n0\n0\n6\n4\n7\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ny\n;\ns\nt\na\ng\ne\nd\n \nb\ni\nl\na\nt\ne\nr\na\nl\nT\nH\nR\ns\n \n(\n2\nM\nI\n \no\nn\n \no\nn\ne\nh\ni\np\n \na\nn\nd\n \nM\nI\n \no\nn\n \nt\nh\ne\no\nt\nh\ne\nr\n)\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\n2\n0\n0\n3\n\u2013\n4\nF\nu\nn\nd\ni\nn\ng\n:\nm\na\nn\nu\nf\na\nc\nt\nu\nr\ne\nr\n(\nZ\ni\nm\nm\ne\nr\n)\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n6\nm\no\nn\nt\nh\ns\n \na\nf\nt\ne\nr\n \n2\nn\nd\ns\nu\nr\ng\ne\nr\ny\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \ns\nt\na\ng\ne\nd\n \nb\ni\nl\na\nt\ne\nr\na\nl\nT\nH\nR\ns\n;\n \np\na\nt\ni\ne\nn\nt\ns\n \nw\ni\nt\nh\n \na\n \ns\nu\nc\nc\ne\ns\ns\nf\nu\nl\nc\nl\ni\nn\ni\nc\na\nl\n \no\nu\nt\nc\no\nm\ne\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \np\na\nt\ni\ne\nn\nt\ns\n \nw\ni\nt\nh\nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\ns\n \n(\n2\n \ni\nn\n \n2\nM\nI\n,\n \n1\n \ni\nn\n \nM\nI\n)\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n2\n9\nN\ns\ne\nl\ne\nc\nt\ne\nd\n:\n \n2\n7\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nn\no\nn\ne\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n2\n6\n\/\n2\n6\nA\ng\ne\n(\ny\ne\na\nr\ns\n)\n:\n \n6\n9\n \n[\n4\n2\n\u2013\n8\n0\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n1\n0\n\/\n1\n6\n \n2\nM\nI\n:\n \nN\n=\n \n2\n6\nM\nI\n:\n \nN\n=\n \n2\n6\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\n2\nM\nI\n:\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \na\np\np\nr\no\na\nc\nh\nU\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \nh\ne\nm\ni\ns\np\nh\ne\nr\ni\nc\na\nl\na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n \na\nn\nd\nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \nf\ne\nm\no\nr\na\nl\n \ns\nt\ne\nm\nM\nI\n:\n \n6\n\u2013\n9\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\nm\ni\nn\ni\n-\ni\nn\nc\ni\ns\ni\no\nn\n \np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\nU\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \nh\ne\nm\ni\ns\np\nh\ne\nr\ni\nc\na\nl\na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n \na\nn\nd\nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \nf\ne\nm\no\nr\na\nl\n \ns\nt\ne\nm\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\nr\ni\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \no\nn\ne\ns\nu\nr\ng\ne\no\nn\n;\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nT\nH\nR\ns\nd\no\nn\ne\n \nw\ni\nt\nh\n \ni\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nf\nl\nu\no\nr\no\ns\nc\no\np\ny\n;\n \nf\no\nc\nu\ns\n \no\nn\n \ne\na\nr\nl\ny\nf\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\n \n1\n2\n\/\n2\n6\n \np\na\nt\ni\ne\nn\nt\ns\n \nh\na\nd\n \n2\nM\nI\n \nT\nH\nR\nf\ni\nr\ns\nt\n \nt\nh\ne\nn\n \nM\nI\n \nT\nH\nR\n \ni\nn\n \nt\nh\ne\no\nt\nh\ne\nr\n \nh\ni\np\n;\n \n1\n4\n\/\n2\n6\n \nh\na\nd\n \nM\nI\n \nT\nH\nR\nf\ni\nr\ns\nt\n,\n \nt\nh\ne\nn\n \n2\nM\nI\n \nT\nH\nR\n \ni\nn\n \nt\nh\ne\no\nt\nh\ne\nr\n \nh\ni\np\n;\n \ns\ne\nc\no\nn\nd\n \nh\ni\np\no\np\ne\nr\na\nt\ne\nd\n \no\nn\n \nw\ni\nt\nh\ni\nn\n \na\n \n2\n-\ny\ne\na\nr\np\ne\nr\ni\no\nd\n;\n \nu\nn\nc\nl\ne\na\nr\n \nw\nh\ne\nt\nh\ne\nr\ns\nu\nr\ng\ni\nc\na\nl\n \na\np\np\nr\no\na\nc\nh\n \nw\na\ns\nr\na\nn\nd\no\nm\ni\ns\ne\nd\n \nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\n \n(\nf\nr\no\nm\np\na\nt\ni\ne\nn\nt\ns\n\u2019\n \nm\ni\nl\ne\ns\nt\no\nn\ne\n \nd\ni\na\nr\ny\n)\nU\ns\ne\n \no\nf\n \na\nm\nb\nu\nl\na\nt\no\nr\ny\n \na\ni\nd\ns\n \n(\nd\na\ny\ns\n)\n:\n \n2\nM\nI\n \n2\n6\n,\n \n2\n8\n[\n7\n\u2013\n5\n6\n]\n,\n \nM\nI\n \n2\n6\n,\n \n2\n7\n \n[\n5\n\u2013\n4\n9\n]\n,\n \np\n=\n \n0\n.\n7\n5\nR\ne\nt\nu\nr\nn\n \nt\no\n \nd\nr\ni\nv\ni\nn\ng\n \n(\nd\na\ny\ns\n)\n:\n \n2\nM\nI\n \n2\n6\n,\n \n3\n2\n \n[\n8\n\u2013\n4\n9\n]\n,\nM\nI\n \n2\n6\n,\n \n3\n4\n \n[\n2\n0\n\u2013\n5\n6\n]\n,\n \np\n=\n \n0\n.\n3\n8\nR\ne\nt\nu\nr\nn\n \nt\no\n \nw\no\nr\nk\n \n(\nd\na\ny\ns\n)\n:\n \n2\nM\nI\n \n2\n6\n,\n \n4\n2\n \n[\n9\n\u2013\n5\n6\n]\n,\nM\nI\n \n2\n6\n,\n \n3\n8\n \n[\n1\n4\n\u2013\n9\n0\n]\n,\n \np\n=\n \n0\n.\n6\n0\nU\nn\na\ns\ns\ni\ns\nt\ne\nd\n \ns\nt\na\ni\nr\n \nc\nl\ni\nm\nb\ni\nn\ng\n \n(\nd\na\ny\ns\n)\n:\n \n2\nM\nI\n \n2\n6\n,\n \n3\n6\n[\n2\n4\n\u2013\n4\n3\n]\n,\n \nM\nI\n \n2\n6\n,\n \n3\n1\n \n[\n1\n0\n\u2013\n5\n6\n]\n,\n \np\n=\n \n0\n.\n2\n5\nW\na\nl\nk\n \n0\n.\n5\n \nm\ni\nl\ne\n \n(\nd\na\ny\ns\n)\n:\n \n2\nM\nI\n \n2\n6\n,\n \n3\n3\n \n[\n3\n\u2013\n4\n9\n]\n,\nM\nI\n2\n6\n,\n \n3\n3\n \n[\n1\n0\n\u2013\n9\n0\n]\n,\n \np\n=\n \n0\n.\n9\n5\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\nP\na\nt\ni\ne\nn\nt\n \np\nr\ne\nf\ne\nr\ne\nn\nc\ne\n \n(\ns\nu\nr\nv\ne\ny\n \na\nt\n \n6\nm\no\nn\nt\nh\ns\n \na\nf\nt\ne\nr\n2\nn\nd\n \ns\nu\nr\ng\ne\nr\ny\n)\nO\np\ne\nr\na\nt\ni\no\nn\n \np\nr\ne\nf\ne\nr\nr\ne\nd\n:\n \n2\nM\nI\n \n8\n\/\n2\n6\n,\n \nM\nI\n \n1\n6\n\/\n2\n6\n,\nn\no\n \np\nr\ne\nf\ne\nr\ne\nn\nc\ne\n \n2\n\/\n2\n6\n,\n \np\n=\n \n0\n.\n0\n1\n5\nP\nr\ne\nf\ne\nr\nr\ne\nd\n \n2\nM\nI\n \nb\ne\nc\na\nu\ns\ne\n \no\nf\n \nb\ne\nt\nt\ne\nr\n \ne\na\nr\nl\ny\nr\ne\ns\nu\nl\nt\ns\n \n8\n\/\n8\n,\n \nb\ne\nt\nt\ne\nr\n \nc\no\ns\nm\ne\nt\ni\nc\n \nr\ne\ns\nu\nl\nt\ns\n \n0\n\/\n8\n,\nb\no\nt\nh\n \n0\n\/\n8\nP\nr\ne\nf\ne\nr\nr\ne\nd\n \nM\nI\n \nb\ne\nc\na\nu\ns\ne\n \no\nf\n \nb\ne\nt\nt\ne\nr\n \ne\na\nr\nl\ny\n \nr\ne\ns\nu\nl\nt\ns\n8\n\/\n1\n6\n,\n \nb\ne\nt\nt\ne\nr\n \nc\no\ns\nm\ne\nt\ni\nc\n \nr\ne\ns\nu\nl\nt\ns\n \n4\n\/\n1\n6\n,\n \nb\no\nt\nh\n4\n\/\n1\n6\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n154\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nT\na\nn\na\nv\na\nl\ne\ne\n,\n \n2\n0\n0\n6\n5\n3\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\nc\no\nm\np\na\nr\ni\ns\no\nn\n \no\nf\n \nt\nw\no\nc\na\ns\ne\n \ns\ne\nr\ni\ne\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nT\nh\na\ni\nl\na\nn\nd\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nO\nc\nt\no\nb\ne\nr\n \n2\n0\n0\n2\n\u2013\nD\ne\nc\ne\nm\nb\ne\nr\n \n2\n0\n0\n4\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \n1\n.\n7\n[\n1\n\u2013\n3\n]\n \ny\ne\na\nr\ns\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \ns\nt\na\nb\nl\ne\n \nm\ne\nd\ni\nc\na\nl\nc\no\nn\nd\ni\nt\ni\no\nn\n;\n \nD\no\nr\nr\n \nA\n \no\nr\n \nB\n \nf\ne\nm\no\nr\na\nl\nc\na\nn\na\nl\n \nm\no\nr\np\nh\no\nm\ne\nt\nr\ny\n;\n \nl\ne\ng\n \nl\ne\nn\ng\nt\nh\nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \nw\ni\nt\nh\ni\nn\n \n2\n \nc\nm\n;\n \nn\no\np\nr\ne\nv\ni\no\nu\ns\n \nh\ni\np\n \ns\nu\nr\ng\ne\nr\ny\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n7\n0\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \np\nr\ni\nm\na\nr\ny\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n2\nM\nI\n \n5\n,\n \nM\nI\n \n4\n;\n \ns\ne\nc\no\nn\nd\na\nr\ny\no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n2\nM\nI\n \n2\n,\n \nM\nI\n \n8\n;\nr\nh\ne\nu\nm\na\nt\no\ni\nd\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n \n2\nM\nI\n \n0\n,\n \nM\nI\n \n1\n;\na\nv\na\ns\nc\nu\nl\na\nr\n \nn\ne\nc\nr\no\ns\ni\ns\n:\n \n2\nM\nI\n \n2\n7\n,\n \nM\nI\n \n1\n5\n;\nd\ne\nv\ne\nl\no\np\nm\ne\nn\nt\na\nl\n \nd\ny\ns\np\nl\na\ns\ni\na\n \no\nf\n \nt\nh\ne\n \nh\ni\np\n2\nM\nI\n \n5\n,\n \nM\nI\n \n4\n;\n \no\nt\nh\ne\nr\ns\n:\n \n2\nM\nI\n \n1\n,\n \nM\nI\n \n4\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \n2\nM\nI\n \n5\n3\n \n[\n3\n4\n\u2013\n7\n5\n]\n,\nM\nI\n5\n4\n.\n9\n \n[\n3\n8\n\u2013\n7\n6\n]\n,\n \nN\nS\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n2\nM\nI\n \n8\n\/\n2\n7\n,\n \nM\nI\n \n2\n0\n\/\n1\n5\n,\np\n=\n0\n.\n0\n0\n7\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \n2\nM\nI\n \n2\n5\n \n[\n1\n7\n.\n1\n\u2013\n3\n3\n.\n3\n]\n,\nM\nI\n \n2\n4\n.\n2\n \n[\n1\n9\n.\n3\n\u2013\n3\n3\n.\n3\n]\n,\n \nN\nS\n2\nM\nI\n:\n \nN\n=\n \n3\n5\n \n(\n4\n0\n \nh\ni\np\ns\n)\nM\nI\n:\n \nN\n=\n \n3\n5\n \n(\n3\n6\n \nh\ni\np\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\n2\nM\nI\n:\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \na\np\np\nr\no\na\nc\nh\nw\ni\nt\nh\n \n5\n.\n2\n \n[\n4\n.\n5\n\u2013\n6\n]\n-\nc\nm\n \na\nn\nt\ne\nr\ni\no\nr\na\nn\nd\n \n3\n.\n6\n \n[\n3\n\u2013\n4\n]\n \np\no\ns\nt\ne\nr\ni\no\nr\ni\nn\nc\ni\ns\ni\no\nn\ns\n \nC\ne\nm\ne\nn\nt\nl\ne\ns\ns\nM\nI\n:\n \n9\n \n[\n7\n\u2013\n1\n2\n]\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \np\no\ns\nt\ne\nr\ni\no\nr\n \na\np\np\nr\no\na\nc\nh\nC\ne\nm\ne\nn\nt\nl\ne\ns\ns\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\nc\na\ns\ne\ns\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \ns\ni\nn\ng\nl\ne\ns\nu\nr\ng\ne\no\nn\n \nw\nh\no\ns\ne\n \nr\no\nu\nt\ni\nn\ne\na\np\np\nr\no\na\nc\nh\n \ni\ns\n \ns\nt\na\nn\nd\na\nr\nd\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\n \np\no\ns\nt\ne\nr\ni\no\nr\n;\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \na\np\np\nr\no\na\nc\nh\n \ni\nn\nc\nl\nu\nd\ne\nd\nt\nh\ne\n \ns\nu\nr\ng\ne\no\nn\n\u2019\ns\n \nl\ne\na\nr\nn\ni\nn\ng\n \nc\nu\nr\nv\ne\na\nn\nd\n \nw\na\ns\n \nd\no\nn\ne\n \nw\ni\nt\nh\ni\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nl\nu\no\nr\no\ns\nc\no\np\ny\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\n2\nM\nI\n \n3\n5\n,\n \n1\n6\n8\n \n[\n1\n3\n0\n\u2013\n2\n1\n0\n]\n,\n \nM\nI\n \n3\n5\n,\n \n1\n1\n3\n \n[\n9\n0\n\u2013\n1\n4\n0\n]\n,\np\n<\n0\n.\n0\n1\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\n2\nM\nI\n \n2\n\/\n3\n5\n,\n \nM\nI\n \n0\n\/\n3\n5\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\nT\nr\na\nn\ns\ni\ne\nn\nt\n \nn\nu\nm\nb\nn\ne\ns\ns\n \na\nl\no\nn\ng\n \nt\nh\ne\n \na\nn\nt\ne\nr\ni\no\nr\n \nt\nh\ni\ng\nh\n \nf\no\nr\n6\n\u2013\n8\n \nw\ne\ne\nk\ns\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nd\nu\ne\n \nt\no\n \no\nv\ne\nr\n-\nt\nr\na\nc\nt\ni\no\nn\n \no\nf\nt\nh\ne\n \na\nn\nt\ne\nr\ni\no\nr\n \nw\no\nu\nn\nd\n:\n \n2\nM\nI\n \n4\n\/\n3\n5\n,\n \nM\nI\n \n0\n\/\n3\n5\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \n2\nM\nI\n \n2\n\/\n3\n5\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \n1\n \nf\na\nl\nl\na\nt\n \n1\n \nm\no\nn\nt\nh\n)\n,\n \nM\nI\n \n0\n\/\n3\n5\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nu\ns\nu\na\nl\n \na\nc\nt\ni\nv\ni\nt\ni\ne\ns\n \n(\nd\na\ny\ns\n)\nR\ne\nt\nu\nr\nn\n \nt\no\n \nw\na\nl\nk\ni\nn\ng\n \n(\nw\ni\nt\nh\n \na\ni\nd\n)\n:\n \n2\nM\nI\n \n3\n5\n,\n \n1\n.\n2\n \n(\n0\n.\n5\n)\n,\n \nM\nI\n \n3\n5\n,\n \n1\n.\n6\n \n(\n0\n.\n7\n)\n,\n \np\n<\n0\n.\n0\n1\nR\ne\nt\nu\nr\nn\n \nt\no\n \nc\nl\ni\nm\nb\ni\nn\ng\n \ns\nt\na\ni\nr\ns\n:\n \n2\nM\nI\n \n3\n5\n,\n \n9\n \n(\n1\n0\n.\n5\n)\n,\n \nM\nI\n \n3\n5\n,\n \n9\n \n(\n4\n.\n2\n)\n,\n \nN\nS\nR\ne\nt\nu\nr\nn\n \nt\no\n \ni\nn\nd\ne\np\ne\nn\nd\ne\nn\nt\n \nw\na\nl\nk\ni\nn\ng\n \n(\nw\ni\nt\nh\no\nu\nt\n \na\ni\nd\n)\n:\n \n2\nM\nI\n \n3\n5\n,\n \n1\n1\n \n(\n1\n1\n)\n,\n \nM\nI\n \n3\n5\n,\n \n1\n9\n \n(\n8\n.\n6\n)\n,\n \np\n<\n0\n.\n0\n1\nR\ne\nt\nu\nr\nn\n \nt\no\n \nw\no\nr\nk\ni\nn\ng\n:\n \n2\nM\nI\n \n3\n5\n,\n \n3\n \n(\n1\n.\n3\n)\n,\n \nM\nI\n \n3\n5\n,\n \n7\n \n(\n2\n.\n1\n)\n,\np\n<\n0\n.\n0\n1\nR\ne\nt\nu\nr\nn\n \nt\no\n \nd\nr\ni\nv\ni\nn\ng\n \n(\no\nn\nl\ny\n \np\na\nt\ni\ne\nn\nt\ns\n \nw\nh\no\n \nw\ne\nr\ne\n \na\nb\nl\ne\n \nt\no\nd\nr\ni\nv\ne\n \np\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\nl\ny\n)\n:\n \n2\nM\nI\n \n1\n6\n,\n \n3\n,\n \nM\nI\n1\n5\n,\n \n5\n,\np\n<\n0\n.\n0\n1\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n \na\nt\n \nt\nh\ne\n \nm\no\ns\nt\nr\ne\nc\ne\nn\nt\n \nf\no\nl\nl\no\nw\n-\nu\np\n \n\u0005\n1\n \ny\ne\na\nr\n)\nF\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \ni\nn\n \nn\ne\nu\nt\nr\na\nl\n \np\no\ns\ni\nt\ni\no\nn\n:\n \n2\nM\nI\n \n8\n0\n%\n(\n2\n8\n\/\n3\n5\n)\n,\n \nM\nI\n \n8\n3\n%\n \n(\n2\n9\n\/\n3\n5\n)\n,\n \np\n=\n \n0\n.\n7\n2\nA\nc\ne\nt\na\nb\nu\nl\na\nr\n \nc\no\nm\np\no\nn\ne\nn\nt\n \nw\ni\nt\nh\ni\nn\n \nt\nh\ne\n \np\nr\ne\no\np\ne\nr\na\nt\ni\nv\ne\nt\na\nr\ng\ne\nt\n \na\nn\ng\nl\ne\n \no\nf\n \n3\n5\n\u2013\n5\n5\n\u00b0\n:\n \n2\nM\nI\n \n8\n9\n%\n \n(\n3\n1\n\/\n3\n5\n)\n,\n \nM\nI\n \n8\n4\n%\n(\n2\n9\n\/\n3\n5\n)\n,\n \np\n=\n0\n.\n4\n1\nA\nc\ne\nt\na\nb\nu\nl\na\nr\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \na\nn\ng\nl\ne\n:\n \n2\nM\nI\n \n4\n6\n.\n7\n\u00b0\n,\n \nM\nI\n \n4\n4\n.\n8\n\u00b0\nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n>\n1\n \ny\ne\na\nr\n \nF\nU\n:\n \n2\nM\nI\n9\n4\n.\n5\n \n(\n4\n.\n7\n)\n,\n \nM\nI\n \n9\n4\n.\n6\n \n(\n4\n.\n5\n)\n,\n \np\n=\n \n0\n.\n9\n5\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\no\nu\nt\nc\no\nm\ne\ns\nI\nm\np\nl\na\nn\nt\n \nm\ni\ng\nr\na\nt\ni\no\nn\n:\n \n2\nM\nI\n \n0\n\/\n3\n5\n,\n \nM\nI\n \n0\n\/\n3\n5\n(\nn\no\n \nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \ne\nv\ni\nd\ne\nn\nc\ne\n \no\nf\ns\nu\nb\ns\ni\nd\ne\nn\nc\ne\n)\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n155\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nY\no\no\nn\n,\n \n2\n0\n0\n5\n7\n9\n(\na\nb\ns\nt\nr\na\nc\nt\n \no\nn\nl\ny\n)\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\nc\no\nm\np\na\nr\ni\ns\no\nn\n \no\nf\nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \np\na\nt\ni\ne\nn\nt\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nK\no\nr\ne\na\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\ne\na\nr\nl\ny\n \nr\ne\ns\nu\nl\nt\ns\n \no\nn\nl\ny\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n2\n7\n;\no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n \n1\n6\n3\n;\n \nr\nh\ne\nu\nm\na\nt\no\ni\nd\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n8\n;\n \na\nn\nk\ny\nl\no\ns\ni\nn\ng\n \ns\np\no\nn\nd\ny\nl\ni\nt\ni\ns\n6\n;\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n \ns\ne\nq\nu\ne\nl\na\ne\n \n9\n \n2\nM\nI\n:\n \nN\n=\n \n1\n1\n8\nM\nI\n:\n \nN\n=\n \n1\n0\n0\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\n2\nM\nI\n:\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \na\np\np\nr\no\na\nc\nh\nM\nI\n:\n \n7\n.\n5\n-\nc\nm\n \ns\ni\nn\ng\nl\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\na\np\np\nr\no\na\nc\nh\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\n2\nM\nI\n \n7\n2\n[\n5\n0\n\u2013\n1\n1\n5\n]\n,\n \nM\nI\n \n5\n2\n[\n3\n5\n\u2013\n7\n5\n]\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nS\nh\no\nr\nt\ne\nr\n \nf\no\nr\n \n2\nM\nI\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\na\ni\nn\n \nP\ne\nr\ni\no\nd\n \nu\ns\ni\nn\ng\n \nc\nr\nu\nt\nc\nh\ne\ns\n:\n \ns\nh\no\nr\nt\ne\nr\n \nf\no\nr\n \n2\nM\nIAppendix 8\n156\nC\na\ns\ne\n \ns\ne\nr\ni\ne\ns\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nA\nr\nc\nh\ni\nb\ne\nc\nk\n,\n \n2\n0\n0\n4\n2\n7\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\np\nr\no\ns\np\ne\nc\nt\ni\nv\ne\n \ns\nu\nr\nv\ne\ny\no\nf\n \nt\nr\na\ni\nn\ne\ne\n \ns\nu\nr\ng\ne\no\nn\ns\n(\nN\n=\n \n1\n5\n9\n)\n \nd\no\ni\nn\ng\n \n8\n5\n1\nc\na\ns\ne\ns\n,\n \nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\n \nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nO\nc\nt\no\nb\ne\nr\n \n2\n0\n0\n2\n\u2013\nA\np\nr\ni\nl\n2\n0\n0\n4\nF\nu\nn\nd\ni\nn\ng\n:\nm\na\nn\nu\nf\na\nc\nt\nu\nr\ne\nr\n(\nZ\ni\nm\nm\ne\nr\n)\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \nN\nR\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \n1\n5\n9\n \ns\nu\nr\ng\ne\no\nn\ns\nl\ne\na\nr\nn\ni\nn\ng\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nM\nI\n \nr\ne\np\no\nr\nt\ne\nd\n8\n5\n1\n \np\nr\no\nc\ne\nd\nu\nr\ne\ns\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nN\nR\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \n8\n3\n1\n \n(\n8\n5\n1\n \nc\na\ns\ne\ns\n)\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \n6\n6\n0\n\/\n8\n5\n1\n;\np\no\ns\nt\n-\nt\nr\na\nu\nm\na\nt\ni\nc\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n \n1\n0\n\/\n8\n5\n1\n;\no\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n \n1\n3\n8\n\/\n8\n5\n1\n;\n \no\nt\nh\ne\nr\n1\n1\n\/\n8\n5\n1\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \n6\n1\n \n[\n2\n1\n\u2013\n1\n0\n0\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \n4\n3\n5\n\/\n3\n9\n6\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \n7\n7\n.\n6\n \n[\n3\n4\n.\n5\n\u2013\n1\n6\n0\n]\nB\nM\nI\n \n(\nk\ng\n\/\nm\n2\n)\n:\n \n2\n6\n \n[\n1\n0\n\u2013\n5\n6\n]\n\u201c\nP\na\nt\ni\ne\nn\nt\n \nd\ne\nm\no\ng\nr\na\np\nh\ni\nc\ns\n \nf\no\nr\n \n8\n5\n1\nc\na\ns\ne\ns\n \ns\nh\no\nw\ne\nd\n \nt\nh\ne\n \np\no\np\nu\nl\na\nt\ni\no\nn\n \nw\na\ns\nt\ny\np\ni\nc\na\nl\n \nf\no\nr\n \nT\nH\nR\n \np\na\nt\ni\ne\nn\nt\ns\n,\n \nw\ni\nt\nh\n \na\ns\nl\ni\ng\nh\nt\n \np\nr\no\np\ne\nn\ns\ni\nt\ny\n \nf\no\nr\n \ny\no\nu\nn\ng\ne\nr\n \na\nn\nd\nt\nh\ni\nn\nn\ne\nr\n \np\na\nt\ni\ne\nn\nt\ns\n\u201d\n \n(\np\n.\n \n2\n3\n3\n \no\nf\nr\ne\nf\n.\n2\n7\n)\n \n2\nM\nI\n:\n \nN\n=\n \n8\n3\n1\n \n(\n8\n5\n1\n \nc\na\ns\ne\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nT\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nM\nI\nS\n \nw\ni\nt\nh\n \n5\n.\n8\n[\n1\n.\n5\n\u2013\n1\n9\n]\n-\nc\nm\n \na\nn\nt\ne\nr\ni\no\nr\n \ni\nn\nc\ni\ns\ni\no\nn\na\nn\nd\n \n3\n.\n7\n \n[\n1\n\u2013\n2\n1\n]\n-\nc\nm\n \np\no\ns\nt\ne\nr\ni\no\nr\ni\nn\nc\ni\ns\ni\no\nn\nC\ne\nm\ne\nn\nt\nl\ne\ns\ns\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\n \na\nn\nd\nf\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\ns\n \nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\n \na\nl\nl\ns\nu\nr\ng\ne\no\nn\ns\n \na\nt\nt\ne\nn\nd\ne\nd\n \nZ\ni\nm\nm\ne\nr\nt\nr\na\ni\nn\ni\nn\ng\n \no\nn\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\np\nr\no\nc\ne\nd\nu\nr\ne\ns\n \na\nn\nd\n \nw\ne\nr\ne\n \na\ns\nk\ne\nd\nt\no\n \nr\ne\np\no\nr\nt\n \nt\no\n \nt\nh\ne\n \nc\no\nm\np\na\nn\ny\n \no\nn\nt\nh\ne\ni\nr\n \nf\ni\nr\ns\nt\n \n1\n0\n \nc\na\ns\ne\ns\n;\n \n4\n9\n\/\n1\n5\n9\ns\nu\nr\ng\ne\no\nn\ns\n \nc\no\nm\np\nl\ne\nt\ne\nd\n \nt\nh\ne\ni\nr\nf\ni\nr\ns\nt\n \n1\n0\n \nc\na\ns\ne\ns\n \n(\n4\n9\n0\n \ni\nn\nd\ne\nx\nc\na\ns\ne\ns\n,\n \no\nf\n \nw\nh\ni\nc\nh\n \n1\n1\n \nc\na\ns\ne\ns\n \nn\no\nt\nr\ne\np\no\nr\nt\ne\nd\n)\n;\n \nf\nl\nu\no\nr\no\ns\nc\no\np\ny\n \nw\na\ns\nu\ns\ne\nd\n;\n \nd\na\nt\na\n \nw\ne\nr\ne\n \ns\ne\nl\nf\n-\nr\ne\np\no\nr\nt\ne\nd\n \nb\ny\n \nt\nh\ne\n \ns\nu\nr\ng\ne\no\nn\ns\ni\nn\nv\no\nl\nv\ne\nd\n \n(\np\no\ns\ns\ni\nb\nl\ne\n \nu\nn\nd\ne\nr\n-\nr\ne\np\no\nr\nt\ni\nn\ng\n \no\nf\n \nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\ns\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\n:\n \n8\n5\n1\n,\n \n1\n4\n8\n[\n5\n0\n\u2013\n4\n5\n5\n]\nD\ne\nc\nr\ne\na\ns\ne\nd\n \na\ns\n \nN\no\nf\n \nc\na\ns\ne\ns\n \ni\nn\nc\nr\ne\na\ns\ne\nd\n(\np\n<\n0\n.\n0\n5\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nb\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nm\nl\n)\n:\n \n8\n5\n1\n,\n \n4\n9\n6\n[\n3\n0\n\u2013\n2\n8\n0\n0\n]\n \nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \n6\n2\n\/\n8\n5\n1\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\n:\n \n8\n\/\n8\n5\n1\nI\nn\nf\ne\nc\nt\ni\no\nn\nD\ne\ne\np\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n:\n \n4\n\/\n8\n5\n1\nS\nu\np\ne\nr\nf\ni\nc\ni\na\nl\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n:\n \n3\n\/\n8\n5\n1\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\n:\n \n2\n7\n\/\n8\n5\n1\n \nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \n2\n\/\n8\n5\n1\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \n5\n\/\n8\n5\n1\nE\na\nr\nl\ny\n \nr\ne\nv\ni\ns\ni\no\nn\n \no\nr\n \nr\ne\no\np\ne\nr\na\nt\ni\no\nn\n:\n \n8\n\/\n8\n5\n1\n\u2022\n2\n \nr\ne\no\np\ne\nr\na\nt\ni\no\nn\ns\n:\n \nr\ne\nm\no\nv\na\nl\n \nf\no\nr\n \nt\nh\ne\n \nT\nH\nR\nd\no\nn\ne\n \nf\no\nr\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n\u2022\n1\n \no\np\ne\nn\n \nr\ne\nd\nu\nc\nt\ni\no\nn\n \na\nn\nd\n \ni\nn\nt\ne\nr\nn\na\nl\n \nf\ni\nx\na\nt\ni\no\nn\n \nf\no\nr\na\n \nf\ne\nm\no\nr\na\nl\n \ns\nh\na\nf\nt\n \nf\nr\na\nc\nt\nu\nr\ne\n\u2022\n1\n \nr\ne\nv\ni\ns\ni\no\nn\n \nf\no\nr\n \nf\nr\na\nc\nt\nu\nr\ne\n \na\nn\nd\n \ns\nt\ne\nm\ns\nu\nb\ns\ni\nd\ne\nn\nc\ne\n\u2022\n3\n \nr\ne\nv\ni\ns\ni\no\nn\ns\n \nf\no\nr\n \nd\ni\ns\nl\no\nc\na\nt\ni\no\nn\n \n\u2022\n1\n \nr\ne\nv\ni\ns\ni\no\nn\n \nf\no\nr\n \ne\na\nr\nl\ny\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\n \nl\no\no\ns\ne\nn\ni\nn\ng\nO\nt\nh\ne\nr\nS\nu\nb\ng\nr\no\nu\np\n \na\nn\na\nl\ny\ns\ni\ns\n \no\nf\n \n4\n7\n9\n \ni\nn\nd\ne\nx\n \nc\na\ns\ne\ns\n \nb\ny\n \n4\n9\ns\nu\nr\ng\ne\no\nn\ns\n\u2022\np\nr\ne\nv\na\nl\ne\nn\nc\ne\n \no\nf\n \nk\ne\ny\n \nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\ns\n \na\ns\n \na\nf\nu\nn\nc\nt\ni\no\nn\n \no\nf\n \nc\na\ns\ne\n \nn\nu\nm\nb\ne\nr\n \n(\nN\nS\n)\n,\n \ns\nu\nr\ng\ne\no\nn\nv\no\nl\nu\nm\ne\n \no\nf\n \nT\nH\nR\ns\n \nb\ne\nf\no\nr\ne\n \nt\nr\na\ni\nn\ni\nn\ng\n(\np\n=\n0\n.\n0\n0\n0\n3\n)\n \na\nn\nd\n \np\na\nt\ni\ne\nn\nt\n \nB\nM\nI\n \n(\np\n=\n0\n.\n0\n5\n)\n\u2022\nt\no\n \ne\nx\np\nl\na\ni\nn\n \nd\ni\nf\nf\ne\nr\ne\nn\nc\ne\n \nb\ne\nt\nw\ne\ne\nn\n \ns\nu\nr\ng\ne\no\nn\ns\nw\nh\no\n \nd\ni\nd\n \nn\no\nt\n \nr\ne\np\no\nr\nt\n \na\n \nk\ne\ny\n \nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\na\nn\nd\n \nt\nh\no\ns\ne\n \nw\nh\no\n \nd\ni\nd\n \n\u2013\n \nr\ne\ng\nr\ne\ns\ns\ni\no\nn\n \na\nn\na\nl\ny\ns\ni\ns\nc\no\nn\nt\ni\nn\nu\ne\ndHealth Technology Assessment 2008; Vol. 12: No. 26\n157\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nD\nu\nw\ne\nl\ni\nu\ns\n,\n \n2\n0\n0\n3\n1\n7\n,\n3\n7\nS\nt\nu\nd\ny\n \nd\ne\ns\ni\ng\nn\n:\n \nc\na\ns\ne\ns\ne\nr\ni\ne\ns\n \ni\nn\n \n4\n \nc\ne\nn\nt\nr\ne\ns\nL\no\nc\na\nt\ni\no\nn\n:\n \nU\nS\nA\nC\ne\nn\nt\nr\ne\n \n1\n \n(\nC\n1\n)\n:\nP\no\nr\nt\nl\na\nn\nd\n,\n \nO\nR\n(\nD\nu\nw\ne\nl\ni\nu\ns\n)\n;\n \nC\ne\nn\nt\nr\ne\n \n2\n \n(\nC\n2\n)\n:\n \nH\na\nc\nk\ne\nn\ns\na\nc\nk\n,\nN\nJ\n \n(\nH\na\nr\nt\nz\nb\na\nn\nd\n)\n;\nC\ne\nn\nt\nr\ne\n \n3\n \n(\nC\n3\n)\n:\nC\nh\ni\nc\na\ng\no\n,\n \nI\nL\n \n(\nB\ne\nr\ng\ne\nr\n)\n;\nC\ne\nn\nt\nr\ne\n \n4\n \n(\nC\n4\n)\n:\nP\ni\nt\nt\ns\nb\nu\nr\ng\nh\n,\n \nP\nA\n(\nM\ne\na\nr\ns\n)\n \n(\nn\na\nm\ne\n \nr\ne\nf\ne\nr\ns\n \nt\no\n \nl\ne\na\nd\ns\nu\nr\ng\ne\no\nn\n \ni\nn\n \ne\na\nc\nh\nc\ne\nn\nt\nr\ne\n)\nR\ne\nc\nr\nu\ni\nt\nm\ne\nn\nt\n \nd\na\nt\ne\ns\n:\nN\nR\nF\nu\nn\nd\ni\nn\ng\n:\n \nN\nR\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \nF\nU\n:\n \nC\n1\n:\n \n1\n \ny\ne\na\nr\nC\n2\n:\n \n1\n \n[\n0\n.\n2\n5\n\u2013\n1\n.\n5\n]\n \ny\ne\na\nr\n \nC\n3\n:\n \nu\nn\nc\nl\ne\na\nr\nC\n4\n:\n \nu\nn\nc\nl\ne\na\nr\nI\nn\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nC\n1\n:\n \nw\ne\ni\ng\nh\nt\n \n<\n1\n0\n0\nk\ng\n,\n \nl\ne\ns\ns\nm\nu\ns\nc\nu\nl\na\nr\nl\ny\n \nd\ne\nv\ne\nl\no\np\ne\nd\n \nt\nh\na\nn\np\na\nt\ni\ne\nn\nt\ns\n \nw\nh\no\n \nh\na\nd\n \no\nn\ne\n-\ni\nn\nc\ni\ns\ni\no\nn\nT\nH\nR\n,\n \na\ng\ne\n \n<\n7\n5\ny\ne\na\nr\ns\n;\nC\n2\n:\n \nN\nR\n;\nC\n3\n:\n \np\ne\nr\nf\no\nr\nm\ne\nd\n \na\ns\n \nt\nh\ne\n \nf\ni\nr\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \np\nr\no\nc\ne\nd\nu\nr\ne\n \no\nf\n \nt\nh\ne\n \nd\na\ny\n;\ni\nn\ni\nt\ni\na\nl\nl\ny\n \np\na\nt\ni\ne\nn\nt\ns\n \nw\ni\nt\nh\ns\nt\nr\na\ni\ng\nh\nt\nf\no\nr\nw\na\nr\nd\n \na\nn\na\nt\no\nm\ny\n \no\nn\nl\ny\n;\nl\na\nt\ne\nr\n \ne\nx\nt\ne\nn\nd\ne\nd\n \nt\no\n \no\nb\ne\ns\ne\n \np\na\nt\ni\ne\nn\nt\ns\na\nn\nd\n \np\na\nt\ni\ne\nn\nt\ns\n \nw\ni\nt\nh\n \nd\ny\ns\np\nl\na\ns\ni\na\n \nC\n4\n:\n \nc\no\nn\ns\ne\nc\nu\nt\ni\nv\ne\n \np\na\nt\ni\ne\nn\nt\ns\n;\n \np\nr\ni\nm\na\nr\ny\nT\nH\nR\ns\nE\nx\nc\nl\nu\ns\ni\no\nn\n \nc\nr\ni\nt\ne\nr\ni\na\n:\n \nC\n1\n:\n \nn\no\n \nm\na\nj\no\nr\n \nc\no\n-\nm\no\nr\nb\ni\nd\ni\nt\ni\ne\ns\n,\no\ns\nt\ne\no\np\no\nr\no\ns\ni\ns\n \no\nr\n \nc\no\ng\nn\ni\nt\ni\nv\ne\ni\nm\np\na\ni\nr\nm\ne\nn\nt\n;\n \nn\no\n \np\nr\ni\no\nr\n \no\np\ne\nr\na\nt\ni\no\nn\n \no\nn\ni\np\ns\ni\nl\na\nt\ne\nr\na\nl\n \nh\ni\np\nC\n2\n:\n \nN\nR\nC\n3\n:\n \nN\nR\nC\n4\n:\n \nn\no\n \np\na\nt\ni\ne\nn\nt\ns\n \ne\nx\nc\nl\nu\nd\ne\nd\n \nd\nu\nr\ni\nn\ng\nt\nh\ne\n \ns\nt\nu\nd\ny\n \np\ne\nr\ni\no\nd\nN\ne\nl\ni\ng\ni\nb\nl\ne\n:\n \nN\nR\nL\no\ns\nt\n \nt\no\n \nF\nU\n:\n \nN\nR\nI\nn\nd\ni\nc\na\nt\ni\no\nn\ns\n:\n \nO\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \nC\n1\n \n9\n4\n\/\n1\n0\n0\n,\nC\n2\n8\n0\n\/\n1\n0\n0\n,\n \nC\n3\n8\n7\n\/\n1\n0\n0\n,\n \nC\n4\n6\n3\n\/\n7\n5\nR\nh\ne\nu\nm\na\nt\no\ni\nd\n \na\nr\nt\nh\nr\ni\nt\ni\ns\n:\n \nC\n1\n2\n\/\n1\n0\n0\n,\nC\n2\n0\n,\n \nC\n3\n0\n\/\n1\n0\n0\n,\n \nC\n4\n3\n\/\n7\n5\nO\ns\nt\ne\no\nn\ne\nc\nr\no\ns\ni\ns\n:\n \nC\n1\n4\n\/\n1\n0\n0\n,\nC\n2\n8\n\/\n1\n0\n0\n,\n \nC\n3\n5\n\/\n1\n0\n0\n,\n \nC\n4\n0\n\/\n7\n5\nD\ne\nv\ne\nl\no\np\nm\ne\nn\nt\na\nl\n \nh\ni\np\n \nd\ny\ns\np\nl\na\ns\ni\na\n:\nC\n1\n0\n\/\n1\n0\n0\n,\n \nC\n2\n9\n\/\n1\n0\n0\n,\n \nC\n3\n8\n\/\n1\n0\n0\n,\nC\n4\n4\n\/\n7\n5\nT\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nC\n1\n:\n \nN\n \n=\n \n1\n0\n0\nC\n2\n:\n \nN\n \n=\n \n1\n0\n0\nC\n3\n:\n \nN\n \n=\n \n1\n0\n0\nC\n4\n:\n \nN\n \n=\n \n7\n5\n \n(\n8\n0\n \nh\ni\np\ns\n)\nO\np\ne\nr\na\nt\ni\nv\ne\n \na\np\np\nr\no\na\nc\nh\nT\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nw\ni\nt\nh\n \n4\n\u2013\n6\n \nc\nm\na\nn\nt\ne\nr\ni\no\nr\n \ni\nn\nc\ni\ns\ni\no\nn\n \na\nn\nd\n \n3\n\u2013\n4\n \nc\nm\np\no\ns\nt\ne\nr\ni\no\nr\n \ni\nn\nc\ni\ns\ni\no\nn\nC\n1\n:\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \ns\nt\ne\nm\n \na\nn\nd\ns\no\nc\nk\ne\nt\nC\n2\n:\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \ns\nt\ne\nm\n \na\nn\nd\ns\no\nc\nk\ne\nt\nC\n3\n:\n \nu\nn\nc\ne\nm\ne\nn\nt\ne\nd\n \ns\nt\ne\nm\n \na\nn\nd\ns\no\nc\nk\ne\nt\nC\n4\n:\n \np\nr\no\nx\ni\nm\na\nl\nl\ny\n \nc\no\na\nt\ne\nd\nf\ne\nm\no\nr\na\nl\n \ns\nt\ne\nm\n \n+\n \nm\nu\nl\nt\ni\n-\nh\no\nl\ne\nd\nc\nu\np\nA\nd\nd\ni\nt\ni\no\nn\na\nl\n \ni\nn\nf\no\nr\nm\na\nt\ni\no\nn\n:\nA\nl\nl\n \nc\ne\nn\nt\nr\ne\ns\n \n\u2013\n \nE\na\nr\nl\ny\n \nr\ne\ns\nu\nl\nt\ns\nf\nr\no\nm\n \nt\nw\no\n-\ni\nn\nc\ni\ns\ni\no\nn\n \nT\nH\nR\ns\np\ne\nr\nf\no\nr\nm\ne\nd\n \nb\ny\n \no\nn\ne\n \ns\nu\nr\ng\ne\no\nn\n \na\nt\ne\na\nc\nh\n \nc\ne\nn\nt\nr\ne\n \nw\ni\nt\nh\n \nf\nl\nu\no\nr\no\ns\nc\no\np\ny\n,\ns\np\ne\nc\ni\na\nl\ni\ns\ne\nd\n \nd\no\ng\n-\nl\ne\ng\n \ni\nn\ns\ne\nr\nt\ne\nr\na\nn\nd\n \ns\np\ne\nc\ni\na\nl\nl\ny\n \nd\ne\ns\ni\ng\nn\ne\nd\nr\ne\na\nm\ne\nr\ns\n;\n \np\na\nt\ni\ne\nn\nt\ns\n \nm\na\nn\na\ng\ne\nd\nw\ni\nt\nh\n \na\nn\n \n\u201c\na\nc\nc\ne\nl\ne\nr\na\nt\ne\nd\n \nc\nr\ni\nt\ni\nc\na\nl\np\na\nt\nh\nw\na\ny\n\u201d\n \n(\nr\na\np\ni\nd\nr\ne\nh\na\nb\ni\nl\ni\nt\na\nt\ni\no\nn\n)\n \nf\no\nr\n \nT\nH\nR\n,\n \nw\ni\nt\nh\np\na\nt\ni\ne\nn\nt\ns\n \ns\ne\ne\nn\n \nb\ny\n \na\np\nh\ny\ns\ni\no\nt\nh\ne\nr\na\np\ni\ns\nt\n \ni\nm\nm\ne\nd\ni\na\nt\ne\nl\ny\nu\np\no\nn\n \nr\ne\nt\nu\nr\nn\n \nf\nr\no\nm\n \nt\nh\ne\nr\ne\nc\no\nv\ne\nr\ny\n \nr\no\no\nm\n \na\nn\nd\n \nw\ne\ni\ng\nh\nt\nb\ne\na\nr\ni\nn\ng\n \na\ns\n \nt\no\nl\ne\nr\na\nt\ne\nd\n \n(\nb\nu\nt\n \nf\ni\nr\ns\nt\n1\n2\n \np\na\nt\ni\ne\nn\nt\ns\n \na\nt\n \nC\ne\nn\nt\nr\ne\n \n3\n \nd\ni\nd\nn\no\nt\n \nr\ne\nc\ne\ni\nv\ne\n \nt\nh\ni\ns\n)\nI\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\n)\nC\n1\n:\n \n1\n0\n0\n,\n \n9\n0\n \n[\n8\n0\n\u2013\n1\n2\n0\n]\n,\n \nC\n2\n:\n \n1\n0\n0\n,\n \n6\n2\n \n[\n3\n8\n\u2013\n1\n4\n0\n]\n,\n \nC\n3\n:\n \nf\ni\nr\ns\nt\n \n1\n2\n,\n \n1\n5\n0\n \n[\n9\n4\n\u2013\n2\n5\n5\n]\n,\n \nl\na\ns\nt\n \n8\n8\n,\n \n1\n0\n1\n[\n8\n0\n\u2013\n1\n2\n0\n]\n,\n \nC\n4\n:\n \n7\n5\n,\n \n8\n5\n \n[\n5\n5\n\u2013\n1\n2\n5\n]\nO\np\np\no\ns\ni\nt\ne\n \nm\ne\nt\nh\no\nd\n \ni\nn\ni\nt\ni\na\nt\ne\nd\nC\n3\n:\n \n0\n\/\n1\n0\n0\nI\nn\nt\nr\na\n-\no\np\ne\nr\na\nt\ni\nv\ne\n \nf\nr\na\nc\nt\nu\nr\ne\nC\n3\n:\n \n1\n\/\n1\n0\n0\nC\n4\n:\n \n2\n\/\n8\n0\n \nh\ni\np\ns\nC\no\nn\nv\ne\nr\ns\ni\no\nn\n:\n \nC\n3\n:\n \n0\n\/\n1\n0\n0\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nD\ni\ns\nl\no\nc\na\nt\ni\no\nn\nC\n1\n:\n \n2\n\/\n1\n0\n0\nI\nn\nf\ne\nc\nt\ni\no\nn\nC\n1\n:\n \n1\n\/\n1\n0\n0\n \n(\n\u2018\np\nr\no\nb\na\nb\nl\ny\n \nd\nu\ne\n \nt\no\nh\ne\nm\na\nt\no\ng\ne\nn\ne\nn\no\nu\ns\n \ni\nn\nf\ne\nc\nt\ni\no\nn\n \nf\nr\no\nm\n \na\n \nl\nu\nn\ng\na\nb\ns\nc\ne\ns\ns\n\u2019\n)\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\nP\na\nr\nt\ni\na\nl\n \nf\ne\nm\no\nr\na\nl\n \nn\ne\nr\nv\ne\n \np\na\nl\ns\ny\n:\n \nC\n4\n \n2\n\/\n7\n5\nH\ny\np\no\ne\ns\nt\nh\ne\ns\ni\na\n \no\nf\n \nt\nh\ne\n \na\nn\nt\ne\nr\ni\no\nr\n \np\na\nr\nt\n \no\nf\n \nt\nh\ne\nt\nh\ni\ng\nh\n,\n \nc\no\nn\ns\ni\ns\nt\ne\nn\nt\n \nw\ni\nt\nh\n \na\n \np\na\nr\nt\ni\na\nl\n \ni\nn\nj\nu\nr\ny\n \nt\no\n \nt\nh\ne\nl\na\nt\ne\nr\na\nl\n \nf\ne\nm\no\nr\na\nl\n \nc\nu\nt\na\nn\ne\no\nu\ns\n \nn\ne\nr\nv\ne\n \no\nf\n \nt\nh\ne\n \nt\nh\ni\ng\nh\n:\nC\n4\n \n1\n6\n\/\n7\n5\n \nD\nV\nT\n:\n \nC\n2\n:\n \n1\n\/\n1\n0\n0\nP\ne\nr\ni\n-\np\nr\no\ns\nt\nh\ne\nt\ni\nc\n \nf\nr\na\nc\nt\nu\nr\ne\n:\n \nC\n1\n \n1\n\/\n1\n0\n0\n,\n \nC\n2\n \n2\n\/\n1\n0\n0\n \nF\nu\nn\nc\nt\ni\no\nn\na\nl\n \nr\ne\ns\nu\nl\nt\ns\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \na\nt\n \n1\n \ny\ne\na\nr\n:\n \nC\n1\n \n1\n0\n0\n,\n \n9\n0\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\ns\n:\n \nC\n1\n:\n \n1\n\/\n1\n0\n0\n,\n \nC\n2\n:\n \n0\n\/\n1\n0\n0\nS\nu\nr\nr\no\ng\na\nt\ne\ns\n \nf\no\nr\n \nl\no\nn\ng\n-\nt\ne\nr\nm\n \no\nu\nt\nc\no\nm\ne\ns\nI\nm\np\nl\na\nn\nt\n \nm\ni\ng\nr\na\nt\ni\no\nn\n:\n \nC\n1\n:\n \n1\n\/\n1\n0\n0\n \nf\ne\nm\no\nr\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \ns\nu\nb\ns\ni\nd\ne\nd\n \na\nn\nd\nr\ne\nq\nu\ni\nr\ne\nd\n \nr\ne\nv\ni\ns\ni\no\nn\nC\n4\n:\n \n1\n\/\n7\n5\n \ns\nt\ne\nm\n \ns\nu\nb\ns\ni\nd\ne\nd\n \nb\nu\nt\n \na\ns\ny\nm\np\nt\no\nm\na\nt\ni\nc\nH\ne\nt\ne\nr\no\nt\no\np\ni\nc\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n:\n \nC\n4\n:\n \n2\n\/\n8\n0\n \nh\ni\np\ns\nG\nr\na\nd\ne\n \nI\n \nh\ne\nt\ne\nr\no\nt\no\np\ni\nc\n \nb\no\nn\ne\nO\nt\nh\ne\nr\n\u2022\nr\ne\na\nd\nm\ni\ns\ns\ni\no\nn\n \nf\no\nr\n \nm\ne\nd\ni\nc\na\nl\n \nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\ns\n:\nC\n1\n \n0\n\/\n1\n0\n0\n,\n \nC\n2\n \n0\n\/\n1\n0\n0\n,\n \nC\n3\n \n0\n\/\n1\n0\n0\n,\n \nC\n4\n \n0\n\/\n7\n5\n\u2022\nb\no\nw\ne\nl\n \no\nb\ns\nt\nr\nu\nc\nt\ni\no\nn\n:\n \nC\n2\n:\n \n1\n\/\n1\n0\n0\n\u2022\n\u2018\no\nt\nh\ne\nr\n\u2019\n \nc\no\nm\np\nl\ni\nc\na\nt\ni\no\nn\ns\n:\n \nC\n3\n:\n \n0\n\/\n1\n0\n0\nc\no\nn\nt\ni\nn\nu\ne\ndAppendix 8\n158\nS\nt\nu\nd\ny\n \nd\ne\nt\na\ni\nl\ns\nP\na\nr\nt\ni\nc\ni\np\na\nn\nt\n \nc\nh\na\nr\na\nc\nt\ne\nr\ni\ns\nt\ni\nc\ns\nI\nn\nt\ne\nr\nv\ne\nn\nt\ni\no\nn\n\/\nc\no\nm\np\na\nr\na\nt\no\nr\nO\nu\nt\nc\no\nm\ne\ns\nS\nh\no\nr\nt\n \nt\ne\nr\nm\nL\no\nn\ng\n \nt\ne\nr\nm\n \n(\ni\nn\nc\nl\nu\nd\ni\nn\ng\n \ns\nu\nr\nr\no\ng\na\nt\ne\ns\n)\nT\nr\na\nu\nm\na\n:\n \nC\n1\n0\n\/\n1\n0\n0\n,\n \nC\n2\n3\n\/\n1\n0\n0\n,\nC\n3\n0\n\/\n1\n0\n0\n,\n \nC\n4\n0\n\/\n7\n5\nP\no\ns\nt\n-\nt\nr\na\nu\nm\na\nt\ni\nc\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n:\nC\n1\n0\n\/\n1\n0\n0\n,\n \nC\n2\n0\n\/\n1\n0\n0\n,\n \nC\n3\n0\n\/\n1\n0\n0\n,\nC\n4\n5\n\/\n7\n5\nA\ng\ne\n \n(\ny\ne\na\nr\ns\n)\n:\n \nC\n1\n \nM\n \n5\n7\n,\n \nF\n \n6\n0\n;\n \nC\n2\n \n5\n6\n;\n \nC\n3\n \n5\n5\n \n[\n3\n0\n\u2013\n7\n6\n]\n;\n \nC\n4\n \nM\n \n5\n8\n[\n3\n2\n\u2013\n8\n4\n]\n,\n \nF\n \n6\n2\n \n[\n4\n3\n\u2013\n8\n2\n]\nS\ne\nx\n \n(\nM\n\/\nF\n)\n:\n \nC\n1\n \n5\n7\n\/\n4\n3\n,\n \nC\n2\n \n5\n6\n\/\n4\n4\n,\nC\n3\n \n7\n5\n\/\n2\n5\n,\n \nC\n4\n \nN\nR\nB\no\nd\ny\n \nw\ne\ni\ng\nh\nt\n \n(\nk\ng\n)\n:\n \nC\n1\n \nM\n \n8\n3\n.\n5\n,\nF\n6\n4\n;\n \nC\n2\n \nM\n \n8\n8\n.\n1\n,\n \nF\n \n6\n7\n.\n2\n;\n \nC\n3\n1\n7\n6\n[\n1\n0\n2\n\u2013\n2\n6\n5\n]\n;\n \nC\n4\n \nM\n \n1\n0\n4\n \n[\n7\n0\n\u2013\n1\n4\n3\n]\n,\nF\n8\n3\n.\n5\n \n[\n5\n1\n\u2013\n1\n2\n3\n]\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n:\n \nC\n1\n \n5\n2\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)\nC\n3\n:\n \nf\ni\nr\ns\nt\n \n1\n2\n,\n \n1\n.\n5\n \n[\n1\n\u2013\n3\n]\nN\nB\n:\n \np\na\nt\ni\ne\nn\nt\ns\n \nn\no\nt\n \ns\nu\nb\nj\ne\nc\nt\ne\nd\n \nt\no\n \nr\na\np\ni\nd\nr\ne\nh\na\nb\ni\nl\ni\nt\na\nt\ni\no\nn\nD\ni\ns\nc\nh\na\nr\ng\ne\nd\n \nh\no\nm\ne\n \nw\ni\nt\nh\ni\nn\n \n2\n4\n \nh\no\nu\nr\ns\n \no\nf\ns\nu\nr\ng\ne\nr\ny\n:\n \nC\n1\n \n9\n0\n\/\n1\n0\n0\n,\n \nC\n2\n \n7\n7\n\/\n1\n0\n0\n,\n \nC\n3\n \n7\n5\n\/\n8\n8\n,\nC\n4\n \n7\n\/\n7\n5\nD\ni\ns\nc\nh\na\nr\ng\ne\nd\n \nt\nh\ne\n \nn\ne\nx\nt\n \nd\na\ny\n:\n \nC\n1\n \n1\n0\n\/\n1\n0\n0\n,\nC\n3\n1\n3\n\/\n8\n8\n,\n \nC\n4\n5\n8\n\/\n7\n5\nS\nt\na\ny\ne\nd\n \n>\n2\n3\n \nh\no\nu\nr\ns\n \na\nf\nt\ne\nr\n \ns\nu\nr\ng\ne\nr\ny\n:\n \nC\n3\n \n0\n\/\n8\n8\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nr\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n)\nC\n1\n \n\u2013\n \nc\nu\np\n \na\nb\nd\nu\nc\nt\ni\no\nn\n \na\nn\ng\nl\ne\n \n4\n7\n\u00b0\n(\nD\nu\nw\ne\nl\ni\nu\ns\n,\n2\n0\n0\n6\n6\n2\n)\nC\n3\n \n\u2013\n \nR\na\nd\ni\no\ng\nr\na\np\nh\ni\nc\n \na\nn\na\nl\ny\ns\ni\ns\n \na\nt\n \n1\n \ny\ne\na\nr\n \nf\no\nr\n3\n0\n\/\n1\n0\n0\n \np\na\nt\ni\ne\nn\nt\ns\n \n(\nB\ne\nr\ng\ne\nr\n,\n \n2\n0\n0\n3\n6\n0\n)\n\u2022\nf\ne\nm\no\nr\na\nl\n \ns\nt\ne\nm\n \ni\nn\n \nn\ne\nu\nt\nr\na\nl\n \na\nl\ni\ng\nn\nm\ne\nn\nt\n(\nb\ne\nt\nw\ne\ne\nn\n \nn\ne\nu\nt\nr\na\nl\n \na\nn\nd\n \n3\n\u00b0\nv\na\nl\ng\nu\ns\n)\n:\n \n9\n1\n%\n\u2022\na\nb\nd\nu\nc\nt\ni\no\nn\n \na\nn\ng\nl\ne\n \no\nf\n \na\nc\ne\nt\na\nb\nu\nl\na\nr\nc\no\nm\np\no\nn\ne\nn\nt\n:\n \n4\n5\n\u00b0\n[\n3\n6\n\u2013\n5\n4\n]Health Technology Assessment 2008; Vol. 12: No. 26\n159\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 9\nSummary of outcomes reported in the \nincluded studiesC\nl\ni\nn\ni\nc\na\nl\n \np\ne\nr\nf\no\nr\nm\na\nn\nc\ne\n,\n \ns\na\nf\ne\nt\ny\n \na\nn\nd\n \nr\ne\ns\no\nu\nr\nc\ne\n \nu\nt\ni\nl\ni\nt\ny\n \nAppendix 9\n160\nS\nt\nu\nd\ny\n \nC\nl\ni\nn\ni\nc\na\nl\n \np\ne\nr\nf\no\nr\nm\na\nn\nc\ne\n \nS\na\nf\ne\nt\ny\n \nR\ne\ns\no\nu\nr\nc\ne\n \nu\nt\ni\nl\ni\nt\ny\n \nO\nn\ne\n \ni\nn\nc\ni\ns\ni\no\nn\nR\nC\nT\n \na\nn\nd\n \nq\nu\na\ns\ni\n-\nR\nC\nT\nC\nh\na\nr\nl\ne\ns\n,\n \n2\n0\n0\n6\n6\n9\n\u2713\n\u2713\n\u2713\n\u2713\nC\nh\ni\nm\ne\nn\nt\no\n,\n \n2\n0\n0\n5\n3\n1\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nC\nh\nu\nn\ng\n,\n \n2\n0\n0\n4\n3\n2\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nH\na\nr\nt\n,\n \n2\n0\n0\n5\n4\n0\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nK\ni\nm\n,\n \n2\n0\n0\n6\n4\n3\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nO\ng\no\nn\nd\na\n,\n \n2\n0\n0\n5\n4\n6\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nR\na\nc\nh\nb\na\nu\ne\nr\n,\n \n2\n0\n0\n6\n7\n5\n\u2713\n\u2713\nS\nh\na\nr\nm\na\n,\n \n2\n0\n0\n6\n7\n7\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nZ\nh\na\nn\ng\n,\n \n2\n0\n0\n6\n5\n8\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nC\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ni\ne\ns\nA\ns\na\ny\na\nm\na\n,\n \n2\n0\n0\n6\n2\n8\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nB\ne\nr\ng\ne\nr\n,\n \n2\n0\n0\n4\n2\n9\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nC\nh\ne\nn\n,\n \n2\n0\n0\n6\n3\n0\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nC\ni\nm\ni\nn\ni\ne\nl\nl\no\n,\n \n2\n0\n0\n6\n3\n3\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nd\ne\n \nB\ne\ne\nr\n,\n \n2\n0\n0\n4\n3\n4\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nD\ni\nG\ni\no\ni\na\n,\n \n2\n0\n0\n3\n3\n5\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nD\no\nr\nr\n,\n \n2\n0\n0\n7\n3\n6\nc\no\nn\nt\ni\nn\nu\ne\nd\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\n \n(\nn\nu\nm\nb\ne\nr\n \nh\na\nv\ni\nn\ng\nr\ne\nv\ni\ns\ni\no\nn\n \ns\nu\nr\ng\ne\nr\ny\n)\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nd\ni\ns\nl\no\nc\na\nt\ni\no\nn\n \nr\na\nt\ne\ns\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nc\nu\np\n,\n \nn\nu\nm\nb\ne\nr\np\no\no\nr\nl\ny\n \np\nl\na\nc\ne\nd\n)\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\ns\nt\ne\nm\n,\n \nn\nu\nm\nb\ne\nr\np\no\no\nr\nl\ny\n \np\nl\na\nc\ne\nd\n)\nI\nm\np\nl\na\nn\nt\n \nm\ni\ng\nr\na\nt\ni\no\nn\nH\ne\nt\ne\nr\no\nt\no\np\ni\nc\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n(\nn\nu\nm\nb\ne\nr\n \nw\ni\nt\nh\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n)\nC\ne\nm\ne\nn\nt\n \nq\nu\na\nl\ni\nt\ny\n \n(\nn\nu\nm\nb\ne\nr\n \nw\ni\nt\nh\np\no\no\nr\n \nq\nu\na\nl\ni\nt\ny\n)\nL\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ni\nn\ne\nq\nu\na\nl\ni\nt\ny\n \n(\nn\nu\nm\nb\ne\nr\nw\ni\nt\nh\n \nu\nn\ne\nq\nu\na\nl\n \nl\ne\nn\ng\nt\nh\ns\n)\nB\nl\no\no\nd\n \nl\no\ns\ns\n \n(\ni\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n,\n \nm\nl\n)\nB\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nt\no\nt\na\nl\n,\n \nm\nl\n)\nF\nr\na\nc\nt\nu\nr\ne\ns\n:\n \ni\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nF\nr\na\nc\nt\nu\nr\ne\ns\n:\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nI\nn\nf\ne\nc\nt\ni\no\nn\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\nV\na\ns\nc\nu\nl\na\nr\n \ni\nn\nj\nu\nr\ny\nD\nV\nT\n \nP\nE\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)Health Technology Assessment 2008; Vol. 12: No. 26\n161\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nC\nl\ni\nn\ni\nc\na\nl\n \np\ne\nr\nf\no\nr\nm\na\nn\nc\ne\n \nS\na\nf\ne\nt\ny\n \nR\ne\ns\no\nu\nr\nc\ne\n \nu\nt\ni\nl\ni\nt\ny\n \nH\no\nw\ne\nl\nl\n,\n \n2\n0\n0\n4\n4\n2\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nL\ni\n,\n \n2\n0\n0\n5\n4\n4\n\u2713\n\u2713\n\u2713\nO\n\u2019\nB\nr\ni\ne\nn\n,\n \n2\n0\n0\n5\n4\n5\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nP\na\nn\ni\ns\ne\nl\nl\no\n,\n \n2\n0\n0\n6\n7\n4\n\u2713\nP\ni\nl\no\nt\n,\n \n2\n0\n0\n6\n4\n8\n\u2713\n\u2713\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\n(\nM\nI\n\/\nM\nD\n)\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\n(\nM\nI\n\/\nS\nI\n)\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nT\na\nk\na\nh\ni\nr\na\n,\n \n2\n0\n0\n6\n7\n8\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nT\ne\ne\nt\n,\n \n2\n0\n0\n6\n5\n4\n\u2713\n\u2713\nW\no\no\nl\ns\no\nn\n,\n \n2\n0\n0\n4\n5\n5\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nW\nr\ni\ng\nh\nt\n,\n \n2\n0\n0\n4\n5\n6\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nC\na\ns\ne\n \ns\ne\nr\ni\ne\ns\n \na\nn\nd\n \nr\ne\ng\ni\ns\nt\nr\ny\nF\nl\n\u00f6\nr\ne\nn\n,\n \n2\n0\n0\n6\n3\n9\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nH\na\nr\nt\nz\nb\na\nn\nd\n,\n \n2\n0\n0\n6\n4\n1\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nP\ni\np\ni\nn\no\n,\n \n2\n0\n0\n4\n4\n9\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nS\ni\ng\nu\ni\ne\nr\n,\n \n2\n0\n0\n4\n5\n0\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nS\nw\na\nn\ns\no\nn\n,\n \n2\n0\n0\n5\n5\n1\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nN\no\nr\nw\ne\ng\ni\na\nn\n \nA\nr\nt\nh\nr\no\np\nl\na\ns\nt\ny\n \nR\ne\ng\ni\ns\nt\ne\nr\n,\n \n2\n0\n0\n5\n\u2013\n6\n1\n1\n\u2713\nc\no\nn\nt\ni\nn\nu\ne\nd\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\n \n(\nn\nu\nm\nb\ne\nr\n \nh\na\nv\ni\nn\ng\nr\ne\nv\ni\ns\ni\no\nn\n \ns\nu\nr\ng\ne\nr\ny\n)\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nd\ni\ns\nl\no\nc\na\nt\ni\no\nn\n \nr\na\nt\ne\ns\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nc\nu\np\n,\n \nn\nu\nm\nb\ne\nr\np\no\no\nr\nl\ny\n \np\nl\na\nc\ne\nd\n)\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\ns\nt\ne\nm\n,\n \nn\nu\nm\nb\ne\nr\np\no\no\nr\nl\ny\n \np\nl\na\nc\ne\nd\n)\nI\nm\np\nl\na\nn\nt\n \nm\ni\ng\nr\na\nt\ni\no\nn\nH\ne\nt\ne\nr\no\nt\no\np\ni\nc\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n(\nn\nu\nm\nb\ne\nr\n \nw\ni\nt\nh\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n)\nC\ne\nm\ne\nn\nt\n \nq\nu\na\nl\ni\nt\ny\n \n(\nn\nu\nm\nb\ne\nr\n \nw\ni\nt\nh\np\no\no\nr\n \nq\nu\na\nl\ni\nt\ny\n)\nL\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ni\nn\ne\nq\nu\na\nl\ni\nt\ny\n \n(\nn\nu\nm\nb\ne\nr\nw\ni\nt\nh\n \nu\nn\ne\nq\nu\na\nl\n \nl\ne\nn\ng\nt\nh\ns\n)\nB\nl\no\no\nd\n \nl\no\ns\ns\n \n(\ni\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n,\n \nm\nl\n)\nB\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nt\no\nt\na\nl\n,\n \nm\nl\n)\nF\nr\na\nc\nt\nu\nr\ne\ns\n:\n \ni\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nF\nr\na\nc\nt\nu\nr\ne\ns\n:\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nI\nn\nf\ne\nc\nt\ni\no\nn\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\nV\na\ns\nc\nu\nl\na\nr\n \ni\nn\nj\nu\nr\ny\nD\nV\nT\n \nP\nE\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)Appendix 9\n162\nS\nt\nu\nd\ny\n \nC\nl\ni\nn\ni\nc\na\nl\n \np\ne\nr\nf\no\nr\nm\na\nn\nc\ne\n \nS\na\nf\ne\nt\ny\n \nR\ne\ns\no\nu\nr\nc\ne\n \nu\nt\ni\nl\ni\nt\ny\n \nT\nw\no\n \ni\nn\nc\ni\ns\ni\no\nn\ns\nR\nC\nT\n \na\nn\nd\n \nq\nu\na\ns\ni\n-\nR\nC\nT\nP\na\ng\nn\na\nn\no\n,\n \n2\n0\n0\n7\na\n7\n2\nP\na\ng\nn\na\nn\no\n,\n \n2\n0\n0\n7\nb\n7\n3\nY\na\nn\n,\n \n2\n0\n0\n5\n5\n7\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nC\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ni\ne\ns\nD\nu\nw\ne\nl\ni\nu\ns\n,\n \n2\n0\n0\n7\n3\n8\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nG\nr\ne\ni\nd\na\nn\nu\ns\n,\n \n2\n0\n0\n6\n7\n1\n\u2713\n\u2713\nP\na\ng\nn\na\nn\no\n,\n \n2\n0\n0\n6\n4\n7\nT\na\nn\na\nv\na\nl\ne\ne\n,\n \n2\n0\n0\n6\n5\n3\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nY\no\no\nn\n,\n \n2\n0\n0\n5\n7\n9\n\u2713\n\u2713\nC\na\ns\ne\n \ns\ne\nr\ni\ne\ns\nA\nr\nc\nh\ni\nb\ne\nc\nk\n,\n \n2\n0\n0\n4\n2\n7\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nD\nu\nw\ne\nl\ni\nu\ns\n,\n \n2\n0\n0\n3\n3\n7\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nR\ne\nv\ni\ns\ni\no\nn\n \nr\na\nt\ne\n \n(\nn\nu\nm\nb\ne\nr\n \nh\na\nv\ni\nn\ng\nr\ne\nv\ni\ns\ni\no\nn\n \ns\nu\nr\ng\ne\nr\ny\n)\nP\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\n \nd\ni\ns\nl\no\nc\na\nt\ni\no\nn\n \nr\na\nt\ne\ns\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\nc\nu\np\n,\n \nn\nu\nm\nb\ne\nr\np\no\no\nr\nl\ny\n \np\nl\na\nc\ne\nd\n)\nI\nm\np\nl\na\nn\nt\n \np\no\ns\ni\nt\ni\no\nn\n \n(\ns\nt\ne\nm\n,\n \nn\nu\nm\nb\ne\nr\np\no\no\nr\nl\ny\n \np\nl\na\nc\ne\nd\n)\nI\nm\np\nl\na\nn\nt\n \nm\ni\ng\nr\na\nt\ni\no\nn\nH\ne\nt\ne\nr\no\nt\no\np\ni\nc\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n(\nn\nu\nm\nb\ne\nr\n \nw\ni\nt\nh\n \no\ns\ns\ni\nf\ni\nc\na\nt\ni\no\nn\n)\nC\ne\nm\ne\nn\nt\n \nq\nu\na\nl\ni\nt\ny\n \n(\nn\nu\nm\nb\ne\nr\n \nw\ni\nt\nh\np\no\no\nr\n \nq\nu\na\nl\ni\nt\ny\n)\nL\ni\nm\nb\n \nl\ne\nn\ng\nt\nh\n \ni\nn\ne\nq\nu\na\nl\ni\nt\ny\n \n(\nn\nu\nm\nb\ne\nr\nw\ni\nt\nh\n \nu\nn\ne\nq\nu\na\nl\n \nl\ne\nn\ng\nt\nh\ns\n)\nB\nl\no\no\nd\n \nl\no\ns\ns\n \n(\ni\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\n,\n \nm\nl\n)\nB\nl\no\no\nd\n \nl\no\ns\ns\n \n(\nt\no\nt\na\nl\n,\n \nm\nl\n)\nF\nr\na\nc\nt\nu\nr\ne\ns\n:\n \ni\nn\nt\nr\na\no\np\ne\nr\na\nt\ni\nv\ne\nF\nr\na\nc\nt\nu\nr\ne\ns\n:\n \np\no\ns\nt\no\np\ne\nr\na\nt\ni\nv\ne\nI\nn\nf\ne\nc\nt\ni\no\nn\nN\ne\nr\nv\ne\n \ni\nn\nj\nu\nr\ny\nV\na\ns\nc\nu\nl\na\nr\n \ni\nn\nj\nu\nr\ny\nD\nV\nT\n \nP\nE\nD\nu\nr\na\nt\ni\no\nn\n \no\nf\n \no\np\ne\nr\na\nt\ni\no\nn\n \n(\nm\ni\nn\nu\nt\ne\ns\n)\nL\ne\nn\ng\nt\nh\n \no\nf\n \nh\no\ns\np\ni\nt\na\nl\n \ns\nt\na\ny\n \n(\nd\na\ny\ns\n)Health Technology Assessment 2008; Vol. 12: No. 26\n163\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nP\na\nt\ni\ne\nn\nt\n-\nc\ne\nn\nt\nr\ne\nd\n \nm\ne\na\ns\nu\nr\ne\ns\nO\nn\ne\n \ni\nn\nc\ni\ns\ni\no\nn\nR\nC\nT\n \na\nn\nd\n \nq\nu\na\ns\ni\n-\nR\nC\nT\nC\nh\na\nr\nl\ne\ns\n,\n \n2\n0\n0\n6\n6\n9\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nC\nh\ni\nm\ne\nn\nt\no\n,\n \n2\n0\n0\n5\n3\n1\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nC\nh\nu\nn\ng\n,\n \n2\n0\n0\n4\n3\n2\n\u2713\n\u2713\n\u2713\nH\na\nr\nt\n,\n \n2\n0\n0\n5\n4\n0\n\u2713\n\u2713\nK\ni\nm\n,\n \n2\n0\n0\n6\n4\n3\n\u2713\n\u2713\n\u2713\nO\ng\no\nn\nd\na\n,\n \n2\n0\n0\n5\n4\n6\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nR\na\nc\nh\nb\na\nu\ne\nr\n,\n \n2\n0\n0\n6\n7\n5\n\u2713\n\u2713\n\u2713\nS\nh\na\nr\nm\na\n,\n \n2\n0\n0\n6\n7\n7\n\u2713\nZ\nh\na\nn\ng\n,\n \n2\n0\n0\n6\n5\n8\n\u2713\n\u2713\nC\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ni\ne\ns\nA\ns\na\ny\na\nm\na\n,\n \n2\n0\n0\n6\n2\n8\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nB\ne\nr\ng\ne\nr\n,\n \n2\n0\n0\n4\n2\n9\nC\nh\ne\nn\n,\n \n2\n0\n0\n6\n3\n0\n\u2713\n\u2713\nC\ni\nm\ni\nn\ni\ne\nl\nl\no\n,\n \n2\n0\n0\n6\n3\n3\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nc\no\nn\nt\ni\nn\nu\ne\nd\nD\ne\na\nt\nh\n \n(\n3\n0\n-\nd\na\ny\ns\n)\nD\ne\na\nt\nh\n \n(\nl\no\nn\ng\n-\nt\ne\nr\nm\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\nt\ni\ne\nn\nt\n-\nc\no\nn\nt\nr\no\nl\nl\ne\nd\n \na\nn\na\ne\ns\nt\nh\ne\ns\ni\na\n \n(\nm\ng\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \nt\no\nt\na\nl\n \nn\na\nr\nc\no\nt\ni\nc\n \nr\ne\nc\ne\ni\nv\ne\nd\n \n(\nm\ng\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \nn\na\nr\nc\no\nt\ni\nc\n \n(\nd\na\ny\ns\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\ns\nc\no\nr\ne\n)\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\ns\nc\no\nr\ne\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nn\no\nr\nm\na\nl\n \na\nc\nt\ni\nv\ni\nt\ny\n \n(\nd\na\ny\ns\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \ns\nh\no\np\np\ni\nn\ng\n \n(\nd\na\ny\ns\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nd\nr\ni\nv\ni\nn\ng\n \n(\nd\na\ny\ns\n)\nU\ns\ne\n \no\nf\n \nw\na\nl\nk\ni\nn\ng\n \na\ni\nd\ns\n:\n \ns\nh\no\nr\nt\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nU\ns\ne\n \no\nf\n \nw\na\nl\nk\ni\nn\ng\n \na\ni\nd\ns\n \n(\nd\na\ny\ns\n)\nL\ni\nm\np\n:\n \ns\nh\no\nr\nt\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nL\ni\nm\np\n:\n \nl\no\nn\ng\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\n \nm\no\nn\nt\nh\ns\n)\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n>\n3\n \nm\no\nn\nt\nh\ns\n)\nW\nO\nM\nA\nC\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \ni\nn\nd\ne\nx\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nO\nx\nf\no\nr\nd\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\n \nm\no\nn\nt\nh\ns\n)\nM\ne\nr\nl\ne\n \nd\n\u2019\nA\nu\nb\ni\ng\nn\n\u00e9\n\u2013\nC\nh\na\nr\nn\nl\ne\ny\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nM\ne\nr\nl\ne\n \nd\n\u2019\nA\nu\nb\ni\ng\nn\n\u00e9\n\u2013\nC\nh\na\nr\nn\nl\ne\ny\n \ns\nc\no\nr\ne\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n1\n2\n \np\nh\ny\ns\ni\nc\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n1\n2\n \nm\ne\nn\nt\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \np\nh\ny\ns\ni\nc\na\nl\n \nf\nu\nn\nc\nt\ni\no\nn\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \np\nh\ny\ns\ni\nc\na\nl\n \nf\nu\nn\nc\nt\ni\no\nn\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \nm\ne\nn\nt\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n \nd\ni\ns\ns\na\nt\ni\ns\nf\ni\ne\nd\n)\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \n(\ns\nc\no\nr\ne\n)\nS\nc\na\nr\n \nc\no\nn\nt\nr\na\nc\nt\ni\no\nnAppendix 9\n164\nS\nt\nu\nd\ny\n \nP\na\nt\ni\ne\nn\nt\n-\nc\ne\nn\nt\nr\ne\nd\n \nm\ne\na\ns\nu\nr\ne\ns\nd\ne\n \nB\ne\ne\nr\n,\n \n2\n0\n0\n4\n3\n4\n\u2713\n\u2713\n\u2713\n\u2713\nD\ni\nG\ni\no\ni\na\n,\n \n2\n0\n0\n3\n3\n5\n\u2713\n\u2713\nD\no\nr\nr\n,\n \n2\n0\n0\n7\n3\n6\n\u2713\n\u2713\n\u2713\nH\no\nw\ne\nl\nl\n,\n \n2\n0\n0\n4\n4\n2\nL\ni\n,\n \n2\n0\n0\n5\n4\n4\n\u2713\nO\n\u2019\nB\nr\ni\ne\nn\n,\n \n2\n0\n0\n5\n4\n5\nP\na\nn\ni\ns\ne\nl\nl\no\n,\n \n2\n0\n0\n6\n7\n4\nP\ni\nl\no\nt\n,\n \n2\n0\n0\n6\n4\n8\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\n(\nM\nI\n\/\nM\nD\n)\n\u2713\n\u2713\nS\nz\ne\nn\nd\nr\n\u00f3\ni\n,\n \n2\n0\n0\n6\n5\n2\n(\nM\nI\n\/\nS\nI\n)\n\u2713\n\u2713\nT\na\nk\na\nh\ni\nr\na\n,\n \n2\n0\n0\n6\n7\n8\nT\ne\ne\nt\n,\n \n2\n0\n0\n6\n5\n4\nW\no\no\nl\ns\no\nn\n,\n \n2\n0\n0\n4\n5\n5\n\u2713\n\u2713\nW\nr\ni\ng\nh\nt\n,\n \n2\n0\n0\n4\n5\n6\n\u2713\n\u2713\n\u2713\n\u2713\nc\no\nn\nt\ni\nn\nu\ne\nd\nD\ne\na\nt\nh\n \n(\n3\n0\n-\nd\na\ny\ns\n)\nD\ne\na\nt\nh\n \n(\nl\no\nn\ng\n-\nt\ne\nr\nm\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\nt\ni\ne\nn\nt\n-\nc\no\nn\nt\nr\no\nl\nl\ne\nd\n \na\nn\na\ne\ns\nt\nh\ne\ns\ni\na\n \n(\nm\ng\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \nt\no\nt\na\nl\n \nn\na\nr\nc\no\nt\ni\nc\n \nr\ne\nc\ne\ni\nv\ne\nd\n \n(\nm\ng\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \nn\na\nr\nc\no\nt\ni\nc\n \n(\nd\na\ny\ns\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\ns\nc\no\nr\ne\n)\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\ns\nc\no\nr\ne\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nn\no\nr\nm\na\nl\n \na\nc\nt\ni\nv\ni\nt\ny\n \n(\nd\na\ny\ns\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \ns\nh\no\np\np\ni\nn\ng\n \n(\nd\na\ny\ns\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nd\nr\ni\nv\ni\nn\ng\n \n(\nd\na\ny\ns\n)\nU\ns\ne\n \no\nf\n \nw\na\nl\nk\ni\nn\ng\n \na\ni\nd\ns\n:\n \ns\nh\no\nr\nt\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nU\ns\ne\n \no\nf\n \nw\na\nl\nk\ni\nn\ng\n \na\ni\nd\ns\n \n(\nd\na\ny\ns\n)\nL\ni\nm\np\n:\n \ns\nh\no\nr\nt\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nL\ni\nm\np\n:\n \nl\no\nn\ng\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\n \nm\no\nn\nt\nh\ns\n)\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n>\n3\n \nm\no\nn\nt\nh\ns\n)\nW\nO\nM\nA\nC\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \ni\nn\nd\ne\nx\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nO\nx\nf\no\nr\nd\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\n \nm\no\nn\nt\nh\ns\n)\nM\ne\nr\nl\ne\n \nd\n\u2019\nA\nu\nb\ni\ng\nn\n\u00e9\n\u2013\nC\nh\na\nr\nn\nl\ne\ny\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nM\ne\nr\nl\ne\n \nd\n\u2019\nA\nu\nb\ni\ng\nn\n\u00e9\n\u2013\nC\nh\na\nr\nn\nl\ne\ny\n \ns\nc\no\nr\ne\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n1\n2\n \np\nh\ny\ns\ni\nc\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n1\n2\n \nm\ne\nn\nt\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \np\nh\ny\ns\ni\nc\na\nl\n \nf\nu\nn\nc\nt\ni\no\nn\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \np\nh\ny\ns\ni\nc\na\nl\n \nf\nu\nn\nc\nt\ni\no\nn\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \nm\ne\nn\nt\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n \nd\ni\ns\ns\na\nt\ni\ns\nf\ni\ne\nd\n)\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \n(\ns\nc\no\nr\ne\n)\nS\nc\na\nr\n \nc\no\nn\nt\nr\na\nc\nt\ni\no\nnHealth Technology Assessment 2008; Vol. 12: No. 26\n165\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nS\nt\nu\nd\ny\n \nP\na\nt\ni\ne\nn\nt\n-\nc\ne\nn\nt\nr\ne\nd\n \nm\ne\na\ns\nu\nr\ne\ns\nC\na\ns\ne\n \ns\ne\nr\ni\ne\ns\n \na\nn\nd\n \nr\ne\ng\ni\ns\nt\nr\ny\nF\nl\n\u00f6\nr\ne\nn\n,\n \n2\n0\n0\n6\n3\n9\n\u2713\n\u2713\nH\na\nr\nt\nz\nb\na\nn\nd\n,\n \n2\n0\n0\n6\n4\n1\n\u2713\nP\ni\np\ni\nn\no\n,\n \n2\n0\n0\n4\n4\n9\n\u2713\n\u2713\n\u2713\n\u2713\nS\ni\ng\nu\ni\ne\nr\n,\n \n2\n0\n0\n4\n5\n0\n\u2713\nS\nw\na\nn\ns\no\nn\n,\n \n2\n0\n0\n5\n5\n1\n\u2713\n\u2713\nT\nw\no\n \ni\nn\nc\ni\ns\ni\no\nn\ns\nR\nC\nT\n \na\nn\nd\n \nq\nu\na\ns\ni\n-\nR\nC\nT\nP\na\ng\nn\na\nn\no\n,\n \n2\n0\n0\n7\na\n7\n2\n\u2713\nP\na\ng\nn\na\nn\no\n,\n \n2\n0\n0\n7\nb\n7\n3\n\u2713\n\u2713\n\u2713\nY\na\nn\n,\n \n2\n0\n0\n5\n5\n7\n\u2713\n\u2713\nD\nu\nw\ne\nl\ni\nu\ns\n,\n \n2\n0\n0\n7\n3\n8\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\n\u2713\nC\no\nm\np\na\nr\na\nt\ni\nv\ne\n \ns\nt\nu\nd\ni\ne\ns\nG\nr\ne\ni\nd\na\nn\nu\ns\n,\n \n2\n0\n0\n6\n7\n1\n\u2713\nP\na\ng\nn\na\nn\no\n,\n \n2\n0\n0\n6\n4\n7\n\u2713\n\u2713\n\u2713\nc\no\nn\nt\ni\nn\nu\ne\nd\nD\ne\na\nt\nh\n \n(\n3\n0\n-\nd\na\ny\ns\n)\nD\ne\na\nt\nh\n \n(\nl\no\nn\ng\n-\nt\ne\nr\nm\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\nt\ni\ne\nn\nt\n-\nc\no\nn\nt\nr\no\nl\nl\ne\nd\n \na\nn\na\ne\ns\nt\nh\ne\ns\ni\na\n \n(\nm\ng\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \nt\no\nt\na\nl\n \nn\na\nr\nc\no\nt\ni\nc\n \nr\ne\nc\ne\ni\nv\ne\nd\n \n(\nm\ng\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \nn\na\nr\nc\no\nt\ni\nc\n \n(\nd\na\ny\ns\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\ns\nc\no\nr\ne\n)\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\ns\nc\no\nr\ne\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nn\no\nr\nm\na\nl\n \na\nc\nt\ni\nv\ni\nt\ny\n \n(\nd\na\ny\ns\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \ns\nh\no\np\np\ni\nn\ng\n \n(\nd\na\ny\ns\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nd\nr\ni\nv\ni\nn\ng\n \n(\nd\na\ny\ns\n)\nU\ns\ne\n \no\nf\n \nw\na\nl\nk\ni\nn\ng\n \na\ni\nd\ns\n:\n \ns\nh\no\nr\nt\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nU\ns\ne\n \no\nf\n \nw\na\nl\nk\ni\nn\ng\n \na\ni\nd\ns\n \n(\nd\na\ny\ns\n)\nL\ni\nm\np\n:\n \ns\nh\no\nr\nt\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nL\ni\nm\np\n:\n \nl\no\nn\ng\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\n \nm\no\nn\nt\nh\ns\n)\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n>\n3\n \nm\no\nn\nt\nh\ns\n)\nW\nO\nM\nA\nC\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \ni\nn\nd\ne\nx\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nO\nx\nf\no\nr\nd\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\n \nm\no\nn\nt\nh\ns\n)\nM\ne\nr\nl\ne\n \nd\n\u2019\nA\nu\nb\ni\ng\nn\n\u00e9\n\u2013\nC\nh\na\nr\nn\nl\ne\ny\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nM\ne\nr\nl\ne\n \nd\n\u2019\nA\nu\nb\ni\ng\nn\n\u00e9\n\u2013\nC\nh\na\nr\nn\nl\ne\ny\n \ns\nc\no\nr\ne\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n1\n2\n \np\nh\ny\ns\ni\nc\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n1\n2\n \nm\ne\nn\nt\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \np\nh\ny\ns\ni\nc\na\nl\n \nf\nu\nn\nc\nt\ni\no\nn\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \np\nh\ny\ns\ni\nc\na\nl\n \nf\nu\nn\nc\nt\ni\no\nn\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \nm\ne\nn\nt\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n \nd\ni\ns\ns\na\nt\ni\ns\nf\ni\ne\nd\n)\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \n(\ns\nc\no\nr\ne\n)\nS\nc\na\nr\n \nc\no\nn\nt\nr\na\nc\nt\ni\no\nnAppendix 9\n166\nS\nt\nu\nd\ny\n \nP\na\nt\ni\ne\nn\nt\n-\nc\ne\nn\nt\nr\ne\nd\n \nm\ne\na\ns\nu\nr\ne\ns\nT\na\nn\na\nv\na\nl\ne\ne\n,\n \n2\n0\n0\n6\n5\n3\n\u2713\nY\no\no\nn\n,\n \n2\n0\n0\n5\n7\n9\nC\na\ns\ne\n \ns\ne\nr\ni\ne\ns\nA\nr\nc\nh\ni\nb\ne\nc\nk\n,\n \n2\n0\n0\n4\n2\n7\nD\nu\nw\ne\nl\ni\nu\ns\n,\n \n2\n0\n0\n3\n3\n7\n\u2713\nD\ne\na\nt\nh\n \n(\n3\n0\n-\nd\na\ny\ns\n)\nD\ne\na\nt\nh\n \n(\nl\no\nn\ng\n-\nt\ne\nr\nm\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\nt\ni\ne\nn\nt\n-\nc\no\nn\nt\nr\no\nl\nl\ne\nd\n \na\nn\na\ne\ns\nt\nh\ne\ns\ni\na\n \n(\nm\ng\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \nt\no\nt\na\nl\n \nn\na\nr\nc\no\nt\ni\nc\n \nr\ne\nc\ne\ni\nv\ne\nd\n \n(\nm\ng\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \nn\na\nr\nc\no\nt\ni\nc\n \n(\nd\na\ny\ns\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nS\nh\no\nr\nt\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\ns\nc\no\nr\ne\n)\nL\no\nn\ng\n-\nt\ne\nr\nm\n \np\na\ni\nn\n \n(\ns\nc\no\nr\ne\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nn\no\nr\nm\na\nl\n \na\nc\nt\ni\nv\ni\nt\ny\n \n(\nd\na\ny\ns\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \ns\nh\no\np\np\ni\nn\ng\n \n(\nd\na\ny\ns\n)\nT\ni\nm\ne\n \nt\no\n \nr\ne\nt\nu\nr\nn\n \nt\no\n \nd\nr\ni\nv\ni\nn\ng\n \n(\nd\na\ny\ns\n)\nU\ns\ne\n \no\nf\n \nw\na\nl\nk\ni\nn\ng\n \na\ni\nd\ns\n:\n \ns\nh\no\nr\nt\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nU\ns\ne\n \no\nf\n \nw\na\nl\nk\ni\nn\ng\n \na\ni\nd\ns\n \n(\nd\na\ny\ns\n)\nL\ni\nm\np\n:\n \ns\nh\no\nr\nt\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nL\ni\nm\np\n:\n \nl\no\nn\ng\n-\nt\ne\nr\nm\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n)\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\n \nm\no\nn\nt\nh\ns\n)\nH\na\nr\nr\ni\ns\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n>\n3\n \nm\no\nn\nt\nh\ns\n)\nW\nO\nM\nA\nC\n \no\ns\nt\ne\no\na\nr\nt\nh\nr\ni\nt\ni\ns\n \ni\nn\nd\ne\nx\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nO\nx\nf\no\nr\nd\n \nh\ni\np\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\n \nm\no\nn\nt\nh\ns\n)\nM\ne\nr\nl\ne\n \nd\n\u2019\nA\nu\nb\ni\ng\nn\n\u00e9\n\u2013\nC\nh\na\nr\nn\nl\ne\ny\n \ns\nc\no\nr\ne\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nM\ne\nr\nl\ne\n \nd\n\u2019\nA\nu\nb\ni\ng\nn\n\u00e9\n\u2013\nC\nh\na\nr\nn\nl\ne\ny\n \ns\nc\no\nr\ne\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n1\n2\n \np\nh\ny\ns\ni\nc\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n1\n2\n \nm\ne\nn\nt\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \np\nh\ny\ns\ni\nc\na\nl\n \nf\nu\nn\nc\nt\ni\no\nn\n \n(\n\u0001\n\u0001\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \np\nh\ny\ns\ni\nc\na\nl\n \nf\nu\nn\nc\nt\ni\no\nn\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\nF\n-\n3\n6\n \nm\ne\nn\nt\na\nl\n \nc\no\nm\np\no\nn\ne\nn\nt\n \n(\n>\n3\nm\no\nn\nt\nh\ns\n)\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \n(\nn\no\n.\n \no\nf\n \np\na\nt\ni\ne\nn\nt\ns\n \nd\ni\ns\ns\na\nt\ni\ns\nf\ni\ne\nd\n)\nS\na\nt\ni\ns\nf\na\nc\nt\ni\no\nn\n \n(\ns\nc\no\nr\ne\n)\nS\nc\na\nr\n \nc\no\nn\nt\nr\na\nc\nt\ni\no\nnHealth Technology Assessment 2008; Vol. 12: No. 26\n167\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 10\nResults of meta-analyses\nComparison 01: Single mini-incision versus single standard incision\n(reported means and SDs)\n1\/27 0\/29\n0\/60 0\/60\n0\/110 0\/109\n   197     198\n2\/50 0\/52\n1\/60 0\/60\n0\/18 1\/18\n0\/38 0\/43\n0\/38 0\/21\n0\/37 0\/39\n7.96 (0.16 to 402.02)\n      Not estimable\n      Not estimable\n7.96 (0.16 to 402.02)\n7.85 (0.48 to 127.30)\n7.39 (0.15 to 372.38)\n0.14 (0.00 to 6.82)\n      Not estimable\n      Not estimable\n      Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  01 Revision rate (number having revision surgery)\n01 RCT\n Chimento  2005  (RCT)\n Hart  2005  (Q-RCT)\n Ogonda  2005  (RCT)\nSubtotal (95% CI)\nTotal events: 1 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: not application\nTest for overall effect: z = 1.04 (p = 0.30)\n02 Comparative studies\n Asayama  2006\n Ciminiello  2006\n Li  2005\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Wright  2004\nTotal events: 3 (Mini-incision), 1 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n100.00\n49.74\n25.13\n25.13\n0.001 0.01 0.1 1 10 100 1000\nMini-incision Standard incisionAppendix 10\n168\n2\/28 0\/32\n0\/60 0\/60\n1\/60 1\/60\n1\/70 1\/70\n1\/109 1\/110\n0\/20 0\/20\n   347     352\n0\/52 1\/50\n0\/99 0\/100\n0\/51 0\/95\n0\/60 0\/60\n0\/33 0\/33\n0\/34 0\/53\n0\/38 0\/43\n0\/38 0\/21\n1\/73 4\/54\n0\/50 1\/85\n0\/42 1\/42\n8.84 (0.54 to 145.71)\n     Not estimable\n1.00 (0.06 to 16.18)\n1.00 (0.06 to 16.15)\n1.01 (0.06 to 16.24)\n     Not estimable\n1.72 (0.43, 6.92)\n0.13 (0.00 to 6.56)\n     Not estimable\n     Not estimable\n     Not estimable\n     Not estimable\n     Not estimable\n     Not estimable\n     Not estimable\n0.21 (0.03 to 1.24)\n0.20 (0.00 to 11.83)\n0.14 (0.00 to 6.82)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  02 Postoperative dislocation rates\n01 RCT\n Chimento  2005  (RCT)\n Chung  2004  (Q-RCT)\n Hart  2005  (Q-RCT)\n Kim  2006  (Q-RCT)\n Ogonda  2005  (RCT)\n Shama  2006  (Q-RCT)\nSubtotal (95% CI)\nTotal events: 5 (Mini-incision), 3 (Standard incision)\nTest for heterogeneity: \u00032 = 1.75, df = 3 (p = 0.63), I2 = 0%\nTest for overall effect: z = 0.76 (p = 0.45)\n02 Comparative studies\n Asayama  2006\n Berger  2004\n Chen  2006\n Ciminiello  2006\n DiGioia  2003\n O\u2019Brien  2005\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Teet  2006\n Woolson  2004\n Wright  2004\nTotal events: 1 (Mini-incision), 7 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n24.72\n25.05\n25.08\n25.15\n100.00\n13.04\n61.74\n12.17\n13.05\n0.01 0.1 1 10 100\nMini-incision Standard incision\n  0\/60    0\/60\n  6\/70    5\/70\n16\/105 19\/109\n     235       239\n  0\/52    0\/50\n  0\/60    0\/60\n  4\/38    2\/43\n  4\/38    3\/21\n15\/50 13\/85\n  0\/42    0\/42\n     Not estimable\n1.22 (0.36 to 4.15)\n0.85 (0.41 to 1.76)\n0.93 (0.50 to 1.74)\n     Not estimable\n     Not estimable\n2.33 (0.44 to 12.21)\n0.70 (0.14 to 3.60)\n2.43 (1.03 to 5.73)\n     Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  03 Implant position (cup, number poorly placed)\n01 RCT\n Chung  2004  (Q-RCT)\n Kim  2006  (Q-RCT)\n Ogonda  2005  (RCT)\nSubtotal (95% CI)\nTotal events: 22 (Mini-incision), 24 (Standard incision)\nTest for heterogeneity: \u00032 = 0.24, df = 1 (p = 0.62), I2 = 0%\nTest for overall effect: z = 0.21 (p = 0.83)\n02 Comparative studies\n Asayama  2006\n Ciminiello  2006\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Woolson  2004\n Wright  2004\nTotal events: 23 (Mini-incision), 18 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n25.77\n74.23\n100.00\n17.39\n17.86\n64.74\n0.1 0.2 0.5 1 2 5 10\nMini-incision Standard incisionHealth Technology Assessment 2008; Vol. 12: No. 26\n169\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n1\/28 1\/32\n0\/60 0\/60\n6\/60 7\/60\n4\/70 4\/70\n3\/105 8\/109\n   323     331\n0\/52 0\/50\n0\/60 0\/60\n0\/30 0\/30\n1\/34 3\/53\n2\/38 2\/43\n2\/38 1\/21\n4\/73 4\/54\n6\/50 3\/85\n0\/42 0\/42\n1.15 (0.07 to 18.88)\n      Not estimable\n0.84 (0.27 to 2.65)\n1.00 (0.24 to 4.15)\n0.40 (0.12 to 1.34)\n0.70 (0.35 to 1.40)\n     Not estimable\n     Not estimable\n     Not estimable\n0.54 (0.07 to 4.19)\n1.14 (0.15 to 8.42)\n1.11 (0.10 to 12.27)\n0.72 (0.17 to 3.06)\n3.86 (0.96 to 15.59)\n        Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  04 Implant postion (stem, number poorly placed)\n01 RCT\n Chimento  2005  (RCT)\n Chung  2004  (Q-RCT)\n Hart  2005  (Q-RCT)\n Kim  2006  (Q-RCT)\n Ogonda  2005  (RCT)\nSubtotal (95% CI)\nTotal events: 14 (Mini-incision), 20 (Standard incision)\nTest for heterogeneity: \u00032 = 1.28, df = 3 (p = 0.73), I2 = 0%\nTest for overall effect: z = 1.01 (p = 0.31)\n02 Comparative studies\n Asayama  2006\n Ciminiello  2006\n  De Beer 2004\n O\u2019Brien  2005\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Teet  2006\n Woolson  2004\n Wright  2004\nTotal events: 15 (Mini-incision), 13 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n6.17\n36.85\n23.95\n33.04\n100.00\n14.45\n15.07\n10.44\n29.03\n31.02\n0.1 0.2 0.5 1 2 5 10\nMini-incision Standard incision\n0\/60 0\/60\n   60     60\n1\/60 0\/60\n      Not estimable\n      Not estimable\n7.39 (0.15 to 372.38)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  05 Implant migration\n01 RCT\n  Hart 2005 (Q-RCT)\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\n Ciminiello  2006\nTotal events: 1 (Mini-incision), 0 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n0.001 0.01 0.1 1 10 100 1000\nMini-incision Standard incisionAppendix 10\n170\n   0     0\n0\/33 3\/33\n0\/10 1\/10\n      Not estimable\n0.13 (0.01 to 1.27)\n0.14 (0.00 to 6.82)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  06 Heterotopic ossification (number with ossification)\n01 RCT\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\n DiGioia  2003\n Takahira\nTotal events: 0 (Mini-incision), 4 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n74.41\n25.59\n0.1 0.2 0.5 1 2 5 10\nMini-incision Standard incision\n  3\/27    1\/28\n  0\/60    0\/60\n28\/105 26\/100\n     192       197\n  0\/24    0\/25\n  0\/24    0\/11\n  0\/12    0\/21\n  0\/42    0\/42\n3.00 (0.40 to 22.53)\n     Not estimable\n1.16 (0.63 to 2.15)\n1.26 (0.70 to 2.27)\n     Not estimable\n     Not estimable\n     Not estimable\n     Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  07 Cement quality (number with poor quality)\n01 RCT\n Chimento  2005  (RCT)\n Hart  2005  (Q-RCT)\n Ogonda  2005  (RCT)\nSubtotal (95% CI)\nTotal events: 31 (Mini-incision), 27 (Standard incision)\nTest for heterogeneity: \u00032 = 0.78, df = 1 (p = 0.38), I2 = 0%\nTest for overall effect: z = 0.76 (p = 0.45)\n02 Comparative studies\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Woolson  2004\n Wright  2004\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n8.52\n91.48\n100.00\n0.1 0.2 0.5 1 2 5 10\nMini-incision Standard incisionHealth Technology Assessment 2008; Vol. 12: No. 26\n171\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n   0     0\n0\/52 0\/50\n      Not estimable\n      Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  08 Limb length inequality (number with unequal lengths)\n01 RCT\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\n Asayama  2006\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n0.1 0.5 1 2 10\nMini-incision Standard incision\n  20  460.00 (0.00)  20  462.50 (0.00)\n  28  127.00 (48.00)  32  170.00 (65.00)\n  60  136.00 (41.10)  60  200.50 (65.20)\n  60  318.80 (0.00)  60  544.40 (0.00)\n  70  445.80 (0.00)  70  567.50 (0.00)\n109  314.20 (0.00)   110  365.80 (0.00)\n347   352\n  52  217.50 (0.00)  50  247.00 (0.00)\n  99  154.00 (0.00)  100  278.00 (0.00)\n  51  175.49 (51.90)  95  293.68 (84.50)\n  60  201.67 (0.00)   60  191.73 (0.00)\n  30  180.00 (69.00)  30  246.70 (99.00)\n  50  387.00 (155.00)  57  469.00 (147.00)\n  10  699.00 (0.00)  10  540.00 (0.00)\n  38  244.00 (100.00)  43  265.00 (114.00)\n  38  244.00 (100.00)  43  304.00 (136.00)\n  50  603.00 (0.00)  85  507.00 (0.00)\n  42  151.80 (53.90)  42  173.20 (57.50)\n        Not estimable\n\u201343.00 (\u201371.69 to \u201314.31)\n\u201364.50 (\u201384.00 to \u201345.00)\n        Not estimable\n        Not estimable\n        Not estimable\n\u201357.71 (\u201373.84 to \u201341.58)\n        Not estimable\n        Not estimable\n\u2013118.19 (\u2013140.36 to \u201396.02)\n        Not estimable\n\u201366.70 (\u2013109.88 to \u201323.52)\n\u201382.00 (\u2013139.46 to \u201324.54)\n        Not estimable\n\u201321.00 (\u201367.60 to 25.60)\n\u201360.00 (\u2013111.61 to \u20138.39)\n        Not estimable\n\u201321.40 (\u201345.24 to 2.44)         \nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  09 Blood loss (intraoperative, ml)\n01 RCT\n  Charles 2006 (RCT)\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Hart 2005 (Q-RCT)\n  Kim 2006 (Q-RCT)\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 1.48, df = 1 (p = 0.22), I2 = 32.2%\nTest for overall effect: z = 7.01 (p < 0.00001)\n02 Comparative studies\n Asayama  2006\n Berger  2004\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n Howell  2004\n Pilot  2006\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n31.60\n 68.40\n100.00\n 37.19\n  9.81\n  5.54\n  8.42\n  6.87\n 32.18\n\u2013100 \u201350 0 50 100\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Appendix 10\n172\n28  378.00 (151.00)  32  504.00 (205.00)\n60  613.30 (0.00)  60  853.70 (0.00)\n88   92\n51  369.51 (65.05)  95  509.63 (117.39)\n18  318.00 (223.00)  18  523.00 (210.70)\n38  744.00 (260.00)  43  708.00 (221.00)\n38  744.00 (260.00)  21  771.00 (235.00)\n10  796.00 (0.00)  10  772.00 (0.00)\n\u2013126.00 (\u2013216.41 to \u201335.59)\n        Not estimable\n\u2013126.00 (\u2013216.41 to \u201335.59)\n\u2013140.12 (\u2013169.72 to \u2013110.52)\n\u2013205.00 (\u2013346.73 to \u201363.27)\n    36.00 (\u201369.82 to 141.82)\n  \u201327.00 (\u2013157.14 to 103.14)\n        Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  10 Blood loss (total, ml)\n01 RCT\n  Chimento 2005 (RCT)\n  Hart 2005 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 2.73 (p = 0.008)\n02 Comparative studies\n Chen  2006\n Li  2005\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Takahira  2006\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n85.21\n3.72\n6.67\n4.41\n\u20131000 \u2013500 0 500 1000\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n0\/60 0\/60\n0\/109 2\/110\n   169     170\n2\/52 0\/50\n1\/99 1\/100\n2\/50 0\/57\n2\/34 1\/53\n0\/38 0\/43\n0\/38 0\/21\n1\/10 0\/10\n2\/50 0\/85\n        Not estimable\n  0.14 (0.01 to 2.18)\n  0.14 (0.01 to 2.18)\n  7.25 (0.45 to 117.60)\n  1.01 (0.06 to 16.26)\n  8.67 (0.53 to 141.36)\n  3.27 (0.31 to 34.22)\n     Not estimable\n     Not estimable\n  7.39 (0.15 to 372.38)\n15.18 (0.85 to 270.70)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  11 Fractures: intraoperative\n01 RCT\n Hart  2005  (Q-RCT)\n Ogonda  2005  (RCT)\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 2 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 1.41 (p = 0.16)\n02 Comparative studies\n Asayama  2006\n Beger  2004\n Howell  2004\n O\u2019Brien  2005\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Takahira  2006\n Woolson  2004\nTotal events: 10 (Mini-incision), 12 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n100.00\n17.09\n17.18\n17.03\n24.09\n8.63\n15.98\n0.01 0.1 1 10 100\nMini-incision Standard incisionHealth Technology Assessment 2008; Vol. 12: No. 26\n173\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n0\/60 0\/60\n0\/20 0\/20\n   80     80\n3\/51 4\/95\n0\/60 0\/60\n1\/30 0\/30\n     Not estimable\n     Not estimable\n     Not estimable\n1.44 (0.29 to 7.03)\n     Not estimable\n7.39 (0.15 to 372.38)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  12 Fractures: postoperative\n01 RCT\n Hart  2005  (Q-RCT)\n Sharma  2006  (Q-RCT)\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\n Chen  2006\n Chiminiello  2006 \n  de Beer 2004\nTotal events: 4 (Mini-incision), 4 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n85.92\n14.08\n0.01 0.1 1 10 100\nMini-incision Standard incision\n0\/28 0\/32\n0\/60 0\/60\n0\/60 0\/60\n1\/70 0\/70\n2\/109 0\/110\n0\/20 0\/20\n0\/60 0\/60\n   407     412\n0\/52 1\/50\n0\/99 0\/100\n0\/60 0\/60\n0\/50 1\/57\n0\/34 0\/53\n0\/38 0\/43\n0\/38 0\/21\n1\/50 0\/85\n0\/42 0\/42\n      Not estimable\n      Not estimable\n      Not estimable\n  7.39 (0.15 to 372.38)\n  7.53 (0.47 to 121.10)\n      Not estimable\n      Not estimable\n  7.48 (0.78 to 72.16)\n  0.13 (0.00 to 6.56)\n      Not estimable\n      Not estimable\n  0.15 (0.00 to 7.78)\n      Not estimable\n      Not estimable\n      Not estimable\n14.88 (0.26 to 861.53)\n      Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome: 13  Infection\n01 RCT\n Chimento  2005  (RCT)\n Chung  2004  (Q-RCT)\n Hart  2005  (Q-RCT)\n Kim  2006  (Q-RCT)\n Ogonda  2005  (RCT)\n Sharma  2006  (Q-RCT)\n Zhang  2006  (RCT)\nSubtotal (95% CI)\nTotal events: 3 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: \u00032 = 0.00, df = 1 (p = 0.99), I2 = 0%\nTest for overall effect: z = 1.74 (p = 0.08)\n02 Comparative studies\n Asayama  2006\n Berger  2004\n Ciminiello  2006\n Howell  2004\n O\u2019Brien  2005\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Woolson  2004\n Wright  2004\nTotal events: 1 (Mini-incision), 2 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n33.44\n66.56\n100.00\n34.14\n34.01\n31.86\n0.01 0.1 1 10 100\nMini-incision Standard incisionAppendix 10\n174\n1\/20 0\/20\n0\/28 0\/32\n0\/60 0\/60\n0\/60 0\/60\n1\/70 1\/70\n0\/60 0\/60\n   298     302\n0\/52 0\/50\n0\/51 2\/95\n0\/33 0\/33\n0\/34 0\/53\n2\/38 3\/43\n2\/38 0\/21\n1\/10 0\/10\n1\/50 1\/85\n0\/42 0\/42\n   348     432\n7.39 (0.15 to 372.38)\n      Not estimable\n      Not estimable\n      Not estimable\n1.00 (0.06 to 16.15)\n        Not estimable\n1.95 (0.20 to 18.89)\n      Not estimable\n0.21 (0.01 to 3.93)\n      Not estimable\n      Not estimable\n0.75 (0.12 to 4.53)\n4.85 (0.26 to 89.99)\n7.39 (0.15 to 372.38)\n1.75 (0.10 to 31.21)\n      Not estimable\n1.16 (0.36 to 3.76)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  14 Nerve injury\n01 RCT\n Charles  2006  (RCT) \n Chimento  2005  (RCT)\n Chung  2004  (Q-RCT)\n Hart  2005  (Q-RCT)\n Kim  2006  (Q-RCT)\n Zhang  2006  (RCT)\nSubtotal (95% CI)\nTotal events: 2 (Mini-incision), 1 (Standard incision)\nTest for heterogeneity: \u00032 = 0.67, df = 1 (p = 0.41), I2 = 0%\nTest for overall effect: z = 0.58 (p = 0.56)\n02 Comparative studies\n Asayama  2006\n Chen  2006\n DiGioia  2003\n O\u2019Brien  2005\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Takahira  2006\n Woolson  2004\n Wright  2004\nSubtotal (95% CI)\nTotal events: 6 (Mini-incision), 6 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n33.49\n66.51\n100.00\n16.14\n42.28\n16.10\n8.94\n16.54\n100.00\n0.01 0.1 1 10 100\nMini-incision Standard incision\n0\/60 0\/60\n   60     60\n   0     0\n      Not estimable\n      Not estimable\n      Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  15 Vascular injury\n01 RCT\n  Zhang 2006 (RCT)\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n0.1 0.5 0.2 1 5 21 0\nMini-incision Standard incisionHealth Technology Assessment 2008; Vol. 12: No. 26\n175\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n       0\/28                      0\/32\n       3\/60                      5\/60\n       0\/60                      0\/60\n       0\/109                    1\/110\n       0\/60                      2\/60\n          317                       322\n       0\/52                      1\/50\n       0\/30                      1\/30\n       0\/34                      3\/53\n       2\/38                      3\/43\n       2\/38                      2\/21\n       1\/50                      2\/85\n        Not estimable\n     0.59 (0.14 to 2.45)\n        Not estimable\n     0.14 (0.00 to 6.88)\n     0.13 (0.01 to 2.15)\n     0.39 (0.12 to 1.30)\n     0.13 (0.00 to 6.56)\n     0.14 (0.00 to 6.82)\n     0.19 (0.02 to 1.95)\n     0.75 (0.12 to 4.53)\n     0.52 (0.06 to 4.22)\n     0.85 (0.08 to 9.02)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  16 DVT (deep venous thrombosis)\n01 RCT\n Chimento  2005  (RCT)\n Chung  2004  (Q-RCT)\n Hart  2005  (Q-RCT)\n Ogonda  2005  (RCT)\n Zhang  2006  (RCT)\nSubtotal (95% CI)\nTotal events: 3 (Mini-incision), 8 (Standard incision)\nTest for heterogeneity: \u00032 = 1.17, df = 2 (p = 0.56), I2 = 0%\nTest for overall effect: z = 1.54 (p = 0.12)\n02 Comparative studies\n Asayama  2006\n  de Beer 2004\n O\u2019Brien  2005\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Woolson  2004\nTotal events: 5 (Mini-incision), 12 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n \n71.62\n  9.51\n 18.86\n100.00\n  6.34\n  6.35\n 17.71\n 30.03\n 22.07\n 17.49\n0.1 0.5 0.2 1 10 5 2\nMini-incision Standard incision\n       0\/60                      0\/60\n          60                         60\n       0\/99                      0\/100\n       1\/34                      0\/53 \n        Not estimable\n        Not estimable\n        Not estimable\n12.92 (0.23 to 717.46)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  17 Pulmonary embolism\n01 RCT\n Hart  2005  (Q-RCT)\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\n Berger  2004\n O\u2019Brien  2005\nTotal events: 1 (Mini-incision), 0 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n \n100.00\n0.001 0.1 0.01 1 1000 100 10\nMini-incision Standard incisionAppendix 10\n176\n  20    95.20 (0.00)  20    87.70 (0.00)\n  28    70.30 (10.70)  32    70.00 (8.50)\n  60    49.00 (9.40)  60    55.10 (17.90)\n  60    71.00 (0.00)  60    70.00 (0.00)\n  70    52.00 (0.00)  70    61.00 (0.00)\n109    60.30 (9.20)  110    65.90 (13.20)\n  20      0.00 (0.00)  20      0.00 (0.00)\n  60    75.00 (0.00)  60    69.00 (0.00)\n427   432\n  50    58.60 (0.00)  50    57.90 (0.00)\n  99    72.00 (0.00)  100    66.00 (0.00)\n  51    88.41 (17.60)  95    90.85 (17.81)\n  60    55.45 (0.00)  60    56.95 (0.00)\n  30    46.60 (0.00)  30    44.50 (0.00)\n  33  120.00 (0.00)  33  100.00 (0.00)\n  50    97.00 (19.00)  57    84.00 (15.00)\n  18    91.00 (16.40)  18    97.00 (15.60)\n  32    74.00 (15.00)  51    80.00 (10.00)\n  10    99.50 (0.00)  10    81.00 (0.00)\n  38    84.00 (16.00)  43    93.00 (18.00)\n  38    84.00 (16.00)  21  102.00 (12.00)\n  10  126.50 (0.00)  10  119.90 (0.00)\n  50    97.00 (0.00)  85  105.00 (0.00)\n  42    71.40 (11.20)  42    77.70 (13.20)\n        Not estimable\n    0.30 (\u20134.64 to 5.24)\n  \u20136.10 (\u201311.22 to \u20130.98)\n        Not estimable\n        Not estimable\n  \u20135.60 (\u20138.61 to \u20132.59)\n        Not estimable\n        Not estimable\n  \u20134.42 (\u20136.72 to \u20132.13)\n        Not estimable\n        Not estimable\n  \u20132.44 (\u20138.45 to 3.57)\n        Not estimable\n        Not estimable\n        Not estimable\n  13.00 (6.45 to 19.55)\n  \u20136.00 (\u201316.46 to 4.46)\n  \u20136.00 (\u201311.88 to \u20130.12)\n        Not estimable\n  \u20139.00 (\u201316.40 to \u20131.60)\n\u201318.00 (\u201325.23 to \u201310.77)\n        Not estimable\n        Not estimable\n  \u20136.30 (\u201311.54 to \u20131.06)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  18 Duration of operation (minutes)\n01 RCT\n  Charles 2006 (RCT)\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Hart 2005 (Q-RCT)\n  Kim 2006 (Q-RCT)\n  Ogonda 2005 (RCT)\n  Sharma 2006 (Q-RCT)\n  Zhang 2006 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 4.51, df = 2 (p = 0.10), I2 = 55.7%\nTest for overall effect: z = 3.77 (p = 0.0002)\n02 Comparative studies\n Asayama  2006\n Berger  2004\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n DiGioia  2003\n Howell  2004\n Li  2005\n O\u2019Brien  2005\n Pilot  2006\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Takahira  2006\n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n21.64\n 20.16\n \n58.19\n100.00\n \n16.97\n \n14.31\n  5.61\n 17.77\n \n11.19\n 11.75\n \n22.39\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26\n177\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n  20    5.35 (0.00)  20    5.70 (0.00)\n  28    5.80 (0.00)  32    5.50 (0.00)\n  60    4.41 (1.10)  60    5.34 (1.40)\n109    3.65 (2.04)  110    3.68 (2.45)\n  20    0.00 (0.00)  20    0.00 (0.00)\n  60    7.00 (0.00)  60  13.50 (0.00)\n297   302\n  52    2.96 (0.00)  50    2.94 (0.00)\n100    1.90 (0.00)  100    3.50 (0.00)\n  51  11.16 (0.83)  95  12.83 (1.96)\n  60    3.70 (0.00)  60    3.63 (0.00)\n  30    5.13 (0.00)  30    5.10 (0.00)\n  33    3.80 (0.00)  33    3.90 (0.00)\n  50    4.40 (2.90)  57    5.70 (3.10)\n  35    5.40 (2.10)  53    6.20 (2.80)\n  40    5.60 (0.00)  40    6.70 (0.00)\n  10  22.00 (0.00)  10  23.40 (0.00)\n  50    4.30 (0.00)  85    4.00 (0.00)\n  42    6.12 (0.00)  42    6.07 (0.00)\n        Not estimable\n        Not estimable\n\u20130.93 (\u20131.38 to \u20130.48)\n\u20130.03 (\u20130.63 to 0.57)\n        Not estimable\n        Not estimable\n\u20130.60 (\u20130.96 to \u20130.24)\n        Not estimable\n        Not estimable\n\u20131.67 (\u20132.13 to \u20131.21)\n        Not estimable\n        Not estimable\n        Not estimable\n\u20131.30 (\u20132.44 to \u20130.16)\n\u20130.80 (\u20131.83 to 0.23)\n        Not estimable\n        Not estimable\n        Not estimable\n        Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  19 Length of hospital stay (days)\n01 RCT\n  Charles 2006 (RCT)\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Ogonda 2005 (RCT)\n  Sharma 2006 (Q-RCT)\n  Zhang 2006 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 5.56, df = 1 (p = 0.02), I2 = 82.0%\nTest for overall effect: z = 3.29 (p = 0.001)\n02 Comparative studies\n Asayama  2006\n Berger  2004\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n DiGioia  2003\n Howell  2004\n O\u2019Brien  2005\n Panisello  2006\n Takahira  2006\n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n 63.71\n 36.29\n100.00\n 73.69\n 11.80\n 14.51\n\u20134 \u20132 0 2 4\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n       0\/109                    2\/110\n          109                       110\n       0\/60                      0\/60\n       0\/42                      0\/42\n     0.14 (0.01 to 2.18)\n     0.14 (0.01 to 2.18)\n        Not estimable\n        Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  20 Death (30 days)\n01 RCT\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 2 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 1.41 (p = 0.16)\n02 Comparative studies\n Ciminiello  2006\n Wright  2004\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n100.00\n0.01 0.1 1 100 10\nMini-incision Standard incisionAppendix 10\n178\n       0\/28                      2\/32\n          28                         32\n       0\/60                      0\/60\n       2\/42                      2\/42\n     0.15 (0.01 to 2.45)\n     0.15 (0.01 to 2.45)\n        Not estimable\n     1.00 (0.14 to 7.36)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  21 Death (long term)\n01 RCT\n  Chimento 2005 (RCT)\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 2 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 1.33 (p = 0.18)\n02 Comparative studies\n Ciminiello  2006\n Wright  2004\nTotal events: 2 (Mini-incision), 2 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n100.00\n100.00\n0.01 0.1 1 100 10\nMini-incision Standard incision\n  18    22.80 (0.00)  19    19.50 (0.00)\n  28  285.00 (185.00)  32  319.00 (177.00)\n109    42.90 (97.40)  110    45.00 (96.80)\n155   161\n          Not estimable\n\u201334.00 (\u2013125.96 to 57.96)\n  \u20132.10 (\u201327.82 to 23.62)\n  \u20134.41 (\u201329.18 to 20.36)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  22 Short-term patient-controlled anaesthesia (mg)\n01 RCT\n  Charles 2006 (RCT)\n  Chimento 2005 (RCT)\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 0.43, df = 1 (p = 0.51), I2 = 0%\nTest for overall effect: z = 0.35 (p = 0.73)\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n7.26\n 92.74\n100.00\n\u2013100 \u201350 0 50 100\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26\n179\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n  0    0\n52      92.70 (0.00)  50      94.90 (0.00)\n60    118.00 (0.00)  60    121.00 (0.00)\n30    147.70 (0.00)  30    169.30 (0.00)\n        Not estimable\n        Not estimable\n        Not estimable\n        Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  23 short-term total narcotic received (mg)\n01 RCT\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\n Asayama  2006\n Ciminiello  2006\n  de Beer 2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n60      2.20 (0.00)  60      2.64 (0.00)\n60 60\n        Not estimable\n        Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  24 Short-term narcotic (days)\n01 RCT\n  Chung 2004 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n\u2013100 \u201350 0 50 100\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Appendix 10\n180\n            0                           0\n       2\/52                      3\/49\n       0\/60                      0\/60\n       0\/30                      1\/30\n       Not estimable\n   0.62 (0.10 to 3.71)\n       Not estimable\n   0.14 (0.00 to 6.82)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  25 Short-term pain (N of patients)\n01 RCT\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative  studies\n Asayama  2006\n Ciminiello  2006\n  de Beer 2004\nTotal events: 2 (Mini-incision), 4 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n 82.75\n 17.25\n0.1 0.5 0.2 1 10 25\nMini-incision Standard incision\n  18  3.94 (0.00)  19  3.68 (0.00)\n  70  0.00 (0.00)  70  0.00 (0.00)\n109  3.30 (1.80)  110  3.36 (1.96)\n  20  4.05 (0.00)  20  6.25 (0.00)\n217   219\n  38  1.50 (1.15)  43  2.15 (1.20)\n  38  1.50 (1.15)  21  2.10 (1.30)\n        Not estimable\n        Not estimable\n\u20130.06 (\u20130.56 to 0.44)\n        Not estimable\n\u20130.06 (\u20130.56 to 0.44)\n\u20130.65 (\u20131.16 to \u20130.14)\n\u20130.60 (\u20131.27 to 0.07)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  26 Short-term pain (score)\n01 RCT\n  Charles 2006 (RCT)\n  Kim 2006 (Q-RCT)\n  Ogonda 2005 (RCT)\n  Sharma 2006 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 0.24 (p = 0.81)\n02 Comparative studies\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n 62.80\n 37.20\n\u20134 \u20132 0 2 4\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26\n181\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n 70  0.00 (0.00)  70  0.00 (0.00)\n 70    70\n        Not estimable\n        Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  27 Long-term pain (score)\n01 RCT\n  Kim 2006 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n   0     0\n  51  60.00 (12.00)  95  116.00 (11.00)\n         Not estimable\n\u201356.00 (\u201359.97 to \u201352.03)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  28 Time to return to normal activity (days)\n01 RCT\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\n Chen  2006 \nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n\u2013100 \u201350 0 50 100\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n       9\/28                    15\/32\n          28                         32\n       4\/52                      4\/49\n     0.55 (0.20 to 1.53)\n     0.55 (0.20 to 1.53)\n     0.94 (0.22 to 3.95)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  29 Use of walking aids: short-term (N of patients)\n01 RCT\n  Chimento 2005 (RCT)\nSubtotal (95% CI)\nTotal events: 9 (Mini-incision), 15 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 1.15 (p = 0.25)\n02 Comparative  studies\n Asayama  2006\nTotal events: 4 (Mini-incision), 4 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n100.00\n100.00\n0.1 0.5 0.2 1 10 25\nMini-incision Standard incisionAppendix 10\n182\n  60  21.40 (4.80)  60  24.80 (5.40)\n  60    60\n  \u20133.40 (\u20135.23 to \u20131.57)\n  \u20133.40 (\u20135.23 to \u20131.57)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  30 Use of walking aids (days)\n01 RCT\n  Chung 2004 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 3.65 (p = 0.0003)\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n       6\/28                    15\/31\n          28                         31\n     19\/52                    16\/49\n    0.31 (0.11 to 0.91)\n    0.31 (0.11 to 0.91)\n    1.19 (0.52 to 2.68)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  31 Limp: short term (N of patients)\n01 RCT\n  Chimento 2005 (RCT)\nSubtotal (95% CI)\nTotal events: 6 (Mini-incision), 15 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 2.14 (p = 0.03)\n02 Comparative  studies\n Asayama  2006\nTotal events: 19 (Mini-incision), 16 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n100.00\n100.00\n0.1 0.5 0.2 1 10 25\nMini-incision Standard incisionHealth Technology Assessment 2008; Vol. 12: No. 26\n183\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n       0\/27                      0\/29\n          27                         29\n        Not estimable\n        Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  32 Limp: long-term (N of patients)\n01 RCT\n  Chimento 2005 (RCT)\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative  studies\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n0.1 0.5 0.2 1 10 25\nMini-incision Standard incision\n107  \u201384.15 (10.56)  108  \u201383.36 ( 8.33)\n  60  \u201391.40 (0.00)  60  \u201378.50 (0.00)\n167   168\n  60  \u201391.02 (0.00)  60  \u201394.93 (0.00)\n  30  \u201371.10 (9.80)  30  \u201366.60 (12.20)\n  33  \u201386.29 (0.00)  33  \u201380.44 (0.00)\n  \u20130.79 (\u20133.33 to 1.75)\n         Not estimable\n  \u20130.79 (\u20133.33 to 1.75)\n         Not estimable\n  \u20134.50 (\u201310.10 to 1.10)\n         Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  33 Harris hip score (\u00013 months)\n01 RCT\n  Ogonda 2005 (RCT)\n  Zhang 2006 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 0.61 (p = 0.54)\n02 Comparative studies\n Ciminiello  2006\n  de Beer 2004\n DiGioia  2003\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n100.00\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Appendix 10\n184\n  27  \u201394.50 (0.00)  29  \u201394.50 (0.00)\n  60  \u201395.50 (0.00)  60  \u201393.50 (0.00)\n  70  \u201393.00 (0.00)  70  \u201391.00 (0.00)\n  60  \u201395.10 (0.00)  60  \u201395.60 (0.00)\n217   219\n  52  \u201396.20 (0.00)  50  \u201396.20 (0.00)\n  51  \u201389.71 (3.62)  95  \u201383.78 (8.03)\n  33  \u201396.00 (0.00)  33  \u201394.00 (0.00)\n  18  \u201392.00 (0.00)  18  \u201390.00 (0.00)\n  20  \u201399.00 (0.00)  14  \u201397.00 (0.00)\n  37  \u201386.90 (4.10)  39  \u201384.20 (6.40)\n         Not estimable\n         Not estimable\n         Not estimable\n         Not estimable\n         Not estimable\n         Not estimable\n  \u20135.93 (\u20137.83 to \u20134.03)\n         Not estimable\n         Not estimable\n         Not estimable\n  \u20132.70 (\u20135.10 to \u20130.30)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  34 Harris hip score (>3 months)\n01 RCT\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Kim 2006 (Q-RCT)\n  Zhang 2006 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\n Asayama  2006\n Chen  2006\n DiGioia  2003\n Li  2005\n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n 61.66\n 38.34\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n  16  91.99 (0.00)  19  89.60 (0.00)\n107  74.40 (13.88)  108  73.95 (12.90)\n123   127\n         Not estimable\n    0.45 (\u20133.13 to 4.03)\n    0.45 (\u20133.13 to 4.03)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  35 WOMAC osteoarthritis index (\u00013 months)\n01 RCT\n  Charles 2006 (RCT)\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 0.25 (p = 0.81)\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26\n185\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n107  24.97 (7.33)  108  25.88 (6.29)\n107   108\n  30  26.50 (8.40)  30  28.40 (7.50)\n  \u20130.91 (\u20132.74 to 0.92)\n  \u20130.91 (\u20132.74 to 0.92)\n  \u20131.90 (\u20135.93 to 2.13)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  36 Oxford hip score (\u00013 months)\n01 RCT\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 0.98 (p = 0.33)\n02 Comparative studies\n  de Beer 2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n100.00\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n  60  \u201316.60 (0.00)  60  \u201314.10 (0.00)\n  60    60\n         Not estimable\n         Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  37 Merle d\u2019Aubigne-Charnley Score (\u00013 months) \n01 RCT\n  Hart 2005 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n  60  \u201317.40 (0.00)  60  \u201317.30 (0.00)\n  60    60\n         Not estimable\n         Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  38 Merle d\u2019Aubigne-Charnley Score (>3 months)\n01 RCT\n  Hart 2005 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Appendix 10\n186\n107  \u201338.48 (10.20)  108  \u201337.73 (9.48)\n107   108\n  \u20130.75 (\u20133.38 to 1.88)\n  \u20130.75 (\u20133.38 to 1.88)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  39 SF-12 physical component (\u00013 months)\n01 RCT\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 0.56 (p = 0.58)\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n107  \u201350.61 (11.05)  108  \u201351.11 (10.54)\n107   108\n     0.50 (\u20132.39 to 3.39)\n     0.50 (\u20132.39 to 3.39)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  40 SF-12 mental component (>3 months)\n01 RCT\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 0.34 (p = 0.73)\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n  16  \u201340.80 (0.00)  19  \u201340.40 (0.00)\n  16    19\n          Not estimable\n          Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  41 SF-36 physical function (\u00013 months)\n01 RCT\n  Charles 2006 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26\n187\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n    0    0\n109  \u201354.50 (4.29)  56  \u201356.24 (3.87)\n          Not estimable\n     1.74 (0.45 to 3.03)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  42 SF-36 physical function (>3 months)\n01 RCT\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\n Dorr  2007\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n    0    0\n109  \u201360.38 (3.84)  56  \u201360.74 (3.42)\n          Not estimable\n     0.36 (\u20130.79 to 1.51)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  43 SF-36 mental component (>3 months)\n01 RCT\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\n Dorr  2007\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Appendix 10\n188\n       0                           0\n       0\/109                  21\/56\n       0\/20                      0\/14\n       0\/37                      5\/37\n        Not estimable\n     0.03 (0.01 to 0.09)\n        Not estimable\n     0.12 (0.02 to 0.73)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  44 Satisfaction (number of patients dissatisfied)\n01 RCT\nSubtotal (95% CI)\nTotal events: 0 (Mini-incision), 0 (Standard incision)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative  studies\n Corr  2007\n Woolson  2004\n Wright  2004\nTotal events: 0 (Mini-incision), 26 (Standard incision)\nStudy\nor subcategory\nMini-incision\nn\/N\nStandard incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n \n77.77\n \n22.23\n0.01 0.1 1 100 10\nMini-incision Standard incision\n  18  \u201315.22 (0.00)  19  \u201314.59 (0.00)\n  18    19\n          Not estimable\n          Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome: 45  Satisfaction  (score)\n01 RCT\n  Charles 2006 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26\n189\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n107  11.00 (0.00)  108  12.00 (0.00)\n107   108\n          Not estimable\n          Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  01 Mini-incision versus standard incision\nOutcome:  46 Scar contraction (% of total wound length from end of surgery)\n01 RCT\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\nComparison 02: Single mini-incision versus single standard incision\n(reported means and SDs supplemented with calculated SDs from \np-values)\n  20  460.00 (184.25)  20  462.50 (184.25)\n  28  127.00 (48.00)  32  170.00 (65.00)\n  60  136.00 (41.10)  60  200.50 (65.20)\n  60  318.80 (0.00)  60  544.40 (0.00)\n  70  445.80 (521.95)  70  567.50 (521.95)\n109  314.20 (174.78)  110  365.80 (174.78)\n347   352\n  52  217.50 (0.00)  50  247.00 (0.00)\n  99  154.00 (443.49)  100  278.00 (443.49)\n  51  175.49 (51.90)  95  293.68 (84.50)\n  60  201.67 (228.39)  60  191.73 (228.39)\n  30  180.00 (69.00)  30  246.70 (99.00)\n  50  387.00 (155.00)  57  469.00 (147.00)\n  10  699.00 (319.20)  10  540.00 (319.20)\n  38  244.00 (100.00)  43  265.00 (114.00)\n  38  244.00 (100.00)  43  304.00 (136.00)\n  50  603.00 (344.21)  85  507.00 (344.21)\n  42  151.80 (53.90)  42  173.20 (57.50)\n    \u20132.50 (\u2013116.70 to 111.70)\n  \u201343.00 (\u201371.69 to \u201314.31)\n  \u201364.50 (\u201384.00 to \u201345.00)\n        Not estimable\n\u2013121.70 (\u2013294.62 to 51.22)\n  \u201351.60 (\u201397.90 to \u20135.30)\n  \u201356.59 (\u201371.63 to \u201341.55)\n        Not estimable\n\u2013124.00 (\u2013247.24 to \u20130.76)\n\u2013118.19 (\u2013140.36 to \u201396.02)\n      9.94 (\u201371.79 to 91.67)\n  \u201366.70 (\u2013109.88 to \u201323.52)\n  \u201382.00 (\u2013139.46 to \u201324.54)\n  159.00 (\u2013120.79 to 438.79)\n  \u201321.00 (\u201367.60 to 25.60)\n  \u201360.00 (\u2013111.61 to \u20138.39)\n    96.00 (\u201324.24 to 216.24)\n  \u201321.40 (\u201345.24 to 2.44)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  09 Blood loss (intraoperative, ml)\n01 RCT\n  Charles 2006 (RCT)\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Hart 2005 (Q-RCT)\n  Kim 2006 (Q-RCT)\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 2.94, df = 4 (p = 0.57), I2 = 0%\nTest for overall effect: z = 7.37 (p < 0.00001)\n02 Comparative studies\n Asayama  2006\n Berger  2004\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n Howell  2004\n Pilot  2006\n Szendr\u00f3i  2006  MI\/MD \n Szendr\u00f3i  2006  MI\/SI \n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n  1.73\n 27.48\n 59.48\n  0.76\n 10.55\n100.00\n  1.14\n 35.27\n  2.60\n  9.30\n  5.25\n  0.22\n  7.98\n  6.51\n  1.20\n 30.52\n\u2013100 \u201350 0 50 100\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Appendix 10\n190\n  28  378.00 (151.00)  32  504.00 (205.00)\n  60  613.30 (0.00)  60  853.70 (0.00)\n  88    92\n  51  369.51 (65.05)  95  509.63 (117.39)\n  18  318.00 (223.00)  18  523.00 (210.70)\n  38  744.00 (260.00)  43  708.00 (221.00)\n  38  744.00 (260.00)  21  771.00 (235.00)\n  10  796.00 (0.00)  10  772.00 (0.00)\n\u2013126.00 (\u2013216.41 to \u201335.59)\n          Not estimable\n\u2013126.00 (\u2013216.41 to \u201335.59)\n\u2013140.12 (\u2013169.72 to \u2013110.52)\n\u2013205.00 (\u2013346.73 to \u201363.27)\n    36.00 (\u201369.82 to 141.82)\n  \u201327.00 (\u2013157.14 to 103.14)\n          Not estimable\n\u2013125.80 (\u2013153.13 to \u201398.48)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  10 Blood loss (total, ml)\n01 RCT\n  Chimento 2005 (RCT)\n  Hart 2005 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 2.73 (p = 0.006)\n02 Comparative studies\n Chen  2006\n Li  2005\n Szendr\u00f3i  2006  MI\/MD \n Szendr\u00f3i  2006  MI\/SI \n Takahira  2006\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n 85.21\n  3.72\n  6.67\n  4.41\n100.00\n\u20131000 \u2013500 0 500 1000\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n  20    95.20 (23.29)  20    87.70 (23.29)\n  28    70.30 (10.70)  32    70.00 (8.50)\n  60    49.00 (9.40)  60    55.10 (17.90)\n  60    71.00 (0.00)  60    70.00 (0.00)\n  70    52.00 (15.84)  70    61.00 (15.84)\n109    60.30 (9.20)  110    65.90 (13.20)\n  20      0.00 (0.00)  20      0.00 (0.00)\n  60    75.00 (16.60)  60    69.00 (16.60)\n427   432\n  50    58.60 (0.00)  50    57.90 (0.00)\n  99    72.00(0.00)  100    66.00 (0.00)\n  51    88.41 (17.60)  95    90.85 (17.81)\n  60    55.45 (4.91)  60    56.95 (4.91)\n  30    46.60 (14.31)  30    44.50 (14.31)\n  33  120.00 (0.00)  33  100.00 (0.00)\n  50    97.00 (19.00)  57    84.00 (15.00)\n  18    91.00 (16.40)  18    97.00 (15.60)\n  32    74.00 (15.00)  51    80.00 (10.00)\n  10    99.50 (20.25)  10    81.00 (20.25)\n  38    84.00 (16.00)  43    93.00 (18.00)\n  38    84.00 (16.00)  21  102.00 (12.00)\n  10  126.50 (0.00)  10  119.90 (0.00)\n  50    97.00 (29.46)  85  105.00 (29.46)\n  42    71.40 (11.20)  42    77.70 (13.20)\n     7.50 (\u20136.94 to 21.94)\n     0.30 (\u20134.64 to 5.24)\n   \u20136.10 (\u201311.22 to \u20130.98)\n        Not estimable\n   \u20139.00 (\u201314.25 to \u20133.75)\n   \u20135.60 (\u20138.61 to \u20132.59)\n        Not estimable\n     6.00 (\u20130.06 to 11.94)\n   \u20133.70 (\u20135.67 to \u20131.74)\n        Not estimable\n        Not estimable\n   \u20132.44 (\u20138.45 to 3.57)\n   \u20131.50 (\u20133.26 to 0.26)\n     2.10 (\u20135.14 to 9.34)\n        Not estimable\n   13.00 (6.45 to 19.55)\n   \u20136.00 (\u201316.46 to 4.46)\n   \u20136.00 (\u201311.88 to \u20130.12)\n   18.50 (0.75 to 36.25)\n   \u20139.00 (\u201316.40 to \u20131.60)\n \u201318.00 (\u201325.23 to \u201310.77)\n        Not estimable\n   \u20138.00 (\u201318.29 to 2.29)\n   \u20136.30 (\u201311.54 to \u20131.06)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  18 Duration of operation (minutes)\n01 RCT\n  Charles 2006 (RCT)\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Hart 2005 (Q-RCT)\n  Kim 2006 (Q-RCT)\n  Ogonda 2005 (RCT)\n  Sharma 2006 (Q-RCT)\n  Zhang 2006 (RCT) \nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 21.37, df = 5 (p = 0.0007), I2 = 76.6%\nTest for overall effect: z = 3.69 (p < 0.0002)\n02 Comparative studies\n Asayama  2006\n Berger  2004\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n DiGioia  2003\n Howell  2004\n Li  2005\n O\u2019Brien  2005\n Pilot  2006\n Szendr\u00f3i  2006  MI\/MD \n Szendr\u00f3i  2006  MI\/SI\n Takahira  2006\n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n  1.85\n 15.84\n 14.76\n 14.02\n 42.59\n 10.94\n100.00\n  5.33\n 62.47\n  3.68\n  4.50\n  1.76\n  5.58\n  0.61\n  3.52\n  3.69\n  1.82\n  7.04\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26\n191\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n  18    22.80 (6.03)  19    19.50 (6.03)\n  28  285.00 (185.00)  32  319.00 (177.00)\n109    42.90 (97.40)  110    45.00 (96.80)\n155   161\n    3.30 (\u20130.59 to 7.19)\n\u201334.00 (\u2013125.96 to 57.96)\n  \u20132.10 (\u201327.82 to 23.62)\n    3.11 (\u20130.73 to 6.95)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  22 Short-term patient-controlled anaesthesia (mg)\n01 RCT\n  Charles 2006 (RCT)\n  Chimento 2005 (RCT)\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 0.79, df = 2 (p = 0.67), I2 = 0%\nTest for overall effect: z = 1.59 (p = 0.11)\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n 97.60\n  0.17\n  2.23\n100.00\n\u2013100 \u201350 0 50 100\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n  20    5.35 (1.63)  20    5.70 (1.63)\n  28    5.80 (2.20)  32    5.50 (2.20)\n  60    4.41 (1.10)  60    5.34 (1.40)\n109    3.65 (2.04)  110    3.68 (2.45)\n  20    0.00 (0.00)  20    0.00 (0.00)\n  60    7.00 (0.00)  60  13.50 (0.00)\n297   302\n  52    2.96 (0.56)  50    2.94 (0.56)\n100    1.90 (5.74)  100    3.50 (5.74)\n  51  11.16 (0.83)  95  12.83 (1.96)\n  60    3.70 (5.08)  60    3.63 (5.08)\n  30    5.13 (0.87)  30    5.10 (0.87)\n  33    3.80 (0.77)  33    3.90 (0.77)\n  50    4.40 (2.90)  57    5.70 (3.10)\n  35    5.40 (2.10)  53    6.20 (2.80)\n  40    5.60 (0.00)  40    6.70 (0.00)\n  10  22.00 (0.00)  10  23.40 (0.00)\n  50    4.30 (2.17)  85    4.00 (2.17)\n  42    6.12 (2.27)  42    6.07 (2.27)\n  \u20130.35 (\u20131.36 to 0.66)\n    0.30 (\u20130.82 to 1.42)\n  \u20130.93 (\u20131.38 to \u20130.48)\n  \u20130.03 (\u20130.63 to 0.57)\n        Not estimable\n        Not estimable\n  \u20130.50 (\u20130.83 to \u20130.18)\n    0.02 (\u20130.20 to 0.24)\n  \u20131.60 (\u20133.19 to \u20130.01)\n  \u20131.67 (\u20132.13 to \u20131.21)\n    0.07 (\u20131.75 to 1.89)\n    0.03 (\u20130.41 to 0.47)\n  \u20130.10 (\u20130.47 to 0.27)\n  \u20131.30 (\u20132.44 to \u20130.16)\n  \u20130.80 (\u20131.83 to 0.23)\n        Not estimable\n        Not estimable\n    0.30 (\u20130.46 to 1.06)\n    0.05 (\u20130.92 to 1.02)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  19 Length of hospital stay (days)\n01 RCT\n  Charles 2006 (RCT)\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Ogonda 2005 (RCT)\n  Sharma 2006 (Q-RCT)\n  Zhang 2006 (RCT) \nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 7.94, df = 3 (p = 0.05), I2 = 62.2%\nTest for overall effect: z = 3.03 (p < 0.002)\n02 Comparative studies\n Asayama  2006\n Berger  2004\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n DiGioia  2003\n Howell  2004\n O\u2019Brien  2005\n Panisello  2006\n Takahira  2006\n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n 10.30\n  8.44\n 51.77\n 29.49\n100.00\n 48.52\n  0.91\n 11.07\n  0.69\n 11.83\n 16.61\n  1.77\n  2.18\n  3.99\n  2.43\n\u20134 \u20132 0 2 4\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Appendix 10\n192\n    0    0\n  52    92.70 (0.00)  50    94.90 (0.00)\n  60  118.00 (41.12)  60  121.00 (41.12)\n  30  147.70 (86.75)  30  169.30 (86.75)\n        Not estimable\n        Not estimable\n   \u20133.00 (\u201317.71 to 11.71)\n \u201321.60 (\u201365.50 to 22.30)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  23 Short-term total narcotic received (mg)\n01 RCT\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 0.79, df = 2 (p = 0.67), I2 = 0%\nTest for overall effect: z = 1.59 (p < 0.11)\n02 Comparative studies\n Asayama  2006\n Ciminiello  2006\n  de Beer 2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n89.90\n 10.10\n\u2013100 \u201350 0 50 100\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n  18  3.94 (0.51)  19  3.68 (0.51)\n  70  0.00 (0.00)  70  0.00 (0.00)\n109  3.30 (1.80)  110  3.36 (1.96)\n  20  4.05 (2.52)  20  6.25 (2.52)\n217   219\n  38  1.50 (1.15)  43  2.15 (1.20)\n  38  1.50 (1.15)  21  2.10 (1.30)\n    0.26 (\u20130.07 to 0.59)\n        Not estimable\n  \u20130.06 (\u20130.56 to 0.44)\n  \u20132.20 (\u20133.76 to \u20130.64)\n    0.09 (\u20130.18 to 0.36)\n  \u20130.65 (\u20131.16 to \u20130.14)\n  \u20130.60 (\u20131.27 to 0.07)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  26 Short-term pain (score)\n01 RCT\n  Charles 2006 (RCT)\n  Kim 2006 (Q-RCT)\n  Ogonda 2005 (RCT)\n  Sharma 2006 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 9.63, df = 2 (p = 0.008), I2 = 79.2%\nTest for overall effect: z = 0.67 (p = 0.50)\n02 Comparative studies\n Szendr\u00f3i  2006  MI\/MD \n Szendr\u00f3i  2006  MI\/SI \nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n 67.59\n 29.42\n  2.99\n100.00\n 62.80\n 37.20\n\u20134 \u20132 0 2 4\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26\n193\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n107  \u201384.15 (10.56)  108  \u201383.36 (8.33)\n  60  \u201391.40 (35.68)  60  \u201378.50 (35.68)\n167   168\n  60  \u201391.02 (12.17)  60  \u201394.93 (12.17)\n  30  \u201371.10 (9.80)  30  \u201366.60 (12.20)\n  33  \u201386.29 (11.62)  33  \u201380.44 (11.62)\n   \u20130.79 (\u20133.33 to 1.75)\n \u201312.90 (\u201325.67 to \u20130.13)\n   \u20131.25 (\u20133.75 to 1.24)\n     3.91 (\u20130.44 to 8.26)\n   \u20134.50 (\u201310.10 to 1.10)\n   \u20135.85 (\u201311.46 to \u20130.24)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  33 Harris hip score (\u00013 months)\n01 RCT\n  Ogonda 2005 (RCT)\n  Zhang 2006 (RCT) \nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 3.32, df = 1 (p = 0.07), I2 = 69.9%\nTest for overall effect: z = 0.67 (p = 0.50)\n02 Comparative studies\n Ciminiello  2006\n  de Beer 2004\n DiGioia  2003\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n 96.18\n  3.82\n100.00\n 45.29\n 27.39\n 27.32\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n  27  \u201394.50 (0.00)  29  \u201394.50 (0.00)\n  60  \u201395.50 (5.53)  60  \u201393.50 (5.53)\n  70  \u201393.00 (35.58)  70  \u201391.00 (35.58)\n  60  \u201395.10 (1.38)  60  \u201395.60 (1.38)\n217   219\n  52  \u201396.20 (0.00)  50  \u201396.20 (0.00)\n  51  \u201389.71 (3.62)  95  \u201383.78 (8.03) \n  33  \u201396.00 (4.57)  33  \u201394.00 (4.57)\n  18  \u201392.00 (2.95)  18  \u201390.00 (2.95)\n  20  \u201399.00 (7.18)  14  \u201397.00 (7.18)\n  37  \u201386.90 (4.10)  39  \u201384.20 (6.40)\n        Not estimable\n  \u20132.00 (\u20133.98 to \u20130.02)\n  \u20132.00 (\u201313.79 to 9.79)\n    0.50 (0.01 to 0.99)\n    0.35 (\u20130.13 to 0.83)\n        Not estimable\n  \u20135.93 (\u20137.83 to \u20134.03)\n  \u20132.00 (\u20134.21 to 0.21)\n  \u20132.00 (\u20133.93 to \u20130.07)\n  \u20132.00 (\u20136.90 to 2.90)\n  \u20132.70 (\u20135.10 to \u20130.30)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  34 Harris hip score (>3 months)\n01 RCT\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Kim 2006 (Q-RCT)\n  Zhang 2006 (RCT) \nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 5.92, df = 2 (p = 0.05), I2 = 66.2%\nTest for overall effect: z = 1.43 (p = 0.15)\n02 Comparative studies\n Asayama  2006\n Chen  2006\n DiGioia  2003\n Li  2005\n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n  5.85\n  0.16\n 93.98\n100.00\n 28.75\n 21.25\n 27.82\n  4.30\n 17.88\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Appendix 10\n194\n  16  91.99 (17.51)  19  89.60 (17.51)\n107  74.40 (13.88)  108  73.95 (12.90)\n123   127\n    2.39 (\u20139.25 to 14.03)\n   0.45 (\u20133.13 to 4.03)\n   0.62 (\u20132.81 to 4.04)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  35 WOMAC osteoarthritis index (\u00013 months)\n01 RCT\n  Charles 2006 (RCT)\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 0.10, df = 1 (p = 0.75), I2 = 0%\nTest for overall effect: z = 0.35 (p = 0.72)\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n  8.65\n 91.35\n100.00\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n  16  \u201340.80 (2.13)  19  \u201340.40 (2.13)\n  16    19\n\u20130.40 (\u20131.82 to 1.02)\n\u20130.40 (\u20131.82 to 1.02)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  41 SF-36 physical function (\u00013 months)\n01 RCT\n  Charles 2006 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 0.55 (p = 0.58)\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n  60  \u201316.60 (5.80)  60  \u201314.10 (5.80)\n  60    60\n\u20132.50 (\u20134.58 to \u20130.42)\n\u20132.50 (\u20134.58 to \u20130.42)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  02 Mini-incision versus standard incision (p-value)\nOutcome:  37 Merle d\u2019Aubigne-Charnley Score (\u00013 months)\n01 RCT\n  Hart 2005 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: z = 2.36 (p = 0.02)\n02 Comparative studies\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26\n195\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nComparison 03: Single mini-incision versus single standard incision\n(reported means and SDs supplemented with calculated SDs from \np-values and imputed SDs)\n  20  460.00 (184.25)    20  462.50 (184.25)\n  28  127.00 (48.00)  32  170.00 (65.00)\n  60  136.00 (41.10)  60  200.50 (65.20)\n  60  318.80 (72.74)  60  544.40 (72.74)\n  70  445.80 (521.95)  70  567.50 (521.95)\n109  314.20 (174.78)  110  365.80 (174.78)\n347   352\n  52  217.50 (88.91)  50  247.00 (88.91)\n  99  154.00 (443.49)  100  278.00 (443.49)\n  51    75.49 (51.90)  95  293.68 (84.50)\n  60  201.67 (228.39)  60  191.73 (228.39)\n  30  180.00 (69.00)  30  246.70 (99.00)\n  50  387.00 (155.00)  57  469.00 (147.00)\n  10  699.00 (319.20)  10  540.00 (319.20)\n  38  244.00 (100.00)  43  265.00 (114.00)\n  38  244.00 (100.00)  43  304.00 (136.00)\n  50  603.00 (344.21)  85  507.00 (344.21)\n  42  151.80 (53.90)  42  173.20 (57.50)\n    \u20132.50 (\u2013116.70 to 111.70)\n  \u201343.00 (\u201371.69 to \u201314.31)\n  \u201364.50 (\u201384.00 to \u201345.00)\n\u2013225.60 (\u2013251.63 to \u2013199.57)\n\u2013121.70 (\u2013294.62 to 51.22)\n  \u201351.60 (\u201397.90 to \u20135.30)\n  \u201398.89 (\u2013111.92 to \u201385.87)\n  \u201329.50 (\u201364.02 to 5.02)\n\u2013124.00 (\u2013247.24 to \u20130.76)\n\u2013118.19 (\u2013140.36 to \u201396.02)\n      9.94 (\u201371.79 to 91.67)\n  \u201366.70 (\u2013109.88 to \u201323.52)\n  \u201382.00 (\u2013139.46 to \u201324.54)\n  159.00 (\u2013120.79 to 438.79)\n  \u201321.00 (\u201367.60 to 25.60)\n  \u201360.00 (\u2013111.61 to \u20138.39)\n    96.00 (\u201324.24 to 216.24)\n  \u201321.40 (\u201345.24 to 2.44)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  03 Mini-incision versus standard incision (dummy)\nOutcome:  09 Blood loss (intraoperative, ml)\n01 RCT\n  Charles 2006 (CT)\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Hart 2005 (Q-RCT)\n  Kim 2006 (Q-RCT)\n  Ogonda 2005 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 124.36, df = 5 (p < 0.00001), I2 = 96.0%\nTest for overall effect: z = 14.88 (p < 0.00001)\n02 Comparative studies\n Asayama  2006\n Berger  2004\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n Howell  2004\n Pilot  2006\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n1.30\n20.60\n44.59\n25.03\n0.57\n7.91\n100.00\n12.71\n1.00\n30.79\n2.27\n8.12\n4.58\n0.19\n6.97\n5.68\n1.05\n26.64\n\u2013100 \u201350 0 50 100\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Appendix 10\n196\n  20    95.20 (23.29)  20    87.70 (23.29)\n  28    70.30 (10.70)  32    70.00 (8.50)\n  60    49.00 (9.40)  60    55.10 (17.90)\n  60    71.00 (12.77)   60    70.00 (12.77)\n  70    52.00 (15.84)  70    61.00 (15.84)\n109    60.30 (9.20)  110    65.90 (13.20)\n  20    67.54 (12.77)  20    68.38 (12.77)\n  60    75.00 (16.60)  60    69.00 (16.60)\n427   432\n  50    58.60 (8.91)  50    57.90 (8.91)\n  99    72.00 (8.91)  100    66.00 (8.91)\n  51    88.41 (17.60)  95    90.85 (17.81)\n  60    55.45 (4.91)  60    56.95(4.91)\n  30    46.60 (14.31)  30    44.50 (14.31)\n  33  120.00 (8.91)  33  100.00 (8.91)\n  50    97.00 (19.00)  57    84.00 (15.00)\n  18    91.00 (16.40)  18    97.00 (15.60)\n  32    74.00 (15.00)  51    80.00 (10.00)\n  10    99.50 (20.25)  10    81.00 (20.25)\n  38    84.00 16.00)  43    93.00 (18.00)\n  38    84.00 (16.00)  21  102.00 (12.00)\n  10  126.50 (8.91)  10  119.90 (8.91)\n  50    97.00 (29.46)   85  105.00 (29.46)\n  42    71.40 (11.20)  42    77.70 (13.20)\n    7.50 (\u20136.94 to 21.94)\n    0.30 (\u20134.64 to 5.24)\n  \u20136.10 (\u201311.22 to \u20130.98)\n    1.00 (\u20133.57 to 5.57)\n  \u20139.00 (\u201314.25 to \u20133.75)\n  \u20135.60 (\u20138.61 to \u20132.59)\n  \u20130.84 (\u20138.75 to 7.07)\n    6.00 (0.06 to 11.94)\n  \u20132.86 (\u20134.62 to \u20131.10)\n   0.70 (\u20132.79 to 4.19)\n    6.00 (3.52 to 8.48)\n  \u20132.44 (\u20138.45 to 3.57)\n  \u20131.50 (\u20133.26 to 0.26)\n    2.10 (\u20135.14 to 9.34)\n  20.00 (15.70 to 24.30)\n  13.00 (6.45 to 19.55)\n  \u20136.00 (\u201316.46 to 4.46)\n  \u20136.00 (\u201311.88 to \u20130.12)\n  18.50 (0.75 to 36.25)\n  \u20139.00 (\u201316.40 to \u20131.60)\n\u201318.00 (\u201325.23 to \u201310.77)\n    6.60 (\u20131.21 to 14.41)\n  \u20138.00 (\u201318.29 to 2.29)\n  \u20136.30 (\u201311.54 to \u20131.06)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  03 Mini-incision versus standard incision (dummy)\nOutcome:  18 Duration of operation (minutes)\n01 RCT\n  Charles 2006 (CT)\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Hart 2005 (Q-RCT)\n  Kim 2006 (Q-RCT)\n  Ogonda 2005 (RCT)\n  Sharma 2006 (Q-RCT)\n  Zhang 2006 (RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 25.07, df = 5 (p = 0.0007), I2 = 72.1%\nTest for overall effect: z = 3.19 (p = 0.001)\n02 Comparative studies\n Asayama  2006\n Berger  2004\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n DiGioia  2003\n Howell  2004\n Li  2005\n O\u2019Brien  2005\n Pilot  2006\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Takahira  2006\n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n1.49\n12.71\n11.84\n14.84\n11.25\n34.16\n4.95\n8.78\n100.00\n9.83\n19.56\n3.32\n38.83\n2.29\n6.49\n2.79\n1.10\n3.47\n0.38\n2.19\n2.30\n1.97\n1.13\n4.37\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n28  378.00 (151.00)  32  504.00 (205.00)\n60  613.30 (178.00)  60  853.70  (178.00)\n88   92\n51  369.51 (65.05)  95  509.63 (117.39)\n18  318.00 (223.00)  18  523.00 (210.70)\n38  744.00 (260.00)  43  708.00 (221.00)\n38  744.00 (260.00)  21  771.00 (235.00)\n10  796.00 (112.72)  10  772.00 (112.72)\n\u2013126.00 (\u2013216.41 to \u201335.59)\n\u2013240.40 (\u2013304.10 to \u2013176.70)\n\u2013202.45 (\u2013254.52 to \u2013150.38)\n\u2013140.12 (\u2013169.72 to \u2013110.52)\n\u2013205.00 (\u2013346.73 to \u201363.27)\n    36.00 (\u201369.82 to 141.82)\n  \u201327.00 (\u2013157.14 to 103.14)\n    24.00 (\u201374.80 to 122.80]\nReview:  Minimal incision approaches to total hip replacement\nComparison:  03 Mini-incision versus standard incision (dummy)\nOutcome:  10 Blood loss (total, ml)\n01 RCT\n  Chimento 2005 (RCT)\n  Hart 2005 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 4.11, df = 1 (p = 0.04), I2 = 75.7%\nTest for overall effect: z = 7.62 (p < 0.00001)\n02 Comparative studies\n Chen  2006\n Li  2005\n Szendr\u00f3i  2006  MI\/MD\n Szendr\u00f3i  2006  MI\/SI\n Takahira  2006\nTest for heterogeneity: \u00032 = 21.50, df = 4 (p = 0.0003), I2 = 81.4%\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n33.17\n66.83\n100.00\n79.16\n3.45\n6.19\n4.07\n7.10\n\u20131000 \u2013500 0 500 1000\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26\n197\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n  20    5.35 (1.63)  20    5.70 (1.63)\n  28    5.80 (2.20)  32    5.50 (2.20)\n  60    4.41 (1.10)  60    5.34 (1.40)\n109    3.65 (2.04)  110    3.68 (2.45)\n  20    5.24 (1.66)  20    6.74 (1.66)\n  60    7.00 (1.66)  60  13.50 (1.66)\n297   302\n  52    2.96 (0.56)  50    2.94 (0.56)\n100    1.90 (5.74)  100    3.50 (5.74)\n  51  11.16 (0.83)  95  12.83 (1.96)\n  60    3.70 (5.08)  60    3.63 (5.08)\n  30    5.13 (0.87)  30    5.10 (0.87)\n  33    3.80 (0.77)  33    3.90 (0.77)\n  50    4.40 (2.90)  57    5.70 (3.10)\n  35    5.40 (2.10)  53    6.20 (2.80)\n  40    5.60 (0.99)  40    6.70 (0.99)\n  10  22.00 (0.99)  10  23.40 (0.99)\n  50    4.30 (2.17)  85    4.00 (2.17)\n  42    6.12 (2.27)  42    6.07 (2.27)\n\u20130.35 (\u20131.36 to 0.66)\n  0.30 (\u20130.82 to 1.42)\n\u20130.93 (\u20131.38 to \u20130.48)\n\u20130.03 (\u20130.63 to 0.57)\n\u20131.50 (\u20132.53 to \u20130.47)\n\u20136.50 (\u20137.09 to \u20135.91)\n\u20131.85 (\u20132.13 to \u20131.58)\n  0.02 (\u20130.20 to 0.24)\n\u20131.60 (\u20133.19 to \u20130.01)\n\u20131.67 (\u20132.13 to \u20131.21)\n  0.07 (\u20131.75 to 1.89)\n  0.03 (\u20130.41 to 0.47)\n\u20130.10 (\u20130.47 to 0.27)\n\u20131.30 (\u20132.44 to \u20130.16)\n\u20130.80 (\u20131.83 to 0.23)\n\u20131.10 (\u20131.53 to \u20130.67)\n\u20131.40 (\u20132.27 to \u20130.53)\n  0.30 (\u20130.46 to 1.06)\n  0.05 (\u20130.92 to 1.02)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  03 Mini-incision versus standard incision (dummy)\nOutcome:  19 Length of hospital stay (days)\n01 RCT\n  Charles 2006 (RCT)\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Ogonda 2005 (RCT)\n  Sharma 2006 (Q-RCT)\n  Zhang 2006 (RCT) \nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 310.31, df = 5 (p < 0.00001), I2 = 98.4%\nTest for overall effect: z = 13.23 (p < 0.00001)\n02 Comparative studies\n Asayama  2006\n Berger  2004\n Chen  2006\n Ciminiello  2006\n  de Beer 2004\n DiGioia  2003\n Howell  2004\n O\u2019Brien  2005\n Panisello  2006\n Takahira  2006\n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n  7.37\n  6.04\n 37.06\n 21.11\n  7.11\n 21.32\n100.00\n 42.11\n  0.79\n  9.60\n  0.60\n 10.27\n 14.42\n  1.54\n  1.89\n 10.57\n  2.64\n  3.46\n  2.11\n\u20134 \u20132 0 2 4\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n   0      0\n  52    92.70 (45.73)  50    94.90 (45.73)\n  60  118.00 (41.12)  60  121.00 (41.12)\n  30  147.70 (86.75)  30  169.30 (86.75)\n            Not estimable\n    \u20132.20 (\u201319.95 to 15.55)\n    \u20133.00 (\u201317.71 to 11.71)\n  \u201321.60 (\u201365.50 to 22.30)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  03 Mini-incision versus standard incision (dummy)\nOutcome:  23 Short-term total narcotic received (mg)\n01 RCT\nSubtotal (95% CI)\nTest for heterogeneity: not applicable\nTest for overall effect: not applicable\n02 Comparative studies\n Asayama  2006\n Ciminiello  2006\n  de Beer 2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n 38.18\n 55.58\n  6.24\n\u2013100 \u201350 0 50 100\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Appendix 10\n198\n  18  3.94 (0.51)  19  3.68 (0.51)\n  70  3.76 (0.97)  70  4.43 (0.97)\n109  3.30 (1.80)  110  3.36 (1.96)\n  20  4.05 (2.52)  20  6.25 (2.52)\n217   219\n  38  1.50 (1.15)  43  2.15 (1.20)\n  38  1.50 (1.15)  21  2.10 (1.30)\n      0.26 (\u20130.07 to 0.59)\n    \u20130.67 (\u20130.99 to \u20130.35)\n    \u20130.06 (\u20130.56 to 0.44)\n    \u20132.20 (\u20133.76 to \u20130.64)\n    \u20130.22 (\u20130.43 to \u20130.02)\n    \u20130.65 (\u20131.16 to \u20130.14)\n    \u20130.60 (\u20131.27 to 0.07)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  03 Mini-incision versus standard incision (dummy)\nOutcome:  26 Short-term pain (score)\n01 RCT\n  Charles 2006 (RCT)\n  Kim 2006 (Q-RCT)\n  Ogonda 2005 (RCT)\n  Sharma 2006 (Q-RCT)\nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 22.29, df = 3 (p < 0.0001), I2 = 86.5%\nTest for overall effect: z = 2.12 (p = 0.03)\n02 Comparative studies\n Szendr\u00f3i  2006  MI\/MD \n Szendr\u00f3i  2006  MI\/SI\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n 39.58\n 41.43\n 17.23\n  1.75\n100.00\n 62.80\n 37.20\n\u20134 \u20132 0 2 4\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)\n  27  \u201394.50 (1.68)  29  \u201394.50 (1.68)\n  60  \u201395.50 (5.53)  60  \u201393.50 (5.53)\n  70  \u201393.00 (35.58)  70  \u201391.00 (35.58)\n  60  \u201395.10 (1.38)  60  \u201395.60 (1.38)\n217   219\n  52  \u201396.20 (4.72)  50  \u201396.20 (4.72)\n  51  \u201389.71 (3.62)  95  \u201383.78 (8.03)\n  33  \u201396.00 (4.57)  33  \u201394.00 (4.57)\n  18  \u201392.00 (2.95)  18  \u201390.00 (2.95)\n  20  \u201399.00 (7.18)  14  \u201397.00 (7.18)\n  37  \u201386.90 (4.10)  39  \u201384.20 (6.40)\n      0.00 (\u20130.88 to 0.88)\n    \u20132.00 (\u20133.98 to \u20130.02)\n    \u20132.00 (\u201313.79 to 9.79)\n      0.50 (0.01 to 0.99)\n      0.27 (\u20130.15 to 0.69)\n      0.00 (\u20131.83 to 1.83)\n    \u20135.93 (\u20137.83 to \u20134.03)\n    \u20132.00 (\u20134.21 to 0.21)\n    \u20132.00 (\u20133.93 to \u20130.07)\n    \u20132.00 (\u20136.90 to 2.90)\n    \u20132.70 (\u20135.10 to \u20130.30)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  03 Mini-incision versus standard incision (dummy)\nOutcome:  34 Harris hip score (>3 months)\n01 RCT\n  Chimento 2005 (RCT)\n  Chung 2004 (Q-RCT)\n  Kim 2006 (Q-RCT)\n  Zhang 2006 (RCT) \nSubtotal (95% CI)\nTest for heterogeneity: \u00032 = 6.39, df = 3 (p < 0.09), I2 = 53.1%\nTest for overall effect: z = 1.26 (p = 0.21)\n02 Comparative studies\n Asayama  2006\n Chen  2006\n DiGioia  2003\n Li  2005\n Woolson  2004\n Wright  2004\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n 22.81\n  4.52\n  0.13\n 72.54\n100.00\n 23.54\n 21.98\n 16.25\n 21.27\n  3.29\n 13.67\n\u201310 \u20135 0 5 10\nMini-incision Standard incision\nN Mean (SD) N Mean (SD)Health Technology Assessment 2008; Vol. 12: No. 26\n199\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nComparison 04: Two incisions versus single standard or mini-incision\n(reported means and SDs)\n       0\/43                      0\/43          Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  01 Revision rate (number having revision surgery)\n01 RCT\n02 Comparative  studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions\nn\/N\nSingle incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n \n0.01 0.1 1 100 10\nTwo incisions Single incision\n       0\/15                      0\/15         Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  02 Postoperative dislocation rates\n01 RCT\n Yan  2005  (Q-RCT)\n02 Comparative  studies\nStudy\nor subcategory\nTwo incisions\nn\/N\nSingle incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n \n0.01 0.1 1 100 10\nTwo incisions Single incision\n       4\/43                      2\/43\n       4\/35                      6\/35\n   2.03 (0.39 to 10.57)\n   0.63 (0.17 to 2.39)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  03 Implant position (cup, number poorly placed)\n01 RCT\n02 Comparative  studies\n Duwelius  2007\n  Tanavalee 2006      \nStudy\nor subcategory\nTwo incisions\nn\/N\nSingle incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n 39.37\n 60.63\n0.1 0.2 0.5 1 10 5 2\nTwo incisions Single incisionAppendix 10\n200\n       0\/15                      0\/15\n       1\/43                      1\/43\n       7\/35                      6\/35\n        Not estimable\n  1.00 (0.06 to 16.25)\n  1.20 (0.36 to 3.98)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  04 Implant position (stem, number poorly placed)\n01 RCT\n  Yan 2005 (Q-RCT)    \n02 Comparative  studies\n Duwelius  2007\n  Tanavalee 2006      \nStudy\nor subcategory\nTwo incisions\nn\/N\nSingle incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n \n15.54\n 84.46\n0.1 0.2 0.5 1 10 5 2\nTwo incisions Single incision\n       0\/43                      0\/43\n       0\/35                      0\/35\n        Not estimable\n        Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome: 05  Implant  migration \n01 RCT\n02 Comparative  studies\n Duwelius  2007\n  Tanavalee 2006      \nStudy\nor subcategory\nTwo incisions\nn\/N\nSingle incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n \n0.1 0.2 0.5 1 10 5 2\nTwo incisions Single incision\n       6\/39                      6\/38     0.97 (0.29 to 3.30)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  06 Limb length inequality (number with unequal lengths)\n01 RCT\n02 Comparative  studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions\nn\/N\nSingle incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n0.2 0.5 1 5 2\nTwo incisions Single incisionHealth Technology Assessment 2008; Vol. 12: No. 26\n201\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n  15  760.00 (0.00)  15  650.00 (0.00)\n  43  366.00 (215.00)  43  247.00 (90.00)\n           Not estimable\n   119.00 (49.34 to 188.66)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  07 Blood loss (intra-operative, ml)\n01 RCT\n  Yan 2005 (Q-RCT) \n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n\u20131000 \u2013500 0 500 1000\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  35    699.00 (0.00)          35    603.00 (0.00)            Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  08 Blood loss (total, ml)\n01 RCT\n02 Comparative studies\n Tanavalee  2006\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n\u20131000 \u2013500 0 500 1000\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n        3\/43                          1\/43\n        2\/35                          0\/35\n  2.82 (0.38 to 20.74)\n  7.61 (0.47 to 124.15)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  09 Fractures: intra-operative\n01 RCT\n02 Comparative  studies\n Duwelius  2007\n  Tanavalee 2006      \nStudy\nor subcategory\nTwo incisions\nn\/N\nSingle incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n 66.19\n 33.81\n0.01 0.1 1 100 10\nTwo incisions Single incisionAppendix 10\n202\n       1\/15                      1\/15\n       2\/35                      0\/35\n  1.00 (0.06 to 16.79)\n  7.61 (0.47 to 124.15)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  10 Fractures:  post-operative\n01 RCT\n Yan  2005  (Q-RCT)\n02 Comparative  studies\n  Tanavalee 2006      \nStudy\nor subcategory\nTwo incisions\nn\/N\nSingle incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n100.00\n0.01 0.1 1 100 10\nTwo incisions Single incision\n       0\/15                      0\/15         Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome: 11  Infection\n01 RCT\n Yan  2005  (Q-RCT)\n02 Comparative  studies\nStudy\nor subcategory\nTwo incisions\nn\/N\nSingle incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n \n0.1 0.5 0.2 1 10 25\nTwo incisions Single incision\n       1\/15                      0\/15\n       6\/43                      0\/43\n       4\/35                      0\/35\n 7.39 (0.15 to 372.38)\n 8.37 (1.61 to 43.58)\n 8.09 (1.09 to 60.03)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  12 Nerve injury\n01 RCT\n Yan  2005  (Q-RCT)\n02 Comparative  studies\n Duwelius  2007\n  Tanavalee 2006      \nStudy\nor subcategory\nTwo incisions\nn\/N\nSingle incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n 59.61\n 40.39\n0.001 0.01 0.1 1 1000 100 10\nTwo incisions Single incisionHealth Technology Assessment 2008; Vol. 12: No. 26\n203\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n  15  100.00 (0.00)  15    80.00 (0.00)\n  43    93.70 (90.00)  43    61.70 (60.00)\n  35  168.00 (0.00)  35  113.00 (0.00)\n100  72.00 (0.00)  118    52.00 (0.00)\n           Not estimable\n    32.00 (\u20130.33 to 64.33)\n           Not estimable\n           Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  13 Duration of operation (minutes)\n01 RCT\n  Yan 2005 (Q-RCT)\n02 Comparative studies\n Duwelius  2007\n Tanavalee  2006\n Yoon  2005\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n\u2013100 \u201350 0 50 100\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  15  6.00 (0.00)  15  13.00 (0.00)\n  43  1.25 (0.00)  43    1.90 (0.00)\n            Not estimable\n            Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  14 Length of hospital stay (days)\n01 RCT\n  Yan 2005 (Q-RCT)\n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n\u20134 \u20132 0 2 4\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n     20\/43                    10\/43   2.75 (1.14 to 6.64)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  15 Short-term pain (N of patients)\n01 RCT\n02 Comparative  studies\n Duwelius  2007 \nStudy\nor subcategory\nTwo incisions\nn\/N\nSingle incision\nn\/N\nPeto OR\n95% CI\nPeto OR\n95% CI\nWeight\n%\n100.00\n0.1 0.2 0.5 1 10 5 2\nTwo incisions Single incisionAppendix 10\n204\n  43  2.00 (0.00)  43  2.50 (0.00)             Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  16 Short-term pain (score)\n01 RCT\n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  37  1.60 (0.00)  30  1.60 (0.00)             Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  17 Long-term pain (score)\n01 RCT\n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  43  14.00 (0.00)   43  26.00 (0.00)             Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  18 Time to return to shopping (days)\n01 RCT\n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n\u2013100 \u201350 0 50 100\nN Mean (SD) N Mean (SD)\nTwo incisions Single incisionHealth Technology Assessment 2008; Vol. 12: No. 26\n205\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n  43  13.00 (0.00)  43  24.00 (0.00)\n  26  32.00 (0.00)  26  34.00 (0.00)\n            Not estimable\n            Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  19 Time to return to driving (days)\n01 RCT\n02 Comparative studies\n Duwelius  2007\n  Pagnano 2006        \nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  26  28.00 (0.00)  26  27.00 (0.00)             Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  20 Use of walking aids (days)\n01 RCT\n02 Comparative studies\n  Pagnano 2006        \nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  15  \u201389.00 (0.00)  15  \u201386.00 (0.00)\n  43  \u201389.00 (0.00)  43  \u201388.00 (0.00)\n            Not estimable\n            Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  21 Harris hip score (\u00013 months)\n01 RCT\n  Yan 2005 (Q-RCT)\n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incisionAppendix 10\n206\n  15  \u201393.00 (0.00)  15  \u201393.00 (0.00)\n  43  \u201394.00 (0.00)  43  \u201388.00 (0.00)\n  35  \u201394.50 (4.70)  35  \u201394.60 (4.50)\n            Not estimable\n            Not estimable\n       0.10 (\u20132.06 to 2.26)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  22 Harris hip score (>3 months)\n01 RCT\n  Yan 2005 (Q-RCT)\n02 Comparative studies\n Duwelius  2007\n Tanavalee  2006\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  43  \u201380.00 (0.00)  43  \u201370.00 (0.00)             Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  23 SF-36 physical function (\u00013 months)\n01 RCT\n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  37  \u201380.00 (0.00)  30  \u201385.00 (0.00)             Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  04 Two incisions versus single standard or mini-incision\nOutcome:  24 SF-36 physical function (>3 months)\n01 RCT\n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n \n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incisionHealth Technology Assessment 2008; Vol. 12: No. 26\n207\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nComparison 05: Two incisions versus single standard or mini-incision\n(reported means and SDs supplemented with calculated SDs from \np-values)\n  15  760.00 (147.06)  15  650.00 (147.06)\n  43  366.00 (215.00)  43  247.00 (90.00)\n  110.00 (4.75 to 215.25)\n  119.00 (49.34 to 188.66)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  05 Two incisions versus single standard or mini-incision (p-value)\nOutcome:  07 Blood loss (intra-operative, ml)\n01 RCT\n  Yan 2005 (Q-RCT)\n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n\u20131000 \u2013500 0 500 1000\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  35  699.00 (168.56)  35  603.00 (168.56)    96.00 (17.03 to 174.97)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  05 Two incisions versus single standard or mini-incision (p-value)\nOutcome:  08 Blood loss (total, ml)\n01 RCT\n02 Comparative studies\n Tanavalee  2006\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n\u20131000 \u2013500 0 500 1000\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  15  100.00 (26.74)  15    80.00 (26.74)\n  43    93.70 (90.00)  43    61.70 (60.00)\n  35  168.00 (86.82)  35  113.00 (86.82)\n100    72.00 (0.00)  118    52.00 (0.00)\n     20.00 (0.86 to 39.14)\n     32.00 (\u20130.33 to 64.33)\n     55.00 (14.32 to 95.68)\n           Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  05 Two incisions versus single standard or mini-incision (p-value)\nOutcome:  13 Duration of operation (minutes)\n01 RCT\n  Yan 2005 (Q-RCT)\n02 Comparative studies\n Duwelius  2007\n Tanavalee  2006\n Yoon  2005\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n 61.29\n 38.71\n\u2013100 \u201350 0 50 100\nN Mean (SD) N Mean (SD)\nTwo incisions Single incisionAppendix 10\n208\n  15  6.00 (5.22)  15  13.00 (5.22)\n  43  1.25 (0.88)  43    1.90 (0.88)\n    \u20137.00 (\u201310.74 to \u20133.26)\n    \u20130.65 (\u20131.02 to \u20130.28)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  05 Two incisions versus single standard or mini-incision (p-value)\nOutcome:  14 Length of hospital stay (days)\n01 RCT\n  Yan 2005 (Q-RCT)\n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n100.00\n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  43  14.00 (21.11)  43  26.00 (21.11)   \u201312.00 (\u201320.92 to \u20133.08)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  05 Two incisions versus single standard or mini-incision (p-value)\nOutcome:  18 Time to return to shopping (days)\n01 RCT\n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n\u2013100 \u201350 0 50 100\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  43  13.00 (24.45)  43  24.00 (24.45)\n  26  32.00 (8.14)  26  34.00 (8.14)\n  \u201311.00 (\u201321.33 to \u20130.67)\n    \u20132.00 (\u20136.42 to 2.42)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  05 Two incisions versus single standard or mini-incision (p-value)\nOutcome:  19 Time to return to driving (days)\n01 RCT\n02 Comparative studies\n Duwelius  2007\n Pagnano  2006\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n 15.49\n 84.51\n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incisionHealth Technology Assessment 2008; Vol. 12: No. 26\n209\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\n  26  28.00 (11.25)  26  27.00 (11.25)        1.00 (\u20135.12 to 7.12)\nReview:  Minimal incision approaches to total hip replacement\nComparison:  05 Two incisions versus single standard or mini-incision (p-value)\nOutcome:  20 Use of walking aids (days)\n01 RCT\n02 Comparative studies\n Pagnano  2006\nStudy\nor subcategory\nMini-incision Standard incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision\n  15  \u201389.00 (4.01)  15  \u201386.00 (4.01)\n  43  \u201389.00 (0.00)  43  \u201388.00 (0.00)\n  \u20133.00 (\u20135.87 to \u20130.13)\n        Not estimable\nReview:  Minimal incision approaches to total hip replacement\nComparison:  05 Two incisions versus single standard or mini-incision (p-value)\nOutcome:  21 Harris hip score (\u00013 months)\n01 RCT\n  Yan 2005 (Q-RCT)\n02 Comparative studies\n Duwelius  2007\nStudy\nor subcategory\nTwo incisions Single incision WMD (fixed)\n95% CI\nWMD (fixed)\n95% CI\nWeight\n%\n100.00\n\u201310 \u20135 0 5 10\nN Mean (SD) N Mean (SD)\nTwo incisions Single incision(Coyle D and Coyle K, University of Ottawa:\npersonal communication, 18 May 2007)\nBased on the completed SF-36 questionnaire data,\nSF-6D scores were calculated using the algorithm\nof Brazier and colleagues.80 Overall data were\ncollected for the 40 participants within the study.\nThere were, however, a number of individuals with\nmissing data. To look at the impact of this, three\nanalyses were conducted, each using a different\napproach to missing values. \nIn the first analysis, a last value carried forward\napproach was used. There were, however, four\nparticipants who did not have any data for the\nbaseline assessment and these individuals were\ntherefore removed from the analysis, leaving 36\nparticipants in the analysis. In the second analysis,\ndata from all participants were included without\nregard to whether or not they had complete data.\nConsequently, the number of participants with\ndata to analyse changes from one analysis \nperiod to the next. In the final analysis, all \ncases that did not have a complete data set were\ndeleted, which left only 24 individuals within the\nanalysis. \nIn each of these three analyses, mean scores of\neach time point were compared in an analysis of\ncovariance adjusting for baseline SF-6D scores.\nOverall, the differences between the minimally\ninvasive arm and the control arm were small and\nthe different approaches to handling missing\nvalues did not significantly affect the results\n(Tables 55\u201357). \nHealth Technology Assessment 2008; Vol. 12: No. 26\n211\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 11\nDetailed analyses of SF-6D scores based on the trial \nby Charles and colleagues69\nTABLE 55 Analysis using last value carried forward approach to missing values\nPeriod Group N Mean SD SE of mean Adjusted  p-Value\ndifference (SE)\nPreoperation Control 18 0.6527 0.15075 0.03553\nMIS 18 0.5722 0.16453 0.03878\n3 months postoperation Control 18 0.7632 0.10304 0.02429\nMIS 18 0.7924 0.08298 0.01956\nDifference 0.045 (0.31) 0.158\n6 months postoperation Control 18 0.8014 0.09470 0.02232\nMIS 18 0.8001 0.07565 0.01783\nDifference 0.001 (0.030) 0.963\n1 year postoperation Control 18 0.8139 0.11936 0.02813\nMIS 18 0.7895 0.06912 0.01629\nDifference \u20130.011 (0.033)  0.731\n2 years postoperation Control 18 0.8186 0.09312 0.02195\nMIS 18 0.8026 0.07627 0.01798\nDifference \u20130.006 (0.029) 0.842\nSD, standard deviation; SE, standard error.Appendix 11\n212\nTABLE 56 Analysis of complete dataset without regard to missing values\nPeriod Group N Mean SD SE of mean Adjusted  p-Value\ndifference (SE)\nPreoperation Control 18 0.6527 0.15075 0.03553\nMIS 18 0.5722 0.16453 0.03878\n3 months postoperation Control 18 0.7687 0.10421 0.02456\nMIS 19 0.7884 0.08419 0.01932\nDifference 0.047 (0.031) 0.142\n6 months postoperation Control 18 0.8151 0.08430 0.01987\nMIS 17 0.7954 0.07376 0.01789\nDifference \u20130.002 (0.028) 0.936\n1 year postoperation Control 20 0.8149 0.11301 0.02527\nMIS 19 0.7906 0.06473 0.01485\nDifference \u20130.005 (0.032) 0.880\n2 years postoperation Control 16 0.8371 0.07071 0.01768\nMIS 14 0.8101 0.06748 0.01803\nDifference \u20130.011 (0.029) 0.719\nSD, standard deviation; SE, standard error.\nTABLE 57 Analysis of cases with complete datasets\nPeriod Group N Mean SD SE of mean Adjusted  p-Value\ndifference (SE)\nPreoperation Control 14 0.6722 0.13263 0.03545\nMIS 10 0.5762 0.17112 0.05411\n3 months postoperation Control 14 0.7844 0.08720 0.02330\nMIS 10 0.7915 0.09543 0.03018\nDifference 0.030 (0.037) 0.437\n6 months postoperation Control 14 0.7902 0.07735 0.02067\nMIS 10 0.8170 0.05719 0.01808\nDifference 0.028 (0.031) 0.371\n1 year postoperation Control 14 0.8415 0.10403 0.02780\nMIS 10 0.7899 0.04939 0.01562\nDifference \u20130.031 (0.035) 0.398\n2 years postoperation Control 14 0.8350 0.07544 0.02016\nMIS 10 0.8066 0.07307 0.02311\nDifference \u20130.015 (0.032) 0.644\nSD, standard deviation; SE, standard error.Health Technology Assessment 2008; Vol. 12: No. 26\n213\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 12\nSummary of included economic evaluations\nStudy identification Author and year Duwelius, 2006 (unpublished)\nInterventions studied\/ Mini-incision and MIS 2-incision total hip replacement (THR)\/\ncomparators standard THR\nHypothesis\/question To evaluate the cost-effectiveness at 6 weeks of minimally invasive\nTHR (mini-incision and two mini-incision) relative to the standard\ntechnique in patients with advanced degenerative joint disease\nKey elements of the study Type of study Cost-effectiveness analysis based on data from 10 hospitals in\nvarious geographic locations in the USA. Non-randomised,\nunmatched cohorts\nTarget population\/ Patients with advanced degenerative joint disease in 10 USA \nstudy sample hospitals\nSetting Secondary care with inclusion of some community costs. \n10 unspecified US hospitals and 14 orthopaedic surgeons\nDates to which data relate 2002\u20135\nSource of effectiveness data Effectiveness data derived from a prospective unmatched\ncomparative cohort study \nModelling NA\nLink between effectiveness  The costing was undertaken retrospectively on the same sample \nand cost data as that used for the effectiveness study. Charge data provided by 9\nof 10 hospitals regarding initial hospitalisation and for\ncomplications requiring re-hospitalisation and cost-to-charge ratios\nwere used to convert billed charges into estimated costs \nIndirect costs in terms of productivity losses from time away from\nwork linked to time to WWOS, which is assumed as an indicator\nof ability to return to work \nDetails about clinical  Eligibility\/patient group\/ No specified eligibility criteria or patient group stated\/14 surgeons \nevidence: study design  study sample at 10 hospitals provided data on 591 patients (235 MIS two-\nand main outcomes incision, 325 mini-incision, 31 standard THR) \nStudy design Prospective unmatched cohort study\nAnalysis of effectiveness The main clinical outcomes were time to WWOS, psychometric\nhealth status as measured through SF-36, postoperative recovery\napproximated by WWOS from the Harris hip score and HRQoL.\nSF-6D estimated from the SF-36 scores using UK algorithm \nEffectiveness results\/ Significantly different (p \u0001 0.05) demographics between groups at \noutcome measures time of surgery. MIS 2-incision hip procedure had greatest\noperating time averaging 20 minutes more than standard\ntechnique. Duration of acute hospital stay for MIS 2-incision\npatients was 2.4 days shorter than standard cases (p \u0001 0.05).\nCompared with standard surgery, MIS 2-incision and mini-incision\npatients had a 60 and 44% decline in hospital length of stay,\nrespectively; discharges to facility-based rehabilitation declined by\n97 and 80%, respectively; and WWOS at 6 weeks increased by\n209 and 123%, respectively. Intraoperative and postoperative\ncomplications were low for all groups. Dislocation related\ncomplications, resulting in re-hospitalisation within 6 months \npost-surgery, reported for 2 (n = 325) mini-incision cases \ncontinuedAppendix 11\n214\nClinical conclusions The MIS 2-incision and mini-incision cases had a similar or better\npostoperative quality of life than standard technique cases and\nexperienced a significantly earlier recovery from THR \nEconomic analysis Measure of health benefits  QALYs estimated as the product of the surgical technique-specific \nused in the economic  HRQoL estimates by the proportion of subjects able to WWOS at \nanalysis 6 weeks (used as predictive of ability to return to work). In the\ncalculation of QALYs, patient selection was compensated by three\nmethods: WWOS multiplied by average HRQoL, HRQoL within\neach stratum and stratified HRQoL including covariance analysis. \nIt is unclear if this is an appropriate approach to calculate QALYs \nDirect costs Surgeon costs estimated from the Medicare unadjusted national\naverage rate for primary THR, weighted for annual volume.\nCharge data provided by 9 of 10 hospitals regarding initial\nhospitalisation and for complications requiring re-hospitalisation\nfor 518 of 591 cases (201 MIS 2-incision, 296 mini-incision and 21\nstandard technique); one hospital did not release any charge data.\nTwo hospitals provided only technique-specific annual average\ncharges. Hospital cost-to-charge ratios were used to convert billed\ncharges into estimated costs. Post-acute rehabilitation provider\ncosts were modelled from inpatient hospital discharge and\nMedicare reimbursement schedules. Hospital discharge data were\nobtained from the study for the minimally invasive techniques (189\nMIS 2-incision, 291 mini-incision) and from publicly available survey\ndata for the standard technique \nIndirect costs Wages foregone by employed THR patients during recovery from\nsurgery were estimated as indirect costs and modelled from the\npatient being able to WWOS, THR incidence and employment\ndata\nCurrency US$. Unclear what the price year is and if prices have been\nadjusted for differential timing, although sensitivity analysis around\ninflation rates has been performed \nStatistical analysis of  HRQoL was calculated using two propensity scoring methods to \nquantities\/costs minimise selection bias. 1st method: average HRQoL within five\nstrata formed from percentiles of pooled preoperative SF-6D\nscores estimated followed by weighted averaging over strata. 2nd\nmethod: propensity scores estimated from two logistic models\nfollowed by covariance analysis of HRQoL, adjusted for propensity\nscores to reflect differences in case mix. QALYs estimated using a\nnon-standard method; the validity of this approach is unclear \nSensitivity analysis Two-way sensitivity analysis of all costs and utility values. Inpatient\nrehabilitation facility, skilled nursing facility, home healthcare, home\nonly (no rehabilitation) and physician costs all varied by either\n+30% or \u201330% of BC values. Wages and hospital cost-to-charge\nratio varied by either +10% or \u201310% of BC values. Inflation\nvaried by +5% or \u20135% of BC values. Combined incremental\neffectiveness presented, although it is unclear what has been\ncombined in order to calculate this measure. Minimum\nincremental effectiveness and maximum incremental effectiveness\nof minimally invasive procedures relative to standard procedure\nalso presented. Four methods of imputing data for missing HRQoL\nentries performed; imputation using last observation carried\nforward, imputation of the interval-by-approach average, use of all\navailable data and restriction to complete cases with no missing\ndata. BC, minimum incremental effectiveness and maximum\nincremental effectiveness are presented \ncontinuedHealth Technology Assessment 2008; Vol. 12: No. 26\n215\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nResults Estimated benefits used in  6-week QALYs for all techniques: 0.053 QALYs for 2-incision, \nthe economic evaluation 0.039 QALYs for mini-incision and 0.016 QALYs for standard\ntechnique. Incremental effectiveness of minimally invasive\ntechniques compared with standard techniques: BC 0.037 QALYs\nfor 2-incision and 0.023 QALYs for mini-incision. Minimum\nincremental effectiveness: 0.037 QALYs for MIS 2-incision and\n0.021 QALYs for mini-incision. Maximum incremental\neffectiveness: 0.040 QALYs for 2-incision and 0.023 QALYs for\nmini-incision. Note: differences in QALYs are not statistically\nsignificant and it is likely that CIs would be wide. Some attempt to\nadjust for case mix was performed. It is also worth noting that the\neffectiveness measure used to calculate utilities (SF-6D), based on\npostoperative recovery, may not capture all the potential gains that\npatients who receive MIS might benefit from \nCosts results Total costs were lower for the MIS 2-incision hip procedure and\nhighest for the standard technique (MIS 2-incision, $16,085; mini-\nincision, $16,615 and standard technique, $21,705). Rate adjusting\nsurgical technique costs suggest nearly identical hospital cost for\nthe MIS 2-incision and the mini-incision technique (MIS 2-incision,\n$12,725; mini-incision, $12,720; and standard technique, $14,903).\nLowest indirect costs reported for MIS 2-incision patients as they\nwere able, at higher proportions, to walk without support earlier\nthan mini-incision and standard technique patients (MIS 2-incision,\n$1433; mini-incision, $1790 and standard technique, $2254).\nRehabilitation resource utilisation reflected the need for and\nintensity of post-acute care treatment (MIS 2-incision, $540; mini-\nincision, $719; and standard technique, $3161). Surgeon costs for\nall three procedures were identical; $1386. It is not stated if\ndifferences in costs are statistically significant and no confidence\nintervals are reported. No adjustments have been made for case\nmix \nSynthesis of costs and  Incremental costs and incremental QALYs are reported for the \nbenefits two minimally invasive procedures relative to the standard\nprocedure, but no attempt is made to combine these into cost-\neffectiveness ratios as MIS is assumed to be cost saving and more\neffective although the difference in QALYs is not statistically\nsignificant and differences in cost are not tested. Furthermore, it is\nunclear if the method of converting for case mix adequately\ncorrects for selection biases. Principle cost drivers are hospital,\nrehabilitation and indirect costs \nAuthors\u2019 conclusions Even under conservative assumptions, MIS 2-incision and mini-\nincision THR techniques have better 6-week outcomes at less cost\nthan the standard technique \nStudy identification Author and year Straumann, 200682\nInterventions studied\/ Minimal invasive surgery total hip replacement (MIS THR) vs \ncomparators standard THR \nHypothesis\/question To evaluate and illustrate the cost-effectiveness, economic\nconsequences and QALYs of MIS THR in Switzerland using a\nmodel-based and quantitative analysis \nKey elements of the study Type of study Modelling with retrospective costing exercise of standard THR.\nEffectiveness data and cost difference based on a US study\nTarget population\/ Cost data estimated for standard THR patients originating from \nstudy sample the Balgrist Orthopaedic University Hospital of Zurich. This figure\nwas then applied to the total number of THRs performed in\nSwitzerland to obtain the aggregate cost \nSetting Secondary care with inclusion of some community costs\ncontinuedAppendix 11\n216\nDates to which data relate Cost data from Switzerland taken for the year 2003.\nSource of effectiveness data No effectiveness data are presented in the paper, assumed MIS\nbetter based on US study. Differences in indirect costs\n(productivity losses) utilised by applying the human capital\naccounting method to estimate benefit in terms of productivity\nsavings \nModelling Applied mean difference in cost between minimally invasive and\nstandard THR from previous US-based cost-effectiveness analysis\nand applied this mean difference in cost to total cost data for all\nstandard THR \nLink between effectiveness  Effectiveness taken from a US-based unpublished cost-\nand cost data effectiveness analysis (Duwelius and colleagues, 2006). Little\ninformation on this paper is reported \nDetails about clinical  Eligibility\/patient group\/ 13,101 primary THRs performed in Switzerland in 2003. \nevidence: study design  study sample Aggregate estimation of savings following MIS techniques, \nand main outcomes estimated from decreases in productivity losses and rehabilitation\ncosts at indication rates of 30% (conservative) and 50%\n(optimistic) \nStudy design Data based on an unpublished US study with potential serious\nbiases in assessment of effectiveness\nAnalysis of effectiveness Productivity losses are only measure of benefit\nEffectiveness results\/ NA\noutcome measures\nClinical conclusions No primary clinical outcomes sought as part of this study, although\nstated that early postoperative recovery is apparent after MIS\ntechniques (assumed from results of unpublished data which are\nutilised heavily) and suffers from serious selection bias\nEconomic analysis Measure of health benefits  Human capital accounting method applied to determine gains in \nused in the economic  productivity following MIS techniques \nanalysis\nDirect costs 2003 average cost total cost data for THR originating from the\nBalgrist Orthopaedic University Hospital of Zurich. Definitive cost\ndifference between standard and MIS techniques taken from an\nunpublished cost-effectiveness analysis and applied to Swiss cost\ndata to obtain cost of operation for a standard and minimally\ninvasive patient relevant to Switzerland. For rehabilitation costs, it\nis assumed 50% patients (n = 6550) need outpatient rehabilitation\nat \u20ac1335 per patient. 40% (n = 5240) take advantage of a\nrehabilitation programme outside a hospital (\u20ac3335 per patient)\nand 10% (n = 1311) need in-hospital rehabilitation (\u20ac13,335 per\npatient). It should be noted that it is unclear what biases these\nassumptions have \nIndirect costs Productivity losses incurred from inability to return to work\nmeasured and applied to standard and minimally invasive groups to\nestimate potential productivity losses that might be avoided by\nadopting MIS techniques. 80.1% reduction in productivity loss\nfrom MIS estimated from average work disability (assumed\n45 days) with unemployment rate of 4.4% for the employed age\ncategory (n = 6547) and an employment rate of 7.4% for patients\nolder than 70 years (n = 464). Total number of days saved is\n252,324, which is multiplied by average GDP per work day\/person\n(\u20ac315) to obtain the potential reduction of productivity losses.\nAssumed average disability of 45 days, but unclear why this\nassumption is made. Figure of 80.1% reduction is productivity\nlosses given, but it is unclear where this number has come from \ncontinuedHealth Technology Assessment 2008; Vol. 12: No. 26\n217\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nCurrency Euros. 2003 prices \nStatistical analysis of  None performed\nquantities\/costs\nSensitivity analysis Two indication rates for MIS used, 30% (conservative) and 50%\n(optimistic). Both presented as part of main analysis \nResults Estimated benefits used  No measure of benefit other than cost savings from reduction in \nin the economic evaluation productivity losses \nCosts results Indirect costs, assumed to be productivity losses, totalling \u20ac79.4\nmillion (if 100% of THRs are performed using minimally invasive\nmethods). For the assumed MIS indication rates the effective\nreduction of productivity losses ranges between \u20ac23.8 million\n(conservative) and \u20ac39.7 million (optimistic) \nThere were 36 fewer work days lost per employed patient with\nMIS THR than with the standard THR technique \nAverage hospital costs per patient were \u20ac13,511 for standard\nTHR and \u20ac11,534.40 for MIS THR. Given the total THRs in\nSwitzerland (\u20ac13,101) and indications rates of THR of 30 and\n50%, calculated effective hospital cost savings are \u20ac7.8 million and\n\u20ac12.9 million \nOverall rehabilitation costs are \u20ac43.7 million. Rehabilitation costs\nare 82.9% lower with MIS 2-incision and 77.3% lower with mini-\nincision technique. Using assumed MIS indication rates, the\neffective cost savings range between \u20ac10.9 million and\n\u20ac18.1 million for MIS 2-incision procedure and between\n\u20ac10.1 million and \u20ac16.9 million for mini-incision technique \nSynthesis of costs and  No attempt is made to synthesise cost and benefits as the main \nbenefits benefit measure \u201cproductivity loss\u201d is measured as a cost.\nAssumption made of equal or better outcomes and application of\ncost saving rate from USA assumes that data are correct even for\nthe USA and the data might be applicable to Switzerland \nAuthors\u2019 conclusions Recommendation of adoption of MIS techniques in THR as they\nmay allow the reduction of healthcare costs \nBC, base-case; HRQoL, health-related quality of life; NA, not applicable; WWOS, walking without support.T\nhe diagram below displays the unpopulated model for the standard THR arm. The tree structures for\nboth the standard and minimal incision arms are identical. \nHealth Technology Assessment 2008; Vol. 12: No. 26\n219\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 13\nMarkov model for the management of arthritic \ndisease of the hip\nSuccessful THR\nDead\nDead\nsurvive\ndie\nDead\nSuccessful THR\nMI THR\n--- Markov \nInfor... \nTerm: \nStandard or \nMI THR?\nM\nStandard \nTHR\n--- Markov \nInfor... \nTerm: \nM\nPrimary THR\n--- Markov Information\nInit Rwd: 0\nIncr Rwd: 0\nFinal Rwd: 0\nSuccessful THR\n--- Markov Information\nInit Rwd: 0\nIncr Rwd: 0\nFinal Rwd: 0\nRevision\n--- Markov Information\nInit Rwd: 0\nIncr Rwd: 0\nFinal Rwd: 0\nSuccessful THR Revision\n--- Markov Information\nInit Rwd: 0\nIncr Rwd: 0\nFinal Rwd: 0\nDead\n--- Markov Information\nInit Rwd: 0\nIncr Rwd: 0\nFinal Rwd: 0\nNon-operative \nmanagement \n--- Markov Information\nInit Rwd: 0\nIncr Rwd: 0\nFinal Rwd: 0\nsuccess\nfail\nsurvive\ndie\nsurvive\ndie\nRevision\nNon-operative \nmanagement \nrevision\nnon-operative \nmanagement\nSuccessful THR Revision\nDead\nDead\nsurvive\ndie\nDead\nsuccess\nfail\nsurvive\ndie\nsurvive\ndie\nRevision\nNon-operative \nmanagement \nrevision\nnon-operative \nmanagement\nsurvive\ndie\nDead\nsuccess\nfail\nRevision\nNon-operative management \nrevision\nnon-operative \nmanagement\nSuccessful THR Revision\nsurvive\ndie\nDead\nsuccess\nfail\nRevision\nNon-operative management \nrevision\nnon-operative \nmanagement\nNon-operative management \nDead\nnon-operative \nmanagement\ndieM\nortality is weighted by sex as the National Joint Registry reports that 60% of all primary total hip\nreplacements are performed on women; therefore, the all-cause mortality for the model cohort was\nweighted to reflect this. \nHealth Technology Assessment 2008; Vol. 12: No. 26\n221\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 14\nBalanced life table for general mortality \n(40% male, 60% female)\nAge (years) Mortality Age (years) Mortality\n68 0.016562 89 0.153176\n69 0.018324 90 0.164534\n70 0.019946 91 0.179646\n71 0.022501 92 0.196954\n72 0.02522 93 0.217126\n73 0.027967 94 0.232363\n74 0.031561 95 0.255651\n75 0.035162 96 0.27421\n76 0.039297 97 0.29536\n77 0.043814 98 0.314326\n78 0.048593 99 0.329341\n79 0.054145 100 0.356988\n80 0.059932 101 0.356988\n81 0.066966 102 0.356988\n82 0.073952 103 0.356988\n83 0.081779 104 0.356988\n84 0.088514 105 0.356988\n85 0.098279 106 0.356988\n86 0.109397 107 0.356988\n87 0.126424 108 0.356988\n88 0.138485B\noth standard and mini-incision THR patients would move through the model as shown. It is the cost\nand outcomes associated with the two forms of surgery that drive the cost\u2013utility results.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n223\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nAppendix 15\nCohort analysis showing 1000 patients as they \nprogress through the 40-year model for both\nstandard and mini-incision THR\nStage Primary THR Successful THR Revision Successful THR  Non-operative  Dead\n(revision) management\n0 1000 0 0 0 0 0\n1 09 6 8 70 02 6\n2 0 938 12 7 0 43\n3 0 903 16 18 0 63\n4 0 865 18 33 0 84\n5 0 820 24 49 0 107\n6 0 769 29 70 0 132\n7 0 713 33 94 0 160\n8 0 654 37 120 0 190\n9 0 591 41 147 0 222\n10 0 523 45 175 0 256\n11 0 456 47 204 0 293\n12 0 389 48 231 0 332\n13 0 325 48 255 0 372\n14 0 265 46 274 0 415\n15 0 212 43 287 0 458\n16 0 166 39 292 0 503\n17 0 127 36 290 0 547\n18 0 94 31 282 0 592\n19 0 68 27 267 0 637\n20 0 48 23 246 0 683\n21 0 33 20 220 0 727\n22 0 22 16 193 0 769\n23 0 14 13 165 0 807\n24 0 9 11 138 0 842\n25 0 6 9 112 0 873\n2 6 0 378 9 09 0 1\n2 7 0 256 9 09 2 4\n2 8 0 145 1 09 4 3\n2 9 0 133 8 09 5 9\n3 0 0 022 7 09 7 1\n3 1 0 011 8 09 8 0\n3 2 0 011 2 09 8 7\n33 0 0 1 8 0 991\n34 0 0 0 5 0 995\n35 0 0 0 3 0 996\n36 0 0 0 2 0 998\n37 0 0 0 1 0 999\n38 0 0 0 1 0 999\n39 0 0 0 1 0 999\n40 0 0 0 0 0 1000Volume 1, 1997\nNo. 1\nHome parenteral nutrition: a systematic\nreview.\nBy Richards DM, Deeks JJ, Sheldon\nTA, Shaffer JL.\nNo. 2\nDiagnosis, management and screening\nof early localised prostate cancer.\nA review by Selley S, Donovan J,\nFaulkner A, Coast J, Gillatt D.\nNo. 3\nThe diagnosis, management, treatment\nand costs of prostate cancer in England\nand Wales.\nA review by Chamberlain J, Melia J,\nMoss S, Brown J.\nNo. 4\nScreening for fragile X syndrome.\nA review by Murray J, Cuckle H,\nTaylor G, Hewison J.\nNo. 5\nA review of near patient testing in\nprimary care.\nBy Hobbs FDR, Delaney BC,\nFitzmaurice DA, Wilson S, Hyde CJ,\nThorpe GH, et al.\nNo. 6\nSystematic review of outpatient services\nfor chronic pain control.\nBy McQuay HJ, Moore RA, Eccleston\nC, Morley S, de C Williams AC.\nNo. 7\nNeonatal screening for inborn errors of\nmetabolism: cost, yield and outcome.\nA review by Pollitt RJ, Green A,\nMcCabe CJ, Booth A, Cooper NJ,\nLeonard JV, et al.\nNo. 8\nPreschool vision screening.\nA review by Snowdon SK, \nStewart-Brown SL.\nNo. 9\nImplications of socio-cultural contexts\nfor the ethics of clinical trials.\nA review by Ashcroft RE, Chadwick\nDW, Clark SRL, Edwards RHT, Frith L,\nHutton JL.\nNo. 10\nA critical review of the role of neonatal\nhearing screening in the detection of\ncongenital hearing impairment.\nBy Davis A, Bamford J, Wilson I,\nRamkalawan T, Forshaw M, Wright S.\nNo. 11\nNewborn screening for inborn errors of\nmetabolism: a systematic review.\nBy Seymour CA, Thomason MJ,\nChalmers RA, Addison GM, Bain MD,\nCockburn F, et al.\nNo. 12\nRoutine preoperative testing: \na systematic review of the evidence.\nBy Munro J, Booth A, Nicholl J.\nNo. 13\nSystematic review of the effectiveness \nof laxatives in the elderly.\nBy Petticrew M, Watt I, Sheldon T.\nNo. 14\nWhen and how to assess fast-changing\ntechnologies: a comparative study of\nmedical applications of four generic\ntechnologies.\nA review by Mowatt G, Bower DJ,\nBrebner JA, Cairns JA, Grant AM,\nMcKee L.\nVolume 2, 1998\nNo. 1\nAntenatal screening for Down\u2019s\nsyndrome.\nA review by Wald NJ, Kennard A,\nHackshaw A, McGuire A.\nNo. 2\nScreening for ovarian cancer: \na systematic review.\nBy Bell R, Petticrew M, Luengo S,\nSheldon TA.\nNo. 3\nConsensus development methods, and\ntheir use in clinical guideline\ndevelopment.\nA review by Murphy MK, Black NA,\nLamping DL, McKee CM, Sanderson\nCFB, Askham J, et al.\nNo. 4\nA cost\u2013utility analysis of interferon \nbeta for multiple sclerosis.\nBy Parkin D, McNamee P, Jacoby A,\nMiller P, Thomas S, Bates D.\nNo. 5\nEffectiveness and efficiency of methods\nof dialysis therapy for end-stage renal\ndisease: systematic reviews.\nBy MacLeod A, Grant A, \nDonaldson C, Khan I, Campbell M,\nDaly C, et al.\nNo. 6\nEffectiveness of hip prostheses in\nprimary total hip replacement: a critical\nreview of evidence and an economic\nmodel.\nBy Faulkner A, Kennedy LG, \nBaxter K, Donovan J, Wilkinson M,\nBevan G.\nNo. 7\nAntimicrobial prophylaxis in colorectal\nsurgery: a systematic review of\nrandomised controlled trials.\nBy Song F, Glenny AM.\nNo. 8\nBone marrow and peripheral blood\nstem cell transplantation for malignancy.\nA review by Johnson PWM, Simnett SJ,\nSweetenham JW, Morgan GJ, Stewart LA.\nNo. 9\nScreening for speech and language\ndelay: a systematic review of the\nliterature.\nBy Law J, Boyle J, Harris F, Harkness\nA, Nye C.\nNo. 10\nResource allocation for chronic stable\nangina: a systematic review of\neffectiveness, costs and \ncost-effectiveness of alternative\ninterventions.\nBy Sculpher MJ, Petticrew M, \nKelland JL, Elliott RA, Holdright DR,\nBuxton MJ.\nNo. 11\nDetection, adherence and control of\nhypertension for the prevention of\nstroke: a systematic review.\nBy Ebrahim S.\nNo. 12\nPostoperative analgesia and vomiting,\nwith special reference to day-case\nsurgery: a systematic review.\nBy McQuay HJ, Moore RA.\nNo. 13\nChoosing between randomised and\nnonrandomised studies: a systematic\nreview.\nBy Britton A, McKee M, Black N,\nMcPherson K, Sanderson C, Bain C.\nNo. 14\nEvaluating patient-based outcome\nmeasures for use in clinical \ntrials.\nA review by Fitzpatrick R, Davey C,\nBuxton MJ, Jones DR.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n225\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.\nHealth Technology Assessment reports \npublished to dateNo. 15\nEthical issues in the design and conduct\nof randomised controlled trials.\nA review by Edwards SJL, Lilford RJ,\nBraunholtz DA, Jackson JC, Hewison J,\nThornton J.\nNo. 16\nQualitative research methods in health\ntechnology assessment: a review of the\nliterature.\nBy Murphy E, Dingwall R, Greatbatch\nD, Parker S, Watson P.\nNo. 17\nThe costs and benefits of paramedic\nskills in pre-hospital trauma care.\nBy Nicholl J, Hughes S, Dixon S,\nTurner J, Yates D.\nNo. 18\nSystematic review of endoscopic\nultrasound in gastro-oesophageal\ncancer.\nBy Harris KM, Kelly S, Berry E,\nHutton J, Roderick P, Cullingworth J, et al.\nNo. 19\nSystematic reviews of trials and other\nstudies.\nBy Sutton AJ, Abrams KR, Jones DR,\nSheldon TA, Song F.\nNo. 20\nPrimary total hip replacement surgery: \na systematic review of outcomes and\nmodelling of cost-effectiveness\nassociated with different prostheses.\nA review by Fitzpatrick R, Shortall E,\nSculpher M, Murray D, Morris R, Lodge\nM, et al.\nVolume 3, 1999\nNo. 1\nInformed decision making: an annotated\nbibliography and systematic review.\nBy Bekker H, Thornton JG, \nAirey CM, Connelly JB, Hewison J,\nRobinson MB, et al.\nNo. 2\nHandling uncertainty when performing\neconomic evaluation of healthcare\ninterventions.\nA review by Briggs AH, Gray AM.\nNo. 3\nThe role of expectancies in the placebo\neffect and their use in the delivery of\nhealth care: a systematic review.\nBy Crow R, Gage H, Hampson S,\nHart J, Kimber A, Thomas H.\nNo. 4\nA randomised controlled trial of\ndifferent approaches to universal\nantenatal HIV testing: uptake and\nacceptability. Annex: Antenatal HIV\ntesting \u2013 assessment of a routine\nvoluntary approach.\nBy Simpson WM, Johnstone FD, Boyd\nFM, Goldberg DJ, Hart GJ, Gormley\nSM, et al.\nNo. 5\nMethods for evaluating area-wide and\norganisation-based interventions in\nhealth and health care: a systematic\nreview.\nBy Ukoumunne OC, Gulliford MC,\nChinn S, Sterne JAC, Burney PGJ.\nNo. 6\nAssessing the costs of healthcare\ntechnologies in clinical trials.\nA review by Johnston K, Buxton MJ,\nJones DR, Fitzpatrick R.\nNo. 7\nCooperatives and their primary care\nemergency centres: organisation and\nimpact.\nBy Hallam L, Henthorne K.\nNo. 8\nScreening for cystic fibrosis.\nA review by Murray J, Cuckle H,\nTaylor G, Littlewood J, Hewison J.\nNo. 9\nA review of the use of health status\nmeasures in economic evaluation.\nBy Brazier J, Deverill M, Green C,\nHarper R, Booth A.\nNo. 10\nMethods for the analysis of quality-of-\nlife and survival data in health\ntechnology assessment.\nA review by Billingham LJ, Abrams\nKR, Jones DR.\nNo. 11\nAntenatal and neonatal\nhaemoglobinopathy screening in the\nUK: review and economic analysis.\nBy Zeuner D, Ades AE, Karnon J,\nBrown J, Dezateux C, Anionwu EN.\nNo. 12\nAssessing the quality of reports of\nrandomised trials: implications for the\nconduct of meta-analyses.\nA review by Moher D, Cook DJ, Jadad\nAR, Tugwell P, Moher M, Jones A, et al.\nNo. 13\n\u2018Early warning systems\u2019 for identifying\nnew healthcare technologies.\nBy Robert G, Stevens A, Gabbay J.\nNo. 14\nA systematic review of the role of human\npapillomavirus testing within a cervical\nscreening programme.\nBy Cuzick J, Sasieni P, Davies P,\nAdams J, Normand C, Frater A, et al.\nNo. 15\nNear patient testing in diabetes clinics:\nappraising the costs and outcomes.\nBy Grieve R, Beech R, Vincent J,\nMazurkiewicz J.\nNo. 16\nPositron emission tomography:\nestablishing priorities for health\ntechnology assessment.\nA review by Robert G, Milne R.\nNo. 17 (Pt 1)\nThe debridement of chronic wounds: \na systematic review.\nBy Bradley M, Cullum N, Sheldon T.\nNo. 17 (Pt 2)\nSystematic reviews of wound care\nmanagement: (2) Dressings and topical\nagents used in the healing of chronic\nwounds.\nBy Bradley M, Cullum N, Nelson EA,\nPetticrew M, Sheldon T, Torgerson D.\nNo. 18\nA systematic literature review of spiral\nand electron beam computed\ntomography: with particular reference to\nclinical applications in hepatic lesions,\npulmonary embolus and coronary artery\ndisease.\nBy Berry E, Kelly S, Hutton J, \nHarris KM, Roderick P, Boyce JC, et al.\nNo. 19\nWhat role for statins? A review and\neconomic model.\nBy Ebrahim S, Davey Smith G,\nMcCabe C, Payne N, Pickin M, Sheldon\nTA, et al.\nNo. 20\nFactors that limit the quality, number\nand progress of randomised controlled\ntrials.\nA review by Prescott RJ, Counsell CE,\nGillespie WJ, Grant AM, Russell IT,\nKiauka S, et al.\nNo. 21\nAntimicrobial prophylaxis in total hip\nreplacement: a systematic review.\nBy Glenny AM, Song F.\nNo. 22\nHealth promoting schools and health\npromotion in schools: two systematic\nreviews.\nBy Lister-Sharp D, Chapman S,\nStewart-Brown S, Sowden A.\nNo. 23\nEconomic evaluation of a primary care-\nbased education programme for patients\nwith osteoarthritis of the knee.\nA review by Lord J, Victor C,\nLittlejohns P, Ross FM, Axford JS.\nVolume 4, 2000\nNo. 1\nThe estimation of marginal time\npreference in a UK-wide sample\n(TEMPUS) project.\nA review by Cairns JA, van der Pol\nMM.\nNo. 2\nGeriatric rehabilitation following\nfractures in older people: a systematic\nreview.\nBy Cameron I, Crotty M, Currie C,\nFinnegan T, Gillespie L, Gillespie W, \net al.\nHealth Technology Assessment reports published to date\n226No. 3\nScreening for sickle cell disease and\nthalassaemia: a systematic review with\nsupplementary research.\nBy Davies SC, Cronin E, Gill M,\nGreengross P, Hickman M, Normand C.\nNo. 4\nCommunity provision of hearing aids\nand related audiology services.\nA review by Reeves DJ, Alborz A,\nHickson FS, Bamford JM.\nNo. 5\nFalse-negative results in screening\nprogrammes: systematic review of\nimpact and implications.\nBy Petticrew MP, Sowden AJ, \nLister-Sharp D, Wright K.\nNo. 6\nCosts and benefits of community\npostnatal support workers: a\nrandomised controlled trial.\nBy Morrell CJ, Spiby H, Stewart P,\nWalters S, Morgan A.\nNo. 7\nImplantable contraceptives (subdermal\nimplants and hormonally impregnated\nintrauterine systems) versus other forms\nof reversible contraceptives: two\nsystematic reviews to assess relative\neffectiveness, acceptability, tolerability\nand cost-effectiveness.\nBy French RS, Cowan FM, Mansour\nDJA, Morris S, Procter T, Hughes D, \net al.\nNo. 8\nAn introduction to statistical methods\nfor health technology assessment.\nA review by White SJ, Ashby D, \nBrown PJ.\nNo. 9\nDisease-modifying drugs for multiple\nsclerosis: a rapid and systematic \nreview.\nBy Clegg A, Bryant J, Milne R.\nNo. 10\nPublication and related biases.\nA review by Song F, Eastwood AJ,\nGilbody S, Duley L, Sutton AJ.\nNo. 11\nCost and outcome implications of the\norganisation of vascular services.\nBy Michaels J, Brazier J, Palfreyman\nS, Shackley P, Slack R.\nNo. 12\nMonitoring blood glucose control in\ndiabetes mellitus: a systematic review.\nBy Coster S, Gulliford MC, Seed PT,\nPowrie JK, Swaminathan R.\nNo. 13\nThe effectiveness of domiciliary health\nvisiting: a systematic review of\ninternational studies \nand a selective review of the British\nliterature.\nBy Elkan R, Kendrick D, Hewitt M,\nRobinson JJA, Tolley K, Blair M, et al.\nNo. 14\nThe determinants of screening uptake\nand interventions for increasing uptake:\na systematic review.\nBy Jepson R, Clegg A, Forbes C,\nLewis R, Sowden A, Kleijnen J.\nNo. 15\nThe effectiveness and cost-effectiveness\nof prophylactic removal of wisdom\nteeth. \nA rapid review by Song F, O\u2019Meara S,\nWilson P, Golder S, Kleijnen J.\nNo. 16\nUltrasound screening in pregnancy: a\nsystematic review of the clinical\neffectiveness, cost-effectiveness and\nwomen\u2019s views.\nBy Bricker L, Garcia J, Henderson J,\nMugford M, Neilson J, Roberts T, et al.\nNo. 17\nA rapid and systematic review of the\neffectiveness and cost-effectiveness of\nthe taxanes used in the treatment of\nadvanced breast and ovarian cancer.\nBy Lister-Sharp D, McDonagh MS,\nKhan KS, Kleijnen J.\nNo. 18\nLiquid-based cytology in cervical\nscreening: a rapid and systematic review.\nBy Payne N, Chilcott J, McGoogan E.\nNo. 19\nRandomised controlled trial of non-\ndirective counselling,\ncognitive\u2013behaviour therapy and usual\ngeneral practitioner care in the\nmanagement of depression as well as\nmixed anxiety and depression in\nprimary care.\nBy King M, Sibbald B, Ward E, Bower\nP, Lloyd M, Gabbay M, et al.\nNo. 20\nRoutine referral for radiography of\npatients presenting with low back pain:\nis patients\u2019 outcome influenced by GPs\u2019\nreferral for plain radiography?\nBy Kerry S, Hilton S, Patel S, Dundas\nD, Rink E, Lord J.\nNo. 21\nSystematic reviews of wound care\nmanagement: (3) antimicrobial agents\nfor chronic wounds; (4) diabetic foot\nulceration.\nBy O\u2019Meara S, Cullum N, Majid M,\nSheldon T.\nNo. 22\nUsing routine data to complement and\nenhance the results of randomised\ncontrolled trials.\nBy Lewsey JD, Leyland AH, \nMurray GD, Boddy FA.\nNo. 23\nCoronary artery stents in the treatment\nof ischaemic heart disease: a rapid and\nsystematic review.\nBy Meads C, Cummins C, Jolly K,\nStevens A, Burls A, Hyde C.\nNo. 24\nOutcome measures for adult critical\ncare: a systematic review.\nBy Hayes JA, Black NA, \nJenkinson C, Young JD, Rowan KM,\nDaly K, et al.\nNo. 25\nA systematic review to evaluate the\neffectiveness of interventions to \npromote the initiation of \nbreastfeeding.\nBy Fairbank L, O\u2019Meara S, Renfrew\nMJ, Woolridge M, Sowden AJ, \nLister-Sharp D.\nNo. 26\nImplantable cardioverter defibrillators:\narrhythmias. A rapid and systematic\nreview.\nBy Parkes J, Bryant J, Milne R.\nNo. 27\nTreatments for fatigue in multiple\nsclerosis: a rapid and systematic \nreview.\nBy Bra\u00f1as P, Jordan R, Fry-Smith A,\nBurls A, Hyde C.\nNo. 28\nEarly asthma prophylaxis, natural\nhistory, skeletal development and\neconomy (EASE): a pilot randomised\ncontrolled trial.\nBy Baxter-Jones ADG, Helms PJ,\nRussell G, Grant A, Ross S, Cairns JA, \net al.\nNo. 29\nScreening for hypercholesterolaemia\nversus case finding for familial\nhypercholesterolaemia: a systematic\nreview and cost-effectiveness analysis.\nBy Marks D, Wonderling D,\nThorogood M, Lambert H, Humphries\nSE, Neil HAW.\nNo. 30\nA rapid and systematic review of the\nclinical effectiveness and cost-\neffectiveness of glycoprotein IIb\/IIIa\nantagonists in the medical management\nof unstable angina.\nBy McDonagh MS, Bachmann LM,\nGolder S, Kleijnen J, ter Riet G.\nNo. 31\nA randomised controlled trial of\nprehospital intravenous fluid\nreplacement therapy in serious trauma.\nBy Turner J, Nicholl J, Webber L,\nCox H, Dixon S, Yates D.\nNo. 32\nIntrathecal pumps for giving opioids in\nchronic pain: a systematic review.\nBy Williams JE, Louw G, Towlerton G.\nNo. 33\nCombination therapy (interferon alfa\nand ribavirin) in the treatment of\nchronic hepatitis C: a rapid and\nsystematic review.\nBy Shepherd J, Waugh N, \nHewitson P.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n227\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.No. 34\nA systematic review of comparisons of\neffect sizes derived from randomised\nand non-randomised studies.\nBy MacLehose RR, Reeves BC,\nHarvey IM, Sheldon TA, Russell IT,\nBlack AMS.\nNo. 35\nIntravascular ultrasound-guided\ninterventions in coronary artery disease:\na systematic literature review, with\ndecision-analytic modelling, of outcomes\nand cost-effectiveness.\nBy Berry E, Kelly S, Hutton J,\nLindsay HSJ, Blaxill JM, Evans JA, et al.\nNo. 36\nA randomised controlled trial to\nevaluate the effectiveness and cost-\neffectiveness of counselling patients with\nchronic depression.\nBy Simpson S, Corney R, Fitzgerald P,\nBeecham J.\nNo. 37\nSystematic review of treatments for\natopic eczema.\nBy Hoare C, Li Wan Po A, Williams H.\nNo. 38\nBayesian methods in health technology\nassessment: a review.\nBy Spiegelhalter DJ, Myles JP, \nJones DR, Abrams KR.\nNo. 39\nThe management of dyspepsia: a\nsystematic review.\nBy Delaney B, Moayyedi P, Deeks J,\nInnes M, Soo S, Barton P, et al.\nNo. 40\nA systematic review of treatments for\nsevere psoriasis.\nBy Griffiths CEM, Clark CM, Chalmers\nRJG, Li Wan Po A, Williams HC.\nVolume 5, 2001\nNo. 1\nClinical and cost-effectiveness of\ndonepezil, rivastigmine and\ngalantamine for Alzheimer\u2019s disease: a\nrapid and systematic review.\nBy Clegg A, Bryant J, Nicholson T,\nMcIntyre L, De Broe S, Gerard K, et al.\nNo. 2\nThe clinical effectiveness and cost-\neffectiveness of riluzole for motor\nneurone disease: a rapid and systematic\nreview.\nBy Stewart A, Sandercock J, Bryan S,\nHyde C, Barton PM, Fry-Smith A, et al.\nNo. 3\nEquity and the economic evaluation of\nhealthcare.\nBy Sassi F, Archard L, Le Grand J.\nNo. 4\nQuality-of-life measures in chronic\ndiseases of childhood.\nBy Eiser C, Morse R.\nNo. 5\nEliciting public preferences for\nhealthcare: a systematic review of\ntechniques.\nBy Ryan M, Scott DA, Reeves C, Bate\nA, van Teijlingen ER, Russell EM, et al.\nNo. 6\nGeneral health status measures for\npeople with cognitive impairment:\nlearning disability and acquired brain\ninjury.\nBy Riemsma RP, Forbes CA, \nGlanville JM, Eastwood AJ, Kleijnen J.\nNo. 7\nAn assessment of screening strategies for\nfragile X syndrome in the UK.\nBy Pembrey ME, Barnicoat AJ,\nCarmichael B, Bobrow M, Turner G.\nNo. 8\nIssues in methodological research:\nperspectives from researchers and\ncommissioners.\nBy Lilford RJ, Richardson A, Stevens\nA, Fitzpatrick R, Edwards S, Rock F, et al.\nNo. 9\nSystematic reviews of wound care\nmanagement: (5) beds; (6) compression;\n(7) laser therapy, therapeutic\nultrasound, electrotherapy and\nelectromagnetic therapy.\nBy Cullum N, Nelson EA, Flemming\nK, Sheldon T.\nNo. 10\nEffects of educational and psychosocial\ninterventions for adolescents with\ndiabetes mellitus: a systematic review.\nBy Hampson SE, Skinner TC, Hart J,\nStorey L, Gage H, Foxcroft D, et al.\nNo. 11\nEffectiveness of autologous chondrocyte\ntransplantation for hyaline cartilage\ndefects in knees: a rapid and systematic\nreview.\nBy Jobanputra P, Parry D, Fry-Smith\nA, Burls A.\nNo. 12\nStatistical assessment of the learning\ncurves of health technologies.\nBy Ramsay CR, Grant AM, \nWallace SA, Garthwaite PH, Monk AF,\nRussell IT.\nNo. 13\nThe effectiveness and cost-effectiveness\nof temozolomide for the treatment of\nrecurrent malignant glioma: a rapid and\nsystematic review.\nBy Dinnes J, Cave C, Huang S, \nMajor K, Milne R.\nNo. 14\nA rapid and systematic review of the\nclinical effectiveness and cost-\neffectiveness of debriding agents in\ntreating surgical wounds healing by\nsecondary intention.\nBy Lewis R, Whiting P, ter Riet G,\nO\u2019Meara S, Glanville J.\nNo. 15\nHome treatment for mental health\nproblems: a systematic review.\nBy Burns T, Knapp M, \nCatty J, Healey A, Henderson J, \nWatt H, et al.\nNo. 16\nHow to develop cost-conscious\nguidelines.\nBy Eccles M, Mason J.\nNo. 17\nThe role of specialist nurses in multiple\nsclerosis: a rapid and systematic review.\nBy De Broe S, Christopher F, \nWaugh N.\nNo. 18\nA rapid and systematic review of the\nclinical effectiveness and cost-\neffectiveness of orlistat in the\nmanagement of obesity.\nBy O\u2019Meara S, Riemsma R, \nShirran L, Mather L, ter Riet G.\nNo. 19\nThe clinical effectiveness and cost-\neffectiveness of pioglitazone for type 2\ndiabetes mellitus: a rapid and systematic\nreview.\nBy Chilcott J, Wight J, Lloyd Jones\nM, Tappenden P.\nNo. 20\nExtended scope of nursing practice: a\nmulticentre randomised controlled trial\nof appropriately trained nurses and\npreregistration house officers in pre-\noperative assessment in elective general\nsurgery.\nBy Kinley H, Czoski-Murray C,\nGeorge S, McCabe C, Primrose J, \nReilly C, et al.\nNo. 21\nSystematic reviews of the effectiveness of\nday care for people with severe mental\ndisorders: (1) Acute day hospital versus\nadmission; (2) Vocational rehabilitation;\n(3) Day hospital versus outpatient \ncare.\nBy Marshall M, Crowther R, Almaraz-\nSerrano A, Creed F, Sledge W, \nKluiter H, et al.\nNo. 22\nThe measurement and monitoring of\nsurgical adverse events.\nBy Bruce J, Russell EM, Mollison J,\nKrukowski ZH.\nNo. 23\nAction research: a systematic review and\nguidance for assessment.\nBy Waterman H, Tillen D, Dickson R,\nde Koning K.\nNo. 24\nA rapid and systematic review of the\nclinical effectiveness and cost-\neffectiveness of gemcitabine for the\ntreatment of pancreatic cancer.\nBy Ward S, Morris E, Bansback N,\nCalvert N, Crellin A, Forman D, et al.\nHealth Technology Assessment reports published to date\n228No. 25\nA rapid and systematic review of the\nevidence for the clinical effectiveness\nand cost-effectiveness of irinotecan,\noxaliplatin and raltitrexed for the\ntreatment of advanced colorectal cancer.\nBy Lloyd Jones M, Hummel S,\nBansback N, Orr B, Seymour M.\nNo. 26\nComparison of the effectiveness of\ninhaler devices in asthma and chronic\nobstructive airways disease: a systematic\nreview of the literature.\nBy Brocklebank D, Ram F, Wright J,\nBarry P, Cates C, Davies L, et al.\nNo. 27\nThe cost-effectiveness of magnetic\nresonance imaging for investigation of\nthe knee joint.\nBy Bryan S, Weatherburn G, Bungay\nH, Hatrick C, Salas C, Parry D, et al.\nNo. 28\nA rapid and systematic review of the\nclinical effectiveness and cost-\neffectiveness of topotecan for ovarian\ncancer.\nBy Forbes C, Shirran L, Bagnall A-M,\nDuffy S, ter Riet G.\nNo. 29\nSuperseded by a report published in a\nlater volume.\nNo. 30\nThe role of radiography in primary care\npatients with low back pain of at least 6\nweeks duration: a randomised\n(unblinded) controlled trial.\nBy Kendrick D, Fielding K, Bentley E,\nMiller P, Kerslake R, Pringle M.\nNo. 31\nDesign and use of questionnaires: a\nreview of best practice applicable to\nsurveys of health service staff and\npatients.\nBy McColl E, Jacoby A, Thomas L,\nSoutter J, Bamford C, Steen N, et al.\nNo. 32\nA rapid and systematic review of the\nclinical effectiveness and cost-\neffectiveness of paclitaxel, docetaxel,\ngemcitabine and vinorelbine in non-\nsmall-cell lung cancer.\nBy Clegg A, Scott DA, Sidhu M,\nHewitson P, Waugh N.\nNo. 33\nSubgroup analyses in randomised\ncontrolled trials: quantifying the risks of\nfalse-positives and false-negatives.\nBy Brookes ST, Whitley E, \nPeters TJ, Mulheran PA, Egger M,\nDavey Smith G.\nNo. 34\nDepot antipsychotic medication in the\ntreatment of patients with schizophrenia:\n(1) Meta-review; (2) Patient and nurse\nattitudes.\nBy David AS, Adams C.\nNo. 35\nA systematic review of controlled trials\nof the effectiveness and cost-\neffectiveness of brief psychological\ntreatments for depression.\nBy Churchill R, Hunot V, Corney R,\nKnapp M, McGuire H, Tylee A, et al.\nNo. 36\nCost analysis of child health\nsurveillance.\nBy Sanderson D, Wright D, Acton C,\nDuree D.\nVolume 6, 2002\nNo. 1\nA study of the methods used to select\nreview criteria for clinical audit.\nBy Hearnshaw H, Harker R, Cheater\nF, Baker R, Grimshaw G.\nNo. 2\nFludarabine as second-line therapy for\nB cell chronic lymphocytic leukaemia: \na technology assessment.\nBy Hyde C, Wake B, Bryan S, Barton\nP, Fry-Smith A, Davenport C, et al.\nNo. 3\nRituximab as third-line treatment for\nrefractory or recurrent Stage III or IV\nfollicular non-Hodgkin\u2019s lymphoma: a\nsystematic review and economic\nevaluation.\nBy Wake B, Hyde C, Bryan S, Barton\nP, Song F, Fry-Smith A, et al.\nNo. 4\nA systematic review of discharge\narrangements for older people.\nBy Parker SG, Peet SM, McPherson A,\nCannaby AM, Baker R, Wilson A, et al.\nNo. 5\nThe clinical effectiveness and cost-\neffectiveness of inhaler devices used in\nthe routine management of chronic\nasthma in older children: a systematic\nreview and economic evaluation.\nBy Peters J, Stevenson M, Beverley C,\nLim J, Smith S.\nNo. 6\nThe clinical effectiveness and cost-\neffectiveness of sibutramine in the\nmanagement of obesity: a technology\nassessment.\nBy O\u2019Meara S, Riemsma R, Shirran\nL, Mather L, ter Riet G.\nNo. 7\nThe cost-effectiveness of magnetic\nresonance angiography for carotid\nartery stenosis and peripheral vascular\ndisease: a systematic review.\nBy Berry E, Kelly S, Westwood ME,\nDavies LM, Gough MJ, Bamford JM,\net al.\nNo. 8\nPromoting physical activity in South\nAsian Muslim women through \u2018exercise\non prescription\u2019.\nBy Carroll B, Ali N, Azam N.\nNo. 9\nZanamivir for the treatment of influenza\nin adults: a systematic review and\neconomic evaluation.\nBy Burls A, Clark W, Stewart T,\nPreston C, Bryan S, Jefferson T, et al.\nNo. 10\nA review of the natural history and\nepidemiology of multiple sclerosis:\nimplications for resource allocation and\nhealth economic models.\nBy Richards RG, Sampson FC, \nBeard SM, Tappenden P.\nNo. 11\nScreening for gestational diabetes: a\nsystematic review and economic\nevaluation.\nBy Scott DA, Loveman E, McIntyre L,\nWaugh N.\nNo. 12\nThe clinical effectiveness and cost-\neffectiveness of surgery for people with\nmorbid obesity: a systematic review and\neconomic evaluation.\nBy Clegg AJ, Colquitt J, Sidhu MK,\nRoyle P, Loveman E, Walker A.\nNo. 13\nThe clinical effectiveness of trastuzumab\nfor breast cancer: a systematic review.\nBy Lewis R, Bagnall A-M, Forbes C,\nShirran E, Duffy S, Kleijnen J, et al.\nNo. 14\nThe clinical effectiveness and cost-\neffectiveness of vinorelbine for breast\ncancer: a systematic review and\neconomic evaluation.\nBy Lewis R, Bagnall A-M, King S,\nWoolacott N, Forbes C, Shirran L, et al.\nNo. 15\nA systematic review of the effectiveness\nand cost-effectiveness of metal-on-metal\nhip resurfacing arthroplasty for\ntreatment of hip disease.\nBy Vale L, Wyness L, McCormack K,\nMcKenzie L, Brazzelli M, Stearns SC.\nNo. 16\nThe clinical effectiveness and cost-\neffectiveness of bupropion and nicotine\nreplacement therapy for smoking\ncessation: a systematic review and\neconomic evaluation.\nBy Woolacott NF, Jones L, Forbes CA,\nMather LC, Sowden AJ, Song FJ, et al.\nNo. 17\nA systematic review of effectiveness and\neconomic evaluation of new drug\ntreatments for juvenile idiopathic\narthritis: etanercept.\nBy Cummins C, Connock M, \nFry-Smith A, Burls A.\nNo. 18\nClinical effectiveness and cost-\neffectiveness of growth hormone in\nchildren: a systematic review and\neconomic evaluation.\nBy Bryant J, Cave C, Mihaylova B,\nChase D, McIntyre L, Gerard K, et al.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n229\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.No. 19\nClinical effectiveness and cost-\neffectiveness of growth hormone in\nadults in relation to impact on quality of\nlife: a systematic review and economic\nevaluation.\nBy Bryant J, Loveman E, Chase D,\nMihaylova B, Cave C, Gerard K, et al.\nNo. 20\nClinical medication review by a\npharmacist of patients on repeat\nprescriptions in general practice: a\nrandomised controlled trial.\nBy Zermansky AG, Petty DR, Raynor\nDK, Lowe CJ, Freementle N, Vail A.\nNo. 21\nThe effectiveness of infliximab and\netanercept for the treatment of\nrheumatoid arthritis: a systematic review\nand economic evaluation.\nBy Jobanputra P, Barton P, Bryan S,\nBurls A.\nNo. 22\nA systematic review and economic\nevaluation of computerised cognitive\nbehaviour therapy for depression and\nanxiety.\nBy Kaltenthaler E, Shackley P, Stevens\nK, Beverley C, Parry G, Chilcott J.\nNo. 23\nA systematic review and economic\nevaluation of pegylated liposomal\ndoxorubicin hydrochloride for ovarian\ncancer.\nBy Forbes C, Wilby J, Richardson G,\nSculpher M, Mather L, Reimsma R.\nNo. 24\nA systematic review of the effectiveness\nof interventions based on a stages-of-\nchange approach to promote individual\nbehaviour change.\nBy Riemsma RP, Pattenden J, Bridle C,\nSowden AJ, Mather L, Watt IS, et al.\nNo. 25\nA systematic review update of the\nclinical effectiveness and cost-\neffectiveness of glycoprotein IIb\/IIIa\nantagonists.\nBy Robinson M, Ginnelly L, Sculpher\nM, Jones L, Riemsma R, Palmer S, et al.\nNo. 26\nA systematic review of the effectiveness,\ncost-effectiveness and barriers to\nimplementation of thrombolytic and\nneuroprotective therapy for acute\nischaemic stroke in the NHS.\nBy Sandercock P, Berge E, Dennis M,\nForbes J, Hand P, Kwan J, et al.\nNo. 27\nA randomised controlled crossover \ntrial of nurse practitioner versus \ndoctor-led outpatient care in a\nbronchiectasis clinic.\nBy Caine N, Sharples LD,\nHollingworth W, French J, Keogan M,\nExley A, et al.\nNo. 28\nClinical effectiveness and cost \u2013\nconsequences of selective serotonin\nreuptake inhibitors in the treatment of\nsex offenders.\nBy Adi Y, Ashcroft D, Browne K,\nBeech A, Fry-Smith A, Hyde C.\nNo. 29\nTreatment of established osteoporosis: \na systematic review and cost\u2013utility\nanalysis.\nBy Kanis JA, Brazier JE, Stevenson M,\nCalvert NW, Lloyd Jones M.\nNo. 30\nWhich anaesthetic agents are cost-\neffective in day surgery? Literature\nreview, national survey of practice and\nrandomised controlled trial.\nBy Elliott RA Payne K, Moore JK,\nDavies LM, Harper NJN, St Leger AS,\net al.\nNo. 31\nScreening for hepatitis C among\ninjecting drug users and in\ngenitourinary medicine clinics:\nsystematic reviews of effectiveness,\nmodelling study and national survey of\ncurrent practice.\nBy Stein K, Dalziel K, Walker A,\nMcIntyre L, Jenkins B, Horne J, et al.\nNo. 32\nThe measurement of satisfaction with\nhealthcare: implications for practice\nfrom a systematic review of the\nliterature.\nBy Crow R, Gage H, Hampson S,\nHart J, Kimber A, Storey L, et al.\nNo. 33\nThe effectiveness and cost-effectiveness\nof imatinib in chronic myeloid\nleukaemia: a systematic review.\nBy Garside R, Round A, Dalziel K,\nStein K, Royle R.\nNo. 34\nA comparative study of hypertonic\nsaline, daily and alternate-day \nrhDNase in children with cystic \nfibrosis.\nBy Suri R, Wallis C, Bush A,\nThompson S, Normand C, Flather M, \net al.\nNo. 35\nA systematic review of the costs and\neffectiveness of different models of\npaediatric home care.\nBy Parker G, Bhakta P, Lovett CA,\nPaisley S, Olsen R, Turner D, et al.\nVolume 7, 2003\nNo. 1\nHow important are comprehensive\nliterature searches and the assessment of\ntrial quality in systematic reviews?\nEmpirical study.\nBy Egger M, J\u00fcni P, Bartlett C,\nHolenstein F, Sterne J.\nNo. 2\nSystematic review of the effectiveness\nand cost-effectiveness, and economic\nevaluation, of home versus hospital or\nsatellite unit haemodialysis for people\nwith end-stage renal failure.\nBy Mowatt G, Vale L, Perez J, Wyness\nL, Fraser C, MacLeod A, et al.\nNo. 3\nSystematic review and economic\nevaluation of the effectiveness of\ninfliximab for the treatment of Crohn\u2019s\ndisease.\nBy Clark W, Raftery J, Barton P, \nSong F, Fry-Smith A, Burls A.\nNo. 4\nA review of the clinical effectiveness and\ncost-effectiveness of routine anti-D\nprophylaxis for pregnant women who\nare rhesus negative.\nBy Chilcott J, Lloyd Jones M, Wight\nJ, Forman K, Wray J, Beverley C, et al.\nNo. 5\nSystematic review and evaluation of the\nuse of tumour markers in paediatric\noncology: Ewing\u2019s sarcoma and\nneuroblastoma.\nBy Riley RD, Burchill SA, Abrams KR,\nHeney D, Lambert PC, Jones DR, et al.\nNo. 6\nThe cost-effectiveness of screening for\nHelicobacter pylori to reduce mortality\nand morbidity from gastric cancer and\npeptic ulcer disease: a discrete-event\nsimulation model.\nBy Roderick P, Davies R, Raftery J,\nCrabbe D, Pearce R, Bhandari P, et al.\nNo. 7\nThe clinical effectiveness and cost-\neffectiveness of routine dental checks: a\nsystematic review and economic\nevaluation.\nBy Davenport C, Elley K, Salas C,\nTaylor-Weetman CL, Fry-Smith A, \nBryan S, et al.\nNo. 8\nA multicentre randomised controlled\ntrial assessing the costs and benefits of\nusing structured information and\nanalysis of women\u2019s preferences in the\nmanagement of menorrhagia.\nBy Kennedy ADM, Sculpher MJ,\nCoulter A, Dwyer N, Rees M, \nHorsley S, et al.\nNo. 9\nClinical effectiveness and cost\u2013utility of\nphotodynamic therapy for wet age-related\nmacular degeneration: a systematic review\nand economic evaluation.\nBy Meads C, Salas C, Roberts T,\nMoore D, Fry-Smith A, Hyde C.\nNo. 10\nEvaluation of molecular tests for\nprenatal diagnosis of chromosome\nabnormalities.\nBy Grimshaw GM, Szczepura A,\nHult\u00e9n M, MacDonald F, Nevin NC,\nSutton F, et al.\nHealth Technology Assessment reports published to date\n230No. 11\nFirst and second trimester antenatal\nscreening for Down\u2019s syndrome: the\nresults of the Serum, Urine and\nUltrasound Screening Study \n(SURUSS).\nBy Wald NJ, Rodeck C, \nHackshaw AK, Walters J, Chitty L,\nMackinson AM.\nNo. 12\nThe effectiveness and cost-effectiveness\nof ultrasound locating devices for\ncentral venous access: a systematic\nreview and economic evaluation.\nBy Calvert N, Hind D, McWilliams\nRG, Thomas SM, Beverley C, \nDavidson A.\nNo. 13\nA systematic review of atypical\nantipsychotics in schizophrenia.\nBy Bagnall A-M, Jones L, Lewis R,\nGinnelly L, Glanville J, Torgerson D, \net al.\nNo. 14\nProstate Testing for Cancer and\nTreatment (ProtecT) feasibility \nstudy.\nBy Donovan J, Hamdy F, Neal D,\nPeters T, Oliver S, Brindle L, et al.\nNo. 15\nEarly thrombolysis for the treatment \nof acute myocardial infarction: a\nsystematic review and economic\nevaluation.\nBy Boland A, Dundar Y, Bagust A,\nHaycox A, Hill R, Mujica Mota R,\net al.\nNo. 16\nScreening for fragile X syndrome: \na literature review and modelling.\nBy Song FJ, Barton P, Sleightholme V,\nYao GL, Fry-Smith A.\nNo. 17\nSystematic review of endoscopic sinus\nsurgery for nasal polyps.\nBy Dalziel K, Stein K, Round A,\nGarside R, Royle P. \nNo. 18\nTowards efficient guidelines: how to\nmonitor guideline use in primary \ncare.\nBy Hutchinson A, McIntosh A, Cox S,\nGilbert C. \nNo. 19\nEffectiveness and cost-effectiveness of\nacute hospital-based spinal cord injuries\nservices: systematic review.\nBy Bagnall A-M, Jones L, \nRichardson G, Duffy S, \nRiemsma R. \nNo. 20\nPrioritisation of health technology\nassessment. The PATHS model:\nmethods and case studies.\nBy Townsend J, Buxton M, \nHarper G.\nNo. 21\nSystematic review of the clinical\neffectiveness and cost-effectiveness \nof tension-free vaginal tape for\ntreatment of urinary stress \nincontinence.\nBy Cody J, Wyness L, Wallace S,\nGlazener C, Kilonzo M, Stearns S,\net al.\nNo. 22\nThe clinical and cost-effectiveness of\npatient education models for diabetes: \na systematic review and economic\nevaluation.\nBy Loveman E, Cave C, Green C,\nRoyle P, Dunn N, Waugh N. \nNo. 23\nThe role of modelling in prioritising\nand planning clinical trials.\nBy Chilcott J, Brennan A, Booth A,\nKarnon J, Tappenden P. \nNo. 24\nCost\u2013benefit evaluation of routine\ninfluenza immunisation in people 65\u201374\nyears of age.\nBy Allsup S, Gosney M, Haycox A,\nRegan M. \nNo. 25\nThe clinical and cost-effectiveness of\npulsatile machine perfusion versus cold\nstorage of kidneys for transplantation\nretrieved from heart-beating and non-\nheart-beating donors.\nBy Wight J, Chilcott J, Holmes M,\nBrewer N. \nNo. 26\nCan randomised trials rely on existing\nelectronic data? A feasibility study to\nexplore the value of routine data in\nhealth technology assessment.\nBy Williams JG, Cheung WY, \nCohen DR, Hutchings HA, Longo MF, \nRussell IT. \nNo. 27\nEvaluating non-randomised intervention\nstudies.\nBy Deeks JJ, Dinnes J, D\u2019Amico R,\nSowden AJ, Sakarovitch C, Song F, et al.\nNo. 28\nA randomised controlled trial to assess\nthe impact of a package comprising a\npatient-orientated, evidence-based self-\nhelp guidebook and patient-centred\nconsultations on disease management\nand satisfaction in inflammatory bowel\ndisease.\nBy Kennedy A, Nelson E, Reeves D,\nRichardson G, Roberts C, Robinson A,\net al.\nNo. 29\nThe effectiveness of diagnostic tests for\nthe assessment of shoulder pain due to\nsoft tissue disorders: a systematic review.\nBy Dinnes J, Loveman E, McIntyre L,\nWaugh N.\nNo. 30\nThe value of digital imaging in diabetic\nretinopathy.\nBy Sharp PF, Olson J, Strachan F,\nHipwell J, Ludbrook A, O\u2019Donnell M, \net al.\nNo. 31\nLowering blood pressure to prevent\nmyocardial infarction and stroke: \na new preventive strategy.\nBy Law M, Wald N, Morris J.\nNo. 32\nClinical and cost-effectiveness of\ncapecitabine and tegafur with uracil for\nthe treatment of metastatic colorectal\ncancer: systematic review and economic\nevaluation.\nBy Ward S, Kaltenthaler E, Cowan J,\nBrewer N.\nNo. 33\nClinical and cost-effectiveness of new \nand emerging technologies for early\nlocalised prostate cancer: a systematic\nreview. \nBy Hummel S, Paisley S, Morgan A,\nCurrie E, Brewer N.\nNo. 34\nLiterature searching for clinical and\ncost-effectiveness studies used in health\ntechnology assessment reports carried\nout for the National Institute for\nClinical Excellence appraisal \nsystem.\nBy Royle P, Waugh N.\nNo. 35\nSystematic review and economic\ndecision modelling for the prevention\nand treatment of influenza \nA and B.\nBy Turner D, Wailoo A, Nicholson K,\nCooper N, Sutton A, Abrams K.\nNo. 36\nA randomised controlled trial to\nevaluate the clinical and cost-\neffectiveness of Hickman line \ninsertions in adult cancer patients by\nnurses.\nBy Boland A, Haycox A, Bagust A,\nFitzsimmons L.\nNo. 37\nRedesigning postnatal care: a\nrandomised controlled trial of \nprotocol-based midwifery-led care\nfocused on individual women\u2019s \nphysical and psychological health \nneeds.\nBy MacArthur C, Winter HR, \nBick DE, Lilford RJ, Lancashire RJ,\nKnowles H, et al.\nNo. 38\nEstimating implied rates of discount in\nhealthcare decision-making. \nBy West RR, McNabb R, \nThompson AGH, Sheldon TA, \nGrimley Evans J.\nHealth Technology Assessment 2008; Vol. 12: No. 26\n231\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.No. 39\nSystematic review of isolation policies in\nthe hospital management of methicillin-\nresistant Staphylococcus aureus: a review of\nthe literature with epidemiological and\neconomic modelling. \nBy Cooper BS, Stone SP, Kibbler CC,\nCookson BD, Roberts JA, Medley GF, \net al.\nNo. 40\nTreatments for spasticity and pain in\nmultiple sclerosis: a systematic review.\nBy Beard S, Hunn A, Wight J.\nNo. 41\nThe inclusion of reports of randomised\ntrials published in languages other than\nEnglish in systematic reviews. \nBy Moher D, Pham B, Lawson ML,\nKlassen TP.\nNo. 42\nThe impact of screening on future\nhealth-promoting behaviours and health\nbeliefs: a systematic review.\nBy Bankhead CR, Brett J, Bukach C,\nWebster P, Stewart-Brown S, Munafo M,\net al.\nVolume 8, 2004\nNo. 1\nWhat is the best imaging strategy for\nacute stroke?\nBy Wardlaw JM, Keir SL, Seymour J,\nLewis S, Sandercock PAG, Dennis MS, \net al. \nNo. 2\nSystematic review and modelling of the\ninvestigation of acute and chronic chest\npain presenting in primary care.\nBy Mant J, McManus RJ, Oakes RAL,\nDelaney BC, Barton PM, Deeks JJ, et al.\nNo. 3\nThe effectiveness and cost-effectiveness\nof microwave and thermal balloon\nendometrial ablation for heavy\nmenstrual bleeding: a systematic review\nand economic modelling. \nBy Garside R, Stein K, Wyatt K,\nRound A, Price A.\nNo. 4\nA systematic review of the role of\nbisphosphonates in metastatic disease. \nBy Ross JR, Saunders Y, Edmonds PM,\nPatel S, Wonderling D, Normand C, et al. \nNo. 5\nSystematic review of the clinical\neffectiveness and cost-effectiveness of\ncapecitabine (Xeloda\u00ae) for locally\nadvanced and\/or metastatic breast cancer. \nBy Jones L, Hawkins N, Westwood M,\nWright K, Richardson G, Riemsma R. \nNo. 6\nEffectiveness and efficiency of guideline\ndissemination and implementation\nstrategies. \nBy Grimshaw JM, Thomas RE,\nMacLennan G, Fraser C, Ramsay CR,\nVale L, et al. \nNo. 7\nClinical effectiveness and costs of the\nSugarbaker procedure for the treatment\nof pseudomyxoma peritonei.\nBy Bryant J, Clegg AJ, Sidhu MK,\nBrodin H, Royle P, Davidson P. \nNo. 8\nPsychological treatment for insomnia in\nthe regulation of long-term hypnotic\ndrug use. \nBy Morgan K, Dixon S, Mathers N,\nThompson J, Tomeny M. \nNo. 9\nImproving the evaluation of therapeutic\ninterventions in multiple sclerosis:\ndevelopment of a patient-based measure\nof outcome. \nBy Hobart JC, Riazi A, Lamping DL,\nFitzpatrick R, Thompson AJ. \nNo. 10\nA systematic review and economic\nevaluation of magnetic resonance\ncholangiopancreatography compared\nwith diagnostic endoscopic retrograde\ncholangiopancreatography.\nBy Kaltenthaler E, Bravo Vergel Y,\nChilcott J, Thomas S, Blakeborough T,\nWalters SJ, et al. \nNo. 11\nThe use of modelling to evaluate new\ndrugs for patients with a chronic\ncondition: the case of antibodies against\ntumour necrosis factor in rheumatoid\narthritis. \nBy Barton P, Jobanputra P, Wilson J,\nBryan S, Burls A. \nNo. 12\nClinical effectiveness and cost-\neffectiveness of neonatal screening for\ninborn errors of metabolism using\ntandem mass spectrometry: a systematic\nreview. \nBy Pandor A, Eastham J, Beverley C,\nChilcott J, Paisley S.\nNo. 13\nClinical effectiveness and cost-\neffectiveness of pioglitazone and\nrosiglitazone in the treatment of \ntype 2 diabetes: a systematic \nreview and economic \nevaluation. \nBy Czoski-Murray C, Warren E,\nChilcott J, Beverley C, Psyllaki MA,\nCowan J. \nNo. 14\nRoutine examination of the newborn:\nthe EMREN study. Evaluation of an\nextension of the midwife role \nincluding a randomised controlled \ntrial of appropriately trained midwives\nand paediatric senior house \nofficers. \nBy Townsend J, Wolke D, Hayes J,\nDav\u00e9 S, Rogers C, Bloomfield L, \net al. \nNo. 15\nInvolving consumers in research and\ndevelopment agenda setting for the\nNHS: developing an evidence-based\napproach. \nBy Oliver S, Clarke-Jones L, \nRees R, Milne R, Buchanan P, \nGabbay J, et al. \nNo. 16\nA multi-centre randomised controlled\ntrial of minimally invasive direct\ncoronary bypass grafting versus\npercutaneous transluminal coronary\nangioplasty with stenting for proximal\nstenosis of the left anterior descending\ncoronary artery. \nBy Reeves BC, Angelini GD, Bryan\nAJ, Taylor FC, Cripps T, Spyt TJ, et al. \nNo. 17\nDoes early magnetic resonance imaging\ninfluence management or improve\noutcome in patients referred to\nsecondary care with low back pain? \nA pragmatic randomised controlled\ntrial. \nBy Gilbert FJ, Grant AM, Gillan\nMGC, Vale L, Scott NW, Campbell MK,\net al. \nNo. 18\nThe clinical and cost-effectiveness of\nanakinra for the treatment of\nrheumatoid arthritis in adults: a\nsystematic review and economic analysis. \nBy Clark W, Jobanputra P, Barton P,\nBurls A.\nNo. 19\nA rapid and systematic review and\neconomic evaluation of the clinical and\ncost-effectiveness of newer drugs for\ntreatment of mania associated with\nbipolar affective disorder. \nBy Bridle C, Palmer S, Bagnall A-M,\nDarba J, Duffy S, Sculpher M, et al. \nNo. 20\nLiquid-based cytology in cervical\nscreening: an updated rapid and\nsystematic review and economic \nanalysis.\nBy Karnon J, Peters J, Platt J, \nChilcott J, McGoogan E, Brewer N.\nNo. 21\nSystematic review of the long-term\neffects and economic consequences of\ntreatments for obesity and implications\nfor health improvement. \nBy Avenell A, Broom J, Brown TJ,\nPoobalan A, Aucott L, Stearns SC, et al.\nNo. 22\nAutoantibody testing in children with\nnewly diagnosed type 1 diabetes\nmellitus. \nBy Dretzke J, Cummins C,\nSandercock J, Fry-Smith A, Barrett T,\nBurls A.\nHealth Technology Assessment reports published to date\n232No. 23\nClinical effectiveness and cost-\neffectiveness of prehospital intravenous\nfluids in trauma patients.\nBy Dretzke J, Sandercock J, Bayliss S,\nBurls A. \nNo. 24\nNewer hypnotic drugs for the short-\nterm management of insomnia: a\nsystematic review and economic\nevaluation.\nBy D\u00fcndar Y, Boland A, Strobl J,\nDodd S, Haycox A, Bagust A, \net al. \nNo. 25\nDevelopment and validation of methods\nfor assessing the quality of diagnostic\naccuracy studies.\nBy Whiting P, Rutjes AWS, Dinnes J,\nReitsma JB, Bossuyt PMM, Kleijnen J.\nNo. 26\nEVALUATE hysterectomy trial: a\nmulticentre randomised trial comparing\nabdominal, vaginal and laparoscopic\nmethods of hysterectomy.\nBy Garry R, Fountain J, Brown J,\nManca A, Mason S, Sculpher M, et al. \nNo. 27\nMethods for expected value of\ninformation analysis in complex health\neconomic models: developments on the\nhealth economics of interferon-\u0006 and\nglatiramer acetate for multiple sclerosis.\nBy Tappenden P, Chilcott JB,\nEggington S, Oakley J, McCabe C.\nNo. 28\nEffectiveness and cost-effectiveness of\nimatinib for first-line treatment of\nchronic myeloid leukaemia in chronic\nphase: a systematic review and economic\nanalysis. \nBy Dalziel K, Round A, Stein K,\nGarside R, Price A. \nNo. 29\nVenUS I: a randomised controlled trial\nof two types of bandage for treating\nvenous leg ulcers. \nBy Iglesias C, Nelson EA, Cullum NA,\nTorgerson DJ on behalf of the VenUS\nTeam.\nNo. 30\nSystematic review of the effectiveness\nand cost-effectiveness, and economic\nevaluation, of myocardial perfusion\nscintigraphy for the diagnosis and\nmanagement of angina and myocardial\ninfarction. \nBy Mowatt G, Vale L, Brazzelli M,\nHernandez R, Murray A, Scott N, et al. \nNo. 31\nA pilot study on the use of decision\ntheory and value of information analysis\nas part of the NHS Health Technology\nAssessment programme.\nBy Claxton K on K, Ginnelly L, Sculpher\nM, Philips Z, Palmer S. \nNo. 32\nThe Social Support and Family Health\nStudy: a randomised controlled trial and\neconomic evaluation of two alternative\nforms of postnatal support for mothers\nliving in disadvantaged inner-city areas. \nBy Wiggins M, Oakley A, Roberts I,\nTurner H, Rajan L, Austerberry H, et al. \nNo. 33\nPsychosocial aspects of genetic screening\nof pregnant women and newborns: \na systematic review. \nBy Green JM, Hewison J, Bekker HL,\nBryant, Cuckle HS.\nNo. 34\nEvaluation of abnormal uterine\nbleeding: comparison of three\noutpatient procedures within cohorts\ndefined by age and menopausal status. \nBy Critchley HOD, Warner P, \nLee AJ, Brechin S, Guise J, Graham B. \nNo. 35\nCoronary artery stents: a rapid systematic\nreview and economic evaluation. \nBy Hill R, Bagust A, Bakhai A,\nDickson R, D\u00fcndar Y, Haycox A, et al. \nNo. 36\nReview of guidelines for good practice\nin decision-analytic modelling in health\ntechnology assessment. \nBy Philips Z, Ginnelly L, Sculpher M,\nClaxton K, Golder S, Riemsma R, et al.\nNo. 37\nRituximab (MabThera\u00ae) for aggressive\nnon-Hodgkin\u2019s lymphoma: systematic\nreview and economic evaluation. \nBy Knight C, Hind D, Brewer N,\nAbbott V. \nNo. 38\nClinical effectiveness and cost-\neffectiveness of clopidogrel and\nmodified-release dipyridamole in the\nsecondary prevention of occlusive\nvascular events: a systematic review and\neconomic evaluation. \nBy Jones L, Griffin S, Palmer S, Main\nC, Orton V, Sculpher M, et al.\nNo. 39\nPegylated interferon \u0007-2a and -2b in\ncombination with ribavirin in the\ntreatment of chronic hepatitis C: a\nsystematic review and economic\nevaluation. \nBy Shepherd J, Brodin H, Cave C,\nWaugh N, Price A, Gabbay J. \nNo. 40\nClopidogrel used in combination with\naspirin compared with aspirin alone in\nthe treatment of non-ST-segment-\nelevation acute coronary syndromes: a\nsystematic review and economic\nevaluation. \nBy Main C, Palmer S, Griffin S, \nJones L, Orton V, Sculpher M, et al.\nNo. 41\nProvision, uptake and cost of cardiac\nrehabilitation programmes: improving\nservices to under-represented groups. \nBy Beswick AD, Rees K, Griebsch I,\nTaylor FC, Burke M, West RR, et al.\nNo. 42\nInvolving South Asian patients in\nclinical trials. \nBy Hussain-Gambles M, Leese B,\nAtkin K, Brown J, Mason S, Tovey P. \nNo. 43\nClinical and cost-effectiveness of\ncontinuous subcutaneous insulin\ninfusion for diabetes. \nBy Colquitt JL, Green C, Sidhu MK,\nHartwell D, Waugh N. \nNo. 44\nIdentification and assessment of\nongoing trials in health technology\nassessment reviews. \nBy Song FJ, Fry-Smith A, Davenport\nC, Bayliss S, Adi Y, Wilson JS, et al. \nNo. 45\nSystematic review and economic\nevaluation of a long-acting insulin\nanalogue, insulin glargine\nBy Warren E, Weatherley-Jones E,\nChilcott J, Beverley C. \nNo. 46\nSupplementation of a home-based\nexercise programme with a class-based\nprogramme for people with osteoarthritis\nof the knees: a randomised controlled\ntrial and health economic analysis. \nBy McCarthy CJ, Mills PM, \nPullen R, Richardson G, Hawkins N,\nRoberts CR, et al. \nNo. 47\nClinical and cost-effectiveness of once-\ndaily versus more frequent use of same\npotency topical corticosteroids for atopic\neczema: a systematic review and\neconomic evaluation. \nBy Green C, Colquitt JL, Kirby J,\nDavidson P, Payne E. \nNo. 48\nAcupuncture of chronic headache\ndisorders in primary care: randomised\ncontrolled trial and economic analysis. \nBy Vickers AJ, Rees RW, Zollman CE,\nMcCarney R, Smith CM, Ellis N, et al. \nNo. 49\nGeneralisability in economic evaluation\nstudies in healthcare: a review and case\nstudies. \nBy Sculpher MJ, Pang FS, Manca A,\nDrummond MF, Golder S, Urdahl H, \net al. \nNo. 50\nVirtual outreach: a randomised\ncontrolled trial and economic evaluation\nof joint teleconferenced medical\nconsultations. \nBy Wallace P, Barber J, Clayton W,\nCurrell R, Fleming K, Garner P, et al. \nHealth Technology Assessment 2008; Vol. 12: No. 26\n233\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Volume 9, 2005\nNo. 1\nRandomised controlled multiple\ntreatment comparison to provide a \ncost-effectiveness rationale for the\nselection of antimicrobial therapy in\nacne. \nBy Ozolins M, Eady EA, Avery A,\nCunliffe WJ, O\u2019Neill C, Simpson NB, \net al.\nNo. 2\nDo the findings of case series studies\nvary significantly according to\nmethodological characteristics?\nBy Dalziel K, Round A, Stein K,\nGarside R, Castelnuovo E, Payne L.\nNo. 3\nImproving the referral process for\nfamilial breast cancer genetic\ncounselling: findings of three\nrandomised controlled trials of two\ninterventions.\nBy Wilson BJ, Torrance N, Mollison J,\nWordsworth S, Gray JR, Haites NE, et al.\nNo. 4\nRandomised evaluation of alternative\nelectrosurgical modalities to treat\nbladder outflow obstruction in men with\nbenign prostatic hyperplasia. \nBy Fowler C, McAllister W, Plail R,\nKarim O, Yang Q. \nNo. 5\nA pragmatic randomised controlled trial\nof the cost-effectiveness of palliative\ntherapies for patients with inoperable\noesophageal cancer. \nBy Shenfine J, McNamee P, Steen N,\nBond J, Griffin SM. \nNo. 6\nImpact of computer-aided detection\nprompts on the sensitivity and specificity\nof screening mammography. \nBy Taylor P, Champness J, Given-\nWilson R, Johnston K, Potts H. \nNo. 7\nIssues in data monitoring and interim\nanalysis of trials. \nBy Grant AM, Altman DG, Babiker\nAB, Campbell MK, Clemens FJ,\nDarbyshire JH, et al. \nNo. 8\nLay public\u2019s understanding of equipoise\nand randomisation in randomised\ncontrolled trials.\nBy Robinson EJ, Kerr CEP, Stevens\nAJ, Lilford RJ, Braunholtz DA, Edwards\nSJ, et al. \nNo. 9\nClinical and cost-effectiveness of\nelectroconvulsive therapy for depressive\nillness, schizophrenia, catatonia and\nmania: systematic reviews and economic\nmodelling studies. \nBy Greenhalgh J, Knight C, Hind D,\nBeverley C, Walters S. \nNo. 10\nMeasurement of health-related quality\nof life for people with dementia:\ndevelopment of a new instrument\n(DEMQOL) and an evaluation of\ncurrent methodology. \nBy Smith SC, Lamping DL, \nBanerjee S, Harwood R, Foley B, \nSmith P, et al. \nNo. 11\nClinical effectiveness and cost-\neffectiveness of drotrecogin alfa\n(activated) (Xigris\u00ae) for the treatment of\nsevere sepsis in adults: a systematic\nreview and economic evaluation. \nBy Green C, Dinnes J, Takeda A,\nShepherd J, Hartwell D, Cave C, \net al. \nNo. 12\nA methodological review of how\nheterogeneity has been examined in\nsystematic reviews of diagnostic test\naccuracy. \nBy Dinnes J, Deeks J, Kirby J,\nRoderick P. \nNo. 13\nCervical screening programmes: can\nautomation help? Evidence from\nsystematic reviews, an economic analysis\nand a simulation modelling exercise\napplied to the UK.\nBy Willis BH, Barton P, Pearmain P,\nBryan S, Hyde C. \nNo. 14\nLaparoscopic surgery for inguinal\nhernia repair: systematic review of\neffectiveness and economic evaluation. \nBy McCormack K, Wake B, Perez J,\nFraser C, Cook J, McIntosh E, et al. \nNo. 15\nClinical effectiveness, tolerability and\ncost-effectiveness of newer drugs for\nepilepsy in adults: a systematic review\nand economic evaluation. \nBy Wilby J, Kainth A, Hawkins N,\nEpstein D, McIntosh H, McDaid C, et al.\nNo. 16\nA randomised controlled trial to\ncompare the cost-effectiveness of\ntricyclic antidepressants, selective\nserotonin reuptake inhibitors and\nlofepramine. \nBy Peveler R, Kendrick T, Buxton M,\nLongworth L, Baldwin D, Moore M, \net al. \nNo. 17\nClinical effectiveness and cost-\neffectiveness of immediate angioplasty\nfor acute myocardial infarction:\nsystematic review and economic\nevaluation. \nBy Hartwell D, Colquitt J, Loveman\nE, Clegg AJ, Brodin H, Waugh N, \net al. \nNo. 18\nA randomised controlled comparison of\nalternative strategies in stroke care. \nBy Kalra L, Evans A, Perez I, \nKnapp M, Swift C, Donaldson N. \nNo. 19\nThe investigation and analysis of critical\nincidents and adverse events in\nhealthcare. \nBy Woloshynowych M, Rogers S,\nTaylor-Adams S, Vincent C. \nNo. 20\nPotential use of routine databases in\nhealth technology assessment. \nBy Raftery J, Roderick P, Stevens A. \nNo. 21\nClinical and cost-effectiveness of newer\nimmunosuppressive regimens in renal\ntransplantation: a systematic review and\nmodelling study. \nBy Woodroffe R, Yao GL, Meads C,\nBayliss S, Ready A, Raftery J, et al. \nNo. 22\nA systematic review and economic\nevaluation of alendronate, etidronate,\nrisedronate, raloxifene and teriparatide\nfor the prevention and treatment of\npostmenopausal osteoporosis. \nBy Stevenson M, Lloyd Jones M, \nDe Nigris E, Brewer N, Davis S, \nOakley J. \nNo. 23\nA systematic review to examine the\nimpact of psycho-educational\ninterventions on health outcomes and\ncosts in adults and children with difficult\nasthma. \nBy Smith JR, Mugford M, Holland R,\nCandy B, Noble MJ, Harrison BDW, et al. \nNo. 24\nAn evaluation of the costs, effectiveness\nand quality of renal replacement\ntherapy provision in renal satellite units\nin England and Wales. \nBy Roderick P, Nicholson T, Armitage\nA, Mehta R, Mullee M, Gerard K, et al. \nNo. 25\nImatinib for the treatment of patients\nwith unresectable and\/or metastatic\ngastrointestinal stromal tumours:\nsystematic review and economic\nevaluation.\nBy Wilson J, Connock M, Song F, Yao\nG, Fry-Smith A, Raftery J, et al. \nNo. 26\nIndirect comparisons of competing\ninterventions. \nBy Glenny AM, Altman DG, Song F,\nSakarovitch C, Deeks JJ, D\u2019Amico R, et al. \nNo. 27\nCost-effectiveness of alternative\nstrategies for the initial medical\nmanagement of non-ST elevation acute\ncoronary syndrome: systematic review\nand decision-analytical modelling. \nBy Robinson M, Palmer S, Sculpher\nM, Philips Z, Ginnelly L, Bowens A, et al. \nHealth Technology Assessment reports published to date\n234No. 28\nOutcomes of electrically stimulated\ngracilis neosphincter surgery. \nBy Tillin T, Chambers M, Feldman R.\nNo. 29\nThe effectiveness and cost-effectiveness\nof pimecrolimus and tacrolimus for\natopic eczema: a systematic review and\neconomic evaluation. \nBy Garside R, Stein K, Castelnuovo E,\nPitt M, Ashcroft D, Dimmock P, et al. \nNo. 30\nSystematic review on urine albumin\ntesting for early detection of diabetic\ncomplications. \nBy Newman DJ, Mattock MB, Dawnay\nABS, Kerry S, McGuire A, Yaqoob M, et al. \nNo. 31\nRandomised controlled trial of the cost-\neffectiveness of water-based therapy for\nlower limb osteoarthritis. \nBy Cochrane T, Davey RC, \nMatthes Edwards SM. \nNo. 32\nLonger term clinical and economic\nbenefits of offering acupuncture care to\npatients with chronic low back pain. \nBy Thomas KJ, MacPherson H,\nRatcliffe J, Thorpe L, Brazier J,\nCampbell M, et al. \nNo. 33\nCost-effectiveness and safety of epidural\nsteroids in the management of sciatica. \nBy Price C, Arden N, Coglan L,\nRogers P. \nNo. 34\nThe British Rheumatoid Outcome Study\nGroup (BROSG) randomised controlled\ntrial to compare the effectiveness and\ncost-effectiveness of aggressive versus\nsymptomatic therapy in established\nrheumatoid arthritis. \nBy Symmons D, Tricker K, Roberts C,\nDavies L, Dawes P, Scott DL. \nNo. 35\nConceptual framework and systematic\nreview of the effects of participants\u2019 and\nprofessionals\u2019 preferences in randomised\ncontrolled trials. \nBy King M, Nazareth I, Lampe F,\nBower P, Chandler M, Morou M, et al. \nNo. 36\nThe clinical and cost-effectiveness of\nimplantable cardioverter defibrillators: \na systematic review. \nBy Bryant J, Brodin H, Loveman E,\nPayne E, Clegg A. \nNo. 37\nA trial of problem-solving by community\nmental health nurses for anxiety,\ndepression and life difficulties among\ngeneral practice patients. The CPN-GP\nstudy. \nBy Kendrick T, Simons L, \nMynors-Wallis L, Gray A, Lathlean J,\nPickering R, et al. \nNo. 38\nThe causes and effects of socio-\ndemographic exclusions from clinical\ntrials. \nBy Bartlett C, Doyal L, Ebrahim S,\nDavey P, Bachmann M, Egger M, \net al. \nNo. 39\nIs hydrotherapy cost-effective? A\nrandomised controlled trial of combined\nhydrotherapy programmes compared\nwith physiotherapy land techniques in\nchildren with juvenile idiopathic\narthritis. \nBy Epps H, Ginnelly L, Utley M,\nSouthwood T, Gallivan S, Sculpher M, \net al. \nNo. 40\nA randomised controlled trial and cost-\neffectiveness study of systematic\nscreening (targeted and total population\nscreening) versus routine practice for\nthe detection of atrial fibrillation in\npeople aged 65 and over. The SAFE\nstudy. \nBy Hobbs FDR, Fitzmaurice DA,\nMant J, Murray E, Jowett S, Bryan S, \net al.\nNo. 41\nDisplaced intracapsular hip fractures \nin fit, older people: a randomised\ncomparison of reduction and fixation,\nbipolar hemiarthroplasty and total hip\narthroplasty.\nBy Keating JF, Grant A, Masson M,\nScott NW, Forbes JF. \nNo. 42\nLong-term outcome of cognitive\nbehaviour therapy clinical trials in\ncentral Scotland. \nBy Durham RC, Chambers JA, \nPower KG, Sharp DM, Macdonald RR,\nMajor KA, et al. \nNo. 43\nThe effectiveness and cost-effectiveness\nof dual-chamber pacemakers compared\nwith single-chamber pacemakers for\nbradycardia due to atrioventricular\nblock or sick sinus syndrome: \nsystematic review and economic\nevaluation. \nBy Castelnuovo E, Stein K, Pitt M,\nGarside R, Payne E. \nNo. 44\nNewborn screening for congenital heart\ndefects: a systematic review and \ncost-effectiveness analysis. \nBy Knowles R, Griebsch I, Dezateux\nC, Brown J, Bull C, Wren C. \nNo. 45\nThe clinical and cost-effectiveness of left\nventricular assist devices for end-stage\nheart failure: a systematic review and\neconomic evaluation.\nBy Clegg AJ, Scott DA, Loveman E,\nColquitt J, Hutchinson J, Royle P, \net al. \nNo. 46\nThe effectiveness of the Heidelberg\nRetina Tomograph and laser diagnostic\nglaucoma scanning system (GDx) in\ndetecting and monitoring glaucoma.\nBy Kwartz AJ, Henson DB, \nHarper RA, Spencer AF, \nMcLeod D. \nNo. 47\nClinical and cost-effectiveness of\nautologous chondrocyte implantation\nfor cartilage defects in knee joints:\nsystematic review and economic\nevaluation. \nBy Clar C, Cummins E, McIntyre L,\nThomas S, Lamb J, Bain L, et al. \nNo. 48\nSystematic review of effectiveness of\ndifferent treatments for childhood\nretinoblastoma. \nBy McDaid C, Hartley S, \nBagnall A-M, Ritchie G, Light K,\nRiemsma R. \nNo. 49\nTowards evidence-based guidelines \nfor the prevention of venous\nthromboembolism: systematic \nreviews of mechanical methods, oral\nanticoagulation, dextran and regional\nanaesthesia as thromboprophylaxis. \nBy Roderick P, Ferris G, Wilson K,\nHalls H, Jackson D, Collins R,\net al. \nNo. 50\nThe effectiveness and cost-effectiveness\nof parent training\/education\nprogrammes for the treatment of\nconduct disorder, including oppositional\ndefiant disorder, in children. \nBy Dretzke J, Frew E, Davenport C,\nBarlow J, Stewart-Brown S, \nSandercock J, et al. \nVolume 10, 2006\nNo. 1\nThe clinical and cost-effectiveness of\ndonepezil, rivastigmine, galantamine\nand memantine for Alzheimer\u2019s \ndisease.\nBy Loveman E, Green C, Kirby J,\nTakeda A, Picot J, Payne E, \net al. \nNo. 2\nFOOD: a multicentre randomised trial\nevaluating feeding policies in patients\nadmitted to hospital with a recent\nstroke. \nBy Dennis M, Lewis S, Cranswick G,\nForbes J. \nNo. 3\nThe clinical effectiveness and cost-\neffectiveness of computed tomography\nscreening for lung cancer: systematic\nreviews.\nBy Black C, Bagust A, Boland A,\nWalker S, McLeod C, De Verteuil R, \net al. \nHealth Technology Assessment 2008; Vol. 12: No. 26\n235\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.No. 4\nA systematic review of the effectiveness\nand cost-effectiveness of neuroimaging\nassessments used to visualise the \nseizure focus in people with refractory\nepilepsy being considered for \nsurgery. \nBy Whiting P, Gupta R, Burch J,\nMujica Mota RE, Wright K, Marson A, \net al. \nNo. 5\nComparison of conference abstracts \nand presentations with full-text \narticles in the health technology\nassessments of rapidly evolving\ntechnologies. \nBy Dundar Y, Dodd S, Dickson R,\nWalley T, Haycox A, Williamson PR. \nNo. 6\nSystematic review and evaluation of\nmethods of assessing urinary\nincontinence. \nBy Martin JL, Williams KS, Abrams\nKR, Turner DA, Sutton AJ, Chapple C,\net al.\nNo. 7\nThe clinical effectiveness and cost-\neffectiveness of newer drugs for children\nwith epilepsy. A systematic review. \nBy Connock M, Frew E, Evans B-W, \nBryan S, Cummins C, Fry-Smith A, \net al.\nNo. 8\nSurveillance of Barrett\u2019s oesophagus:\nexploring the uncertainty through\nsystematic review, expert workshop and\neconomic modelling. \nBy Garside R, Pitt M, Somerville M,\nStein K, Price A, Gilbert N. \nNo. 9\nTopotecan, pegylated liposomal\ndoxorubicin hydrochloride and\npaclitaxel for second-line or subsequent\ntreatment of advanced ovarian cancer: a\nsystematic review and economic\nevaluation. \nBy Main C, Bojke L, Griffin S,\nNorman G, Barbieri M, Mather L, \net al. \nNo. 10\nEvaluation of molecular techniques \nin prediction and diagnosis of\ncytomegalovirus disease in\nimmunocompromised patients. \nBy Szczepura A, Westmoreland D,\nVinogradova Y, Fox J, Clark M. \nNo. 11\nScreening for thrombophilia in high-risk\nsituations: systematic review and cost-\neffectiveness analysis. The Thrombosis:\nRisk and Economic Assessment of\nThrombophilia Screening (TREATS)\nstudy. \nBy Wu O, Robertson L, Twaddle S,\nLowe GDO, Clark P, Greaves M, \net al. \nNo. 12\nA series of systematic reviews to inform\na decision analysis for sampling and\ntreating infected diabetic foot \nulcers. \nBy Nelson EA, O\u2019Meara S, Craig D,\nIglesias C, Golder S, Dalton J, \net al. \nNo. 13\nRandomised clinical trial, observational\nstudy and assessment of cost-\neffectiveness of the treatment of varicose\nveins (REACTIV trial). \nBy Michaels JA, Campbell WB,\nBrazier JE, MacIntyre JB, Palfreyman\nSJ, Ratcliffe J, et al. \nNo. 14\nThe cost-effectiveness of screening for\noral cancer in primary care. \nBy Speight PM, Palmer S, Moles DR,\nDowner MC, Smith DH, Henriksson M\net al. \nNo. 15\nMeasurement of the clinical and cost-\neffectiveness of non-invasive diagnostic\ntesting strategies for deep vein\nthrombosis. \nBy Goodacre S, Sampson F, Stevenson\nM, Wailoo A, Sutton A, Thomas S, et al. \nNo. 16\nSystematic review of the effectiveness\nand cost-effectiveness of HealOzone\u00ae\nfor the treatment of occlusal pit\/fissure\ncaries and root caries. \nBy Brazzelli M, McKenzie L, Fielding\nS, Fraser C, Clarkson J, Kilonzo M, \net al. \nNo. 17\nRandomised controlled trials of\nconventional antipsychotic versus new\natypical drugs, and new atypical drugs\nversus clozapine, in people with\nschizophrenia responding poorly \nto, or intolerant of, current drug\ntreatment. \nBy Lewis SW, Davies L, Jones PB,\nBarnes TRE, Murray RM, Kerwin R, \net al. \nNo. 18\nDiagnostic tests and algorithms used in\nthe investigation of haematuria:\nsystematic reviews and economic\nevaluation.\nBy Rodgers M, Nixon J, Hempel S,\nAho T, Kelly J, Neal D, et al. \nNo. 19\nCognitive behavioural therapy in\naddition to antispasmodic therapy for\nirritable bowel syndrome in primary\ncare: randomised controlled \ntrial.\nBy Kennedy TM, Chalder T, \nMcCrone P, Darnley S, Knapp M, \nJones RH, et al. \nNo. 20\nA systematic review of the clinical\neffectiveness and cost-effectiveness of\nenzyme replacement therapies for\nFabry\u2019s disease and\nmucopolysaccharidosis type 1. \nBy Connock M, Juarez-Garcia A, Frew\nE, Mans A, Dretzke J, Fry-Smith A, et al. \nNo. 21\nHealth benefits of antiviral therapy for\nmild chronic hepatitis C: randomised\ncontrolled trial and economic\nevaluation. \nBy Wright M, Grieve R, Roberts J,\nMain J, Thomas HC on behalf of the\nUK Mild Hepatitis C Trial Investigators. \nNo. 22\nPressure relieving support surfaces: a\nrandomised evaluation.\nBy Nixon J, Nelson EA, Cranny G,\nIglesias CP, Hawkins K, Cullum NA, et al. \nNo. 23\nA systematic review and economic\nmodel of the effectiveness and cost-\neffectiveness of methylphenidate,\ndexamfetamine and atomoxetine for the\ntreatment of attention deficit\nhyperactivity disorder in children and\nadolescents. \nBy King S, Griffin S, Hodges Z,\nWeatherly H, Asseburg C, Richardson G,\net al.\nNo. 24\nThe clinical effectiveness and cost-\neffectiveness of enzyme replacement\ntherapy for Gaucher\u2019s disease: \na systematic review. \nBy Connock M, Burls A, Frew E, \nFry-Smith A, Juarez-Garcia A, \nMcCabe C, et al. \nNo. 25\nEffectiveness and cost-effectiveness of\nsalicylic acid and cryotherapy for\ncutaneous warts. An economic decision\nmodel. \nBy Thomas KS, Keogh-Brown MR,\nChalmers JR, Fordham RJ, Holland RC,\nArmstrong SJ, et al. \nNo. 26\nA systematic literature review of the\neffectiveness of non-pharmacological\ninterventions to prevent wandering in\ndementia and evaluation of the ethical\nimplications and acceptability of their\nuse. \nBy Robinson L, Hutchings D, Corner\nL, Beyer F, Dickinson H, Vanoli A, et al. \nNo. 27\nA review of the evidence on the effects\nand costs of implantable cardioverter\ndefibrillator therapy in different patient\ngroups, and modelling of cost-\neffectiveness and cost\u2013utility for these\ngroups in a UK context. \nBy Buxton M, Caine N, Chase D,\nConnelly D, Grace A, Jackson C, et al. \nHealth Technology Assessment reports published to date\n236No. 28\nAdefovir dipivoxil and pegylated\ninterferon alfa-2a for the treatment of\nchronic hepatitis B: a systematic review\nand economic evaluation. \nBy Shepherd J, Jones J, Takeda A,\nDavidson P, Price A. \nNo. 29\nAn evaluation of the clinical and cost-\neffectiveness of pulmonary artery\ncatheters in patient management in\nintensive care: a systematic review and a\nrandomised controlled trial. \nBy Harvey S, Stevens K, Harrison D,\nYoung D, Brampton W, McCabe C, et al. \nNo. 30\nAccurate, practical and cost-effective\nassessment of carotid stenosis in the UK.\nBy Wardlaw JM, Chappell FM,\nStevenson M, De Nigris E, Thomas S,\nGillard J, et al. \nNo. 31\nEtanercept and infliximab for the\ntreatment of psoriatic arthritis: \na systematic review and economic\nevaluation. \nBy Woolacott N, Bravo Vergel Y,\nHawkins N, Kainth A, Khadjesari Z,\nMisso K, et al. \nNo. 32\nThe cost-effectiveness of testing for\nhepatitis C in former injecting drug\nusers. \nBy Castelnuovo E, Thompson-Coon J,\nPitt M, Cramp M, Siebert U, Price A, \net al. \nNo. 33\nComputerised cognitive behaviour\ntherapy for depression and anxiety\nupdate: a systematic review and\neconomic evaluation. \nBy Kaltenthaler E, Brazier J, \nDe Nigris E, Tumur I, Ferriter M,\nBeverley C, et al. \nNo. 34\nCost-effectiveness of using prognostic\ninformation to select women with breast \ncancer for adjuvant systemic therapy. \nBy Williams C, Brunskill S, Altman D,\nBriggs A, Campbell H, Clarke M, \net al. \nNo. 35\nPsychological therapies including\ndialectical behaviour therapy for\nborderline personality disorder: \na systematic review and preliminary\neconomic evaluation. \nBy Brazier J, Tumur I, Holmes M,\nFerriter M, Parry G, Dent-Brown K, et al.\nNo. 36\nClinical effectiveness and cost-\neffectiveness of tests for the diagnosis\nand investigation of urinary tract\ninfection in children: a systematic review\nand economic model. \nBy Whiting P, Westwood M, Bojke L,\nPalmer S, Richardson G, Cooper J, et al.\nNo. 37\nCognitive behavioural therapy in\nchronic fatigue syndrome: a randomised\ncontrolled trial of an outpatient group\nprogramme. \nBy O\u2019Dowd H, Gladwell P, Rogers CA,\nHollinghurst S, Gregory A. \nNo. 38\nA comparison of the cost-effectiveness of\nfive strategies for the prevention of non-\nsteroidal anti-inflammatory drug-induced\ngastrointestinal toxicity: a systematic\nreview with economic modelling. \nBy Brown TJ, Hooper L, Elliott RA,\nPayne K, Webb R, Roberts C, et al. \nNo. 39\nThe effectiveness and cost-effectiveness\nof computed tomography screening for\ncoronary artery disease: systematic\nreview. \nBy Waugh N, Black C, Walker S,\nMcIntyre L, Cummins E, Hillis G. \nNo. 40\nWhat are the clinical outcome and cost-\neffectiveness of endoscopy undertaken\nby nurses when compared with doctors?\nA Multi-Institution Nurse Endoscopy\nTrial (MINuET). \nBy Williams J, Russell I, Durai D,\nCheung W-Y, Farrin A, Bloor K, et al. \nNo. 41\nThe clinical and cost-effectiveness of\noxaliplatin and capecitabine for the\nadjuvant treatment of colon cancer:\nsystematic review and economic\nevaluation. \nBy Pandor A, Eggington S, Paisley S,\nTappenden P, Sutcliffe P. \nNo. 42\nA systematic review of the effectiveness\nof adalimumab, etanercept and\ninfliximab for the treatment of\nrheumatoid arthritis in adults and an\neconomic evaluation of their cost-\neffectiveness. \nBy Chen Y-F, Jobanputra P, Barton P,\nJowett S, Bryan S, Clark W, et al. \nNo. 43\nTelemedicine in dermatology: \na randomised controlled trial. \nBy Bowns IR, Collins K, Walters SJ,\nMcDonagh AJG. \nNo. 44\nCost-effectiveness of cell salvage and\nalternative methods of minimising\nperioperative allogeneic blood\ntransfusion: a systematic review and\neconomic model. \nBy Davies L, Brown TJ, Haynes S,\nPayne K, Elliott RA, McCollum C. \nNo. 45\nClinical effectiveness and cost-\neffectiveness of laparoscopic surgery for\ncolorectal cancer: systematic reviews and\neconomic evaluation. \nBy Murray A, Lourenco T, \nde Verteuil R, Hernandez R, Fraser C,\nMcKinley A, et al. \nNo. 46\nEtanercept and efalizumab for the\ntreatment of psoriasis: a systematic\nreview. \nBy Woolacott N, Hawkins N, \nMason A, Kainth A, Khadjesari Z, \nBravo Vergel Y, et al. \nNo. 47\nSystematic reviews of clinical decision\ntools for acute abdominal pain.\nBy Liu JLY, Wyatt JC, Deeks JJ,\nClamp S, Keen J, Verde P, et al. \nNo. 48\nEvaluation of the ventricular assist\ndevice programme in the UK.\nBy Sharples L, Buxton M, Caine N,\nCafferty F, Demiris N, Dyer M, \net al. \nNo. 49\nA systematic review and economic\nmodel of the clinical and cost-\neffectiveness of immunosuppressive\ntherapy for renal transplantation in\nchildren. \nBy Yao G, Albon E, Adi Y, Milford D,\nBayliss S, Ready A, et al. \nNo. 50\nAmniocentesis results: investigation of\nanxiety. The ARIA trial. \nBy Hewison J, Nixon J, Fountain J,\nCocks K, Jones C, Mason G, et al. \nVolume 11, 2007\nNo. 1\nPemetrexed disodium for the treatment\nof malignant pleural mesothelioma: \na systematic review and economic\nevaluation. \nBy Dundar Y, Bagust A, Dickson R,\nDodd S, Green J, Haycox A, et al. \nNo. 2\nA systematic review and economic\nmodel of the clinical effectiveness and\ncost-effectiveness of docetaxel in\ncombination with prednisone or\nprednisolone for the treatment of\nhormone-refractory metastatic prostate\ncancer. \nBy Collins R, Fenwick E, Trowman R,\nPerard R, Norman G, Light K, \net al. \nNo. 3\nA systematic review of rapid diagnostic\ntests for the detection of tuberculosis\ninfection. \nBy Dinnes J, Deeks J, Kunst H,\nGibson A, Cummins E, Waugh N, et al. \nNo. 4\nThe clinical effectiveness and cost-\neffectiveness of strontium ranelate for\nthe prevention of osteoporotic \nfragility fractures in postmenopausal\nwomen. \nBy Stevenson M, Davis S, \nLloyd-Jones M, Beverley C. \nHealth Technology Assessment 2008; Vol. 12: No. 26\n237\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.No. 5\nA systematic review of quantitative and\nqualitative research on the role and\neffectiveness of written information\navailable to patients about individual\nmedicines.\nBy Raynor DK, Blenkinsopp A,\nKnapp P, Grime J, Nicolson DJ, \nPollock K, et al.\nNo. 6\nOral naltrexone as a treatment for\nrelapse prevention in formerly \nopioid-dependent drug users: \na systematic review and economic\nevaluation. \nBy Adi Y, Juarez-Garcia A, Wang D,\nJowett S, Frew E, Day E, et al. \nNo. 7\nGlucocorticoid-induced osteoporosis: \na systematic review and cost\u2013utility \nanalysis. \nBy Kanis JA, Stevenson M, \nMcCloskey EV, Davis S, Lloyd-Jones M. \nNo. 8\nEpidemiological, social, diagnostic and\neconomic evaluation of population\nscreening for genital chlamydial \ninfection. \nBy Low N, McCarthy A, Macleod J,\nSalisbury C, Campbell R, Roberts TE, \net al. \nNo. 9\nMethadone and buprenorphine for the\nmanagement of opioid dependence: \na systematic review and economic\nevaluation. \nBy Connock M, Juarez-Garcia A,\nJowett S, Frew E, Liu Z, Taylor RJ, \net al. \nNo. 10\nExercise Evaluation Randomised Trial\n(EXERT): a randomised trial comparing\nGP referral for leisure centre-based\nexercise, community-based walking and\nadvice only.\nBy Isaacs AJ, Critchley JA, \nSee Tai S, Buckingham K, Westley D,\nHarridge SDR, et al.\nNo. 11\nInterferon alfa (pegylated and \nnon-pegylated) and ribavirin for the\ntreatment of mild chronic hepatitis C: \na systematic review and economic\nevaluation. \nBy Shepherd J, Jones J, Hartwell D,\nDavidson P, Price A, Waugh N. \nNo. 12\nSystematic review and economic\nevaluation of bevacizumab and\ncetuximab for the treatment of\nmetastatic colorectal cancer. \nBy Tappenden P, Jones R, Paisley S,\nCarroll C. \nNo. 13\nA systematic review and economic\nevaluation of epoetin alfa, epoetin beta\nand darbepoetin alfa in anaemia\nassociated with cancer, especially that\nattributable to cancer treatment. \nBy Wilson J, Yao GL, Raftery J,\nBohlius J, Brunskill S, Sandercock J, \net al. \nNo. 14\nA systematic review and economic\nevaluation of statins for the prevention\nof coronary events. \nBy Ward S, Lloyd Jones M, Pandor A,\nHolmes M, Ara R, Ryan A, et al. \nNo. 15\nA systematic review of the effectiveness\nand cost-effectiveness of different\nmodels of community-based respite \ncare for frail older people and their\ncarers.\nBy Mason A, Weatherly H, Spilsbury\nK, Arksey H, Golder S, Adamson J, \net al. \nNo. 16\nAdditional therapy for young children\nwith spastic cerebral palsy: \na randomised controlled trial. \nBy Weindling AM, Cunningham CC,\nGlenn SM, Edwards RT, Reeves DJ. \nNo. 17\nScreening for type 2 diabetes: literature\nreview and economic modelling. \nBy Waugh N, Scotland G, \nMcNamee P, Gillett M, Brennan A,\nGoyder E, et al.\nNo. 18\nThe effectiveness and cost-effectiveness\nof cinacalcet for secondary\nhyperparathyroidism in end-stage \nrenal disease patients on dialysis: a\nsystematic review and economic\nevaluation.\nBy Garside R, Pitt M, Anderson R,\nMealing S, Roome C, Snaith A, \net al. \nNo. 19\nThe clinical effectiveness and \ncost-effectiveness of gemcitabine for\nmetastatic breast cancer: a systematic\nreview and economic evaluation. \nBy Takeda AL, Jones J, Loveman E,\nTan SC, Clegg AJ. \nNo. 20\nA systematic review of duplex\nultrasound, magnetic resonance\nangiography and computed tomography\nangiography for the diagnosis \nand assessment of symptomatic, lower\nlimb peripheral arterial disease. \nBy Collins R, Cranny G, Burch J,\nAguiar-Ib\u00e1\u00f1ez R, Craig D, Wright K, et al. \nNo. 21\nThe clinical effectiveness and cost-\neffectiveness of treatments for children\nwith idiopathic steroid-resistant\nnephrotic syndrome: a systematic review. \nBy Colquitt JL, Kirby J, Green C,\nCooper K, Trompeter RS. \nNo. 22\nA systematic review of the routine\nmonitoring of growth in children of\nprimary school age to identify \ngrowth-related conditions. \nBy Fayter D, Nixon J, Hartley S,\nRithalia A, Butler G, Rudolf M, et al. \nNo. 23\nSystematic review of the effectiveness of\npreventing and treating Staphylococcus\naureus carriage in reducing peritoneal\ncatheter-related infections. \nBy McCormack K, Rabindranath K,\nKilonzo M, Vale L, Fraser C, McIntyre L,\net al. \nNo. 24\nThe clinical effectiveness and cost of\nrepetitive transcranial magnetic\nstimulation versus electroconvulsive\ntherapy in severe depression: \na multicentre pragmatic randomised\ncontrolled trial and economic \nanalysis. \nBy McLoughlin DM, Mogg A, \nEranti S, Pluck G, Purvis R, Edwards D,\net al. \nNo. 25\nA randomised controlled trial and\neconomic evaluation of direct versus\nindirect and individual versus group\nmodes of speech and language therapy\nfor children with primary language\nimpairment. \nBy Boyle J, McCartney E, Forbes J,\nO\u2019Hare A. \nNo. 26\nHormonal therapies for early breast\ncancer: systematic review and economic\nevaluation. \nBy Hind D, Ward S, De Nigris E,\nSimpson E, Carroll C, Wyld L. \nNo. 27\nCardioprotection against the toxic \neffects of anthracyclines given to\nchildren with cancer: a systematic \nreview. \nBy Bryant J, Picot J, Levitt G, \nSullivan I, Baxter L, Clegg A. \nNo. 28\nAdalimumab, etanercept and infliximab\nfor the treatment of ankylosing\nspondylitis: a systematic review and\neconomic evaluation. \nBy McLeod C, Bagust A, Boland A,\nDagenais P, Dickson R, Dundar Y, et al. \nHealth Technology Assessment reports published to date\n238No. 29\nPrenatal screening and treatment\nstrategies to prevent group B\nstreptococcal and other bacterial\ninfections in early infancy: cost-\neffectiveness and expected value of\ninformation analyses.\nBy Colbourn T, Asseburg C, Bojke L,\nPhilips Z, Claxton K, Ades AE, et al.\nNo. 30\nClinical effectiveness and cost-\neffectiveness of bone morphogenetic\nproteins in the non-healing of fractures\nand spinal fusion: a systematic \nreview. \nBy Garrison KR, Donell S, Ryder J,\nShemilt I, Mugford M, Harvey I, \net al. \nNo. 31\nA randomised controlled trial of\npostoperative radiotherapy following\nbreast-conserving surgery in a\nminimum-risk older population. The\nPRIME trial. \nBy Prescott RJ, Kunkler IH, Williams\nLJ, King CC, Jack W, van der Pol M, \net al. \nNo. 32\nCurrent practice, accuracy, effectiveness\nand cost-effectiveness of the school\nentry hearing screen. \nBy Bamford J, Fortnum H, Bristow K,\nSmith J, Vamvakas G, Davies L, et al. \nNo. 33\nThe clinical effectiveness and \ncost-effectiveness of inhaled insulin \nin diabetes mellitus: a systematic \nreview and economic evaluation. \nBy Black C, Cummins E, Royle P,\nPhilip S, Waugh N. \nNo. 34\nSurveillance of cirrhosis for\nhepatocellular carcinoma: systematic\nreview and economic analysis. \nBy Thompson Coon J, Rogers G,\nHewson P, Wright D, Anderson R,\nCramp M, et al. \nNo. 35\nThe Birmingham Rehabilitation Uptake\nMaximisation Study (BRUM). Home-\nbased compared with hospital-based\ncardiac rehabilitation in a multi-ethnic\npopulation: cost-effectiveness and\npatient adherence. \nBy Jolly K, Taylor R, Lip GYH,\nGreenfield S, Raftery J, Mant J, et al. \nNo. 36\nA systematic review of the clinical,\npublic health and cost-effectiveness \nof rapid diagnostic tests for the\ndetection and identification of \nbacterial intestinal pathogens in \nfaeces and food. \nBy Abubakar I, Irvine L, Aldus CF, \nWyatt GM, Fordham R, Schelenz S, et al.\nNo. 37\nA randomised controlled trial\nexamining the longer-term outcomes of\nstandard versus new antiepileptic drugs. \nThe SANAD trial.\nBy Marson AG, Appleton R, Baker GA,\nChadwick DW, Doughty J, Eaton B, et al. \nNo. 38\nClinical effectiveness and cost-\neffectiveness of different models \nof managing long-term oral\nanticoagulation therapy: a systematic\nreview and economic modelling. \nBy Connock M, Stevens C, Fry-Smith A,\nJowett S, Fitzmaurice D, Moore D, et al. \nNo. 39\nA systematic review and economic\nmodel of the clinical effectiveness and\ncost-effectiveness of interventions for\npreventing relapse in people with\nbipolar disorder. \nBy Soares-Weiser K, Bravo Vergel Y,\nBeynon S, Dunn G, Barbieri M, Duffy S,\net al. \nNo. 40\nTaxanes for the adjuvant treatment of\nearly breast cancer: systematic review\nand economic evaluation. \nBy Ward S, Simpson E, Davis S, \nHind D, Rees A, Wilkinson A. \nNo. 41\nThe clinical effectiveness and cost-\neffectiveness of screening for open angle\nglaucoma: a systematic review and\neconomic evaluation. \nBy Burr JM, Mowatt G, Hern\u00e1ndez R,\nSiddiqui MAR, Cook J, Lourenco T, \net al. \nNo. 42\nAcceptability, benefit and costs of early\nscreening for hearing disability: a study\nof potential screening tests and \nmodels.\nBy Davis A, Smith P, Ferguson M,\nStephens D, Gianopoulos I. \nNo. 43\nContamination in trials of educational\ninterventions. \nBy Keogh-Brown MR, Bachmann\nMO, Shepstone L, Hewitt C, Howe A,\nRamsay CR, et al. \nNo. 44\nOverview of the clinical effectiveness of\npositron emission tomography imaging\nin selected cancers. \nBy Facey K, Bradbury I, Laking G,\nPayne E. \nNo. 45\nThe effectiveness and cost-effectiveness of\ncarmustine implants and temozolomide\nfor the treatment of newly diagnosed\nhigh-grade glioma: a systematic review\nand economic evaluation. \nBy Garside R, Pitt M, Anderson R,\nRogers G, Dyer M, Mealing S, et al. \nNo. 46\nDrug-eluting stents: a systematic review\nand economic evaluation. \nBy Hill RA, Boland A, Dickson R, \nD\u00fcndar Y, Haycox A, McLeod C, \net al. \nNo. 47\nThe clinical effectiveness and cost-\neffectiveness of cardiac resynchronisation\n(biventricular pacing) for heart failure:\nsystematic review and economic model. \nBy Fox M, Mealing S, Anderson R,\nDean J, Stein K, Price A, et al. \nNo. 48\nRecruitment to randomised trials:\nstrategies for trial enrolment and\nparticipation study. The STEPS study. \nBy Campbell MK, Snowdon C,\nFrancis D, Elbourne D, McDonald AM,\nKnight R, et al. \nNo. 49\nCost-effectiveness of functional \ncardiac testing in the diagnosis and\nmanagement of coronary artery disease: \na randomised controlled trial. \nThe CECaT trial. \nBy Sharples L, Hughes V, Crean A,\nDyer M, Buxton M, Goldsmith K, et al. \nNo. 50\nEvaluation of diagnostic tests when\nthere is no gold standard. A review of\nmethods.\nBy Rutjes AWS, Reitsma JB,\nCoomarasamy A, Khan KS, \nBossuyt PMM. \nNo. 51\nSystematic reviews of the clinical\neffectiveness and cost-effectiveness of\nproton pump inhibitors in acute upper\ngastrointestinal bleeding. \nBy Leontiadis GI, Sreedharan A,\nDorward S, Barton P, Delaney B,\nHowden CW, et al. \nNo. 52\nA review and critique of modelling in\nprioritising and designing screening\nprogrammes.\nBy Karnon J, Goyder E, Tappenden P,\nMcPhie S, Towers I, Brazier J, et al. \nNo. 53\nAn assessment of the impact of the \nNHS Health Technology Assessment\nProgramme. \nBy Hanney S, Buxton M, Green C,\nCoulson D, Raftery J. \nVolume 12, 2008\nNo. 1\nA systematic review and economic\nmodel of switching from non-\nglycopeptide to glycopeptide antibiotic\nprophylaxis for surgery.\nBy Cranny G, Elliott R, Weatherly H,\nChambers D, Hawkins N, Myers L, et al. \nHealth Technology Assessment 2008; Vol. 12: No. 26\n239\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.No. 2\n\u2018Cut down to quit\u2019 with nicotine\nreplacement therapies in smoking\ncessation: a systematic review of\neffectiveness and economic analysis. \nBy Wang D, Connock M, Barton P,\nFry-Smith A, Aveyard P, Moore D. \nNo. 3\nA systematic review of the effectiveness\nof strategies for reducing fracture risk in\nchildren with juvenile idiopathic\narthritis with additional data on long-\nterm risk of fracture and cost of disease\nmanagement. \nBy Thornton J, Ashcroft D, O\u2019Neill T,\nElliott R, Adams J, Roberts C, et al. \nNo. 4\nDoes befriending by trained lay workers\nimprove psychological well-being and\nquality of life for carers of people \nwith dementia, and at what cost? \nA randomised controlled trial. \nBy Charlesworth G, Shepstone L,\nWilson E, Thalanany M, Mugford M,\nPoland F. \nNo. 5\nA multi-centre retrospective cohort study\ncomparing the efficacy, safety and cost-\neffectiveness of hysterectomy and\nuterine artery embolisation for the\ntreatment of symptomatic uterine\nfibroids. The HOPEFUL study. \nBy Hirst A, Dutton S, Wu O, Briggs A,\nEdwards C, Waldenmaier L, et al. \nNo. 6\nMethods of prediction and prevention\nof pre-eclampsia: systematic reviews of\naccuracy and effectiveness literature with\neconomic modelling. \nBy Meads CA, Cnossen JS, Meher S,\nJuarez-Garcia A, ter Riet G, Duley L, \net al.\nNo. 7\nThe use of economic evaluations in\nNHS decision-making: a review and\nempirical investigation. \nBy Williams I, McIver S, Moore D,\nBryan S. \nNo. 8\nStapled haemorrhoidectomy\n(haemorrhoidopexy) for the treatment\nof haemorrhoids: a systematic review\nand economic evaluation.\nBy Burch J, Epstein D, Baba-Akbari A,\nWeatherly H, Fox D, Golder S, et al. \nNo. 9\nThe clinical effectiveness of diabetes\neducation models for Type 2 diabetes: \na systematic review. \nBy Loveman E, Frampton GK, \nClegg AJ.\nNo. 10\nPayment to healthcare professionals for\npatient recruitment to trials: systematic\nreview and qualitative study. \nBy Raftery J, Bryant J, Powell J, \nKerr C, Hawker S. \nNo. 11\nCyclooxygenase-2 selective non-steroidal\nanti-inflammatory drugs (etodolac,\nmeloxicam, celecoxib, rofecoxib,\netoricoxib, valdecoxib and lumiracoxib)\nfor osteoarthritis and rheumatoid\narthritis: a systematic review and\neconomic evaluation. \nBy Chen Y-F, Jobanputra P, Barton P,\nBryan S, Fry-Smith A, Harris G, et al. \nNo. 12\nThe clinical effectiveness and cost-\neffectiveness of central venous catheters\ntreated with anti-infective agents in\npreventing bloodstream infections: \na systematic review and economic\nevaluation.\nBy Hockenhull JC, Dwan K, Boland\nA, Smith G, Bagust A, D\u00fcndar Y, et al. \nNo. 13\nStepped treatment of older adults on\nlaxatives. The STOOL trial. \nBy Mihaylov S, Stark C, McColl E,\nSteen N, Vanoli A, Rubin G, et al. \nNo. 14\nA randomised controlled trial of\ncognitive behaviour therapy in\nadolescents with major depression\ntreated by selective serotonin reuptake\ninhibitors. The ADAPT trial. \nBy Goodyer IM, Dubicka B, \nWilkinson P, Kelvin R, Roberts C, \nByford S, et al. \nNo. 15\nThe use of irinotecan, oxaliplatin and\nraltitrexed for the treatment of\nadvanced colorectal cancer: systematic\nreview and economic evaluation.\nBy Hind D, Tappenden P, Tumur I,\nEggington E, Sutcliffe P, Ryan A. \nNo. 16\nRanibizumab and pegaptanib for the\ntreatment of age-related macular\ndegeneration: a systematic review and\neconomic evaluation. \nBy Colquitt JL, Jones J, Tan SC,\nTakeda A, Clegg AJ, Price A. \nNo. 17\nSystematic review of the clinical\neffectiveness and cost-effectiveness of\n64-slice or higher computed\ntomography angiography as an\nalternative to invasive coronary\nangiography in the investigation of\ncoronary artery disease. \nBy Mowatt G, Cummins E, Waugh N,\nWalker S, Cook J, Jia X, et al. \nNo. 18\nStructural neuroimaging in psychosis: \na systematic review and economic\nevaluation. \nBy Albon E, Tsourapas A, Frew E,\nDavenport C, Oyebode F, Bayliss S, \net al.\nNo. 19\nSystematic review and economic analysis\nof the comparative effectiveness of\ndifferent inhaled corticosteroids and\ntheir usage with long-acting beta2\nagonists for the treatment of chronic\nasthma in adults and children aged \n12 years and over. \nBy Shepherd J, Rogers G, Anderson R,\nMain C, Thompson-Coon J, Hartwell D,\net al. \nNo. 20\nSystematic review and economic analysis\nof the comparative effectiveness of\ndifferent inhaled corticosteroids and\ntheir usage with long-acting beta2\nagonists for the treatment of chronic\nasthma in children under the age \nof 12 years. \nBy Main C, Shepherd J, Anderson R,\nRogers G, Thompson-Coon J, Liu Z, et al.\nNo. 21\nEzetimibe for the treatment of\nhypercholesterolaemia: a systematic\nreview and economic evaluation.\nBy Ara R, Tumur I, Pandor A, \nDuenas A, Williams R, Wilkinson A, et al. \nNo. 22\nTopical or oral ibuprofen for chronic\nknee pain in older people. The TOIB\nstudy. \nBy Underwood M, Ashby D, Carnes D,\nCastelnuovo E, Cross P, Harding G, et al.\nNo. 23\nA prospective randomised comparison\nof minor surgery in primary and\nsecondary care. The MiSTIC trial. \nBy George S, Pockney P, Primrose J,\nSmith H, Little P, Kinley H, et al.\nNo. 24\nA review and critical appraisal of\nmeasures of therapist\u2013patient\ninteractions in mental health settings. \nBy Cahill J, Barkham M, Hardy G,\nGilbody S, Richards D, Bower P, et al.\nNo. 25\nThe clinical effectiveness and cost-\neffectiveness of screening programmes\nfor amblyopia and strabismus in\nchildren up to the age of 4\u20135 years: \na systematic review and economic\nevaluation. \nBy Carlton J, Karnon J, \nCzoski-Murray C, Smith KJ, Marr J. \nNo. 26\nA systematic review of the clinical\neffectiveness and cost-effectiveness and\neconomic modelling of minimal incision\ntotal hip replacement approaches in the\nmanagement of arthritic disease of the\nhip. \nBy de Verteuil R, Imamura M, Zhu S,\nGlazener C, Fraser C, Munro N, et al. \nHealth Technology Assessment reports published to date\n240Health Technology Assessment 2008; Vol. 12: No. 26\n241\nHealth Technology Assessment\nProgramme\nPrioritisation Strategy Group\nMembers\nChair,\nProfessor Tom Walley, \nDirector, NHS HTA Programme,\nDepartment of Pharmacology &\nTherapeutics,\nUniversity of Liverpool\nProfessor Bruce Campbell,\nConsultant Vascular & General\nSurgeon, Royal Devon & Exeter\nHospital\nProfessor Robin E Ferner,\nConsultant Physician and\nDirector, West Midlands Centre\nfor Adverse Drug Reactions,\nCity Hospital NHS Trust,\nBirmingham\nDr Edmund Jessop, Medical\nAdviser, National Specialist,\nCommissioning Advisory Group\n(NSCAG), Department of\nHealth, London\nProfessor Jon Nicholl, Director,\nMedical Care Research Unit,\nUniversity of Sheffield, \nSchool of Health and \nRelated Research\nDr Ron Zimmern, Director,\nPublic Health Genetics Unit,\nStrangeways Research\nLaboratories, Cambridge\nDirector, \nProfessor Tom Walley, \nDirector, NHS HTA Programme,\nDepartment of Pharmacology &\nTherapeutics,\nUniversity of Liverpool\nDeputy Director, \nProfessor Jon Nicholl,\nDirector, Medical Care Research\nUnit, University of Sheffield,\nSchool of Health and Related\nResearch\nHTA Commissioning Board\nMembers\nProgramme Director, \nProfessor Tom Walley, \nDirector, NHS HTA Programme,\nDepartment of Pharmacology &\nTherapeutics,\nUniversity of Liverpool\nChair,\nProfessor Jon Nicholl,\nDirector, Medical Care Research\nUnit, University of Sheffield,\nSchool of Health and Related\nResearch\nDeputy Chair, \nDr Andrew Farmer, \nUniversity Lecturer in General\nPractice, Department of \nPrimary Health Care, \nUniversity of Oxford\nDr Jeffrey Aronson,\nReader in Clinical\nPharmacology, Department of\nClinical Pharmacology,\nRadcliffe Infirmary, Oxford\nProfessor Deborah Ashby,\nProfessor of Medical Statistics,\nDepartment of Environmental\nand Preventative Medicine,\nQueen Mary University of\nLondon\nProfessor Ann Bowling,\nProfessor of Health Services\nResearch, Primary Care and\nPopulation Studies,\nUniversity College London\nProfessor John Cairns, \nProfessor of Health Economics,\nPublic Health Policy, \nLondon School of Hygiene \nand Tropical Medicine, \nLondon\nProfessor Nicky Cullum,\nDirector of Centre for Evidence\nBased Nursing, Department of\nHealth Sciences, University of\nYork\nProfessor Jon Deeks, \nProfessor of Health Statistics,\nUniversity of Birmingham\nProfessor Jenny Donovan,\nProfessor of Social Medicine,\nDepartment of Social Medicine,\nUniversity of Bristol\nProfessor Freddie Hamdy,\nProfessor of Urology, \nUniversity of Sheffield\nProfessor Allan House, \nProfessor of Liaison Psychiatry,\nUniversity of Leeds\nProfessor Sallie Lamb, Director,\nWarwick Clinical Trials Unit,\nUniversity of Warwick\nProfessor Stuart Logan,\nDirector of Health & Social\nCare Research, The Peninsula\nMedical School, Universities of\nExeter & Plymouth\nProfessor Miranda Mugford,\nProfessor of Health Economics,\nUniversity of East Anglia\nDr Linda Patterson, \nConsultant Physician,\nDepartment of Medicine,\nBurnley General Hospital\nProfessor Ian Roberts, \nProfessor of Epidemiology &\nPublic Health, Intervention\nResearch Unit, London School\nof Hygiene and Tropical\nMedicine\nProfessor Mark Sculpher,\nProfessor of Health Economics,\nCentre for Health Economics,\nInstitute for Research in the\nSocial Services, \nUniversity of York\nProfessor Kate Thomas,\nProfessor of Complementary\nand Alternative Medicine,\nUniversity of Leeds\nProfessor David John Torgerson,\nDirector of York Trial Unit,\nDepartment of Health Sciences,\nUniversity of York\nProfessor Hywel Williams,\nProfessor of \nDermato-Epidemiology,\nUniversity of Nottingham\nCurrent and past membership details of all HTA \u2018committees\u2019 are available from the HTA website (www.hta.ac.uk)\n\u00a9 Queen\u2019s Printer and Controller of HMSO 2008. All rights reserved.Health Technology Assessment Programme\n242\nDiagnostic Technologies & Screening Panel\nMembers\nChair,\nDr Ron Zimmern, Director of\nthe Public Health Genetics Unit,\nStrangeways Research\nLaboratories, Cambridge\nMs Norma Armston,\nFreelance Consumer Advocate,\nBolton\nProfessor Max Bachmann,\nProfessor of Health Care\nInterfaces, Department of\nHealth Policy and Practice,\nUniversity of East Anglia\nProfessor Rudy Bilous\nProfessor of Clinical Medicine &\nConsultant Physician,\nThe Academic Centre,\nSouth Tees Hospitals NHS Trust\nMs Dea Birkett, Service User\nRepresentative, London\nDr Paul Cockcroft, Consultant\nMedical Microbiologist and\nClinical Director of Pathology,\nDepartment of Clinical\nMicrobiology, St Mary's\nHospital, Portsmouth\nProfessor Adrian K Dixon,\nProfessor of Radiology,\nUniversity Department of\nRadiology, University of\nCambridge Clinical School\nDr David Elliman, Consultant in\nCommunity Child Health,\nIslington PCT & Great Ormond\nStreet Hospital, London \nProfessor Glyn Elwyn, \nResearch Chair, Centre for\nHealth Sciences Research,\nCardiff University, Department\nof General Practice, Cardiff\nProfessor Paul Glasziou,\nDirector, Centre for \nEvidence-Based Practice,\nUniversity of Oxford\nDr Jennifer J Kurinczuk,\nConsultant Clinical\nEpidemiologist, National\nPerinatal Epidemiology Unit,\nOxford\nDr Susanne M Ludgate, \nClinical Director, Medicines &\nHealthcare Products Regulatory\nAgency, London\nMr Stephen Pilling, Director,\nCentre for Outcomes, \nResearch & Effectiveness, \nJoint Director, National\nCollaborating Centre for Mental\nHealth, University College\nLondon\nMrs Una Rennard, \nService User Representative,\nOxford\nDr Phil Shackley, Senior\nLecturer in Health Economics,\nAcademic Vascular Unit,\nUniversity of Sheffield\nDr Margaret Somerville,\nDirector of Public Health\nLearning, Peninsula Medical\nSchool, University of Plymouth\nDr Graham Taylor, Scientific\nDirector & Senior Lecturer,\nRegional DNA Laboratory, The\nLeeds Teaching Hospitals\nProfessor Lindsay Wilson\nTurnbull, Scientific Director,\nCentre for MR Investigations &\nYCR Professor of Radiology,\nUniversity of Hull\nProfessor Martin J Whittle,\nClinical Co-director, National\nCo-ordinating Centre for\nWomen\u2019s and Childhealth \nDr Dennis Wright, \nConsultant Biochemist &\nClinical Director, \nThe North West London\nHospitals NHS Trust, \nMiddlesex\nPharmaceuticals Panel\nMembers\nChair,\nProfessor Robin Ferner,\nConsultant Physician and\nDirector, West Midlands Centre\nfor Adverse Drug Reactions, \nCity Hospital NHS Trust,\nBirmingham\nMs Anne Baileff, Consultant\nNurse in First Contact Care,\nSouthampton City Primary Care\nTrust, University of\nSouthampton\nProfessor Imti Choonara,\nProfessor in Child Health,\nAcademic Division of Child\nHealth, University of\nNottingham\nProfessor John Geddes,\nProfessor of Epidemiological\nPsychiatry, University of \nOxford\nMrs Barbara Greggains, \nNon-Executive Director,\nGreggains Management Ltd\nDr Bill Gutteridge, Medical\nAdviser, National Specialist\nCommissioning Advisory Group\n(NSCAG), London\nMrs Sharon Hart, \nConsultant Pharmaceutical\nAdviser, Reading\nDr Jonathan Karnon, Senior\nResearch Fellow, Health\nEconomics and Decision\nScience, University of Sheffield\nDr Yoon Loke, Senior Lecturer\nin Clinical Pharmacology,\nUniversity of East Anglia\nMs Barbara Meredith,\nLay Member, Epsom \nDr Andrew Prentice, Senior\nLecturer and Consultant\nObstetrician & Gynaecologist,\nDepartment of Obstetrics &\nGynaecology, University of\nCambridge \nDr Frances Rotblat, CPMP\nDelegate, Medicines &\nHealthcare Products Regulatory\nAgency, London\nDr Martin Shelly, \nGeneral Practitioner, \nLeeds\nMrs Katrina Simister, Assistant\nDirector New Medicines,\nNational Prescribing Centre,\nLiverpool\nDr Richard Tiner, Medical\nDirector, Medical Department,\nAssociation of the British\nPharmaceutical Industry,\nLondon\nCurrent and past membership details of all HTA \u2018committees\u2019 are available from the HTA website (www.hta.ac.uk)Health Technology Assessment 2008; Vol. 12: No. 26\n243\nTherapeutic Procedures Panel\nMembers\nChair, \nProfessor Bruce Campbell,\nConsultant Vascular and\nGeneral Surgeon, Department\nof Surgery, Royal Devon &\nExeter Hospital\nDr Mahmood Adil, Deputy\nRegional Director of Public\nHealth, Department of Health,\nManchester\nDr Aileen Clarke,\nConsultant in Public Health,\nPublic Health Resource Unit,\nOxford\nProfessor Matthew Cooke,\nProfessor of Emergency\nMedicine, Warwick Emergency\nCare and Rehabilitation,\nUniversity of Warwick\nMr Mark Emberton, Senior\nLecturer in Oncological\nUrology, Institute of Urology,\nUniversity College Hospital\nProfessor Paul Gregg,\nProfessor of Orthopaedic\nSurgical Science, Department of\nGeneral Practice and Primary\nCare, South Tees Hospital NHS\nTrust, Middlesbrough\nMs Maryann L Hardy, \nLecturer, Division of\nRadiography, University of\nBradford\nDr Simon de Lusignan,\nSenior Lecturer, Primary Care\nInformatics, Department of\nCommunity Health Sciences,\nSt George\u2019s Hospital Medical\nSchool, London\nDr Peter Martin, Consultant\nNeurologist, Addenbrooke\u2019s\nHospital, Cambridge\nProfessor Neil McIntosh,\nEdward Clark Professor of Child\nLife & Health, Department of\nChild Life & Health, University\nof Edinburgh\nProfessor Jim Neilson,\nProfessor of Obstetrics and\nGynaecology, Department of\nObstetrics and Gynaecology,\nUniversity of Liverpool\nDr John C Pounsford,\nConsultant Physician,\nDirectorate of Medical Services,\nNorth Bristol NHS Trust\nDr Karen Roberts, Nurse\nConsultant, Queen Elizabeth\nHospital, Gateshead\nDr Vimal Sharma, Consultant\nPsychiatrist\/Hon. Senior \nLecturer, Mental Health\nResource Centre, Cheshire and\nWirral Partnership NHS Trust,\nWallasey \nProfessor Scott Weich, \nProfessor of Psychiatry, \nDivision of Health in the\nCommunity, University of\nWarwick\nDisease Prevention Panel\nMembers\nChair, \nDr Edmund Jessop, Medical\nAdviser, National Specialist\nCommissioning Advisory Group\n(NSCAG), London\nMrs Sheila Clark, Chief\nExecutive, St James\u2019s Hospital,\nPortsmouth\nMr Richard Copeland, \nLead Pharmacist: Clinical\nEconomy\/Interface, \nWansbeck General Hospital,\nNorthumberland\nDr Elizabeth Fellow-Smith,\nMedical Director, \nWest London Mental Health\nTrust, Middlesex\nMr Ian Flack, Director PPI\nForum Support, Council of\nEthnic Minority Voluntary\nSector Organisations, \nStratford\nDr John Jackson, \nGeneral Practitioner, \nNewcastle upon Tyne\nMrs Veronica James, Chief\nOfficer, Horsham District Age\nConcern, Horsham\nProfessor Mike Kelly, \nDirector, Centre for Public\nHealth Excellence, \nNational Institute for Health\nand Clinical Excellence, \nLondon\nProfessor Yi Mien Koh, \nDirector of Public Health and\nMedical Director, London \nNHS (North West London\nStrategic Health Authority),\nLondon\nMs Jeanett Martin, \nDirector of Clinical Leadership\n& Quality, Lewisham PCT,\nLondon\nDr Chris McCall, General\nPractitioner, Dorset\nDr David Pencheon, Director,\nEastern Region Public Health\nObservatory, Cambridge\nDr Ken Stein, Senior Clinical\nLecturer in Public Health,\nDirector, Peninsula Technology\nAssessment Group, \nUniversity of Exeter, \nExeter\nDr Carol Tannahill, Director,\nGlasgow Centre for Population\nHealth, Glasgow\nProfessor Margaret Thorogood,\nProfessor of Epidemiology,\nUniversity of Warwick, \nCoventry\nDr Ewan Wilkinson, \nConsultant in Public Health,\nRoyal Liverpool University\nHospital, Liverpool\nCurrent and past membership details of all HTA \u2018committees\u2019 are available from the HTA website (www.hta.ac.uk)Health Technology Assessment Programme\n244\nCurrent and past membership details of all HTA \u2018committees\u2019 are available from the HTA website (www.hta.ac.uk)\nExpert Advisory Network\nMembers\nProfessor Douglas Altman,\nProfessor of Statistics in\nMedicine, Centre for Statistics\nin Medicine, University of\nOxford\nProfessor John Bond,\nDirector, Centre for Health\nServices Research, University of\nNewcastle upon Tyne, School of\nPopulation & Health Sciences,\nNewcastle upon Tyne\nProfessor Andrew Bradbury,\nProfessor of Vascular Surgery,\nSolihull Hospital, Birmingham\nMr Shaun Brogan, \nChief Executive, Ridgeway\nPrimary Care Group, Aylesbury\nMrs Stella Burnside OBE,\nChief Executive, \nRegulation and Improvement\nAuthority, Belfast\nMs Tracy Bury, \nProject Manager, World\nConfederation for Physical\nTherapy, London\nProfessor Iain T Cameron,\nProfessor of Obstetrics and\nGynaecology and Head of the\nSchool of Medicine,\nUniversity of Southampton\nDr Christine Clark,\nMedical Writer & Consultant\nPharmacist, Rossendale\nProfessor Collette Clifford,\nProfessor of Nursing & Head of\nResearch, School of Health\nSciences, University of\nBirmingham, Edgbaston,\nBirmingham\nProfessor Barry Cookson,\nDirector, Laboratory of\nHealthcare Associated Infection,\nHealth Protection Agency,\nLondon\nDr Carl Counsell, Clinical\nSenior Lecturer in Neurology,\nDepartment of Medicine &\nTherapeutics, University of\nAberdeen\nProfessor Howard Cuckle,\nProfessor of Reproductive\nEpidemiology, Department of\nPaediatrics, Obstetrics &\nGynaecology, University of\nLeeds\nDr Katherine Darton, \nInformation Unit, MIND \u2013 \nThe Mental Health Charity,\nLondon\nProfessor Carol Dezateux, \nProfessor of Paediatric\nEpidemiology, London\nDr Keith Dodd, Consultant\nPaediatrician, Derby\nMr John Dunning,\nConsultant Cardiothoracic\nSurgeon, Cardiothoracic\nSurgical Unit, Papworth\nHospital NHS Trust, Cambridge\nMr Jonothan Earnshaw,\nConsultant Vascular Surgeon,\nGloucestershire Royal Hospital,\nGloucester\nProfessor Martin Eccles, \nProfessor of Clinical\nEffectiveness, Centre for Health\nServices Research, University of\nNewcastle upon Tyne\nProfessor Pam Enderby,\nProfessor of Community\nRehabilitation, Institute of\nGeneral Practice and Primary\nCare, University of Sheffield\nProfessor Gene Feder, Professor\nof Primary Care Research &\nDevelopment, Centre for Health\nSciences, Barts & The London\nQueen Mary\u2019s School of\nMedicine & Dentistry, London\nMr Leonard R Fenwick, \nChief Executive, Newcastle\nupon Tyne Hospitals NHS Trust\nMrs Gillian Fletcher, \nAntenatal Teacher & Tutor and\nPresident, National Childbirth\nTrust, Henfield\nProfessor Jayne Franklyn,\nProfessor of Medicine,\nDepartment of Medicine,\nUniversity of Birmingham,\nQueen Elizabeth Hospital,\nEdgbaston, Birmingham\nDr Neville Goodman, \nConsultant Anaesthetist,\nSouthmead Hospital, Bristol\nProfessor Robert E Hawkins, \nCRC Professor and Director of\nMedical Oncology, Christie CRC\nResearch Centre, Christie\nHospital NHS Trust, Manchester\nProfessor Allen Hutchinson, \nDirector of Public Health &\nDeputy Dean of ScHARR,\nDepartment of Public Health,\nUniversity of Sheffield\nProfessor Peter Jones, Professor\nof Psychiatry, University of\nCambridge, Cambridge\nProfessor Stan Kaye, Cancer\nResearch UK Professor of\nMedical Oncology, Section of\nMedicine, Royal Marsden\nHospital & Institute of Cancer\nResearch, Surrey\nDr Duncan Keeley,\nGeneral Practitioner (Dr Burch\n& Ptnrs), The Health Centre,\nThame\nDr Donna Lamping,\nResearch Degrees Programme\nDirector & Reader in Psychology,\nHealth Services Research Unit,\nLondon School of Hygiene and\nTropical Medicine, London\nMr George Levvy,\nChief Executive, Motor \nNeurone Disease Association,\nNorthampton\nProfessor James Lindesay,\nProfessor of Psychiatry for the\nElderly, University of Leicester,\nLeicester General Hospital\nProfessor Julian Little,\nProfessor of Human Genome\nEpidemiology, Department of\nEpidemiology & Community\nMedicine, University of Ottawa\nProfessor Rajan Madhok, \nConsultant in Public Health,\nSouth Manchester Primary \nCare Trust, Manchester\nProfessor Alexander Markham, \nDirector, Molecular Medicine\nUnit, St James\u2019s University\nHospital, Leeds\nProfessor Alistaire McGuire,\nProfessor of Health Economics,\nLondon School of Economics\nDr Peter Moore, \nFreelance Science Writer, Ashtead\nDr Andrew Mortimore, Public\nHealth Director, Southampton\nCity Primary Care Trust,\nSouthampton\nDr Sue Moss, Associate Director,\nCancer Screening Evaluation\nUnit, Institute of Cancer\nResearch, Sutton\nMrs Julietta Patnick, \nDirector, NHS Cancer Screening\nProgrammes, Sheffield\nProfessor Robert Peveler,\nProfessor of Liaison Psychiatry,\nRoyal South Hants Hospital,\nSouthampton\nProfessor Chris Price, \nVisiting Professor in Clinical\nBiochemistry, University of\nOxford\nProfessor William Rosenberg,\nProfessor of Hepatology and\nConsultant Physician, University\nof Southampton, Southampton\nProfessor Peter Sandercock,\nProfessor of Medical Neurology,\nDepartment of Clinical\nNeurosciences, University of\nEdinburgh\nDr Susan Schonfield, Consultant\nin Public Health, Hillingdon\nPCT, Middlesex\nDr Eamonn Sheridan,\nConsultant in Clinical Genetics,\nGenetics Department,\nSt James\u2019s University Hospital,\nLeeds\nProfessor Sarah Stewart-Brown, \nProfessor of Public Health,\nUniversity of Warwick, \nDivision of Health in the\nCommunity Warwick Medical\nSchool, LWMS, Coventry\nProfessor Ala Szczepura, \nProfessor of Health Service\nResearch, Centre for Health\nServices Studies, University of\nWarwick\nDr Ross Taylor, \nSenior Lecturer, Department of\nGeneral Practice and Primary\nCare, University of Aberdeen\nMrs Joan Webster, \nConsumer member, HTA \u2013\nExpert Advisory NetworkHow to obtain copies of this and other HTA Programme reports.\nAn electronic version of this publication, in Adobe Acrobat format, is available for downloading free of\ncharge for personal use from the HTA website (http:\/\/www.hta.ac.uk). A fully searchable CD-ROM is\nalso available (see below). \nPrinted copies of HTA monographs cost \u00a320 each (post and packing free in the UK) to both public and\nprivate sector purchasers from our Despatch Agents.\nNon-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is\n\u00a32 per monograph and for the rest of the world \u00a33 per monograph.\nYou can order HTA monographs from our Despatch Agents:\n\u2013 fax (with credit card or of\ufb01cial purchase order) \n\u2013 post (with credit card or of\ufb01cial purchase order or cheque)\n\u2013 phone during of\ufb01ce hours (credit card only).\nAdditionally the HTA website allows you either to pay securely by credit card or to print out your\norder and then post or fax it.\nContact details are as follows:\nHTA Despatch Email: orders@hta.ac.uk\nc\/o Direct Mail Works Ltd Tel: 02392 492 000\n4 Oakwood Business Centre Fax: 02392 478 555\nDownley, HAVANT PO9 2NP , UK Fax from outside the UK: +44 2392 478 555\nNHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of \n\u00a3100 for each volume (normally comprising 30\u201340 titles). The commercial subscription rate is \u00a3300 \nper volume. Please see our website for details. Subscriptions can only be purchased for the current or\nforthcoming volume.\nPayment methods\nPaying by cheque\nIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd\nand drawn on a bank with a UK address.\nPaying by credit card\nThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard,\nMastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email.\nPaying by of\ufb01cial purchase order\nYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK.\nWe cannot at present accept purchase orders from commercial companies or from outside the UK.\nHow do I get a copy of HTA on CD?\nPlease use the form on the HTA website (www.hta.ac.uk\/htacd.htm). Or contact Direct Mail Works (see\ncontact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.\nThe website also provides information about the HTA Programme and lists the membership of the various\ncommittees.\nHTAA systematic review of the clinical\neffectiveness and cost-effectiveness and\neconomic modelling of minimal incision\ntotal hip replacement approaches \nin the management of arthritic \ndisease of the hip\nR de Verteuil, M Imamura, S Zhu, \nC Glazener, C Fraser, N Munro, J Hutchison, \nA Grant, D Coyle, K Coyle and L Vale\nHealth Technology Assessment 2008; Vol. 12: No. 26\nHTA\nHealth Technology Assessment\nNHS R&D HTA Programme\nwww.hta.ac.uk\nThe National Coordinating Centre for Health Technology Assessment,\nAlpha House, Enterprise Road\nSouthampton Science Park\nChilworth\nSouthampton SO16 7NS, UK.\nFax: +44 (0) 23 8059 5639 Email: hta@hta.ac.uk\nhttp:\/\/www.hta.ac.uk ISSN 1366-5278\nFeedback\nThe HTA Programme and the authors would like to know \nyour views about this report.\nThe Correspondence Page on the HTA website\n(http:\/\/www.hta.ac.uk) is a convenient way to publish \nyour comments. If you prefer, you can send your comments \nto the address below, telling us whether you would like \nus to transfer them to the website.\nWe look forward to hearing from you.\nJune 2008\nH\ne\na\nl\nt\nh\n \nT\ne\nc\nh\nn\no\nl\no\ng\ny\n \nA\ns\ns\ne\ns\ns\nm\ne\nn\nt\n \n2\n0\n0\n8\n;\nV\no\nl\n.\n \n1\n2\n:\n \nN\no\n.\n \n2\n6\nT\no\nt\na\nl\n \nh\ni\np\n \nr\ne\np\nl\na\nc\ne\nm\ne\nn\nt\n \na\np\np\nr\no\na\nc\nh\ne\ns\n \ni\nn\n \nt\nh\ne\n \nm\na\nn\na\ng\ne\nm\ne\nn\nt\n \no\nf\n \na\nr\nt\nh\nr\ni\nt\ni\nc\n \nd\ni\ns\ne\na\ns\ne\n \no\nf\n \nt\nh\ne\n \nh\ni\np"}